data_1xoy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xoy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 9' ' ' ILE . 2.0 mp . . . . . 0 N--CA 1.399 -2.978 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.64 -166.55 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -104.55 109.17 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.414 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.14 -41.69 0.89 Allowed Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -137.8 142.58 40.84 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.449 -0.876 . . . . 0.0 111.214 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -106.52 156.4 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.8 143.97 43.74 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.632 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.6 mp -102.82 7.18 39.52 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.653 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.52 -43.24 85.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.66 -16.67 60.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.662 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.39 -2.85 57.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 16' ' ' LEU . 94.9 mt -74.66 145.38 11.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.6 -42.54 70.84 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 122.751 0.421 . . . . 0.0 111.097 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 72.44 -33.97 0.28 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -79.11 -37.14 39.43 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.832 0.348 . . . . 0.0 110.871 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 17.68 55.28 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.48 -0.867 . . . . 0.0 114.011 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.61 143.64 14.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 117.487 0.643 . . . . 0.0 109.793 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -141.2 134.93 30.22 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.858 0.361 . . . . 0.0 110.395 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 81.2 m -135.72 121.86 20.22 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.045 0.45 . . . . 0.0 111.104 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.44 5.94 21.96 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.832 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 57' ' ' ASP . 50.3 t-20 -151.64 -67.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 4.0 pt20 50.98 25.22 2.14 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 125.342 1.457 . . . . 0.0 112.653 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.2 m 78.89 112.91 0.07 Allowed 'General case' 0 C--O 1.208 -1.095 0 C-N-CA 125.08 1.352 . . . . 0.0 108.616 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -52.58 -25.27 10.09 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -112.86 -1.89 14.49 Favored 'General case' 0 CA--C 1.562 1.43 0 O-C-N 121.847 -0.533 . . . . 0.0 112.349 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -126.34 166.56 16.93 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.0 m -105.82 166.26 10.6 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.011 -0.431 . . . . 0.0 111.78 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 3.1 tm? -64.92 -50.09 64.66 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 3.0 Cg_endo -46.03 -29.35 6.13 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 123.85 3.033 . . . . 0.0 114.066 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 50' ' ' LEU . 3.2 m-20 -44.47 -48.96 10.07 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.872 1.669 . . . . 0.0 113.375 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -111.19 -7.9 14.42 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.116 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.4 tp -104.23 -42.81 5.4 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.903 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -84.28 103.88 13.84 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 19.9 mm-40 -59.19 127.03 30.11 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.683 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.26 -42.41 1.38 Allowed Glycine 1 N--CA 1.388 -4.559 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.197 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.6 -9.36 44.4 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.144 1.777 . . . . 0.0 115.747 -174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.51 104.33 16.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.734 -0.604 . . . . 0.0 111.503 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 18.1 t70 -70.93 85.58 0.69 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.352 0.596 . . . . 0.0 110.756 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 5.8 mm-40 -167.78 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 127.6 2.36 . . . . 0.0 106.307 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.02 -54.92 0.89 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.913 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 1.4 pt? -140.27 137.8 34.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.43 165.74 34.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 tp -99.1 128.87 45.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.4 171.05 14.59 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-O 121.723 0.773 . . . . 0.0 112.967 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 71.9 p -96.93 111.47 23.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.33 -50.44 59.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.168 0.508 . . . . 0.0 110.1 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.1 -41.87 0.65 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.128 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 54' ' ' SER . 3.8 m-20 -85.73 112.85 21.44 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.696 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -70.57 -26.82 63.71 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.815 0.697 . . . . 0.0 110.046 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -84.15 113.75 21.29 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.854 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.3 mt -116.4 134.6 54.69 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.404 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.44 114.91 22.5 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.12 124.19 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.418 ' HD1' ' OG1' ' A' ' 137' ' ' THR . 69.4 t80 -104.0 123.71 47.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.14 116.36 31.17 Favored Pre-proline 0 N--CA 1.437 -1.109 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.527 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -90.01 153.05 4.84 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.158 1.905 . . . . 0.0 109.794 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -112.2 162.42 15.48 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.141 0.496 . . . . 0.0 112.195 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -87.98 -22.69 24.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.64 156.68 47.78 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.72 114.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.839 0.828 . . . . 0.0 111.008 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.74 172.96 14.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.164 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HG3' ' OXT' ' A' ' 161' ' ' THR . 56.4 mttp -106.44 129.88 54.34 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.301 0.501 . . . . 0.0 109.915 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.499 HD11 HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -77.13 126.14 30.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -116.03 -38.64 3.59 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.727 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.6 p -147.88 154.11 39.97 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.501 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -130.4 154.98 47.14 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.564 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -143.57 110.25 5.55 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.563 0.345 . . . . 0.0 110.643 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -122.27 134.5 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.603 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 53.5 mtpt -129.19 153.58 47.6 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.311 0.577 . . . . 0.0 112.256 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.39 -166.16 29.75 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -71.42 158.04 55.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 122.215 1.943 . . . . 0.0 109.657 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.43 -37.27 86.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.35 -33.61 22.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.12 13.98 33.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.237 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.42 147.61 25.76 Favored Glycine 0 C--N 1.301 -1.406 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.583 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 6.0 Cg_exo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.49 2.127 . . . . 0.0 111.908 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 3.7 tmmm? -95.29 -48.06 6.06 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.729 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -85.8 95.02 9.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.443 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.42 119.03 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.399 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.98 148.21 41.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -132.58 155.21 49.09 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.642 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 52.3 p90 -152.29 118.96 5.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.587 0.708 . . . . 0.0 110.673 168.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.2 t -103.53 175.93 5.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.251 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 m120 66.12 23.27 11.02 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.423 0.689 . . . . 0.0 111.615 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HA ' ' HZ1' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -148.25 107.27 3.86 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.184 0.516 . . . . 0.0 109.971 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.96 122.07 30.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.4 m80 71.01 107.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.441 ' HB3' ' CE2' ' A' ' 91' ' ' PHE . 51.2 ttm -161.48 128.55 4.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.452 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -90.2 162.62 15.16 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.512 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 50.5 p90 -61.8 -18.5 60.15 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -173.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.8 t -60.87 -36.13 78.41 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.99 0.424 . . . . 0.0 110.315 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 41.8 m-80 -89.39 -25.07 21.75 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.835 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 40.3 t -62.89 -13.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.263 1.03 . . . . 0.0 110.323 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.23 -20.53 28.36 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.786 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.06 -23.77 13.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.516 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -96.6 133.19 24.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.585 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.45 126.67 16.62 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.364 2.043 . . . . 0.0 110.657 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.52 161.5 34.89 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 122.566 2.177 . . . . 0.0 111.253 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.642 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 39.6 m -63.34 -45.42 91.31 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.463 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 17.7 t70 -158.88 153.78 24.94 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -126.87 115.28 19.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.29 165.08 12.05 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.573 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 8.9 mp0 -123.77 138.25 54.54 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.4 tp -72.64 107.77 5.3 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.5 p -82.16 160.96 22.96 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.15 -30.73 71.25 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.846 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.22 -32.52 66.82 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.693 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.564 HD22 ' HA ' ' A' ' 76' ' ' ALA . 1.6 t-20 -66.4 -36.89 83.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.603 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 2.6 tm? -64.05 -8.0 10.45 Favored 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 126.786 2.035 . . . . 0.0 110.387 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 90.8 mttt -110.94 -6.85 14.62 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.541 0.736 . . . . 0.0 109.498 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 78' ' ' LYS . . . 99.06 30.92 6.45 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.811 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -102.37 121.59 49.53 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.523 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.08 112.84 1.34 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.272 2.648 . . . . 0.0 111.458 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 132.52 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.08 136.61 22.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.524 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.499 HD13 HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -115.4 -172.84 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.491 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.463 ' HG2' ' OD1' ' A' ' 109' ' ' ASP . 72.5 mmtt -70.57 89.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -68.5 -21.95 64.57 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.787 1.235 . . . . 0.0 110.52 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.71 -24.89 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.443 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -94.57 -36.21 11.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.346 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -79.08 93.25 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.264 0.554 . . . . 0.0 110.778 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -114.6 -41.06 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -121.95 115.64 22.92 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.887 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.72 102.37 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.973 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -104.17 -24.08 13.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 168.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.3 p -138.74 144.24 39.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.852 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.8 tp -147.27 121.1 9.28 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.418 ' OG1' ' HD1' ' A' ' 63' ' ' TYR . 23.2 m -105.74 132.11 52.26 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.857 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -105.15 117.75 51.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -117.86 107.23 13.85 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.52 0.676 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' ' 60' ' ' LEU . 11.3 pt -107.1 114.06 45.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.463 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.43 -23.0 12.91 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.28 152.0 44.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.812 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.449 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 31.7 p30 -108.92 170.08 8.27 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.981 -178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 21.0 tp60 -48.32 -60.03 2.98 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.917 1.687 . . . . 0.0 113.799 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.8 m -104.0 7.82 36.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.439 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.36 46.12 94.53 Favored Glycine 0 C--O 1.224 -0.509 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 m -90.5 10.8 23.89 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.21 0.604 . . . . 0.0 112.342 -171.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 43.9 mt-10 69.85 -45.83 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.147 0.979 . . . . 0.0 112.802 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.52 137.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.119 0.485 . . . . 0.0 109.844 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.5 m -120.33 138.31 53.79 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -131.1 135.42 47.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.6 125.77 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -86.9 -48.81 7.85 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -153.8 143.17 21.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -177.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.3 mt -121.86 132.3 71.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.44 134.09 26.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -113.56 135.81 53.5 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -120.01 133.13 55.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.381 0.61 . . . . 0.0 109.908 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -128.87 178.63 17.14 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.5 m -128.82 25.94 5.59 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 117.151 0.476 . . . . 0.0 112.266 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.597 ' OXT' ' HG3' ' A' ' 71' ' ' LYS . 63.8 p . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 11' ' ' LYS . 3.2 mp . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -95.02 29.22 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.552 2.834 . . . . 0.0 110.95 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 9' ' ' ILE . 41.0 ttmt 68.44 106.25 0.05 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.281 1.433 . . . . 0.0 112.16 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.32 -79.84 0.2 Allowed Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.11 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 26.8 mm-40 -109.84 -173.82 2.35 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.57 152.5 8.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 3.1 p30 -74.62 138.95 43.29 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.197 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.511 ' O ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -78.78 -13.26 59.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.441 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 4.6 tt -59.79 -43.5 94.39 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.174 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -24.72 62.58 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -90.29 14.74 11.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.322 0.582 . . . . 0.0 111.34 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 16' ' ' LEU . 67.3 mt -100.48 134.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.32 -26.04 51.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.738 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 74.09 2.75 4.25 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -88.63 -28.13 20.85 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.946 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.21 23.15 7.74 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 119.33 -1.414 . . . . 0.0 114.515 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.63 133.44 31.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 117.564 0.682 . . . . 0.0 110.838 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.06 154.93 46.19 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.217 -0.302 . . . . 0.0 110.809 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB3' HE21 ' A' ' 30' ' ' GLN . 47.2 t -136.21 141.11 43.97 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.911 0.485 . . . . 0.0 109.836 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.549 HD12 ' CZ ' ' A' ' 99' ' ' PHE . 5.7 tt -52.71 -61.48 2.26 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.885 1.274 . . . . 0.0 110.928 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.442 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 28.2 t-20 -95.11 -88.8 0.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.613 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 27' ' ' CYS . 7.8 tt0 55.47 17.88 2.41 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.503 1.144 . . . . 0.0 109.426 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -81.54 -23.5 37.18 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.233 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 34' ' ' HIS . 44.7 t -55.37 -4.75 0.1 Allowed 'General case' 0 CA--C 1.578 2.022 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.976 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 m 80.11 -17.16 0.6 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.35 1.46 . . . . 0.0 110.158 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.795 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 12.7 m170 -71.39 110.82 6.25 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -95.23 164.4 12.87 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -164.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.416 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 5.4 tt -63.73 -50.51 71.11 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.417 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 85.2 Cg_exo -53.67 -27.01 40.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.964 1.776 . . . . 0.0 112.835 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.472 ' ND2' HD22 ' A' ' 50' ' ' LEU . 13.4 m120 -59.61 -48.18 82.66 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-O 120.995 0.426 . . . . 0.0 110.338 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HA ' ' NE ' ' A' ' 45' ' ' ARG . . . -102.88 -0.35 31.31 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 44.2 tp -132.34 5.64 4.1 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 119.431 -0.907 . . . . 0.0 113.024 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -121.97 143.72 49.3 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 121.222 -0.924 . . . . 0.0 111.574 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.62 152.13 36.02 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.511 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.85 -52.27 4.69 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.58 -9.61 59.77 Favored 'General case' 0 C--O 1.194 -1.851 0 C-N-CA 123.017 0.527 . . . . 0.0 111.059 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' HA ' ' NE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -75.07 -91.83 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.329 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' H ' ' HB3' ' A' ' 45' ' ' ARG 0.311 9.3 pt-20 39.39 84.73 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.883 0.849 . . . . 0.0 113.061 -174.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.338 5.6 p-10 -67.24 85.68 0.15 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -169.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 169.91 103.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 107.31 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.32 -99.5 0.44 Allowed Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.472 HD22 ' ND2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -77.67 147.19 35.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.795 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.8 p30 -164.59 169.36 17.13 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.406 HD21 ' C ' ' A' ' 52' ' ' LEU . 7.2 tt -105.47 121.87 44.83 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.065 -1.454 . . . . 0.0 108.626 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.33 159.68 41.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.652 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 25.1 p -85.91 177.21 7.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.528 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.7 -64.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.05 68.4 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.652 ' O ' ' HB2' ' A' ' 54' ' ' SER . 8.5 t70 -131.64 174.44 10.11 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -109.61 -24.58 10.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 141' ' ' GLU . 87.8 mm-40 -84.28 139.46 32.31 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.588 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 29' ' ' ASN . 47.2 mt -135.64 122.39 21.02 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 122.12 0.962 . . . . 0.0 112.725 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.9 tt -130.42 120.96 25.02 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.13 123.02 66.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -101.38 123.43 45.44 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.18 113.91 32.32 Favored Pre-proline 0 N--CA 1.441 -0.887 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -89.18 139.23 3.55 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.862 2.374 . . . . 0.0 111.051 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.16 163.33 17.91 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.252 35.9 t-20 -104.44 -38.59 6.75 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 111.993 -2.367 . . . . 0.0 106.355 170.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -153.44 144.76 23.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 m -75.09 128.09 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.189 0.519 . . . . 0.0 111.114 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.34 173.21 11.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -97.37 117.93 32.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.97 123.72 25.65 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -106.19 -48.54 3.56 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.4 p -145.26 160.18 41.89 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -130.37 151.52 50.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.518 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' C ' HD12 ' A' ' 77' ' ' ILE . . . -148.99 116.69 6.24 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 mp -132.25 122.45 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -99.13 163.25 12.64 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.162 0.506 . . . . 0.0 110.344 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.05 -177.51 48.26 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -74.82 172.36 16.44 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.53 1.665 . . . . 0.0 108.306 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 -56.28 5.29 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.331 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.21 -55.25 26.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.115 0.959 . . . . 0.0 110.896 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -90.62 17.13 7.88 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.404 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.09 159.29 25.33 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 9.8 Cg_exo -72.54 107.26 2.26 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 119.417 1.608 . . . . 0.0 110.434 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 113' ' ' LEU . 12.6 tmtt? -83.34 -51.39 7.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.94 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.3 m -103.63 108.9 20.37 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.575 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.457 HG11 HG22 ' A' ' 140' ' ' ILE . 30.4 m -108.52 134.91 48.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.047 0.451 . . . . 0.0 111.321 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -121.69 134.26 54.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.31 138.85 47.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.495 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.3 m-85 -128.9 118.51 22.81 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.0 p -110.2 133.93 52.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.454 ' C ' ' HE3' ' A' ' 94' ' ' LYS . 86.4 m-20 76.37 -4.29 2.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.557 1.543 . . . . 0.0 114.991 173.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.548 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -88.35 104.43 16.76 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.56 150.11 31.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 72.1 99.63 0.07 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.275 1.03 . . . . 0.0 109.639 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 12.7 mmt -134.35 137.52 44.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.456 ' H ' ' HB2' ' A' ' 101' ' ' ASN . 32.0 p -159.17 -172.16 3.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.549 ' CZ ' HD12 ' A' ' 28' ' ' LEU . 92.7 m-85 -54.75 -44.57 73.71 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.301 0.501 . . . . 0.0 111.621 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 m -62.02 -20.61 64.11 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.482 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.3 m120 -93.67 -47.44 6.8 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.499 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.49 -20.13 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -93.2 -12.98 28.94 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.999 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -99.13 -37.57 9.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.892 0.377 . . . . 0.0 111.628 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -96.83 142.34 24.4 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.427 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.98 143.51 29.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 122.166 1.911 . . . . 0.0 111.293 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.14 163.8 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.413 2.075 . . . . 0.0 111.984 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -72.99 -44.8 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -169.35 171.95 7.5 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t -143.92 145.3 32.17 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.34 172.3 13.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.11 139.41 53.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.324 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 50.9 tp -60.5 112.68 2.07 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.923 0.764 . . . . 0.0 110.902 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.3 p -113.62 172.48 6.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.236 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.19 -24.69 67.35 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.728 0.775 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.31 -34.05 67.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.311 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.482 ' ND2' HG23 ' A' ' 123' ' ' VAL . 13.5 m120 -71.02 -45.42 63.95 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.269 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.35 -26.43 66.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.705 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.77 -13.75 55.71 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.228 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.88 41.41 23.23 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -95.5 134.96 23.52 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.12 109.94 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.782 1.655 . . . . 0.0 110.161 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.482 HG23 ' ND2' ' A' ' 117' ' ' ASN . 61.6 t -98.34 131.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.89 105.97 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.54 0.686 . . . . 0.0 111.458 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.61 -165.85 1.23 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.767 174.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -76.97 92.18 3.67 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.165 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.43 -27.55 66.14 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.615 1.566 . . . . 0.0 111.753 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.41 -16.04 16.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -80.82 -51.1 8.99 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.817 0.818 . . . . 0.0 110.149 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 90.33 6.63 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.178 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -98.91 -31.42 11.84 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.131 0.491 . . . . 0.0 110.272 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -149.39 119.55 7.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.395 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.09 112.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.742 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -92.65 -45.58 8.0 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -141.1 139.68 34.04 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.444 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.8 tp -131.69 125.31 31.77 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.233 0.54 . . . . 0.0 110.152 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 96.2 m -106.97 126.54 52.46 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.565 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.7 109.49 27.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 49.2 t80 -113.59 111.23 21.52 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.106 0.479 . . . . 0.0 110.646 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.457 HG22 HG11 ' A' ' 88' ' ' VAL . 30.9 pt -100.94 113.72 37.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 14.7 pt-20 -99.59 -12.94 19.65 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.643 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.76 142.32 10.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 118.99 -1.084 . . . . 0.0 113.385 -175.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.71 -173.76 2.47 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 170.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -60.49 -56.03 26.26 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.1 m -124.64 6.58 8.2 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.826 -169.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.82 60.9 3.48 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.2 m -83.07 17.34 2.0 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.898 0.879 . . . . 0.0 111.766 -174.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 78.51 -32.05 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 112.794 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.5 147.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 92.5 m -114.05 124.27 51.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.43 ' HE3' ' ND2' ' A' ' 51' ' ' ASN . 88.1 tttt -111.37 134.35 53.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 123.174 0.589 . . . . 0.0 110.071 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 44.5 t -125.23 126.12 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -97.42 -11.44 23.9 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 39.8 ttmt -170.15 130.45 0.95 Allowed 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.82 -0.55 . . . . 0.0 111.449 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.95 116.65 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.29 121.09 21.91 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 84.1 mt -117.45 144.62 44.84 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 88.0 m-85 -126.24 145.47 50.38 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.818 0.342 . . . . 0.0 111.629 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -148.46 -168.64 14.62 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.384 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.5 p -151.07 140.65 21.63 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 122.5 0.32 . . . . 0.0 110.504 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.631 176.265 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.3 mm . . . . . 0 N--CA 1.421 -1.904 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HG2' HE21 ' A' ' 13' ' ' GLN . 59.1 Cg_endo -95.56 -178.9 0.51 Allowed 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 122.432 2.088 . . . . 0.0 110.468 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -76.37 131.25 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.49 -51.55 0.83 Allowed Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.155 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.482 HE21 ' HG2' ' A' ' 10' ' ' PRO . 1.6 pm0 -130.84 172.15 12.35 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 159' ' ' GLY . 14.5 p -118.04 154.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.79 147.47 37.21 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 20' ' ' ILE . 66.4 mt -108.27 17.75 21.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.8 -43.47 75.56 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -83.06 -11.7 57.8 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.507 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.99 0.93 42.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.904 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 16' ' ' LEU . 70.9 mt -86.72 140.39 15.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.22 -28.9 31.68 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.544 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.586 ' CH2' HD11 ' A' ' 40' ' ' LEU . 98.9 m95 76.45 -4.37 2.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 t -102.89 -30.76 10.63 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.61 -0.39 66.98 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.706 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.4 m -64.83 139.2 21.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 117.146 0.473 . . . . 0.0 111.453 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.35 143.77 27.08 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.457 ' HB3' ' NE2' ' A' ' 30' ' ' GLN . 51.6 t -137.39 140.32 41.29 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.9 mm? -123.69 90.92 3.36 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.177 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 28' ' ' LEU . 10.7 t30 152.47 -17.29 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.963 1.305 . . . . 0.0 111.83 170.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.595 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -54.74 -14.73 1.48 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 122.897 0.479 . . . . 0.0 111.681 176.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.4 t -58.81 -21.96 57.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.621 1.169 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.465 ' HB2' ' H ' ' A' ' 56' ' ' ALA . 33.7 p -77.14 -14.96 59.71 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -154.75 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.595 ' O ' ' HB2' ' A' ' 30' ' ' GLN . 68.7 m-70 -124.35 162.95 22.74 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -88.82 172.87 8.89 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -169.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.454 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -70.52 -55.3 7.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.16 -20.13 36.89 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.08 1.853 . . . . 0.0 111.85 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.691 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 2.4 m-20 -58.04 -41.54 83.45 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 124.839 1.255 . . . . 0.0 111.628 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -110.96 6.63 21.21 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.21 0.529 . . . . 0.0 110.659 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.586 HD11 ' CH2' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -105.22 -43.22 5.07 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -79.83 130.4 35.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.135 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -45.82 139.04 4.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.239 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.28 -52.89 4.38 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 114.935 -1.029 . . . . 0.0 114.179 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -67.47 -28.74 68.12 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.24 -13.12 16.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.139 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -48.49 119.55 3.12 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.652 0.595 . . . . 0.0 110.596 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 153' ' ' GLN 0.258 4.8 p-10 -72.49 96.62 1.96 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -169.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 175.91 -52.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.356 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.54 -69.62 1.37 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.691 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -128.78 145.37 51.2 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.967 0.413 . . . . 0.0 111.107 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.443 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 3.5 p-10 -159.08 166.38 31.77 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 53.5 tp -84.22 130.04 34.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 35.5 tt0 -143.0 135.54 27.54 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.146 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.619 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 46.1 p -110.45 112.83 25.01 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.32 -44.72 7.8 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 120.796 0.331 . . . . 0.0 111.591 -175.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' H ' ' HB2' ' A' ' 32' ' ' SER . . . -81.78 -57.93 3.22 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.211 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 54' ' ' SER . 11.5 m-20 -106.87 141.88 37.39 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.964 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.49 4.3 47.1 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.575 1.179 . . . . 0.0 109.319 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.92 120.9 43.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.395 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 tt -141.26 130.57 23.63 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.52 0.676 . . . . 0.0 111.028 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 62' ' ' ILE . 1.1 tm? -101.79 134.13 45.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.914 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 61' ' ' LEU . 29.9 mt -129.19 129.98 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -112.71 115.73 29.0 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.11 116.76 31.02 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.45 144.35 4.72 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.515 2.143 . . . . 0.0 110.925 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.11 143.87 36.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.788 0.804 . . . . 0.0 112.854 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -56.51 -42.63 78.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 126.413 1.885 . . . . 0.0 110.515 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -142.71 154.36 44.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.95 123.42 38.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 121.525 0.679 . . . . 0.0 111.513 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -130.52 173.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.74 127.47 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.15 109.27 15.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -91.53 -52.04 4.97 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.41 . . . . 0.0 111.237 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 p -140.36 157.12 46.03 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.194 0.521 . . . . 0.0 111.89 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 111' ' ' ALA . 35.4 p90 -127.1 152.55 47.16 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -144.17 106.43 4.37 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.784 0.326 . . . . 0.0 111.722 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 62.4 mt -111.18 118.16 56.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 154' ' ' LYS . 10.0 tmtt? -101.79 134.83 44.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.11 -176.21 41.48 Favored Glycine 0 N--CA 1.414 -2.812 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.007 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.85 151.87 57.44 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.755 2.304 . . . . 0.0 110.521 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -61.66 -34.02 74.97 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.21 -38.12 11.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.79 18.26 16.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.351 -173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.49 148.1 19.13 Favored Glycine 0 C--N 1.299 -1.516 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.891 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.3 107.48 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 CA-C-N 119.328 1.564 . . . . 0.0 110.058 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 31.5 ttpt -85.75 -55.12 4.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.131 0.491 . . . . 0.0 110.477 -173.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -82.29 103.84 12.17 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.245 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.21 136.93 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.812 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.52 151.14 50.47 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -126.17 155.93 40.96 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.97 161.5 14.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.9 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.9 p -95.95 79.27 3.24 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 38.04 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -151.94 166.97 29.86 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -101.77 146.51 27.68 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.579 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 51.99 84.41 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.48 1.112 . . . . 0.0 112.125 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.583 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 17.3 tpt -119.09 110.51 17.16 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 23.7 p -124.49 -170.7 2.2 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 83.3 t80 -63.62 -26.03 68.49 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 118.838 0.744 . . . . 0.0 111.639 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.8 m -71.16 -8.64 54.91 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.661 0.743 . . . . 0.0 110.4 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.583 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 12.1 m120 -105.64 -20.17 13.54 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.473 1.109 . . . . 0.0 110.35 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 55.5 t -58.39 -39.69 75.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.32 10.51 37.78 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.43 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -120.37 -35.77 3.36 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -96.46 127.64 39.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 O-C-N 121.953 -0.467 . . . . 0.0 111.801 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -54.11 129.56 35.01 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.893 3.062 . . . . 0.0 114.036 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.79 156.55 20.95 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.648 2.232 . . . . 0.0 110.885 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.1 m -84.32 -45.9 12.32 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.896 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.44 ' HB2' ' HE2' ' A' ' 129' ' ' LYS . 28.9 t70 -163.07 171.71 16.02 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.1 p -127.96 119.9 26.48 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.98 152.42 24.98 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 39.9 tt0 -126.49 125.6 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 ' NE2' ' A' ' 144' ' ' GLN . 19.6 tp -66.96 145.57 55.29 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 117' ' ' ASN . 2.8 t -135.23 163.67 29.43 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -58.63 -27.29 64.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.672 0.749 . . . . 0.0 110.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -65.52 -51.4 60.24 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.026 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.574 HD22 ' HA ' ' A' ' 76' ' ' ALA . 2.3 t-20 -65.31 -49.4 69.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.915 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 3.0 pp -71.31 -9.45 58.16 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -89.59 3.72 51.67 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.24 33.66 6.17 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.682 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.2 tmtp? -115.96 120.75 35.02 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 117.271 0.536 . . . . 0.0 109.675 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.489 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 32.5 Cg_exo -58.69 117.72 4.49 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 C-N-CA 123.574 2.849 . . . . 0.0 112.29 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.459 HG21 ' ND2' ' A' ' 117' ' ' ASN . 80.9 t -93.51 131.06 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -73.68 123.29 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.42 HD23 ' CD1' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -98.7 174.52 6.37 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.827 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -86.51 89.96 8.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -101.52 21.17 14.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.78 -3.76 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -123.02 1.01 9.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -101.03 78.62 1.94 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.2 -32.36 15.11 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.303 0.573 . . . . 0.0 110.023 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -141.78 121.62 13.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.772 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.56 108.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -96.4 -40.33 9.15 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 m -138.13 136.39 36.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -126.74 119.84 27.91 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.282 0.563 . . . . 0.0 110.236 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 93.6 m -102.27 121.32 42.03 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.591 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.4 mt -104.71 113.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 82.3 t80 -111.5 116.91 31.68 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.5 pp -106.91 136.03 43.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.633 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.0 pt-20 -123.47 -13.73 7.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.61 146.03 20.61 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.148 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -97.85 174.83 6.39 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.496 ' NE2' HD22 ' A' ' 113' ' ' LEU . 18.3 mp0 -60.47 -52.54 64.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.001 0.429 . . . . 0.0 110.855 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.3 t -92.04 -22.19 20.08 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.369 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.33 81.54 0.45 Allowed Glycine 0 CA--C 1.499 -0.928 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 149' ' ' VAL . 34.4 m -111.78 6.21 19.58 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.427 -0.386 . . . . 0.0 111.868 -172.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 67.76 -36.16 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.496 1.118 . . . . 0.0 112.72 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 147' ' ' SER . 4.6 p -102.87 132.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 123.498 0.719 . . . . 0.0 109.674 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.619 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 61.3 m -121.39 128.83 52.61 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.412 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 40.1 ttmt -109.9 132.66 53.95 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 19.4 t -123.71 116.3 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 97.5 mt-30 -94.77 -19.48 20.32 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.363 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -172.34 134.33 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.588 0.355 . . . . 0.0 110.563 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.443 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 1.8 mp -129.88 117.85 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.93 147.78 35.81 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.897 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.54 141.18 48.07 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.489 ' CE2' ' HG3' ' A' ' 122' ' ' PRO . 82.2 m-85 -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.43 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -139.58 -168.34 11.27 Favored Glycine 0 CA--C 1.488 -1.651 0 C-N-CA 119.909 -1.138 . . . . 0.0 112.487 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.3 p -163.08 147.89 11.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 120.487 0.184 . . . . 0.0 110.883 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--N 1.297 -1.716 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.382 170.551 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.517 HG23 ' H ' ' A' ' 11' ' ' LYS . 4.2 mp . . . . . 0 C--O 1.237 0.443 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.7 25.25 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.06 2.507 . . . . 0.0 110.887 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' H ' HG23 ' A' ' 9' ' ' ILE . 40.6 ttmt 61.85 99.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.767 1.227 . . . . 0.0 111.272 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.55 -78.83 0.19 Allowed Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 9' ' ' ILE . 28.0 mm-40 -109.7 168.42 9.42 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 15.5 m -105.34 156.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.886 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 17' ' ' LEU . 3.3 p30 -78.28 112.63 15.47 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 122.694 1.235 . . . . 0.0 109.531 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.594 ' O ' HG13 ' A' ' 20' ' ' ILE . 36.9 mt -68.65 6.04 0.93 Allowed 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.639 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 15' ' ' ASP . 5.2 tt -60.42 -41.65 94.38 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.67 -22.01 60.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.173 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 32.8 m-85 -93.71 15.11 17.17 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.982 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 16' ' ' LEU . 86.8 mt -95.97 134.95 31.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.52 -44.38 96.11 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 94.4 m95 66.46 7.19 4.84 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.96 -84.96 1.66 Allowed Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.457 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 t 39.16 84.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.951 1.3 . . . . 0.0 111.87 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -117.5 131.53 56.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.127 -168.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . 49.1 t -129.18 130.99 47.05 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.25 -72.01 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -70.69 -59.55 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 35.0 tt0 59.78 27.53 16.84 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.172 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 30.0 t 71.06 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.135 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -57.83 -34.12 69.34 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.238 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -109.67 -48.14 3.26 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' A' ' 31' ' ' SER . 97.9 m-70 -99.58 164.92 11.87 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -169.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.425 ' C ' HD21 ' A' ' 52' ' ' LEU . 16.2 m -100.82 141.5 33.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.734 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 3.0 tm? -62.37 -46.38 90.09 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.094 0.558 . . . . 0.0 112.281 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 9.9 Cg_endo -52.04 -24.45 19.69 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.275 1.984 . . . . 0.0 112.492 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' HD13 ' A' ' 50' ' ' LEU . 96.6 m-20 -69.03 -19.3 64.11 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.2 1.22 18.57 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.232 0.539 . . . . 0.0 110.573 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -124.36 -40.36 2.25 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.36 103.52 16.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.151 0.5 . . . . 0.0 111.066 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.428 ' H ' HD13 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -75.51 113.35 12.83 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.98 -50.43 0.43 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 105.772 -2.931 . . . . 0.0 105.772 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -89.7 -41.27 12.01 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 153' ' ' GLN . 54.2 ttp180 -73.53 122.17 21.78 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.275 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.54 106.77 8.73 Favored 'General case' 0 C--N 1.262 -3.206 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 165.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 153' ' ' GLN 0.335 7.7 p-10 -64.03 84.54 0.03 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -166.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 160.42 99.71 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 128.758 2.823 . . . . 0.0 104.401 175.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.46 -103.47 0.46 Allowed Glycine 0 C--N 1.303 -1.271 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 HD11 ' O ' ' A' ' 50' ' ' LEU 0.251 1.9 pp -77.09 125.73 29.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.941 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -154.44 165.72 35.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.498 HD21 ' N ' ' A' ' 36' ' ' LEU . 2.9 tm? -94.84 112.13 23.87 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.5 pt-20 -131.15 121.33 24.7 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.771 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -69.59 149.23 48.39 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -103.99 -28.52 11.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.64 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.83 -53.87 2.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.042 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.74 158.36 44.08 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 117.489 -1.685 . . . . 0.0 115.333 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.418 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 41.9 mt-10 -70.15 -33.22 71.51 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.32 1.048 . . . . 0.0 112.119 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.25 109.54 12.46 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.657 0.741 . . . . 0.0 111.131 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.7 tp -116.42 134.22 55.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.93 127.69 49.26 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 HG13 ' HG ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -144.34 127.52 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 CA-C-O 121.473 0.654 . . . . 0.0 111.547 177.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.554 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 5.1 t80 -91.89 123.88 35.6 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.614 1.566 . . . . 0.0 111.414 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.3 mt -120.79 120.29 29.59 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -89.66 152.38 5.17 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.944 2.429 . . . . 0.0 111.178 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -88.15 162.79 16.53 Favored 'General case' 0 CA--C 1.474 -1.955 0 CA-C-O 121.919 0.866 . . . . 0.0 112.752 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -99.45 -32.94 10.89 Favored 'General case' 0 N--CA 1.404 -2.775 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.662 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.67 145.99 25.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.1 t -73.74 108.75 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.02 173.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -90.75 133.24 35.32 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.18 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.506 ' CD1' ' HB3' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -83.2 121.46 27.11 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.27 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -115.23 -46.16 2.91 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -153.62 169.23 23.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -139.88 154.49 47.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -141.1 117.33 10.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.0 mt -126.72 119.84 54.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.34 144.35 25.96 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.68 176.31 34.81 Favored Glycine 1 C--N 1.253 -4.08 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.69 178.09 6.14 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 CA-C-N 119.612 1.706 . . . . 0.0 111.03 175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -68.56 -44.35 74.66 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.402 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.59 -53.31 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.82 12.33 2.73 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 147.69 28.89 Favored Glycine 0 C--O 1.251 1.191 0 C-N-CA 120.134 -1.032 . . . . 0.0 110.768 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_endo -77.12 115.99 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.847 1.698 . . . . 0.0 110.209 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HE3' ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -87.06 -71.04 0.58 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.025 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.8 m -75.34 102.05 4.96 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.488 0.661 . . . . 0.0 111.28 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.76 144.44 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.397 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -133.75 133.79 42.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.91 146.06 43.21 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.672 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -129.82 115.06 16.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 m -103.3 154.76 19.03 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 120.87 0.367 . . . . 0.0 110.748 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 73.96 -42.12 0.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.25 1.42 . . . . 0.0 112.853 173.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -69.08 122.44 18.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 0.0 110.081 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 35.9 tt0 -93.68 122.34 36.04 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.279 -174.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t60 58.4 96.08 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 124.174 0.989 . . . . 0.0 112.923 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 53.0 mtm -131.34 155.59 46.97 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.152 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.495 ' O ' HG23 ' A' ' 102' ' ' VAL . 24.5 p -109.19 -179.16 3.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -58.68 -30.6 67.51 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.838 0.455 . . . . 0.0 111.706 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 t -62.29 -41.61 98.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.057 0.455 . . . . 0.0 109.859 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -85.88 -15.8 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 98' ' ' CYS . 51.3 t -62.0 -29.23 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.588 0.709 . . . . 0.0 110.121 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.84 9.29 39.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.597 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.13 -48.27 3.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.414 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -97.5 127.01 39.33 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.97 136.35 74.55 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.801 2.334 . . . . 0.0 111.782 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.28 158.03 57.07 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.723 2.282 . . . . 0.0 112.878 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -70.19 -45.77 65.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -164.84 157.44 16.35 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -141.16 117.06 10.45 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.58 172.5 11.51 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.944 -170.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.2 mp0 -117.04 137.81 52.01 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.9 tp -61.55 113.09 2.5 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.704 0.801 . . . . 0.0 109.049 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.6 t -107.11 165.45 11.35 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.57 -37.44 62.93 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.202 0.525 . . . . 0.0 111.57 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.14 -35.05 70.93 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.634 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.586 HD22 ' HA ' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -71.31 -36.87 71.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.756 -175.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.85 -21.84 65.16 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -83.61 6.68 19.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.979 0.895 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.32 26.3 64.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.438 -1.256 . . . . 0.0 113.591 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -92.57 135.02 26.97 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.944 0.372 . . . . 0.0 111.492 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.518 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 35.5 Cg_endo -65.51 109.46 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.323 2.682 . . . . 0.0 112.465 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.9 t -86.97 132.25 32.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.1 m -80.59 132.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.582 0.706 . . . . 0.0 112.67 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.37 -178.92 3.8 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.696 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.58 105.36 0.2 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.826 0.822 . . . . 0.0 111.102 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -111.1 -22.69 11.32 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.416 -170.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.1 t -71.2 -27.52 29.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.362 0.601 . . . . 0.0 111.028 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -96.63 -10.28 27.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.563 0.697 . . . . 0.0 110.538 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.506 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . 83.2 m-85 -120.43 112.7 19.31 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -123.77 -0.64 8.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.302 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -149.21 127.55 12.19 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.974 -175.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.9 t -97.58 115.07 36.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.523 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 135' ' ' SER . 12.7 mmm180 -115.19 -0.38 13.28 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.261 174.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 134' ' ' ARG . 12.0 t 171.98 163.67 0.1 Allowed 'General case' 0 C--O 1.252 1.214 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -155.56 119.88 4.63 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.128 0.489 . . . . 0.0 110.012 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.1 m -108.76 126.92 53.54 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.38 124.09 58.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -124.36 131.0 53.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 26.3 pt -116.02 132.01 66.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.582 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -107.41 -31.08 8.31 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.16 143.7 27.26 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.433 0.635 . . . . 0.0 111.899 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.415 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 5.8 m-20 -96.56 163.07 13.19 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.043 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.617 ' OE1' ' HE3' ' A' ' 86' ' ' LYS . 6.4 tp-100 -47.94 -45.73 31.34 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 112.778 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.2 t -122.55 16.2 10.38 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.497 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.44 4.3 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 149' ' ' VAL . 19.6 m -96.09 11.87 32.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.319 13.0 pt-20 63.3 -23.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.368 1.867 . . . . 0.0 115.163 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 147' ' ' SER . 34.3 m -136.78 158.93 37.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 27.6 m -121.45 136.93 54.91 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 121.338 -0.145 . . . . 0.0 111.231 -175.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -114.99 134.23 55.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 27.5 m -129.71 122.09 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 110.013 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 18.3 mm-40 -87.96 -44.73 10.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.054 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.64 111.49 5.07 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.877 -174.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.54 125.52 66.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.84 144.46 32.53 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.107 0.48 . . . . 0.0 110.488 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 5.3 mp -106.88 138.16 43.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 98.7 m-85 -125.22 135.34 52.46 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.033 0.444 . . . . 0.0 112.046 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -158.0 -156.97 8.19 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.9 t -153.23 149.44 27.97 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.749 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 C--O 1.255 1.355 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.137 174.188 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.28 130.98 26.87 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.484 1.456 . . . . 0.0 110.677 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -69.21 99.17 1.11 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.68 -36.38 0.63 Allowed Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.443 ' HA ' ' OG ' ' A' ' 160' ' ' SER . 28.9 mm-40 -120.35 -173.98 2.69 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -134.41 153.42 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -71.42 127.98 34.34 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 20' ' ' ILE . 57.3 mt -76.51 -1.45 27.34 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.37 -36.03 41.39 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.809 0.814 . . . . 0.0 109.306 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.31 -24.22 66.5 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.001 -175.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -106.52 7.06 30.67 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 16' ' ' LEU . 77.3 mt -85.34 136.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.96 115.17 27.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -88.52 10.09 21.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.9 m -97.79 -33.8 11.13 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.318 0.58 . . . . 0.0 109.438 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.82 -18.89 53.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.945 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.61 126.06 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.02 143.84 49.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.805 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.557 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 80.2 m -136.47 133.42 36.57 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.037 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 28' ' ' LEU . 2.9 tm? -61.13 -40.57 94.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.746 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' HB3' HD11 ' A' ' 60' ' ' LEU . 62.2 t30 -126.65 149.28 49.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.557 ' NE2' ' HB2' ' A' ' 27' ' ' CYS . 4.1 pt20 164.1 -5.63 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 126.791 2.036 . . . . 0.0 107.007 -168.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 33' ' ' SER . 38.9 t -65.66 -19.61 65.97 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.682 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 m -55.44 16.83 0.0 OUTLIER 'General case' 0 CA--C 1.594 2.642 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 31' ' ' SER . 44.6 t 75.33 -1.05 3.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.17 0.988 . . . . 0.0 113.218 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -125.05 153.0 43.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -107.27 167.62 9.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.903 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.1 tm? -57.52 -49.72 92.25 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.632 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 4.6 Cg_endo -48.98 -25.99 9.56 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.866 2.378 . . . . 0.0 112.879 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.422 ' HA ' HD13 ' A' ' 50' ' ' LEU . 2.1 m-20 -60.93 -31.68 71.21 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.24 0.616 . . . . 0.0 111.607 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 52' ' ' LEU . . . -121.96 23.53 9.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.09 0.472 . . . . 0.0 110.329 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.492 HD21 ' O ' ' A' ' 155' ' ' ILE . 0.7 OUTLIER -139.91 -36.7 0.49 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.72 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -78.32 105.98 9.93 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-O 121.237 0.542 . . . . 0.0 111.051 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.509 ' HG2' ' NH2' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -49.91 118.2 2.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.3 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.17 -62.26 0.59 Allowed Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HB3' ' HG ' ' A' ' 50' ' ' LEU . 21.7 m-85 -99.03 -11.08 21.82 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.722 -0.281 . . . . 0.0 110.349 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' NH2' ' HG2' ' A' ' 42' ' ' GLN 0.371 3.4 ppt_? -70.26 -4.69 23.09 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 -170.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -83.33 156.6 22.95 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.367 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.03 145.63 41.28 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 81.86 2.14 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.992 1.717 . . . . 0.0 111.735 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.436 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -95.98 -86.01 1.74 Allowed Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 44' ' ' TYR . 7.1 mt -135.24 170.31 16.12 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.5 p-10 -157.86 152.83 25.42 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 119.115 0.87 . . . . 0.0 109.272 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.44 ' H ' ' HB1' ' A' ' 39' ' ' ALA . 55.2 tp -87.11 142.58 27.81 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.68 148.97 44.67 Favored 'General case' 0 C--N 1.255 -3.505 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.499 ' HB3' ' H ' ' A' ' 150' ' ' THR . 23.3 t -112.75 21.37 15.6 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.648 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.39 84.93 0.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.109 0.48 . . . . 0.0 111.116 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 174.29 -44.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.778 1.631 . . . . 0.0 107.952 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -140.26 157.62 45.3 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.416 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 148' ' ' GLU . 0.8 OUTLIER -79.17 -25.33 42.8 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -177.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -101.97 151.04 22.59 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.497 0.665 . . . . 0.0 110.705 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.476 HD11 ' HB3' ' A' ' 29' ' ' ASN . 24.2 tp -134.89 131.33 37.2 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 5.6 tt -140.66 127.63 20.68 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.63 132.07 71.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -106.82 122.86 47.23 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.222 0.609 . . . . 0.0 109.537 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -116.83 119.91 34.79 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.981 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -95.92 123.0 0.28 Allowed 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.757 2.304 . . . . 0.0 111.319 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.62 155.27 17.38 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.763 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -73.36 -14.76 61.34 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -157.95 177.72 11.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 29.5 m -89.03 132.4 33.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.728 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.91 171.92 11.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.488 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -85.35 113.75 21.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.79 154.48 41.9 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.516 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 40.5 t60 -153.49 -67.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 p -142.18 152.44 43.16 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.426 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 42.0 p90 -125.55 155.19 41.04 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.78 116.7 6.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.775 0.321 . . . . 0.0 110.528 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 63.9 mt -119.75 134.41 63.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -123.97 168.51 12.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.028 0.442 . . . . 0.0 110.162 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 153' ' ' GLN . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.33 134.72 23.27 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 CA-C-N 119.61 1.705 . . . . 0.0 108.547 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.48 -37.37 62.63 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.43 -36.43 19.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.72 0.16 56.73 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.15 33.03 Favored Glycine 0 C--O 1.26 1.726 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.033 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.8 Cg_endo -84.24 125.54 3.52 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.853 2.369 . . . . 0.0 111.323 -176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 32.8 ttpt -91.26 -72.09 0.6 Allowed 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.946 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.4 m -77.93 97.58 5.36 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.105 0.479 . . . . 0.0 110.072 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.409 HG13 HG21 ' A' ' 140' ' ' ILE . 24.3 m -108.59 139.52 30.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.46 ' CG ' ' HB3' ' A' ' 139' ' ' PHE . 18.2 ptpt -125.39 155.3 40.59 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 24.6 m-85 -132.07 151.19 51.9 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 137' ' ' THR . 22.5 p90 -154.72 149.94 27.07 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 123.528 0.517 . . . . 0.0 109.838 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.8 m -127.22 155.77 42.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 69.67 -37.93 0.39 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.087 2.155 . . . . 0.0 116.015 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.509 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 1.1 tpmt? -75.19 109.41 8.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.135 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.03 149.18 24.15 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 65.52 62.48 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 109.13 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.3 tpp -134.77 110.13 9.02 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.251 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.464 ' O ' HG12 ' A' ' 102' ' ' VAL . 75.2 m -129.41 -172.22 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -52.13 -29.9 23.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -88.8 -1.39 58.06 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.967 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -118.29 -32.45 4.66 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.83 0.348 . . . . 0.0 110.104 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 98' ' ' CYS . 31.0 m -58.62 -15.58 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -171.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -93.1 73.57 4.68 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.664 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 172.69 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.74 1.216 . . . . 0.0 110.53 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.76 128.31 40.08 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.22 122.58 11.36 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.937 2.425 . . . . 0.0 112.61 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.429 ' HA ' ' HB3' ' A' ' 91' ' ' PHE . 83.2 Cg_endo -82.08 -178.56 4.17 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 122.26 1.974 . . . . 0.0 110.711 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.584 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 18.3 m -76.78 -47.17 22.43 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 110' ' ' THR . 18.7 t70 172.58 -167.1 0.02 OUTLIER 'General case' 0 C--O 1.248 0.999 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.438 ' H ' ' CG ' ' A' ' 109' ' ' ASP . 7.4 t -148.99 143.18 25.95 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.84 12.13 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 33.5 mt-10 -120.92 140.26 52.09 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 124.227 1.011 . . . . 0.0 110.252 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 57.8 tp -59.58 101.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.078 0.861 . . . . 0.0 110.322 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.464 HG21 ' H ' ' A' ' 117' ' ' ASN . 4.4 t -95.26 164.43 12.85 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.978 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.5 -23.89 59.12 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.616 0.766 . . . . 0.0 110.385 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 123' ' ' VAL . 31.0 tt0 -71.88 -45.41 61.38 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.464 ' H ' HG21 ' A' ' 114' ' ' THR . 2.3 m120 -65.42 -47.78 75.08 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.951 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.18 -30.84 66.73 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.599 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -92.41 -1.82 56.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.328 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.8 20.49 26.27 Favored Glycine 0 CA--C 1.494 -1.266 0 C-N-CA 120.318 -0.944 . . . . 0.0 114.727 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 1.0 OUTLIER -95.81 134.46 23.98 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.821 177.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 12.7 Cg_exo -70.86 109.83 2.63 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.426 2.084 . . . . 0.0 111.271 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.504 HG22 ' OE2' ' A' ' 116' ' ' GLU . 94.3 t -87.5 128.24 40.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.7 m -77.56 125.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.164 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.49 175.91 6.5 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.46 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . 0.313 50.0 mtmt -91.48 84.94 5.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.898 1.332 . . . . 0.0 113.782 -175.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 36.2 p90 -87.94 19.16 3.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.848 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -60.01 -29.1 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.456 ' HG2' ' CE2' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -107.22 10.72 29.85 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.434 174.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 91.4 m-85 -123.47 86.28 2.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 112.074 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -105.63 -9.19 17.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -144.08 113.69 7.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.813 0.816 . . . . 0.0 111.304 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 65.9 t -122.53 120.65 61.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.032 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -103.0 -38.92 7.13 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.1 m -120.72 134.0 55.31 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.3 tp -126.02 140.24 52.77 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 22.8 m -134.21 131.36 38.46 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 138' ' ' ILE . 3.0 mp -111.7 128.04 68.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.46 ' HB3' ' CG ' ' A' ' 89' ' ' LYS . 51.6 t80 -122.76 126.31 47.21 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.439 HG12 ' H ' ' A' ' 60' ' ' LEU . 24.2 pt -95.42 129.2 45.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 117.98 -1.488 . . . . 0.0 107.505 172.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -93.92 -24.03 17.85 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.214 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -166.2 142.76 5.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.084 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -90.82 161.79 15.12 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.488 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -46.23 -44.86 16.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.058 0.943 . . . . 0.0 112.227 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.5 p -124.42 9.87 8.51 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.298 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 59.62 70.62 0.95 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 149' ' ' VAL . 22.8 t -86.7 -10.11 54.45 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.921 -165.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 40.0 mt-10 66.9 -44.6 0.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.291 0.637 . . . . 0.0 110.869 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 147' ' ' SER . 3.3 p -119.34 96.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-O 122.386 1.089 . . . . 0.0 109.197 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.499 ' H ' ' HB3' ' A' ' 54' ' ' SER . 31.1 m -82.15 119.65 24.32 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.587 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.16 132.36 35.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.3 t -119.71 115.49 47.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.035 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.42 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 53.3 tt0 -71.69 -63.7 1.07 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -160.48 145.19 14.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.375 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.492 ' O ' HD21 ' A' ' 40' ' ' LEU . 78.3 mt -120.5 114.64 44.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.32 160.81 36.23 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.94 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 158' ' ' TYR . 6.7 tt -147.23 140.43 25.28 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.46 ' N ' HD22 ' A' ' 157' ' ' LEU . 76.9 m-85 -114.67 141.91 47.17 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.333 0.587 . . . . 0.0 110.19 -175.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -156.89 -165.3 14.65 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 13' ' ' GLN . 75.4 m -164.72 167.42 19.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.993 0.897 . . . . 0.0 109.046 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.264 -3.138 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.756 175.204 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.26 178.73 7.12 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.762 2.308 . . . . 0.0 111.827 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -97.75 101.5 13.02 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.48 -39.68 0.7 Allowed Glycine 0 C--N 1.303 -1.292 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.533 ' HG3' ' OG ' ' A' ' 74' ' ' SER . 1.4 pm0 -135.48 149.37 49.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.818 0.847 . . . . 0.0 109.766 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 4.4 m -111.37 170.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 123.431 0.457 . . . . 0.0 110.501 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.0 98.64 0.78 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.457 1.122 . . . . 0.0 110.285 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.49 HD11 ' O ' ' A' ' 16' ' ' LEU . 2.4 tm? -55.72 -23.81 31.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.267 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.9 tt -53.0 -35.95 59.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.311 1.044 . . . . 0.0 110.986 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.0 -20.45 61.01 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' C ' ' HB2' ' A' ' 67' ' ' ASN . 47.8 m-85 -94.65 22.33 6.39 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.096 0.474 . . . . 0.0 110.964 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.4 131.46 47.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.13 -23.54 41.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.219 0.533 . . . . 0.0 111.185 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 41' ' ' LYS . 97.3 m95 67.43 10.22 7.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.1 p -87.1 10.82 15.48 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.278 0.561 . . . . 0.0 110.768 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.04 -88.35 0.13 Allowed Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.276 11.0 p 43.9 75.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.196 1.399 . . . . 0.0 113.002 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -119.72 151.16 39.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.596 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 49.2 t -136.6 130.96 33.09 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 HD13 ' C ' ' A' ' 28' ' ' LEU . 2.7 tm? -45.58 -63.34 0.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.724 1.209 . . . . 0.0 112.38 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.42 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.2 t30 -90.2 -57.76 2.74 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 34.2 tt0 69.51 -78.56 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.782 1.233 . . . . 0.0 107.889 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.548 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 35.7 t 176.35 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -53.29 -20.09 3.9 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -130.63 -34.07 1.58 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' SER . 94.5 m-70 -93.39 163.92 13.41 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.983 -0.448 . . . . 0.0 111.853 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -122.96 150.27 43.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.471 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 53.1 tp -70.49 -48.87 17.01 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.545 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 7.7 Cg_endo -48.23 -28.04 10.5 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.584 2.19 . . . . 0.0 113.003 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.486 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.2 m-20 -66.29 -29.38 69.59 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.912 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.06 6.07 13.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.712 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.481 HD11 ' CH2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -104.41 -43.76 5.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 18.6 ptpt -90.53 148.1 22.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.656 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.526 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 20.5 mm-40 -81.64 144.62 31.08 Favored 'General case' 0 CA--C 1.473 -2.002 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.607 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 121.72 -50.38 0.84 Allowed Glycine 0 N--CA 1.397 -3.927 0 C-N-CA 119.115 -1.517 . . . . 0.0 111.013 -171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 50' ' ' LEU . 96.8 m-85 -92.97 -10.47 36.25 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -55.86 25.98 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.075 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -95.08 102.09 13.88 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.35 97.86 1.01 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.249 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -156.75 -80.45 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.31 1.444 . . . . 0.0 110.226 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.23 -26.21 24.26 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 44' ' ' TYR . 2.3 pp -126.31 137.17 53.46 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.798 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.1 p-10 -163.77 166.77 21.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.491 ' HB3' ' CG2' ' A' ' 152' ' ' VAL . 40.4 tp -103.84 106.87 17.51 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.754 -1.578 . . . . 0.0 108.515 171.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -127.66 134.7 49.62 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.847 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.577 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 62.4 p -64.96 160.69 20.14 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.383 0.427 . . . . 0.0 110.243 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -123.84 -78.82 0.6 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.544 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.76 -14.76 36.36 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.742 0.306 . . . . 0.0 111.258 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 54' ' ' SER . 32.0 t70 -156.05 148.98 24.17 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.229 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' HD22 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -99.96 14.17 31.44 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -83.71 119.22 24.52 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.437 0.637 . . . . 0.0 110.152 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.495 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 3.8 mm? -115.46 107.34 15.05 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.558 0.694 . . . . 0.0 111.32 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 6.3 tt -116.76 115.46 25.64 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.2 mt -113.42 136.59 49.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 123.328 0.651 . . . . 0.0 111.113 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 95' ' ' GLU . 93.4 t80 -107.94 123.97 49.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -108.08 115.52 58.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.298 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -77.83 142.8 20.36 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.706 2.27 . . . . 0.0 109.53 175.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -101.68 162.04 13.2 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -167.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' PHE . 17.5 t-20 -91.99 -50.9 5.46 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.869 -2.423 . . . . 0.0 108.482 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -156.57 177.93 10.91 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.222 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.73 124.03 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.92 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -92.93 115.72 28.38 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.81 124.23 25.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -120.38 -49.94 2.24 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.911 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.533 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 50.3 p -143.95 161.76 37.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -134.99 152.9 52.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -146.82 115.95 6.95 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.08 0.467 . . . . 0.0 111.305 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.402 ' HB ' HD11 ' A' ' 113' ' ' LEU . 69.1 mt -123.63 128.46 74.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -112.26 120.5 41.94 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.409 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -149.25 -172.99 19.46 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -66.36 -175.7 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.83 2.353 . . . . 0.0 111.48 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -71.67 -56.88 4.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -173.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.28 -18.13 20.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.297 0.57 . . . . 0.0 112.135 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.52 15.68 6.38 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.486 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.53 156.98 16.0 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.451 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.457 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 32.2 Cg_exo -62.68 153.26 73.3 Favored 'Trans proline' 0 C--O 1.204 -1.192 0 C-N-CA 122.095 1.863 . . . . 0.0 110.16 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 37.2 ttpt -126.27 -65.41 0.98 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.868 -0.52 . . . . 0.0 110.377 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.9 m -75.75 101.74 5.16 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.24 0.543 . . . . 0.0 110.464 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 86' ' ' LYS . 52.5 t -106.02 130.52 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.103 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -130.61 151.84 50.64 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.769 0.828 . . . . 0.0 110.139 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.421 ' CE2' HD13 ' A' ' 125' ' ' LEU . 14.0 m-85 -136.0 160.71 37.8 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.178 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.35 116.69 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -84.24 14.6 4.18 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.89 1.276 . . . . 0.0 114.342 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -147.05 172.22 14.07 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.061 -0.4 . . . . 0.0 110.133 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.497 ' HZ3' ' HB2' ' A' ' 94' ' ' LYS . 3.4 ttmp? 69.94 145.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 10.4 pt-20 -102.81 138.25 39.95 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.467 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m80 55.82 72.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.507 0.723 . . . . 0.0 112.489 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.429 ' HE1' ' HA ' ' A' ' 102' ' ' VAL . 12.6 tpt -90.85 94.15 9.53 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.03 154.06 29.76 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.772 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.537 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 72.9 t80 -57.36 -23.23 47.74 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.7 t -79.71 -11.97 59.82 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.943 -0.473 . . . . 0.0 110.637 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -124.36 -13.31 7.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.583 . . . . 0.0 110.61 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 6.4 p -62.9 -30.06 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 C-N-CA 124.451 1.1 . . . . 0.0 112.129 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -109.03 -1.66 18.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.331 0.586 . . . . 0.0 111.098 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -82.65 -40.24 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -100.63 139.38 20.55 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.3 140.95 94.45 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.86 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.66 179.1 5.97 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.771 2.314 . . . . 0.0 110.747 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.714 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 44.8 m -79.56 -49.13 12.67 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.442 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -162.0 -179.6 7.26 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -153.27 150.49 29.0 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.73 169.21 18.2 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 5.6 tp10 -126.18 106.64 9.7 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.516 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.1 tt -73.05 122.57 21.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.7 p -122.04 -176.58 3.37 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.643 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.521 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 1.6 mp0 -51.77 -36.34 47.11 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 125.118 1.367 . . . . 0.0 109.813 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.495 ' CG ' ' HD2' ' A' ' 121' ' ' LYS . 40.4 tt0 -64.56 -38.78 92.21 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.412 HD21 ' CG2' ' A' ' 123' ' ' VAL . 23.8 t-20 -71.0 -38.28 72.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.81 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.44 -14.42 60.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.55 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.52 -1.69 56.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.555 0.693 . . . . 0.0 109.687 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.39 27.47 20.24 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.602 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.495 ' HD2' ' CG ' ' A' ' 116' ' ' GLU . 96.6 mttt -99.81 142.49 24.72 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 117.271 0.536 . . . . 0.0 111.146 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.83 103.78 1.71 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.897 1.731 . . . . 0.0 109.313 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.412 ' CG2' HD21 ' A' ' 117' ' ' ASN . 78.9 t -84.58 127.34 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.748 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.68 101.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -54.57 -71.53 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.293 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.535 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 80.1 tttt -171.47 165.39 6.96 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -144.31 24.8 1.58 Allowed 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.689 -171.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.91 -47.24 13.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.714 ' HB3' ' O ' ' A' ' 108' ' ' SER . 8.8 tmtt? -111.29 -9.12 14.3 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.694 -166.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -60.51 10.2 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.927 0 O-C-N 121.497 -0.752 . . . . 0.0 112.94 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 129' ' ' LYS . 79.9 mm-40 -59.7 119.42 7.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.217 0.532 . . . . 0.0 111.279 -166.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.355 0.2 OUTLIER 59.54 113.74 0.01 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 128.078 2.551 . . . . 0.0 112.997 -170.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.3 t -102.3 110.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.892 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -88.75 -31.5 18.38 Favored 'General case' 0 C--O 1.19 -2.077 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.575 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -160.86 164.09 31.56 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 tp -126.86 118.82 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 117.684 -1.607 . . . . 0.0 112.889 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 97' ' ' MET . 91.7 m -103.03 123.87 47.44 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.12 109.85 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 141' ' ' GLU . 53.1 t80 -114.5 111.72 21.83 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.407 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.495 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 1.8 pp -104.53 131.44 53.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.1 pt-20 -112.37 -2.27 14.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.06 142.16 5.92 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.311 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.41 HD22 ' HB2' ' A' ' 58' ' ' GLU . 38.4 m-80 -83.67 177.76 8.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.809 0.693 . . . . 0.0 109.864 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 2.4 mp0 -50.11 -58.53 5.34 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.4 m -119.64 -22.31 6.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.954 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.43 1.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 m -84.37 16.33 3.14 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.445 0.698 . . . . 0.0 112.305 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 73.48 -52.15 0.7 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.652 1.181 . . . . 0.0 111.078 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.18 106.09 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.014 0.912 . . . . 0.0 111.397 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.716 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.0 m -82.68 116.26 21.98 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.465 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -104.29 133.97 48.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 30.5 m -132.96 128.15 56.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.201 0.524 . . . . 0.0 109.609 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -84.41 -33.79 23.67 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 141.46 4.47 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.164 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.6 111.98 33.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.49 124.58 21.56 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 159.4 15.47 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 83.8 m-85 -125.37 113.44 17.56 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.15 0.5 . . . . 0.0 109.939 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.62 167.2 12.25 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.0 m -120.34 132.98 55.52 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 117.39 0.595 . . . . 0.0 110.55 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--N 1.281 -2.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.832 173.256 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.473 HG13 ' HB2' ' A' ' 15' ' ' ASP . 2.6 mp . . . . . 0 N--CA 1.44 -0.933 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.56 159.4 19.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.602 2.201 . . . . 0.0 110.421 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -83.81 101.9 11.95 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.834 0.826 . . . . 0.0 111.961 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.96 -30.77 2.34 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.205 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 19.4 mp0 -121.96 170.15 10.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 122.281 -0.54 . . . . 0.0 110.783 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.94 143.01 18.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.473 ' HB2' HG13 ' A' ' 9' ' ' ILE . 11.8 t70 -71.95 127.43 32.53 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.86 0.362 . . . . 0.0 110.108 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 19' ' ' PHE . 33.2 mt -101.33 3.47 40.68 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 42' ' ' GLN . 3.1 tm? -73.06 -35.33 66.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.165 0.983 . . . . 0.0 108.541 -177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.94 -9.83 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.044 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.461 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 92.0 t80 -97.77 14.26 27.57 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 124.766 1.226 . . . . 0.0 110.977 -172.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.7 mt -88.84 142.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.489 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -93.9 120.24 33.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -92.93 7.9 42.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 m -103.64 -12.11 17.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.258 0.552 . . . . 0.0 110.836 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.95 -18.53 5.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.396 -0.906 . . . . 0.0 113.578 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.75 129.5 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.9 142.93 50.7 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.776 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' ' NE2' ' A' ' 30' ' ' GLN . 9.3 p -131.87 119.7 21.55 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.536 -175.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 3.8 mm? -94.41 132.34 39.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.222 0.534 . . . . 0.0 110.214 176.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.0 t30 68.65 -70.97 0.12 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 126.945 2.098 . . . . 0.0 110.186 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 8.1 tt0 63.31 -168.93 0.2 Allowed 'General case' 0 C--N 1.372 1.573 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 41.5 t -93.39 123.42 36.68 Favored 'General case' 0 C--N 1.251 -3.714 0 O-C-N 120.449 -1.407 . . . . 0.0 108.477 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -57.93 -17.46 16.95 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.891 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -100.16 -43.6 6.26 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.656 ' O ' ' HB3' ' A' ' 31' ' ' SER . 83.4 m-70 -122.06 151.97 40.31 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 122.05 -0.406 . . . . 0.0 110.745 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.523 ' HA ' ' OE1' ' A' ' 30' ' ' GLN . 49.0 m -87.98 160.89 17.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.72 -49.47 2.1 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.68 -23.99 28.22 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.072 1.848 . . . . 0.0 111.284 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.468 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.2 m-20 -58.91 -27.68 65.48 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 125.636 1.574 . . . . 0.0 111.453 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB1' ' H ' ' A' ' 52' ' ' LEU . . . -123.7 8.41 8.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 tp -118.36 -47.71 2.54 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.649 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -83.0 130.81 35.18 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.81 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' HB2' ' CD1' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -67.94 123.26 20.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.43 -47.49 0.98 Allowed Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.084 -2.007 . . . . 0.0 108.084 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -93.93 -44.37 8.11 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -54.97 101.96 0.06 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.389 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 178.45 125.07 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.69 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 18.5 t70 -68.07 85.36 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 47' ' ' ASP . 35.3 mt-10 -173.1 108.08 0.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 127.227 2.211 . . . . 0.0 110.137 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.27 -52.87 4.11 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.996 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.468 ' HB2' HD21 ' A' ' 38' ' ' ASN . 1.3 pt? -133.44 127.77 34.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 122.737 -0.273 . . . . 0.0 110.405 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 153' ' ' GLN . 6.7 t30 -161.35 153.32 19.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.433 ' H ' ' HB1' ' A' ' 39' ' ' ALA . 2.8 tm? -85.32 110.25 18.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.941 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 150' ' ' THR . 12.6 pt-20 -132.31 112.65 12.4 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.5 p -59.95 137.37 58.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -141.74 85.42 1.94 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.519 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 164.94 -50.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.155 1.782 . . . . 0.0 107.129 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -147.7 155.71 42.02 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.085 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -85.08 -25.2 27.72 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -77.0 130.83 38.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.738 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.462 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.8 mt -133.88 143.07 48.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.622 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.5 tm? -135.08 119.47 17.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.85 129.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -105.63 122.84 46.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.24 113.02 39.3 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.685 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -90.27 125.33 1.21 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 122.58 2.186 . . . . 0.0 108.835 168.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 90.3 m-85 -87.92 158.17 18.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -59.69 -51.75 68.44 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.251 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -125.41 173.23 9.02 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.087 -0.383 . . . . 0.0 109.981 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 120.908 0.385 . . . . 0.0 110.501 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -132.87 172.61 16.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -96.83 136.23 37.68 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.622 HD13 ' CD2' ' A' ' 130' ' ' PHE . 82.6 mt -76.01 146.63 39.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.431 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 27.6 t60 -124.83 -50.54 1.71 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -139.46 163.37 32.7 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -136.23 154.47 50.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.575 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -149.81 106.39 3.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.502 0.668 . . . . 0.0 111.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.13 131.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.533 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 53.6 mtpt -121.16 161.82 21.17 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.05 0.452 . . . . 0.0 111.716 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.07 -169.18 39.28 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.42 ' CG ' ' HD2' ' A' ' 151' ' ' LYS . 14.2 Cg_exo -73.37 166.47 29.8 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.937 2.424 . . . . 0.0 111.157 175.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.66 -41.48 86.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.12 -26.26 15.55 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -92.53 11.29 26.88 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.891 -169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.21 146.13 18.15 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.778 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 22.7 Cg_exo -67.05 110.05 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.332 2.021 . . . . 0.0 111.356 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.8 OUTLIER -82.84 -39.67 21.36 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.925 -176.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.1 m -103.44 112.01 24.7 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.84 130.2 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.015 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -117.29 146.28 43.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.74 149.22 52.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 65.6 t80 -143.42 115.77 8.52 Favored 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.494 169.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 135' ' ' SER . 48.9 m -102.36 153.73 19.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.677 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 81.44 145.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.052 1.341 . . . . 0.0 108.573 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 72.9 116.0 0.05 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.57 149.74 29.81 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.689 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.267 13.9 p-80 50.31 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.4 ' HE2' ' HA ' ' A' ' 102' ' ' VAL . 88.1 mtp -139.6 142.08 37.11 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 22.8 p -120.06 174.08 6.69 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -69.84 -18.86 63.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 p -77.72 -21.72 51.48 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -130.35 18.75 5.34 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.4 ' HA ' ' HE2' ' A' ' 97' ' ' MET . 9.3 p -69.72 -32.28 51.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.177 0.513 . . . . 0.0 110.717 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -97.27 73.53 2.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.637 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -124.41 -4.17 7.83 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -139.24 156.51 71.95 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.648 -1.615 . . . . 0.0 106.862 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.83 140.93 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.117 1.212 . . . . 0.0 109.589 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.72 153.52 36.1 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 122.42 2.08 . . . . 0.0 111.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 31.8 m -62.09 -44.8 95.88 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.717 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -169.56 166.78 9.98 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -139.24 139.71 37.52 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.4 172.71 11.57 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.673 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 37.2 tt0 -122.61 134.54 54.51 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 34.0 tp -62.99 108.58 1.24 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.701 0.626 . . . . 0.0 109.713 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.5 m -82.23 156.85 24.17 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -54.27 -39.58 67.0 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.191 0.596 . . . . 0.0 111.046 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.94 -31.47 68.07 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.244 0.618 . . . . 0.0 112.231 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 1.7 t-20 -62.56 -39.68 94.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.561 ' O ' HD21 ' A' ' 118' ' ' LEU . 7.5 tt -71.99 -7.62 49.79 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 45.2 mmtm -104.3 -14.15 15.89 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 121.761 -0.587 . . . . 0.0 110.136 176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.533 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 127.59 -14.43 6.43 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 119.926 -1.131 . . . . 0.0 114.005 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 53.8 mtpt -74.88 133.36 76.13 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 35.8 Cg_exo -64.15 116.99 4.04 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.541 2.828 . . . . 0.0 111.707 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 135.7 26.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.92 131.29 34.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.16 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.38 177.47 5.03 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.809 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.6 96.49 10.49 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -80.08 21.83 0.55 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.89 -13.58 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.09 21.06 9.82 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.365 0.602 . . . . 0.0 110.668 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 72' ' ' LEU . 96.3 m-85 -122.62 27.01 8.02 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.444 -173.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -63.22 -35.59 80.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -129.16 115.51 17.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.28 0.562 . . . . 0.0 109.805 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.455 HG23 ' HG ' ' A' ' 72' ' ' LEU . 47.4 t -121.15 104.47 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -108.27 -44.04 4.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 170.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 92' ' ' SER . 32.9 t -104.91 130.78 53.0 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.943 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.3 tp -137.87 104.23 5.21 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.137 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.5 m -92.3 115.42 28.07 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.74 122.73 58.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -121.53 127.71 51.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.897 0.38 . . . . 0.0 110.439 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.462 HG13 ' HB2' ' A' ' 60' ' ' LEU . 12.0 pt -133.29 116.44 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -31.47 4.11 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.378 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.77 126.45 52.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.83 -174.84 2.65 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.709 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 86' ' ' LYS . 2.2 mp0 -56.4 -66.51 0.42 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.6 t -120.14 9.27 11.09 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.545 -173.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.27 93.21 0.2 Allowed Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.462 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 23.4 t -111.99 -1.86 15.27 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 147' ' ' SER . 10.2 pt-20 68.0 -40.85 0.43 Allowed 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 126.764 2.026 . . . . 0.0 111.344 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 147' ' ' SER . 5.1 p -102.53 113.28 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.4 176.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 43.7 m -92.92 125.64 37.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.42 ' HD2' ' CG ' ' A' ' 80' ' ' PRO . 39.2 ttmt -123.52 133.67 53.98 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.5 120.02 31.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.008 0.432 . . . . 0.0 111.117 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.466 ' HA ' ' OD1' ' A' ' 51' ' ' ASN . 4.7 pt20 -93.21 -6.24 48.17 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.675 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -172.11 144.81 1.7 Allowed 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.84 109.97 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 165.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.64 134.08 29.91 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.85 156.29 28.64 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -123.14 127.97 49.42 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -135.22 -163.92 10.25 Favored Glycine 0 C--N 1.302 -1.329 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.381 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.571 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.1 t -142.18 143.29 32.87 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 117.428 0.614 . . . . 0.0 109.715 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.433 -1.286 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.045 -177.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.44 -0.932 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.24 144.0 14.36 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.971 1.781 . . . . 0.0 110.451 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.12 105.68 1.44 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.543 0.687 . . . . 0.0 110.214 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.79 -23.28 3.98 Favored Glycine 0 N--CA 1.42 -2.378 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.38 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -129.83 174.89 9.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.21 145.05 34.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -77.84 130.33 36.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.488 HD13 ' CD1' ' A' ' 70' ' ' ILE . 4.1 mm? -68.15 -8.85 42.07 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.822 0.849 . . . . 0.0 113.277 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.0 tm? -55.51 -34.06 64.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.26 -25.94 64.52 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.057 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.78 22.84 15.17 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -172.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.45 133.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.9 105.84 18.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -75.09 -13.44 60.48 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 m -73.87 -22.23 59.81 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 6.4 13.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.574 -1.298 . . . . 0.0 114.387 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.14 136.91 25.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 CA-C-N 117.838 0.819 . . . . 0.0 110.176 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -152.17 148.14 27.26 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.093 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.89 123.82 22.73 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 28' ' ' LEU . 2.5 tm? -61.63 -44.71 96.47 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.693 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.69 -94.23 0.1 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.587 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 59.6 11.69 2.49 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.722 0.772 . . . . 0.0 109.996 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -83.56 -12.93 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.489 ' HG ' ' HA ' ' A' ' 54' ' ' SER . 3.0 m -50.25 -47.83 54.99 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.5 m 153.14 -55.21 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 127.967 2.507 . . . . 0.0 108.372 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 80.1 m-70 -67.96 149.26 49.98 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.1 m -108.13 -175.84 2.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -171.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.418 HD22 HD23 ' A' ' 52' ' ' LEU . 2.4 tm? -90.84 -49.18 0.35 Allowed Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.693 0.797 . . . . 0.0 112.431 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 31.2 Cg_exo -62.38 -2.0 2.89 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.931 2.421 . . . . 0.0 114.46 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' HB2' HD12 ' A' ' 50' ' ' LEU . 34.8 p30 -84.02 -48.61 9.75 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.219 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.38 -2.5 57.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.3 tp -109.23 -9.12 15.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 5.8 tmtt? -89.7 133.29 34.74 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -54.58 133.21 46.32 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.78 -34.56 2.1 Favored Glycine 0 N--CA 1.413 -2.886 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.8 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.66 -20.77 45.86 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 117.657 0.728 . . . . 0.0 109.944 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 18.03 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.67 109.33 3.26 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.19 117.58 15.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 175.3 -81.39 0.0 OUTLIER 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.547 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.26 -33.1 77.16 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 50' ' ' LEU . 3.9 pp -119.66 126.69 51.76 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 8.1 p30 -163.54 167.26 21.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.418 HD23 HD22 ' A' ' 36' ' ' LEU . 48.1 tp -94.56 103.78 15.73 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 150' ' ' THR . 11.7 pt-20 -124.67 159.77 30.06 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.729 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.489 ' HA ' ' HG ' ' A' ' 32' ' ' SER . 86.9 p -95.74 -174.29 3.1 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.816 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 t70 175.03 -48.41 0.01 OUTLIER 'General case' 0 CA--C 1.467 -2.245 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.34 35.73 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.148 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 59' ' ' GLN . 10.6 t70 -157.44 146.97 20.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.18 -31.53 69.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.955 0.902 . . . . 0.0 112.49 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.54 ' HG2' ' OD1' ' A' ' 57' ' ' ASP . 3.9 pt20 -86.91 126.74 34.88 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.121 0.962 . . . . 0.0 111.949 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 140' ' ' ILE . 54.5 mt -131.07 120.73 23.83 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.343 -173.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -96.96 119.77 36.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.81 128.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 95' ' ' GLU . 8.6 t80 -109.84 117.91 35.08 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.1 mt -122.55 114.0 30.33 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-O 120.515 0.198 . . . . 0.0 111.37 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -89.33 141.18 4.0 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 121.998 1.798 . . . . 0.0 109.881 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -103.93 150.87 23.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.597 0.713 . . . . 0.0 112.638 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -55.35 -45.61 76.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -153.98 163.16 40.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.81 127.61 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.901 0.858 . . . . 0.0 111.748 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.488 ' CD1' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -128.3 172.1 15.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -96.28 114.18 25.84 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' HB3' ' A' ' 157' ' ' LEU . 53.2 tp -73.27 154.47 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 31.3 t60 -139.16 -38.17 0.5 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.785 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.1 p -153.97 169.73 22.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.477 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -141.29 155.17 46.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.59 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -149.65 100.2 2.95 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.868 0.366 . . . . 0.0 111.934 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.8 mt -106.24 136.58 40.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.425 ' HB3' ' OE1' ' A' ' 153' ' ' GLN . 90.1 mttt -112.06 150.96 29.94 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.991 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.56 168.01 39.85 Favored Glycine 0 N--CA 1.41 -3.041 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.22 151.94 79.2 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.892 1.728 . . . . 0.0 111.117 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -39.78 68.32 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.346 0.659 . . . . 0.0 111.62 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.48 -44.0 8.09 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -101.56 18.95 18.94 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.692 -166.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.93 178.87 36.45 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.163 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -73.5 -179.88 4.9 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 119.765 1.782 . . . . 0.0 110.439 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.535 ' HG2' ' OE2' ' A' ' 112' ' ' GLU . 23.0 ttpp -154.98 -71.23 0.12 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.863 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.4 m -85.74 118.19 25.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.261 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG13 HG21 ' A' ' 140' ' ' ILE . 23.0 m -118.28 137.19 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.762 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -110.95 133.87 53.03 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -113.97 145.3 41.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -135.37 114.96 12.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 171.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -94.42 133.81 37.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.7 OUTLIER 74.35 175.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.411 1.084 . . . . 0.0 111.357 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.573 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER 72.82 127.8 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.819 0.819 . . . . 0.0 110.902 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 3.6 mp0 -93.89 146.68 23.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.948 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.1 m80 69.91 98.14 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.955 1.302 . . . . 0.0 111.948 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 92.5 mmm -139.26 142.54 37.78 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.004 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.531 ' O ' HG21 ' A' ' 102' ' ' VAL . 26.4 p -144.78 169.73 17.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.61 -30.5 68.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.276 0.489 . . . . 0.0 112.072 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 t -63.54 -24.26 67.74 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 120.689 0.28 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.433 ' O ' ' HD1' ' A' ' 105' ' ' PHE . 92.8 m-20 -98.6 -23.11 15.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.945 0.402 . . . . 0.0 111.315 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 98' ' ' CYS . 56.0 t -58.53 -32.09 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.718 0.807 . . . . 0.0 112.271 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.85 -15.59 60.2 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -113.44 -15.89 12.53 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.699 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.433 ' HD1' ' O ' ' A' ' 101' ' ' ASN . 79.3 m-85 -96.75 148.05 33.85 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -82.56 139.81 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.164 1.909 . . . . 0.0 112.032 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.07 149.05 64.34 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.133 1.889 . . . . 0.0 110.939 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.8 m -73.76 -45.16 53.58 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.553 0.692 . . . . 0.0 109.332 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -161.25 160.6 30.12 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -131.7 125.72 32.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.23 170.19 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.32 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.535 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.8 tp10 -125.25 134.96 52.12 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.8 tp -70.11 101.94 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 117' ' ' ASN . 5.1 t -80.07 158.4 26.45 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.62 -22.83 66.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.588 0.709 . . . . 0.0 109.749 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.09 -35.31 74.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.257 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.59 HD22 ' HA ' ' A' ' 76' ' ' ALA . 1.5 t-20 -71.73 -32.72 68.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.48 -23.27 49.01 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.737 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.14 -12.65 52.35 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.712 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 2.82 55.56 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 122.71 88.13 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.096 0.448 . . . . 0.0 110.389 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -59.42 111.12 0.84 Allowed 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 123.157 2.571 . . . . 0.0 112.107 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.497 HG21 ' ND2' ' A' ' 117' ' ' ASN . 86.4 t -82.98 124.88 39.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.7 101.54 2.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.198 0.523 . . . . 0.0 109.952 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.89 172.8 13.27 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.637 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -89.64 84.06 6.31 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.19 0.995 . . . . 0.0 110.031 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.521 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 39.9 p90 -76.42 24.69 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.919 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.448 HG12 ' HD2' ' A' ' 129' ' ' LYS . 7.4 p -63.47 -25.57 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.679 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HD2' HG12 ' A' ' 128' ' ' VAL . 13.1 mptt -93.43 -20.29 20.46 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.436 0.636 . . . . 0.0 110.501 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 127' ' ' TYR . 82.2 m-85 -91.1 32.63 1.0 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.633 -171.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -67.32 -31.76 72.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.807 0.337 . . . . 0.0 111.309 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -142.2 116.15 9.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.54 106.51 20.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.795 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -89.52 -62.9 1.37 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.2 t -109.03 151.57 26.17 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.195 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.4 tp -147.95 129.67 15.12 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.261 0.553 . . . . 0.0 109.952 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 m -114.71 124.64 52.32 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.5 112.23 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 69.3 t80 -109.0 114.62 28.53 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.851 0.357 . . . . 0.0 110.697 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.512 HG21 HG13 ' A' ' 88' ' ' VAL . 2.3 pp -97.47 124.45 50.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 11.5 pt-20 -110.79 -22.56 11.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.339 -0.945 . . . . 0.0 111.968 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.64 156.39 44.96 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.847 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -110.61 148.09 32.9 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 126.221 1.809 . . . . 0.0 107.862 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -36.37 -56.81 0.77 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.652 1.181 . . . . 0.0 111.973 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -124.25 -12.02 7.41 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.688 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 87.59 0.94 Allowed Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 149' ' ' VAL . 32.6 t -111.05 9.55 22.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.98 -0.13 . . . . 0.0 110.7 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 77.14 -23.59 0.24 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 124.441 1.096 . . . . 0.0 110.157 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 147' ' ' SER . 25.9 m -128.5 124.31 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.9 m -101.41 111.1 23.23 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HG3' ' OD1' ' A' ' 51' ' ' ASN . 87.2 tttt -95.95 133.6 39.96 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 92.9 t -122.66 115.8 47.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.425 ' OE1' ' HB3' ' A' ' 78' ' ' LYS . 97.0 mt-30 -74.1 -44.33 54.35 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.839 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.05 153.66 3.85 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.495 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.9 mt -124.49 118.03 52.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.4 141.02 35.59 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.422 ' HB3' HD13 ' A' ' 72' ' ' LEU . 6.2 mp -120.43 151.59 39.1 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -124.44 127.11 47.02 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.723 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.3 -163.59 10.23 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.2 m -143.94 138.36 28.44 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.383 0.611 . . . . 0.0 111.863 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 C--N 1.293 -1.88 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.087 174.572 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.241 0.646 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.11 -173.55 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.633 2.222 . . . . 0.0 112.349 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -92.74 11.76 25.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.812 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -143.7 -50.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.741 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -87.42 173.38 9.17 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.924 0.392 . . . . 0.0 111.107 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 18.0 m -115.36 167.79 7.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 17' ' ' LEU . 6.2 p-10 -82.51 108.56 16.0 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.363 1.078 . . . . 0.0 108.979 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 44.7 mt -68.82 3.98 1.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.778 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 15' ' ' ASP . 2.6 tm? -62.62 -41.45 99.01 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.16 -7.42 57.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.867 0.841 . . . . 0.0 110.86 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 13.4 m-85 -92.1 1.71 57.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.01 133.35 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.07 -28.05 22.79 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.837 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.5 m95 66.15 -6.85 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 m -82.18 -19.95 38.82 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.614 -0.679 . . . . 0.0 112.659 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.35 26.69 4.9 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.75 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -71.89 139.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 110.911 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.68 128.2 32.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.108 0.48 . . . . 0.0 109.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 6.1 p -103.23 118.15 36.12 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.82 -14.92 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.483 0.659 . . . . 0.0 110.746 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -160.45 -83.98 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.776 168.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 27' ' ' CYS 0.394 3.1 pp0? 51.65 14.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.51 1.124 . . . . 0.0 112.634 -168.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 33' ' ' SER 0.293 58.6 m 72.68 115.02 0.06 Allowed 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 126.995 2.118 . . . . 0.0 114.007 -173.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -55.34 16.9 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 C-N-CA 126.965 2.106 . . . . 0.0 115.218 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 31' ' ' SER . 34.1 t -103.91 -58.67 1.84 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.711 -0.618 . . . . 0.0 109.962 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.562 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 23.7 p80 -93.81 163.37 13.55 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 17.7 m -90.49 166.97 12.94 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.818 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 62.1 tp -67.45 -45.58 47.96 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 11.6 Cg_endo -55.47 -25.91 51.29 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.957 1.771 . . . . 0.0 111.503 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 1.9 m-20 -63.04 -24.55 67.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.281 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . . . -95.11 -49.53 5.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.154 0.502 . . . . 0.0 111.886 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.2 tp -105.16 -20.71 13.43 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -170.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -80.08 118.66 21.99 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.292 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -70.87 140.72 51.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.558 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.58 -33.25 6.58 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -98.92 -50.13 4.3 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.44 0.296 . . . . 0.0 110.859 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -52.75 119.29 4.41 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.998 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -153.7 124.4 7.2 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.53 92.61 0.85 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.649 0.738 . . . . 0.0 112.522 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 170.86 -66.26 0.01 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.693 1.597 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.42 -57.03 1.81 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.29 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.4 pt? -134.68 113.71 11.97 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.626 0.727 . . . . 0.0 110.808 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -161.41 169.48 21.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.533 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.6 tt -75.92 122.69 24.52 Favored 'General case' 0 CA--C 1.487 -1.461 0 C-N-CA 117.191 -1.803 . . . . 0.0 106.17 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.562 ' H ' ' NE2' ' A' ' 34' ' ' HIS . 26.2 tt0 -138.22 110.12 7.2 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 113.094 -1.866 . . . . 0.0 107.267 -174.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.431 ' HB3' ' H ' ' A' ' 150' ' ' THR . 8.0 t -93.48 123.65 36.94 Favored 'General case' 0 N--CA 1.411 -2.397 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.325 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.414 ' H ' ' CB ' ' A' ' 31' ' ' SER . 13.1 t70 -119.11 -24.1 6.6 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.722 -175.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.95 -69.61 0.68 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.314 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.91 171.5 8.59 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.534 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 148' ' ' GLU . 5.2 tm-20 -89.9 -24.77 21.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.028 0.931 . . . . 0.0 109.945 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -114.27 134.65 54.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.122 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' CD2' ' HA ' ' A' ' 30' ' ' GLN . 8.4 mp -128.76 165.28 21.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.373 0.606 . . . . 0.0 112.39 -172.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 tt -152.42 128.1 10.14 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.02 135.5 63.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.72 118.74 35.85 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -121.64 122.71 27.79 Favored Pre-proline 0 C--O 1.214 -0.772 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.357 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -92.56 137.43 1.6 Allowed 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.657 2.238 . . . . 0.0 111.415 171.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -92.43 162.89 14.06 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.293 0.568 . . . . 0.0 111.421 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.477 ' OD1' ' HG2' ' A' ' 68' ' ' GLN . 34.4 p30 -69.84 -36.11 75.29 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.477 ' HG2' ' OD1' ' A' ' 67' ' ' ASN . 19.5 pt20 -147.63 176.88 9.73 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.029 -0.419 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.18 124.48 39.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.23 0.538 . . . . 0.0 110.384 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.414 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -137.0 172.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 174.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -93.24 114.31 26.75 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 65.4 tp -76.66 127.97 33.8 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -126.08 -45.94 1.69 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.866 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 p -142.74 155.18 44.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -128.27 158.24 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.24 113.77 5.64 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 122.602 0.361 . . . . 0.0 110.284 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.2 mt -125.17 126.35 70.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 54.2 mtpt -117.79 152.42 35.35 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.421 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.85 -167.96 30.23 Favored Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 108.186 -1.965 . . . . 0.0 108.186 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.11 155.53 69.17 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.85 1.7 . . . . 0.0 109.078 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.97 -42.83 60.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.91 -37.25 10.78 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -76.6 2.27 14.49 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.77 150.2 30.78 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.594 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.9 161.74 35.21 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 121.938 1.759 . . . . 0.0 111.088 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 69.8 tttt -127.89 -73.98 0.59 Allowed 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.561 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.488 ' HA ' ' HG2' ' A' ' 112' ' ' GLU . 29.5 m -76.15 103.91 6.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.477 0.656 . . . . 0.0 110.193 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 86' ' ' LYS . 99.8 t -114.93 116.66 53.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.627 -173.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.91 147.23 26.78 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.231 -0.293 . . . . 0.0 110.26 172.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.54 138.91 54.47 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 86.6 m-85 -130.95 116.78 18.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 135' ' ' SER . 50.8 p -100.63 -14.09 18.29 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 26.1 t-20 -140.3 84.7 1.97 Allowed 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.146 -1.421 . . . . 0.0 113.87 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.475 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 85.5 tttt 171.69 148.81 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.109 1.364 . . . . 0.0 108.06 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -85.97 122.94 30.71 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.289 0.566 . . . . 0.0 111.427 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.366 0.3 OUTLIER 39.39 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.002 2.521 . . . . 0.0 117.299 176.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.475 ' SD ' ' HD3' ' A' ' 94' ' ' LYS . 91.7 mmm -83.91 148.51 26.9 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 174.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.7 m -129.33 162.93 26.84 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -52.68 -38.63 60.84 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 t -81.29 3.26 24.69 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HA ' ' OD1' ' A' ' 104' ' ' ASP . 4.0 p-10 -147.23 13.64 1.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.229 0.538 . . . . 0.0 110.616 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 p -75.5 -25.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -96.63 4.78 51.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.478 0.656 . . . . 0.0 110.618 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.421 ' OD1' ' HA ' ' A' ' 101' ' ' ASN . 8.3 m-20 -91.71 4.61 52.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.923 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -144.19 134.65 12.09 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.08 127.0 17.48 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.628 2.219 . . . . 0.0 111.7 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.14 168.55 23.02 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.597 2.198 . . . . 0.0 112.505 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.8 m -69.72 -40.66 76.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.43 174.11 3.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 76.0 m -143.7 113.45 7.11 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.27 163.7 20.18 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.563 -174.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.695 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 50.5 mt-10 -128.04 138.75 52.7 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.768 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.1 116.71 7.49 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 112.651 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 t -96.42 174.07 7.05 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.44 -36.34 68.91 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 118.257 0.48 . . . . 0.0 110.715 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -59.93 -42.36 93.79 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.434 HD21 HG22 ' A' ' 123' ' ' VAL . 14.1 t-20 -71.54 -41.66 68.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.538 ' O ' HD22 ' A' ' 118' ' ' LEU . 8.4 tt -73.85 -0.76 16.9 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.735 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -113.61 -5.07 13.41 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.174 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.508 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 118.63 -3.33 15.29 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.645 -1.264 . . . . 0.0 116.136 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -88.33 126.57 60.02 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.91 108.54 0.49 Allowed 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.707 2.938 . . . . 0.0 111.844 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 117' ' ' ASN . 68.9 t -88.65 127.1 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.23 141.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.412 0.445 . . . . 0.0 111.75 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.63 -172.85 2.2 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -72.7 103.79 3.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 110.355 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -75.16 1.77 12.51 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.361 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.64 -22.52 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.79 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -109.69 -9.97 14.83 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -170.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -77.62 11.11 2.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.128 -0.982 . . . . 0.0 112.447 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -58.51 133.42 55.8 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -163.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.294 2.8 p-10 53.7 113.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.911 2.084 . . . . 0.0 112.697 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.01 122.51 67.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.674 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -117.3 -28.28 6.19 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.551 0.691 . . . . 0.0 109.545 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' SER . 52.3 p -144.67 171.86 13.8 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.897 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.92 106.49 4.85 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 97' ' ' MET . 19.9 m -96.73 120.24 36.7 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.5 mt -105.1 111.28 33.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 141' ' ' GLU . 65.1 t80 -107.55 107.89 18.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.99 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.9 pt -106.64 113.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.633 0.73 . . . . 0.0 109.986 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 41.8 tt0 -112.66 13.38 19.9 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.999 0.904 . . . . 0.0 111.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.3 153.44 11.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.764 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.421 ' C ' ' HB2' ' A' ' 86' ' ' LYS . 39.8 m-80 -117.76 168.34 10.54 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 124.044 0.84 . . . . 0.0 108.91 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -44.21 -43.5 7.22 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.814 0.846 . . . . 0.0 112.186 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.2 m -124.1 8.77 8.61 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.732 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.39 55.56 28.99 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -83.35 2.72 34.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -168.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.411 ' HA ' ' CB ' ' A' ' 58' ' ' GLU . 47.2 mt-10 69.22 -4.28 1.34 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.802 0.841 . . . . 0.0 112.536 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.95 103.3 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 123.829 0.852 . . . . 0.0 110.114 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' ' 54' ' ' SER . 41.0 m -82.57 122.78 28.53 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 87.8 tttt -131.12 134.17 46.32 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 52' ' ' LEU . 11.3 m -130.46 148.38 33.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.129 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -86.54 -44.83 11.62 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.328 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.13 145.11 6.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.702 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 73.9 mt -117.98 122.87 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.1 137.28 42.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.27 137.56 51.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 74.3 m-85 -122.33 139.33 53.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.753 0.787 . . . . 0.0 111.703 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.94 -168.46 22.84 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.9 m -145.73 149.82 35.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 117.431 0.616 . . . . 0.0 109.676 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--N 1.29 -2.016 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.295 178.171 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 15' ' ' ASP . 2.0 mp . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.1 1.63 9.07 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.805 2.336 . . . . 0.0 112.964 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm 70.83 118.95 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.796 1.238 . . . . 0.0 111.423 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.81 -44.31 1.28 Allowed Glycine 0 C--N 1.307 -1.05 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -134.87 152.37 51.69 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 13.0 m -106.2 167.51 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.069 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.428 ' CG ' HH22 ' A' ' 45' ' ' ARG . 21.9 t70 -76.82 95.33 4.03 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.75 -0.38 0.11 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 126.917 2.087 . . . . 0.0 114.054 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 17' ' ' LEU . 5.5 tt -64.02 -31.73 73.02 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.49 -24.12 67.69 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.864 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.75 8.66 41.8 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.047 -0.408 . . . . 0.0 110.398 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.9 mt -85.57 119.08 33.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.25 -34.82 42.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' HG13 ' A' ' 25' ' ' VAL . 96.2 m95 70.23 6.57 5.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.8 t -84.96 -28.79 25.59 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.8 -89.23 1.78 Allowed Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 108.089 -2.005 . . . . 0.0 108.089 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.496 HG13 ' CZ3' ' A' ' 22' ' ' TRP . 92.3 t 41.89 94.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.246 1.418 . . . . 0.0 114.283 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.48 128.1 56.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.906 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.2 p -102.01 119.87 39.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.645 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.472 HD13 ' C ' ' A' ' 28' ' ' LEU . 2.6 tm? -64.3 -44.29 92.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.066 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -117.64 -99.63 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.127 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 8.5 tt0 56.08 22.14 5.7 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.301 1.048 . . . . 0.0 110.204 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -102.77 -12.67 17.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.88 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -54.76 -48.31 72.8 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.5 m 179.97 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 124.483 1.113 . . . . 0.0 110.399 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -73.31 163.36 28.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.628 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.449 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 45.8 m -98.51 140.22 33.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.542 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' CB ' ' HG ' ' A' ' 52' ' ' LEU . 7.0 tt -77.85 -44.82 2.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.453 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.07 -24.66 20.41 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.141 1.894 . . . . 0.0 112.79 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 86.0 m-20 -57.37 -48.43 79.07 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 121.227 0.537 . . . . 0.0 110.264 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.02 4.94 20.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.109 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' HZ2' ' A' ' 22' ' ' TRP . 49.2 tp -140.25 10.5 2.33 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -127.68 141.75 51.52 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 15.6 mm-40 -58.88 132.81 55.06 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -39.77 2.77 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.478 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -76.0 -48.25 21.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.611 -0.294 . . . . 0.0 111.287 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.447 ' NH1' HD12 ' A' ' 17' ' ' LEU . 32.1 ptt180 -68.12 107.8 2.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.056 0.931 . . . . 0.0 111.596 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.82 100.63 5.77 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB2' ' OE1' ' A' ' 153' ' ' GLN . 4.8 p-10 -71.68 84.65 0.89 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -173.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 16.9 tp10 168.96 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 113.241 -1.799 . . . . 0.0 108.29 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.11 -68.88 1.51 Allowed Glycine 0 C--O 1.238 0.396 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.785 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' A' ' 38' ' ' ASN . 1.9 pp -104.79 158.07 16.77 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 120.966 0.412 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.437 ' ND2' ' HG3' ' A' ' 151' ' ' LYS . 3.5 p-10 -161.76 166.41 26.56 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.464 ' HG ' ' CB ' ' A' ' 36' ' ' LEU . 3.2 tm? -111.51 128.82 56.13 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.04 162.44 35.46 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.763 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.658 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 51.2 p -92.12 176.09 6.63 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.944 0.153 . . . . 0.0 110.774 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 175.79 -46.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.925 0.89 . . . . 0.0 109.067 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.19 -28.84 63.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.59 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.658 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.3 t70 -160.29 145.71 15.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -74.06 -27.81 61.09 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 123.519 0.512 . . . . 0.0 112.236 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.2 132.19 34.06 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.304 0.574 . . . . 0.0 110.542 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.464 ' HB2' HG13 ' A' ' 140' ' ' ILE . 93.2 mt -131.12 144.43 51.39 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.327 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 62' ' ' ILE . 6.0 tt -153.06 144.35 23.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.52 ' N ' HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -150.29 138.94 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.482 ' N ' HD13 ' A' ' 62' ' ' ILE . 68.2 t80 -105.32 122.76 46.62 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.914 0.486 . . . . 0.0 111.825 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.415 ' CD1' HD11 ' A' ' 62' ' ' ILE . 2.3 mp -116.26 119.47 36.45 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.652 177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -86.84 127.74 2.7 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.538 2.159 . . . . 0.0 109.219 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -90.81 162.65 14.75 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -48.8 -57.6 6.12 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 126.376 1.87 . . . . 0.0 110.165 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -149.48 177.94 9.26 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 57.7 t -78.49 111.72 15.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.57 173.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -100.61 133.8 44.52 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 125' ' ' LEU . 2.4 tt -98.19 123.22 42.15 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -102.2 -41.44 6.39 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.822 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.0 p -154.63 160.93 41.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.027 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -135.23 150.23 50.03 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.608 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -143.6 98.11 3.19 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.7 mt -108.26 132.21 56.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 54.0 mtpt -116.55 159.3 22.31 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.264 0.554 . . . . 0.0 112.42 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.4 39.64 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -73.85 172.62 15.49 Favored 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 122.25 1.966 . . . . 0.0 110.356 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -27.93 60.51 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.834 0.35 . . . . 0.0 110.668 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.22 -47.17 7.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.18 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 151' ' ' LYS . 43.7 mt-10 -89.7 1.8 55.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.745 -176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.76 45.45 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.798 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 7.5 Cg_exo -71.21 107.07 2.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.174 1.916 . . . . 0.0 111.15 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.34 -43.39 13.74 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.7 m -92.74 97.22 10.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.143 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 111' ' ' ALA . 33.8 m -107.38 142.28 20.52 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -146.65 133.46 20.08 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.27 144.69 45.61 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.011 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -131.98 115.65 16.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.6 t -93.27 134.54 35.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 73.67 178.29 0.23 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.829 1.252 . . . . 0.0 111.501 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.4 tptm 72.41 101.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.063 1.345 . . . . 0.0 110.736 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.8 122.96 19.66 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.643 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t60 70.87 97.35 0.07 Allowed 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.389 1.056 . . . . 0.0 112.997 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 83.5 mtp -126.39 152.77 45.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 85.5 m -142.7 174.85 10.28 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.498 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 55.5 p90 -65.54 -17.6 64.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.1 m -73.19 -23.33 60.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.626 0.25 . . . . 0.0 111.454 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -128.51 3.34 5.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 111.514 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 8.3 p -65.09 -34.77 72.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.867 -173.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -97.71 5.1 49.73 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.75 -24.56 18.53 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.173 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -97.38 149.74 36.04 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.718 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.59 128.88 18.88 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 122.67 2.247 . . . . 0.0 112.028 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.68 160.27 41.29 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.436 2.09 . . . . 0.0 111.256 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -76.79 -41.95 42.55 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.489 0.661 . . . . 0.0 109.378 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.63 ' OD2' ' HG3' ' A' ' 126' ' ' LYS . 14.9 t70 -161.71 146.71 13.24 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -127.99 124.17 36.54 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 173.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.407 ' HB1' ' CG2' ' A' ' 88' ' ' VAL . . . -119.05 172.89 7.24 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.085 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.44 134.59 55.14 Favored 'General case' 0 N--CA 1.405 -2.676 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 28.4 tp -69.57 121.54 17.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -98.03 169.59 9.52 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.861 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -31.77 72.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.87 -33.88 71.05 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.82 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.608 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -64.44 -42.57 95.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.464 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 87.2 mt -62.19 -4.87 1.93 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.83 1.252 . . . . 0.0 113.642 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -113.14 -9.39 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 122.821 0.448 . . . . 0.0 109.976 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.83 0.58 34.19 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.914 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 31.9 mmmt -75.34 131.52 77.74 Favored Pre-proline 0 C--O 1.246 0.907 0 O-C-N 123.592 0.231 . . . . 0.0 111.375 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 29.7 Cg_exo -65.14 119.54 6.59 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.288 2.659 . . . . 0.0 111.639 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.0 t -97.54 136.0 29.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.04 117.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.405 0.621 . . . . 0.0 111.252 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.54 -175.59 4.74 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.401 176.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.63 ' HG3' ' OD2' ' A' ' 109' ' ' ASP . 29.9 mtpp -64.54 89.9 0.07 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.619 0.723 . . . . 0.0 112.06 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -69.68 -21.37 63.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.732 1.213 . . . . 0.0 110.959 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 m -80.33 -19.23 12.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.03 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 9.9 tmtt? -92.85 -41.84 9.86 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CD1' HD12 ' A' ' 125' ' ' LEU . 91.8 m-85 -75.77 78.97 2.71 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 112.021 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -107.99 -40.44 5.23 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.418 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.29 112.65 23.44 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.388 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 49.0 t -123.3 102.38 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -95.87 -31.07 13.32 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.4 p -156.94 162.99 39.62 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 137' ' ' THR . 4.4 tt -148.82 133.99 18.29 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.461 ' N ' HD22 ' A' ' 136' ' ' LEU . 64.6 m -104.32 124.7 49.65 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mp -103.03 125.96 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.63 118.25 27.72 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 60' ' ' LEU . 10.5 pt -112.46 114.32 46.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.68 0.753 . . . . 0.0 109.76 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.66 -42.43 9.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.612 -172.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.24 150.58 38.16 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.899 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.08 167.99 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.834 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.463 HE21 HD22 ' A' ' 113' ' ' LEU . 82.6 mm-40 -48.47 -48.61 37.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.0 m -92.84 -19.45 21.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.81 42.38 61.26 Favored Glycine 0 C--N 1.311 -0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.6 t -87.86 9.86 20.57 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.938 -0.631 . . . . 0.0 110.752 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 68.15 8.39 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.379 1.072 . . . . 0.0 112.318 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.02 112.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-O 121.976 0.893 . . . . 0.0 109.378 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.6 m -106.74 121.28 44.05 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 83' ' ' GLU . 4.9 ttmp? -113.4 133.62 55.07 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.232 0.539 . . . . 0.0 110.485 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.7 t -125.68 116.1 45.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.654 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 47' ' ' ASP . 9.7 pt20 -85.87 -29.92 23.32 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.45 145.43 12.96 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.28 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.36 129.32 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.59 129.63 20.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.98 144.73 42.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 84.5 m-85 -124.16 113.21 18.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.307 0.575 . . . . 0.0 111.042 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.96 -167.24 11.0 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.4 p -162.44 162.95 27.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 118.315 1.057 . . . . 0.0 112.556 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.302 -1.469 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.315 173.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.6 mt . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.26 143.22 4.62 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 122.3 2.0 . . . . 0.0 111.715 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -59.18 130.67 48.09 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.69 0.757 . . . . 0.0 112.021 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -42.26 1.96 Allowed Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -106.67 173.3 6.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.615 0.721 . . . . 0.0 110.064 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -130.15 143.94 39.5 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 154.5 29.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.029 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 20' ' ' ILE . 4.3 mm? -101.64 8.83 41.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.927 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.48 -48.49 15.24 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.85 -27.22 68.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.788 -1.097 . . . . 0.0 110.918 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -84.07 9.84 11.56 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 16' ' ' LEU . 75.4 mt -93.71 127.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.28 -15.99 41.6 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.508 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 25' ' ' VAL . 86.0 m95 58.88 30.7 20.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.709 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -57.31 -36.19 70.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.933 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.2 -47.37 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 22' ' ' TRP . 2.7 t 62.7 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.348 1.059 . . . . 0.0 109.885 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -121.78 139.85 53.08 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.018 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.54 128.74 29.81 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.58 -26.78 68.77 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -99.41 -105.02 0.22 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.325 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 54.73 15.61 1.15 Allowed 'General case' 0 CA--C 1.573 1.842 0 CA-C-O 122.322 1.058 . . . . 0.0 110.306 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 t -78.36 -30.1 47.81 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.613 1.165 . . . . 0.0 107.931 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 4.9 p -64.95 7.09 0.18 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m 76.66 -17.23 0.56 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.409 ' ND1' ' HB3' ' A' ' 53' ' ' GLU . 29.6 m80 -77.62 134.98 38.08 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.659 174.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -83.05 157.31 22.93 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -81.74 -53.74 0.7 Allowed Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.83 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.3 -15.19 33.57 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 121.845 1.697 . . . . 0.0 113.661 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' HB2' HD11 ' A' ' 50' ' ' LEU . 32.0 p30 -75.25 -22.64 57.69 Favored 'General case' 0 C--O 1.209 -1.045 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.905 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.79 1.18 36.92 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.362 0.601 . . . . 0.0 110.825 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.84 -43.7 2.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.091 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.11 130.43 35.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.925 0.393 . . . . 0.0 110.947 -174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -57.82 140.05 52.66 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 124.501 1.12 . . . . 0.0 110.641 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.8 -59.5 0.53 Allowed Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -73.77 -41.04 62.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.7 ' HD2' ' O ' ' A' ' 45' ' ' ARG . 2.7 tmm_? -53.49 -11.44 0.34 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.961 2.104 . . . . 0.0 111.569 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -65.44 100.53 0.5 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.22 98.83 0.84 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.0 -75.24 0.32 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.225 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.34 -54.38 0.79 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.957 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 38' ' ' ASN . 1.8 pp -85.03 147.46 26.67 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.757 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -164.06 166.32 21.51 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.641 -177.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.2 tp -83.59 123.47 29.81 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.409 ' HB3' ' ND1' ' A' ' 34' ' ' HIS . 32.2 tt0 -140.71 130.53 24.41 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.729 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.624 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 64.7 p -101.91 151.05 22.56 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -123.8 -54.28 1.74 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.584 -170.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.95 -26.41 25.52 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.192 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -130.39 145.97 51.89 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 117.958 -1.497 . . . . 0.0 111.634 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.25 -31.75 24.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.929 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -68.49 114.96 7.36 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.334 0.587 . . . . 0.0 110.855 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.8 tp -126.05 107.53 10.51 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.408 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.61 130.71 54.87 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.61 132.87 68.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -113.91 126.19 54.89 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.71 121.23 44.78 Favored Pre-proline 0 N--CA 1.425 -1.694 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.36 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.94 112.59 3.3 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.593 2.196 . . . . 0.0 110.273 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -80.2 164.13 23.5 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 126.065 1.746 . . . . 0.0 113.922 -175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -106.11 -37.53 6.57 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.069 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -150.62 160.6 43.71 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.64 128.2 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 124.028 0.83 . . . . 0.0 109.323 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.429 ' CD1' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -134.44 174.06 13.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 174.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 160' ' ' SER . 38.6 ttpt -97.13 146.8 24.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 133' ' ' VAL . 87.3 mt -78.83 159.11 27.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HA ' ' CE2' ' A' ' 127' ' ' TYR . 13.2 t60 -146.82 -66.02 0.28 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.793 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.9 p -137.77 163.02 32.38 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.821 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -140.1 149.06 42.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.99 111.66 8.73 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.745 0.307 . . . . 0.0 110.25 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.7 mt -123.81 120.6 60.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -96.46 136.38 37.04 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.273 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -164.39 156.56 28.53 Favored Glycine 1 C--N 1.25 -4.23 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 177.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.53 172.49 12.32 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 122.002 1.801 . . . . 0.0 112.887 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.98 -24.53 55.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.959 0.885 . . . . 0.0 109.416 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.19 -55.14 4.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.0 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -109.18 7.96 25.68 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.703 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.94 158.23 36.41 Favored Glycine 0 C--N 1.305 -1.188 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.272 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.616 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.0 Cg_exo -77.12 107.66 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.888 1.725 . . . . 0.0 110.902 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 1.0 OUTLIER -89.19 -51.78 5.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.981 -176.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.7 m -93.44 95.46 9.3 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.715 0.769 . . . . 0.0 109.699 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -98.02 135.04 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.779 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.58 141.82 49.77 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.813 0.816 . . . . 0.0 110.256 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 53.3 m-85 -115.17 145.39 42.44 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.547 ' CZ ' ' HB ' ' A' ' 102' ' ' VAL 0.257 76.2 m-85 -118.12 146.74 43.93 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 178.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -74.14 -158.5 0.07 Allowed 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.651 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 134' ' ' ARG . 27.7 t-20 -53.21 -20.06 3.67 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.492 1.917 . . . . 0.0 112.862 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -72.33 111.8 7.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.38 161.15 13.79 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 65.35 23.48 12.05 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 111.365 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 79.7 mtp -68.29 135.41 51.88 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.897 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.458 ' O ' HG11 ' A' ' 102' ' ' VAL . 19.9 p -102.91 174.04 6.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -62.37 -29.14 70.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -87.27 -5.7 58.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -104.4 -19.64 13.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.547 ' HB ' ' CZ ' ' A' ' 91' ' ' PHE . 33.1 m -83.69 2.72 3.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.778 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.62 -26.33 21.96 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.993 0.425 . . . . 0.0 111.944 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -110.48 10.22 23.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.796 0.331 . . . . 0.0 111.166 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -124.22 131.68 24.22 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.65 126.93 11.88 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.76 162.03 42.96 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.356 2.037 . . . . 0.0 111.567 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 16.7 m -60.42 -45.36 93.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.038 0.923 . . . . 0.0 108.826 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -167.9 166.18 13.51 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -133.45 128.58 35.76 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.0 172.85 8.21 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.302 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 39.4 tt0 -125.38 138.05 54.04 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.94 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 27.6 tp -70.15 100.87 1.73 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.9 t -91.37 167.61 12.16 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.3 -35.68 67.79 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.69 0.396 . . . . 0.0 111.748 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.4 -38.84 85.27 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.36 -44.41 65.08 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 79' ' ' GLY . 5.1 tt -57.91 -31.81 67.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.527 1.531 . . . . 0.0 109.671 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -85.2 -3.02 58.67 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.02 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -94.24 137.05 22.94 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.08 115.19 2.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.673 2.915 . . . . 0.0 112.934 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.4 t -96.42 137.71 23.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.68 123.88 32.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.18 176.87 5.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.587 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -94.9 110.5 22.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.063 0.458 . . . . 0.0 110.394 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.425 ' CE2' ' HA ' ' A' ' 73' ' ' HIS . 45.2 p90 -125.41 26.48 6.81 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.47 -33.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.01 0.434 . . . . 0.0 111.463 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -90.42 -32.6 16.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.407 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 56.3 m-85 -90.41 69.94 6.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.814 0.816 . . . . 0.0 112.169 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -88.41 -12.7 42.44 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.79 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -146.2 120.99 9.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.436 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 72' ' ' LEU . 94.1 t -121.42 104.61 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.139 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.418 ' HB3' ' ND2' ' A' ' 93' ' ' ASN . 29.3 tpt180 -71.78 -50.44 29.83 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.801 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.6 p -134.66 150.72 50.68 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -129.98 135.44 48.3 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.869 0.366 . . . . 0.0 110.511 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 70.2 m -121.95 129.64 52.67 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.7 mp -107.56 121.21 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 74.3 t80 -124.35 125.72 44.8 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.014 0.435 . . . . 0.0 112.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.1 pt -119.51 126.13 75.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.555 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.9 pt-20 -108.78 -17.98 13.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.97 22.34 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.253 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -98.15 -174.22 2.79 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -62.08 -63.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.485 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -103.43 -42.22 5.77 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.927 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.79 69.21 0.64 Allowed Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 -174.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.8 m -84.78 16.72 3.14 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.409 0.684 . . . . 0.0 111.329 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 76.2 -43.67 0.48 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.405 1.482 . . . . 0.0 111.9 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.4 m -102.35 157.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.624 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 59.2 m -121.94 128.68 51.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -129.25 133.58 47.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.001 0.429 . . . . 0.0 110.079 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 7.2 p -134.77 125.36 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -73.68 -47.57 38.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.532 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 147.06 10.31 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -122.74 122.99 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.73 121.42 12.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.05 147.09 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -124.93 118.95 27.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.97 -157.0 11.05 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 38.7 m -152.75 126.22 8.75 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.276 -2.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.422 175.604 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--O 1.243 0.737 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -87.0 170.56 7.14 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.257 1.971 . . . . 0.0 112.855 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -59.62 114.73 2.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.544 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.51 -61.98 0.55 Allowed Glycine 0 N--CA 1.423 -2.202 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.105 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.439 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -112.53 -171.86 1.94 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.395 0.617 . . . . 0.0 111.034 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.49 150.48 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 173.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 32.9 t0 -72.29 126.38 29.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 157' ' ' LEU . 59.2 mt -81.06 4.36 20.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 5.4 tt -51.42 -35.86 41.14 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.299 1.047 . . . . 0.0 108.411 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.37 -38.93 81.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.21 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.69 -2.46 58.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.5 mt -74.11 136.98 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.509 ' O ' HG13 ' A' ' 25' ' ' VAL . 16.2 t70 -99.54 112.89 25.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -80.52 1.51 29.18 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -93.05 -35.89 12.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.36 -19.99 61.27 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.756 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 21' ' ' ASP . 28.4 m -54.2 130.89 16.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.756 0.789 . . . . 0.0 112.126 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.7 tp10 -112.06 127.5 55.92 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.604 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 26.4 p -130.26 113.59 14.6 Favored 'General case' 0 N--CA 1.398 -3.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.198 -175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.62 -75.17 0.14 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.299 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.454 HD22 ' HB3' ' A' ' 56' ' ' ALA . 64.2 t30 -116.41 -81.43 0.61 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.561 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' ' 27' ' ' CYS . 1.9 mp0 62.82 23.29 13.9 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 14.4 m 89.52 139.86 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 127.609 2.363 . . . . 0.0 112.675 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.4 t -70.35 -46.36 64.29 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.675 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.3 m -77.45 -35.68 53.66 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.684 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 98.1 m-70 -124.61 149.27 47.25 Favored 'General case' 0 C--O 1.189 -2.102 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -140.98 -168.29 2.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 116.745 -1.982 . . . . 0.0 115.378 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 29.8 tp -60.88 -52.47 72.1 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 50.2 Cg_exo -54.47 -32.23 72.4 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.1 1.867 . . . . 0.0 112.751 -172.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.548 ' HB2' HD12 ' A' ' 50' ' ' LEU . 2.9 p-10 -84.43 3.43 36.16 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.87 -23.8 3.04 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.936 0.398 . . . . 0.0 112.042 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -105.13 -18.12 14.25 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.116 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -80.28 147.68 31.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -66.09 143.67 57.17 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.32 -37.09 3.03 Favored Glycine 0 N--CA 1.413 -2.882 0 CA-C-N 114.87 -1.059 . . . . 0.0 114.386 170.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -74.6 -25.71 59.44 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.301 0.0 OUTLIER -60.14 67.51 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -160.91 141.76 11.56 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.754 1.622 . . . . 0.0 107.979 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.8 100.43 10.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.646 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.12 17.9 0.76 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.426 0.631 . . . . 0.0 109.931 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.14 -59.92 0.23 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 38' ' ' ASN . 2.3 pp -105.19 149.38 25.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.684 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 47.1 t30 -161.72 163.41 29.69 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.407 HD22 HD21 ' A' ' 60' ' ' LEU . 3.8 tt -105.32 111.98 24.91 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 171.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -141.45 122.34 14.48 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.62 ' HA ' ' OG ' ' A' ' 31' ' ' SER 0.27 36.2 p -51.76 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -171.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 18.8 t70 -113.52 88.13 2.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.14 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.454 ' HB3' HD22 ' A' ' 29' ' ' ASN . . . 157.4 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.211 2.204 . . . . 0.0 107.987 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -139.03 157.16 46.48 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.986 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -89.02 75.14 8.02 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.497 HE21 ' C ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -174.53 139.66 0.58 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.396 1.078 . . . . 0.0 109.139 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 140' ' ' ILE . 10.3 mp -135.19 147.28 49.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.619 0.768 . . . . 0.0 109.645 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 4.6 tt -149.24 124.44 10.14 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -139.43 135.05 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.543 ' N ' HD12 ' A' ' 62' ' ' ILE . 45.1 t80 -105.78 125.64 51.23 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.93 0.892 . . . . 0.0 110.324 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -116.77 120.73 33.82 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.403 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -97.85 127.43 0.23 Allowed 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 123.054 2.503 . . . . 0.0 110.421 170.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -95.14 139.75 31.04 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.21 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -72.73 -20.57 61.18 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.164 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -147.48 144.47 28.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.77 120.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.684 0.754 . . . . 0.0 111.16 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 168.43 10.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HB3' ' HZ3' ' A' ' 71' ' ' LYS . 7.5 mtpm? -96.16 113.62 25.24 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 55.3 tp -71.2 152.5 43.29 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.424 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 17.9 t60 -139.22 -49.57 0.5 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.978 0.418 . . . . 0.0 111.526 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -147.19 167.54 23.92 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 122.036 -0.415 . . . . 0.0 111.91 -175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 12.3 p90 -129.43 158.21 39.81 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -151.66 131.94 13.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.868 0.366 . . . . 0.0 111.039 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.19 128.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -104.04 155.63 18.52 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.347 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.26 -178.07 42.61 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.489 ' CD ' ' HB2' ' A' ' 151' ' ' LYS . 15.3 Cg_exo -68.18 159.99 50.76 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 122.91 2.407 . . . . 0.0 110.86 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.09 -29.15 68.02 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 35.1 mt-10 -93.34 -41.53 9.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.42 0.629 . . . . 0.0 111.463 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 15.35 25.88 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.096 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -85.79 150.73 24.43 Favored Glycine 0 C--N 1.307 -1.054 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 47.8 Cg_exo -55.61 160.66 8.97 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.807 2.338 . . . . 0.0 112.646 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.82 -56.31 0.18 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.8 m -80.99 100.05 8.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.861 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 140' ' ' ILE . 48.8 t -123.39 119.72 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.361 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.22 131.12 56.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 109' ' ' ASP 0.253 32.5 p90 -138.26 134.11 33.98 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 177.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -110.25 159.39 17.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 p -148.47 167.54 25.05 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 117.965 0.348 . . . . 0.0 111.838 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.268 19.2 m120 86.48 -24.59 0.12 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -97.92 148.09 23.8 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.889 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.84 134.85 37.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 68.25 94.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.275 1.03 . . . . 0.0 111.365 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.6 mmm -127.41 107.2 9.75 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.652 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 22.0 p -98.45 177.99 5.17 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -67.35 -25.87 66.21 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.9 t -56.62 -49.85 73.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.35 -38.89 92.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.958 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 82.5 t -64.97 -29.79 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.04 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.69 -19.87 58.81 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.299 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -104.61 -42.38 5.43 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.32 124.83 47.69 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.953 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.95 135.93 71.9 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.963 2.442 . . . . 0.0 110.882 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.17 167.36 14.58 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.552 2.168 . . . . 0.0 112.383 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -83.14 -44.77 14.72 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 20.0 t70 -143.14 151.02 40.23 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.915 174.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.1 p -115.35 118.21 32.59 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.34 150.73 26.95 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.103 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.98 107.04 10.43 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 8.5 tt -72.21 134.42 45.64 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.197 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.4 p -116.36 169.17 9.51 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.483 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.64 -33.05 72.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.867 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.17 -40.99 91.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.29 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.551 HD22 ' HA ' ' A' ' 76' ' ' ALA . 2.9 t-20 -63.38 -47.18 83.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.621 -177.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.46 -14.26 61.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -87.76 10.32 18.76 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.716 0.77 . . . . 0.0 109.065 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.06 12.7 56.12 Favored Glycine 0 CA--C 1.507 -0.438 0 CA-C-N 114.272 -1.331 . . . . 0.0 114.627 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 12.2 mptt -99.31 117.55 63.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.35 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 67.3 Cg_exo -56.29 119.73 7.11 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.954 3.103 . . . . 0.0 112.481 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 58.5 t -93.01 131.59 39.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 m -83.19 127.45 39.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 121.523 0.678 . . . . 0.0 111.455 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.52 179.03 4.99 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.933 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.59 94.49 6.3 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 20.0 p90 -105.08 12.43 32.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.75 -26.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.539 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -99.33 14.54 29.28 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.176 175.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.04 74.87 1.18 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.463 ' OE1' ' HE2' ' A' ' 71' ' ' LYS . 28.7 mm-40 -109.1 -37.91 5.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -112.55 114.31 26.9 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 t -122.48 100.88 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.806 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.592 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -87.1 -36.39 18.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 109.766 169.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.9 p -141.84 141.67 33.11 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.598 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 137' ' ' THR . 5.8 tt -140.16 141.48 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.562 ' N ' HD23 ' A' ' 136' ' ' LEU . 35.7 m -127.01 120.64 29.55 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -104.97 122.16 57.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 122.799 0.44 . . . . 0.0 110.405 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -122.59 107.27 11.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 60' ' ' LEU . 2.0 pp -104.45 141.14 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.512 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -111.13 -25.66 9.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -158.51 158.43 34.03 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.66 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -99.9 179.4 4.52 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.621 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 85.8 mm-40 -50.12 -59.82 3.55 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.632 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.5 m -91.03 -8.44 49.07 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.203 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.14 42.28 96.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.2 m -88.96 15.64 8.23 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 74.38 -42.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.807 1.243 . . . . 0.0 113.54 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -102.14 105.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.368 1.08 . . . . 0.0 110.576 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 34.5 m -97.02 124.22 40.95 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.109 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.489 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -97.11 133.73 41.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.412 0.625 . . . . 0.0 109.64 177.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.11 107.78 10.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 124.946 1.298 . . . . 0.0 107.742 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -91.12 -32.33 15.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.28 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.54 ' NZ ' ' HB1' ' A' ' 156' ' ' ALA . 7.4 tmtm? -152.93 133.49 13.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.2 mt -118.52 136.69 54.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.54 ' HB1' ' NZ ' ' A' ' 154' ' ' LYS . . . -144.36 148.59 34.92 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 121.411 0.624 . . . . 0.0 110.643 174.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 2.8 mm? -117.57 127.38 53.92 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 13' ' ' GLN . 61.7 m-85 -108.38 128.81 55.1 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -149.72 -166.73 13.54 Favored Glycine 0 C--N 1.286 -2.218 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -152.92 142.66 22.0 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.309 0.555 . . . . 0.0 110.44 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 117.566 -1.207 . . . . 0.0 109.743 176.535 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.474 HG21 ' H ' ' A' ' 11' ' ' LYS . 45.9 mm . . . . . 0 N--CA 1.427 -1.581 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -91.95 27.1 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.284 2.656 . . . . 0.0 111.214 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' H ' HG21 ' A' ' 9' ' ' ILE . 88.1 tttt 64.06 112.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.744 1.618 . . . . 0.0 112.028 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.89 -81.21 0.19 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.84 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 2.2 mp0 -100.1 175.48 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 17.4 m -107.2 162.54 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 CA-C-O 120.803 0.335 . . . . 0.0 111.406 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.81 118.63 21.77 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 70' ' ' ILE . 35.3 mt -69.99 2.52 3.45 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.236 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.58 -42.86 97.55 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.127 0.965 . . . . 0.0 108.651 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.49 -26.1 67.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.016 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -102.55 22.33 13.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.092 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 16' ' ' LEU . 78.6 mt -97.45 126.33 50.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 121.411 -0.116 . . . . 0.0 110.815 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.74 118.05 28.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -90.82 6.82 42.8 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.486 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 m -89.93 -18.72 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 7.31 7.21 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.586 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.18 141.08 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 117.645 0.723 . . . . 0.0 111.538 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -129.61 134.56 47.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.232 0.539 . . . . 0.0 110.144 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . 19.8 p -110.92 114.56 27.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.958 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD13 ' C ' ' A' ' 28' ' ' LEU . 3.1 tm? -63.9 -68.82 0.32 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.75 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.41 ' OD1' HD13 ' A' ' 60' ' ' LEU 0.255 7.2 p-10 -104.17 -52.9 2.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 33.1 tt0 69.36 0.95 3.09 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 122.923 0.489 . . . . 0.0 111.551 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.588 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 79.1 p 73.94 130.29 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 127.472 2.309 . . . . 0.0 110.712 -168.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.7 m -62.35 15.65 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 31' ' ' SER . 38.0 m -138.2 -28.91 0.84 Allowed 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -124.48 165.57 17.55 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.715 -0.616 . . . . 0.0 112.18 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -91.07 -179.44 5.45 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -174.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.439 ' H ' ' HD2' ' A' ' 37' ' ' PRO . 15.8 tp -98.3 -56.8 0.18 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HD2' ' H ' ' A' ' 36' ' ' LEU . 24.7 Cg_endo -58.11 -22.09 54.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.663 2.242 . . . . 0.0 112.584 -175.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.492 HD21 ' HB2' ' A' ' 50' ' ' LEU . 31.7 p-10 -64.83 -30.04 71.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.57 -6.17 12.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.616 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -105.27 -25.23 12.51 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.391 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -81.87 137.24 35.27 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.463 0.649 . . . . 0.0 111.603 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -63.29 134.89 56.58 Favored 'General case' 0 N--CA 1.39 -3.47 0 C-N-CA 125.182 1.393 . . . . 0.0 108.538 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.09 -56.81 1.78 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.666 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.84 -35.74 79.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.896 0.478 . . . . 0.0 111.488 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.441 ' HD2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -54.79 174.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.414 2.375 . . . . 0.0 117.414 -175.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 153' ' ' GLN 0.375 44.3 mt-10 74.34 145.43 0.08 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.751 1.62 . . . . 0.0 115.162 177.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.03 117.88 6.56 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.06 -172.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.57 -68.48 0.26 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.97 -51.39 0.1 OUTLIER Glycine 0 CA--C 1.484 -1.886 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HB2' HD21 ' A' ' 38' ' ' ASN . 3.8 pp -78.87 156.34 28.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.007 -0.597 . . . . 0.0 109.808 174.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -161.38 165.88 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.438 ' CD1' HD11 ' A' ' 36' ' ' LEU . 4.7 tt -118.05 116.8 27.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.588 ' O ' ' HB3' ' A' ' 31' ' ' SER . 8.3 pt-20 -109.99 163.03 13.95 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.8 p -52.0 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 O-C-N 123.763 0.664 . . . . 0.0 112.211 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 54' ' ' SER . 13.8 t70 163.59 -156.89 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' H ' ' CG ' ' A' ' 55' ' ' ASP . . . -71.67 -24.75 61.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.09 154.86 18.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.992 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.67 16.75 21.05 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -103.56 104.47 14.54 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.41 HD13 ' OD1' ' A' ' 29' ' ' ASN . 60.8 tp -114.53 132.62 56.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.484 HD21 ' N ' ' A' ' 62' ' ' ILE . 5.0 tt -137.87 133.83 34.36 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.913 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.484 ' N ' HD21 ' A' ' 61' ' ' LEU . 3.3 mp -133.76 132.18 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -100.94 129.18 46.75 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 20' ' ' ILE . 3.0 mp -120.98 124.02 27.62 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.582 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -95.64 157.64 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.977 2.451 . . . . 0.0 110.815 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -84.52 162.24 19.93 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.497 1.141 . . . . 0.0 113.438 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -97.82 -47.91 5.39 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.881 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -133.46 149.25 51.76 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.661 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.45 116.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -129.95 173.06 14.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -91.9 143.63 26.3 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.44 158.02 21.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -148.76 -63.77 0.24 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.3 p -143.7 165.71 26.9 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.724 -171.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 4.9 p90 -133.51 159.25 40.98 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -151.98 100.13 2.62 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 120.914 0.388 . . . . 0.0 111.802 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 64.8 mt -102.62 136.13 36.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -118.49 144.09 46.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.454 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.23 -178.74 38.64 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 22.4 Cg_exo -69.29 157.23 62.06 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.202 1.935 . . . . 0.0 110.29 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 mt-10 -62.0 -35.92 79.98 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.54 -48.22 6.2 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 43.7 mt-10 -80.1 20.44 0.65 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.631 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.62 167.5 24.55 Favored Glycine 0 C--N 1.301 -1.416 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.274 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 35.9 Cg_endo -76.79 178.97 6.95 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 121.835 1.69 . . . . 0.0 111.012 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 3.1 tmmm? -144.26 -61.85 0.38 Allowed 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.608 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 51.3 m -80.43 103.45 10.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.55 116.51 51.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.436 -175.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -107.66 135.84 48.41 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.547 0.689 . . . . 0.0 111.111 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.41 134.76 53.76 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.0 m-85 -124.57 115.57 21.06 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 175.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.402 ' HB2' ' CE1' ' A' ' 130' ' ' PHE . 20.4 m -110.92 150.57 29.03 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m120 82.08 154.68 0.12 Allowed 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.801 1.313 . . . . 0.0 108.39 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER 67.68 100.87 0.05 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.649 0.737 . . . . 0.0 110.287 -175.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.63 140.16 38.45 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.527 0.68 . . . . 0.0 112.056 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 67.45 89.58 0.1 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 125.664 1.586 . . . . 0.0 111.839 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 81.8 mtp -119.86 142.37 48.72 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 102' ' ' VAL . 59.9 m -128.98 176.39 7.91 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -56.9 -20.42 23.16 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.0 m -81.5 -50.26 9.61 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.695 -0.628 . . . . 0.0 111.31 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -95.57 6.65 48.42 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.894 0.378 . . . . 0.0 111.529 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 11.4 p -59.31 -37.35 68.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 123.823 0.849 . . . . 0.0 112.222 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -108.78 16.82 22.48 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.782 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -86.51 -20.98 27.24 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.064 0.935 . . . . 0.0 109.06 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -113.41 138.7 22.59 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.106 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.46 138.05 68.47 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.698 2.265 . . . . 0.0 112.538 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.23 152.67 45.16 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.4 2.066 . . . . 0.0 111.875 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -61.71 -45.58 93.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -167.98 168.96 11.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -128.59 123.19 32.72 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.41 169.05 10.36 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.365 0.603 . . . . 0.0 111.777 -174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.6 mp0 -120.31 127.46 52.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.42 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.48 110.89 7.19 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.9 t -101.0 174.46 6.0 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.65 -34.8 74.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.758 0.823 . . . . 0.0 110.641 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.21 -32.55 68.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.997 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.562 HD22 ' HA ' ' A' ' 76' ' ' ALA . 1.3 t-20 -68.81 -34.27 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.2 2.68 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.493 1.517 . . . . 0.0 113.26 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 117' ' ' ASN . 39.5 ttmt -113.1 -14.11 12.97 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.472 1.109 . . . . 0.0 108.944 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.5 1.89 43.77 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.999 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -75.55 126.32 87.6 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.75 121.53 8.77 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.408 2.739 . . . . 0.0 114.067 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 57.7 t -99.04 141.37 16.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.62 144.01 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -131.9 -174.75 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.046 0.938 . . . . 0.0 111.745 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -82.39 115.74 21.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -138.63 15.03 2.73 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.434 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.22 -38.51 81.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.181 0.515 . . . . 0.0 110.429 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -95.0 2.36 55.33 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 92' ' ' SER . 76.6 m-85 -117.78 66.32 0.75 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.653 0.74 . . . . 0.0 111.737 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.83 1.91 53.43 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 0.0 109.483 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -148.2 116.07 6.39 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.78 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.8 t -116.88 137.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.444 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -116.98 -55.84 2.31 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.288 1.035 . . . . 0.0 108.802 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.0 p -118.57 139.21 51.83 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.8 tp -135.35 111.95 9.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.874 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 29.3 m -102.64 121.62 42.77 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.81 116.73 49.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 61.1 t80 -122.83 119.62 31.11 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 140' ' ' ILE . 2.3 pp -108.9 131.41 59.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.469 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 12.9 pt-20 -119.86 -14.92 8.92 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.803 -0.759 . . . . 0.0 113.01 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.69 145.8 48.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.472 HD22 ' HB2' ' A' ' 58' ' ' GLU . 87.2 m-20 -101.79 169.14 8.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -62.94 -56.08 20.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.876 0.735 . . . . 0.0 109.167 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.9 t -122.05 9.52 9.94 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.315 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 143' ' ' ASN . . . 62.29 67.59 2.03 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.0 m -100.74 9.2 42.71 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 68.22 -55.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.49 1.116 . . . . 0.0 111.478 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.46 108.05 23.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 62.9 m -102.04 111.43 23.7 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.245 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 64.1 pttt -96.49 134.09 40.11 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.913 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.83 136.47 39.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.117 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.473 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 79.3 mt-30 -87.42 -51.87 5.69 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.57 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.01 149.25 14.1 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.546 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.3 112.86 35.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.64 137.08 29.73 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.05 159.55 18.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 56.1 m-85 -125.72 132.84 52.28 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -153.52 -149.96 5.32 Favored Glycine 0 C--N 1.299 -1.5 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 46.3 m -157.87 161.33 38.3 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.406 HG22 HG21 ' A' ' 70' ' ' ILE . 66.9 p . . . . . 0 C--N 1.279 -2.488 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.384 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 13' ' ' GLN . 2.2 mp . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -72.92 -69.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.271 1.981 . . . . 0.0 111.808 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -162.08 -68.73 0.05 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.94 -10.99 82.19 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.241 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.53 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.72 134.21 50.72 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -174.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 p -105.9 153.69 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.818 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.97 120.62 12.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.45 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.5 mt -93.96 10.19 34.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' HG ' ' NH2' ' A' ' 45' ' ' ARG . 3.4 tm? -64.97 -36.66 85.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.493 0.663 . . . . 0.0 110.922 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -85.52 1.77 47.57 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.237 1.017 . . . . 0.0 110.498 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 m-85 -101.15 7.47 43.16 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.6 mt -89.97 133.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.332 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.58 113.8 23.61 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -85.04 -0.54 54.77 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.855 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.9 m -87.3 -36.79 17.67 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.7 -13.2 32.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.207 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.93 132.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 117.166 0.483 . . . . 0.0 110.626 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 32.6 tt0 -145.05 159.57 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.066 0.46 . . . . 0.0 110.054 -177.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 53.2 t -135.78 135.61 40.05 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -60.27 -57.86 10.97 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.323 1.015 . . . . 0.0 108.543 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.7 -64.19 0.91 Allowed 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 70.27 -52.31 0.65 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.988 1.315 . . . . 0.0 114.274 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 48.0 m -155.86 87.63 1.08 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -175.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.0 p -67.17 -29.34 69.01 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.976 162.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.2 m -154.49 -57.49 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.154 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.502 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.5 m-70 -88.0 162.38 16.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.421 ' HA ' ' HG ' ' A' ' 31' ' ' SER . 42.0 m -112.1 174.79 5.71 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -171.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.44 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -67.82 -58.14 8.61 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.02 -17.92 62.63 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.973 1.782 . . . . 0.0 112.455 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.42 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.0 m-20 -56.82 -46.58 81.55 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.736 1.214 . . . . 0.0 112.238 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 45' ' ' ARG . . . -104.32 2.66 31.66 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.42 0.628 . . . . 0.0 111.458 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -105.31 -44.46 4.73 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -79.94 123.69 28.01 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -173.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.402 ' HA ' ' HG3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -55.36 117.71 3.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.935 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.54 -45.76 1.1 Allowed Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -95.58 -51.49 4.51 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' NH2' ' HG ' ' A' ' 17' ' ' LEU . 89.6 mtt-85 22.7 -83.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 176.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 153' ' ' GLN . 41.9 mt-10 -61.91 134.71 57.01 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -166.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.86 110.26 1.13 Allowed 'General case' 0 C--O 1.249 1.067 0 CA-C-N 113.121 -1.854 . . . . 0.0 110.328 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.71 -73.15 0.15 Allowed 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.56 -30.27 4.13 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 50' ' ' LEU . 2.3 pp -132.21 148.19 52.45 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.014 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 29.8 p-10 -162.56 167.81 22.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 36' ' ' LEU . 40.9 tp -91.41 116.57 28.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 168.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 33.8 tt0 -136.69 112.57 9.57 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.599 0.714 . . . . 0.0 109.881 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB2' HD13 ' A' ' 60' ' ' LEU . 31.8 t -94.79 101.88 13.72 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.816 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.3 -30.44 11.07 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.033 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.36 72.4 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.047 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.99 160.75 22.89 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.86 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.46 ' O ' HD12 ' A' ' 140' ' ' ILE . 43.7 tt0 -92.6 -31.7 15.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -77.32 118.35 19.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.071 -174.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 54' ' ' SER . 23.7 tp -116.31 116.28 27.46 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 6.8 tt -118.95 128.83 54.78 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.59 144.94 35.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 122.951 0.501 . . . . 0.0 109.718 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.416 ' HE1' ' O ' ' A' ' 94' ' ' LYS . 83.9 t80 -117.26 126.86 53.42 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.959 0.504 . . . . 0.0 110.362 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.97 121.58 28.75 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.911 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.79 127.13 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.735 2.29 . . . . 0.0 109.55 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -93.0 141.31 28.54 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -51.89 -50.17 61.56 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.754 2.022 . . . . 0.0 109.623 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -130.58 159.6 36.69 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.389 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 7.3 p -83.26 108.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.45 172.98 12.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.516 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -95.24 132.33 40.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.6 tp -78.04 143.99 37.0 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -129.93 -54.2 1.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.144 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.1 p -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -117.72 158.14 25.25 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.53 105.44 2.83 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.835 0.35 . . . . 0.0 111.851 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 155' ' ' ILE . 55.5 mt -120.39 130.21 74.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 96.4 mttt -104.97 143.24 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.23 32.5 Favored Glycine 0 C--N 1.257 -3.834 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.7 139.42 48.2 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 121.492 1.461 . . . . 0.0 108.936 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 118' ' ' LEU . 11.9 pt-20 -58.68 -25.63 63.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.969 0.414 . . . . 0.0 112.069 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.53 -57.08 4.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.898 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 4.4 mm-40 -81.46 -59.62 2.56 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.905 -170.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.19 119.41 0.0 OUTLIER Glycine 0 N--CA 1.506 3.303 0 C-N-CA 127.326 2.394 . . . . 0.0 118.158 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.649 ' HA ' ' OD1' ' A' ' 143' ' ' ASN . 56.8 Cg_endo -69.29 112.18 2.92 Favored 'Trans proline' 0 C--N 1.356 0.958 0 CA-C-N 119.932 1.866 . . . . 0.0 110.06 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.54 ' H ' ' HA ' ' A' ' 143' ' ' ASN . 30.5 ttmt -90.39 -75.37 0.46 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.071 -171.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.71 102.25 3.29 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.235 -174.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' THR . 34.2 m -104.68 117.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.845 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.426 ' HG3' ' OG1' ' A' ' 110' ' ' THR . 25.7 ttmm -107.11 132.83 52.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -112.69 139.02 48.64 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.54 155.55 19.97 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -77.97 -171.04 2.14 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.125 0.891 . . . . 0.0 110.926 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 135' ' ' SER . 8.9 p30 -57.22 104.4 0.16 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 111.512 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 55.3 tptt -163.51 164.8 24.21 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 96' ' ' HIS . 41.3 tt0 -75.95 174.01 10.5 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.449 ' H ' ' HG2' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -48.76 137.09 12.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.421 ' HE1' ' CD1' ' A' ' 105' ' ' PHE . 18.5 mmt -93.8 173.53 7.63 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.226 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.503 ' O ' HG11 ' A' ' 102' ' ' VAL . 75.6 m -149.36 155.55 40.66 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -55.99 -24.65 40.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.4 t -85.09 -6.41 59.31 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -116.72 -15.99 10.7 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 98' ' ' CYS . 29.0 m -67.64 -3.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -97.18 -19.4 18.66 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.398 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -89.33 -37.32 14.98 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.746 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.421 ' CD1' ' HE1' ' A' ' 97' ' ' MET . 93.5 m-85 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.302 -1.47 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.138 -175.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 13.3 Cg_exo -70.13 128.72 16.07 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.741 2.294 . . . . 0.0 111.216 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.31 165.23 29.73 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.548 2.165 . . . . 0.0 111.521 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.44 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 22.4 m -76.48 -47.48 22.74 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.441 ' C ' ' HG1' ' A' ' 110' ' ' THR . 15.8 m-20 -162.72 169.09 20.57 Favored 'General case' 0 CA--C 1.471 -2.09 0 C-N-CA 123.513 0.725 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.441 ' HG1' ' C ' ' A' ' 109' ' ' ASP . 40.9 m -146.2 114.43 6.64 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.29 172.87 8.32 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.516 ' HB2' ' HG2' ' A' ' 86' ' ' LYS . 11.7 pt-20 -125.35 139.67 53.48 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 86' ' ' LYS . 22.4 tp -59.79 113.2 2.15 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.703 0.801 . . . . 0.0 108.903 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.1 p -85.25 166.4 16.55 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 4.1 mp0 -57.74 -39.21 76.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.46 -38.62 77.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.72 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.498 HD21 HG21 ' A' ' 123' ' ' VAL . 8.8 t-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 81' ' ' GLU . 7.5 tt -62.22 -23.33 66.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.115 1.366 . . . . 0.0 110.671 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.481 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 58.2 mtpt -102.52 1.9 35.61 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.47 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.54 68.04 0.87 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.812 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -137.39 117.58 10.48 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.489 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 15.0 Cg_endo -58.17 101.64 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.379 2.053 . . . . 0.0 111.886 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.498 HG21 HD21 ' A' ' 117' ' ' ASN . 53.3 t -85.43 126.71 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 m -83.35 144.22 10.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.526 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.71 -173.44 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.409 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.99 141.4 34.46 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -96.19 27.45 3.69 Favored 'General case' 0 C--N 1.281 -2.374 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.655 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.32 -49.89 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 108' ' ' SER . 27.5 tptp -95.4 -6.13 41.64 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.79 15.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.22 121.9 14.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.325 20.9 p-10 42.97 112.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 127.221 2.208 . . . . 0.0 114.765 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 44.4 t -121.53 104.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.735 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -99.49 -28.45 13.24 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 59.9 m -143.2 151.17 40.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 137' ' ' THR . 5.6 tt -146.33 138.42 25.01 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.468 ' N ' HD22 ' A' ' 136' ' ' LEU . 60.6 m -118.04 133.07 56.25 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 64.1 mt -108.18 122.86 63.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.33 116.85 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 58' ' ' GLU 0.267 2.0 pp -90.37 138.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 117.749 -1.58 . . . . 0.0 111.079 176.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -94.47 -48.46 6.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.936 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.85 159.78 43.85 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.071 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.649 ' OD1' ' HA ' ' A' ' 85' ' ' PRO . 94.3 m-20 -109.11 167.13 10.33 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.598 HE21 ' HA ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -47.6 -53.14 15.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 111.558 -177.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.3 t -112.93 4.15 16.65 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.541 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.95 62.51 6.28 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -83.88 8.1 16.03 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 65.68 7.09 4.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 112.949 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.68 155.73 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 93.2 m -121.58 111.39 17.17 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.478 0.656 . . . . 0.0 110.736 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.41 149.04 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 20.6 pt20 -118.1 -5.08 10.96 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -172.79 118.66 0.34 Allowed 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.398 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 77' ' ' ILE . 68.4 mt -114.73 124.85 71.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.11 152.07 41.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.32 147.47 51.86 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.489 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 81.9 m-85 -124.38 133.71 53.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.59 -173.23 13.06 Favored Glycine 0 CA--C 1.489 -1.531 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.8 m -134.23 135.32 42.87 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.253 0.549 . . . . 0.0 110.862 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.421 -1.905 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.526 179.114 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.423 HG23 ' H ' ' A' ' 11' ' ' LYS . 39.5 mm . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 120.68 0.276 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -89.79 11.91 2.71 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.58 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.423 ' H ' HG23 ' A' ' 9' ' ' ILE . 39.7 ttmt 65.96 97.02 0.05 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.882 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.61 -63.27 0.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 24.1 mp0 -112.87 176.07 5.17 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.1 m -106.23 169.63 2.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -84.09 95.96 8.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.861 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 157' ' ' LEU . 5.7 mp -74.79 -2.41 26.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.1 tt -74.06 -36.91 64.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.25 -21.14 66.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.998 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -97.21 12.2 33.71 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.022 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 16' ' ' LEU . 74.3 mt -84.13 131.63 33.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.47 124.54 35.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.693 0.759 . . . . 0.0 110.887 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -103.74 19.23 20.28 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.854 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 m -93.12 -30.89 15.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.94 3.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.839 -1.172 . . . . 0.0 114.133 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.0 135.89 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.63 148.91 36.53 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.195 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' HB3' ' CG ' ' A' ' 30' ' ' GLN . 47.7 t -135.87 140.66 44.29 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 97' ' ' MET . 91.1 mt -79.35 19.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.431 0.634 . . . . 0.0 111.808 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 27' ' ' CYS . 52.1 t-20 -154.9 -60.47 0.11 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.543 ' CG ' ' HB3' ' A' ' 27' ' ' CYS . 47.9 mt-30 67.39 14.5 9.67 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 124.116 0.966 . . . . 0.0 109.86 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.658 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 3.2 m 74.75 135.03 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.219 1.808 . . . . 0.0 109.447 -174.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.425 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 33.1 t -66.83 -46.93 73.56 Favored 'General case' 0 CA--C 1.559 1.313 0 O-C-N 121.415 -0.803 . . . . 0.0 111.577 175.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.5 t -89.82 -47.1 8.12 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.108 0.956 . . . . 0.0 111.151 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.658 ' O ' ' HB2' ' A' ' 31' ' ' SER . 54.0 m80 -83.05 166.91 18.36 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 125.054 1.342 . . . . 0.0 111.146 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 m -110.49 169.5 8.71 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.914 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 4.1 tt -65.12 -57.61 14.96 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.022 0.529 . . . . 0.0 111.68 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 5.7 Cg_exo -78.64 -1.83 11.94 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 121.848 1.699 . . . . 0.0 111.296 -176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.443 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.0 t-20 -49.12 -48.45 44.58 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 125.515 1.526 . . . . 0.0 109.648 -176.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.583 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . . . -142.24 78.68 1.63 Allowed 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.764 0.793 . . . . 0.0 110.036 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.0 tp -168.26 -38.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.776 -1.557 . . . . 0.0 106.846 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 10.7 tmtt? -90.66 133.45 35.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 14.9 mm100 -53.28 142.55 20.84 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.48 -37.57 3.44 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.218 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.479 ' O ' HD12 ' A' ' 50' ' ' LEU . 68.6 m-85 -89.72 -43.2 10.87 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -43.49 117.32 1.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.948 1.699 . . . . 0.0 113.206 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -177.53 137.42 0.21 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.78 91.86 8.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.881 0.372 . . . . 0.0 111.924 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -151.6 -71.67 0.16 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.018 0.927 . . . . 0.0 109.577 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -56.8 0.5 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.451 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 44' ' ' TYR . 2.3 pp -89.11 142.21 27.84 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.106 0.479 . . . . 0.0 111.884 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.586 ' ND2' ' HB2' ' A' ' 53' ' ' GLU . 3.6 p-10 -163.49 165.65 23.49 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.482 ' CD2' HD22 ' A' ' 60' ' ' LEU . 3.3 tt -88.07 126.83 35.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 171.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.586 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 44.8 tt0 -128.99 143.17 50.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 90.5 p -78.01 82.26 4.37 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD2' ' HB3' ' A' ' 32' ' ' SER . 38.9 t70 -117.13 96.52 5.48 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.352 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 148.7 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 128.075 2.55 . . . . 0.0 104.878 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 54' ' ' SER . 10.7 t70 -157.75 155.35 29.71 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.676 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.18 -21.13 39.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.003 0.43 . . . . 0.0 110.652 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.81 109.7 17.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.482 HD22 ' CD2' ' A' ' 52' ' ' LEU . 27.8 tp -116.81 117.51 29.96 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.427 0.632 . . . . 0.0 110.487 -174.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 96' ' ' HIS . 1.8 tm? -107.21 124.38 49.65 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.496 HG13 ' SG ' ' A' ' 27' ' ' CYS . 2.0 mp -127.01 134.58 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -103.54 121.57 43.16 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.575 0.75 . . . . 0.0 109.095 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.42 120.17 29.05 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.151 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.02 154.54 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.749 2.299 . . . . 0.0 109.574 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -112.19 152.34 28.49 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -62.73 -50.63 70.33 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.586 1.554 . . . . 0.0 108.084 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -127.51 143.13 51.22 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.671 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.86 112.18 13.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -134.32 173.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.54 143.24 30.31 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.239 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HB2' HG22 ' A' ' 133' ' ' VAL . 57.8 tp -92.32 105.56 17.74 Favored 'General case' 0 C--O 1.19 -2.057 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -96.37 -54.62 3.2 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.979 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 p -145.44 161.87 38.67 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.844 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.443 ' CE1' HD11 ' A' ' 125' ' ' LEU . 2.7 p90 -131.97 157.66 43.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -143.0 114.44 7.95 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.209 0.604 . . . . 0.0 109.773 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.5 mt -113.21 129.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HE2' ' C ' ' A' ' 119' ' ' LYS . 68.2 mttt -117.2 157.98 25.07 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.481 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.03 -152.79 20.89 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.11 152.38 56.51 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.201 1.934 . . . . 0.0 109.533 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.55 -38.93 81.22 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 144' ' ' GLN . 42.5 mt-10 -94.69 -34.7 12.46 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -93.78 11.58 28.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.491 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.8 150.42 25.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.157 -0.802 . . . . 0.0 111.636 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 23.6 Cg_exo -63.05 113.92 2.23 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.436 2.757 . . . . 0.0 113.375 -175.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.31 -49.5 3.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.5 m -83.11 100.52 10.57 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.818 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.9 t -115.57 122.98 70.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.959 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -115.73 133.79 55.67 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -111.96 152.1 28.47 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 25.4 t80 -140.68 117.06 10.72 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 172.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 m -91.61 138.2 31.75 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 47.95 81.91 0.04 OUTLIER 'General case' 0 C--O 1.244 0.775 0 C-N-CA 126.171 1.788 . . . . 0.0 113.965 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -171.51 170.72 5.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -81.43 175.7 10.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.523 ' O ' HD12 ' A' ' 61' ' ' LEU . 33.1 p80 -44.67 -40.65 6.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.452 ' O ' HD11 ' A' ' 28' ' ' LEU . 87.1 mtp 61.6 -165.75 0.22 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.493 ' O ' HG23 ' A' ' 102' ' ' VAL . 30.8 p -150.06 163.81 37.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.427 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 42.0 p90 -68.98 -17.89 63.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -67.47 -20.2 65.44 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -103.76 -31.66 9.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.603 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' CYS . 95.9 t -59.57 -29.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.21 -7.22 58.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.28 -38.45 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.81 0.338 . . . . 0.0 111.557 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -95.75 137.57 21.87 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.138 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.3 131.08 27.13 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.452 2.101 . . . . 0.0 111.508 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.37 161.17 38.07 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.414 2.076 . . . . 0.0 111.487 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.495 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . 28.5 m -61.78 -46.02 91.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 110.03 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.11 143.43 15.42 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -104.85 115.03 29.6 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.52 152.59 24.53 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.62 118.35 25.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.229 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 20.8 tp -61.86 105.17 0.53 Allowed 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -92.64 170.57 9.63 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.49 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 42.9 tt0 -54.98 -46.09 75.07 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.767 0.427 . . . . 0.0 111.276 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -64.85 -34.66 78.91 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.4 t-20 -61.65 -44.59 96.69 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.426 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 tm? -65.36 -32.77 74.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.314 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.503 ' C ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -84.77 9.96 12.69 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.35 31.3 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 115.149 0.819 . . . . 0.0 115.149 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -93.4 132.74 29.65 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 117.648 0.724 . . . . 0.0 111.338 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 26.5 Cg_endo -65.37 117.33 4.49 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 123.208 2.605 . . . . 0.0 112.471 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.87 130.74 44.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.78 133.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 122.956 0.502 . . . . 0.0 111.236 -174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -100.0 175.1 5.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 8.5 mmpt? -86.15 49.05 1.71 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -74.69 25.62 0.09 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -170.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.8 m -57.02 -27.49 27.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -95.24 -41.18 9.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.491 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 28.0 m-85 -72.13 84.42 1.02 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.054 -173.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.55 -11.36 14.07 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.245 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -124.37 113.85 18.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.494 0.664 . . . . 0.0 109.846 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 72' ' ' LEU . 47.1 t -123.31 105.74 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.17 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -104.9 -32.1 8.95 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.9 m -135.93 135.25 39.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.431 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.2 tp -135.65 126.36 27.26 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.877 0.37 . . . . 0.0 110.085 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.6 m -94.2 117.01 29.49 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.27 115.84 50.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 141' ' ' GLU . 48.5 t80 -114.39 114.88 26.47 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.415 HD11 HD23 ' A' ' 60' ' ' LEU . 28.2 pt -104.12 114.85 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.881 0.848 . . . . 0.0 109.277 174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.455 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 43.6 tt0 -90.78 -28.38 18.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.66 -172.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -162.25 154.83 19.62 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.271 -177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -89.63 175.95 7.06 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.006 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 82' ' ' GLU . 8.5 tp-100 -51.12 -43.89 61.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.432 1.093 . . . . 0.0 112.909 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m -96.59 -37.68 10.27 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.515 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.92 42.62 3.03 Favored Glycine 0 C--N 1.302 -1.345 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 149' ' ' VAL . 14.8 m -85.47 13.95 6.14 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.326 1.05 . . . . 0.0 112.655 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 74.93 -34.87 0.27 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.823 1.649 . . . . 0.0 111.625 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 147' ' ' SER . 6.1 p -100.69 98.69 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-O 122.315 1.055 . . . . 0.0 110.471 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.7 m -92.25 113.71 26.06 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.526 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 86.7 tttt -113.96 135.23 54.22 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.018 -174.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.69 137.2 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.309 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -96.7 -28.64 14.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.19 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HZ2' ' HG3' ' A' ' 78' ' ' LYS . 1.1 pptp? -171.23 150.9 3.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.02 111.95 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.411 ' C ' HD11 ' A' ' 157' ' ' LEU . . . -107.69 147.12 31.16 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 4.7 mp -123.34 143.91 49.79 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 67.9 m-85 -125.68 137.94 53.87 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -166.39 -140.62 2.93 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.6 t -162.83 149.9 13.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.423 -1.813 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.6 mm . . . . . 0 N--CA 1.396 -3.169 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -85.5 136.43 5.48 Favored 'Trans proline' 0 N--CA 1.427 -2.42 0 C-N-CA 121.715 1.61 . . . . 0.0 111.191 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -50.64 113.49 0.91 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 112.155 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.13 8.36 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.51 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.19 147.36 34.76 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 117.25 0.525 . . . . 0.0 111.373 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.93 149.14 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.97 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.83 134.42 39.07 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.576 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.2 mm? -62.87 -14.04 41.29 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.373 1.069 . . . . 0.0 113.813 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 41' ' ' LYS . 2.1 tm? -51.32 -36.4 42.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.499 0.666 . . . . 0.0 109.93 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.27 -26.25 60.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.214 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -107.67 34.35 3.58 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.8 mm -116.4 145.1 22.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.056 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -96.23 131.59 42.55 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -104.38 8.85 35.89 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -97.3 -34.96 10.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.22 -4.86 73.71 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.458 -0.792 . . . . 0.0 114.05 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -53.59 143.43 5.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -142.55 139.62 31.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.136 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 30' ' ' GLN . 5.5 p -135.61 128.85 31.93 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.891 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.499 HD23 HD13 ' A' ' 61' ' ' LEU . 2.7 mm? -91.92 123.71 35.5 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.479 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 47.3 t-20 76.26 -59.78 0.5 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.759 1.624 . . . . 0.0 108.263 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.499 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 34.2 tt0 73.14 -74.77 0.08 Allowed 'General case' 0 C--N 1.37 1.474 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p 174.16 115.95 0.02 OUTLIER 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.4 t -48.91 -37.23 19.18 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -100.63 -42.63 6.46 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.725 -0.609 . . . . 0.0 111.233 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -85.13 166.57 16.51 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -106.96 152.94 23.28 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 52' ' ' LEU . 3.1 tm? -54.47 -57.89 16.59 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.82 -17.06 58.36 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.183 1.922 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.443 HD21 ' HB2' ' A' ' 50' ' ' LEU . 3.1 m-20 -58.75 -27.55 65.05 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 113.086 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 51' ' ' ASN . . . -133.04 15.71 4.21 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.206 0.526 . . . . 0.0 110.749 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -112.29 -43.16 3.57 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.21 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HA ' HD21 ' A' ' 17' ' ' LEU . 16.0 ptpt -98.28 137.58 36.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.353 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.19 121.62 14.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.97 -64.64 0.44 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.497 ' O ' HD12 ' A' ' 50' ' ' LEU . 59.0 m-85 -77.04 -39.79 48.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 26.4 ttp180 -37.35 103.58 0.03 OUTLIER 'General case' 0 C--O 1.243 0.739 0 C-N-CA 126.106 1.762 . . . . 0.0 113.324 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -164.65 89.27 0.51 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -57.96 104.32 0.19 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.889 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 178.1 -67.55 0.01 OUTLIER 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.308 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.17 -59.06 0.73 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 50' ' ' LEU . 3.5 pp -104.25 120.9 42.18 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.788 0.804 . . . . 0.0 110.006 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.413 ' HA ' ' HB1' ' A' ' 39' ' ' ALA . 3.0 p-10 -161.48 165.63 28.37 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 36' ' ' LEU . 26.6 tp -91.65 112.42 24.33 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -131.71 113.46 13.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.593 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 35.6 p -74.4 82.22 1.92 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.059 0.933 . . . . 0.0 110.237 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.49 -30.55 29.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.893 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 29' ' ' ASN . . . -69.23 -35.68 76.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 54' ' ' SER . 19.1 t70 -171.47 156.42 4.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.2 tt0 -80.49 -11.69 59.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.911 0.884 . . . . 0.0 112.545 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.89 112.94 17.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -127.14 136.16 51.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.403 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.499 HD13 HD23 ' A' ' 28' ' ' LEU . 1.6 tm? -131.39 126.22 34.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 mp -128.12 134.64 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.65 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 49.4 t80 -103.7 128.1 51.08 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 123.708 0.803 . . . . 0.0 110.187 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.94 124.03 27.63 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.426 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -92.37 159.96 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 123.29 2.66 . . . . 0.0 110.365 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -95.23 154.88 16.97 Favored 'General case' 0 CA--C 1.459 -2.553 0 CA-C-O 122.568 1.175 . . . . 0.0 113.919 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -88.05 -42.89 12.1 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 112.877 -1.965 . . . . 0.0 106.968 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -150.65 139.07 20.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -73.17 124.68 30.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-O 121.639 0.733 . . . . 0.0 111.643 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.402 ' CD1' HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.15 174.59 11.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -92.51 138.68 31.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -79.35 144.16 34.46 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -136.07 -45.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.928 -0.483 . . . . 0.0 111.807 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.6 m -151.38 175.92 11.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.391 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -135.62 152.46 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -158.87 107.65 1.91 Allowed 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 77' ' ' ILE . 2.3 mp -107.38 132.58 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HE2' ' CA ' ' A' ' 120' ' ' GLY . 90.9 mttt -117.69 167.5 11.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.337 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.37 -168.25 34.14 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.76 149.43 73.06 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 122.262 1.974 . . . . 0.0 111.214 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.53 -26.37 66.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.01 -55.92 4.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.918 0.866 . . . . 0.0 111.04 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 151' ' ' LYS . 33.6 mt-10 -100.74 13.04 36.22 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.416 -170.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.31 148.14 26.4 Favored Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -58.1 176.21 0.39 Allowed 'Trans proline' 0 C--O 1.218 -0.52 0 C-N-CA 123.191 2.594 . . . . 0.0 113.971 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 84.0 tttt -154.63 -68.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.8 m -78.26 108.39 11.55 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.47 146.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.072 0.463 . . . . 0.0 111.871 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -130.4 148.84 52.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -126.94 152.97 46.43 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -137.59 144.41 41.98 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.495 ' HB3' ' CE1' ' A' ' 130' ' ' PHE . 48.2 t -137.27 155.19 49.77 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.362 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 m120 76.67 -43.32 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.662 1.585 . . . . 0.0 113.469 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -87.21 107.78 18.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 178.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.65 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 34.6 tt0 -65.03 134.44 53.85 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 59.94 87.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.428 1.091 . . . . 0.0 112.447 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.602 ' SD ' ' HD3' ' A' ' 94' ' ' LYS . 95.6 mmm -123.75 98.63 5.9 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.284 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.513 ' O ' HG23 ' A' ' 102' ' ' VAL . 64.3 m -88.78 167.87 12.94 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.45 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 89.6 t80 -49.11 -33.75 12.47 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.64 0.776 . . . . 0.0 112.585 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -56.64 -26.31 55.67 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.329 0.652 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -114.66 -18.14 11.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 98' ' ' CYS . 60.7 t -63.45 -18.89 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.126 0.971 . . . . 0.0 113.352 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -87.57 -22.91 24.52 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.729 -0.607 . . . . 0.0 112.062 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -94.38 -36.09 12.08 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -95.99 150.4 37.24 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.929 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.89 117.19 5.02 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.677 2.251 . . . . 0.0 113.06 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.37 172.09 17.01 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.088 1.859 . . . . 0.0 110.272 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.475 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 19.7 m -67.43 -46.99 71.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -172.54 -176.08 1.46 Allowed 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -139.91 130.99 26.34 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.02 173.07 11.59 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.382 0.611 . . . . 0.0 112.138 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 35.1 tt0 -123.97 128.97 50.17 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.84 105.52 2.81 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 t -86.85 163.12 17.38 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.24 -37.99 73.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.01 -31.88 68.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 123.238 0.337 . . . . 0.0 111.289 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.2 t-20 -63.66 -47.02 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.534 ' O ' HD22 ' A' ' 118' ' ' LEU . 5.7 tt -67.05 -20.3 65.82 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.002 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' CE ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tpmt? -86.02 -14.29 44.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.065 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.492 ' CA ' ' HE2' ' A' ' 78' ' ' LYS . . . 111.71 11.71 16.32 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.934 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.58 125.53 57.36 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.491 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 55.6 Cg_endo -70.38 109.65 2.49 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.953 2.435 . . . . 0.0 111.15 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.5 t -85.81 122.37 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.91 110.1 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 122.106 0.955 . . . . 0.0 113.048 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -93.05 -165.68 1.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.605 178.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -93.24 115.03 27.65 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 120.639 0.257 . . . . 0.0 111.11 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -132.93 18.13 4.16 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.69 -29.52 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.452 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -83.92 -29.49 27.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' A' ' 92' ' ' SER . 70.8 m-85 -93.12 75.67 4.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.115 0.96 . . . . 0.0 112.537 -172.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -94.58 -2.32 51.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.158 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -151.53 115.75 5.02 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.021 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.94 102.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -81.15 -64.95 1.08 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.06 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 p -132.99 149.4 52.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.498 HD21 ' N ' ' A' ' 137' ' ' THR . 3.5 tt -129.19 139.89 51.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.498 ' N ' HD21 ' A' ' 136' ' ' LEU . 79.3 m -119.78 124.44 46.15 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.9 mp -104.55 123.92 58.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.489 ' CE2' ' HG2' ' A' ' 141' ' ' GLU . 33.8 t80 -116.43 110.84 19.17 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.404 0.621 . . . . 0.0 110.613 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.4 mt -99.92 125.74 53.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.489 ' HG2' ' CE2' ' A' ' 139' ' ' PHE . 36.2 mt-10 -100.5 -50.27 3.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.11 167.69 23.49 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -110.67 170.15 8.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 123.575 0.547 . . . . 0.0 111.454 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -47.38 -57.9 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.255 0.972 . . . . 0.0 110.064 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -87.02 -26.89 23.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.55 75.68 0.59 Allowed Glycine 0 C--O 1.221 -0.679 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.1 t -107.72 -2.22 20.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.581 0.229 . . . . 0.0 110.95 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 38.7 mt-10 74.73 0.44 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.266 1.026 . . . . 0.0 112.13 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 54' ' ' SER . 5.7 p -139.95 124.58 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 32.5 m -109.7 111.78 23.45 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.972 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 18.9 pttm -109.85 134.75 51.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.183 171.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.01 148.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.767 -172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.472 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.5 tp60 -85.81 -48.7 8.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.987 174.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.448 ' NZ ' ' HB3' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -167.53 136.16 2.56 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 176.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.72 112.27 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.448 ' HB3' ' NZ ' ' A' ' 154' ' ' LYS . . . -139.92 157.28 45.94 Favored 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.11 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 1.9 mm? -119.43 157.21 28.69 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 72.4 m-85 -116.18 128.02 55.28 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.37 15.29 Favored Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.392 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 55.7 p -135.1 117.98 16.23 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.218 0.533 . . . . 0.0 111.438 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.0 p . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.653 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.488 HG21 ' H ' ' A' ' 11' ' ' LYS . 45.8 mm . . . . . 0 N--CA 1.415 -2.201 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.96 17.97 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.239 2.626 . . . . 0.0 111.507 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.9 mmpt? 64.69 12.49 7.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.119 1.367 . . . . 0.0 112.999 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.73 -83.43 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 29.7 mm-40 -103.77 -175.99 2.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 m -106.82 158.22 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 19.8 t0 -83.7 105.33 14.53 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.634 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 mp -60.23 -2.21 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 125.46 1.504 . . . . 0.0 114.233 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 42' ' ' GLN . 4.0 tt -56.01 -38.76 70.94 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.1 -17.59 64.59 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.065 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.79 23.35 12.02 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 16' ' ' LEU . 59.5 mt -102.79 142.62 16.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.38 -48.75 78.38 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.581 ' CH2' ' HB3' ' A' ' 40' ' ' LEU . 53.3 m95 70.95 -27.84 0.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 t -69.45 -35.61 75.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.18 -83.51 1.1 Allowed Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.912 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.337 27.6 m 43.22 103.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.74 136.87 51.84 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.322 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -135.76 137.42 41.63 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.127 0.489 . . . . 0.0 110.176 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.3 -30.89 68.01 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.637 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.634 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 14.0 m120 -84.65 -93.57 0.08 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.777 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.423 HE22 ' HB3' ' A' ' 36' ' ' LEU . 4.0 tp-100 51.7 30.3 6.63 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -106.97 -75.39 0.63 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -163.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 p -48.83 -44.68 39.62 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -176.48 -61.92 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.48 0.657 . . . . 0.0 109.44 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.803 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.0 m-70 -72.42 144.0 48.31 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.941 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -107.7 164.36 12.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -169.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.423 ' HB3' HE22 ' A' ' 30' ' ' GLN . 2.8 tm? -60.07 -60.29 11.08 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.242 1.417 . . . . 0.0 113.812 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.15 -22.02 54.32 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.212 1.941 . . . . 0.0 112.965 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.414 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.3 m-20 -59.85 -29.12 68.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.669 1.188 . . . . 0.0 111.422 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.782 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -114.93 7.89 15.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.24 0.543 . . . . 0.0 111.415 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . 11.2 mp -119.49 -53.62 2.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -79.77 142.29 35.51 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.076 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.48 ' H ' HD22 ' A' ' 17' ' ' LEU . 14.0 tm0? -56.78 132.9 53.57 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 124.707 1.203 . . . . 0.0 110.651 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.13 -42.65 1.9 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -88.99 -49.94 6.47 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.367 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.0 ptm180 -47.92 90.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 4.9 tp10 171.03 143.69 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 153' ' ' GLN . 33.6 t70 -74.6 131.16 40.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.69 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.99 -52.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.23 -56.41 0.01 OUTLIER Glycine 0 CA--C 1.474 -2.484 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.6 pp -80.94 135.61 35.91 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.588 174.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.803 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 34.8 p30 -161.83 169.55 21.11 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 tp -98.2 109.68 22.39 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 118.889 0.768 . . . . 0.0 108.989 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.04 131.01 44.01 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.069 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.5 p -97.04 112.41 24.19 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.178 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.38 -35.68 8.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.502 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.37 -48.2 82.35 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.742 0.782 . . . . 0.0 109.291 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.83 151.14 43.72 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -100.32 7.47 44.34 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.937 0.875 . . . . 0.0 109.221 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -105.63 128.6 53.73 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 3.5 tt -133.56 131.74 40.06 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.224 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tt -131.14 132.75 44.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.062 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.73 145.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -114.19 121.5 43.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.65 121.51 37.13 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -91.38 141.93 2.85 Favored 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.265 2.643 . . . . 0.0 111.621 173.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.68 164.37 26.35 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 122.871 1.32 . . . . 0.0 113.874 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -104.82 -45.99 4.43 Favored 'General case' 0 N--CA 1.395 -3.197 0 CA-C-N 112.572 -2.104 . . . . 0.0 107.022 171.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -143.79 146.57 33.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.457 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -75.37 117.47 19.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 122.178 0.99 . . . . 0.0 111.654 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.98 173.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.526 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 3.7 mppt? -97.97 136.37 38.34 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.458 -1.297 . . . . 0.0 111.058 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.491 ' CD1' HD12 ' A' ' 125' ' ' LEU . 2.1 tm? -89.89 114.02 25.73 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -110.01 -37.95 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.8 m -143.62 171.23 14.46 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.207 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -142.75 157.57 44.51 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.39 143.74 25.94 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.837 0.351 . . . . 0.0 110.364 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.1 mt -145.71 137.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.553 ' HE2' ' O ' ' A' ' 119' ' ' LYS . 87.2 mttt -112.86 157.38 21.48 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.372 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 178.5 36.86 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -75.18 160.06 39.98 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.507 1.472 . . . . 0.0 110.032 176.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.51 -29.72 26.54 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.517 1.127 . . . . 0.0 112.065 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -93.15 -57.08 2.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 mp0 -68.44 -52.37 33.41 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.14 109.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.167 0 O-C-N 125.365 1.666 . . . . 0.0 116.56 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.85 108.06 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.208 1.939 . . . . 0.0 110.217 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 38.0 ttpt -99.42 -63.86 1.09 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -167.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.9 m -78.62 94.8 5.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.458 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 111' ' ' ALA . 16.7 m -100.96 137.65 27.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -128.5 141.6 51.33 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.924 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 82.3 m-85 -117.45 148.12 42.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.679 -175.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 47.1 m-85 -114.53 126.72 55.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.724 174.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.5 t -91.79 96.51 10.46 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.186 0.517 . . . . 0.0 110.382 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 64.99 9.64 5.6 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.591 1.156 . . . . 0.0 112.824 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -88.72 139.88 30.02 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.4 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 1.7 mp0 -55.45 169.12 0.32 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.538 1.535 . . . . 0.0 112.197 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -61.7 97.41 0.08 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.748 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.405 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . 83.8 mtp -98.78 106.75 19.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.465 ' O ' HG12 ' A' ' 102' ' ' VAL . 83.2 m -75.86 -168.98 0.98 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 102' ' ' VAL . 60.5 m-85 -46.65 -44.55 18.51 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -81.24 -31.73 33.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.39 0.615 . . . . 0.0 111.127 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -77.96 -19.67 54.12 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.977 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 98' ' ' CYS . 34.0 m -64.27 -5.72 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -91.41 -1.28 57.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.583 0.23 . . . . 0.0 110.9 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -101.55 -31.93 10.62 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -96.22 152.64 38.94 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.203 -171.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -89.09 120.14 1.04 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.031 1.821 . . . . 0.0 108.724 170.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.12 142.27 99.1 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.153 1.902 . . . . 0.0 112.46 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 18.7 m -59.67 -42.41 92.8 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.465 0.65 . . . . 0.0 109.783 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -158.23 168.95 25.63 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.5 t -152.1 115.31 4.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -133.38 161.68 33.88 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.344 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.1 mp0 -114.96 128.61 56.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.2 tt -66.16 134.47 52.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.52 0.676 . . . . 0.0 111.612 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 t -121.15 179.32 4.43 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.32 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 40.8 mt-10 -54.74 -45.92 74.2 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.808 0.843 . . . . 0.0 112.983 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -70.88 -35.24 72.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.238 0.542 . . . . 0.0 109.682 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.463 ' HB3' ' HG ' ' A' ' 113' ' ' LEU . 2.7 t-20 -65.18 -40.19 93.93 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.3 tp -61.02 -24.47 66.2 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 111.127 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 14.4 mmmm -79.29 -3.37 45.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.633 0.73 . . . . 0.0 109.27 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.05 17.02 52.94 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.156 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 98.8 mttt -87.9 141.15 31.33 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-N 116.714 0.257 . . . . 0.0 110.962 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 17.1 Cg_exo -67.31 119.37 6.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.02 2.48 . . . . 0.0 112.633 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.54 134.52 41.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.55 144.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.286 0.565 . . . . 0.0 112.293 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.491 HD12 ' CD1' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -131.86 -170.82 2.47 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.121 174.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -67.92 89.49 0.28 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.43 0.633 . . . . 0.0 112.692 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -69.18 -32.15 71.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.895 0.878 . . . . 0.0 110.107 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.13 -27.63 36.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.896 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 6.1 tmtt? -85.16 -45.26 12.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -78.27 90.26 4.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -106.49 -39.96 5.72 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -113.02 120.28 40.82 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.273 176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.8 102.05 12.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.786 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -102.82 -38.95 7.2 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.683 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.9 m -152.47 154.19 35.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.47 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.408 HD21 ' N ' ' A' ' 137' ' ' THR . 4.1 tt -144.91 130.39 18.83 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.9 m -106.13 131.41 53.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.14 122.28 65.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -122.94 121.82 37.08 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.718 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 140' ' ' ILE . 2.0 pp -115.58 129.13 72.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -106.84 -20.76 13.24 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.421 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.67 31.66 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.064 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 6.8 p30 -102.8 175.4 5.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.019 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.453 HE21 ' HD3' ' A' ' 86' ' ' LYS . 7.9 tp60 -45.13 -50.13 11.42 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.625 1.57 . . . . 0.0 111.68 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -107.36 -37.77 6.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.48 46.83 2.27 Favored Glycine 0 C--N 1.312 -0.789 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.3 t -84.63 12.57 6.89 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.359 0.664 . . . . 0.0 112.771 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 69.26 1.95 3.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.862 0.865 . . . . 0.0 112.61 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.84 134.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 83.5 m -118.47 111.44 18.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -94.4 134.88 36.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.27 120.93 62.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 20.6 pt20 -98.0 -13.44 21.1 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.361 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.782 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 23.1 pttt -168.07 150.21 5.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.149 168.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.4 mt -131.05 112.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.05 137.97 52.38 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 6.1 mp -103.08 140.85 36.77 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 97.5 m-85 -125.32 139.84 53.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.482 0.658 . . . . 0.0 111.279 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 71' ' ' LYS . . . -173.53 -154.86 10.99 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.6 p -161.43 154.52 21.03 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.905 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.42 -1.96 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.789 173.167 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 15' ' ' ASP . 2.3 mp . . . . . 0 N--CA 1.425 -1.7 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.6 143.23 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.826 1.684 . . . . 0.0 108.864 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -69.8 99.29 1.34 Allowed 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.167 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.87 -48.34 0.32 Allowed Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -119.36 178.83 4.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.79 142.6 39.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' CD1' ' A' ' 158' ' ' TYR . 10.1 t0 -72.73 116.87 13.74 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 20' ' ' ILE . 52.6 mt -79.61 5.54 12.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 42' ' ' GLN . 4.7 tt -55.18 -38.11 67.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.919 0.866 . . . . 0.0 108.759 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.76 -17.07 54.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.671 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.528 ' HA ' ' ND2' ' A' ' 67' ' ' ASN . 7.7 m-85 -90.52 -4.85 56.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.597 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 16' ' ' LEU . 92.4 mt -86.64 138.16 19.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.17 101.64 14.38 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 172.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.484 ' CH2' ' HA ' ' A' ' 41' ' ' LYS . 98.7 m95 -76.36 1.55 15.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -92.32 -28.31 17.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.81 4.67 56.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.903 -0.665 . . . . 0.0 114.274 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.6 m -61.22 136.31 24.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.182 0.515 . . . . 0.0 111.765 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -134.57 144.25 47.84 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.568 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 62.7 m -137.28 138.3 39.91 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.857 -176.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 28' ' ' LEU . 3.1 tm? -72.19 -49.03 38.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.134 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -103.87 -64.32 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.568 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 4.3 pt20 54.79 22.9 4.46 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.463 1.505 . . . . 0.0 111.854 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.604 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 40.7 t 73.82 129.64 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.285 1.834 . . . . 0.0 112.47 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.92 -4.87 34.74 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.218 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -121.36 -68.9 0.87 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.437 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.604 ' O ' ' HB3' ' A' ' 31' ' ' SER . 77.4 m-70 -99.95 112.37 24.65 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.421 -173.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 m -66.48 130.16 42.25 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.566 HD11 ' SG ' ' A' ' 27' ' ' CYS 0.258 5.5 tt -45.15 -39.59 9.28 Favored Pre-proline 0 CA--C 1.568 1.656 0 N-CA-C 118.618 2.821 . . . . 0.0 118.618 -177.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.568 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 76.5 Cg_exo -53.97 -1.35 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.823 2.348 . . . . 0.0 114.895 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.458 HD21 ' HB2' ' A' ' 50' ' ' LEU . 30.8 p30 -86.24 -48.1 8.84 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.13 -14.16 15.48 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD21 HD23 ' A' ' 36' ' ' LEU . 45.4 tp -102.23 -40.33 6.83 Favored 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 118.839 -1.144 . . . . 0.0 107.957 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.02 97.87 6.98 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 170.248 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.478 ' HB3' HD11 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -70.22 102.6 2.14 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.308 -172.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.1 -56.11 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.557 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -89.15 -9.9 49.23 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.234 0.614 . . . . 0.0 110.124 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 45' ' ' ARG . 2.4 ppt_? -52.54 130.1 30.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.122 -172.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER 174.06 139.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 173.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.83 88.38 6.78 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.55 -69.34 0.17 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.78 -47.18 0.63 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.43 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HB2' HD21 ' A' ' 38' ' ' ASN . 1.0 OUTLIER -125.61 113.75 17.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.027 0.918 . . . . 0.0 112.566 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -149.04 160.39 43.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 151' ' ' LYS . 3.4 tm? -90.61 120.32 31.58 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.35 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.9 pt-20 -141.01 119.35 12.17 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.341 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 49.6 p -35.05 -65.79 0.21 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.08 1.752 . . . . 0.0 115.549 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 67.16 17.66 10.36 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.701 0.762 . . . . 0.0 112.15 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.01 -62.92 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.286 0.565 . . . . 0.0 109.523 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 54' ' ' SER . 22.7 m-20 -131.36 127.91 38.57 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.608 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -73.47 -30.1 62.95 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 124.078 0.861 . . . . 0.0 110.341 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -74.37 115.58 14.06 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 95.0 mt -119.04 126.78 52.49 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.028 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.445 ' C ' HD13 ' A' ' 62' ' ' ILE . 1.4 tm? -113.0 121.69 45.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.445 HD13 ' C ' ' A' ' 61' ' ' LEU . 2.7 mp -127.92 142.75 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 96' ' ' HIS . 50.5 t80 -110.45 121.81 46.2 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 123.816 0.846 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.4 mm -120.85 121.47 28.9 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.793 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.52 124.82 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.476 2.117 . . . . 0.0 111.23 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -95.71 157.38 15.92 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 121.226 0.536 . . . . 0.0 111.217 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 19' ' ' PHE . 34.2 p30 -78.5 -23.34 46.41 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.92 160.73 39.78 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.572 HG23 ' H ' ' A' ' 133' ' ' VAL . 7.7 p -84.4 108.67 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 172.56 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -90.7 113.58 25.7 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.442 ' HG ' HG21 ' A' ' 133' ' ' VAL . 98.0 mt -69.41 128.46 36.64 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 44.2 t60 -118.39 -50.64 2.43 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.1 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 13.5 p -147.18 174.11 11.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.82 159.74 43.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.06 139.58 39.62 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.215 0.322 . . . . 0.0 110.252 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 71.6 mt -140.93 117.62 7.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -107.45 125.76 51.65 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.818 0.818 . . . . 0.0 110.318 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.98 -174.08 22.99 Favored Glycine 0 C--N 1.261 -3.621 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.48 135.47 3.07 Favored 'Trans proline' 0 N--CA 1.424 -2.604 0 CA-C-N 119.598 1.699 . . . . 0.0 108.632 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -58.57 -25.85 62.99 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.673 0.749 . . . . 0.0 110.798 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.89 -53.17 27.52 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.783 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.456 ' OE1' ' HD3' ' A' ' 151' ' ' LYS . 4.7 mp0 -103.78 -59.82 1.66 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.03 128.75 0.0 OUTLIER Glycine 0 N--CA 1.511 3.647 0 C-N-CA 127.98 2.705 . . . . 0.0 118.443 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.45 114.55 4.0 Favored 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.168 1.912 . . . . 0.0 110.373 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.533 ' O ' HG21 ' A' ' 88' ' ' VAL . 51.3 tttp -99.82 -69.84 0.75 Allowed 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -57.21 106.97 0.37 Allowed 'General case' 0 C--O 1.249 1.073 0 O-C-N 123.183 0.302 . . . . 0.0 111.314 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 86' ' ' LYS . 96.3 t -109.26 116.32 51.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.477 ' HZ3' ' HB2' ' A' ' 89' ' ' LYS . 4.3 ttmp? -118.83 136.46 54.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.443 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -121.83 166.47 14.32 Favored 'General case' 0 C--O 1.201 -1.456 0 O-C-N 122.038 -0.413 . . . . 0.0 111.927 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -151.41 121.64 7.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 t -97.9 143.71 28.21 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.789 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.8 OUTLIER 77.73 172.34 0.2 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 125.08 1.352 . . . . 0.0 112.722 179.022 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 71.21 177.92 0.26 Allowed 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.605 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 155.65 21.42 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 42.9 p-80 -51.08 124.42 11.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 80.6 mtp -98.83 116.93 32.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.362 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 67.6 m -72.02 158.04 36.7 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.539 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 64.6 t80 -48.9 -37.43 19.73 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 m -59.6 -22.56 61.98 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 120.846 0.355 . . . . 0.0 111.591 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.51 -13.06 11.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.099 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 2.7 p -67.48 -33.89 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.801 0.334 . . . . 0.0 111.214 -171.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.53 94.91 10.04 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.948 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -178.77 -45.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.19 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -98.01 149.89 36.19 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.481 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.39 126.74 19.16 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.463 2.109 . . . . 0.0 111.866 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.52 163.51 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.289 2.659 . . . . 0.0 112.398 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 9.6 t -61.43 -47.68 84.63 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 126' ' ' LYS . 20.5 m-20 -174.26 -177.6 1.3 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.15 2.58 . . . . 0.0 104.038 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -157.33 145.61 19.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.751 0.705 . . . . 0.0 110.278 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 88' ' ' VAL . . . -154.63 172.14 18.35 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -125.5 138.13 53.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.53 ' CB ' ' HA ' ' A' ' 86' ' ' LYS . 22.7 tp -61.67 143.84 55.51 Favored 'General case' 0 C--O 1.25 1.092 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.486 HG23 ' H ' ' A' ' 117' ' ' ASN . 8.0 t -134.52 165.47 25.12 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 119' ' ' LYS . 46.3 mt-10 -62.9 -28.24 69.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 119.089 0.859 . . . . 0.0 111.387 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.403 ' HG2' ' CB ' ' A' ' 121' ' ' LYS . 41.1 tt0 -66.34 -40.63 89.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.77 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.486 ' H ' HG23 ' A' ' 114' ' ' THR . 2.4 t-20 -67.47 -34.24 76.77 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.4 tp -67.31 -28.34 67.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.732 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 14.1 mptt -87.76 1.02 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 110.508 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.64 23.93 Favored Glycine 0 C--N 1.303 -1.272 0 C-N-CA 120.294 -0.955 . . . . 0.0 115.146 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' CB ' ' HG2' ' A' ' 116' ' ' GLU . 17.5 tppt? -75.08 119.11 75.38 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 117.93 0.865 . . . . 0.0 108.918 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.89 100.92 0.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.878 1.718 . . . . 0.0 109.663 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.32 133.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 27.9 m -64.68 135.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.48 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 mp -65.06 -67.04 0.47 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 34.8 mmtp -171.54 -174.58 1.42 Allowed 'General case' 0 C--N 1.287 -2.143 1 N-CA-C 100.081 -4.044 . . . . 0.0 100.081 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -146.36 24.39 1.27 Allowed 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 123.186 1.469 . . . . 0.0 108.078 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.16 -40.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.645 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.9 tmtt? -116.53 -20.47 9.62 Favored 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 118.732 -1.187 . . . . 0.0 114.045 -167.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.4 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 32.6 p90 -58.44 18.08 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.445 0 C-N-CA 125.209 1.404 . . . . 0.0 114.415 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 129' ' ' LYS . 49.5 mt-30 -61.37 2.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -163.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -166.56 115.52 0.9 Allowed 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.572 ' H ' HG23 ' A' ' 69' ' ' VAL . 60.4 t -120.01 125.23 74.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.757 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -121.13 -61.29 1.56 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 173.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.6 p -116.37 152.44 33.92 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.9 tp -136.32 122.83 20.82 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.077 0.465 . . . . 0.0 110.006 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.9 m -93.37 113.45 25.63 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.9 mt -104.78 116.52 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -115.4 108.73 16.89 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.291 0.567 . . . . 0.0 111.006 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.54 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 8.2 pt -89.46 114.07 26.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-O 121.848 0.832 . . . . 0.0 108.877 172.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.59 -40.53 16.16 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.13 -1.396 . . . . 0.0 113.028 -168.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.94 150.63 27.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.685 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -91.19 154.66 19.16 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.454 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.446 ' HG3' ' HD2' ' A' ' 86' ' ' LYS . 25.8 tt0 -58.44 -36.4 73.6 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 123.662 0.785 . . . . 0.0 112.295 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.1 t -103.35 -7.6 20.92 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.582 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.72 56.41 23.07 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.9 p -87.77 -1.47 57.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 42.6 mt-10 72.19 -37.07 0.38 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.092 0.957 . . . . 0.0 112.081 -177.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.3 t -106.09 118.24 53.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.178 0.513 . . . . 0.0 109.618 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.706 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 39.4 m -93.29 110.99 22.51 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.521 ' HZ2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -119.35 135.71 54.6 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.874 0.369 . . . . 0.0 110.392 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.1 p -142.09 148.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.04 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 74.1 mt-30 -108.99 -32.35 7.29 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.493 ' HZ1' ' CB ' ' A' ' 156' ' ' ALA . 11.7 tmtt? -155.24 115.97 3.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.762 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.415 ' HB ' ' CD1' ' A' ' 40' ' ' LEU . 66.4 mt -122.71 127.17 74.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.493 ' CB ' ' HZ1' ' A' ' 154' ' ' LYS . . . -144.43 152.67 40.99 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.29 155.56 21.9 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.448 ' CD1' ' HA ' ' A' ' 15' ' ' ASP . 99.5 m-85 -124.56 130.59 52.73 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.573 0.701 . . . . 0.0 111.297 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.05 -171.12 12.24 Favored Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.3 m -142.57 133.88 26.21 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.395 0.617 . . . . 0.0 111.599 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.425 -1.719 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.12 174.047 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.497 HG13 ' CB ' ' A' ' 15' ' ' ASP . 3.0 mp . . . . . 0 N--CA 1.441 -0.916 0 CA-C-O 120.462 0.172 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.46 160.99 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.705 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -71.3 107.02 4.07 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.87 -76.04 0.24 Allowed Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -106.69 168.88 8.88 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.64 125.77 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.534 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' CB ' HG13 ' A' ' 9' ' ' ILE . 34.0 t0 -72.11 130.09 40.05 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 176.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.588 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.2 mm? -68.86 -1.2 6.66 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -51.24 -45.17 61.89 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.571 1.148 . . . . 0.0 109.1 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.42 -16.04 56.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.807 0.813 . . . . 0.0 110.863 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.519 ' CD1' HD11 ' A' ' 16' ' ' LEU . 11.1 t80 -92.58 -14.24 28.54 Favored 'General case' 0 N--CA 1.415 -2.195 0 C-N-CA 124.251 1.02 . . . . 0.0 112.058 -174.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 16' ' ' LEU . 96.3 mt -75.04 140.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 120.701 0.286 . . . . 0.0 111.035 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.76 -29.44 63.32 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.277 0.561 . . . . 0.0 110.527 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.3 m95 71.18 -15.82 0.39 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 173.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -67.86 -25.37 65.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.481 0.658 . . . . 0.0 110.58 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.68 -81.24 1.58 Allowed Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.053 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.51 ' H ' ' CG ' ' A' ' 65' ' ' PRO 0.345 27.4 m 46.87 79.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.983 0 CA-C-O 122.476 1.131 . . . . 0.0 112.842 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -112.83 148.83 34.05 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.951 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.7 t -135.93 128.85 31.27 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.12 7.91 5.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.684 0.754 . . . . 0.0 110.568 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -126.01 -92.16 0.51 Allowed 'General case' 0 CA--C 1.479 -1.785 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.381 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 45.63 32.15 1.11 Allowed 'General case' 0 C--N 1.379 1.85 0 CA-C-O 122.677 1.227 . . . . 0.0 109.467 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.4 t -37.5 -63.64 0.44 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.729 2.811 . . . . 0.0 113.367 -171.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -50.04 -48.1 52.95 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.2 m 147.27 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.749 0 C-N-CA 128.127 2.571 . . . . 0.0 106.664 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.835 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 89.5 m-70 -62.14 132.66 53.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.149 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -106.77 -173.1 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.406 -0.918 . . . . 0.0 113.293 -164.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.8 tp -86.71 -46.74 0.53 Allowed Pre-proline 0 C--O 1.212 -0.895 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.09 -38.8 71.03 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.424 1.416 . . . . 0.0 111.415 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.8 p-10 -75.06 -2.0 25.44 Favored 'General case' 0 C--O 1.203 -1.365 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.618 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.19 0.14 6.43 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 tp -121.64 -30.48 4.18 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.516 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 6.0 tmtt? -82.24 143.13 31.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -68.88 149.14 49.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.575 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.31 -35.41 3.71 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 81.4 m-85 -89.4 -28.03 20.03 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.158 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -68.85 80.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -167.67 110.97 0.65 Allowed 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.005 0.922 . . . . 0.0 109.154 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.472 ' H ' ' HG3' ' A' ' 153' ' ' GLN . 20.0 t70 -71.22 116.47 11.57 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.121 0.486 . . . . 0.0 110.188 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -164.62 -63.12 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.08 -49.82 0.36 Allowed Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.1 pp -105.95 141.42 37.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 120.976 0.417 . . . . 0.0 110.623 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.835 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 36.5 p30 -162.28 169.63 20.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tt -102.16 124.81 48.41 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -138.73 165.07 27.93 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.274 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 66.4 p -101.47 148.65 24.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.961 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -125.17 -68.69 0.83 Allowed 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.4 -39.71 22.3 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.612 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' SER . 40.6 m-20 -123.21 121.21 35.36 Favored 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.784 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.9 tt0 -69.58 -26.22 64.36 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.323 1.015 . . . . 0.0 108.537 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.82 108.22 10.89 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.81 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 96.3 mt -115.54 132.29 56.67 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.49 -172.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.77 128.32 49.39 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.04 136.63 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 122.81 0.444 . . . . 0.0 110.716 -173.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -106.95 131.56 53.89 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.548 0.339 . . . . 0.0 110.887 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -108.38 117.08 55.42 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.022 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.51 ' CG ' ' H ' ' A' ' 25' ' ' VAL . 8.3 Cg_exo -73.34 144.58 36.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.608 2.205 . . . . 0.0 110.942 175.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' HE2' ' NH2' ' A' ' 134' ' ' ARG . 24.5 p90 -122.38 161.91 22.58 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -98.4 -43.34 6.95 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.328 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -153.93 178.85 9.48 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.617 -171.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.04 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.836 -0.166 . . . . 0.0 110.581 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.67 172.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.63 114.13 27.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.6 tp -72.75 133.8 44.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -111.76 -52.71 2.77 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.872 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -145.15 164.63 30.68 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.019 0.438 . . . . 0.0 111.946 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -135.2 153.8 51.82 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.64 110.09 4.43 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.219 0.533 . . . . 0.0 111.227 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.9 117.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HD3' ' N ' ' A' ' 79' ' ' GLY . 7.8 tmtt? -116.43 141.53 48.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -173.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.541 ' N ' ' HD3' ' A' ' 78' ' ' LYS . . . -171.39 -156.35 11.72 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 174.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.06 165.98 30.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.36 2.04 . . . . 0.0 110.902 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -70.41 -33.64 71.59 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.76 -47.84 6.58 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -86.73 15.44 5.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.675 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.28 148.78 19.86 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.01 162.86 12.63 Favored 'Trans proline' 0 C--O 1.217 -0.534 0 C-N-CA 122.614 2.21 . . . . 0.0 111.888 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 36.3 ttpt -132.94 -73.43 0.5 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.062 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.5 m -76.68 108.67 9.85 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.806 0.336 . . . . 0.0 110.122 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.489 HG11 HG21 ' A' ' 140' ' ' ILE . 7.6 m -118.97 142.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 -177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -125.6 149.45 48.37 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -127.09 152.73 46.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.607 ' CE2' ' HB ' ' A' ' 137' ' ' THR 0.252 23.4 p90 -148.83 116.22 6.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.74 0.781 . . . . 0.0 111.66 173.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 135' ' ' SER . 20.6 m -103.99 149.36 25.22 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.849 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.5 116.02 0.05 Allowed 'General case' 0 C--O 1.239 0.537 0 O-C-N 124.632 1.208 . . . . 0.0 109.676 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.279 0.5 OUTLIER 81.75 108.55 0.07 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.4 1.08 . . . . 0.0 112.256 -175.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.51 177.19 4.99 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.324 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 79.01 0.76 2.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.368 1.067 . . . . 0.0 111.022 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.482 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 44.6 ttm -70.22 115.14 9.07 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.851 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.504 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.3 m -100.33 177.11 5.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.256 36.9 p90 -55.8 -29.88 60.44 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.6 p -62.46 -35.95 80.91 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.973 0.892 . . . . 0.0 109.86 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.482 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 2.3 m-20 -87.75 -29.09 21.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.697 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 98' ' ' CYS . 97.8 t -62.4 -29.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.294 0.569 . . . . 0.0 110.52 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -88.71 -10.35 48.72 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.509 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.48 -50.13 6.28 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.063 0.459 . . . . 0.0 109.792 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -96.36 143.25 25.8 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.333 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 143.31 78.41 Favored 'Trans proline' 0 C--O 1.249 1.048 0 C-N-CA 122.144 1.896 . . . . 0.0 111.109 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.23 178.13 7.95 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.36 2.04 . . . . 0.0 111.406 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 32.1 m -78.45 -44.39 24.79 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -168.35 168.85 11.08 Favored 'General case' 0 C--O 1.256 1.395 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -144.16 138.24 28.0 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.95 159.69 39.23 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.491 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.2 tp10 -109.05 116.98 33.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 10.3 tt -61.35 113.27 2.54 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.253 1.025 . . . . 0.0 110.174 -176.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.6 t -85.09 157.9 20.57 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.566 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.88 -22.11 65.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.279 0.561 . . . . 0.0 111.014 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -65.81 -36.55 83.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.486 HD21 HG21 ' A' ' 123' ' ' VAL . 17.3 t-20 -71.77 -42.82 66.7 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 118' ' ' LEU . 7.7 tt -62.02 -21.31 64.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.076 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -82.4 -13.64 56.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.131 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.43 10.9 21.0 Favored Glycine 0 C--O 1.24 0.521 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.083 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -94.04 135.98 24.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 61.4 Cg_endo -71.48 104.58 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.15 2.567 . . . . 0.0 112.353 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 117' ' ' ASN . 66.1 t -83.33 127.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.675 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.29 121.66 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 110.411 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.2 168.5 11.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.395 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.82 94.02 7.58 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.222 0.534 . . . . 0.0 109.911 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . 0.312 26.8 p90 -88.44 67.41 8.59 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.12 -47.49 13.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.2 tmtt? -80.27 -30.74 38.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -73.5 84.16 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.184 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -110.67 -68.18 0.95 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -104.5 115.79 30.97 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.1 t -100.2 103.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 C-N-CA 118.472 -1.291 . . . . 0.0 110.675 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.418 ' NH2' ' HE2' ' A' ' 66' ' ' PHE . 28.8 mmm180 -78.37 -80.64 0.11 Allowed 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.554 170.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' SER . 42.6 p -105.55 149.73 26.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.48 129.75 41.53 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.607 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 20.8 m -130.84 144.18 51.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.4 mt -117.74 135.99 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 122.501 0.32 . . . . 0.0 110.191 -174.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 83.5 t80 -123.21 112.23 17.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.537 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 26.1 pt -109.27 114.96 48.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.451 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.6 pt-20 -105.31 -9.45 17.62 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.29 166.82 29.77 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.129 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -119.18 164.57 15.39 Favored 'General case' 0 CA--C 1.496 -1.117 0 O-C-N 124.164 0.915 . . . . 0.0 109.903 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.414 ' N ' ' HB2' ' A' ' 86' ' ' LYS . 34.2 mm-40 -46.32 -61.4 1.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 110.374 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.2 t -91.24 -11.07 39.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.697 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.64 65.28 2.96 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.6 t -100.21 -2.35 34.15 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 58' ' ' GLU 0.286 45.0 mt-10 68.7 -27.25 0.15 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.2 p -102.22 103.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 25.0 m -101.19 111.27 23.44 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.504 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -104.84 132.49 51.02 Favored 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.485 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.99 124.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.869 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.508 ' OE1' ' HD2' ' A' ' 78' ' ' LYS . 36.0 tt0 -97.3 -27.62 14.42 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.102 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -160.72 129.26 4.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.6 112.11 38.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 165.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.454 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -130.87 141.84 50.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 156' ' ' ALA . 5.8 mp -130.69 142.67 50.44 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 79.4 m-85 -124.53 114.27 19.2 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -109.94 -174.08 20.7 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.3 m -139.23 129.94 26.03 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--N 1.293 -1.866 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.253 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 9' ' ' ILE . 2.5 mp . . . . . 0 N--CA 1.418 -2.038 0 CA-C-O 120.453 0.168 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 13' ' ' GLN . 19.3 Cg_endo -93.09 -173.87 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.513 2.142 . . . . 0.0 110.525 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -96.93 137.45 35.99 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.67 -40.22 2.6 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -143.05 137.52 29.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.83 155.22 7.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 123.816 0.698 . . . . 0.0 110.001 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -58.95 129.53 42.6 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.092 0.957 . . . . 0.0 110.886 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.591 ' O ' HG13 ' A' ' 20' ' ' ILE . 80.6 mt -98.19 5.89 48.03 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.001 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.481 HD23 ' HG2' ' A' ' 42' ' ' GLN . 64.9 tp -64.22 -42.22 96.67 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.797 0.808 . . . . 0.0 109.497 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.5 -20.03 65.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.896 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' C ' ' HB2' ' A' ' 67' ' ' ASN . 24.7 m-85 -95.17 19.87 9.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.914 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 16' ' ' LEU . 72.1 mt -108.19 127.76 64.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.985 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 -38.25 85.1 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.451 ' CZ2' HD13 ' A' ' 40' ' ' LEU . 90.0 m95 76.46 -29.19 0.18 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.4 t -80.05 -36.37 35.78 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.485 0.66 . . . . 0.0 110.044 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.13 12.43 66.34 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.004 -0.617 . . . . 0.0 114.575 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.53 152.31 7.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-N 117.504 0.652 . . . . 0.0 111.989 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.97 127.45 13.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 p -134.02 108.22 8.23 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.677 0.751 . . . . 0.0 109.897 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -76.5 121.49 23.19 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 46.3 t30 72.53 -55.1 0.68 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.371 1.468 . . . . 0.0 110.978 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.2 pt20 63.2 -62.71 0.13 Allowed 'General case' 0 C--O 1.209 -1.069 0 C-N-CA 127.442 2.297 . . . . 0.0 110.0 -176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.578 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 23.9 m 176.87 119.77 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 129.608 3.163 . . . . 0.0 103.109 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.6 p -62.63 -18.39 62.16 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 117.073 -1.851 . . . . 0.0 113.124 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -111.3 -14.72 13.75 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 31' ' ' SER . 94.8 m-70 -125.43 163.62 22.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.914 -0.492 . . . . 0.0 110.289 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.523 ' OG ' ' HD2' ' A' ' 37' ' ' PRO . 29.5 t -114.03 171.19 7.75 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.799 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -77.38 -54.6 1.44 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.941 0.897 . . . . 0.0 112.722 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.523 ' HD2' ' OG ' ' A' ' 35' ' ' SER . 30.8 Cg_exo -40.34 -50.31 3.68 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 123.392 2.728 . . . . 0.0 114.823 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -55.85 -45.81 78.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.76 -11.06 57.63 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.451 HD13 ' CZ2' ' A' ' 22' ' ' TRP . 1.3 tm? -104.28 -27.28 12.1 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.0 120.36 22.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.624 ' NE2' ' HG2' ' A' ' 45' ' ' ARG . 17.9 mm-40 -75.56 92.07 2.88 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 121.923 0.868 . . . . 0.0 109.27 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 45' ' ' ARG . . . 170.14 -56.36 0.19 Allowed Glycine 1 N--CA 1.386 -4.66 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.46 -171.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -81.62 -29.3 33.3 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.511 0.672 . . . . 0.0 110.185 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.624 ' HG2' ' NE2' ' A' ' 42' ' ' GLN . 5.1 ppt_? -60.95 17.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.93 137.15 36.13 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.344 -0.848 . . . . 0.0 112.209 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 8.3 t70 -58.96 85.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.927 1.691 . . . . 0.0 112.497 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER 160.61 -55.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.635 1.974 . . . . 0.0 108.097 174.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.22 -78.24 0.14 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.626 -0.716 . . . . 0.0 114.256 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 163.58 29.28 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.9 p-10 -161.19 166.35 27.96 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tt -110.63 128.69 55.79 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.96 158.82 43.33 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 120.579 0.228 . . . . 0.0 111.435 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.2 p -79.49 79.57 5.94 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 122.187 0.994 . . . . 0.0 108.418 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -97.27 79.97 2.86 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.206 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 155.21 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.514 2.326 . . . . 0.0 107.115 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.8 -170.3 1.63 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.493 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -18.88 12.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -102.27 154.79 18.71 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.023 0.929 . . . . 0.0 109.558 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 140' ' ' ILE . 78.7 mt -146.51 147.32 31.05 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 1.2 tm? -123.21 116.92 24.18 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -124.33 120.89 60.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -109.79 134.52 51.94 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.88 0.472 . . . . 0.0 110.806 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 mm -120.78 131.83 24.35 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.492 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -87.84 150.7 7.25 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.49 2.793 . . . . 0.0 111.577 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -89.6 162.99 15.35 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.545 ' HB2' ' C ' ' A' ' 19' ' ' PHE . 4.6 t-20 -101.66 -43.14 5.96 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 112.509 -2.132 . . . . 0.0 107.322 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -153.07 150.73 29.44 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.29 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.51 122.92 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.67 175.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -81.04 142.47 33.33 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 73' ' ' HIS . 3.1 tm? -81.05 150.91 28.62 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.546 ' N ' HD12 ' A' ' 72' ' ' LEU . 3.6 t-160 -141.96 -62.61 0.45 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.878 177.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' HD22 ' A' ' 125' ' ' LEU . 12.1 p -152.65 163.22 40.07 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 7.7 p90 -125.56 157.17 37.78 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.72 107.13 3.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.783 0.265 . . . . 0.0 110.513 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.87 136.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 91.3 mttt -114.01 158.12 21.6 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.663 176.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.91 -177.49 47.54 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.99 150.14 89.03 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.833 1.689 . . . . 0.0 109.088 172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.59 -25.5 68.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 45.4 mt-10 -87.33 -54.52 4.26 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.486 0.66 . . . . 0.0 111.26 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.73 8.68 18.9 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.203 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.9 153.37 38.05 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.668 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 39.1 Cg_exo -60.98 147.41 95.76 Favored 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 122.14 1.893 . . . . 0.0 110.517 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.6 OUTLIER -130.33 -53.89 1.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 54.6 m -80.53 97.03 6.97 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.57 116.19 40.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.003 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -109.34 132.67 53.91 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -117.07 140.12 49.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.508 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 88.2 t80 -130.3 129.2 42.93 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -113.4 145.79 40.56 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 75.82 172.56 0.25 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.523 1.529 . . . . 0.0 111.272 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt 67.51 164.97 0.22 Allowed 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.373 1.069 . . . . 0.0 111.716 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.09 164.42 26.53 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -49.39 136.02 16.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.416 ' HE2' ' HB3' ' A' ' 105' ' ' PHE . 86.0 mtp -110.15 127.97 55.21 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.524 ' O ' HG21 ' A' ' 102' ' ' VAL . 25.9 p -86.9 176.6 7.6 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.9 -29.41 67.02 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -61.93 -19.34 62.63 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.086 0.554 . . . . 0.0 111.224 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -109.32 -26.74 9.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.306 0.574 . . . . 0.0 110.207 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 98' ' ' CYS . 52.4 t -58.48 -38.04 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.574 1.15 . . . . 0.0 113.838 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -57.85 -14.34 5.89 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.95 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.61 71.19 1.23 Allowed 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.61 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 102' ' ' VAL . 3.0 p90 -128.14 153.77 78.65 Favored Pre-proline 0 C--O 1.249 1.046 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.184 167.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.92 118.55 5.07 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.242 1.961 . . . . 0.0 109.921 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.26 136.19 42.87 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.067 1.845 . . . . 0.0 111.875 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -69.05 -45.27 70.81 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -162.53 155.86 20.22 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.0 p -119.41 114.63 22.62 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.72 153.91 33.62 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.512 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mp0 -114.61 126.43 54.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.832 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 7.6 tt -73.59 113.1 10.33 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -103.26 175.23 5.55 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.449 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -38.22 60.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.023 0.529 . . . . 0.0 111.779 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' OE1' ' HD2' ' A' ' 121' ' ' LYS . 5.4 tp10 -61.33 -43.68 98.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.353 0.661 . . . . 0.0 109.894 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.466 HD21 HG23 ' A' ' 123' ' ' VAL . 13.8 t-20 -71.95 -38.37 69.79 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.442 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 118' ' ' LEU . 2.3 tm? -63.27 -22.93 67.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.832 1.253 . . . . 0.0 108.801 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -87.24 -0.37 56.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.428 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.24 52.73 Favored Glycine 0 CA--C 1.496 -1.103 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.416 ' HD2' ' OE1' ' A' ' 116' ' ' GLU . 98.4 mttt -86.36 142.29 35.36 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.502 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 48.6 Cg_endo -67.83 121.36 8.4 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.453 2.769 . . . . 0.0 112.401 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.466 HG23 HD21 ' A' ' 117' ' ' ASN . 76.7 t -97.35 119.96 46.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 130.5 34.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.314 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 74' ' ' SER . 0.7 OUTLIER -101.87 178.53 4.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 10.4 mptt -89.7 95.24 10.16 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -109.04 23.61 14.3 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.177 -173.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.6 t -53.05 -38.8 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.508 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -103.98 4.93 35.12 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.876 179.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.457 ' CE2' ' HE3' ' A' ' 129' ' ' LYS . 55.5 m-85 -108.23 71.89 0.82 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.932 0.873 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -102.49 0.24 33.37 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.444 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -142.37 114.72 8.38 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.456 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.12 107.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -74.35 -44.48 52.14 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.293 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.7 m -157.43 171.33 20.57 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 tp -142.56 131.64 23.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.931 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 88.9 m -111.46 118.34 35.5 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 138' ' ' ILE . 3.0 mp -104.52 114.97 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -110.68 109.71 20.09 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.533 0.682 . . . . 0.0 109.973 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 60' ' ' LEU . 7.2 pt -96.71 114.5 33.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.256 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.89 -48.65 5.92 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.664 -173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.92 146.2 48.93 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.664 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.12 -179.55 5.29 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.002 0.814 . . . . 0.0 109.121 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.457 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.3 mp0 -54.72 -62.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 p -93.44 -36.49 12.45 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.6 1.54 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.3 m -84.68 16.63 3.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.271 12.8 pt-20 63.11 -1.0 0.55 Allowed 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 126.147 1.779 . . . . 0.0 114.2 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.94 122.57 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.94 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -93.35 128.31 39.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -116.35 133.49 55.96 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 79.1 t -134.02 128.48 53.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -88.99 -46.35 8.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.386 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.435 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -146.02 142.94 29.11 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.396 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.76 127.19 73.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.34 141.24 41.83 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.37 137.31 52.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 88.3 m-85 -124.39 139.11 54.21 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.235 0.541 . . . . 0.0 111.265 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.29 -176.18 14.25 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.9 m -134.04 130.16 37.12 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 117.477 0.639 . . . . 0.0 110.729 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 C--N 1.288 -2.07 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.321 176.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.9 m . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m -85.46 105.58 16.18 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.17 112.74 16.15 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.72 -177.24 5.41 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.7 t -176.49 -73.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.67 73.54 1.41 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 m -113.49 135.21 54.13 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.746 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.18 105.53 13.9 Favored 'General case' 0 CA--C 1.471 -2.069 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.022 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 9' ' ' ILE . 2.0 mp -92.75 116.2 66.1 Favored Pre-proline 0 N--CA 1.399 -2.978 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.546 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.64 -166.55 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -104.55 109.17 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.414 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.14 -41.69 0.89 Allowed Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -137.8 142.58 40.84 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.449 -0.876 . . . . 0.0 111.214 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -106.52 156.4 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.8 143.97 43.74 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.632 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.6 mp -102.82 7.18 39.52 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.653 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.52 -43.24 85.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.66 -16.67 60.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.662 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.39 -2.85 57.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 16' ' ' LEU . 94.9 mt -74.66 145.38 11.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.6 -42.54 70.84 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 122.751 0.421 . . . . 0.0 111.097 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 72.44 -33.97 0.28 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -79.11 -37.14 39.43 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.832 0.348 . . . . 0.0 110.871 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 17.68 55.28 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.48 -0.867 . . . . 0.0 114.011 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.61 143.64 14.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 117.487 0.643 . . . . 0.0 109.793 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -141.2 134.93 30.22 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.858 0.361 . . . . 0.0 110.395 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 81.2 m -135.72 121.86 20.22 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.045 0.45 . . . . 0.0 111.104 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -83.44 5.94 21.96 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.832 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 57' ' ' ASP . 50.3 t-20 -151.64 -67.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 4.0 pt20 50.98 25.22 2.14 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 125.342 1.457 . . . . 0.0 112.653 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.2 m 78.89 112.91 0.07 Allowed 'General case' 0 C--O 1.208 -1.095 0 C-N-CA 125.08 1.352 . . . . 0.0 108.616 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -52.58 -25.27 10.09 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -112.86 -1.89 14.49 Favored 'General case' 0 CA--C 1.562 1.43 0 O-C-N 121.847 -0.533 . . . . 0.0 112.349 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -126.34 166.56 16.93 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.0 m -105.82 166.26 10.6 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.011 -0.431 . . . . 0.0 111.78 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 3.1 tm? -64.92 -50.09 64.66 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 3.0 Cg_endo -46.03 -29.35 6.13 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 123.85 3.033 . . . . 0.0 114.066 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 50' ' ' LEU . 3.2 m-20 -44.47 -48.96 10.07 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.872 1.669 . . . . 0.0 113.375 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -111.19 -7.9 14.42 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.116 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.4 tp -104.23 -42.81 5.4 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.903 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -84.28 103.88 13.84 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 19.9 mm-40 -59.19 127.03 30.11 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.683 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.26 -42.41 1.38 Allowed Glycine 1 N--CA 1.388 -4.559 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.197 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.6 -9.36 44.4 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.144 1.777 . . . . 0.0 115.747 -174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.51 104.33 16.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.734 -0.604 . . . . 0.0 111.503 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 18.1 t70 -70.93 85.58 0.69 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.352 0.596 . . . . 0.0 110.756 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 5.8 mm-40 -167.78 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 127.6 2.36 . . . . 0.0 106.307 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.02 -54.92 0.89 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.913 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 1.4 pt? -140.27 137.8 34.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.43 165.74 34.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.0 tp -99.1 128.87 45.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.4 171.05 14.59 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-O 121.723 0.773 . . . . 0.0 112.967 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 71.9 p -96.93 111.47 23.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.33 -50.44 59.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.168 0.508 . . . . 0.0 110.1 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.1 -41.87 0.65 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.128 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 54' ' ' SER . 3.8 m-20 -85.73 112.85 21.44 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.696 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -70.57 -26.82 63.71 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.815 0.697 . . . . 0.0 110.046 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -84.15 113.75 21.29 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.854 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.3 mt -116.4 134.6 54.69 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.404 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.44 114.91 22.5 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.12 124.19 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.418 ' HD1' ' OG1' ' A' ' 137' ' ' THR . 69.4 t80 -104.0 123.71 47.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.14 116.36 31.17 Favored Pre-proline 0 N--CA 1.437 -1.109 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.527 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -90.01 153.05 4.84 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.158 1.905 . . . . 0.0 109.794 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -112.2 162.42 15.48 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.141 0.496 . . . . 0.0 112.195 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -87.98 -22.69 24.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.64 156.68 47.78 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.72 114.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.839 0.828 . . . . 0.0 111.008 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.74 172.96 14.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.164 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.597 ' HG3' ' OXT' ' A' ' 161' ' ' THR . 56.4 mttp -106.44 129.88 54.34 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.301 0.501 . . . . 0.0 109.915 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.499 HD11 HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -77.13 126.14 30.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -116.03 -38.64 3.59 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.727 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.6 p -147.88 154.11 39.97 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.501 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -130.4 154.98 47.14 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.564 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -143.57 110.25 5.55 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.563 0.345 . . . . 0.0 110.643 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -122.27 134.5 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.603 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 53.5 mtpt -129.19 153.58 47.6 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.311 0.577 . . . . 0.0 112.256 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.39 -166.16 29.75 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -71.42 158.04 55.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 122.215 1.943 . . . . 0.0 109.657 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.43 -37.27 86.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.35 -33.61 22.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.12 13.98 33.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.237 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.42 147.61 25.76 Favored Glycine 0 C--N 1.301 -1.406 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.583 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 6.0 Cg_exo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.49 2.127 . . . . 0.0 111.908 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 3.7 tmmm? -95.29 -48.06 6.06 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.729 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -85.8 95.02 9.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.443 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.42 119.03 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.399 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.98 148.21 41.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -132.58 155.21 49.09 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.642 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 52.3 p90 -152.29 118.96 5.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.587 0.708 . . . . 0.0 110.673 168.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.2 t -103.53 175.93 5.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.251 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 m120 66.12 23.27 11.02 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.423 0.689 . . . . 0.0 111.615 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HA ' ' HZ1' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -148.25 107.27 3.86 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.184 0.516 . . . . 0.0 109.971 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.96 122.07 30.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.4 m80 71.01 107.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.441 ' HB3' ' CE2' ' A' ' 91' ' ' PHE . 51.2 ttm -161.48 128.55 4.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.452 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -90.2 162.62 15.16 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.512 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 50.5 p90 -61.8 -18.5 60.15 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -173.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.8 t -60.87 -36.13 78.41 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.99 0.424 . . . . 0.0 110.315 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 41.8 m-80 -89.39 -25.07 21.75 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.835 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.512 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 40.3 t -62.89 -13.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.263 1.03 . . . . 0.0 110.323 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.23 -20.53 28.36 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.786 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.06 -23.77 13.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.516 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -96.6 133.19 24.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.585 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.45 126.67 16.62 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.364 2.043 . . . . 0.0 110.657 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.52 161.5 34.89 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 122.566 2.177 . . . . 0.0 111.253 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.642 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 39.6 m -63.34 -45.42 91.31 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.463 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 17.7 t70 -158.88 153.78 24.94 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -126.87 115.28 19.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.29 165.08 12.05 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.573 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 8.9 mp0 -123.77 138.25 54.54 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.4 tp -72.64 107.77 5.3 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.5 p -82.16 160.96 22.96 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.15 -30.73 71.25 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.846 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.22 -32.52 66.82 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.693 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.564 HD22 ' HA ' ' A' ' 76' ' ' ALA . 1.6 t-20 -66.4 -36.89 83.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.603 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 2.6 tm? -64.05 -8.0 10.45 Favored 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 126.786 2.035 . . . . 0.0 110.387 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 90.8 mttt -110.94 -6.85 14.62 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.541 0.736 . . . . 0.0 109.498 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 78' ' ' LYS . . . 99.06 30.92 6.45 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.811 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -102.37 121.59 49.53 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.523 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.08 112.84 1.34 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.272 2.648 . . . . 0.0 111.458 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 132.52 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.08 136.61 22.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.524 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.499 HD13 HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -115.4 -172.84 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.491 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' HG2' ' OD1' ' A' ' 109' ' ' ASP . 72.5 mmtt -70.57 89.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -68.5 -21.95 64.57 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.787 1.235 . . . . 0.0 110.52 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.71 -24.89 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.443 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -94.57 -36.21 11.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.346 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -79.08 93.25 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.264 0.554 . . . . 0.0 110.778 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -114.6 -41.06 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -121.95 115.64 22.92 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.887 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.72 102.37 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.973 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -104.17 -24.08 13.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 168.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.3 p -138.74 144.24 39.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.852 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.8 tp -147.27 121.1 9.28 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.418 ' OG1' ' HD1' ' A' ' 63' ' ' TYR . 23.2 m -105.74 132.11 52.26 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.857 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -105.15 117.75 51.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -117.86 107.23 13.85 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.52 0.676 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.539 HG13 ' HB2' ' A' ' 60' ' ' LEU . 11.3 pt -107.1 114.06 45.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.463 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.43 -23.0 12.91 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.28 152.0 44.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.812 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.449 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 31.7 p30 -108.92 170.08 8.27 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.981 -178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 21.0 tp60 -48.32 -60.03 2.98 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.917 1.687 . . . . 0.0 113.799 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.8 m -104.0 7.82 36.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.439 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.36 46.12 94.53 Favored Glycine 0 C--O 1.224 -0.509 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 m -90.5 10.8 23.89 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.21 0.604 . . . . 0.0 112.342 -171.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 43.9 mt-10 69.85 -45.83 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.147 0.979 . . . . 0.0 112.802 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.52 137.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.119 0.485 . . . . 0.0 109.844 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.5 m -120.33 138.31 53.79 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -131.1 135.42 47.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.6 125.77 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -86.9 -48.81 7.85 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -153.8 143.17 21.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -177.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.3 mt -121.86 132.3 71.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.44 134.09 26.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -113.56 135.81 53.5 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -120.01 133.13 55.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.381 0.61 . . . . 0.0 109.908 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -128.87 178.63 17.14 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.5 m -128.82 25.94 5.59 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 117.151 0.476 . . . . 0.0 112.266 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.597 ' OXT' ' HG3' ' A' ' 71' ' ' LYS . 63.8 p . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.3 p . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -95.44 107.49 19.64 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.17 15.12 9.36 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.01 158.85 39.78 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.8 p -88.28 94.8 9.95 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.06 108.32 3.42 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.559 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.4 p -94.44 154.93 17.2 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.824 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 26.1 tt0 -119.09 20.37 12.69 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.009 0.909 . . . . 0.0 109.871 -177.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 11' ' ' LYS . 3.2 mp -79.79 120.44 80.02 Favored Pre-proline 0 C--N 1.298 -1.633 0 O-C-N 121.769 -0.582 . . . . 0.0 111.98 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -95.02 29.22 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.552 2.834 . . . . 0.0 110.95 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 9' ' ' ILE . 41.0 ttmt 68.44 106.25 0.05 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.281 1.433 . . . . 0.0 112.16 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.32 -79.84 0.2 Allowed Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.11 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 26.8 mm-40 -109.84 -173.82 2.35 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.57 152.5 8.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 3.1 p30 -74.62 138.95 43.29 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.197 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.511 ' O ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -78.78 -13.26 59.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.441 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 4.6 tt -59.79 -43.5 94.39 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.174 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -24.72 62.58 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -90.29 14.74 11.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.322 0.582 . . . . 0.0 111.34 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 16' ' ' LEU . 67.3 mt -100.48 134.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.32 -26.04 51.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.738 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 74.09 2.75 4.25 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -88.63 -28.13 20.85 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.946 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.21 23.15 7.74 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 119.33 -1.414 . . . . 0.0 114.515 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.63 133.44 31.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 117.564 0.682 . . . . 0.0 110.838 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.06 154.93 46.19 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.217 -0.302 . . . . 0.0 110.809 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB3' HE21 ' A' ' 30' ' ' GLN . 47.2 t -136.21 141.11 43.97 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.911 0.485 . . . . 0.0 109.836 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.549 HD12 ' CZ ' ' A' ' 99' ' ' PHE . 5.7 tt -52.71 -61.48 2.26 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.885 1.274 . . . . 0.0 110.928 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.442 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 28.2 t-20 -95.11 -88.8 0.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.613 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 27' ' ' CYS . 7.8 tt0 55.47 17.88 2.41 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.503 1.144 . . . . 0.0 109.426 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -81.54 -23.5 37.18 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.233 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 34' ' ' HIS . 44.7 t -55.37 -4.75 0.1 Allowed 'General case' 0 CA--C 1.578 2.022 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.976 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 m 80.11 -17.16 0.6 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.35 1.46 . . . . 0.0 110.158 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.795 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 12.7 m170 -71.39 110.82 6.25 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -95.23 164.4 12.87 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -164.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.416 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 5.4 tt -63.73 -50.51 71.11 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.417 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 85.2 Cg_exo -53.67 -27.01 40.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.964 1.776 . . . . 0.0 112.835 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.472 ' ND2' HD22 ' A' ' 50' ' ' LEU . 13.4 m120 -59.61 -48.18 82.66 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-O 120.995 0.426 . . . . 0.0 110.338 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HA ' ' NE ' ' A' ' 45' ' ' ARG . . . -102.88 -0.35 31.31 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 44.2 tp -132.34 5.64 4.1 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 119.431 -0.907 . . . . 0.0 113.024 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -121.97 143.72 49.3 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 121.222 -0.924 . . . . 0.0 111.574 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.62 152.13 36.02 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.511 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.85 -52.27 4.69 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.58 -9.61 59.77 Favored 'General case' 0 C--O 1.194 -1.851 0 C-N-CA 123.017 0.527 . . . . 0.0 111.059 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' HA ' ' NE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -75.07 -91.83 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.329 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' H ' ' HB3' ' A' ' 45' ' ' ARG 0.311 9.3 pt-20 39.39 84.73 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.883 0.849 . . . . 0.0 113.061 -174.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.338 5.6 p-10 -67.24 85.68 0.15 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -169.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 169.91 103.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 107.31 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.32 -99.5 0.44 Allowed Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.472 HD22 ' ND2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -77.67 147.19 35.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.795 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.8 p30 -164.59 169.36 17.13 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.406 HD21 ' C ' ' A' ' 52' ' ' LEU . 7.2 tt -105.47 121.87 44.83 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.065 -1.454 . . . . 0.0 108.626 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.33 159.68 41.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.652 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 25.1 p -85.91 177.21 7.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.528 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.7 -64.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.05 68.4 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.652 ' O ' ' HB2' ' A' ' 54' ' ' SER . 8.5 t70 -131.64 174.44 10.11 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -109.61 -24.58 10.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 141' ' ' GLU . 87.8 mm-40 -84.28 139.46 32.31 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.588 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 29' ' ' ASN . 47.2 mt -135.64 122.39 21.02 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 122.12 0.962 . . . . 0.0 112.725 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.9 tt -130.42 120.96 25.02 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.13 123.02 66.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -101.38 123.43 45.44 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.18 113.91 32.32 Favored Pre-proline 0 N--CA 1.441 -0.887 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -89.18 139.23 3.55 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.862 2.374 . . . . 0.0 111.051 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.16 163.33 17.91 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.252 35.9 t-20 -104.44 -38.59 6.75 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 111.993 -2.367 . . . . 0.0 106.355 170.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -153.44 144.76 23.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 m -75.09 128.09 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.189 0.519 . . . . 0.0 111.114 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.34 173.21 11.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -97.37 117.93 32.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.97 123.72 25.65 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -106.19 -48.54 3.56 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.4 p -145.26 160.18 41.89 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -130.37 151.52 50.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.518 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' C ' HD12 ' A' ' 77' ' ' ILE . . . -148.99 116.69 6.24 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 mp -132.25 122.45 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -99.13 163.25 12.64 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.162 0.506 . . . . 0.0 110.344 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.05 -177.51 48.26 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -74.82 172.36 16.44 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.53 1.665 . . . . 0.0 108.306 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 -56.28 5.29 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.331 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.21 -55.25 26.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.115 0.959 . . . . 0.0 110.896 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -90.62 17.13 7.88 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.404 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.09 159.29 25.33 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 9.8 Cg_exo -72.54 107.26 2.26 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 119.417 1.608 . . . . 0.0 110.434 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 113' ' ' LEU . 12.6 tmtt? -83.34 -51.39 7.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.94 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.3 m -103.63 108.9 20.37 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.575 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.457 HG11 HG22 ' A' ' 140' ' ' ILE . 30.4 m -108.52 134.91 48.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.047 0.451 . . . . 0.0 111.321 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -121.69 134.26 54.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.31 138.85 47.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.495 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.3 m-85 -128.9 118.51 22.81 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.0 p -110.2 133.93 52.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.454 ' C ' ' HE3' ' A' ' 94' ' ' LYS . 86.4 m-20 76.37 -4.29 2.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.557 1.543 . . . . 0.0 114.991 173.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.548 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -88.35 104.43 16.76 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.56 150.11 31.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 72.1 99.63 0.07 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.275 1.03 . . . . 0.0 109.639 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 12.7 mmt -134.35 137.52 44.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.456 ' H ' ' HB2' ' A' ' 101' ' ' ASN . 32.0 p -159.17 -172.16 3.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.549 ' CZ ' HD12 ' A' ' 28' ' ' LEU . 92.7 m-85 -54.75 -44.57 73.71 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.301 0.501 . . . . 0.0 111.621 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 m -62.02 -20.61 64.11 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.482 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.3 m120 -93.67 -47.44 6.8 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.499 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.49 -20.13 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -93.2 -12.98 28.94 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.999 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -99.13 -37.57 9.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.892 0.377 . . . . 0.0 111.628 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -96.83 142.34 24.4 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.427 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.98 143.51 29.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 122.166 1.911 . . . . 0.0 111.293 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.14 163.8 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.413 2.075 . . . . 0.0 111.984 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -72.99 -44.8 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -169.35 171.95 7.5 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t -143.92 145.3 32.17 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.34 172.3 13.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.11 139.41 53.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.324 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 50.9 tp -60.5 112.68 2.07 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.923 0.764 . . . . 0.0 110.902 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.3 p -113.62 172.48 6.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.236 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.19 -24.69 67.35 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.728 0.775 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.31 -34.05 67.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.311 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.482 ' ND2' HG23 ' A' ' 123' ' ' VAL . 13.5 m120 -71.02 -45.42 63.95 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.269 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.35 -26.43 66.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.705 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.77 -13.75 55.71 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.228 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.88 41.41 23.23 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -95.5 134.96 23.52 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.12 109.94 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.782 1.655 . . . . 0.0 110.161 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.482 HG23 ' ND2' ' A' ' 117' ' ' ASN . 61.6 t -98.34 131.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.89 105.97 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.54 0.686 . . . . 0.0 111.458 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.61 -165.85 1.23 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.767 174.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -76.97 92.18 3.67 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.165 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.43 -27.55 66.14 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.615 1.566 . . . . 0.0 111.753 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.41 -16.04 16.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -80.82 -51.1 8.99 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.817 0.818 . . . . 0.0 110.149 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 90.33 6.63 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.178 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -98.91 -31.42 11.84 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.131 0.491 . . . . 0.0 110.272 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -149.39 119.55 7.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.395 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.09 112.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.742 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -92.65 -45.58 8.0 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -141.1 139.68 34.04 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.444 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.8 tp -131.69 125.31 31.77 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.233 0.54 . . . . 0.0 110.152 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 96.2 m -106.97 126.54 52.46 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.565 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 62.6 mt -104.7 109.49 27.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 49.2 t80 -113.59 111.23 21.52 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.106 0.479 . . . . 0.0 110.646 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.457 HG22 HG11 ' A' ' 88' ' ' VAL . 30.9 pt -100.94 113.72 37.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 14.7 pt-20 -99.59 -12.94 19.65 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.643 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.76 142.32 10.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 118.99 -1.084 . . . . 0.0 113.385 -175.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.71 -173.76 2.47 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 170.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -60.49 -56.03 26.26 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.1 m -124.64 6.58 8.2 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.826 -169.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.82 60.9 3.48 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.2 m -83.07 17.34 2.0 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.898 0.879 . . . . 0.0 111.766 -174.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 78.51 -32.05 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 112.794 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.5 147.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 92.5 m -114.05 124.27 51.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.43 ' HE3' ' ND2' ' A' ' 51' ' ' ASN . 88.1 tttt -111.37 134.35 53.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 123.174 0.589 . . . . 0.0 110.071 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 44.5 t -125.23 126.12 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -97.42 -11.44 23.9 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 39.8 ttmt -170.15 130.45 0.95 Allowed 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.82 -0.55 . . . . 0.0 111.449 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.95 116.65 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.29 121.09 21.91 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 84.1 mt -117.45 144.62 44.84 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.487 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 88.0 m-85 -126.24 145.47 50.38 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.818 0.342 . . . . 0.0 111.629 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -148.46 -168.64 14.62 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.384 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.5 p -151.07 140.65 21.63 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 122.5 0.32 . . . . 0.0 110.504 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.631 176.265 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.629 0.252 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 m -133.18 -177.7 4.64 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.81 91.8 3.83 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.185 0.517 . . . . 0.0 110.891 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.1 140.17 47.51 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.3 t -93.02 85.72 5.2 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.406 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.73 110.46 16.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 p -154.65 145.89 22.88 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.39 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 6.2 tp60 -95.05 87.05 4.79 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.3 mm -100.43 107.66 49.2 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.657 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HG2' HE21 ' A' ' 13' ' ' GLN . 59.1 Cg_endo -95.56 -178.9 0.51 Allowed 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 122.432 2.088 . . . . 0.0 110.468 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -76.37 131.25 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.49 -51.55 0.83 Allowed Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.155 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.482 HE21 ' HG2' ' A' ' 10' ' ' PRO . 1.6 pm0 -130.84 172.15 12.35 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 159' ' ' GLY . 14.5 p -118.04 154.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.79 147.47 37.21 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 20' ' ' ILE . 66.4 mt -108.27 17.75 21.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.8 -43.47 75.56 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -83.06 -11.7 57.8 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.507 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.99 0.93 42.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.904 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 16' ' ' LEU . 70.9 mt -86.72 140.39 15.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.22 -28.9 31.68 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.544 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.586 ' CH2' HD11 ' A' ' 40' ' ' LEU . 98.9 m95 76.45 -4.37 2.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 t -102.89 -30.76 10.63 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.61 -0.39 66.98 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.706 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.4 m -64.83 139.2 21.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 117.146 0.473 . . . . 0.0 111.453 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.35 143.77 27.08 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.457 ' HB3' ' NE2' ' A' ' 30' ' ' GLN . 51.6 t -137.39 140.32 41.29 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.9 mm? -123.69 90.92 3.36 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.177 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 28' ' ' LEU . 10.7 t30 152.47 -17.29 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.963 1.305 . . . . 0.0 111.83 170.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.595 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -54.74 -14.73 1.48 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 122.897 0.479 . . . . 0.0 111.681 176.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.4 t -58.81 -21.96 57.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.621 1.169 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.465 ' HB2' ' H ' ' A' ' 56' ' ' ALA . 33.7 p -77.14 -14.96 59.71 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.1 t -154.75 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.595 ' O ' ' HB2' ' A' ' 30' ' ' GLN . 68.7 m-70 -124.35 162.95 22.74 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -88.82 172.87 8.89 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -169.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.454 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -70.52 -55.3 7.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.16 -20.13 36.89 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.08 1.853 . . . . 0.0 111.85 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.691 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 2.4 m-20 -58.04 -41.54 83.45 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 124.839 1.255 . . . . 0.0 111.628 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -110.96 6.63 21.21 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.21 0.529 . . . . 0.0 110.659 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.586 HD11 ' CH2' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -105.22 -43.22 5.07 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -79.83 130.4 35.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.135 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -45.82 139.04 4.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.239 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.28 -52.89 4.38 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 114.935 -1.029 . . . . 0.0 114.179 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -67.47 -28.74 68.12 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.24 -13.12 16.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.139 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -48.49 119.55 3.12 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.652 0.595 . . . . 0.0 110.596 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 153' ' ' GLN 0.258 4.8 p-10 -72.49 96.62 1.96 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -169.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 175.91 -52.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.356 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.54 -69.62 1.37 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.691 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -128.78 145.37 51.2 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.967 0.413 . . . . 0.0 111.107 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.443 ' HA ' ' HB3' ' A' ' 39' ' ' ALA . 3.5 p-10 -159.08 166.38 31.77 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 53.5 tp -84.22 130.04 34.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 35.5 tt0 -143.0 135.54 27.54 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.146 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.619 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 46.1 p -110.45 112.83 25.01 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.32 -44.72 7.8 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 120.796 0.331 . . . . 0.0 111.591 -175.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' H ' ' HB2' ' A' ' 32' ' ' SER . . . -81.78 -57.93 3.22 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.211 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 54' ' ' SER . 11.5 m-20 -106.87 141.88 37.39 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.964 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.49 4.3 47.1 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.575 1.179 . . . . 0.0 109.319 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.92 120.9 43.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.395 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 tt -141.26 130.57 23.63 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.52 0.676 . . . . 0.0 111.028 -175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 62' ' ' ILE . 1.1 tm? -101.79 134.13 45.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.914 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 61' ' ' LEU . 29.9 mt -129.19 129.98 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -112.71 115.73 29.0 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.11 116.76 31.02 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.45 144.35 4.72 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.515 2.143 . . . . 0.0 110.925 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.11 143.87 36.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.788 0.804 . . . . 0.0 112.854 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -56.51 -42.63 78.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 126.413 1.885 . . . . 0.0 110.515 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -142.71 154.36 44.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.95 123.42 38.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 121.525 0.679 . . . . 0.0 111.513 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -130.52 173.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.74 127.47 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.15 109.27 15.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -91.53 -52.04 4.97 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.41 . . . . 0.0 111.237 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 p -140.36 157.12 46.03 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.194 0.521 . . . . 0.0 111.89 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 111' ' ' ALA . 35.4 p90 -127.1 152.55 47.16 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.574 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -144.17 106.43 4.37 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.784 0.326 . . . . 0.0 111.722 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 62.4 mt -111.18 118.16 56.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 154' ' ' LYS . 10.0 tmtt? -101.79 134.83 44.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.11 -176.21 41.48 Favored Glycine 0 N--CA 1.414 -2.812 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.007 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.85 151.87 57.44 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.755 2.304 . . . . 0.0 110.521 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -61.66 -34.02 74.97 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.21 -38.12 11.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.79 18.26 16.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.351 -173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.49 148.1 19.13 Favored Glycine 0 C--N 1.299 -1.516 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.891 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.3 107.48 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 CA-C-N 119.328 1.564 . . . . 0.0 110.058 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 31.5 ttpt -85.75 -55.12 4.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.131 0.491 . . . . 0.0 110.477 -173.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -82.29 103.84 12.17 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.245 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.21 136.93 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.812 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.52 151.14 50.47 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -126.17 155.93 40.96 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.97 161.5 14.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.9 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.9 p -95.95 79.27 3.24 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 38.04 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -151.94 166.97 29.86 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -101.77 146.51 27.68 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.579 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 51.99 84.41 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.48 1.112 . . . . 0.0 112.125 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.583 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 17.3 tpt -119.09 110.51 17.16 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 23.7 p -124.49 -170.7 2.2 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 83.3 t80 -63.62 -26.03 68.49 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 118.838 0.744 . . . . 0.0 111.639 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.8 m -71.16 -8.64 54.91 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.661 0.743 . . . . 0.0 110.4 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.583 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 12.1 m120 -105.64 -20.17 13.54 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.473 1.109 . . . . 0.0 110.35 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 55.5 t -58.39 -39.69 75.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.32 10.51 37.78 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.43 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -120.37 -35.77 3.36 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -96.46 127.64 39.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 O-C-N 121.953 -0.467 . . . . 0.0 111.801 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -54.11 129.56 35.01 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.893 3.062 . . . . 0.0 114.036 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.79 156.55 20.95 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.648 2.232 . . . . 0.0 110.885 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.1 m -84.32 -45.9 12.32 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.896 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' HB2' ' HE2' ' A' ' 129' ' ' LYS . 28.9 t70 -163.07 171.71 16.02 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.1 p -127.96 119.9 26.48 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.98 152.42 24.98 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 39.9 tt0 -126.49 125.6 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD22 ' NE2' ' A' ' 144' ' ' GLN . 19.6 tp -66.96 145.57 55.29 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 117' ' ' ASN . 2.8 t -135.23 163.67 29.43 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -58.63 -27.29 64.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.672 0.749 . . . . 0.0 110.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -65.52 -51.4 60.24 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.026 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.574 HD22 ' HA ' ' A' ' 76' ' ' ALA . 2.3 t-20 -65.31 -49.4 69.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.915 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 3.0 pp -71.31 -9.45 58.16 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -89.59 3.72 51.67 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.24 33.66 6.17 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.682 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.2 tmtp? -115.96 120.75 35.02 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 117.271 0.536 . . . . 0.0 109.675 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.489 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 32.5 Cg_exo -58.69 117.72 4.49 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 C-N-CA 123.574 2.849 . . . . 0.0 112.29 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.459 HG21 ' ND2' ' A' ' 117' ' ' ASN . 80.9 t -93.51 131.06 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -73.68 123.29 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.42 HD23 ' CD1' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -98.7 174.52 6.37 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.827 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -86.51 89.96 8.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -101.52 21.17 14.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.78 -3.76 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -123.02 1.01 9.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -101.03 78.62 1.94 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.2 -32.36 15.11 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.303 0.573 . . . . 0.0 110.023 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -141.78 121.62 13.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.772 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.56 108.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -96.4 -40.33 9.15 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 m -138.13 136.39 36.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -126.74 119.84 27.91 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.282 0.563 . . . . 0.0 110.236 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 93.6 m -102.27 121.32 42.03 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.591 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.4 mt -104.71 113.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 82.3 t80 -111.5 116.91 31.68 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.5 pp -106.91 136.03 43.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.633 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.0 pt-20 -123.47 -13.73 7.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.61 146.03 20.61 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.148 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -97.85 174.83 6.39 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.496 ' NE2' HD22 ' A' ' 113' ' ' LEU . 18.3 mp0 -60.47 -52.54 64.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.001 0.429 . . . . 0.0 110.855 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.3 t -92.04 -22.19 20.08 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.369 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.33 81.54 0.45 Allowed Glycine 0 CA--C 1.499 -0.928 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 149' ' ' VAL . 34.4 m -111.78 6.21 19.58 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.427 -0.386 . . . . 0.0 111.868 -172.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 67.76 -36.16 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.496 1.118 . . . . 0.0 112.72 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 147' ' ' SER . 4.6 p -102.87 132.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 123.498 0.719 . . . . 0.0 109.674 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.619 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 61.3 m -121.39 128.83 52.61 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 40.1 ttmt -109.9 132.66 53.95 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 19.4 t -123.71 116.3 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 97.5 mt-30 -94.77 -19.48 20.32 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.363 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -172.34 134.33 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.588 0.355 . . . . 0.0 110.563 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.443 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 1.8 mp -129.88 117.85 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.93 147.78 35.81 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.897 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.54 141.18 48.07 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.489 ' CE2' ' HG3' ' A' ' 122' ' ' PRO . 82.2 m-85 -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.43 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -139.58 -168.34 11.27 Favored Glycine 0 CA--C 1.488 -1.651 0 C-N-CA 119.909 -1.138 . . . . 0.0 112.487 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.3 p -163.08 147.89 11.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 120.487 0.184 . . . . 0.0 110.883 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 C--N 1.297 -1.716 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.382 170.551 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 m -139.48 114.5 9.54 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.033 0.444 . . . . 0.0 111.239 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.28 -21.79 24.26 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -89.52 155.63 19.16 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.612 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -78.61 -40.53 34.19 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.08 71.38 0.54 Allowed 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.732 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.0 t -147.79 114.83 6.16 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.236 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HB3' ' HH ' ' A' ' 158' ' ' TYR . 26.8 mm-40 -121.9 4.31 9.95 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.962 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.517 HG23 ' H ' ' A' ' 11' ' ' LYS . 4.2 mp -62.08 117.15 26.72 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.393 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.7 25.25 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.06 2.507 . . . . 0.0 110.887 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' H ' HG23 ' A' ' 9' ' ' ILE . 40.6 ttmt 61.85 99.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.767 1.227 . . . . 0.0 111.272 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.55 -78.83 0.19 Allowed Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.487 ' O ' HG22 ' A' ' 9' ' ' ILE . 28.0 mm-40 -109.7 168.42 9.42 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 15.5 m -105.34 156.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.886 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 17' ' ' LEU . 3.3 p30 -78.28 112.63 15.47 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 122.694 1.235 . . . . 0.0 109.531 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.594 ' O ' HG13 ' A' ' 20' ' ' ILE . 36.9 mt -68.65 6.04 0.93 Allowed 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.639 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 15' ' ' ASP . 5.2 tt -60.42 -41.65 94.38 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.67 -22.01 60.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.173 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 32.8 m-85 -93.71 15.11 17.17 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.982 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 16' ' ' LEU . 86.8 mt -95.97 134.95 31.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.52 -44.38 96.11 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 94.4 m95 66.46 7.19 4.84 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.96 -84.96 1.66 Allowed Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 t 39.16 84.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.951 1.3 . . . . 0.0 111.87 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -117.5 131.53 56.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.127 -168.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . 49.1 t -129.18 130.99 47.05 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.25 -72.01 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -70.69 -59.55 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 35.0 tt0 59.78 27.53 16.84 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.172 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 30.0 t 71.06 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.135 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -57.83 -34.12 69.34 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.238 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -109.67 -48.14 3.26 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.408 ' O ' ' HB3' ' A' ' 31' ' ' SER . 97.9 m-70 -99.58 164.92 11.87 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -169.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.425 ' C ' HD21 ' A' ' 52' ' ' LEU . 16.2 m -100.82 141.5 33.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.734 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 3.0 tm? -62.37 -46.38 90.09 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.094 0.558 . . . . 0.0 112.281 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 9.9 Cg_endo -52.04 -24.45 19.69 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.275 1.984 . . . . 0.0 112.492 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' HD13 ' A' ' 50' ' ' LEU . 96.6 m-20 -69.03 -19.3 64.11 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.2 1.22 18.57 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.232 0.539 . . . . 0.0 110.573 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -124.36 -40.36 2.25 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.36 103.52 16.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.151 0.5 . . . . 0.0 111.066 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.428 ' H ' HD13 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -75.51 113.35 12.83 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.98 -50.43 0.43 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 105.772 -2.931 . . . . 0.0 105.772 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -89.7 -41.27 12.01 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 153' ' ' GLN . 54.2 ttp180 -73.53 122.17 21.78 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.275 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.54 106.77 8.73 Favored 'General case' 0 C--N 1.262 -3.206 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 165.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 153' ' ' GLN 0.335 7.7 p-10 -64.03 84.54 0.03 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -166.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 160.42 99.71 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 128.758 2.823 . . . . 0.0 104.401 175.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.46 -103.47 0.46 Allowed Glycine 0 C--N 1.303 -1.271 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 HD11 ' O ' ' A' ' 50' ' ' LEU 0.251 1.9 pp -77.09 125.73 29.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.941 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -154.44 165.72 35.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.498 HD21 ' N ' ' A' ' 36' ' ' LEU . 2.9 tm? -94.84 112.13 23.87 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.5 pt-20 -131.15 121.33 24.7 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.771 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -69.59 149.23 48.39 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -103.99 -28.52 11.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.64 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.83 -53.87 2.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.042 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.74 158.36 44.08 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 117.489 -1.685 . . . . 0.0 115.333 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.418 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 41.9 mt-10 -70.15 -33.22 71.51 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.32 1.048 . . . . 0.0 112.119 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.25 109.54 12.46 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.657 0.741 . . . . 0.0 111.131 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.7 tp -116.42 134.22 55.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.93 127.69 49.26 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 HG13 ' HG ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -144.34 127.52 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 CA-C-O 121.473 0.654 . . . . 0.0 111.547 177.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.554 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 5.1 t80 -91.89 123.88 35.6 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.614 1.566 . . . . 0.0 111.414 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.3 mt -120.79 120.29 29.59 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -89.66 152.38 5.17 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.944 2.429 . . . . 0.0 111.178 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -88.15 162.79 16.53 Favored 'General case' 0 CA--C 1.474 -1.955 0 CA-C-O 121.919 0.866 . . . . 0.0 112.752 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -99.45 -32.94 10.89 Favored 'General case' 0 N--CA 1.404 -2.775 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.662 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.67 145.99 25.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.1 t -73.74 108.75 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.02 173.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -90.75 133.24 35.32 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.18 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.506 ' CD1' ' HB3' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -83.2 121.46 27.11 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.27 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -115.23 -46.16 2.91 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -153.62 169.23 23.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -139.88 154.49 47.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.586 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -141.1 117.33 10.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.0 mt -126.72 119.84 54.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.34 144.35 25.96 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.68 176.31 34.81 Favored Glycine 1 C--N 1.253 -4.08 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.69 178.09 6.14 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 CA-C-N 119.612 1.706 . . . . 0.0 111.03 175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -68.56 -44.35 74.66 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.402 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.59 -53.31 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.82 12.33 2.73 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 147.69 28.89 Favored Glycine 0 C--O 1.251 1.191 0 C-N-CA 120.134 -1.032 . . . . 0.0 110.768 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_endo -77.12 115.99 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.847 1.698 . . . . 0.0 110.209 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HE3' ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -87.06 -71.04 0.58 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.025 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.8 m -75.34 102.05 4.96 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.488 0.661 . . . . 0.0 111.28 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.76 144.44 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.397 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -133.75 133.79 42.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.91 146.06 43.21 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.672 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -129.82 115.06 16.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 m -103.3 154.76 19.03 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 120.87 0.367 . . . . 0.0 110.748 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 73.96 -42.12 0.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.25 1.42 . . . . 0.0 112.853 173.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -69.08 122.44 18.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 0.0 110.081 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.554 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 35.9 tt0 -93.68 122.34 36.04 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.279 -174.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t60 58.4 96.08 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 124.174 0.989 . . . . 0.0 112.923 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 53.0 mtm -131.34 155.59 46.97 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.152 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.495 ' O ' HG23 ' A' ' 102' ' ' VAL . 24.5 p -109.19 -179.16 3.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -58.68 -30.6 67.51 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.838 0.455 . . . . 0.0 111.706 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 t -62.29 -41.61 98.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.057 0.455 . . . . 0.0 109.859 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -85.88 -15.8 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 98' ' ' CYS . 51.3 t -62.0 -29.23 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.588 0.709 . . . . 0.0 110.121 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.84 9.29 39.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.597 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.13 -48.27 3.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.414 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -97.5 127.01 39.33 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.97 136.35 74.55 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.801 2.334 . . . . 0.0 111.782 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.28 158.03 57.07 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.723 2.282 . . . . 0.0 112.878 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -70.19 -45.77 65.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -164.84 157.44 16.35 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -141.16 117.06 10.45 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.58 172.5 11.51 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.944 -170.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.2 mp0 -117.04 137.81 52.01 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.9 tp -61.55 113.09 2.5 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.704 0.801 . . . . 0.0 109.049 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.6 t -107.11 165.45 11.35 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.57 -37.44 62.93 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.202 0.525 . . . . 0.0 111.57 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.14 -35.05 70.93 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.634 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.586 HD22 ' HA ' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -71.31 -36.87 71.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.756 -175.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.85 -21.84 65.16 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -83.61 6.68 19.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.979 0.895 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.32 26.3 64.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.438 -1.256 . . . . 0.0 113.591 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -92.57 135.02 26.97 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.944 0.372 . . . . 0.0 111.492 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.518 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 35.5 Cg_endo -65.51 109.46 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.323 2.682 . . . . 0.0 112.465 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.9 t -86.97 132.25 32.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.1 m -80.59 132.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.582 0.706 . . . . 0.0 112.67 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.37 -178.92 3.8 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.696 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.58 105.36 0.2 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.826 0.822 . . . . 0.0 111.102 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -111.1 -22.69 11.32 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.416 -170.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.1 t -71.2 -27.52 29.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.362 0.601 . . . . 0.0 111.028 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -96.63 -10.28 27.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.563 0.697 . . . . 0.0 110.538 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.506 ' HB3' ' CD1' ' A' ' 72' ' ' LEU . 83.2 m-85 -120.43 112.7 19.31 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -123.77 -0.64 8.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.302 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -149.21 127.55 12.19 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.974 -175.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.9 t -97.58 115.07 36.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.523 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 135' ' ' SER . 12.7 mmm180 -115.19 -0.38 13.28 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.261 174.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 134' ' ' ARG . 12.0 t 171.98 163.67 0.1 Allowed 'General case' 0 C--O 1.252 1.214 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -155.56 119.88 4.63 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.128 0.489 . . . . 0.0 110.012 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.1 m -108.76 126.92 53.54 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.38 124.09 58.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -124.36 131.0 53.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 26.3 pt -116.02 132.01 66.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.582 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -107.41 -31.08 8.31 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.16 143.7 27.26 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.433 0.635 . . . . 0.0 111.899 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.415 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 5.8 m-20 -96.56 163.07 13.19 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.043 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.617 ' OE1' ' HE3' ' A' ' 86' ' ' LYS . 6.4 tp-100 -47.94 -45.73 31.34 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 112.778 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.2 t -122.55 16.2 10.38 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.497 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.44 4.3 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 149' ' ' VAL . 19.6 m -96.09 11.87 32.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.319 13.0 pt-20 63.3 -23.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.368 1.867 . . . . 0.0 115.163 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 147' ' ' SER . 34.3 m -136.78 158.93 37.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 27.6 m -121.45 136.93 54.91 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 121.338 -0.145 . . . . 0.0 111.231 -175.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -114.99 134.23 55.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 27.5 m -129.71 122.09 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 110.013 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 18.3 mm-40 -87.96 -44.73 10.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.054 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.64 111.49 5.07 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.877 -174.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.9 mt -109.54 125.52 66.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.84 144.46 32.53 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.107 0.48 . . . . 0.0 110.488 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 5.3 mp -106.88 138.16 43.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 98.7 m-85 -125.22 135.34 52.46 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.033 0.444 . . . . 0.0 112.046 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -158.0 -156.97 8.19 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.9 t -153.23 149.44 27.97 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.749 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 C--O 1.255 1.355 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.137 174.188 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.413 ' H2 ' ' CD ' ' A' ' 4' ' ' GLU . 52.5 m . . . . . 0 C--O 1.244 0.808 0 N-CA-C 111.44 0.163 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -151.74 -63.05 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.229 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.02 -55.82 0.49 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.912 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.413 ' CD ' ' H2 ' ' A' ' 1' ' ' SER 0.438 1.5 pm0 40.19 77.44 0.05 Allowed 'General case' 0 C--O 1.236 0.342 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.0 p -150.89 107.53 3.51 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.645 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.05 91.87 0.07 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.252 1.021 . . . . 0.0 111.721 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 p -135.78 133.97 38.49 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.473 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.88 77.29 5.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -175.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -93.24 137.6 23.51 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 170.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.28 130.98 26.87 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.484 1.456 . . . . 0.0 110.677 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -69.21 99.17 1.11 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.68 -36.38 0.63 Allowed Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.443 ' HA ' ' OG ' ' A' ' 160' ' ' SER . 28.9 mm-40 -120.35 -173.98 2.69 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -134.41 153.42 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -71.42 127.98 34.34 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 20' ' ' ILE . 57.3 mt -76.51 -1.45 27.34 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.37 -36.03 41.39 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.809 0.814 . . . . 0.0 109.306 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.31 -24.22 66.5 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.001 -175.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -106.52 7.06 30.67 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 16' ' ' LEU . 77.3 mt -85.34 136.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.96 115.17 27.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -88.52 10.09 21.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.9 m -97.79 -33.8 11.13 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.318 0.58 . . . . 0.0 109.438 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.82 -18.89 53.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.945 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.61 126.06 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.02 143.84 49.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.805 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.557 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 80.2 m -136.47 133.42 36.57 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.037 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 28' ' ' LEU . 2.9 tm? -61.13 -40.57 94.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.746 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' HB3' HD11 ' A' ' 60' ' ' LEU . 62.2 t30 -126.65 149.28 49.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.557 ' NE2' ' HB2' ' A' ' 27' ' ' CYS . 4.1 pt20 164.1 -5.63 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 126.791 2.036 . . . . 0.0 107.007 -168.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 33' ' ' SER . 38.9 t -65.66 -19.61 65.97 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.682 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 m -55.44 16.83 0.0 OUTLIER 'General case' 0 CA--C 1.594 2.642 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 31' ' ' SER . 44.6 t 75.33 -1.05 3.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.17 0.988 . . . . 0.0 113.218 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -125.05 153.0 43.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -107.27 167.62 9.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.903 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.1 tm? -57.52 -49.72 92.25 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.632 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 4.6 Cg_endo -48.98 -25.99 9.56 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.866 2.378 . . . . 0.0 112.879 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.422 ' HA ' HD13 ' A' ' 50' ' ' LEU . 2.1 m-20 -60.93 -31.68 71.21 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.24 0.616 . . . . 0.0 111.607 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 52' ' ' LEU . . . -121.96 23.53 9.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.09 0.472 . . . . 0.0 110.329 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.492 HD21 ' O ' ' A' ' 155' ' ' ILE . 0.7 OUTLIER -139.91 -36.7 0.49 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.72 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -78.32 105.98 9.93 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-O 121.237 0.542 . . . . 0.0 111.051 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.509 ' HG2' ' NH2' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -49.91 118.2 2.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.3 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.17 -62.26 0.59 Allowed Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HB3' ' HG ' ' A' ' 50' ' ' LEU . 21.7 m-85 -99.03 -11.08 21.82 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.722 -0.281 . . . . 0.0 110.349 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' NH2' ' HG2' ' A' ' 42' ' ' GLN 0.371 3.4 ppt_? -70.26 -4.69 23.09 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 -170.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -83.33 156.6 22.95 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.367 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.03 145.63 41.28 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 81.86 2.14 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.992 1.717 . . . . 0.0 111.735 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.436 ' O ' HD21 ' A' ' 50' ' ' LEU . . . -95.98 -86.01 1.74 Allowed Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 44' ' ' TYR . 7.1 mt -135.24 170.31 16.12 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.5 p-10 -157.86 152.83 25.42 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 119.115 0.87 . . . . 0.0 109.272 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' H ' ' HB1' ' A' ' 39' ' ' ALA . 55.2 tp -87.11 142.58 27.81 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.68 148.97 44.67 Favored 'General case' 0 C--N 1.255 -3.505 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.499 ' HB3' ' H ' ' A' ' 150' ' ' THR . 23.3 t -112.75 21.37 15.6 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.648 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.39 84.93 0.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.109 0.48 . . . . 0.0 111.116 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 174.29 -44.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.778 1.631 . . . . 0.0 107.952 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -140.26 157.62 45.3 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.416 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.459 ' HG2' ' HA ' ' A' ' 148' ' ' GLU . 0.8 OUTLIER -79.17 -25.33 42.8 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -177.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -101.97 151.04 22.59 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.497 0.665 . . . . 0.0 110.705 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.476 HD11 ' HB3' ' A' ' 29' ' ' ASN . 24.2 tp -134.89 131.33 37.2 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . 5.6 tt -140.66 127.63 20.68 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.63 132.07 71.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -106.82 122.86 47.23 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.222 0.609 . . . . 0.0 109.537 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -116.83 119.91 34.79 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.981 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -95.92 123.0 0.28 Allowed 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.757 2.304 . . . . 0.0 111.319 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.62 155.27 17.38 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.763 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -73.36 -14.76 61.34 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -157.95 177.72 11.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 29.5 m -89.03 132.4 33.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.728 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.91 171.92 11.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.488 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -85.35 113.75 21.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.79 154.48 41.9 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.516 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 40.5 t60 -153.49 -67.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 p -142.18 152.44 43.16 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.426 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 42.0 p90 -125.55 155.19 41.04 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.78 116.7 6.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.775 0.321 . . . . 0.0 110.528 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 63.9 mt -119.75 134.41 63.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -123.97 168.51 12.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.028 0.442 . . . . 0.0 110.162 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 153' ' ' GLN . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.33 134.72 23.27 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 CA-C-N 119.61 1.705 . . . . 0.0 108.547 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.48 -37.37 62.63 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.43 -36.43 19.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.72 0.16 56.73 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.15 33.03 Favored Glycine 0 C--O 1.26 1.726 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.033 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.8 Cg_endo -84.24 125.54 3.52 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.853 2.369 . . . . 0.0 111.323 -176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 32.8 ttpt -91.26 -72.09 0.6 Allowed 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.946 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.4 m -77.93 97.58 5.36 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.105 0.479 . . . . 0.0 110.072 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.409 HG13 HG21 ' A' ' 140' ' ' ILE . 24.3 m -108.59 139.52 30.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.46 ' CG ' ' HB3' ' A' ' 139' ' ' PHE . 18.2 ptpt -125.39 155.3 40.59 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 24.6 m-85 -132.07 151.19 51.9 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 137' ' ' THR . 22.5 p90 -154.72 149.94 27.07 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 123.528 0.517 . . . . 0.0 109.838 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.8 m -127.22 155.77 42.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 69.67 -37.93 0.39 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.087 2.155 . . . . 0.0 116.015 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.509 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 1.1 tpmt? -75.19 109.41 8.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.135 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.03 149.18 24.15 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 65.52 62.48 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 109.13 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.3 tpp -134.77 110.13 9.02 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.251 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.464 ' O ' HG12 ' A' ' 102' ' ' VAL . 75.2 m -129.41 -172.22 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -52.13 -29.9 23.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -88.8 -1.39 58.06 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.967 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -118.29 -32.45 4.66 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.83 0.348 . . . . 0.0 110.104 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 98' ' ' CYS . 31.0 m -58.62 -15.58 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -171.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -93.1 73.57 4.68 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.664 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 172.69 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.74 1.216 . . . . 0.0 110.53 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.76 128.31 40.08 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.22 122.58 11.36 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.937 2.425 . . . . 0.0 112.61 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.429 ' HA ' ' HB3' ' A' ' 91' ' ' PHE . 83.2 Cg_endo -82.08 -178.56 4.17 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 122.26 1.974 . . . . 0.0 110.711 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.584 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 18.3 m -76.78 -47.17 22.43 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 110' ' ' THR . 18.7 t70 172.58 -167.1 0.02 OUTLIER 'General case' 0 C--O 1.248 0.999 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.438 ' H ' ' CG ' ' A' ' 109' ' ' ASP . 7.4 t -148.99 143.18 25.95 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.84 12.13 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 33.5 mt-10 -120.92 140.26 52.09 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 124.227 1.011 . . . . 0.0 110.252 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 57.8 tp -59.58 101.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.078 0.861 . . . . 0.0 110.322 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.464 HG21 ' H ' ' A' ' 117' ' ' ASN . 4.4 t -95.26 164.43 12.85 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.978 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.5 -23.89 59.12 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.616 0.766 . . . . 0.0 110.385 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.504 ' OE2' HG22 ' A' ' 123' ' ' VAL . 31.0 tt0 -71.88 -45.41 61.38 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.464 ' H ' HG21 ' A' ' 114' ' ' THR . 2.3 m120 -65.42 -47.78 75.08 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.951 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.18 -30.84 66.73 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.599 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -92.41 -1.82 56.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.328 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.8 20.49 26.27 Favored Glycine 0 CA--C 1.494 -1.266 0 C-N-CA 120.318 -0.944 . . . . 0.0 114.727 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 1.0 OUTLIER -95.81 134.46 23.98 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.821 177.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 12.7 Cg_exo -70.86 109.83 2.63 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.426 2.084 . . . . 0.0 111.271 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.504 HG22 ' OE2' ' A' ' 116' ' ' GLU . 94.3 t -87.5 128.24 40.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.7 m -77.56 125.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.164 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.49 175.91 6.5 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.46 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . 0.313 50.0 mtmt -91.48 84.94 5.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.898 1.332 . . . . 0.0 113.782 -175.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.516 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 36.2 p90 -87.94 19.16 3.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.848 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -60.01 -29.1 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.456 ' HG2' ' CE2' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -107.22 10.72 29.85 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.434 174.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.584 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 91.4 m-85 -123.47 86.28 2.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 112.074 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -105.63 -9.19 17.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -144.08 113.69 7.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.813 0.816 . . . . 0.0 111.304 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 65.9 t -122.53 120.65 61.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.032 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -103.0 -38.92 7.13 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.1 m -120.72 134.0 55.31 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.3 tp -126.02 140.24 52.77 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.551 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 22.8 m -134.21 131.36 38.46 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 138' ' ' ILE . 3.0 mp -111.7 128.04 68.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.46 ' HB3' ' CG ' ' A' ' 89' ' ' LYS . 51.6 t80 -122.76 126.31 47.21 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.439 HG12 ' H ' ' A' ' 60' ' ' LEU . 24.2 pt -95.42 129.2 45.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 117.98 -1.488 . . . . 0.0 107.505 172.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -93.92 -24.03 17.85 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.214 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -166.2 142.76 5.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.084 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -90.82 161.79 15.12 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.488 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -46.23 -44.86 16.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.058 0.943 . . . . 0.0 112.227 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.5 p -124.42 9.87 8.51 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.298 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 59.62 70.62 0.95 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.478 ' C ' ' H ' ' A' ' 149' ' ' VAL . 22.8 t -86.7 -10.11 54.45 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.921 -165.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 40.0 mt-10 66.9 -44.6 0.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.291 0.637 . . . . 0.0 110.869 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 147' ' ' SER . 3.3 p -119.34 96.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-O 122.386 1.089 . . . . 0.0 109.197 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.499 ' H ' ' HB3' ' A' ' 54' ' ' SER . 31.1 m -82.15 119.65 24.32 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.587 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.16 132.36 35.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.3 t -119.71 115.49 47.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.035 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.42 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 53.3 tt0 -71.69 -63.7 1.07 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -160.48 145.19 14.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.375 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.492 ' O ' HD21 ' A' ' 40' ' ' LEU . 78.3 mt -120.5 114.64 44.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.32 160.81 36.23 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.94 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 158' ' ' TYR . 6.7 tt -147.23 140.43 25.28 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.46 ' N ' HD22 ' A' ' 157' ' ' LEU . 76.9 m-85 -114.67 141.91 47.17 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.333 0.587 . . . . 0.0 110.19 -175.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -156.89 -165.3 14.65 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 13' ' ' GLN . 75.4 m -164.72 167.42 19.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.993 0.897 . . . . 0.0 109.046 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.264 -3.138 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.756 175.204 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 C--O 1.237 0.413 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -79.14 122.74 26.64 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.9 95.18 10.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.637 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 63.0 -166.28 0.23 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.013 0.821 . . . . 0.0 109.955 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.4 p -134.98 83.57 2.03 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 121.521 0.677 . . . . 0.0 109.472 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.49 117.02 25.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.286 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 m -81.17 76.75 8.11 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.649 0.737 . . . . 0.0 111.066 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -116.06 -25.03 7.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.406 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -70.38 119.96 75.54 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.241 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.26 178.73 7.12 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.762 2.308 . . . . 0.0 111.827 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -97.75 101.5 13.02 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.48 -39.68 0.7 Allowed Glycine 0 C--N 1.303 -1.292 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.533 ' HG3' ' OG ' ' A' ' 74' ' ' SER . 1.4 pm0 -135.48 149.37 49.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.818 0.847 . . . . 0.0 109.766 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 4.4 m -111.37 170.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 123.431 0.457 . . . . 0.0 110.501 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.0 98.64 0.78 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.457 1.122 . . . . 0.0 110.285 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.49 HD11 ' O ' ' A' ' 16' ' ' LEU . 2.4 tm? -55.72 -23.81 31.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.267 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.9 tt -53.0 -35.95 59.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.311 1.044 . . . . 0.0 110.986 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.0 -20.45 61.01 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.417 ' C ' ' HB2' ' A' ' 67' ' ' ASN . 47.8 m-85 -94.65 22.33 6.39 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.096 0.474 . . . . 0.0 110.964 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.4 131.46 47.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.13 -23.54 41.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.219 0.533 . . . . 0.0 111.185 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 41' ' ' LYS . 97.3 m95 67.43 10.22 7.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.1 p -87.1 10.82 15.48 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.278 0.561 . . . . 0.0 110.768 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.04 -88.35 0.13 Allowed Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.276 11.0 p 43.9 75.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.196 1.399 . . . . 0.0 113.002 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -119.72 151.16 39.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.596 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 49.2 t -136.6 130.96 33.09 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 HD13 ' C ' ' A' ' 28' ' ' LEU . 2.7 tm? -45.58 -63.34 0.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.724 1.209 . . . . 0.0 112.38 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.42 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.2 t30 -90.2 -57.76 2.74 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 34.2 tt0 69.51 -78.56 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.782 1.233 . . . . 0.0 107.889 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.548 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 35.7 t 176.35 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -53.29 -20.09 3.9 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -130.63 -34.07 1.58 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' SER . 94.5 m-70 -93.39 163.92 13.41 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.983 -0.448 . . . . 0.0 111.853 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -122.96 150.27 43.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.471 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 53.1 tp -70.49 -48.87 17.01 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.545 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 7.7 Cg_endo -48.23 -28.04 10.5 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.584 2.19 . . . . 0.0 113.003 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.486 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.2 m-20 -66.29 -29.38 69.59 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.912 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.06 6.07 13.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.712 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.481 HD11 ' CH2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -104.41 -43.76 5.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 18.6 ptpt -90.53 148.1 22.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.656 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.526 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 20.5 mm-40 -81.64 144.62 31.08 Favored 'General case' 0 CA--C 1.473 -2.002 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.607 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 121.72 -50.38 0.84 Allowed Glycine 0 N--CA 1.397 -3.927 0 C-N-CA 119.115 -1.517 . . . . 0.0 111.013 -171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.616 ' O ' HD12 ' A' ' 50' ' ' LEU . 96.8 m-85 -92.97 -10.47 36.25 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -55.86 25.98 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.075 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -95.08 102.09 13.88 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.35 97.86 1.01 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.249 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -156.75 -80.45 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.31 1.444 . . . . 0.0 110.226 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.23 -26.21 24.26 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 44' ' ' TYR . 2.3 pp -126.31 137.17 53.46 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.798 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.1 p-10 -163.77 166.77 21.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.491 ' HB3' ' CG2' ' A' ' 152' ' ' VAL . 40.4 tp -103.84 106.87 17.51 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.754 -1.578 . . . . 0.0 108.515 171.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -127.66 134.7 49.62 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.847 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.577 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 62.4 p -64.96 160.69 20.14 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.383 0.427 . . . . 0.0 110.243 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -123.84 -78.82 0.6 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.544 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.76 -14.76 36.36 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.742 0.306 . . . . 0.0 111.258 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 54' ' ' SER . 32.0 t70 -156.05 148.98 24.17 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.229 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' HD22 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -99.96 14.17 31.44 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -83.71 119.22 24.52 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.437 0.637 . . . . 0.0 110.152 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.495 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 3.8 mm? -115.46 107.34 15.05 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.558 0.694 . . . . 0.0 111.32 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 6.3 tt -116.76 115.46 25.64 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.2 mt -113.42 136.59 49.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 123.328 0.651 . . . . 0.0 111.113 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 95' ' ' GLU . 93.4 t80 -107.94 123.97 49.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -108.08 115.52 58.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.298 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -77.83 142.8 20.36 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.706 2.27 . . . . 0.0 109.53 175.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -101.68 162.04 13.2 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -167.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.417 ' HB2' ' C ' ' A' ' 19' ' ' PHE . 17.5 t-20 -91.99 -50.9 5.46 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.869 -2.423 . . . . 0.0 108.482 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -156.57 177.93 10.91 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.222 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.73 124.03 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.92 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -92.93 115.72 28.38 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.81 124.23 25.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -120.38 -49.94 2.24 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.911 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.533 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 50.3 p -143.95 161.76 37.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -134.99 152.9 52.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.401 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -146.82 115.95 6.95 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.08 0.467 . . . . 0.0 111.305 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.402 ' HB ' HD11 ' A' ' 113' ' ' LEU . 69.1 mt -123.63 128.46 74.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -112.26 120.5 41.94 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.409 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -149.25 -172.99 19.46 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -66.36 -175.7 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.83 2.353 . . . . 0.0 111.48 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -71.67 -56.88 4.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -173.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.28 -18.13 20.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.297 0.57 . . . . 0.0 112.135 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.52 15.68 6.38 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.486 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.53 156.98 16.0 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.451 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.457 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 32.2 Cg_exo -62.68 153.26 73.3 Favored 'Trans proline' 0 C--O 1.204 -1.192 0 C-N-CA 122.095 1.863 . . . . 0.0 110.16 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.516 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 37.2 ttpt -126.27 -65.41 0.98 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.868 -0.52 . . . . 0.0 110.377 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.9 m -75.75 101.74 5.16 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.24 0.543 . . . . 0.0 110.464 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 86' ' ' LYS . 52.5 t -106.02 130.52 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.103 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -130.61 151.84 50.64 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.769 0.828 . . . . 0.0 110.139 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.421 ' CE2' HD13 ' A' ' 125' ' ' LEU . 14.0 m-85 -136.0 160.71 37.8 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.178 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.35 116.69 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -84.24 14.6 4.18 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.89 1.276 . . . . 0.0 114.342 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -147.05 172.22 14.07 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.061 -0.4 . . . . 0.0 110.133 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.497 ' HZ3' ' HB2' ' A' ' 94' ' ' LYS . 3.4 ttmp? 69.94 145.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 10.4 pt-20 -102.81 138.25 39.95 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.467 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m80 55.82 72.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.507 0.723 . . . . 0.0 112.489 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.429 ' HE1' ' HA ' ' A' ' 102' ' ' VAL . 12.6 tpt -90.85 94.15 9.53 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.03 154.06 29.76 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.772 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.537 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 72.9 t80 -57.36 -23.23 47.74 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.7 t -79.71 -11.97 59.82 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.943 -0.473 . . . . 0.0 110.637 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -124.36 -13.31 7.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.583 . . . . 0.0 110.61 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 6.4 p -62.9 -30.06 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 C-N-CA 124.451 1.1 . . . . 0.0 112.129 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -109.03 -1.66 18.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.331 0.586 . . . . 0.0 111.098 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -82.65 -40.24 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -100.63 139.38 20.55 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.3 140.95 94.45 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.86 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.66 179.1 5.97 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.771 2.314 . . . . 0.0 110.747 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.714 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 44.8 m -79.56 -49.13 12.67 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.442 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -162.0 -179.6 7.26 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -153.27 150.49 29.0 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.73 169.21 18.2 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 5.6 tp10 -126.18 106.64 9.7 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.516 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.1 tt -73.05 122.57 21.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.7 p -122.04 -176.58 3.37 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.643 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.521 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 1.6 mp0 -51.77 -36.34 47.11 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 125.118 1.367 . . . . 0.0 109.813 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.495 ' CG ' ' HD2' ' A' ' 121' ' ' LYS . 40.4 tt0 -64.56 -38.78 92.21 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.412 HD21 ' CG2' ' A' ' 123' ' ' VAL . 23.8 t-20 -71.0 -38.28 72.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.81 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.44 -14.42 60.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.55 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.52 -1.69 56.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.555 0.693 . . . . 0.0 109.687 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.39 27.47 20.24 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.602 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.495 ' HD2' ' CG ' ' A' ' 116' ' ' GLU . 96.6 mttt -99.81 142.49 24.72 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 117.271 0.536 . . . . 0.0 111.146 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -73.83 103.78 1.71 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.897 1.731 . . . . 0.0 109.313 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.412 ' CG2' HD21 ' A' ' 117' ' ' ASN . 78.9 t -84.58 127.34 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.748 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.68 101.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -54.57 -71.53 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.293 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.535 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 80.1 tttt -171.47 165.39 6.96 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -144.31 24.8 1.58 Allowed 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.689 -171.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.91 -47.24 13.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.714 ' HB3' ' O ' ' A' ' 108' ' ' SER . 8.8 tmtt? -111.29 -9.12 14.3 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.694 -166.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -60.51 10.2 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.927 0 O-C-N 121.497 -0.752 . . . . 0.0 112.94 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 129' ' ' LYS . 79.9 mm-40 -59.7 119.42 7.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.217 0.532 . . . . 0.0 111.279 -166.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.355 0.2 OUTLIER 59.54 113.74 0.01 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 128.078 2.551 . . . . 0.0 112.997 -170.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.3 t -102.3 110.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.892 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -88.75 -31.5 18.38 Favored 'General case' 0 C--O 1.19 -2.077 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.575 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -160.86 164.09 31.56 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 tp -126.86 118.82 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 117.684 -1.607 . . . . 0.0 112.889 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 97' ' ' MET . 91.7 m -103.03 123.87 47.44 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.12 109.85 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 141' ' ' GLU . 53.1 t80 -114.5 111.72 21.83 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.407 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.495 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 1.8 pp -104.53 131.44 53.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.1 pt-20 -112.37 -2.27 14.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.06 142.16 5.92 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.311 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.41 HD22 ' HB2' ' A' ' 58' ' ' GLU . 38.4 m-80 -83.67 177.76 8.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.809 0.693 . . . . 0.0 109.864 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 2.4 mp0 -50.11 -58.53 5.34 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.4 m -119.64 -22.31 6.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.954 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.43 1.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 m -84.37 16.33 3.14 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.445 0.698 . . . . 0.0 112.305 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 73.48 -52.15 0.7 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.652 1.181 . . . . 0.0 111.078 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.18 106.09 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.014 0.912 . . . . 0.0 111.397 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.716 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.0 m -82.68 116.26 21.98 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.465 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -104.29 133.97 48.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 30.5 m -132.96 128.15 56.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.201 0.524 . . . . 0.0 109.609 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -84.41 -33.79 23.67 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 141.46 4.47 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.164 176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.6 111.98 33.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.49 124.58 21.56 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 159.4 15.47 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 83.8 m-85 -125.37 113.44 17.56 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.15 0.5 . . . . 0.0 109.939 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.62 167.2 12.25 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.0 m -120.34 132.98 55.52 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 117.39 0.595 . . . . 0.0 110.55 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--N 1.281 -2.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.832 173.256 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 C--O 1.237 0.44 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.455 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 20.1 m -96.82 9.44 41.8 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.805 0.812 . . . . 0.0 110.134 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.03 1.75 46.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.934 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -108.14 105.72 15.59 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.1 p -101.75 91.63 4.48 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.481 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.22 92.24 4.43 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.563 0.697 . . . . 0.0 110.844 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m -122.42 148.91 44.54 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.567 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -91.16 98.84 11.99 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.473 HG13 ' HB2' ' A' ' 15' ' ' ASP . 2.6 mp -86.7 123.11 71.26 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.016 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.56 159.4 19.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.602 2.201 . . . . 0.0 110.421 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -83.81 101.9 11.95 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.834 0.826 . . . . 0.0 111.961 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.96 -30.77 2.34 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.205 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 19.4 mp0 -121.96 170.15 10.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 122.281 -0.54 . . . . 0.0 110.783 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.94 143.01 18.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.473 ' HB2' HG13 ' A' ' 9' ' ' ILE . 11.8 t70 -71.95 127.43 32.53 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.86 0.362 . . . . 0.0 110.108 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 19' ' ' PHE . 33.2 mt -101.33 3.47 40.68 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 42' ' ' GLN . 3.1 tm? -73.06 -35.33 66.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.165 0.983 . . . . 0.0 108.541 -177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.94 -9.83 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.044 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.461 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 92.0 t80 -97.77 14.26 27.57 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 124.766 1.226 . . . . 0.0 110.977 -172.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.7 mt -88.84 142.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.489 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -93.9 120.24 33.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -92.93 7.9 42.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 m -103.64 -12.11 17.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.258 0.552 . . . . 0.0 110.836 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.95 -18.53 5.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.396 -0.906 . . . . 0.0 113.578 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.75 129.5 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.9 142.93 50.7 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.776 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' ' NE2' ' A' ' 30' ' ' GLN . 9.3 p -131.87 119.7 21.55 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.536 -175.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 3.8 mm? -94.41 132.34 39.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.222 0.534 . . . . 0.0 110.214 176.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.0 t30 68.65 -70.97 0.12 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 126.945 2.098 . . . . 0.0 110.186 -173.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 8.1 tt0 63.31 -168.93 0.2 Allowed 'General case' 0 C--N 1.372 1.573 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 41.5 t -93.39 123.42 36.68 Favored 'General case' 0 C--N 1.251 -3.714 0 O-C-N 120.449 -1.407 . . . . 0.0 108.477 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -57.93 -17.46 16.95 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.891 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -100.16 -43.6 6.26 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.656 ' O ' ' HB3' ' A' ' 31' ' ' SER . 83.4 m-70 -122.06 151.97 40.31 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 122.05 -0.406 . . . . 0.0 110.745 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.523 ' HA ' ' OE1' ' A' ' 30' ' ' GLN . 49.0 m -87.98 160.89 17.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.72 -49.47 2.1 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.68 -23.99 28.22 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.072 1.848 . . . . 0.0 111.284 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.468 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.2 m-20 -58.91 -27.68 65.48 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 125.636 1.574 . . . . 0.0 111.453 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB1' ' H ' ' A' ' 52' ' ' LEU . . . -123.7 8.41 8.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 tp -118.36 -47.71 2.54 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.649 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -83.0 130.81 35.18 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.81 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' HB2' ' CD1' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -67.94 123.26 20.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . 135.43 -47.49 0.98 Allowed Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.084 -2.007 . . . . 0.0 108.084 -174.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -93.93 -44.37 8.11 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -54.97 101.96 0.06 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.389 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 178.45 125.07 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.69 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 18.5 t70 -68.07 85.36 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.69 ' HG3' ' O ' ' A' ' 47' ' ' ASP . 35.3 mt-10 -173.1 108.08 0.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 127.227 2.211 . . . . 0.0 110.137 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.27 -52.87 4.11 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.996 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.468 ' HB2' HD21 ' A' ' 38' ' ' ASN . 1.3 pt? -133.44 127.77 34.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 122.737 -0.273 . . . . 0.0 110.405 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 153' ' ' GLN . 6.7 t30 -161.35 153.32 19.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.433 ' H ' ' HB1' ' A' ' 39' ' ' ALA . 2.8 tm? -85.32 110.25 18.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.941 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 150' ' ' THR . 12.6 pt-20 -132.31 112.65 12.4 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.5 p -59.95 137.37 58.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -141.74 85.42 1.94 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.519 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 164.94 -50.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.155 1.782 . . . . 0.0 107.129 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -147.7 155.71 42.02 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.085 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -85.08 -25.2 27.72 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -77.0 130.83 38.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.738 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.462 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.8 mt -133.88 143.07 48.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.622 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.5 tm? -135.08 119.47 17.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.85 129.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -105.63 122.84 46.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.24 113.02 39.3 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.685 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -90.27 125.33 1.21 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 122.58 2.186 . . . . 0.0 108.835 168.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 90.3 m-85 -87.92 158.17 18.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -59.69 -51.75 68.44 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.251 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -125.41 173.23 9.02 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.087 -0.383 . . . . 0.0 109.981 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 120.908 0.385 . . . . 0.0 110.501 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -132.87 172.61 16.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -96.83 136.23 37.68 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.622 HD13 ' CD2' ' A' ' 130' ' ' PHE . 82.6 mt -76.01 146.63 39.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.431 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 27.6 t60 -124.83 -50.54 1.71 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -139.46 163.37 32.7 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -136.23 154.47 50.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.575 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -149.81 106.39 3.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.502 0.668 . . . . 0.0 111.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.13 131.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.533 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 53.6 mtpt -121.16 161.82 21.17 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.05 0.452 . . . . 0.0 111.716 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.07 -169.18 39.28 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.42 ' CG ' ' HD2' ' A' ' 151' ' ' LYS . 14.2 Cg_exo -73.37 166.47 29.8 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.937 2.424 . . . . 0.0 111.157 175.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -58.66 -41.48 86.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.12 -26.26 15.55 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -92.53 11.29 26.88 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.891 -169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.21 146.13 18.15 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.778 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 22.7 Cg_exo -67.05 110.05 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.332 2.021 . . . . 0.0 111.356 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.8 OUTLIER -82.84 -39.67 21.36 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.925 -176.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.1 m -103.44 112.01 24.7 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.84 130.2 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.015 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -117.29 146.28 43.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.74 149.22 52.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 65.6 t80 -143.42 115.77 8.52 Favored 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.494 169.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 135' ' ' SER . 48.9 m -102.36 153.73 19.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.677 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 81.44 145.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.052 1.341 . . . . 0.0 108.573 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 72.9 116.0 0.05 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.57 149.74 29.81 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.689 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.267 13.9 p-80 50.31 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.4 ' HE2' ' HA ' ' A' ' 102' ' ' VAL . 88.1 mtp -139.6 142.08 37.11 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 22.8 p -120.06 174.08 6.69 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -69.84 -18.86 63.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 p -77.72 -21.72 51.48 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -130.35 18.75 5.34 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.4 ' HA ' ' HE2' ' A' ' 97' ' ' MET . 9.3 p -69.72 -32.28 51.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.177 0.513 . . . . 0.0 110.717 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -97.27 73.53 2.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.637 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -124.41 -4.17 7.83 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -139.24 156.51 71.95 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.648 -1.615 . . . . 0.0 106.862 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.83 140.93 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.117 1.212 . . . . 0.0 109.589 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.72 153.52 36.1 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 122.42 2.08 . . . . 0.0 111.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 31.8 m -62.09 -44.8 95.88 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.717 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -169.56 166.78 9.98 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -139.24 139.71 37.52 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.4 172.71 11.57 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.673 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 37.2 tt0 -122.61 134.54 54.51 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 34.0 tp -62.99 108.58 1.24 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.701 0.626 . . . . 0.0 109.713 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.5 m -82.23 156.85 24.17 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -54.27 -39.58 67.0 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.191 0.596 . . . . 0.0 111.046 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.94 -31.47 68.07 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.244 0.618 . . . . 0.0 112.231 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 1.7 t-20 -62.56 -39.68 94.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.561 ' O ' HD21 ' A' ' 118' ' ' LEU . 7.5 tt -71.99 -7.62 49.79 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 45.2 mmtm -104.3 -14.15 15.89 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 121.761 -0.587 . . . . 0.0 110.136 176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.533 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 127.59 -14.43 6.43 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 119.926 -1.131 . . . . 0.0 114.005 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 53.8 mtpt -74.88 133.36 76.13 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 35.8 Cg_exo -64.15 116.99 4.04 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.541 2.828 . . . . 0.0 111.707 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 135.7 26.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.92 131.29 34.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.16 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.38 177.47 5.03 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.809 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.6 96.49 10.49 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -80.08 21.83 0.55 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.89 -13.58 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.09 21.06 9.82 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.365 0.602 . . . . 0.0 110.668 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 72' ' ' LEU . 96.3 m-85 -122.62 27.01 8.02 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.444 -173.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -63.22 -35.59 80.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -129.16 115.51 17.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.28 0.562 . . . . 0.0 109.805 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.455 HG23 ' HG ' ' A' ' 72' ' ' LEU . 47.4 t -121.15 104.47 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -108.27 -44.04 4.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 170.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 92' ' ' SER . 32.9 t -104.91 130.78 53.0 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.943 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.3 tp -137.87 104.23 5.21 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.137 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.5 m -92.3 115.42 28.07 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.74 122.73 58.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -121.53 127.71 51.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.897 0.38 . . . . 0.0 110.439 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.462 HG13 ' HB2' ' A' ' 60' ' ' LEU . 12.0 pt -133.29 116.44 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -31.47 4.11 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.378 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.77 126.45 52.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.83 -174.84 2.65 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.709 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 86' ' ' LYS . 2.2 mp0 -56.4 -66.51 0.42 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.6 t -120.14 9.27 11.09 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.545 -173.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.27 93.21 0.2 Allowed Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.462 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 23.4 t -111.99 -1.86 15.27 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 147' ' ' SER . 10.2 pt-20 68.0 -40.85 0.43 Allowed 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 126.764 2.026 . . . . 0.0 111.344 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 147' ' ' SER . 5.1 p -102.53 113.28 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.4 176.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 43.7 m -92.92 125.64 37.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.42 ' HD2' ' CG ' ' A' ' 80' ' ' PRO . 39.2 ttmt -123.52 133.67 53.98 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.5 120.02 31.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.008 0.432 . . . . 0.0 111.117 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.466 ' HA ' ' OD1' ' A' ' 51' ' ' ASN . 4.7 pt20 -93.21 -6.24 48.17 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.675 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -172.11 144.81 1.7 Allowed 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.84 109.97 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 165.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.64 134.08 29.91 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.85 156.29 28.64 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -123.14 127.97 49.42 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -135.22 -163.92 10.25 Favored Glycine 0 C--N 1.302 -1.329 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.381 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.571 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.1 t -142.18 143.29 32.87 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 117.428 0.614 . . . . 0.0 109.715 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.433 -1.286 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.045 -177.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 CA--C 1.508 -0.639 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -142.78 79.38 1.65 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.383 0.611 . . . . 0.0 109.715 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.84 87.45 2.29 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.225 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -134.43 140.44 46.26 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.9 t -73.37 107.11 5.48 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.515 0.674 . . . . 0.0 110.644 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.62 15.07 30.33 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -96.78 144.6 26.61 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -110.0 95.28 5.49 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.855 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -77.27 116.48 57.99 Favored Pre-proline 0 C--N 1.303 -1.441 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.704 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.24 144.0 14.36 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.971 1.781 . . . . 0.0 110.451 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.12 105.68 1.44 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.543 0.687 . . . . 0.0 110.214 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.79 -23.28 3.98 Favored Glycine 0 N--CA 1.42 -2.378 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.38 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -129.83 174.89 9.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.21 145.05 34.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -77.84 130.33 36.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.488 HD13 ' CD1' ' A' ' 70' ' ' ILE . 4.1 mm? -68.15 -8.85 42.07 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.822 0.849 . . . . 0.0 113.277 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.0 tm? -55.51 -34.06 64.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.26 -25.94 64.52 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.057 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.78 22.84 15.17 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -172.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.45 133.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.9 105.84 18.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -75.09 -13.44 60.48 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 m -73.87 -22.23 59.81 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 6.4 13.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.574 -1.298 . . . . 0.0 114.387 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.14 136.91 25.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 CA-C-N 117.838 0.819 . . . . 0.0 110.176 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -152.17 148.14 27.26 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.093 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.89 123.82 22.73 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 28' ' ' LEU . 2.5 tm? -61.63 -44.71 96.47 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.693 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.69 -94.23 0.1 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.587 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 59.6 11.69 2.49 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.722 0.772 . . . . 0.0 109.996 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -83.56 -12.93 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.489 ' HG ' ' HA ' ' A' ' 54' ' ' SER . 3.0 m -50.25 -47.83 54.99 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.5 m 153.14 -55.21 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 127.967 2.507 . . . . 0.0 108.372 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 80.1 m-70 -67.96 149.26 49.98 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.1 m -108.13 -175.84 2.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -171.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.418 HD22 HD23 ' A' ' 52' ' ' LEU . 2.4 tm? -90.84 -49.18 0.35 Allowed Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.693 0.797 . . . . 0.0 112.431 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.64 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 31.2 Cg_exo -62.38 -2.0 2.89 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.931 2.421 . . . . 0.0 114.46 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' HB2' HD12 ' A' ' 50' ' ' LEU . 34.8 p30 -84.02 -48.61 9.75 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.219 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.38 -2.5 57.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.3 tp -109.23 -9.12 15.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 5.8 tmtt? -89.7 133.29 34.74 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -54.58 133.21 46.32 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.78 -34.56 2.1 Favored Glycine 0 N--CA 1.413 -2.886 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.8 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.66 -20.77 45.86 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 117.657 0.728 . . . . 0.0 109.944 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 18.03 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.67 109.33 3.26 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.19 117.58 15.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 175.3 -81.39 0.0 OUTLIER 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.547 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.26 -33.1 77.16 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 50' ' ' LEU . 3.9 pp -119.66 126.69 51.76 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 8.1 p30 -163.54 167.26 21.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.418 HD23 HD22 ' A' ' 36' ' ' LEU . 48.1 tp -94.56 103.78 15.73 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 150' ' ' THR . 11.7 pt-20 -124.67 159.77 30.06 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.729 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.489 ' HA ' ' HG ' ' A' ' 32' ' ' SER . 86.9 p -95.74 -174.29 3.1 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.816 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 t70 175.03 -48.41 0.01 OUTLIER 'General case' 0 CA--C 1.467 -2.245 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.34 35.73 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.148 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 59' ' ' GLN . 10.6 t70 -157.44 146.97 20.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.18 -31.53 69.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.955 0.902 . . . . 0.0 112.49 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.54 ' HG2' ' OD1' ' A' ' 57' ' ' ASP . 3.9 pt20 -86.91 126.74 34.88 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.121 0.962 . . . . 0.0 111.949 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' HB2' ' CD1' ' A' ' 140' ' ' ILE . 54.5 mt -131.07 120.73 23.83 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.343 -173.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -96.96 119.77 36.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.81 128.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 95' ' ' GLU . 8.6 t80 -109.84 117.91 35.08 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.1 mt -122.55 114.0 30.33 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-O 120.515 0.198 . . . . 0.0 111.37 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -89.33 141.18 4.0 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 121.998 1.798 . . . . 0.0 109.881 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -103.93 150.87 23.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.597 0.713 . . . . 0.0 112.638 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -55.35 -45.61 76.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -153.98 163.16 40.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.81 127.61 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.901 0.858 . . . . 0.0 111.748 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.488 ' CD1' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -128.3 172.1 15.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -96.28 114.18 25.84 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' HB3' ' A' ' 157' ' ' LEU . 53.2 tp -73.27 154.47 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 31.3 t60 -139.16 -38.17 0.5 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.785 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.1 p -153.97 169.73 22.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.477 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -141.29 155.17 46.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.59 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -149.65 100.2 2.95 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.868 0.366 . . . . 0.0 111.934 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.8 mt -106.24 136.58 40.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.425 ' HB3' ' OE1' ' A' ' 153' ' ' GLN . 90.1 mttt -112.06 150.96 29.94 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.991 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -166.56 168.01 39.85 Favored Glycine 0 N--CA 1.41 -3.041 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.22 151.94 79.2 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.892 1.728 . . . . 0.0 111.117 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -39.78 68.32 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.346 0.659 . . . . 0.0 111.62 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.48 -44.0 8.09 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -101.56 18.95 18.94 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.692 -166.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.93 178.87 36.45 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.163 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -73.5 -179.88 4.9 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 119.765 1.782 . . . . 0.0 110.439 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.535 ' HG2' ' OE2' ' A' ' 112' ' ' GLU . 23.0 ttpp -154.98 -71.23 0.12 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.863 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.4 m -85.74 118.19 25.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.261 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG13 HG21 ' A' ' 140' ' ' ILE . 23.0 m -118.28 137.19 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.762 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -110.95 133.87 53.03 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -113.97 145.3 41.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -135.37 114.96 12.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 171.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -94.42 133.81 37.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.7 OUTLIER 74.35 175.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.411 1.084 . . . . 0.0 111.357 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.573 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER 72.82 127.8 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.819 0.819 . . . . 0.0 110.902 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 3.6 mp0 -93.89 146.68 23.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.948 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.1 m80 69.91 98.14 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.955 1.302 . . . . 0.0 111.948 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 92.5 mmm -139.26 142.54 37.78 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.004 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.531 ' O ' HG21 ' A' ' 102' ' ' VAL . 26.4 p -144.78 169.73 17.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.61 -30.5 68.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.276 0.489 . . . . 0.0 112.072 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 t -63.54 -24.26 67.74 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 120.689 0.28 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.433 ' O ' ' HD1' ' A' ' 105' ' ' PHE . 92.8 m-20 -98.6 -23.11 15.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.945 0.402 . . . . 0.0 111.315 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 98' ' ' CYS . 56.0 t -58.53 -32.09 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.718 0.807 . . . . 0.0 112.271 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.85 -15.59 60.2 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -113.44 -15.89 12.53 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.699 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.433 ' HD1' ' O ' ' A' ' 101' ' ' ASN . 79.3 m-85 -96.75 148.05 33.85 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -82.56 139.81 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.164 1.909 . . . . 0.0 112.032 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.07 149.05 64.34 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.133 1.889 . . . . 0.0 110.939 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.8 m -73.76 -45.16 53.58 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.553 0.692 . . . . 0.0 109.332 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -161.25 160.6 30.12 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -131.7 125.72 32.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.23 170.19 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.32 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.535 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.8 tp10 -125.25 134.96 52.12 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.8 tp -70.11 101.94 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 117' ' ' ASN . 5.1 t -80.07 158.4 26.45 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.62 -22.83 66.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.588 0.709 . . . . 0.0 109.749 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.09 -35.31 74.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.257 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.59 HD22 ' HA ' ' A' ' 76' ' ' ALA . 1.5 t-20 -71.73 -32.72 68.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.48 -23.27 49.01 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.737 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.14 -12.65 52.35 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.712 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 2.82 55.56 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 122.71 88.13 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.096 0.448 . . . . 0.0 110.389 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -59.42 111.12 0.84 Allowed 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 123.157 2.571 . . . . 0.0 112.107 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.497 HG21 ' ND2' ' A' ' 117' ' ' ASN . 86.4 t -82.98 124.88 39.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.7 101.54 2.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.198 0.523 . . . . 0.0 109.952 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.89 172.8 13.27 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.637 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -89.64 84.06 6.31 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.19 0.995 . . . . 0.0 110.031 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.521 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 39.9 p90 -76.42 24.69 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.919 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.448 HG12 ' HD2' ' A' ' 129' ' ' LYS . 7.4 p -63.47 -25.57 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.679 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HD2' HG12 ' A' ' 128' ' ' VAL . 13.1 mptt -93.43 -20.29 20.46 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.436 0.636 . . . . 0.0 110.501 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 127' ' ' TYR . 82.2 m-85 -91.1 32.63 1.0 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.633 -171.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -67.32 -31.76 72.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.807 0.337 . . . . 0.0 111.309 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -142.2 116.15 9.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.54 106.51 20.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.795 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -89.52 -62.9 1.37 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.2 t -109.03 151.57 26.17 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.195 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.4 tp -147.95 129.67 15.12 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.261 0.553 . . . . 0.0 109.952 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 m -114.71 124.64 52.32 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.5 112.23 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 69.3 t80 -109.0 114.62 28.53 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.851 0.357 . . . . 0.0 110.697 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.512 HG21 HG13 ' A' ' 88' ' ' VAL . 2.3 pp -97.47 124.45 50.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 11.5 pt-20 -110.79 -22.56 11.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.339 -0.945 . . . . 0.0 111.968 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.64 156.39 44.96 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.847 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -110.61 148.09 32.9 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 126.221 1.809 . . . . 0.0 107.862 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -36.37 -56.81 0.77 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.652 1.181 . . . . 0.0 111.973 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -124.25 -12.02 7.41 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.688 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 87.59 0.94 Allowed Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 149' ' ' VAL . 32.6 t -111.05 9.55 22.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.98 -0.13 . . . . 0.0 110.7 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 77.14 -23.59 0.24 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 124.441 1.096 . . . . 0.0 110.157 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 147' ' ' SER . 25.9 m -128.5 124.31 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.9 m -101.41 111.1 23.23 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HG3' ' OD1' ' A' ' 51' ' ' ASN . 87.2 tttt -95.95 133.6 39.96 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 92.9 t -122.66 115.8 47.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.425 ' OE1' ' HB3' ' A' ' 78' ' ' LYS . 97.0 mt-30 -74.1 -44.33 54.35 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.839 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.05 153.66 3.85 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.495 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.9 mt -124.49 118.03 52.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.4 141.02 35.59 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.422 ' HB3' HD13 ' A' ' 72' ' ' LEU . 6.2 mp -120.43 151.59 39.1 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -124.44 127.11 47.02 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.723 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.3 -163.59 10.23 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.2 m -143.94 138.36 28.44 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.383 0.611 . . . . 0.0 111.863 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 C--N 1.293 -1.88 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.087 174.572 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.799 0.333 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -90.09 -54.59 3.96 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.8 104.36 0.69 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.43 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -111.93 84.86 2.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.0 m -76.04 108.46 8.96 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.01 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 69.92 -57.99 0.54 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.025 1.33 . . . . 0.0 111.914 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.7 p 50.82 83.55 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.394 1.478 . . . . 0.0 113.7 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -100.06 66.68 1.35 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.213 0.53 . . . . 0.0 111.064 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.25 133.09 64.85 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.034 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.11 -173.55 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.633 2.222 . . . . 0.0 112.349 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -92.74 11.76 25.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.812 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -143.7 -50.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.741 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -87.42 173.38 9.17 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.924 0.392 . . . . 0.0 111.107 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 18.0 m -115.36 167.79 7.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 17' ' ' LEU . 6.2 p-10 -82.51 108.56 16.0 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.363 1.078 . . . . 0.0 108.979 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 44.7 mt -68.82 3.98 1.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.778 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 15' ' ' ASP . 2.6 tm? -62.62 -41.45 99.01 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.16 -7.42 57.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.867 0.841 . . . . 0.0 110.86 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 13.4 m-85 -92.1 1.71 57.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.01 133.35 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.07 -28.05 22.79 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.837 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.5 m95 66.15 -6.85 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 m -82.18 -19.95 38.82 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.614 -0.679 . . . . 0.0 112.659 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.35 26.69 4.9 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.75 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -71.89 139.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 110.911 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.68 128.2 32.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.108 0.48 . . . . 0.0 109.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.496 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 6.1 p -103.23 118.15 36.12 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.82 -14.92 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.483 0.659 . . . . 0.0 110.746 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -160.45 -83.98 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.776 168.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 27' ' ' CYS 0.394 3.1 pp0? 51.65 14.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.51 1.124 . . . . 0.0 112.634 -168.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 33' ' ' SER 0.293 58.6 m 72.68 115.02 0.06 Allowed 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 126.995 2.118 . . . . 0.0 114.007 -173.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -55.34 16.9 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 C-N-CA 126.965 2.106 . . . . 0.0 115.218 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 31' ' ' SER . 34.1 t -103.91 -58.67 1.84 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.711 -0.618 . . . . 0.0 109.962 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.562 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 23.7 p80 -93.81 163.37 13.55 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 17.7 m -90.49 166.97 12.94 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.818 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 62.1 tp -67.45 -45.58 47.96 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 11.6 Cg_endo -55.47 -25.91 51.29 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.957 1.771 . . . . 0.0 111.503 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 1.9 m-20 -63.04 -24.55 67.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.281 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . . . -95.11 -49.53 5.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.154 0.502 . . . . 0.0 111.886 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.2 tp -105.16 -20.71 13.43 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -170.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -80.08 118.66 21.99 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.292 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -70.87 140.72 51.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.558 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.58 -33.25 6.58 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -98.92 -50.13 4.3 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.44 0.296 . . . . 0.0 110.859 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -52.75 119.29 4.41 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.998 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -153.7 124.4 7.2 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.53 92.61 0.85 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.649 0.738 . . . . 0.0 112.522 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 170.86 -66.26 0.01 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.693 1.597 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.42 -57.03 1.81 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.29 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.4 pt? -134.68 113.71 11.97 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.626 0.727 . . . . 0.0 110.808 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -161.41 169.48 21.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.533 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.6 tt -75.92 122.69 24.52 Favored 'General case' 0 CA--C 1.487 -1.461 0 C-N-CA 117.191 -1.803 . . . . 0.0 106.17 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.562 ' H ' ' NE2' ' A' ' 34' ' ' HIS . 26.2 tt0 -138.22 110.12 7.2 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 113.094 -1.866 . . . . 0.0 107.267 -174.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.431 ' HB3' ' H ' ' A' ' 150' ' ' THR . 8.0 t -93.48 123.65 36.94 Favored 'General case' 0 N--CA 1.411 -2.397 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.325 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.414 ' H ' ' CB ' ' A' ' 31' ' ' SER . 13.1 t70 -119.11 -24.1 6.6 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.722 -175.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.95 -69.61 0.68 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.314 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.91 171.5 8.59 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.534 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 148' ' ' GLU . 5.2 tm-20 -89.9 -24.77 21.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.028 0.931 . . . . 0.0 109.945 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -114.27 134.65 54.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.122 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' CD2' ' HA ' ' A' ' 30' ' ' GLN . 8.4 mp -128.76 165.28 21.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.373 0.606 . . . . 0.0 112.39 -172.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 tt -152.42 128.1 10.14 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.02 135.5 63.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.72 118.74 35.85 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -121.64 122.71 27.79 Favored Pre-proline 0 C--O 1.214 -0.772 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.357 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -92.56 137.43 1.6 Allowed 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.657 2.238 . . . . 0.0 111.415 171.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -92.43 162.89 14.06 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.293 0.568 . . . . 0.0 111.421 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.477 ' OD1' ' HG2' ' A' ' 68' ' ' GLN . 34.4 p30 -69.84 -36.11 75.29 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.477 ' HG2' ' OD1' ' A' ' 67' ' ' ASN . 19.5 pt20 -147.63 176.88 9.73 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.029 -0.419 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.18 124.48 39.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.23 0.538 . . . . 0.0 110.384 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.414 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -137.0 172.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 174.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -93.24 114.31 26.75 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 65.4 tp -76.66 127.97 33.8 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -126.08 -45.94 1.69 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.866 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 p -142.74 155.18 44.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -128.27 158.24 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.24 113.77 5.64 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 122.602 0.361 . . . . 0.0 110.284 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.2 mt -125.17 126.35 70.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 54.2 mtpt -117.79 152.42 35.35 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.421 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.85 -167.96 30.23 Favored Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 108.186 -1.965 . . . . 0.0 108.186 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.11 155.53 69.17 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.85 1.7 . . . . 0.0 109.078 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.97 -42.83 60.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.91 -37.25 10.78 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -76.6 2.27 14.49 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.77 150.2 30.78 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.594 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.9 161.74 35.21 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 121.938 1.759 . . . . 0.0 111.088 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 69.8 tttt -127.89 -73.98 0.59 Allowed 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.561 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.488 ' HA ' ' HG2' ' A' ' 112' ' ' GLU . 29.5 m -76.15 103.91 6.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.477 0.656 . . . . 0.0 110.193 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 86' ' ' LYS . 99.8 t -114.93 116.66 53.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.627 -173.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.91 147.23 26.78 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.231 -0.293 . . . . 0.0 110.26 172.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.54 138.91 54.47 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 86.6 m-85 -130.95 116.78 18.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 135' ' ' SER . 50.8 p -100.63 -14.09 18.29 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 26.1 t-20 -140.3 84.7 1.97 Allowed 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.146 -1.421 . . . . 0.0 113.87 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.475 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 85.5 tttt 171.69 148.81 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.109 1.364 . . . . 0.0 108.06 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -85.97 122.94 30.71 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.289 0.566 . . . . 0.0 111.427 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.366 0.3 OUTLIER 39.39 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.002 2.521 . . . . 0.0 117.299 176.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.475 ' SD ' ' HD3' ' A' ' 94' ' ' LYS . 91.7 mmm -83.91 148.51 26.9 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 174.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.7 m -129.33 162.93 26.84 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -52.68 -38.63 60.84 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 t -81.29 3.26 24.69 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HA ' ' OD1' ' A' ' 104' ' ' ASP . 4.0 p-10 -147.23 13.64 1.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.229 0.538 . . . . 0.0 110.616 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 p -75.5 -25.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -96.63 4.78 51.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.478 0.656 . . . . 0.0 110.618 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.421 ' OD1' ' HA ' ' A' ' 101' ' ' ASN . 8.3 m-20 -91.71 4.61 52.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.923 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -144.19 134.65 12.09 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.08 127.0 17.48 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.628 2.219 . . . . 0.0 111.7 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.14 168.55 23.02 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.597 2.198 . . . . 0.0 112.505 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.8 m -69.72 -40.66 76.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.43 174.11 3.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 76.0 m -143.7 113.45 7.11 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.27 163.7 20.18 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.563 -174.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.695 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 50.5 mt-10 -128.04 138.75 52.7 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.768 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.1 116.71 7.49 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 112.651 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 t -96.42 174.07 7.05 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.44 -36.34 68.91 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 118.257 0.48 . . . . 0.0 110.715 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -59.93 -42.36 93.79 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.434 HD21 HG22 ' A' ' 123' ' ' VAL . 14.1 t-20 -71.54 -41.66 68.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.538 ' O ' HD22 ' A' ' 118' ' ' LEU . 8.4 tt -73.85 -0.76 16.9 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.735 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -113.61 -5.07 13.41 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.174 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.508 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 118.63 -3.33 15.29 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.645 -1.264 . . . . 0.0 116.136 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -88.33 126.57 60.02 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.91 108.54 0.49 Allowed 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.707 2.938 . . . . 0.0 111.844 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.434 HG22 HD21 ' A' ' 117' ' ' ASN . 68.9 t -88.65 127.1 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.23 141.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.412 0.445 . . . . 0.0 111.75 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.63 -172.85 2.2 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -72.7 103.79 3.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 110.355 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -75.16 1.77 12.51 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.361 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.64 -22.52 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.79 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -109.69 -9.97 14.83 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -170.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -77.62 11.11 2.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.128 -0.982 . . . . 0.0 112.447 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -58.51 133.42 55.8 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -163.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.294 2.8 p-10 53.7 113.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.911 2.084 . . . . 0.0 112.697 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -121.01 122.51 67.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.674 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -117.3 -28.28 6.19 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.551 0.691 . . . . 0.0 109.545 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' SER . 52.3 p -144.67 171.86 13.8 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.897 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.92 106.49 4.85 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 97' ' ' MET . 19.9 m -96.73 120.24 36.7 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.5 mt -105.1 111.28 33.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 141' ' ' GLU . 65.1 t80 -107.55 107.89 18.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.99 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.9 pt -106.64 113.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.633 0.73 . . . . 0.0 109.986 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 41.8 tt0 -112.66 13.38 19.9 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.999 0.904 . . . . 0.0 111.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.3 153.44 11.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.764 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.421 ' C ' ' HB2' ' A' ' 86' ' ' LYS . 39.8 m-80 -117.76 168.34 10.54 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 124.044 0.84 . . . . 0.0 108.91 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -44.21 -43.5 7.22 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.814 0.846 . . . . 0.0 112.186 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.2 m -124.1 8.77 8.61 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.732 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.39 55.56 28.99 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -83.35 2.72 34.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -168.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.411 ' HA ' ' CB ' ' A' ' 58' ' ' GLU . 47.2 mt-10 69.22 -4.28 1.34 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.802 0.841 . . . . 0.0 112.536 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.95 103.3 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 123.829 0.852 . . . . 0.0 110.114 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.431 ' H ' ' HB3' ' A' ' 54' ' ' SER . 41.0 m -82.57 122.78 28.53 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 87.8 tttt -131.12 134.17 46.32 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 52' ' ' LEU . 11.3 m -130.46 148.38 33.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.129 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -86.54 -44.83 11.62 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.328 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.13 145.11 6.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.702 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 73.9 mt -117.98 122.87 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.1 137.28 42.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.27 137.56 51.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 74.3 m-85 -122.33 139.33 53.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.753 0.787 . . . . 0.0 111.703 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.94 -168.46 22.84 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.9 m -145.73 149.82 35.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 117.431 0.616 . . . . 0.0 109.676 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--N 1.29 -2.016 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.295 178.171 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.8 p 53.32 27.92 6.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.672 1.189 . . . . 0.0 112.891 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.99 138.39 40.48 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -83.57 -40.35 19.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.723 0.773 . . . . 0.0 109.221 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -150.09 94.24 2.12 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.022 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 87.95 7.38 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.592 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.0 m -95.27 79.61 3.51 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 121.58 0.705 . . . . 0.0 110.268 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 4.8 tp60 -145.26 5.65 1.1 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.788 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 15' ' ' ASP . 2.0 mp -83.61 123.55 76.31 Favored Pre-proline 0 N--CA 1.425 -1.68 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.1 1.63 9.07 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.805 2.336 . . . . 0.0 112.964 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm 70.83 118.95 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.796 1.238 . . . . 0.0 111.423 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.81 -44.31 1.28 Allowed Glycine 0 C--N 1.307 -1.05 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -134.87 152.37 51.69 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 13.0 m -106.2 167.51 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.069 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.428 ' CG ' HH22 ' A' ' 45' ' ' ARG . 21.9 t70 -76.82 95.33 4.03 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.75 -0.38 0.11 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 126.917 2.087 . . . . 0.0 114.054 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 17' ' ' LEU . 5.5 tt -64.02 -31.73 73.02 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.49 -24.12 67.69 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.864 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.75 8.66 41.8 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.047 -0.408 . . . . 0.0 110.398 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.9 mt -85.57 119.08 33.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.25 -34.82 42.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' HG13 ' A' ' 25' ' ' VAL . 96.2 m95 70.23 6.57 5.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.8 t -84.96 -28.79 25.59 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.8 -89.23 1.78 Allowed Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 108.089 -2.005 . . . . 0.0 108.089 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.496 HG13 ' CZ3' ' A' ' 22' ' ' TRP . 92.3 t 41.89 94.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.246 1.418 . . . . 0.0 114.283 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.48 128.1 56.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.906 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.2 p -102.01 119.87 39.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.645 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.472 HD13 ' C ' ' A' ' 28' ' ' LEU . 2.6 tm? -64.3 -44.29 92.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.066 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -117.64 -99.63 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.127 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 8.5 tt0 56.08 22.14 5.7 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.301 1.048 . . . . 0.0 110.204 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -102.77 -12.67 17.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.88 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -54.76 -48.31 72.8 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.5 m 179.97 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 124.483 1.113 . . . . 0.0 110.399 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -73.31 163.36 28.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.628 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.449 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 45.8 m -98.51 140.22 33.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.542 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' CB ' ' HG ' ' A' ' 52' ' ' LEU . 7.0 tt -77.85 -44.82 2.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.453 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.07 -24.66 20.41 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.141 1.894 . . . . 0.0 112.79 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 86.0 m-20 -57.37 -48.43 79.07 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 121.227 0.537 . . . . 0.0 110.264 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.02 4.94 20.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.109 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' O ' ' HZ2' ' A' ' 22' ' ' TRP . 49.2 tp -140.25 10.5 2.33 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -127.68 141.75 51.52 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.543 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 15.6 mm-40 -58.88 132.81 55.06 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -39.77 2.77 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.478 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -76.0 -48.25 21.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.611 -0.294 . . . . 0.0 111.287 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' NH1' HD12 ' A' ' 17' ' ' LEU . 32.1 ptt180 -68.12 107.8 2.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.056 0.931 . . . . 0.0 111.596 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.82 100.63 5.77 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' HB2' ' OE1' ' A' ' 153' ' ' GLN . 4.8 p-10 -71.68 84.65 0.89 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -173.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 16.9 tp10 168.96 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 113.241 -1.799 . . . . 0.0 108.29 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.11 -68.88 1.51 Allowed Glycine 0 C--O 1.238 0.396 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.785 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD13 ' HB3' ' A' ' 38' ' ' ASN . 1.9 pp -104.79 158.07 16.77 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 120.966 0.412 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.437 ' ND2' ' HG3' ' A' ' 151' ' ' LYS . 3.5 p-10 -161.76 166.41 26.56 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.464 ' HG ' ' CB ' ' A' ' 36' ' ' LEU . 3.2 tm? -111.51 128.82 56.13 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.04 162.44 35.46 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.763 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.658 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 51.2 p -92.12 176.09 6.63 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.944 0.153 . . . . 0.0 110.774 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 175.79 -46.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.925 0.89 . . . . 0.0 109.067 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.19 -28.84 63.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.59 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.658 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.3 t70 -160.29 145.71 15.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -74.06 -27.81 61.09 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 123.519 0.512 . . . . 0.0 112.236 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.2 132.19 34.06 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.304 0.574 . . . . 0.0 110.542 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' HB2' HG13 ' A' ' 140' ' ' ILE . 93.2 mt -131.12 144.43 51.39 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.327 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 62' ' ' ILE . 6.0 tt -153.06 144.35 23.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.52 ' N ' HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -150.29 138.94 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.482 ' N ' HD13 ' A' ' 62' ' ' ILE . 68.2 t80 -105.32 122.76 46.62 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.914 0.486 . . . . 0.0 111.825 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.415 ' CD1' HD11 ' A' ' 62' ' ' ILE . 2.3 mp -116.26 119.47 36.45 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.652 177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -86.84 127.74 2.7 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.538 2.159 . . . . 0.0 109.219 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -90.81 162.65 14.75 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -48.8 -57.6 6.12 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 126.376 1.87 . . . . 0.0 110.165 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -149.48 177.94 9.26 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 57.7 t -78.49 111.72 15.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.57 173.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -100.61 133.8 44.52 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 125' ' ' LEU . 2.4 tt -98.19 123.22 42.15 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -102.2 -41.44 6.39 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.822 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.0 p -154.63 160.93 41.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.027 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -135.23 150.23 50.03 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.608 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -143.6 98.11 3.19 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.7 mt -108.26 132.21 56.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 54.0 mtpt -116.55 159.3 22.31 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.264 0.554 . . . . 0.0 112.42 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.4 39.64 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -73.85 172.62 15.49 Favored 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 122.25 1.966 . . . . 0.0 110.356 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -27.93 60.51 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.834 0.35 . . . . 0.0 110.668 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.22 -47.17 7.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.18 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 151' ' ' LYS . 43.7 mt-10 -89.7 1.8 55.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.745 -176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.76 45.45 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.798 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 7.5 Cg_exo -71.21 107.07 2.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.174 1.916 . . . . 0.0 111.15 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.34 -43.39 13.74 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.7 m -92.74 97.22 10.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.143 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 111' ' ' ALA . 33.8 m -107.38 142.28 20.52 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -146.65 133.46 20.08 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.27 144.69 45.61 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.011 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -131.98 115.65 16.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.6 t -93.27 134.54 35.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 73.67 178.29 0.23 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.829 1.252 . . . . 0.0 111.501 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.4 tptm 72.41 101.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.063 1.345 . . . . 0.0 110.736 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.8 122.96 19.66 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.643 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t60 70.87 97.35 0.07 Allowed 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.389 1.056 . . . . 0.0 112.997 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 83.5 mtp -126.39 152.77 45.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 85.5 m -142.7 174.85 10.28 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.498 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 55.5 p90 -65.54 -17.6 64.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.1 m -73.19 -23.33 60.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.626 0.25 . . . . 0.0 111.454 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -128.51 3.34 5.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 111.514 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 8.3 p -65.09 -34.77 72.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.867 -173.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -97.71 5.1 49.73 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.75 -24.56 18.53 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.173 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -97.38 149.74 36.04 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.718 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.59 128.88 18.88 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 122.67 2.247 . . . . 0.0 112.028 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.68 160.27 41.29 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.436 2.09 . . . . 0.0 111.256 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -76.79 -41.95 42.55 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.489 0.661 . . . . 0.0 109.378 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.63 ' OD2' ' HG3' ' A' ' 126' ' ' LYS . 14.9 t70 -161.71 146.71 13.24 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -127.99 124.17 36.54 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 173.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.407 ' HB1' ' CG2' ' A' ' 88' ' ' VAL . . . -119.05 172.89 7.24 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.085 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.44 134.59 55.14 Favored 'General case' 0 N--CA 1.405 -2.676 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 28.4 tp -69.57 121.54 17.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -98.03 169.59 9.52 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.861 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -31.77 72.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -70.87 -33.88 71.05 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.82 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.608 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -64.44 -42.57 95.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.464 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 87.2 mt -62.19 -4.87 1.93 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.83 1.252 . . . . 0.0 113.642 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -113.14 -9.39 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 122.821 0.448 . . . . 0.0 109.976 -178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.83 0.58 34.19 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.914 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 31.9 mmmt -75.34 131.52 77.74 Favored Pre-proline 0 C--O 1.246 0.907 0 O-C-N 123.592 0.231 . . . . 0.0 111.375 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 29.7 Cg_exo -65.14 119.54 6.59 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.288 2.659 . . . . 0.0 111.639 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.0 t -97.54 136.0 29.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.04 117.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.405 0.621 . . . . 0.0 111.252 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.456 HD11 HD23 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.54 -175.59 4.74 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.401 176.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.63 ' HG3' ' OD2' ' A' ' 109' ' ' ASP . 29.9 mtpp -64.54 89.9 0.07 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.619 0.723 . . . . 0.0 112.06 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -69.68 -21.37 63.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.732 1.213 . . . . 0.0 110.959 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 m -80.33 -19.23 12.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.03 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 9.9 tmtt? -92.85 -41.84 9.86 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.438 ' CD1' HD12 ' A' ' 125' ' ' LEU . 91.8 m-85 -75.77 78.97 2.71 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 112.021 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -107.99 -40.44 5.23 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.418 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.29 112.65 23.44 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.388 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 49.0 t -123.3 102.38 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -95.87 -31.07 13.32 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.4 p -156.94 162.99 39.62 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 137' ' ' THR . 4.4 tt -148.82 133.99 18.29 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.461 ' N ' HD22 ' A' ' 136' ' ' LEU . 64.6 m -104.32 124.7 49.65 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mp -103.03 125.96 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.63 118.25 27.72 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 60' ' ' LEU . 10.5 pt -112.46 114.32 46.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.68 0.753 . . . . 0.0 109.76 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.66 -42.43 9.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.612 -172.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.24 150.58 38.16 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.899 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.08 167.99 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.834 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.463 HE21 HD22 ' A' ' 113' ' ' LEU . 82.6 mm-40 -48.47 -48.61 37.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.0 m -92.84 -19.45 21.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.81 42.38 61.26 Favored Glycine 0 C--N 1.311 -0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.6 t -87.86 9.86 20.57 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.938 -0.631 . . . . 0.0 110.752 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 68.15 8.39 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.379 1.072 . . . . 0.0 112.318 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.02 112.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-O 121.976 0.893 . . . . 0.0 109.378 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.6 m -106.74 121.28 44.05 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 83' ' ' GLU . 4.9 ttmp? -113.4 133.62 55.07 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.232 0.539 . . . . 0.0 110.485 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.7 t -125.68 116.1 45.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.654 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 47' ' ' ASP . 9.7 pt20 -85.87 -29.92 23.32 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.45 145.43 12.96 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.28 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.36 129.32 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.59 129.63 20.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.98 144.73 42.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 84.5 m-85 -124.16 113.21 18.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.307 0.575 . . . . 0.0 111.042 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.96 -167.24 11.0 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.4 p -162.44 162.95 27.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 118.315 1.057 . . . . 0.0 112.556 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.302 -1.469 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.315 173.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -168.99 97.21 0.36 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.275 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.11 21.81 13.07 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 173.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.3 110.98 12.48 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.542 0.687 . . . . 0.0 111.817 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.8 m -141.07 93.82 2.63 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.378 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . . . -152.94 134.54 14.48 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.374 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 p -83.55 81.32 8.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.921 0.867 . . . . 0.0 110.77 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -129.41 11.37 5.83 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.486 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.6 mt -104.75 112.67 65.32 Favored Pre-proline 0 C--N 1.299 -1.619 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.66 -172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.26 143.22 4.62 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 122.3 2.0 . . . . 0.0 111.715 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -59.18 130.67 48.09 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.69 0.757 . . . . 0.0 112.021 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -42.26 1.96 Allowed Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -106.67 173.3 6.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.615 0.721 . . . . 0.0 110.064 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -130.15 143.94 39.5 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 154.5 29.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.029 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 20' ' ' ILE . 4.3 mm? -101.64 8.83 41.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.927 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.48 -48.49 15.24 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.85 -27.22 68.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.788 -1.097 . . . . 0.0 110.918 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -84.07 9.84 11.56 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 16' ' ' LEU . 75.4 mt -93.71 127.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.28 -15.99 41.6 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.508 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 25' ' ' VAL . 86.0 m95 58.88 30.7 20.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.709 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -57.31 -36.19 70.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.933 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.2 -47.37 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' HA ' ' A' ' 22' ' ' TRP . 2.7 t 62.7 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.348 1.059 . . . . 0.0 109.885 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -121.78 139.85 53.08 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.018 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.54 128.74 29.81 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.58 -26.78 68.77 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -99.41 -105.02 0.22 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.325 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 54.73 15.61 1.15 Allowed 'General case' 0 CA--C 1.573 1.842 0 CA-C-O 122.322 1.058 . . . . 0.0 110.306 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 t -78.36 -30.1 47.81 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.613 1.165 . . . . 0.0 107.931 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 4.9 p -64.95 7.09 0.18 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m 76.66 -17.23 0.56 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' ND1' ' HB3' ' A' ' 53' ' ' GLU . 29.6 m80 -77.62 134.98 38.08 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.659 174.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -83.05 157.31 22.93 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -81.74 -53.74 0.7 Allowed Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.83 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.3 -15.19 33.57 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 121.845 1.697 . . . . 0.0 113.661 -175.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' HB2' HD11 ' A' ' 50' ' ' LEU . 32.0 p30 -75.25 -22.64 57.69 Favored 'General case' 0 C--O 1.209 -1.045 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.905 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.79 1.18 36.92 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.362 0.601 . . . . 0.0 110.825 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.84 -43.7 2.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.091 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.11 130.43 35.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.925 0.393 . . . . 0.0 110.947 -174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 6' ' ' ALA . 21.5 tm0? -57.82 140.05 52.66 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 124.501 1.12 . . . . 0.0 110.641 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.8 -59.5 0.53 Allowed Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -73.77 -41.04 62.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.7 ' HD2' ' O ' ' A' ' 45' ' ' ARG . 2.7 tmm_? -53.49 -11.44 0.34 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.961 2.104 . . . . 0.0 111.569 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -65.44 100.53 0.5 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.22 98.83 0.84 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.0 -75.24 0.32 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.225 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.34 -54.38 0.79 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.957 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 38' ' ' ASN . 1.8 pp -85.03 147.46 26.67 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.757 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -164.06 166.32 21.51 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.641 -177.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.2 tp -83.59 123.47 29.81 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.409 ' HB3' ' ND1' ' A' ' 34' ' ' HIS . 32.2 tt0 -140.71 130.53 24.41 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.729 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.624 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 64.7 p -101.91 151.05 22.56 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -123.8 -54.28 1.74 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.584 -170.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.95 -26.41 25.52 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.192 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -130.39 145.97 51.89 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 117.958 -1.497 . . . . 0.0 111.634 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.25 -31.75 24.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.929 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -68.49 114.96 7.36 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.334 0.587 . . . . 0.0 110.855 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.8 tp -126.05 107.53 10.51 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.408 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.61 130.71 54.87 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.61 132.87 68.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -113.91 126.19 54.89 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.71 121.23 44.78 Favored Pre-proline 0 N--CA 1.425 -1.694 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.36 -178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.94 112.59 3.3 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.593 2.196 . . . . 0.0 110.273 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -80.2 164.13 23.5 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 126.065 1.746 . . . . 0.0 113.922 -175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -106.11 -37.53 6.57 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.069 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -150.62 160.6 43.71 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.64 128.2 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 124.028 0.83 . . . . 0.0 109.323 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.429 ' CD1' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -134.44 174.06 13.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 174.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 160' ' ' SER . 38.6 ttpt -97.13 146.8 24.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 133' ' ' VAL . 87.3 mt -78.83 159.11 27.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HA ' ' CE2' ' A' ' 127' ' ' TYR . 13.2 t60 -146.82 -66.02 0.28 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.793 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.9 p -137.77 163.02 32.38 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.821 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -140.1 149.06 42.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.99 111.66 8.73 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.745 0.307 . . . . 0.0 110.25 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.7 mt -123.81 120.6 60.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -96.46 136.38 37.04 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.273 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.547 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -164.39 156.56 28.53 Favored Glycine 1 C--N 1.25 -4.23 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 177.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.53 172.49 12.32 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 122.002 1.801 . . . . 0.0 112.887 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.98 -24.53 55.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.959 0.885 . . . . 0.0 109.416 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.19 -55.14 4.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.0 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -109.18 7.96 25.68 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.703 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.94 158.23 36.41 Favored Glycine 0 C--N 1.305 -1.188 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.272 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.616 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.0 Cg_exo -77.12 107.66 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.888 1.725 . . . . 0.0 110.902 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 1.0 OUTLIER -89.19 -51.78 5.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.981 -176.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.7 m -93.44 95.46 9.3 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.715 0.769 . . . . 0.0 109.699 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -98.02 135.04 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.779 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.58 141.82 49.77 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.813 0.816 . . . . 0.0 110.256 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 53.3 m-85 -115.17 145.39 42.44 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.547 ' CZ ' ' HB ' ' A' ' 102' ' ' VAL 0.257 76.2 m-85 -118.12 146.74 43.93 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 178.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -74.14 -158.5 0.07 Allowed 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.651 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 134' ' ' ARG . 27.7 t-20 -53.21 -20.06 3.67 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.492 1.917 . . . . 0.0 112.862 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -72.33 111.8 7.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.38 161.15 13.79 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 65.35 23.48 12.05 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 111.365 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 79.7 mtp -68.29 135.41 51.88 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.897 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.458 ' O ' HG11 ' A' ' 102' ' ' VAL . 19.9 p -102.91 174.04 6.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -62.37 -29.14 70.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -87.27 -5.7 58.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -104.4 -19.64 13.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.547 ' HB ' ' CZ ' ' A' ' 91' ' ' PHE . 33.1 m -83.69 2.72 3.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.778 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.62 -26.33 21.96 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.993 0.425 . . . . 0.0 111.944 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -110.48 10.22 23.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.796 0.331 . . . . 0.0 111.166 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -124.22 131.68 24.22 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.65 126.93 11.88 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.76 162.03 42.96 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.356 2.037 . . . . 0.0 111.567 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 16.7 m -60.42 -45.36 93.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.038 0.923 . . . . 0.0 108.826 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -167.9 166.18 13.51 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -133.45 128.58 35.76 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.0 172.85 8.21 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.302 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 39.4 tt0 -125.38 138.05 54.04 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.94 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 27.6 tp -70.15 100.87 1.73 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.9 t -91.37 167.61 12.16 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.3 -35.68 67.79 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.69 0.396 . . . . 0.0 111.748 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.4 -38.84 85.27 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.36 -44.41 65.08 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 79' ' ' GLY . 5.1 tt -57.91 -31.81 67.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.527 1.531 . . . . 0.0 109.671 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -85.2 -3.02 58.67 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.02 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -94.24 137.05 22.94 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.08 115.19 2.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.673 2.915 . . . . 0.0 112.934 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.4 t -96.42 137.71 23.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.68 123.88 32.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.18 176.87 5.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.587 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -94.9 110.5 22.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.063 0.458 . . . . 0.0 110.394 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.425 ' CE2' ' HA ' ' A' ' 73' ' ' HIS . 45.2 p90 -125.41 26.48 6.81 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.47 -33.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.01 0.434 . . . . 0.0 111.463 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -90.42 -32.6 16.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.407 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 56.3 m-85 -90.41 69.94 6.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.814 0.816 . . . . 0.0 112.169 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -88.41 -12.7 42.44 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.79 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -146.2 120.99 9.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.436 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 72' ' ' LEU . 94.1 t -121.42 104.61 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.139 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.418 ' HB3' ' ND2' ' A' ' 93' ' ' ASN . 29.3 tpt180 -71.78 -50.44 29.83 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.801 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.6 p -134.66 150.72 50.68 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -129.98 135.44 48.3 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.869 0.366 . . . . 0.0 110.511 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 70.2 m -121.95 129.64 52.67 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.7 mp -107.56 121.21 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 74.3 t80 -124.35 125.72 44.8 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.014 0.435 . . . . 0.0 112.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.1 pt -119.51 126.13 75.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.555 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.9 pt-20 -108.78 -17.98 13.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.97 22.34 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.253 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -98.15 -174.22 2.79 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -62.08 -63.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.485 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -103.43 -42.22 5.77 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.927 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.79 69.21 0.64 Allowed Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 -174.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.8 m -84.78 16.72 3.14 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.409 0.684 . . . . 0.0 111.329 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 76.2 -43.67 0.48 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.405 1.482 . . . . 0.0 111.9 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.4 m -102.35 157.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.624 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 59.2 m -121.94 128.68 51.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -129.25 133.58 47.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.001 0.429 . . . . 0.0 110.079 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 7.2 p -134.77 125.36 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -73.68 -47.57 38.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.532 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 147.06 10.31 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -122.74 122.99 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.73 121.42 12.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.05 147.09 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -124.93 118.95 27.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.97 -157.0 11.05 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 38.7 m -152.75 126.22 8.75 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 p . . . . . 0 C--N 1.276 -2.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.422 175.604 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.436 -1.146 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 t -171.6 152.43 3.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.61 134.59 54.64 Favored 'General case' 0 C--O 1.248 0.98 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.47 173.49 6.8 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 121.326 0.584 . . . . 0.0 110.995 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -162.95 141.88 8.61 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.84 80.37 8.5 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.269 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.5 p -101.04 95.04 6.31 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.529 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 67.59 17.56 9.94 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.87 113.09 12.68 Favored Pre-proline 0 C--O 1.243 0.737 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -87.0 170.56 7.14 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.257 1.971 . . . . 0.0 112.855 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -59.62 114.73 2.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.544 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.51 -61.98 0.55 Allowed Glycine 0 N--CA 1.423 -2.202 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.105 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.439 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -112.53 -171.86 1.94 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.395 0.617 . . . . 0.0 111.034 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.49 150.48 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 173.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 32.9 t0 -72.29 126.38 29.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 157' ' ' LEU . 59.2 mt -81.06 4.36 20.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 5.4 tt -51.42 -35.86 41.14 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.299 1.047 . . . . 0.0 108.411 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.37 -38.93 81.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.21 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.69 -2.46 58.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.5 mt -74.11 136.98 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.509 ' O ' HG13 ' A' ' 25' ' ' VAL . 16.2 t70 -99.54 112.89 25.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -80.52 1.51 29.18 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -93.05 -35.89 12.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.36 -19.99 61.27 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.756 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 21' ' ' ASP . 28.4 m -54.2 130.89 16.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.756 0.789 . . . . 0.0 112.126 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.7 tp10 -112.06 127.5 55.92 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.604 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 26.4 p -130.26 113.59 14.6 Favored 'General case' 0 N--CA 1.398 -3.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.198 -175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.62 -75.17 0.14 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.299 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.454 HD22 ' HB3' ' A' ' 56' ' ' ALA . 64.2 t30 -116.41 -81.43 0.61 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.561 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' ' 27' ' ' CYS . 1.9 mp0 62.82 23.29 13.9 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 14.4 m 89.52 139.86 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 127.609 2.363 . . . . 0.0 112.675 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.4 t -70.35 -46.36 64.29 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.675 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.3 m -77.45 -35.68 53.66 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.684 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 98.1 m-70 -124.61 149.27 47.25 Favored 'General case' 0 C--O 1.189 -2.102 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -140.98 -168.29 2.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 116.745 -1.982 . . . . 0.0 115.378 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 29.8 tp -60.88 -52.47 72.1 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 50.2 Cg_exo -54.47 -32.23 72.4 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.1 1.867 . . . . 0.0 112.751 -172.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.548 ' HB2' HD12 ' A' ' 50' ' ' LEU . 2.9 p-10 -84.43 3.43 36.16 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.87 -23.8 3.04 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.936 0.398 . . . . 0.0 112.042 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -105.13 -18.12 14.25 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.116 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -80.28 147.68 31.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -66.09 143.67 57.17 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.32 -37.09 3.03 Favored Glycine 0 N--CA 1.413 -2.882 0 CA-C-N 114.87 -1.059 . . . . 0.0 114.386 170.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -74.6 -25.71 59.44 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.301 0.0 OUTLIER -60.14 67.51 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -160.91 141.76 11.56 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.754 1.622 . . . . 0.0 107.979 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.8 100.43 10.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.646 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.12 17.9 0.76 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.426 0.631 . . . . 0.0 109.931 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.14 -59.92 0.23 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 38' ' ' ASN . 2.3 pp -105.19 149.38 25.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.684 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 47.1 t30 -161.72 163.41 29.69 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.407 HD22 HD21 ' A' ' 60' ' ' LEU . 3.8 tt -105.32 111.98 24.91 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 171.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -141.45 122.34 14.48 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.62 ' HA ' ' OG ' ' A' ' 31' ' ' SER 0.27 36.2 p -51.76 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -171.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 18.8 t70 -113.52 88.13 2.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.14 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.454 ' HB3' HD22 ' A' ' 29' ' ' ASN . . . 157.4 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.211 2.204 . . . . 0.0 107.987 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -139.03 157.16 46.48 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.986 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -89.02 75.14 8.02 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.497 HE21 ' C ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -174.53 139.66 0.58 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.396 1.078 . . . . 0.0 109.139 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 140' ' ' ILE . 10.3 mp -135.19 147.28 49.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.619 0.768 . . . . 0.0 109.645 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 4.6 tt -149.24 124.44 10.14 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -139.43 135.05 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.543 ' N ' HD12 ' A' ' 62' ' ' ILE . 45.1 t80 -105.78 125.64 51.23 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.93 0.892 . . . . 0.0 110.324 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -116.77 120.73 33.82 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.403 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -97.85 127.43 0.23 Allowed 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 123.054 2.503 . . . . 0.0 110.421 170.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -95.14 139.75 31.04 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.21 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -72.73 -20.57 61.18 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.164 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -147.48 144.47 28.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.77 120.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.684 0.754 . . . . 0.0 111.16 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 168.43 10.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HB3' ' HZ3' ' A' ' 71' ' ' LYS . 7.5 mtpm? -96.16 113.62 25.24 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 55.3 tp -71.2 152.5 43.29 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.424 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 17.9 t60 -139.22 -49.57 0.5 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.978 0.418 . . . . 0.0 111.526 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -147.19 167.54 23.92 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 122.036 -0.415 . . . . 0.0 111.91 -175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 12.3 p90 -129.43 158.21 39.81 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -151.66 131.94 13.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.868 0.366 . . . . 0.0 111.039 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.19 128.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -104.04 155.63 18.52 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.347 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.26 -178.07 42.61 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.489 ' CD ' ' HB2' ' A' ' 151' ' ' LYS . 15.3 Cg_exo -68.18 159.99 50.76 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 122.91 2.407 . . . . 0.0 110.86 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.09 -29.15 68.02 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 35.1 mt-10 -93.34 -41.53 9.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.42 0.629 . . . . 0.0 111.463 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 15.35 25.88 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.096 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -85.79 150.73 24.43 Favored Glycine 0 C--N 1.307 -1.054 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 47.8 Cg_exo -55.61 160.66 8.97 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.807 2.338 . . . . 0.0 112.646 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.82 -56.31 0.18 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.8 m -80.99 100.05 8.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.861 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 140' ' ' ILE . 48.8 t -123.39 119.72 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.361 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.22 131.12 56.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 109' ' ' ASP 0.253 32.5 p90 -138.26 134.11 33.98 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 177.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -110.25 159.39 17.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 p -148.47 167.54 25.05 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 117.965 0.348 . . . . 0.0 111.838 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.268 19.2 m120 86.48 -24.59 0.12 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -97.92 148.09 23.8 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.889 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.84 134.85 37.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 68.25 94.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.275 1.03 . . . . 0.0 111.365 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.6 mmm -127.41 107.2 9.75 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.652 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 22.0 p -98.45 177.99 5.17 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -67.35 -25.87 66.21 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.9 t -56.62 -49.85 73.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.35 -38.89 92.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.958 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 82.5 t -64.97 -29.79 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.04 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.69 -19.87 58.81 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.299 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -104.61 -42.38 5.43 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.32 124.83 47.69 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.953 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.95 135.93 71.9 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.963 2.442 . . . . 0.0 110.882 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.17 167.36 14.58 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.552 2.168 . . . . 0.0 112.383 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -83.14 -44.77 14.72 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 20.0 t70 -143.14 151.02 40.23 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.915 174.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.1 p -115.35 118.21 32.59 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.34 150.73 26.95 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.103 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.98 107.04 10.43 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 8.5 tt -72.21 134.42 45.64 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.197 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.4 p -116.36 169.17 9.51 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.483 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.64 -33.05 72.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.867 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.17 -40.99 91.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.29 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.551 HD22 ' HA ' ' A' ' 76' ' ' ALA . 2.9 t-20 -63.38 -47.18 83.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.621 -177.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.46 -14.26 61.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -87.76 10.32 18.76 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.716 0.77 . . . . 0.0 109.065 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.06 12.7 56.12 Favored Glycine 0 CA--C 1.507 -0.438 0 CA-C-N 114.272 -1.331 . . . . 0.0 114.627 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 12.2 mptt -99.31 117.55 63.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.35 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 67.3 Cg_exo -56.29 119.73 7.11 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.954 3.103 . . . . 0.0 112.481 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 58.5 t -93.01 131.59 39.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 m -83.19 127.45 39.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 121.523 0.678 . . . . 0.0 111.455 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.52 179.03 4.99 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.933 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.59 94.49 6.3 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 20.0 p90 -105.08 12.43 32.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.75 -26.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.539 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -99.33 14.54 29.28 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.176 175.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.04 74.87 1.18 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.463 ' OE1' ' HE2' ' A' ' 71' ' ' LYS . 28.7 mm-40 -109.1 -37.91 5.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -112.55 114.31 26.9 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 t -122.48 100.88 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.806 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.592 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -87.1 -36.39 18.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 109.766 169.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.9 p -141.84 141.67 33.11 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.598 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 137' ' ' THR . 5.8 tt -140.16 141.48 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.562 ' N ' HD23 ' A' ' 136' ' ' LEU . 35.7 m -127.01 120.64 29.55 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -104.97 122.16 57.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 122.799 0.44 . . . . 0.0 110.405 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -122.59 107.27 11.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 60' ' ' LEU . 2.0 pp -104.45 141.14 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.512 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -111.13 -25.66 9.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -158.51 158.43 34.03 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.66 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -99.9 179.4 4.52 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.621 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 85.8 mm-40 -50.12 -59.82 3.55 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.632 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.5 m -91.03 -8.44 49.07 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.203 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.14 42.28 96.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.2 m -88.96 15.64 8.23 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 74.38 -42.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.807 1.243 . . . . 0.0 113.54 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -102.14 105.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.368 1.08 . . . . 0.0 110.576 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 34.5 m -97.02 124.22 40.95 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.109 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.489 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -97.11 133.73 41.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.412 0.625 . . . . 0.0 109.64 177.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.11 107.78 10.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 124.946 1.298 . . . . 0.0 107.742 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -91.12 -32.33 15.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.28 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.54 ' NZ ' ' HB1' ' A' ' 156' ' ' ALA . 7.4 tmtm? -152.93 133.49 13.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.2 mt -118.52 136.69 54.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.54 ' HB1' ' NZ ' ' A' ' 154' ' ' LYS . . . -144.36 148.59 34.92 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 121.411 0.624 . . . . 0.0 110.643 174.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 2.8 mm? -117.57 127.38 53.92 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 13' ' ' GLN . 61.7 m-85 -108.38 128.81 55.1 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -149.72 -166.73 13.54 Favored Glycine 0 C--N 1.286 -2.218 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -152.92 142.66 22.0 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.309 0.555 . . . . 0.0 110.44 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 117.566 -1.207 . . . . 0.0 109.743 176.535 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 120.727 0.299 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 29.8 p -93.09 81.2 4.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.792 -0.567 . . . . 0.0 110.648 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.58 134.29 5.25 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.6 163.8 21.21 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.587 0.554 . . . . 0.0 110.67 176.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.7 m -159.76 -54.07 0.06 Allowed 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.26 100.78 3.87 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.123 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 p -118.64 162.21 18.78 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.361 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -86.82 79.34 8.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.474 HG21 ' H ' ' A' ' 11' ' ' LYS . 45.9 mm -98.02 119.49 62.02 Favored Pre-proline 0 C--N 1.289 -2.03 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.264 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -91.95 27.1 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.284 2.656 . . . . 0.0 111.214 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' H ' HG21 ' A' ' 9' ' ' ILE . 88.1 tttt 64.06 112.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.744 1.618 . . . . 0.0 112.028 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.89 -81.21 0.19 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.84 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 2.2 mp0 -100.1 175.48 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 17.4 m -107.2 162.54 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 CA-C-O 120.803 0.335 . . . . 0.0 111.406 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.81 118.63 21.77 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 70' ' ' ILE . 35.3 mt -69.99 2.52 3.45 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.236 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.58 -42.86 97.55 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.127 0.965 . . . . 0.0 108.651 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.49 -26.1 67.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.016 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -102.55 22.33 13.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.092 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' A' ' 2' ' ' SER . 78.6 mt -97.45 126.33 50.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 121.411 -0.116 . . . . 0.0 110.815 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.74 118.05 28.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -90.82 6.82 42.8 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.486 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 m -89.93 -18.72 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 7.31 7.21 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.586 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.18 141.08 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 117.645 0.723 . . . . 0.0 111.538 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -129.61 134.56 47.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.232 0.539 . . . . 0.0 110.144 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . 19.8 p -110.92 114.56 27.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.958 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.449 HD13 ' C ' ' A' ' 28' ' ' LEU . 3.1 tm? -63.9 -68.82 0.32 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.75 -177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.41 ' OD1' HD13 ' A' ' 60' ' ' LEU 0.255 7.2 p-10 -104.17 -52.9 2.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 33.1 tt0 69.36 0.95 3.09 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 122.923 0.489 . . . . 0.0 111.551 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.588 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 79.1 p 73.94 130.29 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 127.472 2.309 . . . . 0.0 110.712 -168.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.7 m -62.35 15.65 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 31' ' ' SER . 38.0 m -138.2 -28.91 0.84 Allowed 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -176.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -124.48 165.57 17.55 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.715 -0.616 . . . . 0.0 112.18 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -91.07 -179.44 5.45 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -174.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.439 ' H ' ' HD2' ' A' ' 37' ' ' PRO . 15.8 tp -98.3 -56.8 0.18 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HD2' ' H ' ' A' ' 36' ' ' LEU . 24.7 Cg_endo -58.11 -22.09 54.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.663 2.242 . . . . 0.0 112.584 -175.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.492 HD21 ' HB2' ' A' ' 50' ' ' LEU . 31.7 p-10 -64.83 -30.04 71.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.57 -6.17 12.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.616 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -105.27 -25.23 12.51 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.391 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -81.87 137.24 35.27 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.463 0.649 . . . . 0.0 111.603 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -63.29 134.89 56.58 Favored 'General case' 0 N--CA 1.39 -3.47 0 C-N-CA 125.182 1.393 . . . . 0.0 108.538 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.09 -56.81 1.78 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.666 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.84 -35.74 79.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.896 0.478 . . . . 0.0 111.488 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' HD2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -54.79 174.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.414 2.375 . . . . 0.0 117.414 -175.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.473 ' HG2' ' HB3' ' A' ' 153' ' ' GLN 0.375 44.3 mt-10 74.34 145.43 0.08 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.751 1.62 . . . . 0.0 115.162 177.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.03 117.88 6.56 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.06 -172.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.57 -68.48 0.26 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.97 -51.39 0.1 OUTLIER Glycine 0 CA--C 1.484 -1.886 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HB2' HD21 ' A' ' 38' ' ' ASN . 3.8 pp -78.87 156.34 28.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.007 -0.597 . . . . 0.0 109.808 174.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -161.38 165.88 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.438 ' CD1' HD11 ' A' ' 36' ' ' LEU . 4.7 tt -118.05 116.8 27.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.588 ' O ' ' HB3' ' A' ' 31' ' ' SER . 8.3 pt-20 -109.99 163.03 13.95 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.8 p -52.0 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 O-C-N 123.763 0.664 . . . . 0.0 112.211 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 54' ' ' SER . 13.8 t70 163.59 -156.89 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' H ' ' CG ' ' A' ' 55' ' ' ASP . . . -71.67 -24.75 61.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.09 154.86 18.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.992 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.67 16.75 21.05 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -103.56 104.47 14.54 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.41 HD13 ' OD1' ' A' ' 29' ' ' ASN . 60.8 tp -114.53 132.62 56.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.484 HD21 ' N ' ' A' ' 62' ' ' ILE . 5.0 tt -137.87 133.83 34.36 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.913 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.484 ' N ' HD21 ' A' ' 61' ' ' LEU . 3.3 mp -133.76 132.18 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -100.94 129.18 46.75 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 20' ' ' ILE . 3.0 mp -120.98 124.02 27.62 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.582 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -95.64 157.64 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.977 2.451 . . . . 0.0 110.815 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -84.52 162.24 19.93 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.497 1.141 . . . . 0.0 113.438 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -97.82 -47.91 5.39 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.881 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -133.46 149.25 51.76 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.661 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.45 116.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -129.95 173.06 14.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -91.9 143.63 26.3 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.44 158.02 21.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -148.76 -63.77 0.24 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.3 p -143.7 165.71 26.9 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.724 -171.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.493 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 4.9 p90 -133.51 159.25 40.98 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HA ' HD22 ' A' ' 117' ' ' ASN . . . -151.98 100.13 2.62 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 120.914 0.388 . . . . 0.0 111.802 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 64.8 mt -102.62 136.13 36.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -118.49 144.09 46.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.454 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.23 -178.74 38.64 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 22.4 Cg_exo -69.29 157.23 62.06 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.202 1.935 . . . . 0.0 110.29 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 mt-10 -62.0 -35.92 79.98 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.54 -48.22 6.2 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 43.7 mt-10 -80.1 20.44 0.65 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.631 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.62 167.5 24.55 Favored Glycine 0 C--N 1.301 -1.416 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.274 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 35.9 Cg_endo -76.79 178.97 6.95 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 121.835 1.69 . . . . 0.0 111.012 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 3.1 tmmm? -144.26 -61.85 0.38 Allowed 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.608 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 51.3 m -80.43 103.45 10.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.55 116.51 51.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.436 -175.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -107.66 135.84 48.41 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.547 0.689 . . . . 0.0 111.111 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.41 134.76 53.76 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.0 m-85 -124.57 115.57 21.06 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 175.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.402 ' HB2' ' CE1' ' A' ' 130' ' ' PHE . 20.4 m -110.92 150.57 29.03 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m120 82.08 154.68 0.12 Allowed 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.801 1.313 . . . . 0.0 108.39 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER 67.68 100.87 0.05 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.649 0.737 . . . . 0.0 110.287 -175.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.63 140.16 38.45 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.527 0.68 . . . . 0.0 112.056 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 67.45 89.58 0.1 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 125.664 1.586 . . . . 0.0 111.839 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 81.8 mtp -119.86 142.37 48.72 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 102' ' ' VAL . 59.9 m -128.98 176.39 7.91 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -56.9 -20.42 23.16 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.0 m -81.5 -50.26 9.61 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.695 -0.628 . . . . 0.0 111.31 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -95.57 6.65 48.42 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.894 0.378 . . . . 0.0 111.529 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 11.4 p -59.31 -37.35 68.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 123.823 0.849 . . . . 0.0 112.222 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -108.78 16.82 22.48 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.782 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -86.51 -20.98 27.24 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.064 0.935 . . . . 0.0 109.06 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -113.41 138.7 22.59 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.106 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.46 138.05 68.47 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.698 2.265 . . . . 0.0 112.538 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.23 152.67 45.16 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.4 2.066 . . . . 0.0 111.875 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -61.71 -45.58 93.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -167.98 168.96 11.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -128.59 123.19 32.72 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.41 169.05 10.36 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.365 0.603 . . . . 0.0 111.777 -174.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.6 mp0 -120.31 127.46 52.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.42 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.48 110.89 7.19 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.9 t -101.0 174.46 6.0 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.65 -34.8 74.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.758 0.823 . . . . 0.0 110.641 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.21 -32.55 68.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.997 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.562 HD22 ' HA ' ' A' ' 76' ' ' ALA . 1.3 t-20 -68.81 -34.27 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.2 2.68 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.493 1.517 . . . . 0.0 113.26 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 117' ' ' ASN . 39.5 ttmt -113.1 -14.11 12.97 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.472 1.109 . . . . 0.0 108.944 -176.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.5 1.89 43.77 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.999 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -75.55 126.32 87.6 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.75 121.53 8.77 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.408 2.739 . . . . 0.0 114.067 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 57.7 t -99.04 141.37 16.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.62 144.01 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -131.9 -174.75 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.046 0.938 . . . . 0.0 111.745 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -82.39 115.74 21.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -138.63 15.03 2.73 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.434 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.22 -38.51 81.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.181 0.515 . . . . 0.0 110.429 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -95.0 2.36 55.33 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 92' ' ' SER . 76.6 m-85 -117.78 66.32 0.75 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.653 0.74 . . . . 0.0 111.737 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.83 1.91 53.43 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 0.0 109.483 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -148.2 116.07 6.39 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.78 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.8 t -116.88 137.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.444 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -116.98 -55.84 2.31 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.288 1.035 . . . . 0.0 108.802 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.0 p -118.57 139.21 51.83 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.8 tp -135.35 111.95 9.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.874 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 29.3 m -102.64 121.62 42.77 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.81 116.73 49.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 61.1 t80 -122.83 119.62 31.11 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.455 ' O ' HD13 ' A' ' 140' ' ' ILE . 2.3 pp -108.9 131.41 59.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.469 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 12.9 pt-20 -119.86 -14.92 8.92 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.803 -0.759 . . . . 0.0 113.01 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.69 145.8 48.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.472 HD22 ' HB2' ' A' ' 58' ' ' GLU . 87.2 m-20 -101.79 169.14 8.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -62.94 -56.08 20.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.876 0.735 . . . . 0.0 109.167 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.9 t -122.05 9.52 9.94 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.315 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 143' ' ' ASN . . . 62.29 67.59 2.03 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.0 m -100.74 9.2 42.71 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 68.22 -55.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.49 1.116 . . . . 0.0 111.478 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.46 108.05 23.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 62.9 m -102.04 111.43 23.7 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.245 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 64.1 pttt -96.49 134.09 40.11 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.913 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.83 136.47 39.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.117 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.473 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 79.3 mt-30 -87.42 -51.87 5.69 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.57 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.01 149.25 14.1 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.546 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.3 112.86 35.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.64 137.08 29.73 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.05 159.55 18.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 56.1 m-85 -125.72 132.84 52.28 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -153.52 -149.96 5.32 Favored Glycine 0 C--N 1.299 -1.5 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 46.3 m -157.87 161.33 38.3 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.406 HG22 HG21 ' A' ' 70' ' ' ILE . 66.9 p . . . . . 0 C--N 1.279 -2.488 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.384 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.2 p -159.21 163.68 35.72 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.05 -177.9 6.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.494 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -86.8 -72.69 0.5 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.016 0.436 . . . . 0.0 111.439 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p -87.12 90.25 8.29 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.151 0.501 . . . . 0.0 111.669 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.521 ' HB3' HE21 ' A' ' 42' ' ' GLN . . . -131.76 92.36 3.13 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.063 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.2 p -165.31 135.7 3.74 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.049 0.452 . . . . 0.0 111.635 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.522 ' H ' HD13 ' A' ' 9' ' ' ILE . 5.4 tp60 -152.36 35.97 0.52 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 13' ' ' GLN . 2.2 mp -72.87 124.75 91.09 Favored Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.388 -174.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -72.92 -69.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.271 1.981 . . . . 0.0 111.808 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -162.08 -68.73 0.05 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.94 -10.99 82.19 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.241 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.53 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.72 134.21 50.72 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -174.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 p -105.9 153.69 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.818 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.97 120.62 12.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.45 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.5 mt -93.96 10.19 34.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' HG ' ' NH2' ' A' ' 45' ' ' ARG . 3.4 tm? -64.97 -36.66 85.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.493 0.663 . . . . 0.0 110.922 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -85.52 1.77 47.57 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.237 1.017 . . . . 0.0 110.498 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 m-85 -101.15 7.47 43.16 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.6 mt -89.97 133.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.332 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.58 113.8 23.61 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -85.04 -0.54 54.77 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.855 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.9 m -87.3 -36.79 17.67 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.7 -13.2 32.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.207 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.93 132.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 117.166 0.483 . . . . 0.0 110.626 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 32.6 tt0 -145.05 159.57 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.066 0.46 . . . . 0.0 110.054 -177.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 53.2 t -135.78 135.61 40.05 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -60.27 -57.86 10.97 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.323 1.015 . . . . 0.0 108.543 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.7 -64.19 0.91 Allowed 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 70.27 -52.31 0.65 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.988 1.315 . . . . 0.0 114.274 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 48.0 m -155.86 87.63 1.08 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -175.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.0 p -67.17 -29.34 69.01 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.976 162.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.2 m -154.49 -57.49 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.154 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.502 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.5 m-70 -88.0 162.38 16.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.421 ' HA ' ' HG ' ' A' ' 31' ' ' SER . 42.0 m -112.1 174.79 5.71 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -171.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.44 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -67.82 -58.14 8.61 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.02 -17.92 62.63 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.973 1.782 . . . . 0.0 112.455 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.42 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.0 m-20 -56.82 -46.58 81.55 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.736 1.214 . . . . 0.0 112.238 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 45' ' ' ARG . . . -104.32 2.66 31.66 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.42 0.628 . . . . 0.0 111.458 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -105.31 -44.46 4.73 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -79.94 123.69 28.01 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -173.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.521 HE21 ' HB3' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -55.36 117.71 3.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.935 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.54 -45.76 1.1 Allowed Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -95.58 -51.49 4.51 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' NH2' ' HG ' ' A' ' 17' ' ' LEU . 89.6 mtt-85 22.7 -83.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 176.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 153' ' ' GLN . 41.9 mt-10 -61.91 134.71 57.01 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -166.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.86 110.26 1.13 Allowed 'General case' 0 C--O 1.249 1.067 0 CA-C-N 113.121 -1.854 . . . . 0.0 110.328 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.71 -73.15 0.15 Allowed 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.56 -30.27 4.13 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 50' ' ' LEU . 2.3 pp -132.21 148.19 52.45 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.014 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 29.8 p-10 -162.56 167.81 22.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 36' ' ' LEU . 40.9 tp -91.41 116.57 28.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 168.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 33.8 tt0 -136.69 112.57 9.57 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.599 0.714 . . . . 0.0 109.881 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB2' HD13 ' A' ' 60' ' ' LEU . 31.8 t -94.79 101.88 13.72 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.816 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.3 -30.44 11.07 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.033 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.36 72.4 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.047 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.99 160.75 22.89 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.86 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.46 ' O ' HD12 ' A' ' 140' ' ' ILE . 43.7 tt0 -92.6 -31.7 15.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -77.32 118.35 19.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.071 -174.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 54' ' ' SER . 23.7 tp -116.31 116.28 27.46 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 6.8 tt -118.95 128.83 54.78 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.59 144.94 35.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 122.951 0.501 . . . . 0.0 109.718 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.416 ' HE1' ' O ' ' A' ' 94' ' ' LYS . 83.9 t80 -117.26 126.86 53.42 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.959 0.504 . . . . 0.0 110.362 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.97 121.58 28.75 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.911 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.79 127.13 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.735 2.29 . . . . 0.0 109.55 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -93.0 141.31 28.54 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -51.89 -50.17 61.56 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.754 2.022 . . . . 0.0 109.623 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -130.58 159.6 36.69 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.389 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 7.3 p -83.26 108.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.45 172.98 12.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.516 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -95.24 132.33 40.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.6 tp -78.04 143.99 37.0 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -129.93 -54.2 1.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.144 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.1 p -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -117.72 158.14 25.25 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.53 105.44 2.83 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.835 0.35 . . . . 0.0 111.851 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 155' ' ' ILE . 55.5 mt -120.39 130.21 74.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 96.4 mttt -104.97 143.24 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.23 32.5 Favored Glycine 0 C--N 1.257 -3.834 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.7 139.42 48.2 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 121.492 1.461 . . . . 0.0 108.936 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 118' ' ' LEU . 11.9 pt-20 -58.68 -25.63 63.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.969 0.414 . . . . 0.0 112.069 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.53 -57.08 4.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.898 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 4.4 mm-40 -81.46 -59.62 2.56 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.905 -170.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.19 119.41 0.0 OUTLIER Glycine 0 N--CA 1.506 3.303 0 C-N-CA 127.326 2.394 . . . . 0.0 118.158 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.649 ' HA ' ' OD1' ' A' ' 143' ' ' ASN . 56.8 Cg_endo -69.29 112.18 2.92 Favored 'Trans proline' 0 C--N 1.356 0.958 0 CA-C-N 119.932 1.866 . . . . 0.0 110.06 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.54 ' H ' ' HA ' ' A' ' 143' ' ' ASN . 30.5 ttmt -90.39 -75.37 0.46 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.071 -171.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.71 102.25 3.29 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.235 -174.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' THR . 34.2 m -104.68 117.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.845 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.426 ' HG3' ' OG1' ' A' ' 110' ' ' THR . 25.7 ttmm -107.11 132.83 52.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -112.69 139.02 48.64 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.54 155.55 19.97 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -77.97 -171.04 2.14 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.125 0.891 . . . . 0.0 110.926 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 135' ' ' SER . 8.9 p30 -57.22 104.4 0.16 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 111.512 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 55.3 tptt -163.51 164.8 24.21 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 96' ' ' HIS . 41.3 tt0 -75.95 174.01 10.5 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.449 ' H ' ' HG2' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -48.76 137.09 12.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.421 ' HE1' ' CD1' ' A' ' 105' ' ' PHE . 18.5 mmt -93.8 173.53 7.63 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.226 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.503 ' O ' HG11 ' A' ' 102' ' ' VAL . 75.6 m -149.36 155.55 40.66 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -55.99 -24.65 40.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.4 t -85.09 -6.41 59.31 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -116.72 -15.99 10.7 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 98' ' ' CYS . 29.0 m -67.64 -3.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -97.18 -19.4 18.66 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.398 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -89.33 -37.32 14.98 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.746 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.421 ' CD1' ' HE1' ' A' ' 97' ' ' MET . 93.5 m-85 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.302 -1.47 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.138 -175.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 13.3 Cg_exo -70.13 128.72 16.07 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.741 2.294 . . . . 0.0 111.216 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.31 165.23 29.73 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.548 2.165 . . . . 0.0 111.521 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.44 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 22.4 m -76.48 -47.48 22.74 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.441 ' C ' ' HG1' ' A' ' 110' ' ' THR . 15.8 m-20 -162.72 169.09 20.57 Favored 'General case' 0 CA--C 1.471 -2.09 0 C-N-CA 123.513 0.725 . . . . 0.0 109.337 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.441 ' HG1' ' C ' ' A' ' 109' ' ' ASP . 40.9 m -146.2 114.43 6.64 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.29 172.87 8.32 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.516 ' HB2' ' HG2' ' A' ' 86' ' ' LYS . 11.7 pt-20 -125.35 139.67 53.48 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 86' ' ' LYS . 22.4 tp -59.79 113.2 2.15 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.703 0.801 . . . . 0.0 108.903 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.1 p -85.25 166.4 16.55 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 4.1 mp0 -57.74 -39.21 76.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.46 -38.62 77.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.72 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.498 HD21 HG21 ' A' ' 123' ' ' VAL . 8.8 t-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 81' ' ' GLU . 7.5 tt -62.22 -23.33 66.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.115 1.366 . . . . 0.0 110.671 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.481 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 58.2 mtpt -102.52 1.9 35.61 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.47 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.54 68.04 0.87 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.812 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -137.39 117.58 10.48 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.489 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 15.0 Cg_endo -58.17 101.64 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.379 2.053 . . . . 0.0 111.886 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.498 HG21 HD21 ' A' ' 117' ' ' ASN . 53.3 t -85.43 126.71 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 m -83.35 144.22 10.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.526 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.71 -173.44 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.409 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.99 141.4 34.46 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -96.19 27.45 3.69 Favored 'General case' 0 C--N 1.281 -2.374 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.655 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.32 -49.89 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 108' ' ' SER . 27.5 tptp -95.4 -6.13 41.64 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.79 15.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.22 121.9 14.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.325 20.9 p-10 42.97 112.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 127.221 2.208 . . . . 0.0 114.765 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 44.4 t -121.53 104.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.735 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -99.49 -28.45 13.24 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 59.9 m -143.2 151.17 40.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 137' ' ' THR . 5.6 tt -146.33 138.42 25.01 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.468 ' N ' HD22 ' A' ' 136' ' ' LEU . 60.6 m -118.04 133.07 56.25 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 64.1 mt -108.18 122.86 63.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.33 116.85 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 58' ' ' GLU 0.267 2.0 pp -90.37 138.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 117.749 -1.58 . . . . 0.0 111.079 176.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -94.47 -48.46 6.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.936 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.85 159.78 43.85 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.071 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.649 ' OD1' ' HA ' ' A' ' 85' ' ' PRO . 94.3 m-20 -109.11 167.13 10.33 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.598 HE21 ' HA ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -47.6 -53.14 15.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 111.558 -177.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.3 t -112.93 4.15 16.65 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.541 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.95 62.51 6.28 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -83.88 8.1 16.03 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 65.68 7.09 4.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 112.949 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.68 155.73 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 93.2 m -121.58 111.39 17.17 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.478 0.656 . . . . 0.0 110.736 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.41 149.04 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 20.6 pt20 -118.1 -5.08 10.96 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.487 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -172.79 118.66 0.34 Allowed 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.398 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 77' ' ' ILE . 68.4 mt -114.73 124.85 71.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.11 152.07 41.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.32 147.47 51.86 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.489 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 81.9 m-85 -124.38 133.71 53.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.59 -173.23 13.06 Favored Glycine 0 CA--C 1.489 -1.531 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.8 m -134.23 135.32 42.87 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.253 0.549 . . . . 0.0 110.862 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.421 -1.905 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.526 179.114 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.445 -0.715 0 CA-C-O 121.005 0.431 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 p -91.43 94.77 9.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.07 116.67 7.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.041 0.448 . . . . 0.0 112.045 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.44 144.37 49.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 39.8 t -105.46 137.05 43.91 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.09 119.42 14.26 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.9 m -40.17 103.65 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 124.966 1.306 . . . . 0.0 114.507 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -94.74 21.29 7.6 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.423 HG23 ' H ' ' A' ' 11' ' ' LYS . 39.5 mm -56.11 113.66 6.2 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.456 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -89.79 11.91 2.71 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.58 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.423 ' H ' HG23 ' A' ' 9' ' ' ILE . 39.7 ttmt 65.96 97.02 0.05 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.882 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.61 -63.27 0.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 24.1 mp0 -112.87 176.07 5.17 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.1 m -106.23 169.63 2.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -84.09 95.96 8.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.861 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 157' ' ' LEU . 5.7 mp -74.79 -2.41 26.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.1 tt -74.06 -36.91 64.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 16.1 t70 -66.25 -21.14 66.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.998 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -97.21 12.2 33.71 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.022 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 16' ' ' LEU . 74.3 mt -84.13 131.63 33.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.47 124.54 35.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.693 0.759 . . . . 0.0 110.887 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -103.74 19.23 20.28 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.854 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 m -93.12 -30.89 15.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.94 3.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.839 -1.172 . . . . 0.0 114.133 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.0 135.89 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.63 148.91 36.53 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.195 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' HB3' ' CG ' ' A' ' 30' ' ' GLN . 47.7 t -135.87 140.66 44.29 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 97' ' ' MET . 91.1 mt -79.35 19.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.431 0.634 . . . . 0.0 111.808 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 27' ' ' CYS . 52.1 t-20 -154.9 -60.47 0.11 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.543 ' CG ' ' HB3' ' A' ' 27' ' ' CYS . 47.9 mt-30 67.39 14.5 9.67 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 124.116 0.966 . . . . 0.0 109.86 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.658 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 3.2 m 74.75 135.03 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.219 1.808 . . . . 0.0 109.447 -174.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.425 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 33.1 t -66.83 -46.93 73.56 Favored 'General case' 0 CA--C 1.559 1.313 0 O-C-N 121.415 -0.803 . . . . 0.0 111.577 175.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.5 t -89.82 -47.1 8.12 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.108 0.956 . . . . 0.0 111.151 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.658 ' O ' ' HB2' ' A' ' 31' ' ' SER . 54.0 m80 -83.05 166.91 18.36 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 125.054 1.342 . . . . 0.0 111.146 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 m -110.49 169.5 8.71 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.914 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 4.1 tt -65.12 -57.61 14.96 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.022 0.529 . . . . 0.0 111.68 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 5.7 Cg_exo -78.64 -1.83 11.94 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 121.848 1.699 . . . . 0.0 111.296 -176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.443 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.0 t-20 -49.12 -48.45 44.58 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 125.515 1.526 . . . . 0.0 109.648 -176.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . . . -142.24 78.68 1.63 Allowed 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.764 0.793 . . . . 0.0 110.036 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.0 tp -168.26 -38.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.776 -1.557 . . . . 0.0 106.846 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 10.7 tmtt? -90.66 133.45 35.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 14.9 mm100 -53.28 142.55 20.84 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.48 -37.57 3.44 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.218 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.479 ' O ' HD12 ' A' ' 50' ' ' LEU . 68.6 m-85 -89.72 -43.2 10.87 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -43.49 117.32 1.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.948 1.699 . . . . 0.0 113.206 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -177.53 137.42 0.21 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.78 91.86 8.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.881 0.372 . . . . 0.0 111.924 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -151.6 -71.67 0.16 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.018 0.927 . . . . 0.0 109.577 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -56.8 0.5 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.451 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 44' ' ' TYR . 2.3 pp -89.11 142.21 27.84 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.106 0.479 . . . . 0.0 111.884 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.586 ' ND2' ' HB2' ' A' ' 53' ' ' GLU . 3.6 p-10 -163.49 165.65 23.49 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.482 ' CD2' HD22 ' A' ' 60' ' ' LEU . 3.3 tt -88.07 126.83 35.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 171.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.586 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 44.8 tt0 -128.99 143.17 50.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 90.5 p -78.01 82.26 4.37 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' OD2' ' HB3' ' A' ' 32' ' ' SER . 38.9 t70 -117.13 96.52 5.48 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.352 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 148.7 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 128.075 2.55 . . . . 0.0 104.878 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 54' ' ' SER . 10.7 t70 -157.75 155.35 29.71 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.676 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.18 -21.13 39.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.003 0.43 . . . . 0.0 110.652 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.81 109.7 17.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.482 HD22 ' CD2' ' A' ' 52' ' ' LEU . 27.8 tp -116.81 117.51 29.96 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.427 0.632 . . . . 0.0 110.487 -174.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 96' ' ' HIS . 1.8 tm? -107.21 124.38 49.65 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.496 HG13 ' SG ' ' A' ' 27' ' ' CYS . 2.0 mp -127.01 134.58 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -103.54 121.57 43.16 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.575 0.75 . . . . 0.0 109.095 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.42 120.17 29.05 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.151 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.02 154.54 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.749 2.299 . . . . 0.0 109.574 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -112.19 152.34 28.49 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -62.73 -50.63 70.33 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.586 1.554 . . . . 0.0 108.084 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -127.51 143.13 51.22 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.671 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.86 112.18 13.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -134.32 173.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.54 143.24 30.31 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.239 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.416 ' HB2' HG22 ' A' ' 133' ' ' VAL . 57.8 tp -92.32 105.56 17.74 Favored 'General case' 0 C--O 1.19 -2.057 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -96.37 -54.62 3.2 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.979 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 p -145.44 161.87 38.67 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.844 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.443 ' CE1' HD11 ' A' ' 125' ' ' LEU . 2.7 p90 -131.97 157.66 43.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -143.0 114.44 7.95 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.209 0.604 . . . . 0.0 109.773 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.5 mt -113.21 129.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HE2' ' C ' ' A' ' 119' ' ' LYS . 68.2 mttt -117.2 157.98 25.07 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.481 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.03 -152.79 20.89 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -72.11 152.38 56.51 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.201 1.934 . . . . 0.0 109.533 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.55 -38.93 81.22 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 144' ' ' GLN . 42.5 mt-10 -94.69 -34.7 12.46 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -93.78 11.58 28.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.491 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.8 150.42 25.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.157 -0.802 . . . . 0.0 111.636 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 23.6 Cg_exo -63.05 113.92 2.23 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.436 2.757 . . . . 0.0 113.375 -175.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.31 -49.5 3.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.5 m -83.11 100.52 10.57 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.818 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.9 t -115.57 122.98 70.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.959 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -115.73 133.79 55.67 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -111.96 152.1 28.47 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 25.4 t80 -140.68 117.06 10.72 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 172.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 m -91.61 138.2 31.75 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 47.95 81.91 0.04 OUTLIER 'General case' 0 C--O 1.244 0.775 0 C-N-CA 126.171 1.788 . . . . 0.0 113.965 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -171.51 170.72 5.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -81.43 175.7 10.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.523 ' O ' HD12 ' A' ' 61' ' ' LEU . 33.1 p80 -44.67 -40.65 6.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.452 ' O ' HD11 ' A' ' 28' ' ' LEU . 87.1 mtp 61.6 -165.75 0.22 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.493 ' O ' HG23 ' A' ' 102' ' ' VAL . 30.8 p -150.06 163.81 37.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.427 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 42.0 p90 -68.98 -17.89 63.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -67.47 -20.2 65.44 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -103.76 -31.66 9.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.603 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 98' ' ' CYS . 95.9 t -59.57 -29.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.21 -7.22 58.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.28 -38.45 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.81 0.338 . . . . 0.0 111.557 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -95.75 137.57 21.87 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.138 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.3 131.08 27.13 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.452 2.101 . . . . 0.0 111.508 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.37 161.17 38.07 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.414 2.076 . . . . 0.0 111.487 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.495 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . 28.5 m -61.78 -46.02 91.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 110.03 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.11 143.43 15.42 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -104.85 115.03 29.6 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.52 152.59 24.53 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -125.62 118.35 25.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.229 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 20.8 tp -61.86 105.17 0.53 Allowed 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -92.64 170.57 9.63 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.49 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 42.9 tt0 -54.98 -46.09 75.07 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.767 0.427 . . . . 0.0 111.276 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -64.85 -34.66 78.91 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.4 t-20 -61.65 -44.59 96.69 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.426 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 tm? -65.36 -32.77 74.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.314 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.503 ' C ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -84.77 9.96 12.69 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.35 31.3 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 115.149 0.819 . . . . 0.0 115.149 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -93.4 132.74 29.65 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 117.648 0.724 . . . . 0.0 111.338 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 26.5 Cg_endo -65.37 117.33 4.49 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 123.208 2.605 . . . . 0.0 112.471 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.87 130.74 44.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.78 133.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 122.956 0.502 . . . . 0.0 111.236 -174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -100.0 175.1 5.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 8.5 mmpt? -86.15 49.05 1.71 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -74.69 25.62 0.09 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -170.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.8 m -57.02 -27.49 27.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -95.24 -41.18 9.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.491 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 28.0 m-85 -72.13 84.42 1.02 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.054 -173.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.55 -11.36 14.07 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.245 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -124.37 113.85 18.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.494 0.664 . . . . 0.0 109.846 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 72' ' ' LEU . 47.1 t -123.31 105.74 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.17 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -104.9 -32.1 8.95 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.9 m -135.93 135.25 39.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.431 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.2 tp -135.65 126.36 27.26 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.877 0.37 . . . . 0.0 110.085 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.6 m -94.2 117.01 29.49 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.27 115.84 50.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 141' ' ' GLU . 48.5 t80 -114.39 114.88 26.47 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.415 HD11 HD23 ' A' ' 60' ' ' LEU . 28.2 pt -104.12 114.85 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.881 0.848 . . . . 0.0 109.277 174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.455 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 43.6 tt0 -90.78 -28.38 18.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.66 -172.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -162.25 154.83 19.62 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.271 -177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -89.63 175.95 7.06 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.006 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 82' ' ' GLU . 8.5 tp-100 -51.12 -43.89 61.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.432 1.093 . . . . 0.0 112.909 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m -96.59 -37.68 10.27 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.515 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.92 42.62 3.03 Favored Glycine 0 C--N 1.302 -1.345 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 149' ' ' VAL . 14.8 m -85.47 13.95 6.14 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.326 1.05 . . . . 0.0 112.655 -174.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 74.93 -34.87 0.27 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.823 1.649 . . . . 0.0 111.625 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 147' ' ' SER . 6.1 p -100.69 98.69 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-O 122.315 1.055 . . . . 0.0 110.471 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.7 m -92.25 113.71 26.06 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.526 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 86.7 tttt -113.96 135.23 54.22 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.018 -174.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.69 137.2 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.309 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -96.7 -28.64 14.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.19 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HZ2' ' HG3' ' A' ' 78' ' ' LYS . 1.1 pptp? -171.23 150.9 3.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.02 111.95 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.411 ' C ' HD11 ' A' ' 157' ' ' LEU . . . -107.69 147.12 31.16 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 4.7 mp -123.34 143.91 49.79 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 67.9 m-85 -125.68 137.94 53.87 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -166.39 -140.62 2.93 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.6 t -162.83 149.9 13.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.423 -1.813 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.2 p . . . . . 0 C--O 1.243 0.717 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 m -105.77 114.1 28.05 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.99 110.14 22.21 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -96.88 173.79 7.11 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.194 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.8 t -155.07 123.97 6.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 120.863 0.363 . . . . 0.0 111.743 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.76 115.47 25.23 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 172.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.6 t -148.78 -179.85 7.3 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -81.31 97.26 7.6 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-O 121.675 0.75 . . . . 0.0 109.158 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.6 mm -93.64 127.64 45.14 Favored Pre-proline 0 N--CA 1.396 -3.169 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -85.5 136.43 5.48 Favored 'Trans proline' 0 N--CA 1.427 -2.42 0 C-N-CA 121.715 1.61 . . . . 0.0 111.191 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -50.64 113.49 0.91 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 112.155 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.13 8.36 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.51 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.19 147.36 34.76 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 117.25 0.525 . . . . 0.0 111.373 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.93 149.14 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.97 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.83 134.42 39.07 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.576 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.2 mm? -62.87 -14.04 41.29 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.373 1.069 . . . . 0.0 113.813 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 41' ' ' LYS . 2.1 tm? -51.32 -36.4 42.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.499 0.666 . . . . 0.0 109.93 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.27 -26.25 60.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.214 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -107.67 34.35 3.58 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.8 mm -116.4 145.1 22.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.056 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -96.23 131.59 42.55 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -104.38 8.85 35.89 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -97.3 -34.96 10.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.22 -4.86 73.71 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.458 -0.792 . . . . 0.0 114.05 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -53.59 143.43 5.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -142.55 139.62 31.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.136 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 30' ' ' GLN . 5.5 p -135.61 128.85 31.93 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.891 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.499 HD23 HD13 ' A' ' 61' ' ' LEU . 2.7 mm? -91.92 123.71 35.5 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 47.3 t-20 76.26 -59.78 0.5 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.759 1.624 . . . . 0.0 108.263 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.499 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 34.2 tt0 73.14 -74.77 0.08 Allowed 'General case' 0 C--N 1.37 1.474 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p 174.16 115.95 0.02 OUTLIER 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.4 t -48.91 -37.23 19.18 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -100.63 -42.63 6.46 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.725 -0.609 . . . . 0.0 111.233 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -85.13 166.57 16.51 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -106.96 152.94 23.28 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 52' ' ' LEU . 3.1 tm? -54.47 -57.89 16.59 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.82 -17.06 58.36 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.183 1.922 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.443 HD21 ' HB2' ' A' ' 50' ' ' LEU . 3.1 m-20 -58.75 -27.55 65.05 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 113.086 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' HB1' ' HA ' ' A' ' 51' ' ' ASN . . . -133.04 15.71 4.21 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.206 0.526 . . . . 0.0 110.749 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -112.29 -43.16 3.57 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.21 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HA ' HD21 ' A' ' 17' ' ' LEU . 16.0 ptpt -98.28 137.58 36.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.353 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.19 121.62 14.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.97 -64.64 0.44 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.497 ' O ' HD12 ' A' ' 50' ' ' LEU . 59.0 m-85 -77.04 -39.79 48.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 26.4 ttp180 -37.35 103.58 0.03 OUTLIER 'General case' 0 C--O 1.243 0.739 0 C-N-CA 126.106 1.762 . . . . 0.0 113.324 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -164.65 89.27 0.51 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -57.96 104.32 0.19 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.889 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 178.1 -67.55 0.01 OUTLIER 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.308 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.17 -59.06 0.73 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 50' ' ' LEU . 3.5 pp -104.25 120.9 42.18 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.788 0.804 . . . . 0.0 110.006 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.413 ' HA ' ' HB1' ' A' ' 39' ' ' ALA . 3.0 p-10 -161.48 165.63 28.37 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 36' ' ' LEU . 26.6 tp -91.65 112.42 24.33 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -131.71 113.46 13.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.593 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 35.6 p -74.4 82.22 1.92 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.059 0.933 . . . . 0.0 110.237 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.49 -30.55 29.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.893 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 29' ' ' ASN . . . -69.23 -35.68 76.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 54' ' ' SER . 19.1 t70 -171.47 156.42 4.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.2 tt0 -80.49 -11.69 59.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.911 0.884 . . . . 0.0 112.545 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.89 112.94 17.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -127.14 136.16 51.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.403 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.499 HD13 HD23 ' A' ' 28' ' ' LEU . 1.6 tm? -131.39 126.22 34.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 mp -128.12 134.64 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.65 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 49.4 t80 -103.7 128.1 51.08 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 123.708 0.803 . . . . 0.0 110.187 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.94 124.03 27.63 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.426 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -92.37 159.96 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 123.29 2.66 . . . . 0.0 110.365 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -95.23 154.88 16.97 Favored 'General case' 0 CA--C 1.459 -2.553 0 CA-C-O 122.568 1.175 . . . . 0.0 113.919 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -88.05 -42.89 12.1 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 112.877 -1.965 . . . . 0.0 106.968 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -150.65 139.07 20.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -73.17 124.68 30.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-O 121.639 0.733 . . . . 0.0 111.643 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.402 ' CD1' HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.15 174.59 11.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -92.51 138.68 31.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -79.35 144.16 34.46 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -136.07 -45.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.928 -0.483 . . . . 0.0 111.807 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.6 m -151.38 175.92 11.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.391 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -135.62 152.46 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.459 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -158.87 107.65 1.91 Allowed 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 77' ' ' ILE . 2.3 mp -107.38 132.58 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HE2' ' CA ' ' A' ' 120' ' ' GLY . 90.9 mttt -117.69 167.5 11.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.337 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.37 -168.25 34.14 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.76 149.43 73.06 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 122.262 1.974 . . . . 0.0 111.214 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.53 -26.37 66.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.01 -55.92 4.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.918 0.866 . . . . 0.0 111.04 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 151' ' ' LYS . 33.6 mt-10 -100.74 13.04 36.22 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.416 -170.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.31 148.14 26.4 Favored Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -58.1 176.21 0.39 Allowed 'Trans proline' 0 C--O 1.218 -0.52 0 C-N-CA 123.191 2.594 . . . . 0.0 113.971 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 84.0 tttt -154.63 -68.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.8 m -78.26 108.39 11.55 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.47 146.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.072 0.463 . . . . 0.0 111.871 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -130.4 148.84 52.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -126.94 152.97 46.43 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -137.59 144.41 41.98 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.495 ' HB3' ' CE1' ' A' ' 130' ' ' PHE . 48.2 t -137.27 155.19 49.77 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.362 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 m120 76.67 -43.32 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.662 1.585 . . . . 0.0 113.469 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -87.21 107.78 18.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 178.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.65 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 34.6 tt0 -65.03 134.44 53.85 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 59.94 87.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.428 1.091 . . . . 0.0 112.447 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.602 ' SD ' ' HD3' ' A' ' 94' ' ' LYS . 95.6 mmm -123.75 98.63 5.9 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.284 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.513 ' O ' HG23 ' A' ' 102' ' ' VAL . 64.3 m -88.78 167.87 12.94 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.45 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 89.6 t80 -49.11 -33.75 12.47 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.64 0.776 . . . . 0.0 112.585 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -56.64 -26.31 55.67 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.329 0.652 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -114.66 -18.14 11.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 98' ' ' CYS . 60.7 t -63.45 -18.89 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.126 0.971 . . . . 0.0 113.352 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -87.57 -22.91 24.52 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.729 -0.607 . . . . 0.0 112.062 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -94.38 -36.09 12.08 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -95.99 150.4 37.24 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.929 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.89 117.19 5.02 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.677 2.251 . . . . 0.0 113.06 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.37 172.09 17.01 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.088 1.859 . . . . 0.0 110.272 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.475 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 19.7 m -67.43 -46.99 71.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -172.54 -176.08 1.46 Allowed 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -139.91 130.99 26.34 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.02 173.07 11.59 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.382 0.611 . . . . 0.0 112.138 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 35.1 tt0 -123.97 128.97 50.17 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.84 105.52 2.81 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 t -86.85 163.12 17.38 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.24 -37.99 73.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.01 -31.88 68.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 123.238 0.337 . . . . 0.0 111.289 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.2 t-20 -63.66 -47.02 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.534 ' O ' HD22 ' A' ' 118' ' ' LEU . 5.7 tt -67.05 -20.3 65.82 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.002 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' CE ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tpmt? -86.02 -14.29 44.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.065 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.492 ' CA ' ' HE2' ' A' ' 78' ' ' LYS . . . 111.71 11.71 16.32 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.934 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.58 125.53 57.36 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.491 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 55.6 Cg_endo -70.38 109.65 2.49 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.953 2.435 . . . . 0.0 111.15 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.5 t -85.81 122.37 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.91 110.1 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 122.106 0.955 . . . . 0.0 113.048 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -93.05 -165.68 1.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.605 178.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -93.24 115.03 27.65 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 120.639 0.257 . . . . 0.0 111.11 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -132.93 18.13 4.16 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.69 -29.52 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.452 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -83.92 -29.49 27.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.219 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' A' ' 92' ' ' SER . 70.8 m-85 -93.12 75.67 4.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.115 0.96 . . . . 0.0 112.537 -172.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -94.58 -2.32 51.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.158 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -151.53 115.75 5.02 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.021 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.94 102.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -81.15 -64.95 1.08 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.06 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 p -132.99 149.4 52.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.498 HD21 ' N ' ' A' ' 137' ' ' THR . 3.5 tt -129.19 139.89 51.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.498 ' N ' HD21 ' A' ' 136' ' ' LEU . 79.3 m -119.78 124.44 46.15 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.9 mp -104.55 123.92 58.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.489 ' CE2' ' HG2' ' A' ' 141' ' ' GLU . 33.8 t80 -116.43 110.84 19.17 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.404 0.621 . . . . 0.0 110.613 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.4 mt -99.92 125.74 53.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.489 ' HG2' ' CE2' ' A' ' 139' ' ' PHE . 36.2 mt-10 -100.5 -50.27 3.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.11 167.69 23.49 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -110.67 170.15 8.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 123.575 0.547 . . . . 0.0 111.454 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -47.38 -57.9 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.255 0.972 . . . . 0.0 110.064 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -87.02 -26.89 23.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.55 75.68 0.59 Allowed Glycine 0 C--O 1.221 -0.679 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.1 t -107.72 -2.22 20.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.581 0.229 . . . . 0.0 110.95 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.548 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 38.7 mt-10 74.73 0.44 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.266 1.026 . . . . 0.0 112.13 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 54' ' ' SER . 5.7 p -139.95 124.58 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 32.5 m -109.7 111.78 23.45 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.972 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 18.9 pttm -109.85 134.75 51.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.183 171.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.2 m -123.01 148.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.767 -172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.472 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.5 tp60 -85.81 -48.7 8.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.987 174.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.448 ' NZ ' ' HB3' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -167.53 136.16 2.56 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 176.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.72 112.27 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.448 ' HB3' ' NZ ' ' A' ' 154' ' ' LYS . . . -139.92 157.28 45.94 Favored 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.11 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 1.9 mm? -119.43 157.21 28.69 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 72.4 m-85 -116.18 128.02 55.28 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.37 15.29 Favored Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.392 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 55.7 p -135.1 117.98 16.23 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.218 0.533 . . . . 0.0 111.438 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.0 p . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.653 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 p . . . . . 0 N--CA 1.445 -0.704 0 CA-C-O 121.193 0.52 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 22' ' ' TRP . 48.3 t -69.29 -67.62 0.46 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.288 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.479 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . . . -158.45 33.3 0.23 Allowed 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.09 100.45 9.78 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 112.1 -2.318 . . . . 0.0 111.461 -169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.472 ' HB2' ' HG3' ' A' ' 42' ' ' GLN . 66.2 m -159.06 149.5 19.54 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.07 105.55 13.08 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.667 0.27 . . . . 0.0 110.907 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -112.77 146.61 38.49 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.754 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 66.52 73.98 0.35 Allowed 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.376 1.084 . . . . 0.0 110.4 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.488 HG21 ' H ' ' A' ' 11' ' ' LYS . 45.8 mm -110.25 115.95 53.8 Favored Pre-proline 0 C--N 1.285 -2.221 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.818 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.96 17.97 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.239 2.626 . . . . 0.0 111.507 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.9 mmpt? 64.69 12.49 7.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.119 1.367 . . . . 0.0 112.999 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.73 -83.43 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 29.7 mm-40 -103.77 -175.99 2.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 m -106.82 158.22 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 19.8 t0 -83.7 105.33 14.53 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.634 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 mp -60.23 -2.21 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 125.46 1.504 . . . . 0.0 114.233 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.48 HD22 ' H ' ' A' ' 42' ' ' GLN . 4.0 tt -56.01 -38.76 70.94 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.1 -17.59 64.59 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.065 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.79 23.35 12.02 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 16' ' ' LEU . 59.5 mt -102.79 142.62 16.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.38 -48.75 78.38 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.581 ' CH2' ' HB3' ' A' ' 40' ' ' LEU . 53.3 m95 70.95 -27.84 0.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 t -69.45 -35.61 75.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.18 -83.51 1.1 Allowed Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.912 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.337 27.6 m 43.22 103.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.74 136.87 51.84 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.322 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -135.76 137.42 41.63 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.127 0.489 . . . . 0.0 110.176 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.3 -30.89 68.01 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.637 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.634 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 14.0 m120 -84.65 -93.57 0.08 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.777 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.423 HE22 ' HB3' ' A' ' 36' ' ' LEU . 4.0 tp-100 51.7 30.3 6.63 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -106.97 -75.39 0.63 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -163.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 p -48.83 -44.68 39.62 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -176.48 -61.92 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.48 0.657 . . . . 0.0 109.44 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.803 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.0 m-70 -72.42 144.0 48.31 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.941 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -107.7 164.36 12.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -169.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.423 ' HB3' HE22 ' A' ' 30' ' ' GLN . 2.8 tm? -60.07 -60.29 11.08 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.242 1.417 . . . . 0.0 113.812 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.15 -22.02 54.32 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.212 1.941 . . . . 0.0 112.965 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.414 HD21 ' HB2' ' A' ' 50' ' ' LEU . 2.3 m-20 -59.85 -29.12 68.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.669 1.188 . . . . 0.0 111.422 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.782 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -114.93 7.89 15.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.24 0.543 . . . . 0.0 111.415 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.581 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . 11.2 mp -119.49 -53.62 2.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -79.77 142.29 35.51 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.076 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' H ' HD22 ' A' ' 17' ' ' LEU . 14.0 tm0? -56.78 132.9 53.57 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 124.707 1.203 . . . . 0.0 110.651 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.13 -42.65 1.9 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -88.99 -49.94 6.47 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.367 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.0 ptm180 -47.92 90.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 4.9 tp10 171.03 143.69 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 153' ' ' GLN . 33.6 t70 -74.6 131.16 40.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.69 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.99 -52.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.23 -56.41 0.01 OUTLIER Glycine 0 CA--C 1.474 -2.484 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.6 pp -80.94 135.61 35.91 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.588 174.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.803 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 34.8 p30 -161.83 169.55 21.11 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 tp -98.2 109.68 22.39 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 118.889 0.768 . . . . 0.0 108.989 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.04 131.01 44.01 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.069 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.5 p -97.04 112.41 24.19 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.178 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.38 -35.68 8.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.502 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.37 -48.2 82.35 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.742 0.782 . . . . 0.0 109.291 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.83 151.14 43.72 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -100.32 7.47 44.34 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.937 0.875 . . . . 0.0 109.221 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -105.63 128.6 53.73 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.634 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 3.5 tt -133.56 131.74 40.06 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.224 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tt -131.14 132.75 44.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.062 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mp -130.73 145.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -114.19 121.5 43.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.65 121.51 37.13 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -91.38 141.93 2.85 Favored 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.265 2.643 . . . . 0.0 111.621 173.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.68 164.37 26.35 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 122.871 1.32 . . . . 0.0 113.874 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -104.82 -45.99 4.43 Favored 'General case' 0 N--CA 1.395 -3.197 0 CA-C-N 112.572 -2.104 . . . . 0.0 107.022 171.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -143.79 146.57 33.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.457 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -75.37 117.47 19.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 122.178 0.99 . . . . 0.0 111.654 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.98 173.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 3.7 mppt? -97.97 136.37 38.34 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.458 -1.297 . . . . 0.0 111.058 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.491 ' CD1' HD12 ' A' ' 125' ' ' LEU . 2.1 tm? -89.89 114.02 25.73 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -110.01 -37.95 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.8 m -143.62 171.23 14.46 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.207 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -142.75 157.57 44.51 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.39 143.74 25.94 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.837 0.351 . . . . 0.0 110.364 175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.1 mt -145.71 137.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.553 ' HE2' ' O ' ' A' ' 119' ' ' LYS . 87.2 mttt -112.86 157.38 21.48 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.372 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 178.5 36.86 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -75.18 160.06 39.98 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.507 1.472 . . . . 0.0 110.032 176.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.51 -29.72 26.54 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.517 1.127 . . . . 0.0 112.065 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -93.15 -57.08 2.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 mp0 -68.44 -52.37 33.41 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.14 109.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.167 0 O-C-N 125.365 1.666 . . . . 0.0 116.56 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.85 108.06 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.208 1.939 . . . . 0.0 110.217 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 38.0 ttpt -99.42 -63.86 1.09 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -167.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.9 m -78.62 94.8 5.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.458 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 111' ' ' ALA . 16.7 m -100.96 137.65 27.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -128.5 141.6 51.33 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.924 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 82.3 m-85 -117.45 148.12 42.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.679 -175.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.446 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 47.1 m-85 -114.53 126.72 55.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.724 174.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.5 t -91.79 96.51 10.46 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.186 0.517 . . . . 0.0 110.382 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 64.99 9.64 5.6 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.591 1.156 . . . . 0.0 112.824 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -88.72 139.88 30.02 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.4 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 1.7 mp0 -55.45 169.12 0.32 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.538 1.535 . . . . 0.0 112.197 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -61.7 97.41 0.08 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.748 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.405 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . 83.8 mtp -98.78 106.75 19.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.465 ' O ' HG12 ' A' ' 102' ' ' VAL . 83.2 m -75.86 -168.98 0.98 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 102' ' ' VAL . 60.5 m-85 -46.65 -44.55 18.51 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -81.24 -31.73 33.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.39 0.615 . . . . 0.0 111.127 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -77.96 -19.67 54.12 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.977 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 98' ' ' CYS . 34.0 m -64.27 -5.72 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -91.41 -1.28 57.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.583 0.23 . . . . 0.0 110.9 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -101.55 -31.93 10.62 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -96.22 152.64 38.94 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.203 -171.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -89.09 120.14 1.04 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.031 1.821 . . . . 0.0 108.724 170.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.12 142.27 99.1 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.153 1.902 . . . . 0.0 112.46 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 18.7 m -59.67 -42.41 92.8 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.465 0.65 . . . . 0.0 109.783 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -158.23 168.95 25.63 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.5 t -152.1 115.31 4.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -133.38 161.68 33.88 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.344 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.1 mp0 -114.96 128.61 56.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.2 tt -66.16 134.47 52.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.52 0.676 . . . . 0.0 111.612 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 t -121.15 179.32 4.43 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.32 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 40.8 mt-10 -54.74 -45.92 74.2 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.808 0.843 . . . . 0.0 112.983 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -70.88 -35.24 72.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.238 0.542 . . . . 0.0 109.682 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.463 ' HB3' ' HG ' ' A' ' 113' ' ' LEU . 2.7 t-20 -65.18 -40.19 93.93 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.3 tp -61.02 -24.47 66.2 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 111.127 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 14.4 mmmm -79.29 -3.37 45.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.633 0.73 . . . . 0.0 109.27 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.05 17.02 52.94 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.156 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 98.8 mttt -87.9 141.15 31.33 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-N 116.714 0.257 . . . . 0.0 110.962 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 17.1 Cg_exo -67.31 119.37 6.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.02 2.48 . . . . 0.0 112.633 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.54 134.52 41.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.55 144.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.286 0.565 . . . . 0.0 112.293 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.491 HD12 ' CD1' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -131.86 -170.82 2.47 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.121 174.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -67.92 89.49 0.28 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.43 0.633 . . . . 0.0 112.692 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -69.18 -32.15 71.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.895 0.878 . . . . 0.0 110.107 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.13 -27.63 36.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.896 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 6.1 tmtt? -85.16 -45.26 12.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -78.27 90.26 4.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -106.49 -39.96 5.72 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -113.02 120.28 40.82 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.273 176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.8 102.05 12.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.786 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -102.82 -38.95 7.2 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.683 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.9 m -152.47 154.19 35.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.47 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.408 HD21 ' N ' ' A' ' 137' ' ' THR . 4.1 tt -144.91 130.39 18.83 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.9 m -106.13 131.41 53.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.14 122.28 65.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -122.94 121.82 37.08 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.718 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 140' ' ' ILE . 2.0 pp -115.58 129.13 72.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -106.84 -20.76 13.24 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.421 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.67 31.66 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.064 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 6.8 p30 -102.8 175.4 5.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.019 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.453 HE21 ' HD3' ' A' ' 86' ' ' LYS . 7.9 tp60 -45.13 -50.13 11.42 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.625 1.57 . . . . 0.0 111.68 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -107.36 -37.77 6.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.48 46.83 2.27 Favored Glycine 0 C--N 1.312 -0.789 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.3 t -84.63 12.57 6.89 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.359 0.664 . . . . 0.0 112.771 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 69.26 1.95 3.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.862 0.865 . . . . 0.0 112.61 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.84 134.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 83.5 m -118.47 111.44 18.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -94.4 134.88 36.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.27 120.93 62.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 20.6 pt20 -98.0 -13.44 21.1 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.361 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.782 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 23.1 pttt -168.07 150.21 5.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.149 168.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.4 mt -131.05 112.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.05 137.97 52.38 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 6.1 mp -103.08 140.85 36.77 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 97.5 m-85 -125.32 139.84 53.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.482 0.658 . . . . 0.0 111.279 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 71' ' ' LYS . . . -173.53 -154.86 10.99 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.6 p -161.43 154.52 21.03 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.905 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.42 -1.96 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.789 173.167 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 m -76.33 88.01 3.14 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -175.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 43' ' ' GLY . . . -150.23 79.11 1.35 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 171.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.454 ' O ' ' HA2' ' A' ' 43' ' ' GLY . 11.6 pt-20 -158.73 171.26 20.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.765 -169.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 p -93.36 127.97 39.19 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 121.101 0.477 . . . . 0.0 109.879 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.14 82.41 1.89 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.531 0.681 . . . . 0.0 109.43 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.1 p -89.99 158.65 17.27 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.991 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.459 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 23.0 tp60 -128.93 86.74 2.47 Favored 'General case' 0 CA--C 1.471 -2.071 0 C-N-CA 119.513 -0.875 . . . . 0.0 108.706 -178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 15' ' ' ASP . 2.3 mp -82.93 114.97 56.15 Favored Pre-proline 0 C--N 1.287 -2.125 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.451 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 8' ' ' GLN . 72.9 Cg_endo -89.6 143.23 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.826 1.684 . . . . 0.0 108.864 172.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -69.8 99.29 1.34 Allowed 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.167 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.87 -48.34 0.32 Allowed Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -119.36 178.83 4.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.79 142.6 39.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.448 ' HA ' ' CD1' ' A' ' 158' ' ' TYR . 10.1 t0 -72.73 116.87 13.74 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 20' ' ' ILE . 52.6 mt -79.61 5.54 12.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 42' ' ' GLN . 4.7 tt -55.18 -38.11 67.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.919 0.866 . . . . 0.0 108.759 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.76 -17.07 54.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.671 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.528 ' HA ' ' ND2' ' A' ' 67' ' ' ASN . 7.7 m-85 -90.52 -4.85 56.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.597 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 16' ' ' LEU . 92.4 mt -86.64 138.16 19.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.17 101.64 14.38 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 172.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.484 ' CH2' ' HA ' ' A' ' 41' ' ' LYS . 98.7 m95 -76.36 1.55 15.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -92.32 -28.31 17.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.81 4.67 56.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.903 -0.665 . . . . 0.0 114.274 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.6 m -61.22 136.31 24.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.182 0.515 . . . . 0.0 111.765 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -134.57 144.25 47.84 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.568 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 62.7 m -137.28 138.3 39.91 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.857 -176.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 28' ' ' LEU . 3.1 tm? -72.19 -49.03 38.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.134 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -103.87 -64.32 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.568 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 4.3 pt20 54.79 22.9 4.46 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.463 1.505 . . . . 0.0 111.854 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.604 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 40.7 t 73.82 129.64 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.285 1.834 . . . . 0.0 112.47 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.92 -4.87 34.74 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.218 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -121.36 -68.9 0.87 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.437 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.604 ' O ' ' HB3' ' A' ' 31' ' ' SER . 77.4 m-70 -99.95 112.37 24.65 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.421 -173.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 m -66.48 130.16 42.25 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.566 HD11 ' SG ' ' A' ' 27' ' ' CYS 0.258 5.5 tt -45.15 -39.59 9.28 Favored Pre-proline 0 CA--C 1.568 1.656 0 N-CA-C 118.618 2.821 . . . . 0.0 118.618 -177.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.568 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 76.5 Cg_exo -53.97 -1.35 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.823 2.348 . . . . 0.0 114.895 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.458 HD21 ' HB2' ' A' ' 50' ' ' LEU . 30.8 p30 -86.24 -48.1 8.84 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.13 -14.16 15.48 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD21 HD23 ' A' ' 36' ' ' LEU . 45.4 tp -102.23 -40.33 6.83 Favored 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 118.839 -1.144 . . . . 0.0 107.957 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.02 97.87 6.98 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 170.248 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.478 ' HB3' HD11 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -70.22 102.6 2.14 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.308 -172.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 4' ' ' GLU . . . -165.1 -56.11 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.557 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -89.15 -9.9 49.23 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.234 0.614 . . . . 0.0 110.124 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 45' ' ' ARG . 2.4 ppt_? -52.54 130.1 30.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.122 -172.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER 174.06 139.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 173.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.83 88.38 6.78 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.55 -69.34 0.17 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.78 -47.18 0.63 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.43 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HB2' HD21 ' A' ' 38' ' ' ASN . 1.0 OUTLIER -125.61 113.75 17.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.027 0.918 . . . . 0.0 112.566 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -149.04 160.39 43.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 151' ' ' LYS . 3.4 tm? -90.61 120.32 31.58 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.35 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.9 pt-20 -141.01 119.35 12.17 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.341 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 49.6 p -35.05 -65.79 0.21 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.08 1.752 . . . . 0.0 115.549 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 67.16 17.66 10.36 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.701 0.762 . . . . 0.0 112.15 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.01 -62.92 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.286 0.565 . . . . 0.0 109.523 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 54' ' ' SER . 22.7 m-20 -131.36 127.91 38.57 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.608 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -73.47 -30.1 62.95 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 124.078 0.861 . . . . 0.0 110.341 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -74.37 115.58 14.06 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 95.0 mt -119.04 126.78 52.49 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.028 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.445 ' C ' HD13 ' A' ' 62' ' ' ILE . 1.4 tm? -113.0 121.69 45.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.445 HD13 ' C ' ' A' ' 61' ' ' LEU . 2.7 mp -127.92 142.75 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 96' ' ' HIS . 50.5 t80 -110.45 121.81 46.2 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 123.816 0.846 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.4 mm -120.85 121.47 28.9 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.793 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.52 124.82 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.476 2.117 . . . . 0.0 111.23 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -95.71 157.38 15.92 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 121.226 0.536 . . . . 0.0 111.217 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 19' ' ' PHE . 34.2 p30 -78.5 -23.34 46.41 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.92 160.73 39.78 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.572 HG23 ' H ' ' A' ' 133' ' ' VAL . 7.7 p -84.4 108.67 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 172.56 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -90.7 113.58 25.7 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.442 ' HG ' HG21 ' A' ' 133' ' ' VAL . 98.0 mt -69.41 128.46 36.64 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 44.2 t60 -118.39 -50.64 2.43 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.1 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 13.5 p -147.18 174.11 11.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.82 159.74 43.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.06 139.58 39.62 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.215 0.322 . . . . 0.0 110.252 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 71.6 mt -140.93 117.62 7.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -107.45 125.76 51.65 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.818 0.818 . . . . 0.0 110.318 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.98 -174.08 22.99 Favored Glycine 0 C--N 1.261 -3.621 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.48 135.47 3.07 Favored 'Trans proline' 0 N--CA 1.424 -2.604 0 CA-C-N 119.598 1.699 . . . . 0.0 108.632 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -58.57 -25.85 62.99 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.673 0.749 . . . . 0.0 110.798 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.89 -53.17 27.52 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.783 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.456 ' OE1' ' HD3' ' A' ' 151' ' ' LYS . 4.7 mp0 -103.78 -59.82 1.66 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.03 128.75 0.0 OUTLIER Glycine 0 N--CA 1.511 3.647 0 C-N-CA 127.98 2.705 . . . . 0.0 118.443 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.45 114.55 4.0 Favored 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.168 1.912 . . . . 0.0 110.373 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.533 ' O ' HG21 ' A' ' 88' ' ' VAL . 51.3 tttp -99.82 -69.84 0.75 Allowed 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -57.21 106.97 0.37 Allowed 'General case' 0 C--O 1.249 1.073 0 O-C-N 123.183 0.302 . . . . 0.0 111.314 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 86' ' ' LYS . 96.3 t -109.26 116.32 51.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.477 ' HZ3' ' HB2' ' A' ' 89' ' ' LYS . 4.3 ttmp? -118.83 136.46 54.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.443 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -121.83 166.47 14.32 Favored 'General case' 0 C--O 1.201 -1.456 0 O-C-N 122.038 -0.413 . . . . 0.0 111.927 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -151.41 121.64 7.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 t -97.9 143.71 28.21 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.789 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 93' ' ' ASN . 0.8 OUTLIER 77.73 172.34 0.2 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 125.08 1.352 . . . . 0.0 112.722 179.022 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 71.21 177.92 0.26 Allowed 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.605 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 155.65 21.42 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 42.9 p-80 -51.08 124.42 11.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 80.6 mtp -98.83 116.93 32.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.362 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 67.6 m -72.02 158.04 36.7 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.539 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 64.6 t80 -48.9 -37.43 19.73 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 m -59.6 -22.56 61.98 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 120.846 0.355 . . . . 0.0 111.591 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.51 -13.06 11.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.099 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 2.7 p -67.48 -33.89 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.801 0.334 . . . . 0.0 111.214 -171.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.53 94.91 10.04 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.948 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -178.77 -45.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.19 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -98.01 149.89 36.19 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.481 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.39 126.74 19.16 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.463 2.109 . . . . 0.0 111.866 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.52 163.51 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.289 2.659 . . . . 0.0 112.398 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 9.6 t -61.43 -47.68 84.63 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 126' ' ' LYS . 20.5 m-20 -174.26 -177.6 1.3 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.15 2.58 . . . . 0.0 104.038 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -157.33 145.61 19.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.751 0.705 . . . . 0.0 110.278 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 88' ' ' VAL . . . -154.63 172.14 18.35 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -125.5 138.13 53.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.53 ' CB ' ' HA ' ' A' ' 86' ' ' LYS . 22.7 tp -61.67 143.84 55.51 Favored 'General case' 0 C--O 1.25 1.092 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.486 HG23 ' H ' ' A' ' 117' ' ' ASN . 8.0 t -134.52 165.47 25.12 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 119' ' ' LYS . 46.3 mt-10 -62.9 -28.24 69.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 119.089 0.859 . . . . 0.0 111.387 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.403 ' HG2' ' CB ' ' A' ' 121' ' ' LYS . 41.1 tt0 -66.34 -40.63 89.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.77 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.486 ' H ' HG23 ' A' ' 114' ' ' THR . 2.4 t-20 -67.47 -34.24 76.77 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.4 tp -67.31 -28.34 67.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.732 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 14.1 mptt -87.76 1.02 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 110.508 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.64 23.93 Favored Glycine 0 C--N 1.303 -1.272 0 C-N-CA 120.294 -0.955 . . . . 0.0 115.146 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' CB ' ' HG2' ' A' ' 116' ' ' GLU . 17.5 tppt? -75.08 119.11 75.38 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 117.93 0.865 . . . . 0.0 108.918 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.89 100.92 0.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.878 1.718 . . . . 0.0 109.663 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.32 133.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 27.9 m -64.68 135.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.48 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 mp -65.06 -67.04 0.47 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 34.8 mmtp -171.54 -174.58 1.42 Allowed 'General case' 0 C--N 1.287 -2.143 1 N-CA-C 100.081 -4.044 . . . . 0.0 100.081 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -146.36 24.39 1.27 Allowed 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 123.186 1.469 . . . . 0.0 108.078 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.16 -40.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.645 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.9 tmtt? -116.53 -20.47 9.62 Favored 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 118.732 -1.187 . . . . 0.0 114.045 -167.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.4 ' HB3' ' OD2' ' A' ' 109' ' ' ASP . 32.6 p90 -58.44 18.08 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.445 0 C-N-CA 125.209 1.404 . . . . 0.0 114.415 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 129' ' ' LYS . 49.5 mt-30 -61.37 2.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -163.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -166.56 115.52 0.9 Allowed 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.572 ' H ' HG23 ' A' ' 69' ' ' VAL . 60.4 t -120.01 125.23 74.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.757 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -121.13 -61.29 1.56 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 173.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.6 p -116.37 152.44 33.92 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.9 tp -136.32 122.83 20.82 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.077 0.465 . . . . 0.0 110.006 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.9 m -93.37 113.45 25.63 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.9 mt -104.78 116.52 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -115.4 108.73 16.89 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.291 0.567 . . . . 0.0 111.006 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.54 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 8.2 pt -89.46 114.07 26.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-O 121.848 0.832 . . . . 0.0 108.877 172.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.59 -40.53 16.16 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.13 -1.396 . . . . 0.0 113.028 -168.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.94 150.63 27.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.685 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -91.19 154.66 19.16 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.454 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.446 ' HG3' ' HD2' ' A' ' 86' ' ' LYS . 25.8 tt0 -58.44 -36.4 73.6 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 123.662 0.785 . . . . 0.0 112.295 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.1 t -103.35 -7.6 20.92 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.582 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.72 56.41 23.07 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.9 p -87.77 -1.47 57.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.608 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 42.6 mt-10 72.19 -37.07 0.38 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.092 0.957 . . . . 0.0 112.081 -177.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.3 t -106.09 118.24 53.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.178 0.513 . . . . 0.0 109.618 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.706 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 39.4 m -93.29 110.99 22.51 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.521 ' HZ2' ' HB2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -119.35 135.71 54.6 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.874 0.369 . . . . 0.0 110.392 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.1 p -142.09 148.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.04 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 74.1 mt-30 -108.99 -32.35 7.29 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.493 ' HZ1' ' CB ' ' A' ' 156' ' ' ALA . 11.7 tmtt? -155.24 115.97 3.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.762 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.415 ' HB ' ' CD1' ' A' ' 40' ' ' LEU . 66.4 mt -122.71 127.17 74.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.493 ' CB ' ' HZ1' ' A' ' 154' ' ' LYS . . . -144.43 152.67 40.99 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.29 155.56 21.9 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.448 ' CD1' ' HA ' ' A' ' 15' ' ' ASP . 99.5 m-85 -124.56 130.59 52.73 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.573 0.701 . . . . 0.0 111.297 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.05 -171.12 12.24 Favored Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.3 m -142.57 133.88 26.21 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.395 0.617 . . . . 0.0 111.599 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.425 -1.719 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.12 174.047 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -98.27 119.33 36.75 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.328 0.585 . . . . 0.0 110.942 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.58 111.27 6.56 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.11 89.62 4.83 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.151 0.977 . . . . 0.0 112.55 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.3 m -156.43 100.76 1.99 Allowed 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.476 ' HB2' ' CD1' ' A' ' 17' ' ' LEU . . . -166.12 107.9 0.73 Allowed 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 123.29 0.369 . . . . 0.0 111.944 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -157.02 111.85 2.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.859 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -134.03 19.34 3.77 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.497 HG13 ' CB ' ' A' ' 15' ' ' ASP . 3.0 mp -76.28 123.67 87.98 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.72 -177.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.46 160.99 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.705 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -71.3 107.02 4.07 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.87 -76.04 0.24 Allowed Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -106.69 168.88 8.88 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.64 125.77 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.534 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' CB ' HG13 ' A' ' 9' ' ' ILE . 34.0 t0 -72.11 130.09 40.05 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 176.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.588 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.2 mm? -68.86 -1.2 6.66 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' CD1' ' HB2' ' A' ' 6' ' ' ALA . 1.6 tm? -51.24 -45.17 61.89 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.571 1.148 . . . . 0.0 109.1 174.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.42 -16.04 56.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.807 0.813 . . . . 0.0 110.863 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.519 ' CD1' HD11 ' A' ' 16' ' ' LEU . 11.1 t80 -92.58 -14.24 28.54 Favored 'General case' 0 N--CA 1.415 -2.195 0 C-N-CA 124.251 1.02 . . . . 0.0 112.058 -174.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 16' ' ' LEU . 96.3 mt -75.04 140.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 120.701 0.286 . . . . 0.0 111.035 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.76 -29.44 63.32 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.277 0.561 . . . . 0.0 110.527 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.3 m95 71.18 -15.82 0.39 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 173.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -67.86 -25.37 65.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.481 0.658 . . . . 0.0 110.58 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.68 -81.24 1.58 Allowed Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.053 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.51 ' H ' ' CG ' ' A' ' 65' ' ' PRO 0.345 27.4 m 46.87 79.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.983 0 CA-C-O 122.476 1.131 . . . . 0.0 112.842 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -112.83 148.83 34.05 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.951 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.7 t -135.93 128.85 31.27 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.12 7.91 5.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.684 0.754 . . . . 0.0 110.568 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -126.01 -92.16 0.51 Allowed 'General case' 0 CA--C 1.479 -1.785 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.381 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 45.63 32.15 1.11 Allowed 'General case' 0 C--N 1.379 1.85 0 CA-C-O 122.677 1.227 . . . . 0.0 109.467 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.4 t -37.5 -63.64 0.44 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.729 2.811 . . . . 0.0 113.367 -171.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -50.04 -48.1 52.95 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.2 m 147.27 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.749 0 C-N-CA 128.127 2.571 . . . . 0.0 106.664 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.835 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 89.5 m-70 -62.14 132.66 53.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.149 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -106.77 -173.1 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.406 -0.918 . . . . 0.0 113.293 -164.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.8 tp -86.71 -46.74 0.53 Allowed Pre-proline 0 C--O 1.212 -0.895 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.09 -38.8 71.03 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.424 1.416 . . . . 0.0 111.415 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.8 p-10 -75.06 -2.0 25.44 Favored 'General case' 0 C--O 1.203 -1.365 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.618 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.19 0.14 6.43 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 tp -121.64 -30.48 4.18 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.516 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 6.0 tmtt? -82.24 143.13 31.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -68.88 149.14 49.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.575 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.31 -35.41 3.71 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 81.4 m-85 -89.4 -28.03 20.03 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.158 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -68.85 80.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -167.67 110.97 0.65 Allowed 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.005 0.922 . . . . 0.0 109.154 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.472 ' H ' ' HG3' ' A' ' 153' ' ' GLN . 20.0 t70 -71.22 116.47 11.57 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.121 0.486 . . . . 0.0 110.188 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -164.62 -63.12 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.08 -49.82 0.36 Allowed Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.1 pp -105.95 141.42 37.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 120.976 0.417 . . . . 0.0 110.623 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.835 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 36.5 p30 -162.28 169.63 20.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tt -102.16 124.81 48.41 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -138.73 165.07 27.93 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.274 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 66.4 p -101.47 148.65 24.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.961 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -125.17 -68.69 0.83 Allowed 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.4 -39.71 22.3 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.612 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' SER . 40.6 m-20 -123.21 121.21 35.36 Favored 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.784 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.9 tt0 -69.58 -26.22 64.36 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.323 1.015 . . . . 0.0 108.537 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.82 108.22 10.89 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.81 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 96.3 mt -115.54 132.29 56.67 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.49 -172.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.77 128.32 49.39 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.04 136.63 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 122.81 0.444 . . . . 0.0 110.716 -173.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -106.95 131.56 53.89 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.548 0.339 . . . . 0.0 110.887 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -108.38 117.08 55.42 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.022 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.51 ' CG ' ' H ' ' A' ' 25' ' ' VAL . 8.3 Cg_exo -73.34 144.58 36.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.608 2.205 . . . . 0.0 110.942 175.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' HE2' ' NH2' ' A' ' 134' ' ' ARG . 24.5 p90 -122.38 161.91 22.58 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -98.4 -43.34 6.95 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.328 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -153.93 178.85 9.48 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.617 -171.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.04 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.836 -0.166 . . . . 0.0 110.581 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.67 172.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.63 114.13 27.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.6 tp -72.75 133.8 44.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -111.76 -52.71 2.77 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.872 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -145.15 164.63 30.68 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.019 0.438 . . . . 0.0 111.946 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -135.2 153.8 51.82 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.64 110.09 4.43 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.219 0.533 . . . . 0.0 111.227 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.9 117.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HD3' ' N ' ' A' ' 79' ' ' GLY . 7.8 tmtt? -116.43 141.53 48.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -173.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.541 ' N ' ' HD3' ' A' ' 78' ' ' LYS . . . -171.39 -156.35 11.72 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 174.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.06 165.98 30.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.36 2.04 . . . . 0.0 110.902 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -70.41 -33.64 71.59 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.76 -47.84 6.58 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -86.73 15.44 5.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.675 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.28 148.78 19.86 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.01 162.86 12.63 Favored 'Trans proline' 0 C--O 1.217 -0.534 0 C-N-CA 122.614 2.21 . . . . 0.0 111.888 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 36.3 ttpt -132.94 -73.43 0.5 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.062 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.5 m -76.68 108.67 9.85 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.806 0.336 . . . . 0.0 110.122 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.489 HG11 HG21 ' A' ' 140' ' ' ILE . 7.6 m -118.97 142.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 -177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -125.6 149.45 48.37 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -127.09 152.73 46.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.607 ' CE2' ' HB ' ' A' ' 137' ' ' THR 0.252 23.4 p90 -148.83 116.22 6.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.74 0.781 . . . . 0.0 111.66 173.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 135' ' ' SER . 20.6 m -103.99 149.36 25.22 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.849 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.5 116.02 0.05 Allowed 'General case' 0 C--O 1.239 0.537 0 O-C-N 124.632 1.208 . . . . 0.0 109.676 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.279 0.5 OUTLIER 81.75 108.55 0.07 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.4 1.08 . . . . 0.0 112.256 -175.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.51 177.19 4.99 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.324 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 79.01 0.76 2.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.368 1.067 . . . . 0.0 111.022 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.482 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 44.6 ttm -70.22 115.14 9.07 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.851 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.504 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.3 m -100.33 177.11 5.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.256 36.9 p90 -55.8 -29.88 60.44 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.6 p -62.46 -35.95 80.91 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.973 0.892 . . . . 0.0 109.86 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.482 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 2.3 m-20 -87.75 -29.09 21.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.697 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 98' ' ' CYS . 97.8 t -62.4 -29.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.294 0.569 . . . . 0.0 110.52 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -88.71 -10.35 48.72 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.509 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.48 -50.13 6.28 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.063 0.459 . . . . 0.0 109.792 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -96.36 143.25 25.8 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.333 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 143.31 78.41 Favored 'Trans proline' 0 C--O 1.249 1.048 0 C-N-CA 122.144 1.896 . . . . 0.0 111.109 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.23 178.13 7.95 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.36 2.04 . . . . 0.0 111.406 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 32.1 m -78.45 -44.39 24.79 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -168.35 168.85 11.08 Favored 'General case' 0 C--O 1.256 1.395 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -144.16 138.24 28.0 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.95 159.69 39.23 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.491 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.2 tp10 -109.05 116.98 33.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 10.3 tt -61.35 113.27 2.54 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.253 1.025 . . . . 0.0 110.174 -176.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.6 t -85.09 157.9 20.57 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.566 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.88 -22.11 65.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.279 0.561 . . . . 0.0 111.014 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -65.81 -36.55 83.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.486 HD21 HG21 ' A' ' 123' ' ' VAL . 17.3 t-20 -71.77 -42.82 66.7 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 118' ' ' LEU . 7.7 tt -62.02 -21.31 64.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.076 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -82.4 -13.64 56.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.131 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.43 10.9 21.0 Favored Glycine 0 C--O 1.24 0.521 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.083 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -94.04 135.98 24.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 61.4 Cg_endo -71.48 104.58 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.15 2.567 . . . . 0.0 112.353 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.486 HG21 HD21 ' A' ' 117' ' ' ASN . 66.1 t -83.33 127.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.675 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.29 121.66 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 110.411 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.2 168.5 11.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.395 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.82 94.02 7.58 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.222 0.534 . . . . 0.0 109.911 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . 0.312 26.8 p90 -88.44 67.41 8.59 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.12 -47.49 13.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.2 tmtt? -80.27 -30.74 38.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -73.5 84.16 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.184 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -110.67 -68.18 0.95 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -104.5 115.79 30.97 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.1 t -100.2 103.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 C-N-CA 118.472 -1.291 . . . . 0.0 110.675 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.418 ' NH2' ' HE2' ' A' ' 66' ' ' PHE . 28.8 mmm180 -78.37 -80.64 0.11 Allowed 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.554 170.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' SER . 42.6 p -105.55 149.73 26.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.48 129.75 41.53 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.607 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 20.8 m -130.84 144.18 51.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.4 mt -117.74 135.99 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 122.501 0.32 . . . . 0.0 110.191 -174.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 83.5 t80 -123.21 112.23 17.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.537 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 26.1 pt -109.27 114.96 48.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.451 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.6 pt-20 -105.31 -9.45 17.62 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.29 166.82 29.77 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.129 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -119.18 164.57 15.39 Favored 'General case' 0 CA--C 1.496 -1.117 0 O-C-N 124.164 0.915 . . . . 0.0 109.903 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.414 ' N ' ' HB2' ' A' ' 86' ' ' LYS . 34.2 mm-40 -46.32 -61.4 1.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 110.374 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.2 t -91.24 -11.07 39.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.697 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.64 65.28 2.96 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.6 t -100.21 -2.35 34.15 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 58' ' ' GLU 0.286 45.0 mt-10 68.7 -27.25 0.15 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.2 p -102.22 103.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 25.0 m -101.19 111.27 23.44 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.504 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -104.84 132.49 51.02 Favored 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.485 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.99 124.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.869 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.508 ' OE1' ' HD2' ' A' ' 78' ' ' LYS . 36.0 tt0 -97.3 -27.62 14.42 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.102 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -160.72 129.26 4.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.6 112.11 38.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 165.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.454 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -130.87 141.84 50.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 156' ' ' ALA . 5.8 mp -130.69 142.67 50.44 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 79.4 m-85 -124.53 114.27 19.2 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -109.94 -174.08 20.7 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.3 m -139.23 129.94 26.03 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--N 1.293 -1.866 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.253 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.417 ' H2 ' ' CD ' ' A' ' 4' ' ' GLU . 48.6 m . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m -154.66 111.96 3.38 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.745 -0.597 . . . . 0.0 112.261 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' LYS . . . 42.31 72.91 0.15 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.127 1.371 . . . . 0.0 113.046 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 41' ' ' LYS . 11.3 pt-20 -149.73 18.68 0.91 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.572 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.1 m -108.36 17.35 22.24 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.969 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.69 35.35 4.3 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.093 -177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -80.84 151.02 28.9 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.152 0.501 . . . . 0.0 110.932 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -105.55 100.25 9.82 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 9' ' ' ILE . 2.5 mp -94.12 114.41 63.15 Favored Pre-proline 0 C--N 1.284 -2.239 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.965 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 13' ' ' GLN . 19.3 Cg_endo -93.09 -173.87 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.513 2.142 . . . . 0.0 110.525 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -96.93 137.45 35.99 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.67 -40.22 2.6 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -143.05 137.52 29.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.83 155.22 7.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 123.816 0.698 . . . . 0.0 110.001 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -58.95 129.53 42.6 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.092 0.957 . . . . 0.0 110.886 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.591 ' O ' HG13 ' A' ' 20' ' ' ILE . 80.6 mt -98.19 5.89 48.03 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.001 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.481 HD23 ' HG2' ' A' ' 42' ' ' GLN . 64.9 tp -64.22 -42.22 96.67 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.797 0.808 . . . . 0.0 109.497 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.5 -20.03 65.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.896 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' C ' ' HB2' ' A' ' 67' ' ' ASN . 24.7 m-85 -95.17 19.87 9.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.914 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 16' ' ' LEU . 72.1 mt -108.19 127.76 64.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.985 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 -38.25 85.1 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.451 ' CZ2' HD13 ' A' ' 40' ' ' LEU . 90.0 m95 76.46 -29.19 0.18 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.4 t -80.05 -36.37 35.78 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.485 0.66 . . . . 0.0 110.044 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.13 12.43 66.34 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.004 -0.617 . . . . 0.0 114.575 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.53 152.31 7.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-N 117.504 0.652 . . . . 0.0 111.989 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.97 127.45 13.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 p -134.02 108.22 8.23 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.677 0.751 . . . . 0.0 109.897 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -76.5 121.49 23.19 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 46.3 t30 72.53 -55.1 0.68 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.371 1.468 . . . . 0.0 110.978 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.2 pt20 63.2 -62.71 0.13 Allowed 'General case' 0 C--O 1.209 -1.069 0 C-N-CA 127.442 2.297 . . . . 0.0 110.0 -176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.578 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 23.9 m 176.87 119.77 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 129.608 3.163 . . . . 0.0 103.109 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.6 p -62.63 -18.39 62.16 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 117.073 -1.851 . . . . 0.0 113.124 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -111.3 -14.72 13.75 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.578 ' O ' ' HB2' ' A' ' 31' ' ' SER . 94.8 m-70 -125.43 163.62 22.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.914 -0.492 . . . . 0.0 110.289 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.523 ' OG ' ' HD2' ' A' ' 37' ' ' PRO . 29.5 t -114.03 171.19 7.75 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.799 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -77.38 -54.6 1.44 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.941 0.897 . . . . 0.0 112.722 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' HD2' ' OG ' ' A' ' 35' ' ' SER . 30.8 Cg_exo -40.34 -50.31 3.68 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 123.392 2.728 . . . . 0.0 114.823 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -55.85 -45.81 78.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.76 -11.06 57.63 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD13 ' CZ2' ' A' ' 22' ' ' TRP . 1.3 tm? -104.28 -27.28 12.1 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 3' ' ' ALA . 70.9 mmtt -78.0 120.36 22.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.624 ' NE2' ' HG2' ' A' ' 45' ' ' ARG . 17.9 mm-40 -75.56 92.07 2.88 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 121.923 0.868 . . . . 0.0 109.27 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 45' ' ' ARG . . . 170.14 -56.36 0.19 Allowed Glycine 1 N--CA 1.386 -4.66 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.46 -171.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -81.62 -29.3 33.3 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.511 0.672 . . . . 0.0 110.185 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.624 ' HG2' ' NE2' ' A' ' 42' ' ' GLN . 5.1 ppt_? -60.95 17.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.93 137.15 36.13 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.344 -0.848 . . . . 0.0 112.209 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 8.3 t70 -58.96 85.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.927 1.691 . . . . 0.0 112.497 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER 160.61 -55.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.635 1.974 . . . . 0.0 108.097 174.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.22 -78.24 0.14 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.626 -0.716 . . . . 0.0 114.256 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 163.58 29.28 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.9 p-10 -161.19 166.35 27.96 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.4 tt -110.63 128.69 55.79 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.96 158.82 43.33 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 120.579 0.228 . . . . 0.0 111.435 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.2 p -79.49 79.57 5.94 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 122.187 0.994 . . . . 0.0 108.418 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -97.27 79.97 2.86 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.206 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 155.21 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.514 2.326 . . . . 0.0 107.115 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.8 -170.3 1.63 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.493 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -18.88 12.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -102.27 154.79 18.71 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.023 0.929 . . . . 0.0 109.558 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' HB2' HG13 ' A' ' 140' ' ' ILE . 78.7 mt -146.51 147.32 31.05 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 1.2 tm? -123.21 116.92 24.18 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -124.33 120.89 60.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -109.79 134.52 51.94 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.88 0.472 . . . . 0.0 110.806 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 mm -120.78 131.83 24.35 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.492 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -87.84 150.7 7.25 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.49 2.793 . . . . 0.0 111.577 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -89.6 162.99 15.35 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.545 ' HB2' ' C ' ' A' ' 19' ' ' PHE . 4.6 t-20 -101.66 -43.14 5.96 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 112.509 -2.132 . . . . 0.0 107.322 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -153.07 150.73 29.44 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.29 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.51 122.92 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.67 175.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -81.04 142.47 33.33 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 73' ' ' HIS . 3.1 tm? -81.05 150.91 28.62 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.546 ' N ' HD12 ' A' ' 72' ' ' LEU . 3.6 t-160 -141.96 -62.61 0.45 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.878 177.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' HD22 ' A' ' 125' ' ' LEU . 12.1 p -152.65 163.22 40.07 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 7.7 p90 -125.56 157.17 37.78 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.72 107.13 3.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.783 0.265 . . . . 0.0 110.513 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.87 136.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 91.3 mttt -114.01 158.12 21.6 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.663 176.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.91 -177.49 47.54 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.99 150.14 89.03 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.833 1.689 . . . . 0.0 109.088 172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.59 -25.5 68.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 45.4 mt-10 -87.33 -54.52 4.26 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.486 0.66 . . . . 0.0 111.26 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.73 8.68 18.9 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.203 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.9 153.37 38.05 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.668 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 39.1 Cg_exo -60.98 147.41 95.76 Favored 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 122.14 1.893 . . . . 0.0 110.517 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 0.6 OUTLIER -130.33 -53.89 1.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 54.6 m -80.53 97.03 6.97 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.57 116.19 40.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.003 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -109.34 132.67 53.91 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -117.07 140.12 49.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.508 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 88.2 t80 -130.3 129.2 42.93 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -113.4 145.79 40.56 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 75.82 172.56 0.25 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.523 1.529 . . . . 0.0 111.272 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt 67.51 164.97 0.22 Allowed 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.373 1.069 . . . . 0.0 111.716 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.09 164.42 26.53 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -49.39 136.02 16.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.416 ' HE2' ' HB3' ' A' ' 105' ' ' PHE . 86.0 mtp -110.15 127.97 55.21 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.524 ' O ' HG21 ' A' ' 102' ' ' VAL . 25.9 p -86.9 176.6 7.6 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.9 -29.41 67.02 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -61.93 -19.34 62.63 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.086 0.554 . . . . 0.0 111.224 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -109.32 -26.74 9.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.306 0.574 . . . . 0.0 110.207 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 98' ' ' CYS . 52.4 t -58.48 -38.04 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.574 1.15 . . . . 0.0 113.838 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -57.85 -14.34 5.89 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.95 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.61 71.19 1.23 Allowed 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.61 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 102' ' ' VAL . 3.0 p90 -128.14 153.77 78.65 Favored Pre-proline 0 C--O 1.249 1.046 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.184 167.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.92 118.55 5.07 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.242 1.961 . . . . 0.0 109.921 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.26 136.19 42.87 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.067 1.845 . . . . 0.0 111.875 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -69.05 -45.27 70.81 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -162.53 155.86 20.22 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.0 p -119.41 114.63 22.62 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.72 153.91 33.62 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.512 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mp0 -114.61 126.43 54.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.832 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 7.6 tt -73.59 113.1 10.33 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -103.26 175.23 5.55 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.449 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -38.22 60.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.023 0.529 . . . . 0.0 111.779 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' OE1' ' HD2' ' A' ' 121' ' ' LYS . 5.4 tp10 -61.33 -43.68 98.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.353 0.661 . . . . 0.0 109.894 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.466 HD21 HG23 ' A' ' 123' ' ' VAL . 13.8 t-20 -71.95 -38.37 69.79 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.442 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 118' ' ' LEU . 2.3 tm? -63.27 -22.93 67.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.832 1.253 . . . . 0.0 108.801 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -87.24 -0.37 56.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.428 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.24 52.73 Favored Glycine 0 CA--C 1.496 -1.103 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.416 ' HD2' ' OE1' ' A' ' 116' ' ' GLU . 98.4 mttt -86.36 142.29 35.36 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.502 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 48.6 Cg_endo -67.83 121.36 8.4 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.453 2.769 . . . . 0.0 112.401 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.466 HG23 HD21 ' A' ' 117' ' ' ASN . 76.7 t -97.35 119.96 46.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 130.5 34.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.314 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 74' ' ' SER . 0.7 OUTLIER -101.87 178.53 4.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 10.4 mptt -89.7 95.24 10.16 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -109.04 23.61 14.3 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.177 -173.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.6 t -53.05 -38.8 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.508 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -103.98 4.93 35.12 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.876 179.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.457 ' CE2' ' HE3' ' A' ' 129' ' ' LYS . 55.5 m-85 -108.23 71.89 0.82 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.932 0.873 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -102.49 0.24 33.37 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.444 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -142.37 114.72 8.38 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.456 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.12 107.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -74.35 -44.48 52.14 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.293 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.7 m -157.43 171.33 20.57 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 tp -142.56 131.64 23.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.931 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 88.9 m -111.46 118.34 35.5 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 138' ' ' ILE . 3.0 mp -104.52 114.97 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -110.68 109.71 20.09 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.533 0.682 . . . . 0.0 109.973 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 60' ' ' LEU . 7.2 pt -96.71 114.5 33.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.256 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.89 -48.65 5.92 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.664 -173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.92 146.2 48.93 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.664 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.12 -179.55 5.29 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.002 0.814 . . . . 0.0 109.121 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.457 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.3 mp0 -54.72 -62.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 p -93.44 -36.49 12.45 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.6 1.54 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.3 m -84.68 16.63 3.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.271 12.8 pt-20 63.11 -1.0 0.55 Allowed 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 126.147 1.779 . . . . 0.0 114.2 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.94 122.57 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.94 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -93.35 128.31 39.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -116.35 133.49 55.96 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 79.1 t -134.02 128.48 53.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -88.99 -46.35 8.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.386 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.435 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -146.02 142.94 29.11 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.396 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.76 127.19 73.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.34 141.24 41.83 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.37 137.31 52.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.502 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 88.3 m-85 -124.39 139.11 54.21 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.235 0.541 . . . . 0.0 111.265 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.29 -176.18 14.25 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.9 m -134.04 130.16 37.12 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 117.477 0.639 . . . . 0.0 110.729 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 C--N 1.288 -2.07 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.321 176.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.456 HG23 ' HA ' ' A' ' 14' ' ' VAL . 2.0 mp . . . . . 0 N--CA 1.399 -2.978 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.64 -166.55 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -104.55 109.17 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.414 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.14 -41.69 0.89 Allowed Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -137.8 142.58 40.84 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.449 -0.876 . . . . 0.0 111.214 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.456 ' HA ' HG23 ' A' ' 9' ' ' ILE . 11.6 p -106.52 156.4 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.8 143.97 43.74 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.651 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.6 mp -102.82 7.18 39.52 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.653 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.52 -43.24 85.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.66 -16.67 60.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.662 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.39 -2.85 57.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 16' ' ' LEU . 94.9 mt -74.66 145.38 11.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.6 -42.54 70.84 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 122.751 0.421 . . . . 0.0 111.097 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 72.44 -33.97 0.28 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -79.11 -37.14 39.43 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.832 0.348 . . . . 0.0 110.871 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 17.68 55.28 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.48 -0.867 . . . . 0.0 114.011 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.61 143.64 14.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 117.487 0.643 . . . . 0.0 109.793 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -141.2 134.93 30.22 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.858 0.361 . . . . 0.0 110.395 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 81.2 m -135.72 121.86 20.22 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.045 0.45 . . . . 0.0 111.104 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.452 HD23 HD12 ' A' ' 61' ' ' LEU . 3.5 mm? -83.44 5.94 21.96 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.832 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 57' ' ' ASP . 50.3 t-20 -151.64 -67.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.495 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 11.8 pt20 50.98 25.22 2.14 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 125.342 1.457 . . . . 0.0 112.653 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 m 78.89 112.91 0.07 Allowed 'General case' 0 C--O 1.208 -1.095 0 C-N-CA 125.08 1.352 . . . . 0.0 108.616 -174.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -52.58 -25.27 10.09 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -112.86 -1.89 14.49 Favored 'General case' 0 CA--C 1.562 1.43 0 O-C-N 121.847 -0.533 . . . . 0.0 112.349 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 94.7 m-70 -126.34 166.56 16.93 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.0 m -105.82 166.26 10.6 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.011 -0.431 . . . . 0.0 111.78 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 3.1 tm? -64.92 -50.09 64.66 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 3.0 Cg_endo -46.03 -29.35 6.13 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 123.85 3.033 . . . . 0.0 114.066 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 50' ' ' LEU . 3.2 m-20 -44.47 -48.96 10.07 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.872 1.669 . . . . 0.0 113.375 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -111.19 -7.9 14.42 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.116 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.4 tp -104.23 -42.81 5.4 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.903 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -84.28 103.88 13.84 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 19.9 mm-40 -59.19 127.03 30.11 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.683 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.26 -42.41 1.38 Allowed Glycine 1 N--CA 1.388 -4.559 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.197 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.6 -9.36 44.4 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.144 1.777 . . . . 0.0 115.747 -174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.51 104.33 16.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.734 -0.604 . . . . 0.0 111.503 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 18.1 t70 -70.93 85.58 0.69 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.352 0.596 . . . . 0.0 110.756 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 5.8 mm-40 -167.78 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 127.6 2.36 . . . . 0.0 106.307 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.02 -54.92 0.89 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.913 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 1.4 pt? -140.27 137.8 34.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.43 165.74 34.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 35.0 tp -99.1 128.87 45.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.4 171.05 14.59 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-O 121.723 0.773 . . . . 0.0 112.967 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 71.9 p -96.93 111.47 23.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.33 -50.44 59.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.168 0.508 . . . . 0.0 110.1 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.1 -41.87 0.65 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.128 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 54' ' ' SER . 3.8 m-20 -85.73 112.85 21.44 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.696 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -70.57 -26.82 63.71 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.815 0.697 . . . . 0.0 110.046 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 15.9 pt20 -84.15 113.75 21.29 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.854 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.3 mt -116.4 134.6 54.69 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.404 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.452 HD12 HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -120.44 114.91 22.5 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.12 124.19 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.42 ' HD1' ' OG1' ' A' ' 137' ' ' THR . 69.4 t80 -104.0 123.71 47.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.14 116.36 31.17 Favored Pre-proline 0 N--CA 1.437 -1.109 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.527 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -90.01 153.05 4.84 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.158 1.905 . . . . 0.0 109.794 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -112.2 162.42 15.48 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.141 0.496 . . . . 0.0 112.195 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -87.98 -22.69 24.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.64 156.68 47.78 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.72 114.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.839 0.828 . . . . 0.0 111.008 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 161' ' ' THR . 2.0 pp -129.74 172.96 14.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.164 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.6 ' HG3' ' OXT' ' A' ' 161' ' ' THR . 56.4 mttp -106.44 129.88 54.34 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.301 0.501 . . . . 0.0 109.915 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -77.13 126.14 30.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -116.03 -38.64 3.59 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.727 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 158' ' ' TYR . 26.6 p -147.88 154.11 39.97 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.501 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -130.4 154.98 47.14 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.62 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -143.57 110.25 5.55 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.563 0.345 . . . . 0.0 110.643 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -122.27 134.5 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 53.5 mtpt -129.19 153.58 47.6 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.311 0.577 . . . . 0.0 112.256 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.39 -166.16 29.75 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -71.42 158.04 55.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 122.215 1.943 . . . . 0.0 109.657 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.43 -37.27 86.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.35 -33.61 22.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.12 13.98 33.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.237 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.42 147.61 25.76 Favored Glycine 0 C--N 1.301 -1.406 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.583 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 6.0 Cg_exo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.49 2.127 . . . . 0.0 111.908 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 3.7 tmmm? -95.29 -48.06 6.06 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.729 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -85.8 95.02 9.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.443 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.42 119.03 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.399 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.98 148.21 41.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -132.58 155.21 49.09 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 52.3 p90 -152.29 118.96 5.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.587 0.708 . . . . 0.0 110.673 168.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.2 t -103.53 175.93 5.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.251 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 m120 66.12 23.27 11.02 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.423 0.689 . . . . 0.0 111.615 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -148.25 107.27 3.86 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.184 0.516 . . . . 0.0 109.971 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.96 122.07 30.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.4 m80 71.01 107.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.487 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 51.2 ttm -161.48 128.55 4.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.452 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -90.2 162.62 15.16 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.521 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 50.5 p90 -61.8 -18.5 60.15 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -173.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.8 t -60.87 -36.13 78.41 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.99 0.424 . . . . 0.0 110.315 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.487 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 41.8 m-80 -89.39 -25.07 21.75 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.835 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 40.3 t -62.89 -13.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.263 1.03 . . . . 0.0 110.323 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -86.23 -20.53 28.36 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.786 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.06 -23.77 13.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.516 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -96.6 133.19 24.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.585 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 24.1 Cg_exo -65.45 126.67 16.62 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.364 2.043 . . . . 0.0 110.657 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 25.1 Cg_exo -64.52 161.5 34.89 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 122.566 2.177 . . . . 0.0 111.253 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 39.6 m -63.34 -45.42 91.31 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 17.7 t70 -158.88 153.78 24.94 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -126.87 115.28 19.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.29 165.08 12.05 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.573 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 8.9 mp0 -123.77 138.25 54.54 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.4 tp -72.64 107.77 5.3 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.5 p -82.16 160.96 22.96 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.15 -30.73 71.25 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.846 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 121' ' ' LYS . 11.4 pt-20 -72.22 -32.52 66.82 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.693 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.62 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.6 t-20 -66.4 -36.89 83.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 2.6 tm? -64.05 -8.0 10.45 Favored 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 126.786 2.035 . . . . 0.0 110.387 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 90.8 mttt -110.94 -6.85 14.62 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.541 0.736 . . . . 0.0 109.498 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 78' ' ' LYS . . . 99.06 30.92 6.45 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.811 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 64.6 tttm -102.37 121.59 49.53 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.523 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.08 112.84 1.34 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.272 2.648 . . . . 0.0 111.458 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 132.52 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.08 136.61 22.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.524 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.525 HD11 HD12 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -115.4 -172.84 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.491 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 109' ' ' ASP . 72.5 mmtt -70.57 89.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -68.5 -21.95 64.57 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.787 1.235 . . . . 0.0 110.52 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.71 -24.89 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.443 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -94.57 -36.21 11.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.346 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -79.08 93.25 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.264 0.554 . . . . 0.0 110.778 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -114.6 -41.06 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -121.95 115.64 22.92 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.887 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.72 102.37 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.973 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -104.17 -24.08 13.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 168.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.3 p -138.74 144.24 39.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.852 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.8 tp -147.27 121.1 9.28 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.42 ' OG1' ' HD1' ' A' ' 63' ' ' TYR . 23.2 m -105.74 132.11 52.26 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.857 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -105.15 117.75 51.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -117.86 107.23 13.85 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.52 0.676 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.637 HG13 ' HB2' ' A' ' 60' ' ' LEU . 11.3 pt -107.1 114.06 45.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.463 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 12.1 pt-20 -105.43 -23.0 12.91 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.28 152.0 44.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.812 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.435 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 31.7 p30 -108.92 170.08 8.27 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.981 -178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 21.0 tp60 -48.32 -60.03 2.98 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.917 1.687 . . . . 0.0 113.799 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.8 m -104.0 7.82 36.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.439 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.36 46.12 94.53 Favored Glycine 0 C--O 1.224 -0.509 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 m -90.5 10.8 23.89 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.21 0.604 . . . . 0.0 112.342 -171.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 43.9 mt-10 69.85 -45.83 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.147 0.979 . . . . 0.0 112.802 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.52 137.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.119 0.485 . . . . 0.0 109.844 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.5 m -120.33 138.31 53.79 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -131.1 135.42 47.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 61.8 t -120.6 125.77 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -86.9 -48.81 7.85 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -153.8 143.17 21.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -177.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.3 mt -121.86 132.3 71.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.44 134.09 26.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -113.56 135.81 53.5 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.414 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 80.1 m-85 -120.01 133.13 55.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.381 0.61 . . . . 0.0 109.908 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -128.87 178.63 17.14 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.5 m -128.82 25.94 5.59 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 117.151 0.476 . . . . 0.0 112.266 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.6 ' OXT' ' HG3' ' A' ' 71' ' ' LYS . 63.8 p . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.643 HG22 ' H ' ' A' ' 11' ' ' LYS . 3.2 mp . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -95.02 29.22 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.552 2.834 . . . . 0.0 110.95 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 9' ' ' ILE . 41.0 ttmt 68.44 106.25 0.05 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.281 1.433 . . . . 0.0 112.16 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.32 -79.84 0.2 Allowed Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.11 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 26.8 mm-40 -109.84 -173.82 2.35 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.57 152.5 8.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 3.1 p30 -74.62 138.95 43.29 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.197 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -78.78 -13.26 59.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.441 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 4.6 tt -59.79 -43.5 94.39 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.174 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -24.72 62.58 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -90.29 14.74 11.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.322 0.582 . . . . 0.0 111.34 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 16' ' ' LEU . 67.3 mt -100.48 134.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.32 -26.04 51.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.738 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 74.09 2.75 4.25 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -88.63 -28.13 20.85 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.946 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.21 23.15 7.74 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 119.33 -1.414 . . . . 0.0 114.515 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.63 133.44 31.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 117.564 0.682 . . . . 0.0 110.838 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.429 ' CG ' ' HB3' ' A' ' 63' ' ' TYR . 11.7 pt-20 -141.06 154.93 46.19 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.217 -0.302 . . . . 0.0 110.809 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 47.2 t -136.21 141.11 43.97 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.911 0.485 . . . . 0.0 109.836 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 5.7 tt -52.71 -61.48 2.26 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.885 1.274 . . . . 0.0 110.928 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 28.2 t-20 -95.11 -88.8 0.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.613 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.433 ' NE2' ' H ' ' A' ' 36' ' ' LEU . 45.0 tt0 55.47 17.88 2.41 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.503 1.144 . . . . 0.0 109.426 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -81.54 -23.5 37.18 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.233 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 34' ' ' HIS . 44.7 t -55.37 -4.75 0.1 Allowed 'General case' 0 CA--C 1.578 2.022 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.976 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 m 80.11 -17.16 0.6 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.35 1.46 . . . . 0.0 110.158 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.799 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 12.7 m170 -71.39 110.82 6.25 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -95.23 164.4 12.87 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -164.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 5.4 tt -63.73 -50.51 71.11 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.417 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 85.2 Cg_exo -53.67 -27.01 40.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.964 1.776 . . . . 0.0 112.835 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.471 ' ND2' HD22 ' A' ' 50' ' ' LEU . 13.4 m120 -59.61 -48.18 82.66 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-O 120.995 0.426 . . . . 0.0 110.338 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HA ' ' HE ' ' A' ' 45' ' ' ARG . . . -102.88 -0.35 31.31 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 44.2 tp -132.34 5.64 4.1 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 119.431 -0.907 . . . . 0.0 113.024 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -121.97 143.72 49.3 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 121.222 -0.924 . . . . 0.0 111.574 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.62 152.13 36.02 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.511 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.85 -52.27 4.69 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.58 -9.61 59.77 Favored 'General case' 0 C--O 1.194 -1.851 0 C-N-CA 123.017 0.527 . . . . 0.0 111.059 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -75.07 -91.83 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.329 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' ARG 0.311 9.3 pt-20 39.39 84.73 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.883 0.849 . . . . 0.0 113.061 -174.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.338 5.6 p-10 -67.24 85.68 0.15 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -169.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 169.91 103.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 107.31 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.32 -99.5 0.44 Allowed Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD22 ' ND2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -77.67 147.19 35.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.799 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.8 p30 -164.59 169.36 17.13 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 52' ' ' LEU . 7.2 tt -105.47 121.87 44.83 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.065 -1.454 . . . . 0.0 108.626 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.33 159.68 41.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.65 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 25.1 p -85.91 177.21 7.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.528 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.7 -64.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.05 68.4 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 54' ' ' SER . 8.5 t70 -131.64 174.44 10.11 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -109.61 -24.58 10.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 141' ' ' GLU . 87.8 mm-40 -84.28 139.46 32.31 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.588 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 29' ' ' ASN . 47.2 mt -135.64 122.39 21.02 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 122.12 0.962 . . . . 0.0 112.725 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.9 tt -130.42 120.96 25.02 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.13 123.02 66.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.429 ' HB3' ' CG ' ' A' ' 26' ' ' GLU . 35.9 t80 -101.38 123.43 45.44 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.18 113.91 32.32 Favored Pre-proline 0 N--CA 1.441 -0.887 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -89.18 139.23 3.55 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.862 2.374 . . . . 0.0 111.051 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.16 163.33 17.91 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.252 35.9 t-20 -104.44 -38.59 6.75 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 111.993 -2.367 . . . . 0.0 106.355 170.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -153.44 144.76 23.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 m -75.09 128.09 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.189 0.519 . . . . 0.0 111.114 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.503 HG22 HG22 ' A' ' 161' ' ' THR . 0.1 OUTLIER -139.34 173.21 11.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.029 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -97.37 117.93 32.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 125' ' ' LEU . 2.1 tm? -74.97 123.72 25.65 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -106.19 -48.54 3.56 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.4 p -145.26 160.18 41.89 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -130.37 151.52 50.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.518 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.422 ' C ' HD12 ' A' ' 77' ' ' ILE . . . -148.99 116.69 6.24 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 mp -132.25 122.45 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -99.13 163.25 12.64 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.162 0.506 . . . . 0.0 110.344 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.05 -177.51 48.26 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -74.82 172.36 16.44 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.53 1.665 . . . . 0.0 108.306 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 -56.28 5.29 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.331 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.5 mp0 -63.21 -55.25 26.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.115 0.959 . . . . 0.0 110.896 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -90.62 17.13 7.88 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.404 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.09 159.29 25.33 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.567 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 9.8 Cg_exo -72.54 107.26 2.26 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 119.417 1.608 . . . . 0.0 110.434 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 113' ' ' LEU . 12.6 tmtt? -83.34 -51.39 7.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.94 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.3 m -103.63 108.9 20.37 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.575 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.54 HG12 HG22 ' A' ' 140' ' ' ILE . 30.4 m -108.52 134.91 48.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.047 0.451 . . . . 0.0 111.321 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -121.69 134.26 54.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.31 138.85 47.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.3 m-85 -128.9 118.51 22.81 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.0 p -110.2 133.93 52.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.46 ' C ' ' HE3' ' A' ' 94' ' ' LYS . 86.4 m-20 76.37 -4.29 2.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.557 1.543 . . . . 0.0 114.991 173.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.541 ' HE3' ' N ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -88.35 104.43 16.76 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.56 150.11 31.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 72.1 99.63 0.07 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.275 1.03 . . . . 0.0 109.639 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 12.7 mmt -134.35 137.52 44.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.476 ' H ' ' HB2' ' A' ' 101' ' ' ASN . 32.0 p -159.17 -172.16 3.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.558 ' CZ ' HD11 ' A' ' 28' ' ' LEU . 92.7 m-85 -54.75 -44.57 73.71 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.301 0.501 . . . . 0.0 111.621 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 m -62.02 -20.61 64.11 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.495 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.3 m120 -93.67 -47.44 6.8 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.499 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.49 -20.13 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -93.2 -12.98 28.94 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.999 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -99.13 -37.57 9.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.892 0.377 . . . . 0.0 111.628 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -96.83 142.34 24.4 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.427 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.98 143.51 29.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 122.166 1.911 . . . . 0.0 111.293 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.14 163.8 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.413 2.075 . . . . 0.0 111.984 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -72.99 -44.8 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -169.35 171.95 7.5 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t -143.92 145.3 32.17 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.34 172.3 13.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.11 139.41 53.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.324 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 50.9 tp -60.5 112.68 2.07 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.923 0.764 . . . . 0.0 110.902 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.3 p -113.62 172.48 6.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.236 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.19 -24.69 67.35 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.728 0.775 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.31 -34.05 67.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.311 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.551 HD21 HG21 ' A' ' 123' ' ' VAL . 13.5 m120 -71.02 -45.42 63.95 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.269 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.35 -26.43 66.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.705 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.77 -13.75 55.71 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.228 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.88 41.41 23.23 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -95.5 134.96 23.52 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.12 109.94 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.782 1.655 . . . . 0.0 110.161 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.551 HG21 HD21 ' A' ' 117' ' ' ASN . 61.6 t -98.34 131.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.89 105.97 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.54 0.686 . . . . 0.0 111.458 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -83.61 -165.85 1.23 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.767 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -76.97 92.18 3.67 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.165 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.43 -27.55 66.14 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.615 1.566 . . . . 0.0 111.753 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.41 -16.04 16.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -80.82 -51.1 8.99 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.817 0.818 . . . . 0.0 110.149 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 90.33 6.63 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.178 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -98.91 -31.42 11.84 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.131 0.491 . . . . 0.0 110.272 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -149.39 119.55 7.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.395 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.09 112.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.742 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -92.65 -45.58 8.0 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -141.1 139.68 34.04 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.444 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.8 tp -131.69 125.31 31.77 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.233 0.54 . . . . 0.0 110.152 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 96.2 m -106.97 126.54 52.46 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.565 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 157' ' ' LEU . 62.6 mt -104.7 109.49 27.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 49.2 t80 -113.59 111.23 21.52 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.106 0.479 . . . . 0.0 110.646 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.54 HG22 HG12 ' A' ' 88' ' ' VAL . 30.9 pt -100.94 113.72 37.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 14.7 pt-20 -99.59 -12.94 19.65 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.643 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.76 142.32 10.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 118.99 -1.084 . . . . 0.0 113.385 -175.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.71 -173.76 2.47 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 170.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -60.49 -56.03 26.26 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.1 m -124.64 6.58 8.2 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.826 -169.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.82 60.9 3.48 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.2 m -83.07 17.34 2.0 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.898 0.879 . . . . 0.0 111.766 -174.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 78.51 -32.05 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 112.794 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.5 147.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 92.5 m -114.05 124.27 51.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HE3' HD21 ' A' ' 51' ' ' ASN . 88.1 tttt -111.37 134.35 53.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 123.174 0.589 . . . . 0.0 110.071 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 44.5 t -125.23 126.12 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -97.42 -11.44 23.9 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 39.8 ttmt -170.15 130.45 0.95 Allowed 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.82 -0.55 . . . . 0.0 111.449 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.95 116.65 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.29 121.09 21.91 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.444 HD11 HD11 ' A' ' 138' ' ' ILE . 84.1 mt -117.45 144.62 44.84 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 88.0 m-85 -126.24 145.47 50.38 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.818 0.342 . . . . 0.0 111.629 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -148.46 -168.64 14.62 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.384 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.5 p -151.07 140.65 21.63 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 122.5 0.32 . . . . 0.0 110.504 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 HG22 ' A' ' 70' ' ' ILE . 40.4 p . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.631 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.3 mm . . . . . 0 N--CA 1.421 -1.904 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HG2' HE21 ' A' ' 13' ' ' GLN . 59.1 Cg_endo -95.56 -178.9 0.51 Allowed 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 122.432 2.088 . . . . 0.0 110.468 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -76.37 131.25 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.49 -51.55 0.83 Allowed Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.155 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.541 HE21 ' HG2' ' A' ' 10' ' ' PRO . 1.6 pm0 -130.84 172.15 12.35 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 159' ' ' GLY . 14.5 p -118.04 154.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.79 147.47 37.21 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 20' ' ' ILE . 66.4 mt -108.27 17.75 21.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.8 -43.47 75.56 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -83.06 -11.7 57.8 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.507 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.99 0.93 42.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.904 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 16' ' ' LEU . 70.9 mt -86.72 140.39 15.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.22 -28.9 31.68 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.544 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CH2' HD12 ' A' ' 40' ' ' LEU . 98.9 m95 76.45 -4.37 2.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 t -102.89 -30.76 10.63 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.61 -0.39 66.98 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.706 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.4 m -64.83 139.2 21.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 117.146 0.473 . . . . 0.0 111.453 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.35 143.77 27.08 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HB3' ' NE2' ' A' ' 30' ' ' GLN . 51.6 t -137.39 140.32 41.29 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.9 mm? -123.69 90.92 3.36 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.177 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' LEU . 10.7 t30 152.47 -17.29 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.963 1.305 . . . . 0.0 111.83 170.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -54.74 -14.73 1.48 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 122.897 0.479 . . . . 0.0 111.681 176.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.4 t -58.81 -21.96 57.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.621 1.169 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.53 ' HB2' ' H ' ' A' ' 56' ' ' ALA . 33.7 p -77.14 -14.96 59.71 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 33.1 t -154.75 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.603 ' O ' ' HB2' ' A' ' 30' ' ' GLN . 63.2 m80 -124.35 162.95 22.74 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -88.82 172.87 8.89 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -169.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -70.52 -55.3 7.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.16 -20.13 36.89 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.08 1.853 . . . . 0.0 111.85 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 2.4 m-20 -58.04 -41.54 83.45 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 124.839 1.255 . . . . 0.0 111.628 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -110.96 6.63 21.21 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.21 0.529 . . . . 0.0 110.659 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.612 HD12 ' CH2' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -105.22 -43.22 5.07 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -79.83 130.4 35.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.135 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -45.82 139.04 4.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.239 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.28 -52.89 4.38 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 114.935 -1.029 . . . . 0.0 114.179 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -67.47 -28.74 68.12 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.24 -13.12 16.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.139 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -48.49 119.55 3.12 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.652 0.595 . . . . 0.0 110.596 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 153' ' ' GLN 0.258 4.8 p-10 -72.49 96.62 1.96 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -169.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 175.91 -52.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.356 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.54 -69.62 1.37 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.691 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -128.78 145.37 51.2 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.967 0.413 . . . . 0.0 111.107 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 8.1 p30 -159.08 166.38 31.77 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 53.5 tp -84.22 130.04 34.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -143.0 135.54 27.54 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.146 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.62 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 46.1 p -110.45 112.83 25.01 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 12.1 t70 -94.32 -44.72 7.8 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 120.796 0.331 . . . . 0.0 111.591 -175.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.53 ' H ' ' HB2' ' A' ' 32' ' ' SER . . . -81.78 -57.93 3.22 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.211 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 54' ' ' SER . 11.5 m-20 -106.87 141.88 37.39 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.964 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.49 4.3 47.1 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.575 1.179 . . . . 0.0 109.319 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.92 120.9 43.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.395 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 HD12 HD22 ' A' ' 29' ' ' ASN . 9.1 tt -141.26 130.57 23.63 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.52 0.676 . . . . 0.0 111.028 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 62' ' ' ILE . 1.1 tm? -101.79 134.13 45.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.914 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 61' ' ' LEU . 29.9 mt -129.19 129.98 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -112.71 115.73 29.0 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.11 116.76 31.02 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.45 144.35 4.72 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.515 2.143 . . . . 0.0 110.925 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.11 143.87 36.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.788 0.804 . . . . 0.0 112.854 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -56.51 -42.63 78.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 126.413 1.885 . . . . 0.0 110.515 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -142.71 154.36 44.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.95 123.42 38.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 121.525 0.679 . . . . 0.0 111.513 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -130.52 173.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.74 127.47 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.15 109.27 15.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.405 ' H ' ' HA2' ' A' ' 159' ' ' GLY . 14.4 t60 -91.53 -52.04 4.97 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.41 . . . . 0.0 111.237 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 p -140.36 157.12 46.03 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.194 0.521 . . . . 0.0 111.89 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.58 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 35.4 p90 -127.1 152.55 47.16 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -144.17 106.43 4.37 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.784 0.326 . . . . 0.0 111.722 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 62.4 mt -111.18 118.16 56.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 154' ' ' LYS . 10.0 tmtt? -101.79 134.83 44.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.11 -176.21 41.48 Favored Glycine 0 N--CA 1.414 -2.812 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.007 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.85 151.87 57.44 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.755 2.304 . . . . 0.0 110.521 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -61.66 -34.02 74.97 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.21 -38.12 11.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.79 18.26 16.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.351 -173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.49 148.1 19.13 Favored Glycine 0 C--N 1.299 -1.516 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.891 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.3 107.48 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 CA-C-N 119.328 1.564 . . . . 0.0 110.058 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 31.5 ttpt -85.75 -55.12 4.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.131 0.491 . . . . 0.0 110.477 -173.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -82.29 103.84 12.17 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.245 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.21 136.93 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.812 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.52 151.14 50.47 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 136' ' ' LEU . 47.4 m-85 -126.17 155.93 40.96 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -105.97 161.5 14.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.9 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.9 p -95.95 79.27 3.24 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 38.04 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -151.94 166.97 29.86 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -101.77 146.51 27.68 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.579 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 51.99 84.41 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.48 1.112 . . . . 0.0 112.125 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 17.3 tpt -119.09 110.51 17.16 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 23.7 p -124.49 -170.7 2.2 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 83.3 t80 -63.62 -26.03 68.49 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 118.838 0.744 . . . . 0.0 111.639 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.8 m -71.16 -8.64 54.91 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.661 0.743 . . . . 0.0 110.4 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.585 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 12.1 m120 -105.64 -20.17 13.54 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.473 1.109 . . . . 0.0 110.35 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 55.5 t -58.39 -39.69 75.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -96.32 10.51 37.78 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.43 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -120.37 -35.77 3.36 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 90.6 m-85 -96.46 127.64 39.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 O-C-N 121.953 -0.467 . . . . 0.0 111.801 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 59.1 Cg_exo -54.11 129.56 35.01 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.893 3.062 . . . . 0.0 114.036 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 71.7 Cg_endo -80.79 156.55 20.95 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.648 2.232 . . . . 0.0 110.885 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.1 m -84.32 -45.9 12.32 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.896 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.476 ' HB2' ' HE2' ' A' ' 129' ' ' LYS . 28.9 t70 -163.07 171.71 16.02 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.1 p -127.96 119.9 26.48 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB1' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.98 152.42 24.98 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.429 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 39.9 tt0 -126.49 125.6 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.555 HD23 HE22 ' A' ' 144' ' ' GLN . 19.6 tp -66.96 145.57 55.29 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.571 HG23 ' H ' ' A' ' 117' ' ' ASN . 2.8 t -135.23 163.67 29.43 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -58.63 -27.29 64.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.672 0.749 . . . . 0.0 110.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -65.52 -51.4 60.24 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.026 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.667 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.3 t-20 -65.31 -49.4 69.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.915 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 3.0 pp -71.31 -9.45 58.16 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -89.59 3.72 51.67 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.24 33.66 6.17 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.682 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.2 tmtp? -115.96 120.75 35.02 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 117.271 0.536 . . . . 0.0 109.675 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 32.5 Cg_exo -58.69 117.72 4.49 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 C-N-CA 123.574 2.849 . . . . 0.0 112.29 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.468 HG23 ' ND2' ' A' ' 117' ' ' ASN . 80.9 t -93.51 131.06 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -73.68 123.29 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.439 HD23 ' CD1' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -98.7 174.52 6.37 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.827 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -86.51 89.96 8.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 130' ' ' PHE . 45.2 p90 -101.52 21.17 14.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.423 ' C ' HE22 ' A' ' 131' ' ' GLN . 35.0 m -64.78 -3.76 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -123.02 1.01 9.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.404 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.0 m-85 -101.03 78.62 1.94 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.423 HE22 ' C ' ' A' ' 128' ' ' VAL . 2.0 mp0 -92.2 -32.36 15.11 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.303 0.573 . . . . 0.0 110.023 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -141.78 121.62 13.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.772 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.56 108.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -96.4 -40.33 9.15 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 m -138.13 136.39 36.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 90' ' ' PHE . 44.1 tp -126.74 119.84 27.91 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.282 0.563 . . . . 0.0 110.236 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 93.6 m -102.27 121.32 42.03 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.591 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.4 mt -104.71 113.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 82.3 t80 -111.5 116.91 31.68 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.5 pp -106.91 136.03 43.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.633 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.0 pt-20 -123.47 -13.73 7.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.61 146.03 20.61 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.148 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -97.85 174.83 6.39 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.555 HE22 HD23 ' A' ' 113' ' ' LEU . 18.3 mp0 -60.47 -52.54 64.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.001 0.429 . . . . 0.0 110.855 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.3 t -92.04 -22.19 20.08 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.369 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.33 81.54 0.45 Allowed Glycine 0 CA--C 1.499 -0.928 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 149' ' ' VAL . 34.4 m -111.78 6.21 19.58 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.427 -0.386 . . . . 0.0 111.868 -172.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 67.76 -36.16 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.496 1.118 . . . . 0.0 112.72 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' SER . 4.6 p -102.87 132.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 123.498 0.719 . . . . 0.0 109.674 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.62 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 61.3 m -121.39 128.83 52.61 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -109.9 132.66 53.95 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 19.4 t -123.71 116.3 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 97.5 mt-30 -94.77 -19.48 20.32 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.363 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -172.34 134.33 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.588 0.355 . . . . 0.0 110.563 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.496 ' HB ' HD22 ' A' ' 40' ' ' LEU . 1.8 mp -129.88 117.85 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.93 147.78 35.81 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.897 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.54 141.18 48.07 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 122' ' ' PRO . 82.2 m-85 -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 14' ' ' VAL . . . -139.58 -168.34 11.27 Favored Glycine 0 CA--C 1.488 -1.651 0 C-N-CA 119.909 -1.138 . . . . 0.0 112.487 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.3 p -163.08 147.89 11.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 120.487 0.184 . . . . 0.0 110.883 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.411 HG23 HG22 ' A' ' 70' ' ' ILE . 18.0 p . . . . . 0 C--N 1.297 -1.716 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.382 170.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 11' ' ' LYS . 4.2 mp . . . . . 0 C--O 1.237 0.443 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.7 25.25 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.06 2.507 . . . . 0.0 110.887 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.639 ' H ' HG22 ' A' ' 9' ' ' ILE . 40.6 ttmt 61.85 99.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.767 1.227 . . . . 0.0 111.272 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.55 -78.83 0.19 Allowed Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.488 ' O ' HG23 ' A' ' 9' ' ' ILE . 28.0 mm-40 -109.7 168.42 9.42 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 15.5 m -105.34 156.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.886 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 17' ' ' LEU . 3.3 p30 -78.28 112.63 15.47 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 122.694 1.235 . . . . 0.0 109.531 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.603 ' O ' HG13 ' A' ' 20' ' ' ILE . 36.9 mt -68.65 6.04 0.93 Allowed 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.639 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.51 HD11 ' H ' ' A' ' 42' ' ' GLN . 5.2 tt -60.42 -41.65 94.38 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.67 -22.01 60.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.173 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 32.8 m-85 -93.71 15.11 17.17 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.982 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 16' ' ' LEU . 86.8 mt -95.97 134.95 31.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.52 -44.38 96.11 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 94.4 m95 66.46 7.19 4.84 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.96 -84.96 1.66 Allowed Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.497 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 t 39.16 84.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.951 1.3 . . . . 0.0 111.87 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -117.5 131.53 56.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.127 -168.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . 49.1 t -129.18 130.99 47.05 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.25 -72.01 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -70.69 -59.55 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 35.0 tt0 59.78 27.53 16.84 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.172 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 30.0 t 71.06 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.135 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -57.83 -34.12 69.34 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.238 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -109.67 -48.14 3.26 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 31' ' ' SER . 97.9 m-70 -99.58 164.92 11.87 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -169.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.432 ' C ' HD23 ' A' ' 52' ' ' LEU . 16.2 m -100.82 141.5 33.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.734 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 3.0 tm? -62.37 -46.38 90.09 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.094 0.558 . . . . 0.0 112.281 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 9.9 Cg_endo -52.04 -24.45 19.69 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.275 1.984 . . . . 0.0 112.492 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.545 ' HB3' HD13 ' A' ' 50' ' ' LEU . 96.6 m-20 -69.03 -19.3 64.11 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -110.2 1.22 18.57 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.232 0.539 . . . . 0.0 110.573 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -124.36 -40.36 2.25 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.36 103.52 16.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.151 0.5 . . . . 0.0 111.066 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' H ' HD11 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -75.51 113.35 12.83 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.98 -50.43 0.43 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 105.772 -2.931 . . . . 0.0 105.772 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -89.7 -41.27 12.01 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 153' ' ' GLN . 54.2 ttp180 -73.53 122.17 21.78 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.275 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.54 106.77 8.73 Favored 'General case' 0 C--N 1.262 -3.206 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 165.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 153' ' ' GLN 0.335 7.7 p-10 -64.03 84.54 0.03 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -166.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 160.42 99.71 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 128.758 2.823 . . . . 0.0 104.401 175.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.46 -103.47 0.46 Allowed Glycine 0 C--N 1.303 -1.271 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 38' ' ' ASN 0.251 1.9 pp -77.09 125.73 29.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.941 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -154.44 165.72 35.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 36' ' ' LEU . 2.9 tm? -94.84 112.13 23.87 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.5 pt-20 -131.15 121.33 24.7 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.771 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -69.59 149.23 48.39 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -103.99 -28.52 11.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.64 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.83 -53.87 2.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.042 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.74 158.36 44.08 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 117.489 -1.685 . . . . 0.0 115.333 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 41.9 mt-10 -70.15 -33.22 71.51 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.32 1.048 . . . . 0.0 112.119 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.25 109.54 12.46 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.657 0.741 . . . . 0.0 111.131 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' H ' HG13 ' A' ' 140' ' ' ILE . 14.7 tp -116.42 134.22 55.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.93 127.69 49.26 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -144.34 127.52 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 CA-C-O 121.473 0.654 . . . . 0.0 111.547 177.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 5.1 t80 -91.89 123.88 35.6 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.614 1.566 . . . . 0.0 111.414 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.426 HG23 HG23 ' A' ' 20' ' ' ILE . 35.3 mt -120.79 120.29 29.59 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -89.66 152.38 5.17 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.944 2.429 . . . . 0.0 111.178 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -88.15 162.79 16.53 Favored 'General case' 0 CA--C 1.474 -1.955 0 CA-C-O 121.919 0.866 . . . . 0.0 112.752 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -99.45 -32.94 10.89 Favored 'General case' 0 N--CA 1.404 -2.775 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.662 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.67 145.99 25.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.1 t -73.74 108.75 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.457 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -133.02 173.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -90.75 133.24 35.32 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.18 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.646 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.2 121.46 27.11 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.27 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -115.23 -46.16 2.91 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -153.62 169.23 23.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -139.88 154.49 47.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -141.1 117.33 10.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.415 HG23 HG12 ' A' ' 155' ' ' ILE . 60.0 mt -126.72 119.84 54.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.34 144.35 25.96 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.68 176.31 34.81 Favored Glycine 1 C--N 1.253 -4.08 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.69 178.09 6.14 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 CA-C-N 119.612 1.706 . . . . 0.0 111.03 175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -68.56 -44.35 74.66 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.402 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.59 -53.31 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.82 12.33 2.73 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 147.69 28.89 Favored Glycine 0 C--O 1.251 1.191 0 C-N-CA 120.134 -1.032 . . . . 0.0 110.768 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_endo -77.12 115.99 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.847 1.698 . . . . 0.0 110.209 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.631 ' HE3' ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -87.06 -71.04 0.58 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.025 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.8 m -75.34 102.05 4.96 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.488 0.661 . . . . 0.0 111.28 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 140' ' ' ILE . 34.9 m -101.76 144.44 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.397 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -133.75 133.79 42.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.91 146.06 43.21 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.672 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' ' 102' ' ' VAL . 95.1 m-85 -129.82 115.06 16.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 m -103.3 154.76 19.03 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 120.87 0.367 . . . . 0.0 110.748 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 73.96 -42.12 0.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.25 1.42 . . . . 0.0 112.853 173.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -69.08 122.44 18.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 0.0 110.081 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.565 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 35.9 tt0 -93.68 122.34 36.04 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.279 -174.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t60 58.4 96.08 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 124.174 0.989 . . . . 0.0 112.923 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 53.0 mtm -131.34 155.59 46.97 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.152 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' VAL . 24.5 p -109.19 -179.16 3.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -58.68 -30.6 67.51 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.838 0.455 . . . . 0.0 111.706 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 t -62.29 -41.61 98.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.057 0.455 . . . . 0.0 109.859 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 104' ' ' ASP . 94.7 m-20 -85.88 -15.8 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 98' ' ' CYS . 51.3 t -62.0 -29.23 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.588 0.709 . . . . 0.0 110.121 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.84 9.29 39.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.597 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 20.6 t70 -109.13 -48.27 3.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.414 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -97.5 127.01 39.33 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 53.0 Cg_exo -57.97 136.35 74.55 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.801 2.334 . . . . 0.0 111.782 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 19.2 Cg_exo -66.28 158.03 57.07 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.723 2.282 . . . . 0.0 112.878 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -70.19 -45.77 65.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -164.84 157.44 16.35 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -141.16 117.06 10.45 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.58 172.5 11.51 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.944 -170.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.2 mp0 -117.04 137.81 52.01 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.9 tp -61.55 113.09 2.5 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.704 0.801 . . . . 0.0 109.049 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.6 t -107.11 165.45 11.35 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.57 -37.44 62.93 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.202 0.525 . . . . 0.0 111.57 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.14 -35.05 70.93 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.634 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.67 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -71.31 -36.87 71.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.756 -175.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.85 -21.84 65.16 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -83.61 6.68 19.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.979 0.895 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.32 26.3 64.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.438 -1.256 . . . . 0.0 113.591 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -92.57 135.02 26.97 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.944 0.372 . . . . 0.0 111.492 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.519 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 35.5 Cg_endo -65.51 109.46 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.323 2.682 . . . . 0.0 112.465 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.9 t -86.97 132.25 32.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.1 m -80.59 132.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.582 0.706 . . . . 0.0 112.67 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.37 -178.92 3.8 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.696 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.58 105.36 0.2 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.826 0.822 . . . . 0.0 111.102 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -111.1 -22.69 11.32 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.416 -170.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.1 t -71.2 -27.52 29.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.362 0.601 . . . . 0.0 111.028 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -96.63 -10.28 27.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.563 0.697 . . . . 0.0 110.538 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.539 ' HB3' HD11 ' A' ' 72' ' ' LEU . 83.2 m-85 -120.43 112.7 19.31 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -123.77 -0.64 8.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.302 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -149.21 127.55 12.19 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.974 -175.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.9 t -97.58 115.07 36.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.523 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' SER . 12.7 mmm180 -115.19 -0.38 13.28 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.261 174.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' ARG . 12.0 t 171.98 163.67 0.1 Allowed 'General case' 0 C--O 1.252 1.214 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -155.56 119.88 4.63 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.128 0.489 . . . . 0.0 110.012 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.1 m -108.76 126.92 53.54 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.5 mp -104.38 124.09 58.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -124.36 131.0 53.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.425 HG22 HG12 ' A' ' 88' ' ' VAL . 26.3 pt -116.02 132.01 66.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.582 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -107.41 -31.08 8.31 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.16 143.7 27.26 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.433 0.635 . . . . 0.0 111.899 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.465 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 5.8 m-20 -96.56 163.07 13.19 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.043 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.631 ' OE1' ' HE3' ' A' ' 86' ' ' LYS . 6.4 tp-100 -47.94 -45.73 31.34 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 112.778 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.2 t -122.55 16.2 10.38 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.497 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.44 4.3 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.6 m -96.09 11.87 32.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.319 13.0 pt-20 63.3 -23.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.368 1.867 . . . . 0.0 115.163 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.78 158.93 37.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 27.6 m -121.45 136.93 54.91 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 121.338 -0.145 . . . . 0.0 111.231 -175.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -114.99 134.23 55.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 27.5 m -129.71 122.09 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 110.013 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 18.3 mm-40 -87.96 -44.73 10.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.054 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.64 111.49 5.07 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.877 -174.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.415 HG12 HG23 ' A' ' 77' ' ' ILE . 65.9 mt -109.54 125.52 66.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.84 144.46 32.53 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.107 0.48 . . . . 0.0 110.488 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 5.3 mp -106.88 138.16 43.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 98.7 m-85 -125.22 135.34 52.46 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.033 0.444 . . . . 0.0 112.046 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -158.0 -156.97 8.19 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.9 t -153.23 149.44 27.97 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.749 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 C--O 1.255 1.355 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.137 174.188 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.408 ' CG1' ' HB2' ' A' ' 15' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.28 130.98 26.87 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.484 1.456 . . . . 0.0 110.677 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -69.21 99.17 1.11 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.68 -36.38 0.63 Allowed Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.449 ' HA ' ' OG ' ' A' ' 160' ' ' SER . 28.9 mm-40 -120.35 -173.98 2.69 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -134.41 153.42 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 11.1 t0 -71.42 127.98 34.34 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 20' ' ' ILE . 57.3 mt -76.51 -1.45 27.34 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.37 -36.03 41.39 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.809 0.814 . . . . 0.0 109.306 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.31 -24.22 66.5 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.001 -175.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -106.52 7.06 30.67 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 16' ' ' LEU . 77.3 mt -85.34 136.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.96 115.17 27.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -88.52 10.09 21.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.9 m -97.79 -33.8 11.13 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.318 0.58 . . . . 0.0 109.438 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.82 -18.89 53.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.945 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG21 HD12 ' A' ' 36' ' ' LEU . 7.1 p -48.61 126.06 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.02 143.84 49.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.805 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 36' ' ' LEU . 80.2 m -136.47 133.42 36.57 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.037 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -61.13 -40.57 94.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.746 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.567 ' HB3' HD12 ' A' ' 60' ' ' LEU . 62.2 t30 -126.65 149.28 49.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.428 ' H ' ' H ' ' A' ' 31' ' ' SER . 12.8 pt20 164.1 -5.63 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 126.791 2.036 . . . . 0.0 107.007 -168.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 30' ' ' GLN . 38.9 t -65.66 -19.61 65.97 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.682 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 m -55.44 16.83 0.0 OUTLIER 'General case' 0 CA--C 1.594 2.642 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.6 t 75.33 -1.05 3.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.17 0.988 . . . . 0.0 113.218 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -125.05 153.0 43.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -107.27 167.62 9.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.903 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.525 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.1 tm? -57.52 -49.72 92.25 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.632 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 4.6 Cg_endo -48.98 -25.99 9.56 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.866 2.378 . . . . 0.0 112.879 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.532 ' HA ' HD12 ' A' ' 50' ' ' LEU . 2.1 m-20 -60.93 -31.68 71.21 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.24 0.616 . . . . 0.0 111.607 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -121.96 23.53 9.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.09 0.472 . . . . 0.0 110.329 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 155' ' ' ILE . 0.7 OUTLIER -139.91 -36.7 0.49 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.72 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -78.32 105.98 9.93 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-O 121.237 0.542 . . . . 0.0 111.051 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HG2' ' NH2' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -49.91 118.2 2.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.3 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.17 -62.26 0.59 Allowed Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.588 ' HB3' ' HG ' ' A' ' 50' ' ' LEU . 21.7 m-85 -99.03 -11.08 21.82 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.722 -0.281 . . . . 0.0 110.349 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.524 ' NH2' ' HG2' ' A' ' 42' ' ' GLN 0.371 3.4 ppt_? -70.26 -4.69 23.09 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 -170.104 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -83.33 156.6 22.95 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.367 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.03 145.63 41.28 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 81.86 2.14 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.992 1.717 . . . . 0.0 111.735 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.443 ' O ' HD23 ' A' ' 50' ' ' LEU . . . -95.98 -86.01 1.74 Allowed Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' A' ' 44' ' ' TYR . 7.1 mt -135.24 170.31 16.12 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.5 p-10 -157.86 152.83 25.42 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 119.115 0.87 . . . . 0.0 109.272 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.521 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 55.2 tp -87.11 142.58 27.81 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.68 148.97 44.67 Favored 'General case' 0 C--N 1.255 -3.505 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.583 ' HB3' ' H ' ' A' ' 150' ' ' THR . 23.3 t -112.75 21.37 15.6 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.648 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.39 84.93 0.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.109 0.48 . . . . 0.0 111.116 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 174.29 -44.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.778 1.631 . . . . 0.0 107.952 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -140.26 157.62 45.3 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.416 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 148' ' ' GLU . 0.8 OUTLIER -79.17 -25.33 42.8 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -177.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -101.97 151.04 22.59 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.497 0.665 . . . . 0.0 110.705 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 29' ' ' ASN . 24.2 tp -134.89 131.33 37.2 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 5.6 tt -140.66 127.63 20.68 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.63 132.07 71.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -106.82 122.86 47.23 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.222 0.609 . . . . 0.0 109.537 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -116.83 119.91 34.79 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.981 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -95.92 123.0 0.28 Allowed 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.757 2.304 . . . . 0.0 111.319 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.62 155.27 17.38 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.763 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -73.36 -14.76 61.34 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -157.95 177.72 11.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 29.5 m -89.03 132.4 33.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.728 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.91 171.92 11.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.488 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -85.35 113.75 21.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.79 154.48 41.9 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 58.1 t-80 -153.49 -67.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 p -142.18 152.44 43.16 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.426 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 42.0 p90 -125.55 155.19 41.04 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.78 116.7 6.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.775 0.321 . . . . 0.0 110.528 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG23 HG12 ' A' ' 155' ' ' ILE . 63.9 mt -119.75 134.41 63.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -123.97 168.51 12.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.028 0.442 . . . . 0.0 110.162 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 153' ' ' GLN . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.33 134.72 23.27 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 CA-C-N 119.61 1.705 . . . . 0.0 108.547 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.48 -37.37 62.63 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.43 -36.43 19.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.72 0.16 56.73 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.15 33.03 Favored Glycine 0 C--O 1.26 1.726 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.033 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.8 Cg_endo -84.24 125.54 3.52 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.853 2.369 . . . . 0.0 111.323 -176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 32.8 ttpt -91.26 -72.09 0.6 Allowed 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.946 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.4 m -77.93 97.58 5.36 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.105 0.479 . . . . 0.0 110.072 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 140' ' ' ILE . 24.3 m -108.59 139.52 30.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.484 ' CG ' ' HB3' ' A' ' 139' ' ' PHE . 18.2 ptpt -125.39 155.3 40.59 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 24.6 m-85 -132.07 151.19 51.9 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.553 ' CE2' ' HB ' ' A' ' 137' ' ' THR . 22.5 p90 -154.72 149.94 27.07 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 123.528 0.517 . . . . 0.0 109.838 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.8 m -127.22 155.77 42.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 69.67 -37.93 0.39 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.087 2.155 . . . . 0.0 116.015 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.589 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 1.1 tpmt? -75.19 109.41 8.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.135 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.03 149.18 24.15 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 65.52 62.48 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 109.13 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.3 tpp -134.77 110.13 9.02 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.251 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.476 ' O ' HG13 ' A' ' 102' ' ' VAL . 75.2 m -129.41 -172.22 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -52.13 -29.9 23.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -88.8 -1.39 58.06 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.967 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -118.29 -32.45 4.66 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.83 0.348 . . . . 0.0 110.104 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 98' ' ' CYS . 31.0 m -58.62 -15.58 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -171.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -93.1 73.57 4.68 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.664 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 172.69 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.74 1.216 . . . . 0.0 110.53 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.76 128.31 40.08 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.22 122.58 11.36 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.937 2.425 . . . . 0.0 112.61 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 91' ' ' PHE . 83.2 Cg_endo -82.08 -178.56 4.17 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 122.26 1.974 . . . . 0.0 110.711 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.618 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 18.3 m -76.78 -47.17 22.43 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 110' ' ' THR . 18.7 t70 172.58 -167.1 0.02 OUTLIER 'General case' 0 C--O 1.248 0.999 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.409 ' H ' ' CG ' ' A' ' 109' ' ' ASP . 7.4 t -148.99 143.18 25.95 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.84 12.13 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.695 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 33.5 mt-10 -120.92 140.26 52.09 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 124.227 1.011 . . . . 0.0 110.252 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 57.8 tp -59.58 101.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.078 0.861 . . . . 0.0 110.322 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 117' ' ' ASN . 4.4 t -95.26 164.43 12.85 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.978 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.5 -23.89 59.12 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.616 0.766 . . . . 0.0 110.385 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.515 ' OE2' HG22 ' A' ' 123' ' ' VAL . 31.0 tt0 -71.88 -45.41 61.38 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.515 ' H ' HG23 ' A' ' 114' ' ' THR . 48.3 m-20 -65.42 -47.78 75.08 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.951 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.18 -30.84 66.73 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.599 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -92.41 -1.82 56.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.328 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.8 20.49 26.27 Favored Glycine 0 CA--C 1.494 -1.266 0 C-N-CA 120.318 -0.944 . . . . 0.0 114.727 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 1.0 OUTLIER -95.81 134.46 23.98 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.821 177.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 12.7 Cg_exo -70.86 109.83 2.63 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.426 2.084 . . . . 0.0 111.271 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.515 HG22 ' OE2' ' A' ' 116' ' ' GLU . 94.3 t -87.5 128.24 40.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.7 m -77.56 125.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.164 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.49 175.91 6.5 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.46 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . 0.313 50.0 mtmt -91.48 84.94 5.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.898 1.332 . . . . 0.0 113.782 -175.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.54 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 36.2 p90 -87.94 19.16 3.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.848 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -60.01 -29.1 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -107.22 10.72 29.85 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.434 174.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.618 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 91.4 m-85 -123.47 86.28 2.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 112.074 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -105.63 -9.19 17.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 3.6 p-10 -144.08 113.69 7.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.813 0.816 . . . . 0.0 111.304 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 65.9 t -122.53 120.65 61.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.032 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.453 ' HB2' HG12 ' A' ' 69' ' ' VAL . 43.1 ttp180 -103.0 -38.92 7.13 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.1 m -120.72 134.0 55.31 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.3 tp -126.02 140.24 52.77 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.553 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 22.8 m -134.21 131.36 38.46 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 3.0 mp -111.7 128.04 68.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HB3' ' CG ' ' A' ' 89' ' ' LYS . 51.6 t80 -122.76 126.31 47.21 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.556 HG12 ' H ' ' A' ' 60' ' ' LEU . 24.2 pt -95.42 129.2 45.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 117.98 -1.488 . . . . 0.0 107.505 172.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -93.92 -24.03 17.85 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.214 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -166.2 142.76 5.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.084 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -90.82 161.79 15.12 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.488 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 6.8 tp-100 -46.23 -44.86 16.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.058 0.943 . . . . 0.0 112.227 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.5 p -124.42 9.87 8.51 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.298 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 59.62 70.62 0.95 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 149' ' ' VAL . 22.8 t -86.7 -10.11 54.45 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.921 -165.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 40.0 mt-10 66.9 -44.6 0.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.291 0.637 . . . . 0.0 110.869 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 147' ' ' SER . 3.3 p -119.34 96.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-O 122.386 1.089 . . . . 0.0 109.197 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.583 ' H ' ' HB3' ' A' ' 54' ' ' SER . 31.1 m -82.15 119.65 24.32 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.587 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.16 132.36 35.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.3 t -119.71 115.49 47.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.035 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.477 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 53.3 tt0 -71.69 -63.7 1.07 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -160.48 145.19 14.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.375 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.501 ' O ' HD22 ' A' ' 40' ' ' LEU . 78.3 mt -120.5 114.64 44.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.32 160.81 36.23 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.94 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 6.7 tt -147.23 140.43 25.28 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.466 ' N ' HD23 ' A' ' 157' ' ' LEU . 76.9 m-85 -114.67 141.91 47.17 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.333 0.587 . . . . 0.0 110.19 -175.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -156.89 -165.3 14.65 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 13' ' ' GLN . 75.4 m -164.72 167.42 19.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.993 0.897 . . . . 0.0 109.046 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.264 -3.138 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.756 175.204 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.26 178.73 7.12 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.762 2.308 . . . . 0.0 111.827 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -97.75 101.5 13.02 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.48 -39.68 0.7 Allowed Glycine 0 C--N 1.303 -1.292 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.543 ' HG3' ' OG ' ' A' ' 74' ' ' SER . 1.4 pm0 -135.48 149.37 49.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.818 0.847 . . . . 0.0 109.766 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 4.4 m -111.37 170.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 123.431 0.457 . . . . 0.0 110.501 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.0 98.64 0.78 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.457 1.122 . . . . 0.0 110.285 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 16' ' ' LEU . 2.4 tm? -55.72 -23.81 31.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.267 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.9 tt -53.0 -35.95 59.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.311 1.044 . . . . 0.0 110.986 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.0 -20.45 61.01 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -94.65 22.33 6.39 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.096 0.474 . . . . 0.0 110.964 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.4 131.46 47.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' PHE . 20.9 t70 -80.13 -23.54 41.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.219 0.533 . . . . 0.0 111.185 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' A' ' 40' ' ' LEU . 97.3 m95 67.43 10.22 7.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.1 p -87.1 10.82 15.48 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.278 0.561 . . . . 0.0 110.768 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.04 -88.35 0.13 Allowed Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' H ' ' HD3' ' A' ' 65' ' ' PRO 0.276 11.0 p 43.9 75.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.196 1.399 . . . . 0.0 113.002 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -119.72 151.16 39.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.596 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 49.2 t -136.6 130.96 33.09 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -45.58 -63.34 0.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.724 1.209 . . . . 0.0 112.38 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -90.2 -57.76 2.74 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 34.2 tt0 69.51 -78.56 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.782 1.233 . . . . 0.0 107.889 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 35.7 t 176.35 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -53.29 -20.09 3.9 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -130.63 -34.07 1.58 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' SER . 94.5 m-70 -93.39 163.92 13.41 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.983 -0.448 . . . . 0.0 111.853 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -122.96 150.27 43.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.477 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 53.1 tp -70.49 -48.87 17.01 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 7.7 Cg_endo -48.23 -28.04 10.5 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.584 2.19 . . . . 0.0 113.003 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.2 m-20 -66.29 -29.38 69.59 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.912 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -116.06 6.07 13.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.712 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.504 HD12 ' CH2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -104.41 -43.76 5.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 18.6 ptpt -90.53 148.1 22.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.656 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 20.5 mm-40 -81.64 144.62 31.08 Favored 'General case' 0 CA--C 1.473 -2.002 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.607 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 121.72 -50.38 0.84 Allowed Glycine 0 N--CA 1.397 -3.927 0 C-N-CA 119.115 -1.517 . . . . 0.0 111.013 -171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.58 ' O ' HD11 ' A' ' 50' ' ' LEU . 96.8 m-85 -92.97 -10.47 36.25 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -55.86 25.98 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.075 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -95.08 102.09 13.88 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.35 97.86 1.01 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.249 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -156.75 -80.45 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.31 1.444 . . . . 0.0 110.226 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.23 -26.21 24.26 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 44' ' ' TYR . 2.3 pp -126.31 137.17 53.46 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.798 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.1 p-10 -163.77 166.77 21.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.503 ' HB3' ' CG2' ' A' ' 152' ' ' VAL . 40.4 tp -103.84 106.87 17.51 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.754 -1.578 . . . . 0.0 108.515 171.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -127.66 134.7 49.62 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.847 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 62.4 p -64.96 160.69 20.14 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.383 0.427 . . . . 0.0 110.243 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -123.84 -78.82 0.6 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.544 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.76 -14.76 36.36 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.742 0.306 . . . . 0.0 111.258 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' SER . 32.0 t70 -156.05 148.98 24.17 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.229 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HB2' HD21 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -99.96 14.17 31.44 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -83.71 119.22 24.52 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.437 0.637 . . . . 0.0 110.152 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.529 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 3.8 mm? -115.46 107.34 15.05 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.558 0.694 . . . . 0.0 111.32 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 6.3 tt -116.76 115.46 25.64 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.2 mt -113.42 136.59 49.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 123.328 0.651 . . . . 0.0 111.113 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 95' ' ' GLU . 93.4 t80 -107.94 123.97 49.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -108.08 115.52 58.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.298 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HD3' ' H ' ' A' ' 25' ' ' VAL . 63.6 Cg_endo -77.83 142.8 20.36 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.706 2.27 . . . . 0.0 109.53 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HD1' ' H ' ' A' ' 66' ' ' PHE . 2.2 p90 -101.68 162.04 13.2 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -167.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -91.99 -50.9 5.46 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.869 -2.423 . . . . 0.0 108.482 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -156.57 177.93 10.91 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.222 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.73 124.03 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.414 HD11 HD21 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.92 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -92.93 115.72 28.38 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 125' ' ' LEU . 1.1 tm? -73.81 124.23 25.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -120.38 -49.94 2.24 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.911 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.543 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 50.3 p -143.95 161.76 37.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -134.99 152.9 52.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -146.82 115.95 6.95 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.08 0.467 . . . . 0.0 111.305 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.466 ' HB ' HD11 ' A' ' 113' ' ' LEU . 69.1 mt -123.63 128.46 74.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 4.7 tmtt? -112.26 120.5 41.94 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.409 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -149.25 -172.99 19.46 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -66.36 -175.7 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.83 2.353 . . . . 0.0 111.48 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -71.67 -56.88 4.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -173.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.28 -18.13 20.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.297 0.57 . . . . 0.0 112.135 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.52 15.68 6.38 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.486 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.53 156.98 16.0 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.451 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 32.2 Cg_exo -62.68 153.26 73.3 Favored 'Trans proline' 0 C--O 1.204 -1.192 0 C-N-CA 122.095 1.863 . . . . 0.0 110.16 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 37.2 ttpt -126.27 -65.41 0.98 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.868 -0.52 . . . . 0.0 110.377 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.9 m -75.75 101.74 5.16 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.24 0.543 . . . . 0.0 110.464 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 86' ' ' LYS . 52.5 t -106.02 130.52 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.103 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -130.61 151.84 50.64 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.769 0.828 . . . . 0.0 110.139 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' A' ' 125' ' ' LEU . 14.0 m-85 -136.0 160.71 37.8 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.178 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.35 116.69 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.45 ' HB2' HG22 ' A' ' 133' ' ' VAL . 21.8 p -84.24 14.6 4.18 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.89 1.276 . . . . 0.0 114.342 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -147.05 172.22 14.07 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.061 -0.4 . . . . 0.0 110.133 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 3.4 ttmp? 69.94 145.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 10.4 pt-20 -102.81 138.25 39.95 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.467 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m80 55.82 72.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.507 0.723 . . . . 0.0 112.489 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.48 ' HB3' HG21 ' A' ' 137' ' ' THR . 12.6 tpt -90.85 94.15 9.53 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.03 154.06 29.76 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.772 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.567 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 72.9 t80 -57.36 -23.23 47.74 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.7 t -79.71 -11.97 59.82 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.943 -0.473 . . . . 0.0 110.637 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -124.36 -13.31 7.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.583 . . . . 0.0 110.61 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.567 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 6.4 p -62.9 -30.06 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 C-N-CA 124.451 1.1 . . . . 0.0 112.129 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -109.03 -1.66 18.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.331 0.586 . . . . 0.0 111.098 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -82.65 -40.24 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -100.63 139.38 20.55 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.3 140.95 94.45 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.86 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.66 179.1 5.97 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.771 2.314 . . . . 0.0 110.747 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.725 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 44.8 m -79.56 -49.13 12.67 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.442 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -162.0 -179.6 7.26 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -153.27 150.49 29.0 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.73 169.21 18.2 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.495 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 5.6 tp10 -126.18 106.64 9.7 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.1 tt -73.05 122.57 21.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.7 p -122.04 -176.58 3.37 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.643 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.607 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 1.6 mp0 -51.77 -36.34 47.11 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 125.118 1.367 . . . . 0.0 109.813 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.505 ' CG ' ' HD2' ' A' ' 121' ' ' LYS . 40.4 tt0 -64.56 -38.78 92.21 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.443 HD22 ' CG2' ' A' ' 123' ' ' VAL . 23.8 t-20 -71.0 -38.28 72.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.81 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.44 -14.42 60.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.55 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.52 -1.69 56.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.555 0.693 . . . . 0.0 109.687 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.39 27.47 20.24 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.602 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.505 ' HD2' ' CG ' ' A' ' 116' ' ' GLU . 96.6 mttt -99.81 142.49 24.72 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 117.271 0.536 . . . . 0.0 111.146 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 39.6 Cg_endo -73.83 103.78 1.71 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.897 1.731 . . . . 0.0 109.313 170.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.443 ' CG2' HD22 ' A' ' 117' ' ' ASN . 78.9 t -84.58 127.34 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.748 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.68 101.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.652 ' HG ' ' H ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -54.57 -71.53 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.293 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.652 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 80.1 tttt -171.47 165.39 6.96 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -144.31 24.8 1.58 Allowed 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.689 -171.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.91 -47.24 13.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.725 ' HB3' ' O ' ' A' ' 108' ' ' SER . 8.8 tmtt? -111.29 -9.12 14.3 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.694 -166.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.406 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 39.7 p90 -60.51 10.2 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.927 0 O-C-N 121.497 -0.752 . . . . 0.0 112.94 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 129' ' ' LYS . 79.9 mm-40 -59.7 119.42 7.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.217 0.532 . . . . 0.0 111.279 -166.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.355 0.2 OUTLIER 59.54 113.74 0.01 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 128.078 2.551 . . . . 0.0 112.997 -170.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 92' ' ' SER . 63.3 t -102.3 110.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.892 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 134' ' ' ARG . 31.8 mmt180 -88.75 -31.5 18.38 Favored 'General case' 0 C--O 1.19 -2.077 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.575 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -160.86 164.09 31.56 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 tp -126.86 118.82 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 117.684 -1.607 . . . . 0.0 112.889 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 97' ' ' MET . 91.7 m -103.03 123.87 47.44 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.12 109.85 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 141' ' ' GLU . 53.1 t80 -114.5 111.72 21.83 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.407 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 1.8 pp -104.53 131.44 53.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.1 pt-20 -112.37 -2.27 14.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.06 142.16 5.92 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.311 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 HD21 ' HB2' ' A' ' 58' ' ' GLU . 38.4 m-80 -83.67 177.76 8.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.809 0.693 . . . . 0.0 109.864 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 2.4 mp0 -50.11 -58.53 5.34 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.4 m -119.64 -22.31 6.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.954 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.43 1.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 m -84.37 16.33 3.14 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.445 0.698 . . . . 0.0 112.305 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 73.48 -52.15 0.7 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.652 1.181 . . . . 0.0 111.078 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.18 106.09 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.014 0.912 . . . . 0.0 111.397 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.0 m -82.68 116.26 21.98 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.465 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -104.29 133.97 48.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.503 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 30.5 m -132.96 128.15 56.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.201 0.524 . . . . 0.0 109.609 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -84.41 -33.79 23.67 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -166.38 141.46 4.47 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.164 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.419 HG23 HG12 ' A' ' 77' ' ' ILE . 71.9 mt -121.6 111.98 33.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.49 124.58 21.56 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 159.4 15.47 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 83.8 m-85 -125.37 113.44 17.56 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.15 0.5 . . . . 0.0 109.939 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.62 167.2 12.25 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.0 m -120.34 132.98 55.52 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 117.39 0.595 . . . . 0.0 110.55 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--N 1.281 -2.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.832 173.256 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 15' ' ' ASP . 2.6 mp . . . . . 0 N--CA 1.44 -0.933 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.56 159.4 19.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.602 2.201 . . . . 0.0 110.421 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -83.81 101.9 11.95 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.834 0.826 . . . . 0.0 111.961 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.96 -30.77 2.34 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.205 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -121.96 170.15 10.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 122.281 -0.54 . . . . 0.0 110.783 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.94 143.01 18.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.572 ' HB2' HG13 ' A' ' 9' ' ' ILE . 11.8 t70 -71.95 127.43 32.53 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.86 0.362 . . . . 0.0 110.108 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 19' ' ' PHE . 33.2 mt -101.33 3.47 40.68 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 42' ' ' GLN . 3.1 tm? -73.06 -35.33 66.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.165 0.983 . . . . 0.0 108.541 -177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.94 -9.83 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.044 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 92.0 t80 -97.77 14.26 27.57 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 124.766 1.226 . . . . 0.0 110.977 -172.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.7 mt -88.84 142.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.489 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -93.9 120.24 33.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -92.93 7.9 42.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 m -103.64 -12.11 17.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.258 0.552 . . . . 0.0 110.836 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.95 -18.53 5.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.396 -0.906 . . . . 0.0 113.578 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.75 129.5 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.9 142.93 50.7 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.776 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' ' NE2' ' A' ' 30' ' ' GLN . 9.3 p -131.87 119.7 21.55 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.536 -175.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 3.8 mm? -94.41 132.34 39.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.222 0.534 . . . . 0.0 110.214 176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' A' ' 56' ' ' ALA . 64.0 t30 68.65 -70.97 0.12 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 126.945 2.098 . . . . 0.0 110.186 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 8.1 tt0 63.31 -168.93 0.2 Allowed 'General case' 0 C--N 1.372 1.573 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.661 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 41.5 t -93.39 123.42 36.68 Favored 'General case' 0 C--N 1.251 -3.714 0 O-C-N 120.449 -1.407 . . . . 0.0 108.477 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -57.93 -17.46 16.95 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.891 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -100.16 -43.6 6.26 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.661 ' O ' ' HB3' ' A' ' 31' ' ' SER . 83.4 m-70 -122.06 151.97 40.31 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 122.05 -0.406 . . . . 0.0 110.745 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.542 ' HA ' ' OE1' ' A' ' 30' ' ' GLN . 49.0 m -87.98 160.89 17.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.72 -49.47 2.1 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.68 -23.99 28.22 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.072 1.848 . . . . 0.0 111.284 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.566 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.2 m-20 -58.91 -27.68 65.48 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 125.636 1.574 . . . . 0.0 111.453 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -123.7 8.41 8.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 tp -118.36 -47.71 2.54 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.649 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -83.0 130.81 35.18 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.81 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.419 ' HG2' HH21 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -67.94 123.26 20.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.43 -47.49 0.98 Allowed Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.084 -2.007 . . . . 0.0 108.084 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -93.93 -44.37 8.11 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.419 HH21 ' HG2' ' A' ' 42' ' ' GLN . 58.9 ttp85 -54.97 101.96 0.06 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.389 -176.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 178.45 125.07 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.696 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 18.5 t70 -68.07 85.36 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.696 ' HG3' ' O ' ' A' ' 47' ' ' ASP . 35.3 mt-10 -173.1 108.08 0.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 127.227 2.211 . . . . 0.0 110.137 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.27 -52.87 4.11 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.996 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.566 ' HB2' HD22 ' A' ' 38' ' ' ASN . 1.3 pt? -133.44 127.77 34.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 122.737 -0.273 . . . . 0.0 110.405 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' A' ' 153' ' ' GLN . 6.7 t30 -161.35 153.32 19.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.46 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 2.8 tm? -85.32 110.25 18.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.941 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' THR . 12.6 pt-20 -132.31 112.65 12.4 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.5 p -59.95 137.37 58.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -141.74 85.42 1.94 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.519 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . 164.94 -50.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.155 1.782 . . . . 0.0 107.129 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -147.7 155.71 42.02 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.085 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -85.08 -25.2 27.72 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -77.0 130.83 38.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.738 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.8 mt -133.88 143.07 48.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.622 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.5 tm? -135.08 119.47 17.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.8 mp -123.85 129.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -105.63 122.84 46.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.24 113.02 39.3 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.685 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -90.27 125.33 1.21 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 122.58 2.186 . . . . 0.0 108.835 168.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.465 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 90.3 m-85 -87.92 158.17 18.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -59.69 -51.75 68.44 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.251 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -125.41 173.23 9.02 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.087 -0.383 . . . . 0.0 109.981 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 120.908 0.385 . . . . 0.0 110.501 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -132.87 172.61 16.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -96.83 136.23 37.68 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 130' ' ' PHE . 82.6 mt -76.01 146.63 39.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 27.6 t60 -124.83 -50.54 1.71 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -139.46 163.37 32.7 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 49.7 p90 -136.23 154.47 50.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -149.81 106.39 3.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.502 0.668 . . . . 0.0 111.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.13 131.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.543 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 53.6 mtpt -121.16 161.82 21.17 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.05 0.452 . . . . 0.0 111.716 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.07 -169.18 39.28 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' CG ' ' HD2' ' A' ' 151' ' ' LYS . 14.2 Cg_exo -73.37 166.47 29.8 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.937 2.424 . . . . 0.0 111.157 175.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 118' ' ' LEU . 13.3 pt-20 -58.66 -41.48 86.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.12 -26.26 15.55 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -92.53 11.29 26.88 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.891 -169.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.21 146.13 18.15 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.778 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 22.7 Cg_exo -67.05 110.05 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.332 2.021 . . . . 0.0 111.356 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HB2' HE21 ' A' ' 144' ' ' GLN . 0.8 OUTLIER -82.84 -39.67 21.36 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.925 -176.552 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.1 m -103.44 112.01 24.7 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.84 130.2 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.015 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -117.29 146.28 43.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.74 149.22 52.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 65.6 t80 -143.42 115.77 8.52 Favored 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.494 169.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 135' ' ' SER . 48.9 m -102.36 153.73 19.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.677 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 81.44 145.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.052 1.341 . . . . 0.0 108.573 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 72.9 116.0 0.05 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.57 149.74 29.81 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.689 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.267 13.9 p-80 50.31 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 88.1 mtp -139.6 142.08 37.11 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 22.8 p -120.06 174.08 6.69 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -69.84 -18.86 63.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 p -77.72 -21.72 51.48 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -130.35 18.75 5.34 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.72 -32.28 51.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.177 0.513 . . . . 0.0 110.717 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -97.27 73.53 2.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.637 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -124.41 -4.17 7.83 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -139.24 156.51 71.95 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.648 -1.615 . . . . 0.0 106.862 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.83 140.93 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.117 1.212 . . . . 0.0 109.589 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.72 153.52 36.1 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 122.42 2.08 . . . . 0.0 111.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 31.8 m -62.09 -44.8 95.88 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.717 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -169.56 166.78 9.98 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -139.24 139.71 37.52 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.4 172.71 11.57 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.673 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 37.2 tt0 -122.61 134.54 54.51 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 34.0 tp -62.99 108.58 1.24 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.701 0.626 . . . . 0.0 109.713 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.5 m -82.23 156.85 24.17 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -54.27 -39.58 67.0 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.191 0.596 . . . . 0.0 111.046 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' HB3' ' HD3' ' A' ' 121' ' ' LYS . 44.9 mt-10 -70.94 -31.47 68.07 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.244 0.618 . . . . 0.0 112.231 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.627 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.7 t-20 -62.56 -39.68 94.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 118' ' ' LEU . 7.5 tt -71.99 -7.62 49.79 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 45.2 mmtm -104.3 -14.15 15.89 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 121.761 -0.587 . . . . 0.0 110.136 176.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.543 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 127.59 -14.43 6.43 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 119.926 -1.131 . . . . 0.0 114.005 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 53.8 mtpt -74.88 133.36 76.13 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 35.8 Cg_exo -64.15 116.99 4.04 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.541 2.828 . . . . 0.0 111.707 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 135.7 26.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.92 131.29 34.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.16 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.38 177.47 5.03 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.809 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.6 96.49 10.49 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -80.08 21.83 0.55 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.89 -13.58 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.09 21.06 9.82 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.365 0.602 . . . . 0.0 110.668 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.636 ' CD2' HD12 ' A' ' 72' ' ' LEU . 96.3 m-85 -122.62 27.01 8.02 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.444 -173.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -63.22 -35.59 80.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -129.16 115.51 17.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.28 0.562 . . . . 0.0 109.805 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.476 HG21 ' HG ' ' A' ' 72' ' ' LEU . 47.4 t -121.15 104.47 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -108.27 -44.04 4.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 170.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' SER . 32.9 t -104.91 130.78 53.0 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.943 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.3 tp -137.87 104.23 5.21 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.137 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.5 m -92.3 115.42 28.07 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.74 122.73 58.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -121.53 127.71 51.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.897 0.38 . . . . 0.0 110.439 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 60' ' ' LEU . 12.0 pt -133.29 116.44 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -31.47 4.11 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.378 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.77 126.45 52.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.83 -174.84 2.65 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.709 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.517 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.2 mp0 -56.4 -66.51 0.42 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.6 t -120.14 9.27 11.09 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.545 -173.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.27 93.21 0.2 Allowed Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 23.4 t -111.99 -1.86 15.27 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 147' ' ' SER . 10.2 pt-20 68.0 -40.85 0.43 Allowed 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 126.764 2.026 . . . . 0.0 111.344 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.53 113.28 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.4 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 43.7 m -92.92 125.64 37.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 80' ' ' PRO . 39.2 ttmt -123.52 133.67 53.98 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.5 120.02 31.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.008 0.432 . . . . 0.0 111.117 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.472 ' HA ' ' OD1' ' A' ' 51' ' ' ASN . 4.7 pt20 -93.21 -6.24 48.17 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.675 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.401 ' CB ' ' HD2' ' A' ' 45' ' ' ARG . 38.5 pttt -172.11 144.81 1.7 Allowed 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.84 109.97 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 165.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.64 134.08 29.91 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 5.5 mp -117.85 156.29 28.64 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -123.14 127.97 49.42 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.22 -163.92 10.25 Favored Glycine 0 C--N 1.302 -1.329 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.381 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.6 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.1 t -142.18 143.29 32.87 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 117.428 0.614 . . . . 0.0 109.715 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 70' ' ' ILE . 41.0 p . . . . . 0 N--CA 1.433 -1.286 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.045 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.44 -0.932 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.24 144.0 14.36 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.971 1.781 . . . . 0.0 110.451 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.12 105.68 1.44 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.543 0.687 . . . . 0.0 110.214 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.79 -23.28 3.98 Favored Glycine 0 N--CA 1.42 -2.378 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.38 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -129.83 174.89 9.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.21 145.05 34.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -77.84 130.33 36.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' A' ' 70' ' ' ILE . 4.1 mm? -68.15 -8.85 42.07 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.822 0.849 . . . . 0.0 113.277 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 42' ' ' GLN . 2.0 tm? -55.51 -34.06 64.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.26 -25.94 64.52 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.057 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.78 22.84 15.17 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -172.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.45 133.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.9 105.84 18.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -75.09 -13.44 60.48 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 m -73.87 -22.23 59.81 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 6.4 13.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.574 -1.298 . . . . 0.0 114.387 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.14 136.91 25.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 CA-C-N 117.838 0.819 . . . . 0.0 110.176 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.8 tp10 -152.17 148.14 27.26 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.093 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.89 123.82 22.73 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.63 -44.71 96.47 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.693 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.69 -94.23 0.1 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.587 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 59.6 11.69 2.49 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.722 0.772 . . . . 0.0 109.996 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -83.56 -12.93 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 3.0 m -50.25 -47.83 54.99 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.5 m 153.14 -55.21 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 127.967 2.507 . . . . 0.0 108.372 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 80.1 m-70 -67.96 149.26 49.98 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.1 m -108.13 -175.84 2.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -171.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.519 HD23 HD22 ' A' ' 52' ' ' LEU . 2.4 tm? -90.84 -49.18 0.35 Allowed Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.693 0.797 . . . . 0.0 112.431 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 31.2 Cg_exo -62.38 -2.0 2.89 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.931 2.421 . . . . 0.0 114.46 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.432 ' HB2' HD13 ' A' ' 50' ' ' LEU . 34.8 p30 -84.02 -48.61 9.75 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.219 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.38 -2.5 57.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.3 tp -109.23 -9.12 15.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 5.8 tmtt? -89.7 133.29 34.74 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.443 ' HB2' HD11 ' A' ' 17' ' ' LEU . 6.4 tp-100 -54.58 133.21 46.32 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.78 -34.56 2.1 Favored Glycine 0 N--CA 1.413 -2.886 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.8 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.66 -20.77 45.86 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 117.657 0.728 . . . . 0.0 109.944 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 18.03 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.67 109.33 3.26 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.19 117.58 15.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 175.3 -81.39 0.0 OUTLIER 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.547 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.26 -33.1 77.16 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 50' ' ' LEU . 3.9 pp -119.66 126.69 51.76 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 8.1 p30 -163.54 167.26 21.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.519 HD22 HD23 ' A' ' 36' ' ' LEU . 48.1 tp -94.56 103.78 15.73 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 150' ' ' THR . 11.7 pt-20 -124.67 159.77 30.06 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.729 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.485 ' HA ' ' OG ' ' A' ' 32' ' ' SER . 86.9 p -95.74 -174.29 3.1 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.816 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 t70 175.03 -48.41 0.01 OUTLIER 'General case' 0 CA--C 1.467 -2.245 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.34 35.73 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.148 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.552 ' OD1' ' HG2' ' A' ' 59' ' ' GLN . 10.6 t70 -157.44 146.97 20.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.18 -31.53 69.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.955 0.902 . . . . 0.0 112.49 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG2' ' OD1' ' A' ' 57' ' ' ASP . 13.9 pt20 -86.91 126.74 34.88 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.121 0.962 . . . . 0.0 111.949 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' HD11 ' A' ' 140' ' ' ILE . 54.5 mt -131.07 120.73 23.83 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.343 -173.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -96.96 119.77 36.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.81 128.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . 8.6 t80 -109.84 117.91 35.08 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.1 mt -122.55 114.0 30.33 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-O 120.515 0.198 . . . . 0.0 111.37 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -89.33 141.18 4.0 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 121.998 1.798 . . . . 0.0 109.881 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -103.93 150.87 23.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.597 0.713 . . . . 0.0 112.638 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -55.35 -45.61 76.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -153.98 163.16 40.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.81 127.61 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.901 0.858 . . . . 0.0 111.748 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.501 ' CD1' HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -128.3 172.1 15.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.058 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -96.28 114.18 25.84 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 157' ' ' LEU . 53.2 tp -73.27 154.47 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.541 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 31.3 t60 -139.16 -38.17 0.5 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.785 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.1 p -153.97 169.73 22.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.477 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -141.29 155.17 46.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -149.65 100.2 2.95 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.868 0.366 . . . . 0.0 111.934 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.446 HG23 HG12 ' A' ' 155' ' ' ILE . 56.8 mt -106.24 136.58 40.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HB3' ' OE1' ' A' ' 153' ' ' GLN . 90.1 mttt -112.06 150.96 29.94 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.991 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 118' ' ' LEU . . . -166.56 168.01 39.85 Favored Glycine 0 N--CA 1.41 -3.041 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 83' ' ' GLU . 32.5 Cg_exo -62.22 151.94 79.2 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.892 1.728 . . . . 0.0 111.117 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HG2' ' HG3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -54.64 -39.78 68.32 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.346 0.659 . . . . 0.0 111.62 -178.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.428 ' HG3' ' HG2' ' A' ' 81' ' ' GLU . 45.6 mt-10 -94.48 -44.0 8.09 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 80' ' ' PRO . 37.5 tt0 -101.56 18.95 18.94 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.692 -166.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.93 178.87 36.45 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.163 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.412 ' HG2' HD22 ' A' ' 113' ' ' LEU . 35.5 Cg_endo -73.5 -179.88 4.9 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 119.765 1.782 . . . . 0.0 110.439 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.56 ' HG2' ' OE2' ' A' ' 112' ' ' GLU . 23.0 ttpp -154.98 -71.23 0.12 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.863 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.4 m -85.74 118.19 25.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.261 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.595 HG12 HG22 ' A' ' 140' ' ' ILE . 23.0 m -118.28 137.19 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.762 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -110.95 133.87 53.03 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -113.97 145.3 41.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -135.37 114.96 12.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 171.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -94.42 133.81 37.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 74.35 175.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.411 1.084 . . . . 0.0 111.357 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.578 ' HE3' ' N ' ' A' ' 94' ' ' LYS . 0.7 OUTLIER 72.82 127.8 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.819 0.819 . . . . 0.0 110.902 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 3.6 mp0 -93.89 146.68 23.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.948 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.1 m80 69.91 98.14 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.955 1.302 . . . . 0.0 111.948 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 92.5 mmm -139.26 142.54 37.78 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.004 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.542 ' O ' HG23 ' A' ' 102' ' ' VAL . 26.4 p -144.78 169.73 17.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.61 -30.5 68.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.276 0.489 . . . . 0.0 112.072 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 t -63.54 -24.26 67.74 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 120.689 0.28 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.432 ' O ' ' HD1' ' A' ' 105' ' ' PHE . 92.8 m-20 -98.6 -23.11 15.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.945 0.402 . . . . 0.0 111.315 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 98' ' ' CYS . 56.0 t -58.53 -32.09 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.718 0.807 . . . . 0.0 112.271 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.85 -15.59 60.2 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -113.44 -15.89 12.53 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.699 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 101' ' ' ASN . 79.3 m-85 -96.75 148.05 33.85 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -82.56 139.81 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.164 1.909 . . . . 0.0 112.032 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.07 149.05 64.34 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.133 1.889 . . . . 0.0 110.939 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.8 m -73.76 -45.16 53.58 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.553 0.692 . . . . 0.0 109.332 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -161.25 160.6 30.12 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -131.7 125.72 32.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.23 170.19 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.32 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.56 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.8 tp10 -125.25 134.96 52.12 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 19.8 tp -70.11 101.94 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 117' ' ' ASN . 5.1 t -80.07 158.4 26.45 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.62 -22.83 66.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.588 0.709 . . . . 0.0 109.749 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.09 -35.31 74.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.257 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.636 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.5 t-20 -71.73 -32.72 68.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 79' ' ' GLY . 96.8 mt -57.48 -23.27 49.01 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.737 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.14 -12.65 52.35 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.712 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 2.82 55.56 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 122.71 88.13 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.096 0.448 . . . . 0.0 110.389 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -59.42 111.12 0.84 Allowed 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 123.157 2.571 . . . . 0.0 112.107 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.508 HG23 ' ND2' ' A' ' 117' ' ' ASN . 86.4 t -82.98 124.88 39.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.7 101.54 2.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.198 0.523 . . . . 0.0 109.952 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.89 172.8 13.27 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.637 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -89.64 84.06 6.31 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.19 0.995 . . . . 0.0 110.031 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 39.9 p90 -76.42 24.69 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.919 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.531 HG13 ' HD2' ' A' ' 129' ' ' LYS . 7.4 p -63.47 -25.57 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.679 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.531 ' HD2' HG13 ' A' ' 128' ' ' VAL . 13.1 mptt -93.43 -20.29 20.46 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.436 0.636 . . . . 0.0 110.501 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 127' ' ' TYR . 82.2 m-85 -91.1 32.63 1.0 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.633 -171.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -67.32 -31.76 72.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.807 0.337 . . . . 0.0 111.309 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -142.2 116.15 9.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.54 106.51 20.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.795 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -89.52 -62.9 1.37 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.2 t -109.03 151.57 26.17 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.195 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.4 tp -147.95 129.67 15.12 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.261 0.553 . . . . 0.0 109.952 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 m -114.71 124.64 52.32 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.5 112.23 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 69.3 t80 -109.0 114.62 28.53 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.851 0.357 . . . . 0.0 110.697 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.595 HG22 HG12 ' A' ' 88' ' ' VAL . 2.3 pp -97.47 124.45 50.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 11.5 pt-20 -110.79 -22.56 11.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.339 -0.945 . . . . 0.0 111.968 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.64 156.39 44.96 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.847 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 147' ' ' SER . 34.2 t-20 -110.61 148.09 32.9 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 126.221 1.809 . . . . 0.0 107.862 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 29.1 mm-40 -36.37 -56.81 0.77 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.652 1.181 . . . . 0.0 111.973 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -124.25 -12.02 7.41 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.688 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 87.59 0.94 Allowed Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 149' ' ' VAL . 32.6 t -111.05 9.55 22.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.98 -0.13 . . . . 0.0 110.7 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 77.14 -23.59 0.24 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 124.441 1.096 . . . . 0.0 110.157 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 147' ' ' SER . 25.9 m -128.5 124.31 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.9 m -101.41 111.1 23.23 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 51' ' ' ASN . 87.2 tttt -95.95 133.6 39.96 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 92.9 t -122.66 115.8 47.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.428 ' OE1' ' HB3' ' A' ' 78' ' ' LYS . 97.0 mt-30 -74.1 -44.33 54.35 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.839 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.05 153.66 3.85 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.495 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.446 HG12 HG23 ' A' ' 77' ' ' ILE . 71.9 mt -124.49 118.03 52.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.4 141.02 35.59 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 72' ' ' LEU . 6.2 mp -120.43 151.59 39.1 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -124.44 127.11 47.02 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.723 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.3 -163.59 10.23 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.2 m -143.94 138.36 28.44 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.383 0.611 . . . . 0.0 111.863 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.464 HG22 HG22 ' A' ' 70' ' ' ILE . 17.8 p . . . . . 0 C--N 1.293 -1.88 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.087 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.241 0.646 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.11 -173.55 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.633 2.222 . . . . 0.0 112.349 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -92.74 11.76 25.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.812 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -143.7 -50.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.741 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -87.42 173.38 9.17 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.924 0.392 . . . . 0.0 111.107 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 18.0 m -115.36 167.79 7.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.51 108.56 16.0 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.363 1.078 . . . . 0.0 108.979 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.488 HD22 HG13 ' A' ' 70' ' ' ILE . 44.7 mt -68.82 3.98 1.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.778 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.62 -41.45 99.01 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.16 -7.42 57.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.867 0.841 . . . . 0.0 110.86 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 13.4 m-85 -92.1 1.71 57.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.01 133.35 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.07 -28.05 22.79 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.837 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.48 ' HA ' HG13 ' A' ' 25' ' ' VAL . 97.5 m95 66.15 -6.85 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 m -82.18 -19.95 38.82 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.614 -0.679 . . . . 0.0 112.659 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.35 26.69 4.9 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.75 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 22' ' ' TRP . 35.7 m -71.89 139.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 110.911 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.68 128.2 32.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.108 0.48 . . . . 0.0 109.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.599 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 6.1 p -103.23 118.15 36.12 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.495 HD23 HD22 ' A' ' 61' ' ' LEU . 3.3 mm? -76.82 -14.92 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.483 0.659 . . . . 0.0 110.746 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -160.45 -83.98 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.776 168.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.615 ' HA ' HD23 ' A' ' 60' ' ' LEU 0.394 3.1 pp0? 51.65 14.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.51 1.124 . . . . 0.0 112.634 -168.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.433 ' CB ' ' H ' ' A' ' 55' ' ' ASP 0.293 58.6 m 72.68 115.02 0.06 Allowed 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 126.995 2.118 . . . . 0.0 114.007 -173.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -55.34 16.9 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 C-N-CA 126.965 2.106 . . . . 0.0 115.218 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 31' ' ' SER . 34.1 t -103.91 -58.67 1.84 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.711 -0.618 . . . . 0.0 109.962 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CE1' ' HA ' ' A' ' 52' ' ' LEU . 23.7 p80 -93.81 163.37 13.55 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 17.7 m -90.49 166.97 12.94 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.818 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 62.1 tp -67.45 -45.58 47.96 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 11.6 Cg_endo -55.47 -25.91 51.29 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.957 1.771 . . . . 0.0 111.503 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 1.9 m-20 -63.04 -24.55 67.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.281 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -95.11 -49.53 5.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.154 0.502 . . . . 0.0 111.886 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.2 tp -105.16 -20.71 13.43 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -170.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -80.08 118.66 21.99 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.292 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -70.87 140.72 51.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.558 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.58 -33.25 6.58 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.438 ' HB3' HD11 ' A' ' 50' ' ' LEU . 95.6 m-85 -98.92 -50.13 4.3 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.44 0.296 . . . . 0.0 110.859 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -52.75 119.29 4.41 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.998 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -153.7 124.4 7.2 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.53 92.61 0.85 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.649 0.738 . . . . 0.0 112.522 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 170.86 -66.26 0.01 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.693 1.597 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.42 -57.03 1.81 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.29 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.4 pt? -134.68 113.71 11.97 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.626 0.727 . . . . 0.0 110.808 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -161.41 169.48 21.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.635 ' HB3' HG22 ' A' ' 152' ' ' VAL . 6.6 tt -75.92 122.69 24.52 Favored 'General case' 0 CA--C 1.487 -1.461 0 C-N-CA 117.191 -1.803 . . . . 0.0 106.17 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -138.22 110.12 7.2 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 113.094 -1.866 . . . . 0.0 107.267 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.516 ' HB3' ' H ' ' A' ' 150' ' ' THR . 8.0 t -93.48 123.65 36.94 Favored 'General case' 0 N--CA 1.411 -2.397 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.325 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.433 ' H ' ' CB ' ' A' ' 31' ' ' SER . 13.1 t70 -119.11 -24.1 6.6 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.722 -175.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.95 -69.61 0.68 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.314 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.91 171.5 8.59 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.534 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 148' ' ' GLU . 5.2 tm-20 -89.9 -24.77 21.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.028 0.931 . . . . 0.0 109.945 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.4 ' C ' HD12 ' A' ' 60' ' ' LEU . 55.5 mt-30 -114.27 134.65 54.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.122 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 30' ' ' GLN . 8.4 mp -128.76 165.28 21.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.373 0.606 . . . . 0.0 112.39 -172.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.495 HD22 HD23 ' A' ' 28' ' ' LEU . 5.9 tt -152.42 128.1 10.14 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 61' ' ' LEU . 2.9 mp -126.02 135.5 63.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.72 118.74 35.85 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -121.64 122.71 27.79 Favored Pre-proline 0 C--O 1.214 -0.772 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.357 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -92.56 137.43 1.6 Allowed 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.657 2.238 . . . . 0.0 111.415 171.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -92.43 162.89 14.06 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.293 0.568 . . . . 0.0 111.421 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 68' ' ' GLN . 34.4 p30 -69.84 -36.11 75.29 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HG2' ' OD1' ' A' ' 67' ' ' ASN . 19.5 pt20 -147.63 176.88 9.73 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.029 -0.419 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 27.3 m -82.18 124.48 39.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.23 0.538 . . . . 0.0 110.384 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.488 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -137.0 172.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 174.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -93.24 114.31 26.75 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 65.4 tp -76.66 127.97 33.8 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 1.3 t-80 -126.08 -45.94 1.69 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.866 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 p -142.74 155.18 44.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -128.27 158.24 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.24 113.77 5.64 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 122.602 0.361 . . . . 0.0 110.284 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.45 HG23 HG12 ' A' ' 155' ' ' ILE . 67.2 mt -125.17 126.35 70.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 54.2 mtpt -117.79 152.42 35.35 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.421 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.85 -167.96 30.23 Favored Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 108.186 -1.965 . . . . 0.0 108.186 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.11 155.53 69.17 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.85 1.7 . . . . 0.0 109.078 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.97 -42.83 60.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.91 -37.25 10.78 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -76.6 2.27 14.49 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.77 150.2 30.78 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.594 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.9 161.74 35.21 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 121.938 1.759 . . . . 0.0 111.088 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 69.8 tttt -127.89 -73.98 0.59 Allowed 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.561 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.606 ' HA ' ' HG2' ' A' ' 112' ' ' GLU . 29.5 m -76.15 103.91 6.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.477 0.656 . . . . 0.0 110.193 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 86' ' ' LYS . 99.8 t -114.93 116.66 53.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.627 -173.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 139' ' ' PHE . 98.8 mttt -101.91 147.23 26.78 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.231 -0.293 . . . . 0.0 110.26 172.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.54 138.91 54.47 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 86.6 m-85 -130.95 116.78 18.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 135' ' ' SER . 50.8 p -100.63 -14.09 18.29 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 7.5 t30 -140.3 84.7 1.97 Allowed 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.146 -1.421 . . . . 0.0 113.87 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 85.5 tttt 171.69 148.81 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.109 1.364 . . . . 0.0 108.06 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -85.97 122.94 30.71 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.289 0.566 . . . . 0.0 111.427 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.366 0.3 OUTLIER 39.39 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.002 2.521 . . . . 0.0 117.299 176.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.553 ' HB2' HG21 ' A' ' 137' ' ' THR . 91.7 mmm -83.91 148.51 26.9 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 174.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.7 m -129.33 162.93 26.84 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -52.68 -38.63 60.84 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 t -81.29 3.26 24.69 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.43 ' HA ' ' OD1' ' A' ' 104' ' ' ASP . 4.0 p-10 -147.23 13.64 1.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.229 0.538 . . . . 0.0 110.616 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 p -75.5 -25.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -96.63 4.78 51.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.478 0.656 . . . . 0.0 110.618 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 101' ' ' ASN . 8.3 m-20 -91.71 4.61 52.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.923 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 82.1 t80 -144.19 134.65 12.09 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 26.2 Cg_exo -65.08 127.0 17.48 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.628 2.219 . . . . 0.0 111.7 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.14 168.55 23.02 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.597 2.198 . . . . 0.0 112.505 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.8 m -69.72 -40.66 76.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.43 174.11 3.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 76.0 m -143.7 113.45 7.11 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.27 163.7 20.18 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.563 -174.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 50.5 mt-10 -128.04 138.75 52.7 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.768 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.1 116.71 7.49 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 112.651 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 t -96.42 174.07 7.05 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.44 -36.34 68.91 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 118.257 0.48 . . . . 0.0 110.715 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 121' ' ' LYS . 38.8 tt0 -59.93 -42.36 93.79 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.498 HD22 HG23 ' A' ' 123' ' ' VAL . 14.1 t-20 -71.54 -41.66 68.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 118' ' ' LEU . 8.4 tt -73.85 -0.76 16.9 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.735 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -113.61 -5.07 13.41 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.174 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.517 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 118.63 -3.33 15.29 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.645 -1.264 . . . . 0.0 116.136 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 116' ' ' GLU . 12.4 mptt -88.33 126.57 60.02 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 46.9 Cg_exo -59.91 108.54 0.49 Allowed 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.707 2.938 . . . . 0.0 111.844 175.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 HD22 ' A' ' 117' ' ' ASN . 68.9 t -88.65 127.1 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.23 141.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.412 0.445 . . . . 0.0 111.75 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.63 -172.85 2.2 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -72.7 103.79 3.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 110.355 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.45 ' HA ' ' CD2' ' A' ' 130' ' ' PHE . 60.4 t80 -75.16 1.77 12.51 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.361 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.64 -22.52 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.79 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -109.69 -9.97 14.83 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -170.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 127' ' ' TYR . 41.4 p90 -77.62 11.11 2.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.128 -0.982 . . . . 0.0 112.447 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -58.51 133.42 55.8 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -163.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.294 2.8 p-10 53.7 113.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.911 2.084 . . . . 0.0 112.697 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 55.0 t -121.01 122.51 67.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.674 -173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -117.3 -28.28 6.19 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.551 0.691 . . . . 0.0 109.545 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 92' ' ' SER . 52.3 p -144.67 171.86 13.8 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.897 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.92 106.49 4.85 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 97' ' ' MET . 19.9 m -96.73 120.24 36.7 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.5 mt -105.1 111.28 33.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 65.1 t80 -107.55 107.89 18.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.99 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 88' ' ' VAL . 11.9 pt -106.64 113.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.633 0.73 . . . . 0.0 109.986 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 41.8 tt0 -112.66 13.38 19.9 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.999 0.904 . . . . 0.0 111.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.3 153.44 11.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.764 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.413 ' C ' ' HB2' ' A' ' 86' ' ' LYS . 39.8 m-80 -117.76 168.34 10.54 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 124.044 0.84 . . . . 0.0 108.91 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -44.21 -43.5 7.22 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.814 0.846 . . . . 0.0 112.186 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.2 m -124.1 8.77 8.61 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.732 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.39 55.56 28.99 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -83.35 2.72 34.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -168.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 58' ' ' GLU . 47.2 mt-10 69.22 -4.28 1.34 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.802 0.841 . . . . 0.0 112.536 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 54' ' ' SER . 2.7 p -137.95 103.3 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 123.829 0.852 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.516 ' H ' ' HB3' ' A' ' 54' ' ' SER . 41.0 m -82.57 122.78 28.53 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 87.8 tttt -131.12 134.17 46.32 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 52' ' ' LEU . 11.3 m -130.46 148.38 33.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.129 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -86.54 -44.83 11.62 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.328 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.13 145.11 6.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.702 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.45 HG12 HG23 ' A' ' 77' ' ' ILE . 73.9 mt -117.98 122.87 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.1 137.28 42.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.27 137.56 51.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 74.3 m-85 -122.33 139.33 53.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.753 0.787 . . . . 0.0 111.703 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.94 -168.46 22.84 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.9 m -145.73 149.82 35.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 117.431 0.616 . . . . 0.0 109.676 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--N 1.29 -2.016 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.295 178.171 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 11' ' ' LYS . 2.0 mp . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.1 1.63 9.07 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.805 2.336 . . . . 0.0 112.964 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' H ' HG22 ' A' ' 9' ' ' ILE . 24.2 ttmm 70.83 118.95 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.796 1.238 . . . . 0.0 111.423 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.81 -44.31 1.28 Allowed Glycine 0 C--N 1.307 -1.05 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -134.87 152.37 51.69 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 13.0 m -106.2 167.51 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.069 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.475 ' H ' HG13 ' A' ' 9' ' ' ILE . 21.9 t70 -76.82 95.33 4.03 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.75 -0.38 0.11 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 126.917 2.087 . . . . 0.0 114.054 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.5 tt -64.02 -31.73 73.02 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.49 -24.12 67.69 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.864 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.75 8.66 41.8 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.047 -0.408 . . . . 0.0 110.398 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.9 mt -85.57 119.08 33.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.25 -34.82 42.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.517 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 96.2 m95 70.23 6.57 5.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.8 t -84.96 -28.79 25.59 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.8 -89.23 1.78 Allowed Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 108.089 -2.005 . . . . 0.0 108.089 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.517 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 92.3 t 41.89 94.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.246 1.418 . . . . 0.0 114.283 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.48 128.1 56.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.906 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.2 p -102.01 119.87 39.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.645 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.424 ' C ' HD13 ' A' ' 28' ' ' LEU . 2.6 tm? -64.3 -44.29 92.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.066 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -117.64 -99.63 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.127 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 48.3 tt0 56.08 22.14 5.7 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.301 1.048 . . . . 0.0 110.204 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -102.77 -12.67 17.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.88 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -54.76 -48.31 72.8 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.5 m 179.97 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 124.483 1.113 . . . . 0.0 110.399 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -73.31 163.36 28.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.628 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.459 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 45.8 m -98.51 140.22 33.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.542 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' CB ' ' HG ' ' A' ' 52' ' ' LEU . 7.0 tt -77.85 -44.82 2.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.453 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.07 -24.66 20.41 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.141 1.894 . . . . 0.0 112.79 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.569 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.0 m-20 -57.37 -48.43 79.07 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 121.227 0.537 . . . . 0.0 110.264 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.02 4.94 20.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.109 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' O ' ' HZ2' ' A' ' 22' ' ' TRP . 49.2 tp -140.25 10.5 2.33 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 5.3 tmtm? -127.68 141.75 51.52 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 12.4 mm100 -58.88 132.81 55.06 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -39.77 2.77 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.478 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -76.0 -48.25 21.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.611 -0.294 . . . . 0.0 111.287 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' A' ' 17' ' ' LEU . 32.1 ptt180 -68.12 107.8 2.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.056 0.931 . . . . 0.0 111.596 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.82 100.63 5.77 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' HB2' ' OE1' ' A' ' 153' ' ' GLN . 4.8 p-10 -71.68 84.65 0.89 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -173.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 16.9 tp10 168.96 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 113.241 -1.799 . . . . 0.0 108.29 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.11 -68.88 1.51 Allowed Glycine 0 C--O 1.238 0.396 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.785 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 38' ' ' ASN . 1.9 pp -104.79 158.07 16.77 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 120.966 0.412 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.449 ' ND2' ' HG3' ' A' ' 151' ' ' LYS . 3.5 p-10 -161.76 166.41 26.56 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.463 ' HG ' ' CB ' ' A' ' 36' ' ' LEU . 3.2 tm? -111.51 128.82 56.13 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.04 162.44 35.46 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.763 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 51.2 p -92.12 176.09 6.63 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.944 0.153 . . . . 0.0 110.774 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 175.79 -46.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.925 0.89 . . . . 0.0 109.067 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.19 -28.84 63.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.59 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.3 t70 -160.29 145.71 15.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -74.06 -27.81 61.09 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 123.519 0.512 . . . . 0.0 112.236 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.2 132.19 34.06 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.304 0.574 . . . . 0.0 110.542 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 54' ' ' SER . 93.2 mt -131.12 144.43 51.39 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.327 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 62' ' ' ILE . 6.0 tt -153.06 144.35 23.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.515 ' N ' HD23 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -150.29 138.94 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.474 ' N ' HD13 ' A' ' 62' ' ' ILE . 68.2 t80 -105.32 122.76 46.62 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.914 0.486 . . . . 0.0 111.825 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 62' ' ' ILE . 2.3 mp -116.26 119.47 36.45 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.652 177.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -86.84 127.74 2.7 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.538 2.159 . . . . 0.0 109.219 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -90.81 162.65 14.75 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -48.8 -57.6 6.12 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 126.376 1.87 . . . . 0.0 110.165 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -149.48 177.94 9.26 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 57.7 t -78.49 111.72 15.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.57 173.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -100.61 133.8 44.52 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 125' ' ' LEU . 2.4 tt -98.19 123.22 42.15 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -102.2 -41.44 6.39 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.822 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.0 p -154.63 160.93 41.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.027 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -135.23 150.23 50.03 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -143.6 98.11 3.19 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.7 mt -108.26 132.21 56.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 54.0 mtpt -116.55 159.3 22.31 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.264 0.554 . . . . 0.0 112.42 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.4 39.64 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -73.85 172.62 15.49 Favored 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 122.25 1.966 . . . . 0.0 110.356 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -74.8 -27.93 60.51 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.834 0.35 . . . . 0.0 110.668 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.22 -47.17 7.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.18 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 151' ' ' LYS . 43.7 mt-10 -89.7 1.8 55.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.745 -176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.76 45.45 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.798 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 7.5 Cg_exo -71.21 107.07 2.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.174 1.916 . . . . 0.0 111.15 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.34 -43.39 13.74 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.7 m -92.74 97.22 10.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.143 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 33.8 m -107.38 142.28 20.52 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -146.65 133.46 20.08 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.27 144.69 45.61 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.011 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -131.98 115.65 16.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.6 t -93.27 134.54 35.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 73.67 178.29 0.23 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.829 1.252 . . . . 0.0 111.501 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.4 tptm 72.41 101.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.063 1.345 . . . . 0.0 110.736 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.8 122.96 19.66 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.643 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t60 70.87 97.35 0.07 Allowed 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.389 1.056 . . . . 0.0 112.997 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 83.5 mtp -126.39 152.77 45.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 85.5 m -142.7 174.85 10.28 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.509 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 55.5 p90 -65.54 -17.6 64.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.1 m -73.19 -23.33 60.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.626 0.25 . . . . 0.0 111.454 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -128.51 3.34 5.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 111.514 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.509 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 8.3 p -65.09 -34.77 72.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.867 -173.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -97.71 5.1 49.73 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.75 -24.56 18.53 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.173 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -97.38 149.74 36.04 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.718 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.59 128.88 18.88 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 122.67 2.247 . . . . 0.0 112.028 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.68 160.27 41.29 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.436 2.09 . . . . 0.0 111.256 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -76.79 -41.95 42.55 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.489 0.661 . . . . 0.0 109.378 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.635 ' OD2' ' HG3' ' A' ' 126' ' ' LYS . 14.9 t70 -161.71 146.71 13.24 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -127.99 124.17 36.54 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 173.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -119.05 172.89 7.24 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.085 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.44 134.59 55.14 Favored 'General case' 0 N--CA 1.405 -2.676 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 118' ' ' LEU . 28.4 tp -69.57 121.54 17.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -98.03 169.59 9.52 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.861 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -31.77 72.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.42 ' HA ' ' HE2' ' A' ' 119' ' ' LYS . 15.0 pt-20 -70.87 -33.88 71.05 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.82 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.631 HD21 ' HA ' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -64.44 -42.57 95.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.052 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 113' ' ' LEU . 87.2 mt -62.19 -4.87 1.93 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.83 1.252 . . . . 0.0 113.642 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 116' ' ' GLU . 57.1 mtmt -113.14 -9.39 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 122.821 0.448 . . . . 0.0 109.976 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.83 0.58 34.19 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.914 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 31.9 mmmt -75.34 131.52 77.74 Favored Pre-proline 0 C--O 1.246 0.907 0 O-C-N 123.592 0.231 . . . . 0.0 111.375 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 29.7 Cg_exo -65.14 119.54 6.59 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.288 2.659 . . . . 0.0 111.639 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.0 t -97.54 136.0 29.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.04 117.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.405 0.621 . . . . 0.0 111.252 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.469 HD11 HD22 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.54 -175.59 4.74 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.401 176.224 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.635 ' HG3' ' OD2' ' A' ' 109' ' ' ASP . 29.9 mtpp -64.54 89.9 0.07 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.619 0.723 . . . . 0.0 112.06 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -69.68 -21.37 63.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.732 1.213 . . . . 0.0 110.959 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 m -80.33 -19.23 12.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.03 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 9.9 tmtt? -92.85 -41.84 9.86 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 125' ' ' LEU . 91.8 m-85 -75.77 78.97 2.71 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 112.021 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -107.99 -40.44 5.23 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.418 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.29 112.65 23.44 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.388 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 49.0 t -123.3 102.38 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -95.87 -31.07 13.32 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.4 p -156.94 162.99 39.62 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 137' ' ' THR . 4.4 tt -148.82 133.99 18.29 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.476 ' N ' HD23 ' A' ' 136' ' ' LEU . 64.6 m -104.32 124.7 49.65 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mp -103.03 125.96 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.63 118.25 27.72 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.501 HG13 ' HB2' ' A' ' 60' ' ' LEU . 10.5 pt -112.46 114.32 46.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.68 0.753 . . . . 0.0 109.76 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.66 -42.43 9.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.612 -172.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.24 150.58 38.16 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.899 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.08 167.99 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.834 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -48.47 -48.61 37.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.0 m -92.84 -19.45 21.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.81 42.38 61.26 Favored Glycine 0 C--N 1.311 -0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.6 t -87.86 9.86 20.57 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.938 -0.631 . . . . 0.0 110.752 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 68.15 8.39 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.379 1.072 . . . . 0.0 112.318 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 54' ' ' SER . 7.7 p -136.02 112.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-O 121.976 0.893 . . . . 0.0 109.378 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.6 m -106.74 121.28 44.05 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.449 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 4.9 ttmp? -113.4 133.62 55.07 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.232 0.539 . . . . 0.0 110.485 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.7 t -125.68 116.1 45.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.654 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.47 ' OE1' ' HB2' ' A' ' 47' ' ' ASP . 9.7 pt20 -85.87 -29.92 23.32 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.45 145.43 12.96 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.28 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.36 129.32 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.59 129.63 20.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.98 144.73 42.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 84.5 m-85 -124.16 113.21 18.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.307 0.575 . . . . 0.0 111.042 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.96 -167.24 11.0 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.4 p -162.44 162.95 27.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 118.315 1.057 . . . . 0.0 112.556 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.302 -1.469 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.315 173.982 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.6 mt . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.26 143.22 4.62 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 122.3 2.0 . . . . 0.0 111.715 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -59.18 130.67 48.09 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.69 0.757 . . . . 0.0 112.021 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -42.26 1.96 Allowed Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -106.67 173.3 6.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.615 0.721 . . . . 0.0 110.064 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.431 HG11 HG23 ' A' ' 161' ' ' THR . 14.6 p -130.15 143.94 39.5 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 154.5 29.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.029 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 20' ' ' ILE . 4.3 mm? -101.64 8.83 41.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.927 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 42' ' ' GLN . 4.4 tt -78.48 -48.49 15.24 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.85 -27.22 68.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.788 -1.097 . . . . 0.0 110.918 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -84.07 9.84 11.56 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.494 HG22 ' H ' ' A' ' 22' ' ' TRP . 75.4 mt -93.71 127.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.28 -15.99 41.6 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.508 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' H ' HG22 ' A' ' 20' ' ' ILE . 86.0 m95 58.88 30.7 20.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.709 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -57.31 -36.19 70.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.933 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.2 -47.37 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 22' ' ' TRP . 2.7 t 62.7 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.348 1.059 . . . . 0.0 109.885 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -121.78 139.85 53.08 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.018 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.54 128.74 29.81 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD13 HD12 ' A' ' 61' ' ' LEU . 8.6 mp -62.58 -26.78 68.77 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -99.41 -105.02 0.22 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.325 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 54.73 15.61 1.15 Allowed 'General case' 0 CA--C 1.573 1.842 0 CA-C-O 122.322 1.058 . . . . 0.0 110.306 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 t -78.36 -30.1 47.81 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.613 1.165 . . . . 0.0 107.931 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 4.9 p -64.95 7.09 0.18 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m 76.66 -17.23 0.56 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.417 ' ND1' ' HB3' ' A' ' 53' ' ' GLU . 29.6 m80 -77.62 134.98 38.08 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.659 174.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -83.05 157.31 22.93 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 52' ' ' LEU . 2.8 tm? -81.74 -53.74 0.7 Allowed Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.83 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 31.9 Cg_exo -60.3 -15.19 33.57 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 121.845 1.697 . . . . 0.0 113.661 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.751 ' HB2' HD13 ' A' ' 50' ' ' LEU . 32.0 p30 -75.25 -22.64 57.69 Favored 'General case' 0 C--O 1.209 -1.045 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.905 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.79 1.18 36.92 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.362 0.601 . . . . 0.0 110.825 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.84 -43.7 2.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.091 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.11 130.43 35.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.925 0.393 . . . . 0.0 110.947 -174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' HB2' HD11 ' A' ' 17' ' ' LEU . 21.5 tm0? -57.82 140.05 52.66 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 124.501 1.12 . . . . 0.0 110.641 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.8 -59.5 0.53 Allowed Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -73.77 -41.04 62.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.7 ' O ' ' HD2' ' A' ' 45' ' ' ARG . 2.7 tmm_? -53.49 -11.44 0.34 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.961 2.104 . . . . 0.0 111.569 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -65.44 100.53 0.5 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.22 98.83 0.84 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.0 -75.24 0.32 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.225 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.34 -54.38 0.79 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.957 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.751 HD13 ' HB2' ' A' ' 38' ' ' ASN . 1.8 pp -85.03 147.46 26.67 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.757 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 30.6 p30 -164.06 166.32 21.51 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.641 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 36' ' ' LEU . 61.2 tp -83.59 123.47 29.81 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' ND1' ' A' ' 34' ' ' HIS . 32.2 tt0 -140.71 130.53 24.41 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.729 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 64.7 p -101.91 151.05 22.56 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' HG12 ' A' ' 149' ' ' VAL . 17.3 t70 -123.8 -54.28 1.74 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.584 -170.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.95 -26.41 25.52 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.192 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -130.39 145.97 51.89 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 117.958 -1.497 . . . . 0.0 111.634 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.25 -31.75 24.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.929 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -68.49 114.96 7.36 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.334 0.587 . . . . 0.0 110.855 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 HD21 ' CD2' ' A' ' 52' ' ' LEU . 17.8 tp -126.05 107.53 10.51 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.408 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD12 HD13 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -107.61 130.71 54.87 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -179.589 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.407 HD11 ' HG ' ' A' ' 60' ' ' LEU . 3.3 mp -127.61 132.87 68.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -113.91 126.19 54.89 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 46.5 mm -107.71 121.23 44.78 Favored Pre-proline 0 N--CA 1.425 -1.694 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.36 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 64' ' ' ILE . 6.3 Cg_exo -77.94 112.59 3.3 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.593 2.196 . . . . 0.0 110.273 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -80.2 164.13 23.5 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 126.065 1.746 . . . . 0.0 113.922 -175.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -106.11 -37.53 6.57 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.069 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -150.62 160.6 43.71 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.64 128.2 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 124.028 0.83 . . . . 0.0 109.323 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -134.44 174.06 13.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 174.717 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 160' ' ' SER . 38.6 ttpt -97.13 146.8 24.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.47 ' HG ' HG21 ' A' ' 133' ' ' VAL . 87.3 mt -78.83 159.11 27.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HA ' ' CE2' ' A' ' 127' ' ' TYR . 13.2 t60 -146.82 -66.02 0.28 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.793 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.9 p -137.77 163.02 32.38 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.821 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 41.7 p90 -140.1 149.06 42.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.99 111.66 8.73 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.745 0.307 . . . . 0.0 110.25 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.7 mt -123.81 120.6 60.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 153' ' ' GLN . 85.2 mttt -96.46 136.38 37.04 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.273 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.574 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -164.39 156.56 28.53 Favored Glycine 1 C--N 1.25 -4.23 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 177.219 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.53 172.49 12.32 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 122.002 1.801 . . . . 0.0 112.887 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -75.98 -24.53 55.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.959 0.885 . . . . 0.0 109.416 177.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.19 -55.14 4.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.0 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -109.18 7.96 25.68 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.703 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.94 158.23 36.41 Favored Glycine 0 C--N 1.305 -1.188 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.272 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.0 Cg_exo -77.12 107.66 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.888 1.725 . . . . 0.0 110.902 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 1.0 OUTLIER -89.19 -51.78 5.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.981 -176.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.7 m -93.44 95.46 9.3 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.715 0.769 . . . . 0.0 109.699 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -98.02 135.04 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.779 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.58 141.82 49.77 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.813 0.816 . . . . 0.0 110.256 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 53.3 m-85 -115.17 145.39 42.44 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.551 ' CZ ' ' HB ' ' A' ' 102' ' ' VAL 0.257 76.2 m-85 -118.12 146.74 43.93 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 178.65 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -74.14 -158.5 0.07 Allowed 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.651 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -53.21 -20.06 3.67 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.492 1.917 . . . . 0.0 112.862 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -72.33 111.8 7.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.38 161.15 13.79 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 65.35 23.48 12.05 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 111.365 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.451 ' HE2' ' HB3' ' A' ' 97' ' ' MET . 79.7 mtp -68.29 135.41 51.88 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.897 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.472 ' O ' HG13 ' A' ' 102' ' ' VAL . 19.9 p -102.91 174.04 6.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -62.37 -29.14 70.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -87.27 -5.7 58.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -104.4 -19.64 13.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.551 ' HB ' ' CZ ' ' A' ' 91' ' ' PHE . 33.1 m -83.69 2.72 3.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.778 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -88.62 -26.33 21.96 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.993 0.425 . . . . 0.0 111.944 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -110.48 10.22 23.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.796 0.331 . . . . 0.0 111.166 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -124.22 131.68 24.22 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.65 126.93 11.88 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.76 162.03 42.96 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.356 2.037 . . . . 0.0 111.567 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 16.7 m -60.42 -45.36 93.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.038 0.923 . . . . 0.0 108.826 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -167.9 166.18 13.51 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -133.45 128.58 35.76 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.0 172.85 8.21 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.302 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 39.4 tt0 -125.38 138.05 54.04 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.94 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 27.6 tp -70.15 100.87 1.73 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.9 t -91.37 167.61 12.16 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.3 -35.68 67.79 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.69 0.396 . . . . 0.0 111.748 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 121' ' ' LYS . 8.4 tp10 -67.4 -38.84 85.27 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.408 ' HB3' HD12 ' A' ' 113' ' ' LEU . 1.4 t-20 -71.36 -44.41 65.08 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 79' ' ' GLY . 5.1 tt -57.91 -31.81 67.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.527 1.531 . . . . 0.0 109.671 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -85.2 -3.02 58.67 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.02 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HB2' ' HG3' ' A' ' 116' ' ' GLU . 73.2 mmtt -94.24 137.05 22.94 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 18.9 Cg_endo -62.08 115.19 2.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.673 2.915 . . . . 0.0 112.934 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.4 t -96.42 137.71 23.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.68 123.88 32.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.18 176.87 5.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.587 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -94.9 110.5 22.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.063 0.458 . . . . 0.0 110.394 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 73' ' ' HIS . 45.2 p90 -125.41 26.48 6.81 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.47 -33.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.01 0.434 . . . . 0.0 111.463 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -90.42 -32.6 16.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.421 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 56.3 m-85 -90.41 69.94 6.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.814 0.816 . . . . 0.0 112.169 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -88.41 -12.7 42.44 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.79 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -146.2 120.99 9.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.436 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.47 HG21 ' HG ' ' A' ' 72' ' ' LEU . 94.1 t -121.42 104.61 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.139 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -71.78 -50.44 29.83 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.801 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.6 p -134.66 150.72 50.68 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -129.98 135.44 48.3 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.869 0.366 . . . . 0.0 110.511 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 70.2 m -121.95 129.64 52.67 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.7 mp -107.56 121.21 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 74.3 t80 -124.35 125.72 44.8 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.014 0.435 . . . . 0.0 112.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.1 pt -119.51 126.13 75.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.9 pt-20 -108.78 -17.98 13.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.97 22.34 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.253 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -98.15 -174.22 2.79 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -62.08 -63.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.485 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -103.43 -42.22 5.77 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.927 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.79 69.21 0.64 Allowed Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 -174.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.8 m -84.78 16.72 3.14 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.409 0.684 . . . . 0.0 111.329 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 76.2 -43.67 0.48 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.405 1.482 . . . . 0.0 111.9 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 55' ' ' ASP . 11.4 m -102.35 157.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.623 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 59.2 m -121.94 128.68 51.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -129.25 133.58 47.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.001 0.429 . . . . 0.0 110.079 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 7.2 p -134.77 125.36 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 12.1 mm100 -73.68 -47.57 38.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.532 -174.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 147.06 10.31 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -122.74 122.99 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.73 121.42 12.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.05 147.09 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -124.93 118.95 27.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.97 -157.0 11.05 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 38.7 m -152.75 126.22 8.75 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.431 HG23 HG11 ' A' ' 14' ' ' VAL . 24.9 p . . . . . 0 C--N 1.276 -2.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.422 175.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--O 1.243 0.737 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -87.0 170.56 7.14 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.257 1.971 . . . . 0.0 112.855 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -59.62 114.73 2.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.544 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.51 -61.98 0.55 Allowed Glycine 0 N--CA 1.423 -2.202 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.105 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -112.53 -171.86 1.94 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.395 0.617 . . . . 0.0 111.034 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.49 150.48 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 173.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 32.9 t0 -72.29 126.38 29.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 157' ' ' LEU . 59.2 mt -81.06 4.36 20.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' HA ' HD12 ' A' ' 20' ' ' ILE . 5.4 tt -51.42 -35.86 41.14 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.299 1.047 . . . . 0.0 108.411 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.37 -38.93 81.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.21 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.69 -2.46 58.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 17' ' ' LEU . 89.5 mt -74.11 136.98 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 25' ' ' VAL . 16.2 t70 -99.54 112.89 25.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -80.52 1.51 29.18 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -93.05 -35.89 12.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.36 -19.99 61.27 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.756 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 21' ' ' ASP . 28.4 m -54.2 130.89 16.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.756 0.789 . . . . 0.0 112.126 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.7 tp10 -112.06 127.5 55.92 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.47 ' HB2' ' OE1' ' A' ' 30' ' ' GLN . 26.4 p -130.26 113.59 14.6 Favored 'General case' 0 N--CA 1.398 -3.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.198 -175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 61' ' ' LEU . 3.2 mm? -72.62 -75.17 0.14 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.299 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.541 HD21 ' HB3' ' A' ' 56' ' ' ALA . 64.2 t30 -116.41 -81.43 0.61 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.561 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.47 ' OE1' ' HB2' ' A' ' 27' ' ' CYS . 3.1 mp0 62.82 23.29 13.9 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 14.4 m 89.52 139.86 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 127.609 2.363 . . . . 0.0 112.675 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.4 t -70.35 -46.36 64.29 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.675 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.3 m -77.45 -35.68 53.66 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.695 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 98.1 m-70 -124.61 149.27 47.25 Favored 'General case' 0 C--O 1.189 -2.102 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -140.98 -168.29 2.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 116.745 -1.982 . . . . 0.0 115.378 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 30' ' ' GLN . 29.8 tp -60.88 -52.47 72.1 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 50.2 Cg_exo -54.47 -32.23 72.4 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.1 1.867 . . . . 0.0 112.751 -172.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.693 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.9 p-10 -84.43 3.43 36.16 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.87 -23.8 3.04 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.936 0.398 . . . . 0.0 112.042 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -105.13 -18.12 14.25 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.116 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -80.28 147.68 31.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -66.09 143.67 57.17 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.32 -37.09 3.03 Favored Glycine 0 N--CA 1.413 -2.882 0 CA-C-N 114.87 -1.059 . . . . 0.0 114.386 170.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -74.6 -25.71 59.44 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.301 0.0 OUTLIER -60.14 67.51 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -160.91 141.76 11.56 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.754 1.622 . . . . 0.0 107.979 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.8 100.43 10.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.646 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.12 17.9 0.76 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.426 0.631 . . . . 0.0 109.931 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.14 -59.92 0.23 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.3 pp -105.19 149.38 25.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.695 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 47.1 t30 -161.72 163.41 29.69 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 60' ' ' LEU . 3.8 tt -105.32 111.98 24.91 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 171.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -141.45 122.34 14.48 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.624 ' HA ' ' OG ' ' A' ' 31' ' ' SER 0.27 36.2 p -51.76 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -171.328 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 18.8 t70 -113.52 88.13 2.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.14 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . 157.4 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.211 2.204 . . . . 0.0 107.987 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -139.03 157.16 46.48 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.986 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -89.02 75.14 8.02 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.1 pp0? -174.53 139.66 0.58 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.396 1.078 . . . . 0.0 109.139 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.662 ' HB2' HG13 ' A' ' 140' ' ' ILE . 10.3 mp -135.19 147.28 49.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.619 0.768 . . . . 0.0 109.645 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 4.6 tt -149.24 124.44 10.14 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -139.43 135.05 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.552 ' N ' HD13 ' A' ' 62' ' ' ILE . 45.1 t80 -105.78 125.64 51.23 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.93 0.892 . . . . 0.0 110.324 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -116.77 120.73 33.82 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.403 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -97.85 127.43 0.23 Allowed 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 123.054 2.503 . . . . 0.0 110.421 170.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -95.14 139.75 31.04 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.21 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -72.73 -20.57 61.18 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.164 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -147.48 144.47 28.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.77 120.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.684 0.754 . . . . 0.0 111.16 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 168.43 10.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HE2' ' OE1' ' A' ' 131' ' ' GLN . 7.5 mtpm? -96.16 113.62 25.24 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 55.3 tp -71.2 152.5 43.29 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 56.3 t-80 -139.22 -49.57 0.5 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.978 0.418 . . . . 0.0 111.526 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -147.19 167.54 23.92 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 122.036 -0.415 . . . . 0.0 111.91 -175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.588 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 12.3 p90 -129.43 158.21 39.81 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.606 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -151.66 131.94 13.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.868 0.366 . . . . 0.0 111.039 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.411 HG21 ' HG2' ' A' ' 85' ' ' PRO . 67.7 mt -140.19 128.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -104.04 155.63 18.52 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.347 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.26 -178.07 42.61 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 151' ' ' LYS . 15.3 Cg_exo -68.18 159.99 50.76 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 122.91 2.407 . . . . 0.0 110.86 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.09 -29.15 68.02 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 35.1 mt-10 -93.34 -41.53 9.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.42 0.629 . . . . 0.0 111.463 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 15.35 25.88 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.096 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -85.79 150.73 24.43 Favored Glycine 0 C--N 1.307 -1.054 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 47.8 Cg_exo -55.61 160.66 8.97 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.807 2.338 . . . . 0.0 112.646 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.82 -56.31 0.18 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.8 m -80.99 100.05 8.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.861 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 140' ' ' ILE . 48.8 t -123.39 119.72 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.361 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.22 131.12 56.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 109' ' ' ASP 0.253 32.5 p90 -138.26 134.11 33.98 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 177.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -110.25 159.39 17.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 p -148.47 167.54 25.05 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 117.965 0.348 . . . . 0.0 111.838 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.268 19.2 m120 86.48 -24.59 0.12 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 48.7 mtpt -97.92 148.09 23.8 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.889 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.84 134.85 37.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 68.25 94.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.275 1.03 . . . . 0.0 111.365 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.6 mmm -127.41 107.2 9.75 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.652 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.405 ' O ' HG23 ' A' ' 102' ' ' VAL . 22.0 p -98.45 177.99 5.17 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -67.35 -25.87 66.21 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.9 t -56.62 -49.85 73.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.35 -38.89 92.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.958 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 98' ' ' CYS . 82.5 t -64.97 -29.79 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -75.69 -19.87 58.81 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.299 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -104.61 -42.38 5.43 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.32 124.83 47.69 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.953 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.95 135.93 71.9 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.963 2.442 . . . . 0.0 110.882 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.17 167.36 14.58 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.552 2.168 . . . . 0.0 112.383 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -83.14 -44.77 14.72 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 20.0 t70 -143.14 151.02 40.23 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.915 174.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.1 p -115.35 118.21 32.59 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.34 150.73 26.95 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.103 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.98 107.04 10.43 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 8.5 tt -72.21 134.42 45.64 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.197 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.4 p -116.36 169.17 9.51 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.483 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.64 -33.05 72.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.867 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 121' ' ' LYS . 39.1 tt0 -60.17 -40.99 91.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.29 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.606 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.9 t-20 -63.38 -47.18 83.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.621 -177.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.46 -14.26 61.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -87.76 10.32 18.76 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.716 0.77 . . . . 0.0 109.065 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.06 12.7 56.12 Favored Glycine 0 CA--C 1.507 -0.438 0 CA-C-N 114.272 -1.331 . . . . 0.0 114.627 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 12.2 mptt -99.31 117.55 63.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.35 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 67.3 Cg_exo -56.29 119.73 7.11 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.954 3.103 . . . . 0.0 112.481 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 58.5 t -93.01 131.59 39.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 m -83.19 127.45 39.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 121.523 0.678 . . . . 0.0 111.455 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.458 HD12 ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.52 179.03 4.99 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.933 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.59 94.49 6.3 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 20.0 p90 -105.08 12.43 32.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.75 -26.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.539 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.611 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -99.33 14.54 29.28 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.176 175.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.04 74.87 1.18 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.475 ' OE1' ' HE2' ' A' ' 71' ' ' LYS . 28.7 mm-40 -109.1 -37.91 5.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -112.55 114.31 26.9 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 t -122.48 100.88 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.806 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.592 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -87.1 -36.39 18.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 109.766 169.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.9 p -141.84 141.67 33.11 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.598 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 137' ' ' THR . 5.8 tt -140.16 141.48 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.578 ' N ' HD23 ' A' ' 136' ' ' LEU . 35.7 m -127.01 120.64 29.55 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -104.97 122.16 57.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 122.799 0.44 . . . . 0.0 110.405 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -122.59 107.27 11.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.662 HG13 ' HB2' ' A' ' 60' ' ' LEU . 2.0 pp -104.45 141.14 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.512 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -111.13 -25.66 9.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -158.51 158.43 34.03 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.66 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.401 ' HB3' HG23 ' A' ' 150' ' ' THR . 7.1 p30 -99.9 179.4 4.52 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.621 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 85.8 mm-40 -50.12 -59.82 3.55 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.632 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.5 m -91.03 -8.44 49.07 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.203 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.14 42.28 96.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.2 m -88.96 15.64 8.23 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 74.38 -42.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.807 1.243 . . . . 0.0 113.54 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -102.14 105.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.368 1.08 . . . . 0.0 110.576 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 34.5 m -97.02 124.22 40.95 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.109 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.515 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -97.11 133.73 41.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.412 0.625 . . . . 0.0 109.64 177.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.11 107.78 10.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 124.946 1.298 . . . . 0.0 107.742 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -91.12 -32.33 15.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.28 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.565 ' HE3' ' HB2' ' A' ' 156' ' ' ALA . 7.4 tmtm? -152.93 133.49 13.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.2 mt -118.52 136.69 54.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.565 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . . . -144.36 148.59 34.92 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 121.411 0.624 . . . . 0.0 110.643 174.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 2.8 mm? -117.57 127.38 53.92 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.451 ' HB3' ' CB ' ' A' ' 13' ' ' GLN . 61.7 m-85 -108.38 128.81 55.1 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -149.72 -166.73 13.54 Favored Glycine 0 C--N 1.286 -2.218 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -152.92 142.66 22.0 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.309 0.555 . . . . 0.0 110.44 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 117.566 -1.207 . . . . 0.0 109.743 176.535 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 11' ' ' LYS . 45.9 mm . . . . . 0 N--CA 1.427 -1.581 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -91.95 27.1 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.284 2.656 . . . . 0.0 111.214 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 9' ' ' ILE . 88.1 tttt 64.06 112.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.744 1.618 . . . . 0.0 112.028 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.89 -81.21 0.19 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.84 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HG2' ' CD2' ' A' ' 73' ' ' HIS . 2.2 mp0 -100.1 175.48 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 19' ' ' PHE . 17.4 m -107.2 162.54 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 CA-C-O 120.803 0.335 . . . . 0.0 111.406 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.81 118.63 21.77 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.521 HD22 HG13 ' A' ' 70' ' ' ILE . 35.3 mt -69.99 2.52 3.45 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.236 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.58 -42.86 97.55 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.127 0.965 . . . . 0.0 108.651 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.49 -26.1 67.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.016 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HE2' HG21 ' A' ' 14' ' ' VAL . 43.6 m-85 -102.55 22.33 13.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.092 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 64' ' ' ILE . 78.6 mt -97.45 126.33 50.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 121.411 -0.116 . . . . 0.0 110.815 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.74 118.05 28.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -90.82 6.82 42.8 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.486 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 m -89.93 -18.72 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 7.31 7.21 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.586 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.18 141.08 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 117.645 0.723 . . . . 0.0 111.538 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -129.61 134.56 47.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.232 0.539 . . . . 0.0 110.144 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . 19.8 p -110.92 114.56 27.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.958 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.9 -68.82 0.32 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.75 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' A' ' 60' ' ' LEU 0.255 7.2 p-10 -104.17 -52.9 2.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.387 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 22.8 tt0 69.36 0.95 3.09 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 122.923 0.489 . . . . 0.0 111.551 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.59 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 79.1 p 73.94 130.29 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 127.472 2.309 . . . . 0.0 110.712 -168.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.7 m -62.35 15.65 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.0 m -138.2 -28.91 0.84 Allowed 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -124.48 165.57 17.55 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.715 -0.616 . . . . 0.0 112.18 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -91.07 -179.44 5.45 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -174.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.546 ' H ' ' HD2' ' A' ' 37' ' ' PRO . 15.8 tp -98.3 -56.8 0.18 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 36' ' ' LEU . 24.7 Cg_endo -58.11 -22.09 54.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.663 2.242 . . . . 0.0 112.584 -175.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.604 HD22 ' HB2' ' A' ' 50' ' ' LEU . 31.7 p-10 -64.83 -30.04 71.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.57 -6.17 12.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.616 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -105.27 -25.23 12.51 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.391 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -81.87 137.24 35.27 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.463 0.649 . . . . 0.0 111.603 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -63.29 134.89 56.58 Favored 'General case' 0 N--CA 1.39 -3.47 0 C-N-CA 125.182 1.393 . . . . 0.0 108.538 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.09 -56.81 1.78 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.666 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.84 -35.74 79.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.896 0.478 . . . . 0.0 111.488 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.486 ' HD2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -54.79 174.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.414 2.375 . . . . 0.0 117.414 -175.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 153' ' ' GLN 0.375 44.3 mt-10 74.34 145.43 0.08 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.751 1.62 . . . . 0.0 115.162 177.477 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.03 117.88 6.56 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.06 -172.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.57 -68.48 0.26 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.97 -51.39 0.1 OUTLIER Glycine 0 CA--C 1.484 -1.886 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' HD22 ' A' ' 38' ' ' ASN . 3.8 pp -78.87 156.34 28.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.007 -0.597 . . . . 0.0 109.808 174.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -161.38 165.88 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 36' ' ' LEU . 4.7 tt -118.05 116.8 27.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' A' ' 31' ' ' SER . 8.3 pt-20 -109.99 163.03 13.95 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.8 p -52.0 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 O-C-N 123.763 0.664 . . . . 0.0 112.211 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 54' ' ' SER . 13.8 t70 163.59 -156.89 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.67 -24.75 61.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.09 154.86 18.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.992 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.531 ' HB2' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.67 16.75 21.05 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -103.56 104.47 14.54 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' OD1' ' A' ' 29' ' ' ASN . 60.8 tp -114.53 132.62 56.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 62' ' ' ILE . 5.0 tt -137.87 133.83 34.36 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.913 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.485 ' N ' HD23 ' A' ' 61' ' ' LEU . 3.3 mp -133.76 132.18 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -100.94 129.18 46.75 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 20' ' ' ILE . 3.0 mp -120.98 124.02 27.62 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.582 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -95.64 157.64 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.977 2.451 . . . . 0.0 110.815 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.413 ' H ' ' HD1' ' A' ' 66' ' ' PHE . 8.7 p90 -84.52 162.24 19.93 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.497 1.141 . . . . 0.0 113.438 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -97.82 -47.91 5.39 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.881 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -133.46 149.25 51.76 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.661 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.45 116.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.521 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -129.95 173.06 14.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -91.9 143.63 26.3 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.44 158.02 21.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.485 ' CD2' ' HG2' ' A' ' 13' ' ' GLN . 57.5 t60 -148.76 -63.77 0.24 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.3 p -143.7 165.71 26.9 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.724 -171.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 4.9 p90 -133.51 159.25 40.98 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.609 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -151.98 100.13 2.62 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 120.914 0.388 . . . . 0.0 111.802 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 64.8 mt -102.62 136.13 36.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 55.2 mtpt -118.49 144.09 46.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.454 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.414 ' HA2' ' HG3' ' A' ' 153' ' ' GLN . . . -165.23 -178.74 38.64 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 22.4 Cg_exo -69.29 157.23 62.06 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.202 1.935 . . . . 0.0 110.29 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 mt-10 -62.0 -35.92 79.98 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.54 -48.22 6.2 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 43.7 mt-10 -80.1 20.44 0.65 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.631 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.62 167.5 24.55 Favored Glycine 0 C--N 1.301 -1.416 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.274 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 35.9 Cg_endo -76.79 178.97 6.95 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 121.835 1.69 . . . . 0.0 111.012 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 144' ' ' GLN . 3.1 tmmm? -144.26 -61.85 0.38 Allowed 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.608 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.41 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 51.3 m -80.43 103.45 10.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.55 116.51 51.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.436 -175.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -107.66 135.84 48.41 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.547 0.689 . . . . 0.0 111.111 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.41 134.76 53.76 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.53 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.0 m-85 -124.57 115.57 21.06 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 175.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' CE1' ' A' ' 130' ' ' PHE . 20.4 m -110.92 150.57 29.03 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m120 82.08 154.68 0.12 Allowed 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.801 1.313 . . . . 0.0 108.39 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.649 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER 67.68 100.87 0.05 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.649 0.737 . . . . 0.0 110.287 -175.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.63 140.16 38.45 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.527 0.68 . . . . 0.0 112.056 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 67.45 89.58 0.1 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 125.664 1.586 . . . . 0.0 111.839 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 81.8 mtp -119.86 142.37 48.72 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.467 ' O ' ' HB ' ' A' ' 102' ' ' VAL . 59.9 m -128.98 176.39 7.91 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -56.9 -20.42 23.16 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.0 m -81.5 -50.26 9.61 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.695 -0.628 . . . . 0.0 111.31 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -95.57 6.65 48.42 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.894 0.378 . . . . 0.0 111.529 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 11.4 p -59.31 -37.35 68.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 123.823 0.849 . . . . 0.0 112.222 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -108.78 16.82 22.48 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.782 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -86.51 -20.98 27.24 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.064 0.935 . . . . 0.0 109.06 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -113.41 138.7 22.59 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.106 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.46 138.05 68.47 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.698 2.265 . . . . 0.0 112.538 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.23 152.67 45.16 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.4 2.066 . . . . 0.0 111.875 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -61.71 -45.58 93.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -167.98 168.96 11.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -128.59 123.19 32.72 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.41 169.05 10.36 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.365 0.603 . . . . 0.0 111.777 -174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.6 mp0 -120.31 127.46 52.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.42 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.403 HD21 HD21 ' A' ' 118' ' ' LEU . 29.9 tp -72.48 110.89 7.19 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.9 t -101.0 174.46 6.0 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.65 -34.8 74.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.758 0.823 . . . . 0.0 110.641 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.21 -32.55 68.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.997 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.609 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.3 t-20 -68.81 -34.27 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 96.9 mt -62.2 2.68 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.493 1.517 . . . . 0.0 113.26 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.1 -14.11 12.97 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.472 1.109 . . . . 0.0 108.944 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.5 1.89 43.77 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.999 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -75.55 126.32 87.6 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.75 121.53 8.77 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.408 2.739 . . . . 0.0 114.067 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 57.7 t -99.04 141.37 16.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.62 144.01 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -131.9 -174.75 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.046 0.938 . . . . 0.0 111.745 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -82.39 115.74 21.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -138.63 15.03 2.73 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.434 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.22 -38.51 81.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.181 0.515 . . . . 0.0 110.429 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -95.0 2.36 55.33 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 92' ' ' SER . 76.6 m-85 -117.78 66.32 0.75 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.653 0.74 . . . . 0.0 111.737 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.83 1.91 53.43 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 0.0 109.483 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -148.2 116.07 6.39 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.78 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.8 t -116.88 137.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.444 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -116.98 -55.84 2.31 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.288 1.035 . . . . 0.0 108.802 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.0 p -118.57 139.21 51.83 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.8 tp -135.35 111.95 9.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.874 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 29.3 m -102.64 121.62 42.77 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.81 116.73 49.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 61.1 t80 -122.83 119.62 31.11 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.466 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.3 pp -108.9 131.41 59.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 12.9 pt-20 -119.86 -14.92 8.92 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.803 -0.759 . . . . 0.0 113.01 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB3' ' CB ' ' A' ' 87' ' ' THR . . . -134.69 145.8 48.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.531 HD21 ' HB2' ' A' ' 58' ' ' GLU . 87.2 m-20 -101.79 169.14 8.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 7.7 tp60 -62.94 -56.08 20.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.876 0.735 . . . . 0.0 109.167 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.9 t -122.05 9.52 9.94 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.315 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.469 ' HA2' ' HB2' ' A' ' 143' ' ' ASN . . . 62.29 67.59 2.03 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.0 m -100.74 9.2 42.71 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 68.22 -55.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.49 1.116 . . . . 0.0 111.478 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 53' ' ' GLU . 49.1 t -102.46 108.05 23.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 62.9 m -102.04 111.43 23.7 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.245 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 64.1 pttt -96.49 134.09 40.11 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.913 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.83 136.47 39.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.117 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 79.3 mt-30 -87.42 -51.87 5.69 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.57 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -162.01 149.25 14.1 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.546 178.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.3 112.86 35.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.64 137.08 29.73 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 5.7 mp -112.05 159.55 18.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 56.1 m-85 -125.72 132.84 52.28 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -153.52 -149.96 5.32 Favored Glycine 0 C--N 1.299 -1.5 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.515 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 46.3 m -157.87 161.33 38.3 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 70' ' ' ILE . 66.9 p . . . . . 0 C--N 1.279 -2.488 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.384 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 13' ' ' GLN . 2.2 mp . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 3.5 Cg_exo -72.92 -69.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.271 1.981 . . . . 0.0 111.808 175.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -162.08 -68.73 0.05 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.94 -10.99 82.19 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.241 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.72 134.21 50.72 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -174.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 p -105.9 153.69 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.818 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.97 120.62 12.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.45 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.5 mt -93.96 10.19 34.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.479 ' HG ' ' NH2' ' A' ' 45' ' ' ARG . 3.4 tm? -64.97 -36.66 85.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.493 0.663 . . . . 0.0 110.922 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -85.52 1.77 47.57 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.237 1.017 . . . . 0.0 110.498 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 m-85 -101.15 7.47 43.16 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.404 HD12 HD22 ' A' ' 17' ' ' LEU . 70.6 mt -89.97 133.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.332 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.58 113.8 23.61 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -85.04 -0.54 54.77 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.855 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.9 m -87.3 -36.79 17.67 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.7 -13.2 32.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.207 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 64' ' ' ILE . 14.5 p -54.93 132.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 117.166 0.483 . . . . 0.0 110.626 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 32.6 tt0 -145.05 159.57 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.066 0.46 . . . . 0.0 110.054 -177.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 53.2 t -135.78 135.61 40.05 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -60.27 -57.86 10.97 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.323 1.015 . . . . 0.0 108.543 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.7 -64.19 0.91 Allowed 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 70.27 -52.31 0.65 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.988 1.315 . . . . 0.0 114.274 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 48.0 m -155.86 87.63 1.08 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -175.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.0 p -67.17 -29.34 69.01 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.976 162.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.2 m -154.49 -57.49 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.154 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.514 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.5 m-70 -88.0 162.38 16.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.0 m -112.1 174.79 5.71 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.45 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -67.82 -58.14 8.61 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 26.8 Cg_exo -63.02 -17.92 62.63 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.973 1.782 . . . . 0.0 112.455 -174.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.0 m-20 -56.82 -46.58 81.55 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.736 1.214 . . . . 0.0 112.238 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 45' ' ' ARG . . . -104.32 2.66 31.66 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.42 0.628 . . . . 0.0 111.458 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -105.31 -44.46 4.73 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -79.94 123.69 28.01 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -173.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -55.36 117.71 3.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.935 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.54 -45.76 1.1 Allowed Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.47 ' HB3' HD11 ' A' ' 50' ' ' LEU . 63.2 m-85 -95.58 -51.49 4.51 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HD3' ' HG2' ' A' ' 154' ' ' LYS . 89.6 mtt-85 22.7 -83.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 176.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 153' ' ' GLN . 41.9 mt-10 -61.91 134.71 57.01 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -166.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.471 ' H ' ' HB2' ' A' ' 153' ' ' GLN . 10.2 t70 -59.86 110.26 1.13 Allowed 'General case' 0 C--O 1.249 1.067 0 CA-C-N 113.121 -1.854 . . . . 0.0 110.328 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.71 -73.15 0.15 Allowed 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.56 -30.27 4.13 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.477 ' HB2' HD22 ' A' ' 38' ' ' ASN . 2.3 pp -132.21 148.19 52.45 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.014 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 29.8 p-10 -162.56 167.81 22.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 36' ' ' LEU . 40.9 tp -91.41 116.57 28.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 168.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.479 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 33.8 tt0 -136.69 112.57 9.57 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.599 0.714 . . . . 0.0 109.881 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.62 ' HB2' HD13 ' A' ' 60' ' ' LEU . 31.8 t -94.79 101.88 13.72 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.816 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.3 -30.44 11.07 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.033 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.36 72.4 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.047 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.99 160.75 22.89 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.86 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.469 ' O ' HD11 ' A' ' 140' ' ' ILE . 43.7 tt0 -92.6 -31.7 15.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -77.32 118.35 19.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.071 -174.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 54' ' ' SER . 23.7 tp -116.31 116.28 27.46 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 6.8 tt -118.95 128.83 54.78 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 57.2 mt -127.59 144.94 35.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 122.951 0.501 . . . . 0.0 109.718 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HE1' ' O ' ' A' ' 94' ' ' LYS . 83.9 t80 -117.26 126.86 53.42 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.959 0.504 . . . . 0.0 110.362 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 25' ' ' VAL . 45.2 mm -120.97 121.58 28.75 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.911 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.79 127.13 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.735 2.29 . . . . 0.0 109.55 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -93.0 141.31 28.54 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -51.89 -50.17 61.56 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.754 2.022 . . . . 0.0 109.623 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -130.58 159.6 36.69 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.389 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 7.3 p -83.26 108.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.45 172.98 12.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.516 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -95.24 132.33 40.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.6 tp -78.04 143.99 37.0 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -129.93 -54.2 1.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.144 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' HD22 ' A' ' 125' ' ' LEU . 16.1 p -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -117.72 158.14 25.25 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -153.53 105.44 2.83 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.835 0.35 . . . . 0.0 111.851 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.531 HG23 HG12 ' A' ' 155' ' ' ILE . 55.5 mt -120.39 130.21 74.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 96.4 mttt -104.97 143.24 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.23 32.5 Favored Glycine 0 C--N 1.257 -3.834 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.7 139.42 48.2 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 121.492 1.461 . . . . 0.0 108.936 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.628 ' HA ' HD11 ' A' ' 118' ' ' LEU . 11.9 pt-20 -58.68 -25.63 63.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.969 0.414 . . . . 0.0 112.069 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.53 -57.08 4.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.898 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 4.4 mm-40 -81.46 -59.62 2.56 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.905 -170.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.19 119.41 0.0 OUTLIER Glycine 0 N--CA 1.506 3.303 0 C-N-CA 127.326 2.394 . . . . 0.0 118.158 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.654 ' HA ' ' OD1' ' A' ' 143' ' ' ASN . 56.8 Cg_endo -69.29 112.18 2.92 Favored 'Trans proline' 0 C--N 1.356 0.958 0 CA-C-N 119.932 1.866 . . . . 0.0 110.06 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 112' ' ' GLU . 30.5 ttmt -90.39 -75.37 0.46 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.071 -171.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.71 102.25 3.29 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.235 -174.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG12 HG22 ' A' ' 140' ' ' ILE . 34.2 m -104.68 117.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.845 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HG3' ' OG1' ' A' ' 110' ' ' THR . 25.7 ttmm -107.11 132.83 52.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -112.69 139.02 48.64 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.54 155.55 19.97 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -77.97 -171.04 2.14 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.125 0.891 . . . . 0.0 110.926 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' SER . 8.9 p30 -57.22 104.4 0.16 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 111.512 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.417 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 55.3 tptt -163.51 164.8 24.21 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 96' ' ' HIS . 41.3 tt0 -75.95 174.01 10.5 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.467 ' H ' ' HG2' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -48.76 137.09 12.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.509 ' HB2' HG21 ' A' ' 137' ' ' THR . 18.5 mmt -93.8 173.53 7.63 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.226 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.513 ' O ' HG13 ' A' ' 102' ' ' VAL . 75.6 m -149.36 155.55 40.66 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -55.99 -24.65 40.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.4 t -85.09 -6.41 59.31 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -116.72 -15.99 10.7 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 98' ' ' CYS . 29.0 m -67.64 -3.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -97.18 -19.4 18.66 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.398 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -89.33 -37.32 14.98 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.746 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 93.5 m-85 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.302 -1.47 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.138 -175.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 13.3 Cg_exo -70.13 128.72 16.07 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.741 2.294 . . . . 0.0 111.216 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.31 165.23 29.73 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.548 2.165 . . . . 0.0 111.521 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 22.4 m -76.48 -47.48 22.74 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -162.72 169.09 20.57 Favored 'General case' 0 CA--C 1.471 -2.09 0 C-N-CA 123.513 0.725 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 40.9 m -146.2 114.43 6.64 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.29 172.87 8.32 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HB2' ' HG2' ' A' ' 86' ' ' LYS . 11.7 pt-20 -125.35 139.67 53.48 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 86' ' ' LYS . 22.4 tp -59.79 113.2 2.15 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.703 0.801 . . . . 0.0 108.903 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.1 p -85.25 166.4 16.55 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 4.1 mp0 -57.74 -39.21 76.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.46 -38.62 77.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.72 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.594 HD22 HG23 ' A' ' 123' ' ' VAL . 8.8 t-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 81' ' ' GLU . 7.5 tt -62.22 -23.33 66.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.115 1.366 . . . . 0.0 110.671 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.477 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 58.2 mtpt -102.52 1.9 35.61 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.47 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.54 68.04 0.87 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.812 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.402 ' HD2' ' HD2' ' A' ' 122' ' ' PRO . 52.3 tptt -137.39 117.58 10.48 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.501 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 15.0 Cg_endo -58.17 101.64 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.379 2.053 . . . . 0.0 111.886 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 117' ' ' ASN . 53.3 t -85.43 126.71 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 m -83.35 144.22 10.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.526 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 74' ' ' SER . 1.2 mm? -98.71 -173.44 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.409 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.99 141.4 34.46 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -96.19 27.45 3.69 Favored 'General case' 0 C--N 1.281 -2.374 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.655 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.32 -49.89 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 108' ' ' SER . 27.5 tptp -95.4 -6.13 41.64 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.79 15.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.22 121.9 14.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.325 20.9 p-10 42.97 112.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 127.221 2.208 . . . . 0.0 114.765 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 44.4 t -121.53 104.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.735 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -99.49 -28.45 13.24 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 59.9 m -143.2 151.17 40.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 137' ' ' THR . 5.6 tt -146.33 138.42 25.01 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 97' ' ' MET . 60.6 m -118.04 133.07 56.25 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 64.1 mt -108.18 122.86 63.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.33 116.85 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 58' ' ' GLU 0.267 2.0 pp -90.37 138.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 117.749 -1.58 . . . . 0.0 111.079 176.389 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -94.47 -48.46 6.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.936 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.85 159.78 43.85 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.071 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.654 ' OD1' ' HA ' ' A' ' 85' ' ' PRO . 94.3 m-20 -109.11 167.13 10.33 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -47.6 -53.14 15.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 111.558 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.3 t -112.93 4.15 16.65 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.541 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.95 62.51 6.28 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -83.88 8.1 16.03 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 65.68 7.09 4.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 112.949 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.68 155.73 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 93.2 m -121.58 111.39 17.17 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.478 0.656 . . . . 0.0 110.736 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.41 149.04 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 20.6 pt20 -118.1 -5.08 10.96 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.562 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -172.79 118.66 0.34 Allowed 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.398 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.531 HG12 HG23 ' A' ' 77' ' ' ILE . 68.4 mt -114.73 124.85 71.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.11 152.07 41.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.32 147.47 51.86 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 81.9 m-85 -124.38 133.71 53.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.59 -173.23 13.06 Favored Glycine 0 CA--C 1.489 -1.531 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.8 m -134.23 135.32 42.87 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.253 0.549 . . . . 0.0 110.862 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.421 -1.905 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.526 179.114 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 11' ' ' LYS . 39.5 mm . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 120.68 0.276 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -89.79 11.91 2.71 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.58 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' H ' HG22 ' A' ' 9' ' ' ILE . 39.7 ttmt 65.96 97.02 0.05 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.882 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.61 -63.27 0.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -112.87 176.07 5.17 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 16' ' ' LEU . 34.1 m -106.23 169.63 2.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -84.09 95.96 8.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.861 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 157' ' ' LEU . 5.7 mp -74.79 -2.41 26.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.1 tt -74.06 -36.91 64.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.25 -21.14 66.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.998 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -97.21 12.2 33.71 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.022 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 16' ' ' LEU . 74.3 mt -84.13 131.63 33.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.47 124.54 35.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.693 0.759 . . . . 0.0 110.887 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -103.74 19.23 20.28 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.854 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 m -93.12 -30.89 15.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.94 3.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.839 -1.172 . . . . 0.0 114.133 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.0 135.89 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.63 148.91 36.53 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.195 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HB3' ' HG2' ' A' ' 30' ' ' GLN . 47.7 t -135.87 140.66 44.29 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 97' ' ' MET . 91.1 mt -79.35 19.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.431 0.634 . . . . 0.0 111.808 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -154.9 -60.47 0.11 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.67 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 47.9 mt-30 67.39 14.5 9.67 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 124.116 0.966 . . . . 0.0 109.86 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.67 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 3.2 m 74.75 135.03 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.219 1.808 . . . . 0.0 109.447 -174.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.429 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 33.1 t -66.83 -46.93 73.56 Favored 'General case' 0 CA--C 1.559 1.313 0 O-C-N 121.415 -0.803 . . . . 0.0 111.577 175.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.5 t -89.82 -47.1 8.12 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.108 0.956 . . . . 0.0 111.151 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.67 ' O ' ' HB2' ' A' ' 31' ' ' SER . 54.0 m80 -83.05 166.91 18.36 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 125.054 1.342 . . . . 0.0 111.146 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 m -110.49 169.5 8.71 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.914 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 4.1 tt -65.12 -57.61 14.96 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.022 0.529 . . . . 0.0 111.68 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 5.7 Cg_exo -78.64 -1.83 11.94 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 121.848 1.699 . . . . 0.0 111.296 -176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.488 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.0 t-20 -49.12 -48.45 44.58 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 125.515 1.526 . . . . 0.0 109.648 -176.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . . . -142.24 78.68 1.63 Allowed 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.764 0.793 . . . . 0.0 110.036 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.0 tp -168.26 -38.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.776 -1.557 . . . . 0.0 106.846 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 10.7 tmtt? -90.66 133.45 35.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.418 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 14.9 mm100 -53.28 142.55 20.84 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.48 -37.57 3.44 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.218 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' HD11 ' A' ' 50' ' ' LEU . 68.6 m-85 -89.72 -43.2 10.87 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 38.0 ttp180 -43.49 117.32 1.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.948 1.699 . . . . 0.0 113.206 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -177.53 137.42 0.21 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.78 91.86 8.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.881 0.372 . . . . 0.0 111.924 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -151.6 -71.67 0.16 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.018 0.927 . . . . 0.0 109.577 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -56.8 0.5 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.451 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 38' ' ' ASN . 2.3 pp -89.11 142.21 27.84 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.106 0.479 . . . . 0.0 111.884 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.595 ' HA ' ' CB ' ' A' ' 39' ' ' ALA . 6.3 p30 -163.49 165.65 23.49 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.505 ' CD2' HD21 ' A' ' 60' ' ' LEU . 3.3 tt -88.07 126.83 35.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 171.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 44.8 tt0 -128.99 143.17 50.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 90.5 p -78.01 82.26 4.37 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 32' ' ' SER . 38.9 t70 -117.13 96.52 5.48 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.352 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 148.7 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 128.075 2.55 . . . . 0.0 104.878 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 54' ' ' SER . 10.7 t70 -157.75 155.35 29.71 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.676 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.18 -21.13 39.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.003 0.43 . . . . 0.0 110.652 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.81 109.7 17.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.527 HD23 HD11 ' A' ' 140' ' ' ILE . 27.8 tp -116.81 117.51 29.96 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.427 0.632 . . . . 0.0 110.487 -174.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.534 HD11 ' O ' ' A' ' 96' ' ' HIS . 1.8 tm? -107.21 124.38 49.65 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.506 HG13 ' SG ' ' A' ' 27' ' ' CYS . 2.0 mp -127.01 134.58 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -103.54 121.57 43.16 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.575 0.75 . . . . 0.0 109.095 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.42 120.17 29.05 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.151 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.02 154.54 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.749 2.299 . . . . 0.0 109.574 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -112.19 152.34 28.49 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -62.73 -50.63 70.33 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.586 1.554 . . . . 0.0 108.084 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -127.51 143.13 51.22 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.671 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.86 112.18 13.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -134.32 173.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.193 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.54 143.24 30.31 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.239 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.442 HD13 HD23 ' A' ' 157' ' ' LEU . 57.8 tp -92.32 105.56 17.74 Favored 'General case' 0 C--O 1.19 -2.057 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -96.37 -54.62 3.2 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.979 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 p -145.44 161.87 38.67 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.844 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' CE1' HD11 ' A' ' 125' ' ' LEU . 2.7 p90 -131.97 157.66 43.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.534 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -143.0 114.44 7.95 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.209 0.604 . . . . 0.0 109.773 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.5 mt -113.21 129.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.513 ' HE2' ' C ' ' A' ' 119' ' ' LYS . 68.2 mttt -117.2 157.98 25.07 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.481 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.03 -152.79 20.89 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 15.0 Cg_exo -72.11 152.38 56.51 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.201 1.934 . . . . 0.0 109.533 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.55 -38.93 81.22 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 144' ' ' GLN . 42.5 mt-10 -94.69 -34.7 12.46 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 5.0 mp0 -93.78 11.58 28.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.491 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.8 150.42 25.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.157 -0.802 . . . . 0.0 111.636 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 23.6 Cg_exo -63.05 113.92 2.23 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.436 2.757 . . . . 0.0 113.375 -175.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HD3' ' HG3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -104.31 -49.5 3.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -176.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.5 m -83.11 100.52 10.57 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.818 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.9 t -115.57 122.98 70.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.959 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -115.73 133.79 55.67 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 92.0 m-85 -111.96 152.1 28.47 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 25.4 t80 -140.68 117.06 10.72 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 172.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 m -91.61 138.2 31.75 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 47.95 81.91 0.04 OUTLIER 'General case' 0 C--O 1.244 0.775 0 C-N-CA 126.171 1.788 . . . . 0.0 113.965 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -171.51 170.72 5.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -81.43 175.7 10.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' HD11 ' A' ' 61' ' ' LEU . 33.1 p80 -44.67 -40.65 6.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.46 ' O ' HD11 ' A' ' 28' ' ' LEU . 87.1 mtp 61.6 -165.75 0.22 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.502 ' O ' HG23 ' A' ' 102' ' ' VAL . 30.8 p -150.06 163.81 37.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 42.0 p90 -68.98 -17.89 63.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -67.47 -20.2 65.44 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -103.76 -31.66 9.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.603 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 98' ' ' CYS . 95.9 t -59.57 -29.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.21 -7.22 58.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.28 -38.45 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.81 0.338 . . . . 0.0 111.557 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -95.75 137.57 21.87 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.138 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.3 131.08 27.13 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.452 2.101 . . . . 0.0 111.508 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.37 161.17 38.07 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.414 2.076 . . . . 0.0 111.487 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . 28.5 m -61.78 -46.02 91.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 110.03 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.11 143.43 15.42 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -104.85 115.03 29.6 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.52 152.59 24.53 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.465 ' HG3' ' HD3' ' A' ' 86' ' ' LYS . 35.0 tt0 -125.62 118.35 25.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.229 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 20.8 tp -61.86 105.17 0.53 Allowed 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -92.64 170.57 9.63 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.505 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 42.9 tt0 -54.98 -46.09 75.07 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.767 0.427 . . . . 0.0 111.276 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -64.85 -34.66 78.91 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.4 t-20 -61.65 -44.59 96.69 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 tm? -65.36 -32.77 74.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.314 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.513 ' C ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -84.77 9.96 12.69 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.35 31.3 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 115.149 0.819 . . . . 0.0 115.149 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -93.4 132.74 29.65 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 117.648 0.724 . . . . 0.0 111.338 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 26.5 Cg_endo -65.37 117.33 4.49 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 123.208 2.605 . . . . 0.0 112.471 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.87 130.74 44.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.78 133.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 122.956 0.502 . . . . 0.0 111.236 -174.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.464 HD11 ' CE1' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -100.0 175.1 5.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.5 mmpt? -86.15 49.05 1.71 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -74.69 25.62 0.09 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -170.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.8 m -57.02 -27.49 27.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -95.24 -41.18 9.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.491 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 28.0 m-85 -72.13 84.42 1.02 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.054 -173.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.55 -11.36 14.07 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.245 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -124.37 113.85 18.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.494 0.664 . . . . 0.0 109.846 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 72' ' ' LEU . 47.1 t -123.31 105.74 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.17 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -104.9 -32.1 8.95 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.9 m -135.93 135.25 39.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.431 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.2 tp -135.65 126.36 27.26 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.877 0.37 . . . . 0.0 110.085 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.6 m -94.2 117.01 29.49 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.27 115.84 50.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 141' ' ' GLU . 48.5 t80 -114.39 114.88 26.47 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 60' ' ' LEU . 28.2 pt -104.12 114.85 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.881 0.848 . . . . 0.0 109.277 174.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.453 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 43.6 tt0 -90.78 -28.38 18.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.66 -172.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -162.25 154.83 19.62 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.271 -177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -89.63 175.95 7.06 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.006 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.45 ' HB3' ' O ' ' A' ' 82' ' ' GLU . 64.6 tp60 -51.12 -43.89 61.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.432 1.093 . . . . 0.0 112.909 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m -96.59 -37.68 10.27 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.515 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.92 42.62 3.03 Favored Glycine 0 C--N 1.302 -1.345 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.8 m -85.47 13.95 6.14 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.326 1.05 . . . . 0.0 112.655 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 74.93 -34.87 0.27 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.823 1.649 . . . . 0.0 111.625 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.1 p -100.69 98.69 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-O 122.315 1.055 . . . . 0.0 110.471 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.7 m -92.25 113.71 26.06 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.418 ' HE3' ' ND2' ' A' ' 51' ' ' ASN . 86.7 tttt -113.96 135.23 54.22 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.018 -174.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.69 137.2 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.309 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 11.7 pt20 -96.7 -28.64 14.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.19 177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -171.23 150.9 3.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.02 111.95 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.404 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -107.69 147.12 31.16 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 4.7 mp -123.34 143.91 49.79 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 67.9 m-85 -125.68 137.94 53.87 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -166.39 -140.62 2.93 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.6 t -162.83 149.9 13.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.423 -1.813 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.951 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.6 mm . . . . . 0 N--CA 1.396 -3.169 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -85.5 136.43 5.48 Favored 'Trans proline' 0 N--CA 1.427 -2.42 0 C-N-CA 121.715 1.61 . . . . 0.0 111.191 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -50.64 113.49 0.91 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 112.155 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.13 8.36 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.51 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.19 147.36 34.76 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 117.25 0.525 . . . . 0.0 111.373 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.93 149.14 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.97 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.83 134.42 39.07 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.2 mm? -62.87 -14.04 41.29 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.373 1.069 . . . . 0.0 113.813 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 41' ' ' LYS . 2.1 tm? -51.32 -36.4 42.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.499 0.666 . . . . 0.0 109.93 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.27 -26.25 60.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.214 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -107.67 34.35 3.58 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.8 mm -116.4 145.1 22.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.056 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -96.23 131.59 42.55 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -104.38 8.85 35.89 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -97.3 -34.96 10.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' C ' ' HG3' ' A' ' 65' ' ' PRO . . . -89.22 -4.86 73.71 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.458 -0.792 . . . . 0.0 114.05 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -53.59 143.43 5.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -142.55 139.62 31.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.136 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 30' ' ' GLN . 5.5 p -135.61 128.85 31.93 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.891 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.657 HD23 HD12 ' A' ' 61' ' ' LEU . 2.7 mm? -91.92 123.71 35.5 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.502 HD21 ' HB3' ' A' ' 56' ' ' ALA . 47.3 t-20 76.26 -59.78 0.5 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.759 1.624 . . . . 0.0 108.263 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 34.2 tt0 73.14 -74.77 0.08 Allowed 'General case' 0 C--N 1.37 1.474 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p 174.16 115.95 0.02 OUTLIER 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.4 t -48.91 -37.23 19.18 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -100.63 -42.63 6.46 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.725 -0.609 . . . . 0.0 111.233 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -85.13 166.57 16.51 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -106.96 152.94 23.28 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.644 ' HA ' HD13 ' A' ' 52' ' ' LEU . 3.1 tm? -54.47 -57.89 16.59 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.82 -17.06 58.36 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.183 1.922 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.538 HD22 ' HB2' ' A' ' 50' ' ' LEU . 3.1 m-20 -58.75 -27.55 65.05 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 113.086 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . . . -133.04 15.71 4.21 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.206 0.526 . . . . 0.0 110.749 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -112.29 -43.16 3.57 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.21 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.448 ' HA ' HD21 ' A' ' 17' ' ' LEU . 16.0 ptpt -98.28 137.58 36.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.353 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.19 121.62 14.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.97 -64.64 0.44 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.501 ' O ' HD11 ' A' ' 50' ' ' LEU . 59.0 m-85 -77.04 -39.79 48.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 26.4 ttp180 -37.35 103.58 0.03 OUTLIER 'General case' 0 C--O 1.243 0.739 0 C-N-CA 126.106 1.762 . . . . 0.0 113.324 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -164.65 89.27 0.51 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -57.96 104.32 0.19 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.889 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 178.1 -67.55 0.01 OUTLIER 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.308 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.17 -59.06 0.73 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HD12 ' A' ' 50' ' ' LEU . 3.5 pp -104.25 120.9 42.18 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.788 0.804 . . . . 0.0 110.006 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.472 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 3.0 p-10 -161.48 165.63 28.37 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.644 HD13 ' HA ' ' A' ' 36' ' ' LEU . 26.6 tp -91.65 112.42 24.33 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -131.71 113.46 13.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.592 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 35.6 p -74.4 82.22 1.92 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.059 0.933 . . . . 0.0 110.237 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.49 -30.55 29.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.893 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.502 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . -69.23 -35.68 76.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 54' ' ' SER . 19.1 t70 -171.47 156.42 4.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.619 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.2 tt0 -80.49 -11.69 59.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.911 0.884 . . . . 0.0 112.545 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.89 112.94 17.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -127.14 136.16 51.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.403 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.657 HD12 HD23 ' A' ' 28' ' ' LEU . 1.6 tm? -131.39 126.22 34.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.3 mp -128.12 134.64 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.659 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 49.4 t80 -103.7 128.1 51.08 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 123.708 0.803 . . . . 0.0 110.187 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.417 ' CG2' HD12 ' A' ' 20' ' ' ILE . 49.5 mm -120.94 124.03 27.63 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 78.2 Cg_endo -92.37 159.96 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 123.29 2.66 . . . . 0.0 110.365 171.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.401 ' H ' ' HD1' ' A' ' 66' ' ' PHE . 4.3 p90 -95.23 154.88 16.97 Favored 'General case' 0 CA--C 1.459 -2.553 0 CA-C-O 122.568 1.175 . . . . 0.0 113.919 -174.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -88.05 -42.89 12.1 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 112.877 -1.965 . . . . 0.0 106.968 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -150.65 139.07 20.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -73.17 124.68 30.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-O 121.639 0.733 . . . . 0.0 111.643 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.15 174.59 11.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -92.51 138.68 31.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -79.35 144.16 34.46 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -136.07 -45.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.928 -0.483 . . . . 0.0 111.807 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.6 m -151.38 175.92 11.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.391 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -135.62 152.46 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -158.87 107.65 1.91 Allowed 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 77' ' ' ILE . 2.3 mp -107.38 132.58 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HE2' ' CA ' ' A' ' 120' ' ' GLY . 90.9 mttt -117.69 167.5 11.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.337 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.37 -168.25 34.14 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HG3' ' HG3' ' A' ' 151' ' ' LYS . 41.9 Cg_endo -68.76 149.43 73.06 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 122.262 1.974 . . . . 0.0 111.214 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.53 -26.37 66.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.01 -55.92 4.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.918 0.866 . . . . 0.0 111.04 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.74 13.04 36.22 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.416 -170.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.31 148.14 26.4 Favored Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 16.4 Cg_endo -58.1 176.21 0.39 Allowed 'Trans proline' 0 C--O 1.218 -0.52 0 C-N-CA 123.191 2.594 . . . . 0.0 113.971 -175.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 84.0 tttt -154.63 -68.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.8 m -78.26 108.39 11.55 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.47 146.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.072 0.463 . . . . 0.0 111.871 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -130.4 148.84 52.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -126.94 152.97 46.43 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -137.59 144.41 41.98 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 130' ' ' PHE . 48.2 t -137.27 155.19 49.77 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.362 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 m120 76.67 -43.32 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.662 1.585 . . . . 0.0 113.469 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.612 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -87.21 107.78 18.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 178.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 34.6 tt0 -65.03 134.44 53.85 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 59.94 87.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.428 1.091 . . . . 0.0 112.447 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.612 ' SD ' ' HD3' ' A' ' 94' ' ' LYS . 95.6 mmm -123.75 98.63 5.9 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.284 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.522 ' O ' HG23 ' A' ' 102' ' ' VAL . 64.3 m -88.78 167.87 12.94 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 89.6 t80 -49.11 -33.75 12.47 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.64 0.776 . . . . 0.0 112.585 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -56.64 -26.31 55.67 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.329 0.652 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -114.66 -18.14 11.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 98' ' ' CYS . 60.7 t -63.45 -18.89 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.126 0.971 . . . . 0.0 113.352 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -87.57 -22.91 24.52 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.729 -0.607 . . . . 0.0 112.062 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -94.38 -36.09 12.08 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -95.99 150.4 37.24 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.929 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.89 117.19 5.02 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.677 2.251 . . . . 0.0 113.06 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.37 172.09 17.01 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.088 1.859 . . . . 0.0 110.272 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.512 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 19.7 m -67.43 -46.99 71.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -172.54 -176.08 1.46 Allowed 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -139.91 130.99 26.34 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.02 173.07 11.59 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.382 0.611 . . . . 0.0 112.138 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 35.1 tt0 -123.97 128.97 50.17 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.84 105.52 2.81 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 t -86.85 163.12 17.38 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.24 -37.99 73.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.01 -31.88 68.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 123.238 0.337 . . . . 0.0 111.289 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.2 t-20 -63.66 -47.02 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 118' ' ' LEU . 5.7 tt -67.05 -20.3 65.82 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.002 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HA ' ' CE ' ' A' ' 119' ' ' LYS . 1.2 tpmt? -86.02 -14.29 44.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.065 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.527 ' CA ' ' HE2' ' A' ' 78' ' ' LYS . . . 111.71 11.71 16.32 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.934 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.58 125.53 57.36 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.498 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 55.6 Cg_endo -70.38 109.65 2.49 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.953 2.435 . . . . 0.0 111.15 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.5 t -85.81 122.37 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.91 110.1 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 122.106 0.955 . . . . 0.0 113.048 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -93.05 -165.68 1.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.605 178.489 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -93.24 115.03 27.65 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 120.639 0.257 . . . . 0.0 111.11 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -132.93 18.13 4.16 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.69 -29.52 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.452 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -83.92 -29.49 27.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.219 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 70.8 m-85 -93.12 75.67 4.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.115 0.96 . . . . 0.0 112.537 -172.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -94.58 -2.32 51.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.158 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -151.53 115.75 5.02 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.021 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.94 102.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -81.15 -64.95 1.08 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.06 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 p -132.99 149.4 52.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 137' ' ' THR . 3.5 tt -129.19 139.89 51.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.506 ' N ' HD23 ' A' ' 136' ' ' LEU . 79.3 m -119.78 124.44 46.15 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -104.55 123.92 58.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.502 ' CE2' ' HG2' ' A' ' 141' ' ' GLU . 33.8 t80 -116.43 110.84 19.17 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.404 0.621 . . . . 0.0 110.613 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.4 mt -99.92 125.74 53.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.502 ' HG2' ' CE2' ' A' ' 139' ' ' PHE . 36.2 mt-10 -100.5 -50.27 3.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.11 167.69 23.49 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' PRO . 83.1 m-20 -110.67 170.15 8.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 123.575 0.547 . . . . 0.0 111.454 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 86' ' ' LYS . 35.4 mm-40 -47.38 -57.9 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.255 0.972 . . . . 0.0 110.064 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -87.02 -26.89 23.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.55 75.68 0.59 Allowed Glycine 0 C--O 1.221 -0.679 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.1 t -107.72 -2.22 20.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.581 0.229 . . . . 0.0 110.95 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 38.7 mt-10 74.73 0.44 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.266 1.026 . . . . 0.0 112.13 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' SER . 5.7 p -139.95 124.58 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 32.5 m -109.7 111.78 23.45 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.972 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 18.9 pttm -109.85 134.75 51.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.183 171.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 155' ' ' ILE . 29.2 m -123.01 148.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.767 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.5 tp60 -85.81 -48.7 8.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.987 174.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -167.53 136.16 2.56 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 176.472 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 152' ' ' VAL . 2.5 mp -104.72 112.27 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 154' ' ' LYS . . . -139.92 157.28 45.94 Favored 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.11 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 1.9 mm? -119.43 157.21 28.69 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 72.4 m-85 -116.18 128.02 55.28 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.37 15.29 Favored Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.392 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 55.7 p -135.1 117.98 16.23 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.218 0.533 . . . . 0.0 111.438 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.0 p . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.653 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 11' ' ' LYS . 45.8 mm . . . . . 0 N--CA 1.415 -2.201 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.96 17.97 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.239 2.626 . . . . 0.0 111.507 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 9.9 mmpt? 64.69 12.49 7.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.119 1.367 . . . . 0.0 112.999 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.73 -83.43 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 29.7 mm-40 -103.77 -175.99 2.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 m -106.82 158.22 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 19.8 t0 -83.7 105.33 14.53 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.643 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 mp -60.23 -2.21 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 125.46 1.504 . . . . 0.0 114.233 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.533 HD21 ' H ' ' A' ' 42' ' ' GLN . 4.0 tt -56.01 -38.76 70.94 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.1 -17.59 64.59 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.065 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.79 23.35 12.02 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 16' ' ' LEU . 59.5 mt -102.79 142.62 16.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.38 -48.75 78.38 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' A' ' 40' ' ' LEU . 53.3 m95 70.95 -27.84 0.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 t -69.45 -35.61 75.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.18 -83.51 1.1 Allowed Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.912 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.416 HG11 ' CE3' ' A' ' 22' ' ' TRP 0.337 27.6 m 43.22 103.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -176.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.74 136.87 51.84 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.322 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -135.76 137.42 41.63 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.127 0.489 . . . . 0.0 110.176 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.3 -30.89 68.01 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.637 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.695 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 14.0 m120 -84.65 -93.57 0.08 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.777 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.503 HE22 ' HB3' ' A' ' 36' ' ' LEU . 4.0 tp-100 51.7 30.3 6.63 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -106.97 -75.39 0.63 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -163.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 p -48.83 -44.68 39.62 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -176.48 -61.92 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.48 0.657 . . . . 0.0 109.44 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.818 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.0 m-70 -72.42 144.0 48.31 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.941 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -107.7 164.36 12.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -169.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.503 ' HB3' HE22 ' A' ' 30' ' ' GLN . 2.8 tm? -60.07 -60.29 11.08 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.242 1.417 . . . . 0.0 113.812 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.15 -22.02 54.32 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.212 1.941 . . . . 0.0 112.965 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.3 m-20 -59.85 -29.12 68.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.669 1.188 . . . . 0.0 111.422 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -114.93 7.89 15.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.24 0.543 . . . . 0.0 111.415 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . 11.2 mp -119.49 -53.62 2.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -79.77 142.29 35.51 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.076 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' H ' HD21 ' A' ' 17' ' ' LEU . 14.0 tm0? -56.78 132.9 53.57 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 124.707 1.203 . . . . 0.0 110.651 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.13 -42.65 1.9 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -88.99 -49.94 6.47 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.367 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.0 ptm180 -47.92 90.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 4.9 tp10 171.03 143.69 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 153' ' ' GLN . 33.6 t70 -74.6 131.16 40.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.69 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.99 -52.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.23 -56.41 0.01 OUTLIER Glycine 0 CA--C 1.474 -2.484 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 50' ' ' LEU . 2.6 pp -80.94 135.61 35.91 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.588 174.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.818 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 34.8 p30 -161.83 169.55 21.11 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 tp -98.2 109.68 22.39 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 118.889 0.768 . . . . 0.0 108.989 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.04 131.01 44.01 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.069 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 60' ' ' LEU . 57.5 p -97.04 112.41 24.19 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.178 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.38 -35.68 8.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.502 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.37 -48.2 82.35 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.742 0.782 . . . . 0.0 109.291 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.83 151.14 43.72 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -100.32 7.47 44.34 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.937 0.875 . . . . 0.0 109.221 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -105.63 128.6 53.73 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.695 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 3.5 tt -133.56 131.74 40.06 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.224 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 7.0 tt -131.14 132.75 44.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.062 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.429 HD11 HD22 ' A' ' 60' ' ' LEU . 2.6 mp -130.73 145.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -114.19 121.5 43.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.65 121.51 37.13 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -91.38 141.93 2.85 Favored 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.265 2.643 . . . . 0.0 111.621 173.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.68 164.37 26.35 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 122.871 1.32 . . . . 0.0 113.874 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -104.82 -45.99 4.43 Favored 'General case' 0 N--CA 1.395 -3.197 0 CA-C-N 112.572 -2.104 . . . . 0.0 107.022 171.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -143.79 146.57 33.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.457 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -75.37 117.47 19.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 122.178 0.99 . . . . 0.0 111.654 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.98 173.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.542 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 3.7 mppt? -97.97 136.37 38.34 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.458 -1.297 . . . . 0.0 111.058 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.532 ' CD1' HD11 ' A' ' 125' ' ' LEU . 2.1 tm? -89.89 114.02 25.73 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -110.01 -37.95 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.8 m -143.62 171.23 14.46 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.207 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -142.75 157.57 44.51 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.604 ' HB3' ' HE1' ' A' ' 158' ' ' TYR . . . -149.39 143.74 25.94 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.837 0.351 . . . . 0.0 110.364 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.1 mt -145.71 137.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HE2' ' O ' ' A' ' 119' ' ' LYS . 87.2 mttt -112.86 157.38 21.48 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.372 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 178.5 36.86 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' CG ' ' HB2' ' A' ' 151' ' ' LYS . 7.5 Cg_exo -75.18 160.06 39.98 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.507 1.472 . . . . 0.0 110.032 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.51 -29.72 26.54 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.517 1.127 . . . . 0.0 112.065 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -93.15 -57.08 2.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 mp0 -68.44 -52.37 33.41 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.14 109.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.167 0 O-C-N 125.365 1.666 . . . . 0.0 116.56 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' CG ' HG22 ' A' ' 152' ' ' VAL . 26.6 Cg_exo -61.85 108.06 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.208 1.939 . . . . 0.0 110.217 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 38.0 ttpt -99.42 -63.86 1.09 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -167.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.9 m -78.62 94.8 5.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.458 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 111' ' ' ALA . 16.7 m -100.96 137.65 27.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -128.5 141.6 51.33 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.924 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 82.3 m-85 -117.45 148.12 42.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.679 -175.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.484 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 47.1 m-85 -114.53 126.72 55.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.724 174.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.5 t -91.79 96.51 10.46 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.186 0.517 . . . . 0.0 110.382 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 64.99 9.64 5.6 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.591 1.156 . . . . 0.0 112.824 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -88.72 139.88 30.02 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.4 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 95' ' ' GLU . 1.7 mp0 -55.45 169.12 0.32 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.538 1.535 . . . . 0.0 112.197 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -61.7 97.41 0.08 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.748 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.416 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . 83.8 mtp -98.78 106.75 19.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.475 ' O ' HG13 ' A' ' 102' ' ' VAL . 83.2 m -75.86 -168.98 0.98 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 102' ' ' VAL . 60.5 m-85 -46.65 -44.55 18.51 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -81.24 -31.73 33.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.39 0.615 . . . . 0.0 111.127 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -77.96 -19.67 54.12 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.977 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 98' ' ' CYS . 34.0 m -64.27 -5.72 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -91.41 -1.28 57.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.583 0.23 . . . . 0.0 110.9 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -101.55 -31.93 10.62 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 5.9 p90 -96.22 152.64 38.94 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.203 -171.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 6.6 Cg_endo -89.09 120.14 1.04 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.031 1.821 . . . . 0.0 108.724 170.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.12 142.27 99.1 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.153 1.902 . . . . 0.0 112.46 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 18.7 m -59.67 -42.41 92.8 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.465 0.65 . . . . 0.0 109.783 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -158.23 168.95 25.63 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.5 t -152.1 115.31 4.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -133.38 161.68 33.88 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.344 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.1 mp0 -114.96 128.61 56.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.2 tt -66.16 134.47 52.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.52 0.676 . . . . 0.0 111.612 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 t -121.15 179.32 4.43 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.32 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 40.8 mt-10 -54.74 -45.92 74.2 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.808 0.843 . . . . 0.0 112.983 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -70.88 -35.24 72.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.238 0.542 . . . . 0.0 109.682 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.442 ' HB3' ' HG ' ' A' ' 113' ' ' LEU . 62.7 t30 -65.18 -40.19 93.93 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.422 HD13 HD21 ' A' ' 113' ' ' LEU . 20.3 tp -61.02 -24.47 66.2 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 111.127 -178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 14.4 mmmm -79.29 -3.37 45.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.633 0.73 . . . . 0.0 109.27 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.05 17.02 52.94 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.156 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 98.8 mttt -87.9 141.15 31.33 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-N 116.714 0.257 . . . . 0.0 110.962 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 17.1 Cg_exo -67.31 119.37 6.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.02 2.48 . . . . 0.0 112.633 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.54 134.52 41.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.55 144.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.286 0.565 . . . . 0.0 112.293 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -131.86 -170.82 2.47 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.121 174.066 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -67.92 89.49 0.28 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.43 0.633 . . . . 0.0 112.692 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -69.18 -32.15 71.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.895 0.878 . . . . 0.0 110.107 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.13 -27.63 36.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.896 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 6.1 tmtt? -85.16 -45.26 12.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -78.27 90.26 4.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -106.49 -39.96 5.72 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -113.02 120.28 40.82 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.273 176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -118.8 102.05 12.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.786 176.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -102.82 -38.95 7.2 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.683 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.9 m -152.47 154.19 35.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.47 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 130.39 18.83 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.9 m -106.13 131.41 53.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 69.8 mt -111.14 122.28 65.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 57.3 t80 -122.94 121.82 37.08 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.718 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.447 HG22 HG12 ' A' ' 88' ' ' VAL . 2.0 pp -115.58 129.13 72.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.4 pt-20 -106.84 -20.76 13.24 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.421 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.67 31.66 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.064 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 6.8 p30 -102.8 175.4 5.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.019 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.502 HE21 ' HD3' ' A' ' 86' ' ' LYS . 7.9 tp60 -45.13 -50.13 11.42 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.625 1.57 . . . . 0.0 111.68 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -107.36 -37.77 6.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.48 46.83 2.27 Favored Glycine 0 C--N 1.312 -0.789 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.3 t -84.63 12.57 6.89 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.359 0.664 . . . . 0.0 112.771 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 69.26 1.95 3.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.862 0.865 . . . . 0.0 112.61 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.84 134.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 83.5 m -118.47 111.44 18.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.407 ' HB2' ' CG ' ' A' ' 80' ' ' PRO . 60.1 mttp -94.4 134.88 36.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.402 HG22 ' CG ' ' A' ' 85' ' ' PRO . 49.0 t -122.27 120.93 62.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.492 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 20.6 pt20 -98.0 -13.44 21.1 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.361 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 23.1 pttt -168.07 150.21 5.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.149 168.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.4 HG13 HG11 ' A' ' 152' ' ' VAL . 65.4 mt -131.05 112.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.05 137.97 52.38 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 6.1 mp -103.08 140.85 36.77 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.604 ' HE1' ' HB3' ' A' ' 76' ' ' ALA . 97.5 m-85 -125.32 139.84 53.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.482 0.658 . . . . 0.0 111.279 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 71' ' ' LYS . . . -173.53 -154.86 10.99 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.6 p -161.43 154.52 21.03 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.905 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.42 -1.96 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.789 173.167 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.525 HG13 ' H ' ' A' ' 15' ' ' ASP . 2.3 mp . . . . . 0 N--CA 1.425 -1.7 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.6 143.23 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.826 1.684 . . . . 0.0 108.864 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -69.8 99.29 1.34 Allowed 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.167 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.87 -48.34 0.32 Allowed Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -119.36 178.83 4.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.79 142.6 39.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' HG13 ' A' ' 9' ' ' ILE . 10.1 t0 -72.73 116.87 13.74 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 20' ' ' ILE . 52.6 mt -79.61 5.54 12.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 42' ' ' GLN . 4.7 tt -55.18 -38.11 67.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.919 0.866 . . . . 0.0 108.759 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.76 -17.07 54.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.671 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' HA ' ' ND2' ' A' ' 67' ' ' ASN . 7.7 m-85 -90.52 -4.85 56.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.597 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 64' ' ' ILE . 92.4 mt -86.64 138.16 19.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.17 101.64 14.38 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 172.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CH2' ' HA ' ' A' ' 41' ' ' LYS . 98.7 m95 -76.36 1.55 15.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -92.32 -28.31 17.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.81 4.67 56.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.903 -0.665 . . . . 0.0 114.274 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.6 m -61.22 136.31 24.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.182 0.515 . . . . 0.0 111.765 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 9.3 tp10 -134.57 144.25 47.84 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.596 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 62.7 m -137.28 138.3 39.91 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.857 -176.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 28' ' ' LEU . 3.1 tm? -72.19 -49.03 38.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.134 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -103.87 -64.32 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.596 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 28.6 pt20 54.79 22.9 4.46 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.463 1.505 . . . . 0.0 111.854 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 40.7 t 73.82 129.64 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.285 1.834 . . . . 0.0 112.47 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.92 -4.87 34.74 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.218 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -121.36 -68.9 0.87 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.437 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.616 ' O ' ' HB3' ' A' ' 31' ' ' SER . 78.0 m80 -99.95 112.37 24.65 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.421 -173.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 m -66.48 130.16 42.25 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.613 HD21 HD23 ' A' ' 40' ' ' LEU 0.258 5.5 tt -45.15 -39.59 9.28 Favored Pre-proline 0 CA--C 1.568 1.656 0 N-CA-C 118.618 2.821 . . . . 0.0 118.618 -177.212 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 76.5 Cg_exo -53.97 -1.35 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.823 2.348 . . . . 0.0 114.895 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.534 HD22 ' HB2' ' A' ' 50' ' ' LEU . 30.8 p30 -86.24 -48.1 8.84 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.13 -14.16 15.48 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 36' ' ' LEU . 45.4 tp -102.23 -40.33 6.83 Favored 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 118.839 -1.144 . . . . 0.0 107.957 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.02 97.87 6.98 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 170.248 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.628 ' HB3' HD11 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -70.22 102.6 2.14 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.308 -172.673 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.1 -56.11 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.557 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -89.15 -9.9 49.23 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.234 0.614 . . . . 0.0 110.124 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 45' ' ' ARG . 2.4 ppt_? -52.54 130.1 30.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.122 -172.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER 174.06 139.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 173.539 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.83 88.38 6.78 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.55 -69.34 0.17 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.78 -47.18 0.63 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.43 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.534 ' HB2' HD22 ' A' ' 38' ' ' ASN . 1.0 OUTLIER -125.61 113.75 17.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.027 0.918 . . . . 0.0 112.566 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -149.04 160.39 43.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 151' ' ' LYS . 3.4 tm? -90.61 120.32 31.58 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.35 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.9 pt-20 -141.01 119.35 12.17 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.341 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 49.6 p -35.05 -65.79 0.21 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.08 1.752 . . . . 0.0 115.549 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 67.16 17.66 10.36 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.701 0.762 . . . . 0.0 112.15 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.01 -62.92 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.286 0.565 . . . . 0.0 109.523 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 54' ' ' SER . 22.7 m-20 -131.36 127.91 38.57 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -73.47 -30.1 62.95 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 124.078 0.861 . . . . 0.0 110.341 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -74.37 115.58 14.06 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.56 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 95.0 mt -119.04 126.78 52.49 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.028 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 62' ' ' ILE . 1.4 tm? -113.0 121.69 45.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 61' ' ' LEU . 2.7 mp -127.92 142.75 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.495 ' HB2' ' HB3' ' A' ' 96' ' ' HIS . 50.5 t80 -110.45 121.81 46.2 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 123.816 0.846 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 20' ' ' ILE . 48.4 mm -120.85 121.47 28.9 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.793 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.52 124.82 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.476 2.117 . . . . 0.0 111.23 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -95.71 157.38 15.92 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 121.226 0.536 . . . . 0.0 111.217 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 19' ' ' PHE . 34.2 p30 -78.5 -23.34 46.41 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.92 160.73 39.78 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.659 HG23 ' H ' ' A' ' 133' ' ' VAL . 7.7 p -84.4 108.67 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 172.56 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -90.7 113.58 25.7 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 133' ' ' VAL . 98.0 mt -69.41 128.46 36.64 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 44.2 t60 -118.39 -50.64 2.43 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.1 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 p -147.18 174.11 11.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.82 159.74 43.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.06 139.58 39.62 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.215 0.322 . . . . 0.0 110.252 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 71.6 mt -140.93 117.62 7.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -107.45 125.76 51.65 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.818 0.818 . . . . 0.0 110.318 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.98 -174.08 22.99 Favored Glycine 0 C--N 1.261 -3.621 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.48 135.47 3.07 Favored 'Trans proline' 0 N--CA 1.424 -2.604 0 CA-C-N 119.598 1.699 . . . . 0.0 108.632 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -58.57 -25.85 62.99 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.673 0.749 . . . . 0.0 110.798 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.89 -53.17 27.52 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.783 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' OE1' ' HD3' ' A' ' 151' ' ' LYS . 4.7 mp0 -103.78 -59.82 1.66 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 85' ' ' PRO . . . 27.03 128.75 0.0 OUTLIER Glycine 0 N--CA 1.511 3.647 0 C-N-CA 127.98 2.705 . . . . 0.0 118.443 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 84' ' ' GLY . 5.7 Cg_exo -75.45 114.55 4.0 Favored 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.168 1.912 . . . . 0.0 110.373 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 51.3 tttp -99.82 -69.84 0.75 Allowed 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -57.21 106.97 0.37 Allowed 'General case' 0 C--O 1.249 1.073 0 O-C-N 123.183 0.302 . . . . 0.0 111.314 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 86' ' ' LYS . 96.3 t -109.26 116.32 51.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.447 ' HZ2' ' HB2' ' A' ' 89' ' ' LYS . 4.3 ttmp? -118.83 136.46 54.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.443 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 97.3 m-85 -121.83 166.47 14.32 Favored 'General case' 0 C--O 1.201 -1.456 0 O-C-N 122.038 -0.413 . . . . 0.0 111.927 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.426 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 80.8 t80 -151.41 121.64 7.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 t -97.9 143.71 28.21 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.789 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 77.73 172.34 0.2 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 125.08 1.352 . . . . 0.0 112.722 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 71.21 177.92 0.26 Allowed 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.605 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 155.65 21.42 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 42.9 p-80 -51.08 124.42 11.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 80.6 mtp -98.83 116.93 32.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.362 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 67.6 m -72.02 158.04 36.7 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.568 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 64.6 t80 -48.9 -37.43 19.73 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 m -59.6 -22.56 61.98 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 120.846 0.355 . . . . 0.0 111.591 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.51 -13.06 11.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.099 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.568 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 2.7 p -67.48 -33.89 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.801 0.334 . . . . 0.0 111.214 -171.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.53 94.91 10.04 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.948 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -178.77 -45.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.19 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -98.01 149.89 36.19 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.481 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.39 126.74 19.16 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.463 2.109 . . . . 0.0 111.866 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.52 163.51 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.289 2.659 . . . . 0.0 112.398 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 9.6 t -61.43 -47.68 84.63 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.53 ' OD1' ' HB2' ' A' ' 126' ' ' LYS . 20.5 m-20 -174.26 -177.6 1.3 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.15 2.58 . . . . 0.0 104.038 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -157.33 145.61 19.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.751 0.705 . . . . 0.0 110.278 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 88' ' ' VAL . . . -154.63 172.14 18.35 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -125.5 138.13 53.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 22.7 tp -61.67 143.84 55.51 Favored 'General case' 0 C--O 1.25 1.092 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 117' ' ' ASN . 8.0 t -134.52 165.47 25.12 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.423 ' O ' ' HD3' ' A' ' 119' ' ' LYS . 46.3 mt-10 -62.9 -28.24 69.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 119.089 0.859 . . . . 0.0 111.387 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.434 ' HG2' ' CB ' ' A' ' 121' ' ' LYS . 41.1 tt0 -66.34 -40.63 89.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.77 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.54 ' H ' HG23 ' A' ' 114' ' ' THR . 2.4 t-20 -67.47 -34.24 76.77 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.4 tp -67.31 -28.34 67.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.732 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 14.1 mptt -87.76 1.02 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 110.508 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.64 23.93 Favored Glycine 0 C--N 1.303 -1.272 0 C-N-CA 120.294 -0.955 . . . . 0.0 115.146 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.434 ' CB ' ' HG2' ' A' ' 116' ' ' GLU . 17.5 tppt? -75.08 119.11 75.38 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 117.93 0.865 . . . . 0.0 108.918 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.89 100.92 0.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.878 1.718 . . . . 0.0 109.663 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.32 133.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 27.9 m -64.68 135.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.48 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 125' ' ' LEU . 2.7 mp -65.06 -67.04 0.47 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.53 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 34.8 mmtp -171.54 -174.58 1.42 Allowed 'General case' 0 C--N 1.287 -2.143 1 N-CA-C 100.081 -4.044 . . . . 0.0 100.081 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.403 ' HA ' ' CE1' ' A' ' 130' ' ' PHE . 37.4 t80 -146.36 24.39 1.27 Allowed 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 123.186 1.469 . . . . 0.0 108.078 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.16 -40.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.658 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.9 tmtt? -116.53 -20.47 9.62 Favored 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 118.732 -1.187 . . . . 0.0 114.045 -167.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 127' ' ' TYR . 32.6 p90 -58.44 18.08 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.445 0 C-N-CA 125.209 1.404 . . . . 0.0 114.415 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.37 2.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -163.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -166.56 115.52 0.9 Allowed 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.659 ' H ' HG23 ' A' ' 69' ' ' VAL . 60.4 t -120.01 125.23 74.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.757 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -121.13 -61.29 1.56 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 173.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 29.6 p -116.37 152.44 33.92 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.9 tp -136.32 122.83 20.82 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.077 0.465 . . . . 0.0 110.006 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 87.9 m -93.37 113.45 25.63 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.9 mt -104.78 116.52 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -115.4 108.73 16.89 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.291 0.567 . . . . 0.0 111.006 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 8.2 pt -89.46 114.07 26.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-O 121.848 0.832 . . . . 0.0 108.877 172.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.59 -40.53 16.16 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.13 -1.396 . . . . 0.0 113.028 -168.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.94 150.63 27.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.685 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -91.19 154.66 19.16 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.454 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.464 ' HG3' ' HD2' ' A' ' 86' ' ' LYS . 25.8 tt0 -58.44 -36.4 73.6 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 123.662 0.785 . . . . 0.0 112.295 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.1 t -103.35 -7.6 20.92 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.582 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.72 56.41 23.07 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.9 p -87.77 -1.47 57.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.616 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 42.6 mt-10 72.19 -37.07 0.38 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.092 0.957 . . . . 0.0 112.081 -177.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.3 t -106.09 118.24 53.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.178 0.513 . . . . 0.0 109.618 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 39.4 m -93.29 110.99 22.51 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.467 ' HD3' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -119.35 135.71 54.6 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.874 0.369 . . . . 0.0 110.392 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.1 p -142.09 148.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.04 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 74.1 mt-30 -108.99 -32.35 7.29 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -155.24 115.97 3.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.762 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.422 ' HB ' ' CD1' ' A' ' 40' ' ' LEU . 66.4 mt -122.71 127.17 74.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.43 152.67 40.99 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.29 155.56 21.9 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 15' ' ' ASP . 99.5 m-85 -124.56 130.59 52.73 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.573 0.701 . . . . 0.0 111.297 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.05 -171.12 12.24 Favored Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.3 m -142.57 133.88 26.21 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.395 0.617 . . . . 0.0 111.599 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.425 -1.719 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.12 174.047 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.569 HG13 ' HB3' ' A' ' 15' ' ' ASP . 3.0 mp . . . . . 0 N--CA 1.441 -0.916 0 CA-C-O 120.462 0.172 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.46 160.99 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.705 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -71.3 107.02 4.07 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.87 -76.04 0.24 Allowed Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -106.69 168.88 8.88 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.64 125.77 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.534 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.569 ' HB3' HG13 ' A' ' 9' ' ' ILE . 34.0 t0 -72.11 130.09 40.05 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 176.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.626 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.2 mm? -68.86 -1.2 6.66 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -51.24 -45.17 61.89 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.571 1.148 . . . . 0.0 109.1 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.42 -16.04 56.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.807 0.813 . . . . 0.0 110.863 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.526 ' CD1' HD12 ' A' ' 16' ' ' LEU . 11.1 t80 -92.58 -14.24 28.54 Favored 'General case' 0 N--CA 1.415 -2.195 0 C-N-CA 124.251 1.02 . . . . 0.0 112.058 -174.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 16' ' ' LEU . 96.3 mt -75.04 140.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 120.701 0.286 . . . . 0.0 111.035 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.76 -29.44 63.32 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.277 0.561 . . . . 0.0 110.527 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' H ' HG22 ' A' ' 20' ' ' ILE . 98.3 m95 71.18 -15.82 0.39 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 173.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -67.86 -25.37 65.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.481 0.658 . . . . 0.0 110.58 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.68 -81.24 1.58 Allowed Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.053 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.565 ' H ' ' CG ' ' A' ' 65' ' ' PRO 0.345 27.4 m 46.87 79.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.983 0 CA-C-O 122.476 1.131 . . . . 0.0 112.842 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -112.83 148.83 34.05 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.951 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.7 t -135.93 128.85 31.27 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.12 7.91 5.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.684 0.754 . . . . 0.0 110.568 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 6.0 m120 -126.01 -92.16 0.51 Allowed 'General case' 0 CA--C 1.479 -1.785 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.381 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 45.63 32.15 1.11 Allowed 'General case' 0 C--N 1.379 1.85 0 CA-C-O 122.677 1.227 . . . . 0.0 109.467 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.4 t -37.5 -63.64 0.44 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.729 2.811 . . . . 0.0 113.367 -171.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -50.04 -48.1 52.95 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.2 m 147.27 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.749 0 C-N-CA 128.127 2.571 . . . . 0.0 106.664 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.843 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 89.5 m-70 -62.14 132.66 53.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.149 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -106.77 -173.1 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.406 -0.918 . . . . 0.0 113.293 -164.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.8 tp -86.71 -46.74 0.53 Allowed Pre-proline 0 C--O 1.212 -0.895 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.09 -38.8 71.03 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.424 1.416 . . . . 0.0 111.415 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.502 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.8 p-10 -75.06 -2.0 25.44 Favored 'General case' 0 C--O 1.203 -1.365 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.618 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.19 0.14 6.43 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 tp -121.64 -30.48 4.18 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.516 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 6.0 tmtt? -82.24 143.13 31.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -68.88 149.14 49.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.575 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.31 -35.41 3.71 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.494 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 81.4 m-85 -89.4 -28.03 20.03 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.158 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -68.85 80.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -167.67 110.97 0.65 Allowed 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.005 0.922 . . . . 0.0 109.154 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.679 ' H ' ' HG3' ' A' ' 153' ' ' GLN . 20.0 t70 -71.22 116.47 11.57 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.121 0.486 . . . . 0.0 110.188 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -164.62 -63.12 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.08 -49.82 0.36 Allowed Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.1 pp -105.95 141.42 37.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 120.976 0.417 . . . . 0.0 110.623 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.843 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 36.5 p30 -162.28 169.63 20.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tt -102.16 124.81 48.41 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -138.73 165.07 27.93 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.274 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 66.4 p -101.47 148.65 24.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.961 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -125.17 -68.69 0.83 Allowed 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.4 -39.71 22.3 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.612 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 54' ' ' SER . 40.6 m-20 -123.21 121.21 35.36 Favored 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.784 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.9 tt0 -69.58 -26.22 64.36 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.323 1.015 . . . . 0.0 108.537 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.82 108.22 10.89 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.81 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.568 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 96.3 mt -115.54 132.29 56.67 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.49 -172.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.77 128.32 49.39 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.04 136.63 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 122.81 0.444 . . . . 0.0 110.716 -173.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -106.95 131.56 53.89 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.548 0.339 . . . . 0.0 110.887 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -108.38 117.08 55.42 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.022 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.565 ' CG ' ' H ' ' A' ' 25' ' ' VAL . 8.3 Cg_exo -73.34 144.58 36.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.608 2.205 . . . . 0.0 110.942 175.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' HE2' ' NH2' ' A' ' 134' ' ' ARG . 24.5 p90 -122.38 161.91 22.58 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -98.4 -43.34 6.95 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.328 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -153.93 178.85 9.48 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.617 -171.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.449 HG22 ' HD2' ' A' ' 134' ' ' ARG . 93.2 t -83.04 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.836 -0.166 . . . . 0.0 110.581 174.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.67 172.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.63 114.13 27.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.6 tp -72.75 133.8 44.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -111.76 -52.71 2.77 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.872 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -145.15 164.63 30.68 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.019 0.438 . . . . 0.0 111.946 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -135.2 153.8 51.82 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -148.64 110.09 4.43 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.219 0.533 . . . . 0.0 111.227 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.9 117.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 79' ' ' GLY . 7.8 tmtt? -116.43 141.53 48.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -173.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.575 ' N ' ' HD3' ' A' ' 78' ' ' LYS . . . -171.39 -156.35 11.72 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 174.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.473 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 78.2 Cg_endo -75.06 165.98 30.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.36 2.04 . . . . 0.0 110.902 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HA ' HD11 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -70.41 -33.64 71.59 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.76 -47.84 6.58 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 31.2 mt-10 -86.73 15.44 5.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.675 -175.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.28 148.78 19.86 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.424 ' O ' HD22 ' A' ' 113' ' ' LEU . 44.9 Cg_exo -59.01 162.86 12.63 Favored 'Trans proline' 0 C--O 1.217 -0.534 0 C-N-CA 122.614 2.21 . . . . 0.0 111.888 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 36.3 ttpt -132.94 -73.43 0.5 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.062 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.5 m -76.68 108.67 9.85 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.806 0.336 . . . . 0.0 110.122 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.633 HG12 HG22 ' A' ' 140' ' ' ILE . 7.6 m -118.97 142.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 -177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -125.6 149.45 48.37 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -127.09 152.73 46.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.614 ' CE2' ' HB ' ' A' ' 137' ' ' THR 0.252 23.4 p90 -148.83 116.22 6.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.74 0.781 . . . . 0.0 111.66 173.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' SER . 20.6 m -103.99 149.36 25.22 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.849 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.5 116.02 0.05 Allowed 'General case' 0 C--O 1.239 0.537 0 O-C-N 124.632 1.208 . . . . 0.0 109.676 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 94' ' ' LYS 0.279 0.5 OUTLIER 81.75 108.55 0.07 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.4 1.08 . . . . 0.0 112.256 -175.288 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.51 177.19 4.99 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.324 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 79.01 0.76 2.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.368 1.067 . . . . 0.0 111.022 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.594 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 44.6 ttm -70.22 115.14 9.07 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.851 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.3 m -100.33 177.11 5.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.256 36.9 p90 -55.8 -29.88 60.44 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.6 p -62.46 -35.95 80.91 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.973 0.892 . . . . 0.0 109.86 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 2.3 m-20 -87.75 -29.09 21.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.697 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 98' ' ' CYS . 97.8 t -62.4 -29.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.294 0.569 . . . . 0.0 110.52 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -88.71 -10.35 48.72 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.509 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.48 -50.13 6.28 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.063 0.459 . . . . 0.0 109.792 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -96.36 143.25 25.8 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.333 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 143.31 78.41 Favored 'Trans proline' 0 C--O 1.249 1.048 0 C-N-CA 122.144 1.896 . . . . 0.0 111.109 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.23 178.13 7.95 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.36 2.04 . . . . 0.0 111.406 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 32.1 m -78.45 -44.39 24.79 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -168.35 168.85 11.08 Favored 'General case' 0 C--O 1.256 1.395 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -144.16 138.24 28.0 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.95 159.69 39.23 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.511 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.2 tp10 -109.05 116.98 33.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 10.3 tt -61.35 113.27 2.54 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.253 1.025 . . . . 0.0 110.174 -176.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 117' ' ' ASN . 9.6 t -85.09 157.9 20.57 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.566 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.88 -22.11 65.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.279 0.561 . . . . 0.0 111.014 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.411 ' HG3' ' HD2' ' A' ' 121' ' ' LYS . 6.7 tp10 -65.81 -36.55 83.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.539 HD22 HG23 ' A' ' 123' ' ' VAL . 17.3 t-20 -71.77 -42.82 66.7 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' A' ' 113' ' ' LEU . 7.7 tt -62.02 -21.31 64.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.076 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -82.4 -13.64 56.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.131 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.43 10.9 21.0 Favored Glycine 0 C--O 1.24 0.521 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.083 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HD2' ' HG3' ' A' ' 116' ' ' GLU . 99.0 mttt -94.04 135.98 24.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 61.4 Cg_endo -71.48 104.58 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.15 2.567 . . . . 0.0 112.353 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.539 HG23 HD22 ' A' ' 117' ' ' ASN . 66.1 t -83.33 127.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.675 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.29 121.66 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 110.411 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.2 168.5 11.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.395 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.82 94.02 7.58 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.222 0.534 . . . . 0.0 109.911 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . 0.312 26.8 p90 -88.44 67.41 8.59 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.12 -47.49 13.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.2 tmtt? -80.27 -30.74 38.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -73.5 84.16 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.184 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -110.67 -68.18 0.95 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.405 ' HB2' HG11 ' A' ' 69' ' ' VAL . 3.1 p30 -104.5 115.79 30.97 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.1 t -100.2 103.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 C-N-CA 118.472 -1.291 . . . . 0.0 110.675 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HD2' HG22 ' A' ' 69' ' ' VAL . 28.8 mmm180 -78.37 -80.64 0.11 Allowed 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.554 170.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 92' ' ' SER . 42.6 p -105.55 149.73 26.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.48 129.75 41.53 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.614 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 20.8 m -130.84 144.18 51.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.4 mt -117.74 135.99 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 122.501 0.32 . . . . 0.0 110.191 -174.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 83.5 t80 -123.21 112.23 17.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.633 HG22 HG12 ' A' ' 88' ' ' VAL . 26.1 pt -109.27 114.96 48.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.6 pt-20 -105.31 -9.45 17.62 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.29 166.82 29.77 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.129 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -119.18 164.57 15.39 Favored 'General case' 0 CA--C 1.496 -1.117 0 O-C-N 124.164 0.915 . . . . 0.0 109.903 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.426 ' N ' ' HB2' ' A' ' 86' ' ' LYS . 34.2 mm-40 -46.32 -61.4 1.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 110.374 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.2 t -91.24 -11.07 39.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.697 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.64 65.28 2.96 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.6 t -100.21 -2.35 34.15 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 58' ' ' GLU 0.286 45.0 mt-10 68.7 -27.25 0.15 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.2 p -102.22 103.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 25.0 m -101.19 111.27 23.44 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.504 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -104.84 132.49 51.02 Favored 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.485 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.99 124.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.869 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.679 ' HG3' ' H ' ' A' ' 47' ' ' ASP . 36.0 tt0 -97.3 -27.62 14.42 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.102 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 20.4 ttmm -160.72 129.26 4.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.6 112.11 38.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 165.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.438 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -130.87 141.84 50.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 156' ' ' ALA . 5.8 mp -130.69 142.67 50.44 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 79.4 m-85 -124.53 114.27 19.2 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -109.94 -174.08 20.7 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.3 m -139.23 129.94 26.03 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--N 1.293 -1.866 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.253 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.5 mp . . . . . 0 N--CA 1.418 -2.038 0 CA-C-O 120.453 0.168 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 13' ' ' GLN . 19.3 Cg_endo -93.09 -173.87 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.513 2.142 . . . . 0.0 110.525 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -96.93 137.45 35.99 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.67 -40.22 2.6 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.452 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -143.05 137.52 29.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.83 155.22 7.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 123.816 0.698 . . . . 0.0 110.001 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -58.95 129.53 42.6 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.092 0.957 . . . . 0.0 110.886 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.599 ' O ' HG13 ' A' ' 20' ' ' ILE . 80.6 mt -98.19 5.89 48.03 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.001 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.527 HD22 ' HG2' ' A' ' 42' ' ' GLN . 64.9 tp -64.22 -42.22 96.67 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.797 0.808 . . . . 0.0 109.497 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.5 -20.03 65.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.896 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.577 ' C ' ' HB2' ' A' ' 67' ' ' ASN . 24.7 m-85 -95.17 19.87 9.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.914 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 16' ' ' LEU . 72.1 mt -108.19 127.76 64.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.985 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 -38.25 85.1 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CZ2' HD12 ' A' ' 40' ' ' LEU . 90.0 m95 76.46 -29.19 0.18 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.4 t -80.05 -36.37 35.78 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.485 0.66 . . . . 0.0 110.044 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.13 12.43 66.34 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.004 -0.617 . . . . 0.0 114.575 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 34.7 m -62.53 152.31 7.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-N 117.504 0.652 . . . . 0.0 111.989 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.97 127.45 13.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 p -134.02 108.22 8.23 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.677 0.751 . . . . 0.0 109.897 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -76.5 121.49 23.19 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.624 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 46.3 t30 72.53 -55.1 0.68 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.371 1.468 . . . . 0.0 110.978 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 23.9 pt20 63.2 -62.71 0.13 Allowed 'General case' 0 C--O 1.209 -1.069 0 C-N-CA 127.442 2.297 . . . . 0.0 110.0 -176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 23.9 m 176.87 119.77 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 129.608 3.163 . . . . 0.0 103.109 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.6 p -62.63 -18.39 62.16 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 117.073 -1.851 . . . . 0.0 113.124 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -111.3 -14.72 13.75 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.584 ' O ' ' HB2' ' A' ' 31' ' ' SER . 94.8 m-70 -125.43 163.62 22.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.914 -0.492 . . . . 0.0 110.289 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.539 ' OG ' ' HD2' ' A' ' 37' ' ' PRO . 29.5 t -114.03 171.19 7.75 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.799 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -77.38 -54.6 1.44 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.941 0.897 . . . . 0.0 112.722 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD2' ' OG ' ' A' ' 35' ' ' SER . 30.8 Cg_exo -40.34 -50.31 3.68 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 123.392 2.728 . . . . 0.0 114.823 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -55.85 -45.81 78.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.76 -11.06 57.63 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.465 HD12 ' CZ2' ' A' ' 22' ' ' TRP . 1.3 tm? -104.28 -27.28 12.1 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.0 120.36 22.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HG2' HD22 ' A' ' 17' ' ' LEU . 8.5 mm100 -75.56 92.07 2.88 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 121.923 0.868 . . . . 0.0 109.27 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.511 ' H ' ' HG3' ' A' ' 45' ' ' ARG . . . 170.14 -56.36 0.19 Allowed Glycine 1 N--CA 1.386 -4.66 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.46 -171.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -81.62 -29.3 33.3 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.511 0.672 . . . . 0.0 110.185 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 43' ' ' GLY . 5.1 ppt_? -60.95 17.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.93 137.15 36.13 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.344 -0.848 . . . . 0.0 112.209 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 8.3 t70 -58.96 85.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.927 1.691 . . . . 0.0 112.497 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER 160.61 -55.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.635 1.974 . . . . 0.0 108.097 174.469 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.22 -78.24 0.14 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.626 -0.716 . . . . 0.0 114.256 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 163.58 29.28 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.9 p-10 -161.19 166.35 27.96 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.474 HD21 HD13 ' A' ' 60' ' ' LEU . 5.4 tt -110.63 128.69 55.79 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 55' ' ' ASP . 10.9 pt-20 -141.96 158.82 43.33 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 120.579 0.228 . . . . 0.0 111.435 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.2 p -79.49 79.57 5.94 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 122.187 0.994 . . . . 0.0 108.418 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 25.8 t70 -97.27 79.97 2.86 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.206 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 155.21 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.514 2.326 . . . . 0.0 107.115 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.8 -170.3 1.63 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.493 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -18.88 12.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -102.27 154.79 18.71 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.023 0.929 . . . . 0.0 109.558 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.518 ' HB2' HG13 ' A' ' 140' ' ' ILE . 78.7 mt -146.51 147.32 31.05 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 1.2 tm? -123.21 116.92 24.18 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -124.33 120.89 60.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -109.79 134.52 51.94 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.88 0.472 . . . . 0.0 110.806 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 mm -120.78 131.83 24.35 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.492 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 53.6 Cg_endo -87.84 150.7 7.25 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.49 2.793 . . . . 0.0 111.577 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.472 ' HD1' ' H ' ' A' ' 66' ' ' PHE . 4.7 p90 -89.6 162.99 15.35 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -173.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.577 ' HB2' ' C ' ' A' ' 19' ' ' PHE . 4.6 t-20 -101.66 -43.14 5.96 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 112.509 -2.132 . . . . 0.0 107.322 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -153.07 150.73 29.44 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.29 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.51 122.92 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.67 175.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.424 ' HE2' ' HG2' ' A' ' 131' ' ' GLN . 38.4 ttmt -81.04 142.47 33.33 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 73' ' ' HIS . 3.1 tm? -81.05 150.91 28.62 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.562 ' N ' HD13 ' A' ' 72' ' ' LEU . 3.6 t-160 -141.96 -62.61 0.45 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.878 177.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.479 ' HA ' HD22 ' A' ' 125' ' ' LEU . 12.1 p -152.65 163.22 40.07 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 7.7 p90 -125.56 157.17 37.78 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -148.72 107.13 3.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.783 0.265 . . . . 0.0 110.513 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.87 136.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 91.3 mttt -114.01 158.12 21.6 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.663 176.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 153' ' ' GLN . . . -178.91 -177.49 47.54 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.99 150.14 89.03 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.833 1.689 . . . . 0.0 109.088 172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.59 -25.5 68.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 45.4 mt-10 -87.33 -54.52 4.26 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.486 0.66 . . . . 0.0 111.26 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.73 8.68 18.9 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.203 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.9 153.37 38.05 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.668 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.577 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 39.1 Cg_exo -60.98 147.41 95.76 Favored 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 122.14 1.893 . . . . 0.0 110.517 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.527 ' HB2' HE21 ' A' ' 144' ' ' GLN . 0.6 OUTLIER -130.33 -53.89 1.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 54.6 m -80.53 97.03 6.97 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.57 116.19 40.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.003 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -109.34 132.67 53.91 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -117.07 140.12 49.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.508 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 88.2 t80 -130.3 129.2 42.93 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -113.4 145.79 40.56 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 75.82 172.56 0.25 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.523 1.529 . . . . 0.0 111.272 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt 67.51 164.97 0.22 Allowed 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.373 1.069 . . . . 0.0 111.716 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.09 164.42 26.53 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -49.39 136.02 16.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.489 ' HE3' ' HB3' ' A' ' 101' ' ' ASN . 86.0 mtp -110.15 127.97 55.21 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.531 ' O ' HG23 ' A' ' 102' ' ' VAL . 25.9 p -86.9 176.6 7.6 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.9 -29.41 67.02 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -61.93 -19.34 62.63 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.086 0.554 . . . . 0.0 111.224 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.489 ' HB3' ' HE3' ' A' ' 97' ' ' MET . 13.3 m120 -109.32 -26.74 9.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.306 0.574 . . . . 0.0 110.207 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 98' ' ' CYS . 52.4 t -58.48 -38.04 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.574 1.15 . . . . 0.0 113.838 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -57.85 -14.34 5.89 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.95 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.61 71.19 1.23 Allowed 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.61 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 102' ' ' VAL . 3.0 p90 -128.14 153.77 78.65 Favored Pre-proline 0 C--O 1.249 1.046 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.184 167.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.92 118.55 5.07 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.242 1.961 . . . . 0.0 109.921 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.26 136.19 42.87 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.067 1.845 . . . . 0.0 111.875 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -69.05 -45.27 70.81 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -162.53 155.86 20.22 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.0 p -119.41 114.63 22.62 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.72 153.91 33.62 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.512 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mp0 -114.61 126.43 54.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.832 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 7.6 tt -73.59 113.1 10.33 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -103.26 175.23 5.55 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.449 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -38.22 60.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.023 0.529 . . . . 0.0 111.779 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.419 ' OE1' ' HD2' ' A' ' 121' ' ' LYS . 5.4 tp10 -61.33 -43.68 98.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.353 0.661 . . . . 0.0 109.894 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.55 HD22 HG23 ' A' ' 123' ' ' VAL . 13.8 t-20 -71.95 -38.37 69.79 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.442 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 118' ' ' LEU . 2.3 tm? -63.27 -22.93 67.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.832 1.253 . . . . 0.0 108.801 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -87.24 -0.37 56.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.428 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.24 52.73 Favored Glycine 0 CA--C 1.496 -1.103 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.419 ' HD2' ' OE1' ' A' ' 116' ' ' GLU . 98.4 mttt -86.36 142.29 35.36 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.515 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 48.6 Cg_endo -67.83 121.36 8.4 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.453 2.769 . . . . 0.0 112.401 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.55 HG23 HD22 ' A' ' 117' ' ' ASN . 76.7 t -97.35 119.96 46.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 130.5 34.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.314 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 74' ' ' SER . 0.7 OUTLIER -101.87 178.53 4.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 10.4 mptt -89.7 95.24 10.16 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -109.04 23.61 14.3 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.177 -173.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.6 t -53.05 -38.8 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.627 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -103.98 4.93 35.12 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.876 179.18 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' HE3' ' A' ' 129' ' ' LYS . 55.5 m-85 -108.23 71.89 0.82 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.932 0.873 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.424 ' HG2' ' HE2' ' A' ' 71' ' ' LYS . 46.4 mt-30 -102.49 0.24 33.37 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.444 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -142.37 114.72 8.38 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.456 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.12 107.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -74.35 -44.48 52.14 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.293 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.7 m -157.43 171.33 20.57 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 tp -142.56 131.64 23.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.931 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.9 m -111.46 118.34 35.5 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.0 mp -104.52 114.97 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -110.68 109.71 20.09 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.533 0.682 . . . . 0.0 109.973 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' A' ' 60' ' ' LEU . 7.2 pt -96.71 114.5 33.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.256 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.89 -48.65 5.92 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.664 -173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.92 146.2 48.93 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.664 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.12 -179.55 5.29 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.002 0.814 . . . . 0.0 109.121 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.527 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.3 mp0 -54.72 -62.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 p -93.44 -36.49 12.45 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.6 1.54 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.3 m -84.68 16.63 3.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.271 12.8 pt-20 63.11 -1.0 0.55 Allowed 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 126.147 1.779 . . . . 0.0 114.2 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.94 122.57 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.94 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -93.35 128.31 39.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -116.35 133.49 55.96 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 79.1 t -134.02 128.48 53.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.405 ' HG2' ' HA2' ' A' ' 79' ' ' GLY . 10.0 mm-40 -88.99 -46.35 8.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.386 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.506 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -146.02 142.94 29.11 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.396 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.76 127.19 73.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.34 141.24 41.83 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.37 137.31 52.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 88.3 m-85 -124.39 139.11 54.21 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.235 0.541 . . . . 0.0 111.265 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.29 -176.18 14.25 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 46.9 m -134.04 130.16 37.12 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 117.477 0.639 . . . . 0.0 110.729 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 C--N 1.288 -2.07 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.321 176.98 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.9 m . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m -85.46 105.58 16.18 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.17 112.74 16.15 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.72 -177.24 5.41 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.7 t -176.49 -73.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.67 73.54 1.41 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 m -113.49 135.21 54.13 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.746 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.18 105.53 13.9 Favored 'General case' 0 CA--C 1.471 -2.069 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.022 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.456 HG23 ' HA ' ' A' ' 14' ' ' VAL . 2.0 mp -92.75 116.2 66.1 Favored Pre-proline 0 N--CA 1.399 -2.978 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.546 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.64 -166.55 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -104.55 109.17 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.414 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.14 -41.69 0.89 Allowed Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -137.8 142.58 40.84 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.449 -0.876 . . . . 0.0 111.214 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.456 ' HA ' HG23 ' A' ' 9' ' ' ILE . 11.6 p -106.52 156.4 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.8 143.97 43.74 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.651 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.6 mp -102.82 7.18 39.52 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.653 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.52 -43.24 85.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.66 -16.67 60.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.662 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.39 -2.85 57.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 16' ' ' LEU . 94.9 mt -74.66 145.38 11.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.6 -42.54 70.84 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 122.751 0.421 . . . . 0.0 111.097 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 72.44 -33.97 0.28 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -79.11 -37.14 39.43 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.832 0.348 . . . . 0.0 110.871 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 17.68 55.28 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.48 -0.867 . . . . 0.0 114.011 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.61 143.64 14.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 117.487 0.643 . . . . 0.0 109.793 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -141.2 134.93 30.22 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.858 0.361 . . . . 0.0 110.395 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 81.2 m -135.72 121.86 20.22 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.045 0.45 . . . . 0.0 111.104 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD23 HD12 ' A' ' 61' ' ' LEU . 3.5 mm? -83.44 5.94 21.96 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.832 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 57' ' ' ASP . 50.3 t-20 -151.64 -67.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.495 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 11.8 pt20 50.98 25.22 2.14 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 125.342 1.457 . . . . 0.0 112.653 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 m 78.89 112.91 0.07 Allowed 'General case' 0 C--O 1.208 -1.095 0 C-N-CA 125.08 1.352 . . . . 0.0 108.616 -174.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -52.58 -25.27 10.09 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -112.86 -1.89 14.49 Favored 'General case' 0 CA--C 1.562 1.43 0 O-C-N 121.847 -0.533 . . . . 0.0 112.349 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 94.7 m-70 -126.34 166.56 16.93 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.0 m -105.82 166.26 10.6 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.011 -0.431 . . . . 0.0 111.78 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 3.1 tm? -64.92 -50.09 64.66 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 3.0 Cg_endo -46.03 -29.35 6.13 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 123.85 3.033 . . . . 0.0 114.066 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 50' ' ' LEU . 3.2 m-20 -44.47 -48.96 10.07 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.872 1.669 . . . . 0.0 113.375 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -111.19 -7.9 14.42 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.116 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.4 tp -104.23 -42.81 5.4 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.903 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -84.28 103.88 13.84 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 19.9 mm-40 -59.19 127.03 30.11 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.683 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.26 -42.41 1.38 Allowed Glycine 1 N--CA 1.388 -4.559 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.197 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.6 -9.36 44.4 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.144 1.777 . . . . 0.0 115.747 -174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.51 104.33 16.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.734 -0.604 . . . . 0.0 111.503 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 18.1 t70 -70.93 85.58 0.69 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.352 0.596 . . . . 0.0 110.756 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 5.8 mm-40 -167.78 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 127.6 2.36 . . . . 0.0 106.307 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.02 -54.92 0.89 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.913 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 1.4 pt? -140.27 137.8 34.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.43 165.74 34.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 35.0 tp -99.1 128.87 45.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.4 171.05 14.59 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-O 121.723 0.773 . . . . 0.0 112.967 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 71.9 p -96.93 111.47 23.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.33 -50.44 59.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.168 0.508 . . . . 0.0 110.1 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.1 -41.87 0.65 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.128 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 54' ' ' SER . 3.8 m-20 -85.73 112.85 21.44 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.696 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -70.57 -26.82 63.71 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.815 0.697 . . . . 0.0 110.046 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 15.9 pt20 -84.15 113.75 21.29 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.854 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.3 mt -116.4 134.6 54.69 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.404 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.452 HD12 HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -120.44 114.91 22.5 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.12 124.19 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.42 ' HD1' ' OG1' ' A' ' 137' ' ' THR . 69.4 t80 -104.0 123.71 47.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.14 116.36 31.17 Favored Pre-proline 0 N--CA 1.437 -1.109 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.527 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -90.01 153.05 4.84 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.158 1.905 . . . . 0.0 109.794 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -112.2 162.42 15.48 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.141 0.496 . . . . 0.0 112.195 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -87.98 -22.69 24.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.64 156.68 47.78 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.72 114.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.839 0.828 . . . . 0.0 111.008 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 161' ' ' THR . 2.0 pp -129.74 172.96 14.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.164 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.6 ' HG3' ' OXT' ' A' ' 161' ' ' THR . 56.4 mttp -106.44 129.88 54.34 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.301 0.501 . . . . 0.0 109.915 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -77.13 126.14 30.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -116.03 -38.64 3.59 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.727 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 158' ' ' TYR . 26.6 p -147.88 154.11 39.97 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.501 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -130.4 154.98 47.14 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.62 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -143.57 110.25 5.55 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.563 0.345 . . . . 0.0 110.643 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -122.27 134.5 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 53.5 mtpt -129.19 153.58 47.6 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.311 0.577 . . . . 0.0 112.256 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.39 -166.16 29.75 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -71.42 158.04 55.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 122.215 1.943 . . . . 0.0 109.657 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.43 -37.27 86.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.35 -33.61 22.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.12 13.98 33.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.237 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.42 147.61 25.76 Favored Glycine 0 C--N 1.301 -1.406 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.583 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 6.0 Cg_exo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.49 2.127 . . . . 0.0 111.908 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 3.7 tmmm? -95.29 -48.06 6.06 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.729 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -85.8 95.02 9.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.443 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.42 119.03 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.399 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.98 148.21 41.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -132.58 155.21 49.09 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 52.3 p90 -152.29 118.96 5.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.587 0.708 . . . . 0.0 110.673 168.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.2 t -103.53 175.93 5.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.251 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 m120 66.12 23.27 11.02 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.423 0.689 . . . . 0.0 111.615 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -148.25 107.27 3.86 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.184 0.516 . . . . 0.0 109.971 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.96 122.07 30.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.4 m80 71.01 107.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.487 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 51.2 ttm -161.48 128.55 4.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.452 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -90.2 162.62 15.16 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.521 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 50.5 p90 -61.8 -18.5 60.15 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -173.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.8 t -60.87 -36.13 78.41 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.99 0.424 . . . . 0.0 110.315 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.487 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 41.8 m-80 -89.39 -25.07 21.75 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.835 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 40.3 t -62.89 -13.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.263 1.03 . . . . 0.0 110.323 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -86.23 -20.53 28.36 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.786 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.06 -23.77 13.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.516 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -96.6 133.19 24.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.585 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 24.1 Cg_exo -65.45 126.67 16.62 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.364 2.043 . . . . 0.0 110.657 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 25.1 Cg_exo -64.52 161.5 34.89 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 122.566 2.177 . . . . 0.0 111.253 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 39.6 m -63.34 -45.42 91.31 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 17.7 t70 -158.88 153.78 24.94 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -126.87 115.28 19.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.29 165.08 12.05 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.573 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 8.9 mp0 -123.77 138.25 54.54 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.4 tp -72.64 107.77 5.3 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.5 p -82.16 160.96 22.96 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.15 -30.73 71.25 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.846 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 121' ' ' LYS . 11.4 pt-20 -72.22 -32.52 66.82 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.693 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.62 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.6 t-20 -66.4 -36.89 83.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 2.6 tm? -64.05 -8.0 10.45 Favored 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 126.786 2.035 . . . . 0.0 110.387 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 90.8 mttt -110.94 -6.85 14.62 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.541 0.736 . . . . 0.0 109.498 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 78' ' ' LYS . . . 99.06 30.92 6.45 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.811 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 64.6 tttm -102.37 121.59 49.53 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.523 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.08 112.84 1.34 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.272 2.648 . . . . 0.0 111.458 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 132.52 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.08 136.61 22.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.524 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.525 HD11 HD12 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -115.4 -172.84 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.491 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 109' ' ' ASP . 72.5 mmtt -70.57 89.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -68.5 -21.95 64.57 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.787 1.235 . . . . 0.0 110.52 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.71 -24.89 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.443 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -94.57 -36.21 11.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.346 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -79.08 93.25 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.264 0.554 . . . . 0.0 110.778 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -114.6 -41.06 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -121.95 115.64 22.92 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.887 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.72 102.37 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.973 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -104.17 -24.08 13.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 168.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.3 p -138.74 144.24 39.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.852 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.8 tp -147.27 121.1 9.28 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.42 ' OG1' ' HD1' ' A' ' 63' ' ' TYR . 23.2 m -105.74 132.11 52.26 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.857 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -105.15 117.75 51.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -117.86 107.23 13.85 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.52 0.676 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.637 HG13 ' HB2' ' A' ' 60' ' ' LEU . 11.3 pt -107.1 114.06 45.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.463 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 12.1 pt-20 -105.43 -23.0 12.91 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.28 152.0 44.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.812 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.435 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 31.7 p30 -108.92 170.08 8.27 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.981 -178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 21.0 tp60 -48.32 -60.03 2.98 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.917 1.687 . . . . 0.0 113.799 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.8 m -104.0 7.82 36.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.439 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.36 46.12 94.53 Favored Glycine 0 C--O 1.224 -0.509 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 m -90.5 10.8 23.89 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.21 0.604 . . . . 0.0 112.342 -171.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 43.9 mt-10 69.85 -45.83 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.147 0.979 . . . . 0.0 112.802 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.52 137.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.119 0.485 . . . . 0.0 109.844 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.5 m -120.33 138.31 53.79 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -131.1 135.42 47.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 61.8 t -120.6 125.77 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -86.9 -48.81 7.85 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -153.8 143.17 21.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -177.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.3 mt -121.86 132.3 71.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.44 134.09 26.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -113.56 135.81 53.5 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.414 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 80.1 m-85 -120.01 133.13 55.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.381 0.61 . . . . 0.0 109.908 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -128.87 178.63 17.14 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.5 m -128.82 25.94 5.59 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 117.151 0.476 . . . . 0.0 112.266 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.6 ' OXT' ' HG3' ' A' ' 71' ' ' LYS . 63.8 p . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.3 p . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -95.44 107.49 19.64 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.17 15.12 9.36 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.01 158.85 39.78 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.8 p -88.28 94.8 9.95 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.06 108.32 3.42 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.559 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.4 p -94.44 154.93 17.2 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.824 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 26.1 tt0 -119.09 20.37 12.69 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.009 0.909 . . . . 0.0 109.871 -177.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.643 HG22 ' H ' ' A' ' 11' ' ' LYS . 3.2 mp -79.79 120.44 80.02 Favored Pre-proline 0 C--N 1.298 -1.633 0 O-C-N 121.769 -0.582 . . . . 0.0 111.98 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -95.02 29.22 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.552 2.834 . . . . 0.0 110.95 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 9' ' ' ILE . 41.0 ttmt 68.44 106.25 0.05 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.281 1.433 . . . . 0.0 112.16 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.32 -79.84 0.2 Allowed Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.11 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 26.8 mm-40 -109.84 -173.82 2.35 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.57 152.5 8.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 3.1 p30 -74.62 138.95 43.29 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.197 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -78.78 -13.26 59.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.441 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 4.6 tt -59.79 -43.5 94.39 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.174 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -24.72 62.58 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -90.29 14.74 11.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.322 0.582 . . . . 0.0 111.34 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 16' ' ' LEU . 67.3 mt -100.48 134.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.32 -26.04 51.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.738 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 74.09 2.75 4.25 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -88.63 -28.13 20.85 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.946 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.21 23.15 7.74 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 119.33 -1.414 . . . . 0.0 114.515 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.63 133.44 31.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 117.564 0.682 . . . . 0.0 110.838 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.429 ' CG ' ' HB3' ' A' ' 63' ' ' TYR . 11.7 pt-20 -141.06 154.93 46.19 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.217 -0.302 . . . . 0.0 110.809 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 47.2 t -136.21 141.11 43.97 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.911 0.485 . . . . 0.0 109.836 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 5.7 tt -52.71 -61.48 2.26 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.885 1.274 . . . . 0.0 110.928 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 28.2 t-20 -95.11 -88.8 0.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.613 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.433 ' NE2' ' H ' ' A' ' 36' ' ' LEU . 45.0 tt0 55.47 17.88 2.41 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.503 1.144 . . . . 0.0 109.426 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -81.54 -23.5 37.18 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.233 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 34' ' ' HIS . 44.7 t -55.37 -4.75 0.1 Allowed 'General case' 0 CA--C 1.578 2.022 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.976 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 m 80.11 -17.16 0.6 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.35 1.46 . . . . 0.0 110.158 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.799 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 12.7 m170 -71.39 110.82 6.25 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -95.23 164.4 12.87 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -164.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 5.4 tt -63.73 -50.51 71.11 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.417 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 85.2 Cg_exo -53.67 -27.01 40.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.964 1.776 . . . . 0.0 112.835 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' ND2' HD22 ' A' ' 50' ' ' LEU . 13.4 m120 -59.61 -48.18 82.66 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-O 120.995 0.426 . . . . 0.0 110.338 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HA ' ' HE ' ' A' ' 45' ' ' ARG . . . -102.88 -0.35 31.31 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 44.2 tp -132.34 5.64 4.1 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 119.431 -0.907 . . . . 0.0 113.024 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -121.97 143.72 49.3 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 121.222 -0.924 . . . . 0.0 111.574 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.62 152.13 36.02 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.511 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.85 -52.27 4.69 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.58 -9.61 59.77 Favored 'General case' 0 C--O 1.194 -1.851 0 C-N-CA 123.017 0.527 . . . . 0.0 111.059 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -75.07 -91.83 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.329 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' ARG 0.311 9.3 pt-20 39.39 84.73 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.883 0.849 . . . . 0.0 113.061 -174.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.338 5.6 p-10 -67.24 85.68 0.15 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -169.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 169.91 103.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 107.31 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.32 -99.5 0.44 Allowed Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD22 ' ND2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -77.67 147.19 35.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.799 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.8 p30 -164.59 169.36 17.13 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 52' ' ' LEU . 7.2 tt -105.47 121.87 44.83 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.065 -1.454 . . . . 0.0 108.626 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.33 159.68 41.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.65 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 25.1 p -85.91 177.21 7.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.528 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.7 -64.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.05 68.4 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 54' ' ' SER . 8.5 t70 -131.64 174.44 10.11 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -109.61 -24.58 10.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 141' ' ' GLU . 87.8 mm-40 -84.28 139.46 32.31 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.588 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 29' ' ' ASN . 47.2 mt -135.64 122.39 21.02 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 122.12 0.962 . . . . 0.0 112.725 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.9 tt -130.42 120.96 25.02 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.13 123.02 66.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.429 ' HB3' ' CG ' ' A' ' 26' ' ' GLU . 35.9 t80 -101.38 123.43 45.44 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.18 113.91 32.32 Favored Pre-proline 0 N--CA 1.441 -0.887 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -89.18 139.23 3.55 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.862 2.374 . . . . 0.0 111.051 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.16 163.33 17.91 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.252 35.9 t-20 -104.44 -38.59 6.75 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 111.993 -2.367 . . . . 0.0 106.355 170.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -153.44 144.76 23.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 m -75.09 128.09 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.189 0.519 . . . . 0.0 111.114 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.503 HG22 HG22 ' A' ' 161' ' ' THR . 0.1 OUTLIER -139.34 173.21 11.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.029 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -97.37 117.93 32.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 125' ' ' LEU . 2.1 tm? -74.97 123.72 25.65 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -106.19 -48.54 3.56 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.4 p -145.26 160.18 41.89 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -130.37 151.52 50.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.518 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.422 ' C ' HD12 ' A' ' 77' ' ' ILE . . . -148.99 116.69 6.24 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 mp -132.25 122.45 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -99.13 163.25 12.64 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.162 0.506 . . . . 0.0 110.344 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.05 -177.51 48.26 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -74.82 172.36 16.44 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.53 1.665 . . . . 0.0 108.306 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 -56.28 5.29 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.331 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.5 mp0 -63.21 -55.25 26.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.115 0.959 . . . . 0.0 110.896 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -90.62 17.13 7.88 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.404 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.09 159.29 25.33 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.567 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 9.8 Cg_exo -72.54 107.26 2.26 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 119.417 1.608 . . . . 0.0 110.434 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 113' ' ' LEU . 12.6 tmtt? -83.34 -51.39 7.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.94 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.3 m -103.63 108.9 20.37 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.575 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.54 HG12 HG22 ' A' ' 140' ' ' ILE . 30.4 m -108.52 134.91 48.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.047 0.451 . . . . 0.0 111.321 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -121.69 134.26 54.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.31 138.85 47.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.3 m-85 -128.9 118.51 22.81 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.0 p -110.2 133.93 52.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.46 ' C ' ' HE3' ' A' ' 94' ' ' LYS . 86.4 m-20 76.37 -4.29 2.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.557 1.543 . . . . 0.0 114.991 173.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.541 ' HE3' ' N ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -88.35 104.43 16.76 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.56 150.11 31.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 72.1 99.63 0.07 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.275 1.03 . . . . 0.0 109.639 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 12.7 mmt -134.35 137.52 44.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.476 ' H ' ' HB2' ' A' ' 101' ' ' ASN . 32.0 p -159.17 -172.16 3.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.558 ' CZ ' HD11 ' A' ' 28' ' ' LEU . 92.7 m-85 -54.75 -44.57 73.71 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.301 0.501 . . . . 0.0 111.621 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 m -62.02 -20.61 64.11 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.495 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.3 m120 -93.67 -47.44 6.8 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.499 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.49 -20.13 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -93.2 -12.98 28.94 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.999 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -99.13 -37.57 9.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.892 0.377 . . . . 0.0 111.628 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -96.83 142.34 24.4 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.427 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.98 143.51 29.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 122.166 1.911 . . . . 0.0 111.293 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.14 163.8 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.413 2.075 . . . . 0.0 111.984 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -72.99 -44.8 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -169.35 171.95 7.5 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t -143.92 145.3 32.17 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.34 172.3 13.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.11 139.41 53.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.324 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 50.9 tp -60.5 112.68 2.07 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.923 0.764 . . . . 0.0 110.902 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.3 p -113.62 172.48 6.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.236 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.19 -24.69 67.35 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.728 0.775 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.31 -34.05 67.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.311 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.551 HD21 HG21 ' A' ' 123' ' ' VAL . 13.5 m120 -71.02 -45.42 63.95 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.269 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.35 -26.43 66.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.705 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.77 -13.75 55.71 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.228 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.88 41.41 23.23 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -95.5 134.96 23.52 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.12 109.94 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.782 1.655 . . . . 0.0 110.161 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.551 HG21 HD21 ' A' ' 117' ' ' ASN . 61.6 t -98.34 131.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.89 105.97 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.54 0.686 . . . . 0.0 111.458 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -83.61 -165.85 1.23 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.767 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -76.97 92.18 3.67 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.165 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.43 -27.55 66.14 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.615 1.566 . . . . 0.0 111.753 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.41 -16.04 16.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -80.82 -51.1 8.99 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.817 0.818 . . . . 0.0 110.149 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 90.33 6.63 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.178 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -98.91 -31.42 11.84 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.131 0.491 . . . . 0.0 110.272 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -149.39 119.55 7.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.395 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.09 112.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.742 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -92.65 -45.58 8.0 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -141.1 139.68 34.04 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.444 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.8 tp -131.69 125.31 31.77 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.233 0.54 . . . . 0.0 110.152 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 96.2 m -106.97 126.54 52.46 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.565 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 157' ' ' LEU . 62.6 mt -104.7 109.49 27.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 49.2 t80 -113.59 111.23 21.52 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.106 0.479 . . . . 0.0 110.646 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.54 HG22 HG12 ' A' ' 88' ' ' VAL . 30.9 pt -100.94 113.72 37.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 14.7 pt-20 -99.59 -12.94 19.65 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.643 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.76 142.32 10.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 118.99 -1.084 . . . . 0.0 113.385 -175.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.71 -173.76 2.47 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 170.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -60.49 -56.03 26.26 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.1 m -124.64 6.58 8.2 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.826 -169.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.82 60.9 3.48 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.2 m -83.07 17.34 2.0 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.898 0.879 . . . . 0.0 111.766 -174.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 78.51 -32.05 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 112.794 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.5 147.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 92.5 m -114.05 124.27 51.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HE3' HD21 ' A' ' 51' ' ' ASN . 88.1 tttt -111.37 134.35 53.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 123.174 0.589 . . . . 0.0 110.071 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 44.5 t -125.23 126.12 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -97.42 -11.44 23.9 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 39.8 ttmt -170.15 130.45 0.95 Allowed 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.82 -0.55 . . . . 0.0 111.449 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.95 116.65 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.29 121.09 21.91 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.444 HD11 HD11 ' A' ' 138' ' ' ILE . 84.1 mt -117.45 144.62 44.84 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 88.0 m-85 -126.24 145.47 50.38 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.818 0.342 . . . . 0.0 111.629 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -148.46 -168.64 14.62 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.384 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.5 p -151.07 140.65 21.63 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 122.5 0.32 . . . . 0.0 110.504 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 HG22 ' A' ' 70' ' ' ILE . 40.4 p . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.631 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.629 0.252 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 m -133.18 -177.7 4.64 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.81 91.8 3.83 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.185 0.517 . . . . 0.0 110.891 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.1 140.17 47.51 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.3 t -93.02 85.72 5.2 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.406 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.73 110.46 16.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 p -154.65 145.89 22.88 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.39 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 6.2 tp60 -95.05 87.05 4.79 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.3 mm -100.43 107.66 49.2 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.657 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HG2' HE21 ' A' ' 13' ' ' GLN . 59.1 Cg_endo -95.56 -178.9 0.51 Allowed 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 122.432 2.088 . . . . 0.0 110.468 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -76.37 131.25 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.49 -51.55 0.83 Allowed Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.155 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.541 HE21 ' HG2' ' A' ' 10' ' ' PRO . 1.6 pm0 -130.84 172.15 12.35 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 159' ' ' GLY . 14.5 p -118.04 154.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.79 147.47 37.21 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 20' ' ' ILE . 66.4 mt -108.27 17.75 21.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.8 -43.47 75.56 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -83.06 -11.7 57.8 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.507 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.99 0.93 42.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.904 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 16' ' ' LEU . 70.9 mt -86.72 140.39 15.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.22 -28.9 31.68 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.544 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CH2' HD12 ' A' ' 40' ' ' LEU . 98.9 m95 76.45 -4.37 2.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 t -102.89 -30.76 10.63 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.61 -0.39 66.98 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.706 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.4 m -64.83 139.2 21.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 117.146 0.473 . . . . 0.0 111.453 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.35 143.77 27.08 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HB3' ' NE2' ' A' ' 30' ' ' GLN . 51.6 t -137.39 140.32 41.29 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.9 mm? -123.69 90.92 3.36 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.177 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' LEU . 10.7 t30 152.47 -17.29 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.963 1.305 . . . . 0.0 111.83 170.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -54.74 -14.73 1.48 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 122.897 0.479 . . . . 0.0 111.681 176.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.4 t -58.81 -21.96 57.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.621 1.169 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.53 ' HB2' ' H ' ' A' ' 56' ' ' ALA . 33.7 p -77.14 -14.96 59.71 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 33.1 t -154.75 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.603 ' O ' ' HB2' ' A' ' 30' ' ' GLN . 63.2 m80 -124.35 162.95 22.74 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -88.82 172.87 8.89 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -169.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -70.52 -55.3 7.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.16 -20.13 36.89 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.08 1.853 . . . . 0.0 111.85 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 2.4 m-20 -58.04 -41.54 83.45 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 124.839 1.255 . . . . 0.0 111.628 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -110.96 6.63 21.21 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.21 0.529 . . . . 0.0 110.659 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.612 HD12 ' CH2' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -105.22 -43.22 5.07 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -79.83 130.4 35.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.135 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -45.82 139.04 4.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.239 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.28 -52.89 4.38 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 114.935 -1.029 . . . . 0.0 114.179 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -67.47 -28.74 68.12 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.24 -13.12 16.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.139 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -48.49 119.55 3.12 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.652 0.595 . . . . 0.0 110.596 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 153' ' ' GLN 0.258 4.8 p-10 -72.49 96.62 1.96 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -169.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 175.91 -52.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.356 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.54 -69.62 1.37 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.691 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -128.78 145.37 51.2 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.967 0.413 . . . . 0.0 111.107 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 8.1 p30 -159.08 166.38 31.77 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 53.5 tp -84.22 130.04 34.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -143.0 135.54 27.54 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.146 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.62 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 46.1 p -110.45 112.83 25.01 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 12.1 t70 -94.32 -44.72 7.8 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 120.796 0.331 . . . . 0.0 111.591 -175.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.53 ' H ' ' HB2' ' A' ' 32' ' ' SER . . . -81.78 -57.93 3.22 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.211 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 54' ' ' SER . 11.5 m-20 -106.87 141.88 37.39 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.964 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.49 4.3 47.1 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.575 1.179 . . . . 0.0 109.319 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.92 120.9 43.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.395 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 HD12 HD22 ' A' ' 29' ' ' ASN . 9.1 tt -141.26 130.57 23.63 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.52 0.676 . . . . 0.0 111.028 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 62' ' ' ILE . 1.1 tm? -101.79 134.13 45.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.914 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 61' ' ' LEU . 29.9 mt -129.19 129.98 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -112.71 115.73 29.0 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.11 116.76 31.02 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.45 144.35 4.72 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.515 2.143 . . . . 0.0 110.925 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.11 143.87 36.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.788 0.804 . . . . 0.0 112.854 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -56.51 -42.63 78.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 126.413 1.885 . . . . 0.0 110.515 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -142.71 154.36 44.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.95 123.42 38.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 121.525 0.679 . . . . 0.0 111.513 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -130.52 173.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.74 127.47 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.15 109.27 15.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.405 ' H ' ' HA2' ' A' ' 159' ' ' GLY . 14.4 t60 -91.53 -52.04 4.97 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.41 . . . . 0.0 111.237 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 p -140.36 157.12 46.03 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.194 0.521 . . . . 0.0 111.89 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.58 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 35.4 p90 -127.1 152.55 47.16 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -144.17 106.43 4.37 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.784 0.326 . . . . 0.0 111.722 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 62.4 mt -111.18 118.16 56.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 154' ' ' LYS . 10.0 tmtt? -101.79 134.83 44.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.11 -176.21 41.48 Favored Glycine 0 N--CA 1.414 -2.812 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.007 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.85 151.87 57.44 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.755 2.304 . . . . 0.0 110.521 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -61.66 -34.02 74.97 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.21 -38.12 11.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.79 18.26 16.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.351 -173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.49 148.1 19.13 Favored Glycine 0 C--N 1.299 -1.516 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.891 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.3 107.48 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 CA-C-N 119.328 1.564 . . . . 0.0 110.058 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 31.5 ttpt -85.75 -55.12 4.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.131 0.491 . . . . 0.0 110.477 -173.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -82.29 103.84 12.17 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.245 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.21 136.93 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.812 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.52 151.14 50.47 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 136' ' ' LEU . 47.4 m-85 -126.17 155.93 40.96 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -105.97 161.5 14.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.9 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.9 p -95.95 79.27 3.24 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 38.04 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -151.94 166.97 29.86 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -101.77 146.51 27.68 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.579 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 51.99 84.41 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.48 1.112 . . . . 0.0 112.125 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 17.3 tpt -119.09 110.51 17.16 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 23.7 p -124.49 -170.7 2.2 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 83.3 t80 -63.62 -26.03 68.49 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 118.838 0.744 . . . . 0.0 111.639 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.8 m -71.16 -8.64 54.91 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.661 0.743 . . . . 0.0 110.4 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.585 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 12.1 m120 -105.64 -20.17 13.54 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.473 1.109 . . . . 0.0 110.35 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 55.5 t -58.39 -39.69 75.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -96.32 10.51 37.78 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.43 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -120.37 -35.77 3.36 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 90.6 m-85 -96.46 127.64 39.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 O-C-N 121.953 -0.467 . . . . 0.0 111.801 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 59.1 Cg_exo -54.11 129.56 35.01 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.893 3.062 . . . . 0.0 114.036 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 71.7 Cg_endo -80.79 156.55 20.95 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.648 2.232 . . . . 0.0 110.885 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.1 m -84.32 -45.9 12.32 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.896 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.476 ' HB2' ' HE2' ' A' ' 129' ' ' LYS . 28.9 t70 -163.07 171.71 16.02 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.1 p -127.96 119.9 26.48 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB1' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.98 152.42 24.98 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.429 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 39.9 tt0 -126.49 125.6 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.555 HD23 HE22 ' A' ' 144' ' ' GLN . 19.6 tp -66.96 145.57 55.29 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.571 HG23 ' H ' ' A' ' 117' ' ' ASN . 2.8 t -135.23 163.67 29.43 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -58.63 -27.29 64.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.672 0.749 . . . . 0.0 110.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -65.52 -51.4 60.24 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.026 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.667 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.3 t-20 -65.31 -49.4 69.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.915 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 3.0 pp -71.31 -9.45 58.16 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -89.59 3.72 51.67 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.24 33.66 6.17 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.682 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.2 tmtp? -115.96 120.75 35.02 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 117.271 0.536 . . . . 0.0 109.675 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 32.5 Cg_exo -58.69 117.72 4.49 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 C-N-CA 123.574 2.849 . . . . 0.0 112.29 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.468 HG23 ' ND2' ' A' ' 117' ' ' ASN . 80.9 t -93.51 131.06 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -73.68 123.29 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.439 HD23 ' CD1' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -98.7 174.52 6.37 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.827 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -86.51 89.96 8.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 130' ' ' PHE . 45.2 p90 -101.52 21.17 14.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.423 ' C ' HE22 ' A' ' 131' ' ' GLN . 35.0 m -64.78 -3.76 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -123.02 1.01 9.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.404 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.0 m-85 -101.03 78.62 1.94 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.423 HE22 ' C ' ' A' ' 128' ' ' VAL . 2.0 mp0 -92.2 -32.36 15.11 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.303 0.573 . . . . 0.0 110.023 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -141.78 121.62 13.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.772 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.56 108.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -96.4 -40.33 9.15 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 m -138.13 136.39 36.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 90' ' ' PHE . 44.1 tp -126.74 119.84 27.91 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.282 0.563 . . . . 0.0 110.236 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 93.6 m -102.27 121.32 42.03 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.591 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.4 mt -104.71 113.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 82.3 t80 -111.5 116.91 31.68 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.5 pp -106.91 136.03 43.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.633 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.0 pt-20 -123.47 -13.73 7.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.61 146.03 20.61 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.148 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -97.85 174.83 6.39 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.555 HE22 HD23 ' A' ' 113' ' ' LEU . 18.3 mp0 -60.47 -52.54 64.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.001 0.429 . . . . 0.0 110.855 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.3 t -92.04 -22.19 20.08 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.369 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.33 81.54 0.45 Allowed Glycine 0 CA--C 1.499 -0.928 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 149' ' ' VAL . 34.4 m -111.78 6.21 19.58 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.427 -0.386 . . . . 0.0 111.868 -172.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 67.76 -36.16 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.496 1.118 . . . . 0.0 112.72 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' SER . 4.6 p -102.87 132.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 123.498 0.719 . . . . 0.0 109.674 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.62 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 61.3 m -121.39 128.83 52.61 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -109.9 132.66 53.95 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 19.4 t -123.71 116.3 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 97.5 mt-30 -94.77 -19.48 20.32 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.363 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -172.34 134.33 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.588 0.355 . . . . 0.0 110.563 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.496 ' HB ' HD22 ' A' ' 40' ' ' LEU . 1.8 mp -129.88 117.85 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.93 147.78 35.81 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.897 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.54 141.18 48.07 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 122' ' ' PRO . 82.2 m-85 -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 14' ' ' VAL . . . -139.58 -168.34 11.27 Favored Glycine 0 CA--C 1.488 -1.651 0 C-N-CA 119.909 -1.138 . . . . 0.0 112.487 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.3 p -163.08 147.89 11.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 120.487 0.184 . . . . 0.0 110.883 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.411 HG23 HG22 ' A' ' 70' ' ' ILE . 18.0 p . . . . . 0 C--N 1.297 -1.716 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.382 170.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 m -139.48 114.5 9.54 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.033 0.444 . . . . 0.0 111.239 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.28 -21.79 24.26 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -89.52 155.63 19.16 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.612 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -78.61 -40.53 34.19 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.08 71.38 0.54 Allowed 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.732 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.0 t -147.79 114.83 6.16 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.236 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -121.9 4.31 9.95 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.962 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 11' ' ' LYS . 4.2 mp -62.08 117.15 26.72 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.393 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.7 25.25 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.06 2.507 . . . . 0.0 110.887 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.639 ' H ' HG22 ' A' ' 9' ' ' ILE . 40.6 ttmt 61.85 99.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.767 1.227 . . . . 0.0 111.272 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.55 -78.83 0.19 Allowed Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.488 ' O ' HG23 ' A' ' 9' ' ' ILE . 28.0 mm-40 -109.7 168.42 9.42 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 15.5 m -105.34 156.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.886 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 17' ' ' LEU . 3.3 p30 -78.28 112.63 15.47 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 122.694 1.235 . . . . 0.0 109.531 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.603 ' O ' HG13 ' A' ' 20' ' ' ILE . 36.9 mt -68.65 6.04 0.93 Allowed 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.639 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.51 HD11 ' H ' ' A' ' 42' ' ' GLN . 5.2 tt -60.42 -41.65 94.38 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.67 -22.01 60.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.173 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 32.8 m-85 -93.71 15.11 17.17 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.982 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 16' ' ' LEU . 86.8 mt -95.97 134.95 31.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.52 -44.38 96.11 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 94.4 m95 66.46 7.19 4.84 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.96 -84.96 1.66 Allowed Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.497 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 t 39.16 84.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.951 1.3 . . . . 0.0 111.87 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -117.5 131.53 56.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.127 -168.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . 49.1 t -129.18 130.99 47.05 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.25 -72.01 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -70.69 -59.55 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 35.0 tt0 59.78 27.53 16.84 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.172 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 30.0 t 71.06 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.135 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -57.83 -34.12 69.34 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.238 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -109.67 -48.14 3.26 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 31' ' ' SER . 97.9 m-70 -99.58 164.92 11.87 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -169.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.432 ' C ' HD23 ' A' ' 52' ' ' LEU . 16.2 m -100.82 141.5 33.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.734 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 3.0 tm? -62.37 -46.38 90.09 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.094 0.558 . . . . 0.0 112.281 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 9.9 Cg_endo -52.04 -24.45 19.69 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.275 1.984 . . . . 0.0 112.492 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.545 ' HB3' HD13 ' A' ' 50' ' ' LEU . 96.6 m-20 -69.03 -19.3 64.11 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -110.2 1.22 18.57 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.232 0.539 . . . . 0.0 110.573 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -124.36 -40.36 2.25 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.36 103.52 16.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.151 0.5 . . . . 0.0 111.066 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' H ' HD11 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -75.51 113.35 12.83 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.98 -50.43 0.43 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 105.772 -2.931 . . . . 0.0 105.772 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -89.7 -41.27 12.01 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 153' ' ' GLN . 54.2 ttp180 -73.53 122.17 21.78 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.275 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.54 106.77 8.73 Favored 'General case' 0 C--N 1.262 -3.206 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 165.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 153' ' ' GLN 0.335 7.7 p-10 -64.03 84.54 0.03 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -166.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 160.42 99.71 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 128.758 2.823 . . . . 0.0 104.401 175.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.46 -103.47 0.46 Allowed Glycine 0 C--N 1.303 -1.271 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 38' ' ' ASN 0.251 1.9 pp -77.09 125.73 29.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.941 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -154.44 165.72 35.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 36' ' ' LEU . 2.9 tm? -94.84 112.13 23.87 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.5 pt-20 -131.15 121.33 24.7 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.771 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -69.59 149.23 48.39 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -103.99 -28.52 11.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.64 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.83 -53.87 2.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.042 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.74 158.36 44.08 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 117.489 -1.685 . . . . 0.0 115.333 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 41.9 mt-10 -70.15 -33.22 71.51 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.32 1.048 . . . . 0.0 112.119 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.25 109.54 12.46 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.657 0.741 . . . . 0.0 111.131 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' H ' HG13 ' A' ' 140' ' ' ILE . 14.7 tp -116.42 134.22 55.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.93 127.69 49.26 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -144.34 127.52 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 CA-C-O 121.473 0.654 . . . . 0.0 111.547 177.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 5.1 t80 -91.89 123.88 35.6 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.614 1.566 . . . . 0.0 111.414 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.426 HG23 HG23 ' A' ' 20' ' ' ILE . 35.3 mt -120.79 120.29 29.59 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -89.66 152.38 5.17 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.944 2.429 . . . . 0.0 111.178 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -88.15 162.79 16.53 Favored 'General case' 0 CA--C 1.474 -1.955 0 CA-C-O 121.919 0.866 . . . . 0.0 112.752 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -99.45 -32.94 10.89 Favored 'General case' 0 N--CA 1.404 -2.775 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.662 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.67 145.99 25.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.1 t -73.74 108.75 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.457 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -133.02 173.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -90.75 133.24 35.32 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.18 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.646 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.2 121.46 27.11 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.27 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -115.23 -46.16 2.91 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -153.62 169.23 23.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -139.88 154.49 47.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -141.1 117.33 10.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.415 HG23 HG12 ' A' ' 155' ' ' ILE . 60.0 mt -126.72 119.84 54.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.34 144.35 25.96 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.68 176.31 34.81 Favored Glycine 1 C--N 1.253 -4.08 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.69 178.09 6.14 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 CA-C-N 119.612 1.706 . . . . 0.0 111.03 175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -68.56 -44.35 74.66 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.402 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.59 -53.31 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.82 12.33 2.73 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 147.69 28.89 Favored Glycine 0 C--O 1.251 1.191 0 C-N-CA 120.134 -1.032 . . . . 0.0 110.768 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_endo -77.12 115.99 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.847 1.698 . . . . 0.0 110.209 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.631 ' HE3' ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -87.06 -71.04 0.58 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.025 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.8 m -75.34 102.05 4.96 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.488 0.661 . . . . 0.0 111.28 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 140' ' ' ILE . 34.9 m -101.76 144.44 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.397 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -133.75 133.79 42.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.91 146.06 43.21 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.672 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' ' 102' ' ' VAL . 95.1 m-85 -129.82 115.06 16.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 m -103.3 154.76 19.03 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 120.87 0.367 . . . . 0.0 110.748 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 73.96 -42.12 0.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.25 1.42 . . . . 0.0 112.853 173.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -69.08 122.44 18.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 0.0 110.081 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.565 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 35.9 tt0 -93.68 122.34 36.04 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.279 -174.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t60 58.4 96.08 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 124.174 0.989 . . . . 0.0 112.923 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 53.0 mtm -131.34 155.59 46.97 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.152 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' VAL . 24.5 p -109.19 -179.16 3.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -58.68 -30.6 67.51 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.838 0.455 . . . . 0.0 111.706 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 t -62.29 -41.61 98.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.057 0.455 . . . . 0.0 109.859 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 104' ' ' ASP . 94.7 m-20 -85.88 -15.8 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 98' ' ' CYS . 51.3 t -62.0 -29.23 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.588 0.709 . . . . 0.0 110.121 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.84 9.29 39.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.597 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 20.6 t70 -109.13 -48.27 3.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.414 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -97.5 127.01 39.33 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 53.0 Cg_exo -57.97 136.35 74.55 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.801 2.334 . . . . 0.0 111.782 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 19.2 Cg_exo -66.28 158.03 57.07 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.723 2.282 . . . . 0.0 112.878 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -70.19 -45.77 65.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -164.84 157.44 16.35 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -141.16 117.06 10.45 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.58 172.5 11.51 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.944 -170.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.2 mp0 -117.04 137.81 52.01 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.9 tp -61.55 113.09 2.5 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.704 0.801 . . . . 0.0 109.049 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.6 t -107.11 165.45 11.35 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.57 -37.44 62.93 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.202 0.525 . . . . 0.0 111.57 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.14 -35.05 70.93 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.634 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.67 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -71.31 -36.87 71.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.756 -175.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.85 -21.84 65.16 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -83.61 6.68 19.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.979 0.895 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.32 26.3 64.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.438 -1.256 . . . . 0.0 113.591 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -92.57 135.02 26.97 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.944 0.372 . . . . 0.0 111.492 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.519 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 35.5 Cg_endo -65.51 109.46 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.323 2.682 . . . . 0.0 112.465 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.9 t -86.97 132.25 32.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.1 m -80.59 132.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.582 0.706 . . . . 0.0 112.67 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.37 -178.92 3.8 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.696 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.58 105.36 0.2 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.826 0.822 . . . . 0.0 111.102 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -111.1 -22.69 11.32 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.416 -170.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.1 t -71.2 -27.52 29.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.362 0.601 . . . . 0.0 111.028 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -96.63 -10.28 27.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.563 0.697 . . . . 0.0 110.538 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.539 ' HB3' HD11 ' A' ' 72' ' ' LEU . 83.2 m-85 -120.43 112.7 19.31 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -123.77 -0.64 8.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.302 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -149.21 127.55 12.19 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.974 -175.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.9 t -97.58 115.07 36.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.523 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' SER . 12.7 mmm180 -115.19 -0.38 13.28 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.261 174.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' ARG . 12.0 t 171.98 163.67 0.1 Allowed 'General case' 0 C--O 1.252 1.214 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -155.56 119.88 4.63 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.128 0.489 . . . . 0.0 110.012 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.1 m -108.76 126.92 53.54 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.5 mp -104.38 124.09 58.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -124.36 131.0 53.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.425 HG22 HG12 ' A' ' 88' ' ' VAL . 26.3 pt -116.02 132.01 66.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.582 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -107.41 -31.08 8.31 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.16 143.7 27.26 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.433 0.635 . . . . 0.0 111.899 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.465 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 5.8 m-20 -96.56 163.07 13.19 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.043 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.631 ' OE1' ' HE3' ' A' ' 86' ' ' LYS . 6.4 tp-100 -47.94 -45.73 31.34 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 112.778 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.2 t -122.55 16.2 10.38 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.497 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.44 4.3 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.6 m -96.09 11.87 32.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.319 13.0 pt-20 63.3 -23.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.368 1.867 . . . . 0.0 115.163 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.78 158.93 37.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 27.6 m -121.45 136.93 54.91 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 121.338 -0.145 . . . . 0.0 111.231 -175.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -114.99 134.23 55.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 27.5 m -129.71 122.09 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 110.013 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 18.3 mm-40 -87.96 -44.73 10.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.054 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.64 111.49 5.07 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.877 -174.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.415 HG12 HG23 ' A' ' 77' ' ' ILE . 65.9 mt -109.54 125.52 66.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.84 144.46 32.53 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.107 0.48 . . . . 0.0 110.488 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 5.3 mp -106.88 138.16 43.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 98.7 m-85 -125.22 135.34 52.46 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.033 0.444 . . . . 0.0 112.046 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -158.0 -156.97 8.19 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.9 t -153.23 149.44 27.97 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.749 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 C--O 1.255 1.355 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.137 174.188 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.244 0.808 0 N-CA-C 111.44 0.163 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -151.74 -63.05 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.229 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.02 -55.82 0.49 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.912 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.438 1.5 pm0 40.19 77.44 0.05 Allowed 'General case' 0 C--O 1.236 0.342 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.0 p -150.89 107.53 3.51 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.645 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.05 91.87 0.07 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.252 1.021 . . . . 0.0 111.721 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 p -135.78 133.97 38.49 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.473 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.88 77.29 5.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -175.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.408 ' CG1' ' HB2' ' A' ' 15' ' ' ASP . 1.7 mp -93.24 137.6 23.51 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 170.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.28 130.98 26.87 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.484 1.456 . . . . 0.0 110.677 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -69.21 99.17 1.11 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.68 -36.38 0.63 Allowed Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.449 ' HA ' ' OG ' ' A' ' 160' ' ' SER . 28.9 mm-40 -120.35 -173.98 2.69 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -134.41 153.42 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 11.1 t0 -71.42 127.98 34.34 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 20' ' ' ILE . 57.3 mt -76.51 -1.45 27.34 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.37 -36.03 41.39 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.809 0.814 . . . . 0.0 109.306 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.31 -24.22 66.5 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.001 -175.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -106.52 7.06 30.67 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 16' ' ' LEU . 77.3 mt -85.34 136.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.96 115.17 27.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -88.52 10.09 21.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.9 m -97.79 -33.8 11.13 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.318 0.58 . . . . 0.0 109.438 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.82 -18.89 53.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.945 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG21 HD12 ' A' ' 36' ' ' LEU . 7.1 p -48.61 126.06 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.02 143.84 49.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.805 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 36' ' ' LEU . 80.2 m -136.47 133.42 36.57 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.037 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -61.13 -40.57 94.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.746 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.567 ' HB3' HD12 ' A' ' 60' ' ' LEU . 62.2 t30 -126.65 149.28 49.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.428 ' H ' ' H ' ' A' ' 31' ' ' SER . 12.8 pt20 164.1 -5.63 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 126.791 2.036 . . . . 0.0 107.007 -168.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 30' ' ' GLN . 38.9 t -65.66 -19.61 65.97 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.682 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 m -55.44 16.83 0.0 OUTLIER 'General case' 0 CA--C 1.594 2.642 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.6 t 75.33 -1.05 3.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.17 0.988 . . . . 0.0 113.218 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -125.05 153.0 43.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -107.27 167.62 9.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.903 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.525 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.1 tm? -57.52 -49.72 92.25 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.632 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 4.6 Cg_endo -48.98 -25.99 9.56 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.866 2.378 . . . . 0.0 112.879 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.532 ' HA ' HD12 ' A' ' 50' ' ' LEU . 2.1 m-20 -60.93 -31.68 71.21 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.24 0.616 . . . . 0.0 111.607 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -121.96 23.53 9.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.09 0.472 . . . . 0.0 110.329 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 155' ' ' ILE . 0.7 OUTLIER -139.91 -36.7 0.49 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.72 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -78.32 105.98 9.93 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-O 121.237 0.542 . . . . 0.0 111.051 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HG2' ' NH2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -49.91 118.2 2.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.3 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.17 -62.26 0.59 Allowed Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.588 ' HB3' ' HG ' ' A' ' 50' ' ' LEU . 21.7 m-85 -99.03 -11.08 21.82 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.722 -0.281 . . . . 0.0 110.349 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.524 ' NH2' ' HG2' ' A' ' 42' ' ' GLN 0.371 3.4 ppt_? -70.26 -4.69 23.09 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 -170.104 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -83.33 156.6 22.95 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.367 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.03 145.63 41.28 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 81.86 2.14 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.992 1.717 . . . . 0.0 111.735 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.443 ' O ' HD23 ' A' ' 50' ' ' LEU . . . -95.98 -86.01 1.74 Allowed Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' A' ' 44' ' ' TYR . 7.1 mt -135.24 170.31 16.12 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.5 p-10 -157.86 152.83 25.42 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 119.115 0.87 . . . . 0.0 109.272 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.521 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 55.2 tp -87.11 142.58 27.81 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.68 148.97 44.67 Favored 'General case' 0 C--N 1.255 -3.505 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.583 ' HB3' ' H ' ' A' ' 150' ' ' THR . 23.3 t -112.75 21.37 15.6 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.648 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.39 84.93 0.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.109 0.48 . . . . 0.0 111.116 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 174.29 -44.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.778 1.631 . . . . 0.0 107.952 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -140.26 157.62 45.3 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.416 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 148' ' ' GLU . 0.8 OUTLIER -79.17 -25.33 42.8 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -177.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -101.97 151.04 22.59 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.497 0.665 . . . . 0.0 110.705 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 29' ' ' ASN . 24.2 tp -134.89 131.33 37.2 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 5.6 tt -140.66 127.63 20.68 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.63 132.07 71.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -106.82 122.86 47.23 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.222 0.609 . . . . 0.0 109.537 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -116.83 119.91 34.79 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.981 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -95.92 123.0 0.28 Allowed 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.757 2.304 . . . . 0.0 111.319 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.62 155.27 17.38 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.763 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -73.36 -14.76 61.34 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -157.95 177.72 11.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 29.5 m -89.03 132.4 33.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.728 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.91 171.92 11.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.488 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -85.35 113.75 21.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.79 154.48 41.9 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 58.1 t-80 -153.49 -67.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 p -142.18 152.44 43.16 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.426 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 42.0 p90 -125.55 155.19 41.04 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.78 116.7 6.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.775 0.321 . . . . 0.0 110.528 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG23 HG12 ' A' ' 155' ' ' ILE . 63.9 mt -119.75 134.41 63.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -123.97 168.51 12.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.028 0.442 . . . . 0.0 110.162 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 153' ' ' GLN . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.33 134.72 23.27 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 CA-C-N 119.61 1.705 . . . . 0.0 108.547 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.48 -37.37 62.63 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.43 -36.43 19.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.72 0.16 56.73 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.15 33.03 Favored Glycine 0 C--O 1.26 1.726 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.033 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.8 Cg_endo -84.24 125.54 3.52 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.853 2.369 . . . . 0.0 111.323 -176.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 32.8 ttpt -91.26 -72.09 0.6 Allowed 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.946 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.4 m -77.93 97.58 5.36 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.105 0.479 . . . . 0.0 110.072 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 140' ' ' ILE . 24.3 m -108.59 139.52 30.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.484 ' CG ' ' HB3' ' A' ' 139' ' ' PHE . 18.2 ptpt -125.39 155.3 40.59 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 24.6 m-85 -132.07 151.19 51.9 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.553 ' CE2' ' HB ' ' A' ' 137' ' ' THR . 22.5 p90 -154.72 149.94 27.07 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 123.528 0.517 . . . . 0.0 109.838 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.8 m -127.22 155.77 42.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 69.67 -37.93 0.39 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.087 2.155 . . . . 0.0 116.015 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.589 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 1.1 tpmt? -75.19 109.41 8.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.135 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.03 149.18 24.15 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 65.52 62.48 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 109.13 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.3 tpp -134.77 110.13 9.02 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.251 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.476 ' O ' HG13 ' A' ' 102' ' ' VAL . 75.2 m -129.41 -172.22 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -52.13 -29.9 23.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -88.8 -1.39 58.06 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.967 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -118.29 -32.45 4.66 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.83 0.348 . . . . 0.0 110.104 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 98' ' ' CYS . 31.0 m -58.62 -15.58 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -171.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -93.1 73.57 4.68 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.664 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 172.69 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.74 1.216 . . . . 0.0 110.53 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.76 128.31 40.08 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.22 122.58 11.36 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.937 2.425 . . . . 0.0 112.61 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 91' ' ' PHE . 83.2 Cg_endo -82.08 -178.56 4.17 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 122.26 1.974 . . . . 0.0 110.711 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.618 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 18.3 m -76.78 -47.17 22.43 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 110' ' ' THR . 18.7 t70 172.58 -167.1 0.02 OUTLIER 'General case' 0 C--O 1.248 0.999 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.409 ' H ' ' CG ' ' A' ' 109' ' ' ASP . 7.4 t -148.99 143.18 25.95 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.84 12.13 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.695 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 33.5 mt-10 -120.92 140.26 52.09 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 124.227 1.011 . . . . 0.0 110.252 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 57.8 tp -59.58 101.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.078 0.861 . . . . 0.0 110.322 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 117' ' ' ASN . 4.4 t -95.26 164.43 12.85 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.978 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.5 -23.89 59.12 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.616 0.766 . . . . 0.0 110.385 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.515 ' OE2' HG22 ' A' ' 123' ' ' VAL . 31.0 tt0 -71.88 -45.41 61.38 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.515 ' H ' HG23 ' A' ' 114' ' ' THR . 48.3 m-20 -65.42 -47.78 75.08 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.951 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.18 -30.84 66.73 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.599 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -92.41 -1.82 56.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.328 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.8 20.49 26.27 Favored Glycine 0 CA--C 1.494 -1.266 0 C-N-CA 120.318 -0.944 . . . . 0.0 114.727 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 1.0 OUTLIER -95.81 134.46 23.98 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.821 177.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 12.7 Cg_exo -70.86 109.83 2.63 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.426 2.084 . . . . 0.0 111.271 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.515 HG22 ' OE2' ' A' ' 116' ' ' GLU . 94.3 t -87.5 128.24 40.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.7 m -77.56 125.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.164 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.49 175.91 6.5 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.46 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . 0.313 50.0 mtmt -91.48 84.94 5.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.898 1.332 . . . . 0.0 113.782 -175.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.54 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 36.2 p90 -87.94 19.16 3.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.848 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -60.01 -29.1 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -107.22 10.72 29.85 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.434 174.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.618 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 91.4 m-85 -123.47 86.28 2.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 112.074 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -105.63 -9.19 17.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 3.6 p-10 -144.08 113.69 7.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.813 0.816 . . . . 0.0 111.304 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 65.9 t -122.53 120.65 61.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.032 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.453 ' HB2' HG12 ' A' ' 69' ' ' VAL . 43.1 ttp180 -103.0 -38.92 7.13 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.1 m -120.72 134.0 55.31 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.3 tp -126.02 140.24 52.77 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.553 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 22.8 m -134.21 131.36 38.46 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 3.0 mp -111.7 128.04 68.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HB3' ' CG ' ' A' ' 89' ' ' LYS . 51.6 t80 -122.76 126.31 47.21 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.556 HG12 ' H ' ' A' ' 60' ' ' LEU . 24.2 pt -95.42 129.2 45.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 117.98 -1.488 . . . . 0.0 107.505 172.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -93.92 -24.03 17.85 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.214 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -166.2 142.76 5.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.084 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -90.82 161.79 15.12 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.488 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 6.8 tp-100 -46.23 -44.86 16.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.058 0.943 . . . . 0.0 112.227 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.5 p -124.42 9.87 8.51 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.298 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 59.62 70.62 0.95 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 149' ' ' VAL . 22.8 t -86.7 -10.11 54.45 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.921 -165.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 40.0 mt-10 66.9 -44.6 0.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.291 0.637 . . . . 0.0 110.869 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 147' ' ' SER . 3.3 p -119.34 96.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-O 122.386 1.089 . . . . 0.0 109.197 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.583 ' H ' ' HB3' ' A' ' 54' ' ' SER . 31.1 m -82.15 119.65 24.32 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.587 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.16 132.36 35.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.3 t -119.71 115.49 47.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.035 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.477 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 53.3 tt0 -71.69 -63.7 1.07 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -160.48 145.19 14.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.375 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.501 ' O ' HD22 ' A' ' 40' ' ' LEU . 78.3 mt -120.5 114.64 44.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.32 160.81 36.23 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.94 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 6.7 tt -147.23 140.43 25.28 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.466 ' N ' HD23 ' A' ' 157' ' ' LEU . 76.9 m-85 -114.67 141.91 47.17 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.333 0.587 . . . . 0.0 110.19 -175.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -156.89 -165.3 14.65 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 13' ' ' GLN . 75.4 m -164.72 167.42 19.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.993 0.897 . . . . 0.0 109.046 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.264 -3.138 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.756 175.204 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 C--O 1.237 0.413 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -79.14 122.74 26.64 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.9 95.18 10.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.637 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 63.0 -166.28 0.23 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.013 0.821 . . . . 0.0 109.955 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.4 p -134.98 83.57 2.03 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 121.521 0.677 . . . . 0.0 109.472 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.49 117.02 25.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.286 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 m -81.17 76.75 8.11 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.649 0.737 . . . . 0.0 111.066 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -116.06 -25.03 7.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.406 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -70.38 119.96 75.54 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.241 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.26 178.73 7.12 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.762 2.308 . . . . 0.0 111.827 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -97.75 101.5 13.02 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.48 -39.68 0.7 Allowed Glycine 0 C--N 1.303 -1.292 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.543 ' HG3' ' OG ' ' A' ' 74' ' ' SER . 1.4 pm0 -135.48 149.37 49.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.818 0.847 . . . . 0.0 109.766 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 4.4 m -111.37 170.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 123.431 0.457 . . . . 0.0 110.501 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.0 98.64 0.78 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.457 1.122 . . . . 0.0 110.285 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 16' ' ' LEU . 2.4 tm? -55.72 -23.81 31.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.267 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.9 tt -53.0 -35.95 59.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.311 1.044 . . . . 0.0 110.986 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.0 -20.45 61.01 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -94.65 22.33 6.39 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.096 0.474 . . . . 0.0 110.964 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.4 131.46 47.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' PHE . 20.9 t70 -80.13 -23.54 41.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.219 0.533 . . . . 0.0 111.185 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' A' ' 40' ' ' LEU . 97.3 m95 67.43 10.22 7.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.1 p -87.1 10.82 15.48 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.278 0.561 . . . . 0.0 110.768 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.04 -88.35 0.13 Allowed Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' H ' ' HD3' ' A' ' 65' ' ' PRO 0.276 11.0 p 43.9 75.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.196 1.399 . . . . 0.0 113.002 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -119.72 151.16 39.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.596 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 49.2 t -136.6 130.96 33.09 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -45.58 -63.34 0.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.724 1.209 . . . . 0.0 112.38 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -90.2 -57.76 2.74 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 34.2 tt0 69.51 -78.56 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.782 1.233 . . . . 0.0 107.889 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 35.7 t 176.35 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -53.29 -20.09 3.9 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -130.63 -34.07 1.58 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' SER . 94.5 m-70 -93.39 163.92 13.41 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.983 -0.448 . . . . 0.0 111.853 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -122.96 150.27 43.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.477 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 53.1 tp -70.49 -48.87 17.01 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 7.7 Cg_endo -48.23 -28.04 10.5 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.584 2.19 . . . . 0.0 113.003 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.2 m-20 -66.29 -29.38 69.59 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.912 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -116.06 6.07 13.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.712 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.504 HD12 ' CH2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -104.41 -43.76 5.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 18.6 ptpt -90.53 148.1 22.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.656 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 20.5 mm-40 -81.64 144.62 31.08 Favored 'General case' 0 CA--C 1.473 -2.002 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.607 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 121.72 -50.38 0.84 Allowed Glycine 0 N--CA 1.397 -3.927 0 C-N-CA 119.115 -1.517 . . . . 0.0 111.013 -171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.58 ' O ' HD11 ' A' ' 50' ' ' LEU . 96.8 m-85 -92.97 -10.47 36.25 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -55.86 25.98 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.075 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -95.08 102.09 13.88 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.35 97.86 1.01 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.249 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -156.75 -80.45 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.31 1.444 . . . . 0.0 110.226 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.23 -26.21 24.26 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 44' ' ' TYR . 2.3 pp -126.31 137.17 53.46 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.798 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.1 p-10 -163.77 166.77 21.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.503 ' HB3' ' CG2' ' A' ' 152' ' ' VAL . 40.4 tp -103.84 106.87 17.51 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.754 -1.578 . . . . 0.0 108.515 171.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -127.66 134.7 49.62 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.847 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 62.4 p -64.96 160.69 20.14 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.383 0.427 . . . . 0.0 110.243 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -123.84 -78.82 0.6 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.544 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.76 -14.76 36.36 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.742 0.306 . . . . 0.0 111.258 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' SER . 32.0 t70 -156.05 148.98 24.17 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.229 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HB2' HD21 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -99.96 14.17 31.44 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -83.71 119.22 24.52 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.437 0.637 . . . . 0.0 110.152 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.529 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 3.8 mm? -115.46 107.34 15.05 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.558 0.694 . . . . 0.0 111.32 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 6.3 tt -116.76 115.46 25.64 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.2 mt -113.42 136.59 49.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 123.328 0.651 . . . . 0.0 111.113 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 95' ' ' GLU . 93.4 t80 -107.94 123.97 49.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -108.08 115.52 58.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.298 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HD3' ' H ' ' A' ' 25' ' ' VAL . 63.6 Cg_endo -77.83 142.8 20.36 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.706 2.27 . . . . 0.0 109.53 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HD1' ' H ' ' A' ' 66' ' ' PHE . 2.2 p90 -101.68 162.04 13.2 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -167.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -91.99 -50.9 5.46 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.869 -2.423 . . . . 0.0 108.482 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -156.57 177.93 10.91 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.222 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.73 124.03 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.414 HD11 HD21 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.92 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -92.93 115.72 28.38 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 125' ' ' LEU . 1.1 tm? -73.81 124.23 25.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -120.38 -49.94 2.24 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.911 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.543 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 50.3 p -143.95 161.76 37.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -134.99 152.9 52.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -146.82 115.95 6.95 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.08 0.467 . . . . 0.0 111.305 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.466 ' HB ' HD11 ' A' ' 113' ' ' LEU . 69.1 mt -123.63 128.46 74.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 4.7 tmtt? -112.26 120.5 41.94 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.409 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -149.25 -172.99 19.46 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -66.36 -175.7 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.83 2.353 . . . . 0.0 111.48 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -71.67 -56.88 4.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -173.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.28 -18.13 20.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.297 0.57 . . . . 0.0 112.135 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.52 15.68 6.38 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.486 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.53 156.98 16.0 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.451 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 32.2 Cg_exo -62.68 153.26 73.3 Favored 'Trans proline' 0 C--O 1.204 -1.192 0 C-N-CA 122.095 1.863 . . . . 0.0 110.16 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 37.2 ttpt -126.27 -65.41 0.98 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.868 -0.52 . . . . 0.0 110.377 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.9 m -75.75 101.74 5.16 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.24 0.543 . . . . 0.0 110.464 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 86' ' ' LYS . 52.5 t -106.02 130.52 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.103 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -130.61 151.84 50.64 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.769 0.828 . . . . 0.0 110.139 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' A' ' 125' ' ' LEU . 14.0 m-85 -136.0 160.71 37.8 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.178 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.35 116.69 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.45 ' HB2' HG22 ' A' ' 133' ' ' VAL . 21.8 p -84.24 14.6 4.18 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.89 1.276 . . . . 0.0 114.342 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -147.05 172.22 14.07 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.061 -0.4 . . . . 0.0 110.133 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 3.4 ttmp? 69.94 145.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 10.4 pt-20 -102.81 138.25 39.95 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.467 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m80 55.82 72.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.507 0.723 . . . . 0.0 112.489 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.48 ' HB3' HG21 ' A' ' 137' ' ' THR . 12.6 tpt -90.85 94.15 9.53 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.03 154.06 29.76 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.772 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.567 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 72.9 t80 -57.36 -23.23 47.74 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.7 t -79.71 -11.97 59.82 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.943 -0.473 . . . . 0.0 110.637 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -124.36 -13.31 7.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.583 . . . . 0.0 110.61 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.567 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 6.4 p -62.9 -30.06 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 C-N-CA 124.451 1.1 . . . . 0.0 112.129 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -109.03 -1.66 18.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.331 0.586 . . . . 0.0 111.098 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -82.65 -40.24 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -100.63 139.38 20.55 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.3 140.95 94.45 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.86 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.66 179.1 5.97 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.771 2.314 . . . . 0.0 110.747 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.725 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 44.8 m -79.56 -49.13 12.67 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.442 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -162.0 -179.6 7.26 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -153.27 150.49 29.0 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.73 169.21 18.2 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.495 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 5.6 tp10 -126.18 106.64 9.7 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.1 tt -73.05 122.57 21.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.7 p -122.04 -176.58 3.37 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.643 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.607 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 1.6 mp0 -51.77 -36.34 47.11 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 125.118 1.367 . . . . 0.0 109.813 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.505 ' CG ' ' HD2' ' A' ' 121' ' ' LYS . 40.4 tt0 -64.56 -38.78 92.21 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.443 HD22 ' CG2' ' A' ' 123' ' ' VAL . 23.8 t-20 -71.0 -38.28 72.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.81 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.44 -14.42 60.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.55 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.52 -1.69 56.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.555 0.693 . . . . 0.0 109.687 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.39 27.47 20.24 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.602 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.505 ' HD2' ' CG ' ' A' ' 116' ' ' GLU . 96.6 mttt -99.81 142.49 24.72 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 117.271 0.536 . . . . 0.0 111.146 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 39.6 Cg_endo -73.83 103.78 1.71 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.897 1.731 . . . . 0.0 109.313 170.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.443 ' CG2' HD22 ' A' ' 117' ' ' ASN . 78.9 t -84.58 127.34 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.748 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.68 101.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.652 ' HG ' ' H ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -54.57 -71.53 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.293 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.652 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 80.1 tttt -171.47 165.39 6.96 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -144.31 24.8 1.58 Allowed 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.689 -171.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.91 -47.24 13.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.725 ' HB3' ' O ' ' A' ' 108' ' ' SER . 8.8 tmtt? -111.29 -9.12 14.3 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.694 -166.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.406 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 39.7 p90 -60.51 10.2 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.927 0 O-C-N 121.497 -0.752 . . . . 0.0 112.94 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 129' ' ' LYS . 79.9 mm-40 -59.7 119.42 7.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.217 0.532 . . . . 0.0 111.279 -166.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.355 0.2 OUTLIER 59.54 113.74 0.01 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 128.078 2.551 . . . . 0.0 112.997 -170.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 92' ' ' SER . 63.3 t -102.3 110.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.892 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 134' ' ' ARG . 31.8 mmt180 -88.75 -31.5 18.38 Favored 'General case' 0 C--O 1.19 -2.077 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.575 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -160.86 164.09 31.56 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 tp -126.86 118.82 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 117.684 -1.607 . . . . 0.0 112.889 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 97' ' ' MET . 91.7 m -103.03 123.87 47.44 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.12 109.85 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 141' ' ' GLU . 53.1 t80 -114.5 111.72 21.83 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.407 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 1.8 pp -104.53 131.44 53.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.1 pt-20 -112.37 -2.27 14.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.06 142.16 5.92 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.311 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 HD21 ' HB2' ' A' ' 58' ' ' GLU . 38.4 m-80 -83.67 177.76 8.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.809 0.693 . . . . 0.0 109.864 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 2.4 mp0 -50.11 -58.53 5.34 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.4 m -119.64 -22.31 6.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.954 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.43 1.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 m -84.37 16.33 3.14 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.445 0.698 . . . . 0.0 112.305 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 73.48 -52.15 0.7 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.652 1.181 . . . . 0.0 111.078 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.18 106.09 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.014 0.912 . . . . 0.0 111.397 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.0 m -82.68 116.26 21.98 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.465 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -104.29 133.97 48.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.503 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 30.5 m -132.96 128.15 56.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.201 0.524 . . . . 0.0 109.609 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -84.41 -33.79 23.67 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -166.38 141.46 4.47 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.164 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.419 HG23 HG12 ' A' ' 77' ' ' ILE . 71.9 mt -121.6 111.98 33.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.49 124.58 21.56 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 159.4 15.47 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 83.8 m-85 -125.37 113.44 17.56 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.15 0.5 . . . . 0.0 109.939 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.62 167.2 12.25 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.0 m -120.34 132.98 55.52 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 117.39 0.595 . . . . 0.0 110.55 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--N 1.281 -2.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.832 173.256 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 C--O 1.237 0.44 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.516 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 20.1 m -96.82 9.44 41.8 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.805 0.812 . . . . 0.0 110.134 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.03 1.75 46.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.934 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -108.14 105.72 15.59 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.1 p -101.75 91.63 4.48 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.481 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.22 92.24 4.43 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.563 0.697 . . . . 0.0 110.844 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m -122.42 148.91 44.54 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.567 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -91.16 98.84 11.99 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 15' ' ' ASP . 2.6 mp -86.7 123.11 71.26 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.016 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.56 159.4 19.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.602 2.201 . . . . 0.0 110.421 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -83.81 101.9 11.95 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.834 0.826 . . . . 0.0 111.961 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.96 -30.77 2.34 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.205 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -121.96 170.15 10.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 122.281 -0.54 . . . . 0.0 110.783 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.94 143.01 18.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.572 ' HB2' HG13 ' A' ' 9' ' ' ILE . 11.8 t70 -71.95 127.43 32.53 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.86 0.362 . . . . 0.0 110.108 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 19' ' ' PHE . 33.2 mt -101.33 3.47 40.68 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 42' ' ' GLN . 3.1 tm? -73.06 -35.33 66.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.165 0.983 . . . . 0.0 108.541 -177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.94 -9.83 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.044 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 92.0 t80 -97.77 14.26 27.57 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 124.766 1.226 . . . . 0.0 110.977 -172.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.7 mt -88.84 142.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.489 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -93.9 120.24 33.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -92.93 7.9 42.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 m -103.64 -12.11 17.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.258 0.552 . . . . 0.0 110.836 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.95 -18.53 5.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.396 -0.906 . . . . 0.0 113.578 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.75 129.5 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.9 142.93 50.7 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.776 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' ' NE2' ' A' ' 30' ' ' GLN . 9.3 p -131.87 119.7 21.55 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.536 -175.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 3.8 mm? -94.41 132.34 39.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.222 0.534 . . . . 0.0 110.214 176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' A' ' 56' ' ' ALA . 64.0 t30 68.65 -70.97 0.12 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 126.945 2.098 . . . . 0.0 110.186 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 8.1 tt0 63.31 -168.93 0.2 Allowed 'General case' 0 C--N 1.372 1.573 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.661 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 41.5 t -93.39 123.42 36.68 Favored 'General case' 0 C--N 1.251 -3.714 0 O-C-N 120.449 -1.407 . . . . 0.0 108.477 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -57.93 -17.46 16.95 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.891 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -100.16 -43.6 6.26 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.661 ' O ' ' HB3' ' A' ' 31' ' ' SER . 83.4 m-70 -122.06 151.97 40.31 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 122.05 -0.406 . . . . 0.0 110.745 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.542 ' HA ' ' OE1' ' A' ' 30' ' ' GLN . 49.0 m -87.98 160.89 17.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.72 -49.47 2.1 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.68 -23.99 28.22 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.072 1.848 . . . . 0.0 111.284 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.566 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.2 m-20 -58.91 -27.68 65.48 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 125.636 1.574 . . . . 0.0 111.453 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -123.7 8.41 8.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 tp -118.36 -47.71 2.54 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.649 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -83.0 130.81 35.18 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.81 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.419 ' HG2' HH21 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -67.94 123.26 20.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . 135.43 -47.49 0.98 Allowed Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.084 -2.007 . . . . 0.0 108.084 -174.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -93.93 -44.37 8.11 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.419 HH21 ' HG2' ' A' ' 42' ' ' GLN . 58.9 ttp85 -54.97 101.96 0.06 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.389 -176.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 178.45 125.07 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.696 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 18.5 t70 -68.07 85.36 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.696 ' HG3' ' O ' ' A' ' 47' ' ' ASP . 35.3 mt-10 -173.1 108.08 0.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 127.227 2.211 . . . . 0.0 110.137 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.27 -52.87 4.11 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.996 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.566 ' HB2' HD22 ' A' ' 38' ' ' ASN . 1.3 pt? -133.44 127.77 34.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 122.737 -0.273 . . . . 0.0 110.405 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' A' ' 153' ' ' GLN . 6.7 t30 -161.35 153.32 19.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.46 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 2.8 tm? -85.32 110.25 18.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.941 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' THR . 12.6 pt-20 -132.31 112.65 12.4 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.5 p -59.95 137.37 58.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -141.74 85.42 1.94 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.519 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . 164.94 -50.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.155 1.782 . . . . 0.0 107.129 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -147.7 155.71 42.02 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.085 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -85.08 -25.2 27.72 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -77.0 130.83 38.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.738 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.8 mt -133.88 143.07 48.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.622 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.5 tm? -135.08 119.47 17.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.8 mp -123.85 129.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -105.63 122.84 46.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.24 113.02 39.3 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.685 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -90.27 125.33 1.21 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 122.58 2.186 . . . . 0.0 108.835 168.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.465 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 90.3 m-85 -87.92 158.17 18.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -59.69 -51.75 68.44 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.251 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -125.41 173.23 9.02 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.087 -0.383 . . . . 0.0 109.981 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 120.908 0.385 . . . . 0.0 110.501 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -132.87 172.61 16.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -96.83 136.23 37.68 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 130' ' ' PHE . 82.6 mt -76.01 146.63 39.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 27.6 t60 -124.83 -50.54 1.71 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -139.46 163.37 32.7 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 49.7 p90 -136.23 154.47 50.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -149.81 106.39 3.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.502 0.668 . . . . 0.0 111.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.13 131.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.543 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 53.6 mtpt -121.16 161.82 21.17 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.05 0.452 . . . . 0.0 111.716 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.07 -169.18 39.28 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' CG ' ' HD2' ' A' ' 151' ' ' LYS . 14.2 Cg_exo -73.37 166.47 29.8 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.937 2.424 . . . . 0.0 111.157 175.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 118' ' ' LEU . 13.3 pt-20 -58.66 -41.48 86.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.12 -26.26 15.55 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -92.53 11.29 26.88 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.891 -169.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.21 146.13 18.15 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.778 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 22.7 Cg_exo -67.05 110.05 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.332 2.021 . . . . 0.0 111.356 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HB2' HE21 ' A' ' 144' ' ' GLN . 0.8 OUTLIER -82.84 -39.67 21.36 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.925 -176.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.1 m -103.44 112.01 24.7 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.84 130.2 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.015 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -117.29 146.28 43.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.74 149.22 52.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 65.6 t80 -143.42 115.77 8.52 Favored 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.494 169.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 135' ' ' SER . 48.9 m -102.36 153.73 19.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.677 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 81.44 145.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.052 1.341 . . . . 0.0 108.573 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 72.9 116.0 0.05 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.57 149.74 29.81 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.689 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.267 13.9 p-80 50.31 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 88.1 mtp -139.6 142.08 37.11 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 22.8 p -120.06 174.08 6.69 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -69.84 -18.86 63.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 p -77.72 -21.72 51.48 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -130.35 18.75 5.34 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.72 -32.28 51.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.177 0.513 . . . . 0.0 110.717 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -97.27 73.53 2.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.637 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -124.41 -4.17 7.83 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -139.24 156.51 71.95 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.648 -1.615 . . . . 0.0 106.862 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.83 140.93 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.117 1.212 . . . . 0.0 109.589 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.72 153.52 36.1 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 122.42 2.08 . . . . 0.0 111.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 31.8 m -62.09 -44.8 95.88 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.717 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -169.56 166.78 9.98 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -139.24 139.71 37.52 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.4 172.71 11.57 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.673 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 37.2 tt0 -122.61 134.54 54.51 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 34.0 tp -62.99 108.58 1.24 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.701 0.626 . . . . 0.0 109.713 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.5 m -82.23 156.85 24.17 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -54.27 -39.58 67.0 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.191 0.596 . . . . 0.0 111.046 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' HB3' ' HD3' ' A' ' 121' ' ' LYS . 44.9 mt-10 -70.94 -31.47 68.07 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.244 0.618 . . . . 0.0 112.231 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.627 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.7 t-20 -62.56 -39.68 94.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 118' ' ' LEU . 7.5 tt -71.99 -7.62 49.79 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 45.2 mmtm -104.3 -14.15 15.89 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 121.761 -0.587 . . . . 0.0 110.136 176.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.543 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 127.59 -14.43 6.43 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 119.926 -1.131 . . . . 0.0 114.005 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 53.8 mtpt -74.88 133.36 76.13 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 35.8 Cg_exo -64.15 116.99 4.04 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.541 2.828 . . . . 0.0 111.707 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 135.7 26.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.92 131.29 34.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.16 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.38 177.47 5.03 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.809 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.6 96.49 10.49 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -80.08 21.83 0.55 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.89 -13.58 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.09 21.06 9.82 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.365 0.602 . . . . 0.0 110.668 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.636 ' CD2' HD12 ' A' ' 72' ' ' LEU . 96.3 m-85 -122.62 27.01 8.02 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.444 -173.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -63.22 -35.59 80.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -129.16 115.51 17.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.28 0.562 . . . . 0.0 109.805 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.476 HG21 ' HG ' ' A' ' 72' ' ' LEU . 47.4 t -121.15 104.47 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -108.27 -44.04 4.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 170.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' SER . 32.9 t -104.91 130.78 53.0 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.943 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.3 tp -137.87 104.23 5.21 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.137 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.5 m -92.3 115.42 28.07 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.74 122.73 58.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -121.53 127.71 51.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.897 0.38 . . . . 0.0 110.439 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 60' ' ' LEU . 12.0 pt -133.29 116.44 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -31.47 4.11 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.378 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.77 126.45 52.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.83 -174.84 2.65 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.709 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.517 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.2 mp0 -56.4 -66.51 0.42 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.6 t -120.14 9.27 11.09 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.545 -173.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.27 93.21 0.2 Allowed Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 23.4 t -111.99 -1.86 15.27 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 147' ' ' SER . 10.2 pt-20 68.0 -40.85 0.43 Allowed 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 126.764 2.026 . . . . 0.0 111.344 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.53 113.28 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.4 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 43.7 m -92.92 125.64 37.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 80' ' ' PRO . 39.2 ttmt -123.52 133.67 53.98 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.5 120.02 31.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.008 0.432 . . . . 0.0 111.117 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.472 ' HA ' ' OD1' ' A' ' 51' ' ' ASN . 4.7 pt20 -93.21 -6.24 48.17 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.675 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' CB ' ' HD2' ' A' ' 45' ' ' ARG . 38.5 pttt -172.11 144.81 1.7 Allowed 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.84 109.97 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 165.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.64 134.08 29.91 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 5.5 mp -117.85 156.29 28.64 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -123.14 127.97 49.42 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.22 -163.92 10.25 Favored Glycine 0 C--N 1.302 -1.329 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.381 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.6 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.1 t -142.18 143.29 32.87 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 117.428 0.614 . . . . 0.0 109.715 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 70' ' ' ILE . 41.0 p . . . . . 0 N--CA 1.433 -1.286 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.045 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 CA--C 1.508 -0.639 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -142.78 79.38 1.65 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.383 0.611 . . . . 0.0 109.715 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.84 87.45 2.29 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.225 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -134.43 140.44 46.26 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.9 t -73.37 107.11 5.48 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.515 0.674 . . . . 0.0 110.644 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.62 15.07 30.33 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -96.78 144.6 26.61 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -110.0 95.28 5.49 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.855 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -77.27 116.48 57.99 Favored Pre-proline 0 C--N 1.303 -1.441 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.704 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.24 144.0 14.36 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.971 1.781 . . . . 0.0 110.451 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.12 105.68 1.44 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.543 0.687 . . . . 0.0 110.214 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.79 -23.28 3.98 Favored Glycine 0 N--CA 1.42 -2.378 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.38 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -129.83 174.89 9.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.21 145.05 34.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -77.84 130.33 36.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' A' ' 70' ' ' ILE . 4.1 mm? -68.15 -8.85 42.07 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.822 0.849 . . . . 0.0 113.277 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 42' ' ' GLN . 2.0 tm? -55.51 -34.06 64.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.26 -25.94 64.52 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.057 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.78 22.84 15.17 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -172.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.45 133.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.9 105.84 18.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -75.09 -13.44 60.48 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 m -73.87 -22.23 59.81 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 6.4 13.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.574 -1.298 . . . . 0.0 114.387 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.14 136.91 25.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 CA-C-N 117.838 0.819 . . . . 0.0 110.176 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.8 tp10 -152.17 148.14 27.26 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.093 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.89 123.82 22.73 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.63 -44.71 96.47 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.693 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.69 -94.23 0.1 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.587 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 59.6 11.69 2.49 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.722 0.772 . . . . 0.0 109.996 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -83.56 -12.93 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 3.0 m -50.25 -47.83 54.99 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.5 m 153.14 -55.21 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 127.967 2.507 . . . . 0.0 108.372 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 80.1 m-70 -67.96 149.26 49.98 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.1 m -108.13 -175.84 2.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -171.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.519 HD23 HD22 ' A' ' 52' ' ' LEU . 2.4 tm? -90.84 -49.18 0.35 Allowed Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.693 0.797 . . . . 0.0 112.431 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 31.2 Cg_exo -62.38 -2.0 2.89 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.931 2.421 . . . . 0.0 114.46 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.432 ' HB2' HD13 ' A' ' 50' ' ' LEU . 34.8 p30 -84.02 -48.61 9.75 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.219 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.38 -2.5 57.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.3 tp -109.23 -9.12 15.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 5.8 tmtt? -89.7 133.29 34.74 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.443 ' HB2' HD11 ' A' ' 17' ' ' LEU . 6.4 tp-100 -54.58 133.21 46.32 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.78 -34.56 2.1 Favored Glycine 0 N--CA 1.413 -2.886 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.8 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.66 -20.77 45.86 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 117.657 0.728 . . . . 0.0 109.944 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 18.03 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.67 109.33 3.26 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.19 117.58 15.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 175.3 -81.39 0.0 OUTLIER 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.547 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.26 -33.1 77.16 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 50' ' ' LEU . 3.9 pp -119.66 126.69 51.76 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 8.1 p30 -163.54 167.26 21.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.519 HD22 HD23 ' A' ' 36' ' ' LEU . 48.1 tp -94.56 103.78 15.73 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 150' ' ' THR . 11.7 pt-20 -124.67 159.77 30.06 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.729 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.485 ' HA ' ' OG ' ' A' ' 32' ' ' SER . 86.9 p -95.74 -174.29 3.1 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.816 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 t70 175.03 -48.41 0.01 OUTLIER 'General case' 0 CA--C 1.467 -2.245 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.34 35.73 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.148 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.552 ' OD1' ' HG2' ' A' ' 59' ' ' GLN . 10.6 t70 -157.44 146.97 20.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.18 -31.53 69.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.955 0.902 . . . . 0.0 112.49 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG2' ' OD1' ' A' ' 57' ' ' ASP . 13.9 pt20 -86.91 126.74 34.88 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.121 0.962 . . . . 0.0 111.949 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' HD11 ' A' ' 140' ' ' ILE . 54.5 mt -131.07 120.73 23.83 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.343 -173.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -96.96 119.77 36.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.81 128.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . 8.6 t80 -109.84 117.91 35.08 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.1 mt -122.55 114.0 30.33 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-O 120.515 0.198 . . . . 0.0 111.37 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -89.33 141.18 4.0 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 121.998 1.798 . . . . 0.0 109.881 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -103.93 150.87 23.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.597 0.713 . . . . 0.0 112.638 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -55.35 -45.61 76.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -153.98 163.16 40.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.81 127.61 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.901 0.858 . . . . 0.0 111.748 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.501 ' CD1' HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -128.3 172.1 15.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.058 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -96.28 114.18 25.84 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 157' ' ' LEU . 53.2 tp -73.27 154.47 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.541 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 31.3 t60 -139.16 -38.17 0.5 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.785 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.1 p -153.97 169.73 22.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.477 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -141.29 155.17 46.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -149.65 100.2 2.95 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.868 0.366 . . . . 0.0 111.934 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.446 HG23 HG12 ' A' ' 155' ' ' ILE . 56.8 mt -106.24 136.58 40.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HB3' ' OE1' ' A' ' 153' ' ' GLN . 90.1 mttt -112.06 150.96 29.94 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.991 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 118' ' ' LEU . . . -166.56 168.01 39.85 Favored Glycine 0 N--CA 1.41 -3.041 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 83' ' ' GLU . 32.5 Cg_exo -62.22 151.94 79.2 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.892 1.728 . . . . 0.0 111.117 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HG2' ' HG3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -54.64 -39.78 68.32 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.346 0.659 . . . . 0.0 111.62 -178.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.428 ' HG3' ' HG2' ' A' ' 81' ' ' GLU . 45.6 mt-10 -94.48 -44.0 8.09 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 80' ' ' PRO . 37.5 tt0 -101.56 18.95 18.94 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.692 -166.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.93 178.87 36.45 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.163 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.412 ' HG2' HD22 ' A' ' 113' ' ' LEU . 35.5 Cg_endo -73.5 -179.88 4.9 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 119.765 1.782 . . . . 0.0 110.439 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.56 ' HG2' ' OE2' ' A' ' 112' ' ' GLU . 23.0 ttpp -154.98 -71.23 0.12 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.863 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.4 m -85.74 118.19 25.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.261 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.595 HG12 HG22 ' A' ' 140' ' ' ILE . 23.0 m -118.28 137.19 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.762 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -110.95 133.87 53.03 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -113.97 145.3 41.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -135.37 114.96 12.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 171.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -94.42 133.81 37.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 74.35 175.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.411 1.084 . . . . 0.0 111.357 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.578 ' HE3' ' N ' ' A' ' 94' ' ' LYS . 0.7 OUTLIER 72.82 127.8 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.819 0.819 . . . . 0.0 110.902 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 3.6 mp0 -93.89 146.68 23.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.948 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.1 m80 69.91 98.14 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.955 1.302 . . . . 0.0 111.948 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 92.5 mmm -139.26 142.54 37.78 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.004 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.542 ' O ' HG23 ' A' ' 102' ' ' VAL . 26.4 p -144.78 169.73 17.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.61 -30.5 68.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.276 0.489 . . . . 0.0 112.072 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 t -63.54 -24.26 67.74 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 120.689 0.28 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.432 ' O ' ' HD1' ' A' ' 105' ' ' PHE . 92.8 m-20 -98.6 -23.11 15.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.945 0.402 . . . . 0.0 111.315 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 98' ' ' CYS . 56.0 t -58.53 -32.09 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.718 0.807 . . . . 0.0 112.271 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.85 -15.59 60.2 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -113.44 -15.89 12.53 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.699 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 101' ' ' ASN . 79.3 m-85 -96.75 148.05 33.85 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -82.56 139.81 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.164 1.909 . . . . 0.0 112.032 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.07 149.05 64.34 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.133 1.889 . . . . 0.0 110.939 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.8 m -73.76 -45.16 53.58 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.553 0.692 . . . . 0.0 109.332 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -161.25 160.6 30.12 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -131.7 125.72 32.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.23 170.19 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.32 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.56 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.8 tp10 -125.25 134.96 52.12 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 19.8 tp -70.11 101.94 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 117' ' ' ASN . 5.1 t -80.07 158.4 26.45 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.62 -22.83 66.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.588 0.709 . . . . 0.0 109.749 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.09 -35.31 74.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.257 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.636 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.5 t-20 -71.73 -32.72 68.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 79' ' ' GLY . 96.8 mt -57.48 -23.27 49.01 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.737 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.14 -12.65 52.35 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.712 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 2.82 55.56 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 122.71 88.13 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.096 0.448 . . . . 0.0 110.389 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -59.42 111.12 0.84 Allowed 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 123.157 2.571 . . . . 0.0 112.107 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.508 HG23 ' ND2' ' A' ' 117' ' ' ASN . 86.4 t -82.98 124.88 39.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.7 101.54 2.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.198 0.523 . . . . 0.0 109.952 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.89 172.8 13.27 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.637 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -89.64 84.06 6.31 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.19 0.995 . . . . 0.0 110.031 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 39.9 p90 -76.42 24.69 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.919 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.531 HG13 ' HD2' ' A' ' 129' ' ' LYS . 7.4 p -63.47 -25.57 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.679 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.531 ' HD2' HG13 ' A' ' 128' ' ' VAL . 13.1 mptt -93.43 -20.29 20.46 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.436 0.636 . . . . 0.0 110.501 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 127' ' ' TYR . 82.2 m-85 -91.1 32.63 1.0 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.633 -171.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -67.32 -31.76 72.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.807 0.337 . . . . 0.0 111.309 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -142.2 116.15 9.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.54 106.51 20.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.795 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -89.52 -62.9 1.37 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.2 t -109.03 151.57 26.17 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.195 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.4 tp -147.95 129.67 15.12 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.261 0.553 . . . . 0.0 109.952 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 m -114.71 124.64 52.32 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.5 112.23 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 69.3 t80 -109.0 114.62 28.53 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.851 0.357 . . . . 0.0 110.697 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.595 HG22 HG12 ' A' ' 88' ' ' VAL . 2.3 pp -97.47 124.45 50.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 11.5 pt-20 -110.79 -22.56 11.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.339 -0.945 . . . . 0.0 111.968 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.64 156.39 44.96 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.847 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 147' ' ' SER . 34.2 t-20 -110.61 148.09 32.9 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 126.221 1.809 . . . . 0.0 107.862 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 29.1 mm-40 -36.37 -56.81 0.77 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.652 1.181 . . . . 0.0 111.973 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -124.25 -12.02 7.41 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.688 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 87.59 0.94 Allowed Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 149' ' ' VAL . 32.6 t -111.05 9.55 22.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.98 -0.13 . . . . 0.0 110.7 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 77.14 -23.59 0.24 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 124.441 1.096 . . . . 0.0 110.157 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 147' ' ' SER . 25.9 m -128.5 124.31 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.9 m -101.41 111.1 23.23 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 51' ' ' ASN . 87.2 tttt -95.95 133.6 39.96 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 92.9 t -122.66 115.8 47.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.428 ' OE1' ' HB3' ' A' ' 78' ' ' LYS . 97.0 mt-30 -74.1 -44.33 54.35 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.839 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.05 153.66 3.85 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.495 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.446 HG12 HG23 ' A' ' 77' ' ' ILE . 71.9 mt -124.49 118.03 52.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.4 141.02 35.59 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 72' ' ' LEU . 6.2 mp -120.43 151.59 39.1 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -124.44 127.11 47.02 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.723 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.3 -163.59 10.23 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.2 m -143.94 138.36 28.44 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.383 0.611 . . . . 0.0 111.863 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.464 HG22 HG22 ' A' ' 70' ' ' ILE . 17.8 p . . . . . 0 C--N 1.293 -1.88 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.087 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.799 0.333 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -90.09 -54.59 3.96 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.8 104.36 0.69 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.43 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -111.93 84.86 2.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.0 m -76.04 108.46 8.96 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.01 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 69.92 -57.99 0.54 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.025 1.33 . . . . 0.0 111.914 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.7 p 50.82 83.55 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.394 1.478 . . . . 0.0 113.7 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -100.06 66.68 1.35 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.213 0.53 . . . . 0.0 111.064 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.25 133.09 64.85 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.034 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.11 -173.55 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.633 2.222 . . . . 0.0 112.349 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -92.74 11.76 25.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.812 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -143.7 -50.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.741 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -87.42 173.38 9.17 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.924 0.392 . . . . 0.0 111.107 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 18.0 m -115.36 167.79 7.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.51 108.56 16.0 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.363 1.078 . . . . 0.0 108.979 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.488 HD22 HG13 ' A' ' 70' ' ' ILE . 44.7 mt -68.82 3.98 1.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.778 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.62 -41.45 99.01 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.16 -7.42 57.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.867 0.841 . . . . 0.0 110.86 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 13.4 m-85 -92.1 1.71 57.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.01 133.35 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.07 -28.05 22.79 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.837 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.48 ' HA ' HG13 ' A' ' 25' ' ' VAL . 97.5 m95 66.15 -6.85 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 m -82.18 -19.95 38.82 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.614 -0.679 . . . . 0.0 112.659 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.35 26.69 4.9 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.75 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 22' ' ' TRP . 35.7 m -71.89 139.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 110.911 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.68 128.2 32.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.108 0.48 . . . . 0.0 109.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.599 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 6.1 p -103.23 118.15 36.12 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.495 HD23 HD22 ' A' ' 61' ' ' LEU . 3.3 mm? -76.82 -14.92 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.483 0.659 . . . . 0.0 110.746 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -160.45 -83.98 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.776 168.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.615 ' HA ' HD23 ' A' ' 60' ' ' LEU 0.394 3.1 pp0? 51.65 14.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.51 1.124 . . . . 0.0 112.634 -168.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.433 ' CB ' ' H ' ' A' ' 55' ' ' ASP 0.293 58.6 m 72.68 115.02 0.06 Allowed 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 126.995 2.118 . . . . 0.0 114.007 -173.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -55.34 16.9 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 C-N-CA 126.965 2.106 . . . . 0.0 115.218 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 31' ' ' SER . 34.1 t -103.91 -58.67 1.84 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.711 -0.618 . . . . 0.0 109.962 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CE1' ' HA ' ' A' ' 52' ' ' LEU . 23.7 p80 -93.81 163.37 13.55 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 17.7 m -90.49 166.97 12.94 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.818 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 62.1 tp -67.45 -45.58 47.96 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 11.6 Cg_endo -55.47 -25.91 51.29 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.957 1.771 . . . . 0.0 111.503 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 1.9 m-20 -63.04 -24.55 67.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.281 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -95.11 -49.53 5.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.154 0.502 . . . . 0.0 111.886 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.2 tp -105.16 -20.71 13.43 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -170.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -80.08 118.66 21.99 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.292 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -70.87 140.72 51.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.558 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.58 -33.25 6.58 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.438 ' HB3' HD11 ' A' ' 50' ' ' LEU . 95.6 m-85 -98.92 -50.13 4.3 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.44 0.296 . . . . 0.0 110.859 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -52.75 119.29 4.41 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.998 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -153.7 124.4 7.2 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.53 92.61 0.85 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.649 0.738 . . . . 0.0 112.522 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 170.86 -66.26 0.01 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.693 1.597 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.42 -57.03 1.81 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.29 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.4 pt? -134.68 113.71 11.97 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.626 0.727 . . . . 0.0 110.808 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -161.41 169.48 21.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.635 ' HB3' HG22 ' A' ' 152' ' ' VAL . 6.6 tt -75.92 122.69 24.52 Favored 'General case' 0 CA--C 1.487 -1.461 0 C-N-CA 117.191 -1.803 . . . . 0.0 106.17 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -138.22 110.12 7.2 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 113.094 -1.866 . . . . 0.0 107.267 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.516 ' HB3' ' H ' ' A' ' 150' ' ' THR . 8.0 t -93.48 123.65 36.94 Favored 'General case' 0 N--CA 1.411 -2.397 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.325 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.433 ' H ' ' CB ' ' A' ' 31' ' ' SER . 13.1 t70 -119.11 -24.1 6.6 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.722 -175.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.95 -69.61 0.68 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.314 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.91 171.5 8.59 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.534 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 148' ' ' GLU . 5.2 tm-20 -89.9 -24.77 21.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.028 0.931 . . . . 0.0 109.945 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.4 ' C ' HD12 ' A' ' 60' ' ' LEU . 55.5 mt-30 -114.27 134.65 54.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.122 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 30' ' ' GLN . 8.4 mp -128.76 165.28 21.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.373 0.606 . . . . 0.0 112.39 -172.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.495 HD22 HD23 ' A' ' 28' ' ' LEU . 5.9 tt -152.42 128.1 10.14 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 61' ' ' LEU . 2.9 mp -126.02 135.5 63.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.72 118.74 35.85 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -121.64 122.71 27.79 Favored Pre-proline 0 C--O 1.214 -0.772 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.357 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -92.56 137.43 1.6 Allowed 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.657 2.238 . . . . 0.0 111.415 171.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -92.43 162.89 14.06 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.293 0.568 . . . . 0.0 111.421 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 68' ' ' GLN . 34.4 p30 -69.84 -36.11 75.29 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HG2' ' OD1' ' A' ' 67' ' ' ASN . 19.5 pt20 -147.63 176.88 9.73 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.029 -0.419 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 27.3 m -82.18 124.48 39.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.23 0.538 . . . . 0.0 110.384 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.488 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -137.0 172.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 174.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -93.24 114.31 26.75 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 65.4 tp -76.66 127.97 33.8 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 1.3 t-80 -126.08 -45.94 1.69 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.866 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 p -142.74 155.18 44.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -128.27 158.24 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.24 113.77 5.64 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 122.602 0.361 . . . . 0.0 110.284 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.45 HG23 HG12 ' A' ' 155' ' ' ILE . 67.2 mt -125.17 126.35 70.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 54.2 mtpt -117.79 152.42 35.35 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.421 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.85 -167.96 30.23 Favored Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 108.186 -1.965 . . . . 0.0 108.186 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.11 155.53 69.17 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.85 1.7 . . . . 0.0 109.078 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.97 -42.83 60.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.91 -37.25 10.78 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -76.6 2.27 14.49 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.77 150.2 30.78 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.594 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.9 161.74 35.21 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 121.938 1.759 . . . . 0.0 111.088 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 69.8 tttt -127.89 -73.98 0.59 Allowed 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.561 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.606 ' HA ' ' HG2' ' A' ' 112' ' ' GLU . 29.5 m -76.15 103.91 6.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.477 0.656 . . . . 0.0 110.193 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 86' ' ' LYS . 99.8 t -114.93 116.66 53.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.627 -173.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 139' ' ' PHE . 98.8 mttt -101.91 147.23 26.78 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.231 -0.293 . . . . 0.0 110.26 172.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.54 138.91 54.47 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 86.6 m-85 -130.95 116.78 18.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 135' ' ' SER . 50.8 p -100.63 -14.09 18.29 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 7.5 t30 -140.3 84.7 1.97 Allowed 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.146 -1.421 . . . . 0.0 113.87 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 85.5 tttt 171.69 148.81 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.109 1.364 . . . . 0.0 108.06 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -85.97 122.94 30.71 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.289 0.566 . . . . 0.0 111.427 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.366 0.3 OUTLIER 39.39 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.002 2.521 . . . . 0.0 117.299 176.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.553 ' HB2' HG21 ' A' ' 137' ' ' THR . 91.7 mmm -83.91 148.51 26.9 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 174.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.7 m -129.33 162.93 26.84 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -52.68 -38.63 60.84 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 t -81.29 3.26 24.69 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.43 ' HA ' ' OD1' ' A' ' 104' ' ' ASP . 4.0 p-10 -147.23 13.64 1.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.229 0.538 . . . . 0.0 110.616 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 p -75.5 -25.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -96.63 4.78 51.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.478 0.656 . . . . 0.0 110.618 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 101' ' ' ASN . 8.3 m-20 -91.71 4.61 52.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.923 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 82.1 t80 -144.19 134.65 12.09 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 26.2 Cg_exo -65.08 127.0 17.48 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.628 2.219 . . . . 0.0 111.7 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.14 168.55 23.02 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.597 2.198 . . . . 0.0 112.505 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.8 m -69.72 -40.66 76.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.43 174.11 3.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 76.0 m -143.7 113.45 7.11 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.27 163.7 20.18 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.563 -174.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 50.5 mt-10 -128.04 138.75 52.7 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.768 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.1 116.71 7.49 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 112.651 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 t -96.42 174.07 7.05 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.44 -36.34 68.91 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 118.257 0.48 . . . . 0.0 110.715 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 121' ' ' LYS . 38.8 tt0 -59.93 -42.36 93.79 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.498 HD22 HG23 ' A' ' 123' ' ' VAL . 14.1 t-20 -71.54 -41.66 68.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 118' ' ' LEU . 8.4 tt -73.85 -0.76 16.9 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.735 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -113.61 -5.07 13.41 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.174 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.517 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 118.63 -3.33 15.29 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.645 -1.264 . . . . 0.0 116.136 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 116' ' ' GLU . 12.4 mptt -88.33 126.57 60.02 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 46.9 Cg_exo -59.91 108.54 0.49 Allowed 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.707 2.938 . . . . 0.0 111.844 175.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 HD22 ' A' ' 117' ' ' ASN . 68.9 t -88.65 127.1 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.23 141.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.412 0.445 . . . . 0.0 111.75 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.63 -172.85 2.2 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -72.7 103.79 3.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 110.355 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.45 ' HA ' ' CD2' ' A' ' 130' ' ' PHE . 60.4 t80 -75.16 1.77 12.51 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.361 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.64 -22.52 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.79 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -109.69 -9.97 14.83 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -170.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 127' ' ' TYR . 41.4 p90 -77.62 11.11 2.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.128 -0.982 . . . . 0.0 112.447 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -58.51 133.42 55.8 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -163.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.294 2.8 p-10 53.7 113.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.911 2.084 . . . . 0.0 112.697 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 55.0 t -121.01 122.51 67.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.674 -173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -117.3 -28.28 6.19 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.551 0.691 . . . . 0.0 109.545 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 92' ' ' SER . 52.3 p -144.67 171.86 13.8 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.897 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.92 106.49 4.85 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 97' ' ' MET . 19.9 m -96.73 120.24 36.7 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.5 mt -105.1 111.28 33.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 65.1 t80 -107.55 107.89 18.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.99 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 88' ' ' VAL . 11.9 pt -106.64 113.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.633 0.73 . . . . 0.0 109.986 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 41.8 tt0 -112.66 13.38 19.9 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.999 0.904 . . . . 0.0 111.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.3 153.44 11.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.764 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.413 ' C ' ' HB2' ' A' ' 86' ' ' LYS . 39.8 m-80 -117.76 168.34 10.54 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 124.044 0.84 . . . . 0.0 108.91 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -44.21 -43.5 7.22 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.814 0.846 . . . . 0.0 112.186 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.2 m -124.1 8.77 8.61 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.732 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.39 55.56 28.99 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -83.35 2.72 34.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -168.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 58' ' ' GLU . 47.2 mt-10 69.22 -4.28 1.34 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.802 0.841 . . . . 0.0 112.536 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 54' ' ' SER . 2.7 p -137.95 103.3 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 123.829 0.852 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.516 ' H ' ' HB3' ' A' ' 54' ' ' SER . 41.0 m -82.57 122.78 28.53 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 87.8 tttt -131.12 134.17 46.32 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 52' ' ' LEU . 11.3 m -130.46 148.38 33.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.129 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -86.54 -44.83 11.62 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.328 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.13 145.11 6.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.702 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.45 HG12 HG23 ' A' ' 77' ' ' ILE . 73.9 mt -117.98 122.87 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.1 137.28 42.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.27 137.56 51.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 74.3 m-85 -122.33 139.33 53.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.753 0.787 . . . . 0.0 111.703 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.94 -168.46 22.84 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.9 m -145.73 149.82 35.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 117.431 0.616 . . . . 0.0 109.676 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--N 1.29 -2.016 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.295 178.171 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.8 p 53.32 27.92 6.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.672 1.189 . . . . 0.0 112.891 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.99 138.39 40.48 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -83.57 -40.35 19.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.723 0.773 . . . . 0.0 109.221 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -150.09 94.24 2.12 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.022 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 87.95 7.38 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.592 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.0 m -95.27 79.61 3.51 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 121.58 0.705 . . . . 0.0 110.268 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.514 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 4.8 tp60 -145.26 5.65 1.1 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.788 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 11' ' ' LYS . 2.0 mp -83.61 123.55 76.31 Favored Pre-proline 0 N--CA 1.425 -1.68 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.1 1.63 9.07 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.805 2.336 . . . . 0.0 112.964 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' H ' HG22 ' A' ' 9' ' ' ILE . 24.2 ttmm 70.83 118.95 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.796 1.238 . . . . 0.0 111.423 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.81 -44.31 1.28 Allowed Glycine 0 C--N 1.307 -1.05 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -134.87 152.37 51.69 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 13.0 m -106.2 167.51 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.069 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.475 ' H ' HG13 ' A' ' 9' ' ' ILE . 21.9 t70 -76.82 95.33 4.03 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.75 -0.38 0.11 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 126.917 2.087 . . . . 0.0 114.054 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.5 tt -64.02 -31.73 73.02 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.49 -24.12 67.69 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.864 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.75 8.66 41.8 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.047 -0.408 . . . . 0.0 110.398 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.9 mt -85.57 119.08 33.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.25 -34.82 42.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.517 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 96.2 m95 70.23 6.57 5.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.8 t -84.96 -28.79 25.59 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.8 -89.23 1.78 Allowed Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 108.089 -2.005 . . . . 0.0 108.089 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.517 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 92.3 t 41.89 94.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.246 1.418 . . . . 0.0 114.283 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.48 128.1 56.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.906 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.2 p -102.01 119.87 39.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.645 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.424 ' C ' HD13 ' A' ' 28' ' ' LEU . 2.6 tm? -64.3 -44.29 92.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.066 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -117.64 -99.63 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.127 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 48.3 tt0 56.08 22.14 5.7 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.301 1.048 . . . . 0.0 110.204 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -102.77 -12.67 17.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.88 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -54.76 -48.31 72.8 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.5 m 179.97 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 124.483 1.113 . . . . 0.0 110.399 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -73.31 163.36 28.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.628 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.459 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 45.8 m -98.51 140.22 33.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.542 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' CB ' ' HG ' ' A' ' 52' ' ' LEU . 7.0 tt -77.85 -44.82 2.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.453 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.07 -24.66 20.41 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.141 1.894 . . . . 0.0 112.79 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.569 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.0 m-20 -57.37 -48.43 79.07 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 121.227 0.537 . . . . 0.0 110.264 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.02 4.94 20.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.109 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' O ' ' HZ2' ' A' ' 22' ' ' TRP . 49.2 tp -140.25 10.5 2.33 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 5.3 tmtm? -127.68 141.75 51.52 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.54 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 15.6 mm-40 -58.88 132.81 55.06 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -39.77 2.77 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.478 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -76.0 -48.25 21.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.611 -0.294 . . . . 0.0 111.287 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' A' ' 17' ' ' LEU . 32.1 ptt180 -68.12 107.8 2.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.056 0.931 . . . . 0.0 111.596 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.82 100.63 5.77 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' HB2' ' OE1' ' A' ' 153' ' ' GLN . 4.8 p-10 -71.68 84.65 0.89 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -173.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 16.9 tp10 168.96 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 113.241 -1.799 . . . . 0.0 108.29 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.11 -68.88 1.51 Allowed Glycine 0 C--O 1.238 0.396 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.785 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 38' ' ' ASN . 1.9 pp -104.79 158.07 16.77 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 120.966 0.412 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.449 ' ND2' ' HG3' ' A' ' 151' ' ' LYS . 3.5 p-10 -161.76 166.41 26.56 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.463 ' HG ' ' CB ' ' A' ' 36' ' ' LEU . 3.2 tm? -111.51 128.82 56.13 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.04 162.44 35.46 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.763 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 51.2 p -92.12 176.09 6.63 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.944 0.153 . . . . 0.0 110.774 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 175.79 -46.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.925 0.89 . . . . 0.0 109.067 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.19 -28.84 63.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.59 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.3 t70 -160.29 145.71 15.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -74.06 -27.81 61.09 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 123.519 0.512 . . . . 0.0 112.236 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.2 132.19 34.06 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.304 0.574 . . . . 0.0 110.542 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 54' ' ' SER . 93.2 mt -131.12 144.43 51.39 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.327 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 62' ' ' ILE . 6.0 tt -153.06 144.35 23.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.515 ' N ' HD23 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -150.29 138.94 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.474 ' N ' HD13 ' A' ' 62' ' ' ILE . 68.2 t80 -105.32 122.76 46.62 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.914 0.486 . . . . 0.0 111.825 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 62' ' ' ILE . 2.3 mp -116.26 119.47 36.45 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.652 177.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -86.84 127.74 2.7 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.538 2.159 . . . . 0.0 109.219 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -90.81 162.65 14.75 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -48.8 -57.6 6.12 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 126.376 1.87 . . . . 0.0 110.165 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -149.48 177.94 9.26 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 57.7 t -78.49 111.72 15.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.57 173.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -100.61 133.8 44.52 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 125' ' ' LEU . 2.4 tt -98.19 123.22 42.15 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -102.2 -41.44 6.39 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.822 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.0 p -154.63 160.93 41.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.027 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -135.23 150.23 50.03 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -143.6 98.11 3.19 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.7 mt -108.26 132.21 56.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 54.0 mtpt -116.55 159.3 22.31 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.264 0.554 . . . . 0.0 112.42 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.4 39.64 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -73.85 172.62 15.49 Favored 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 122.25 1.966 . . . . 0.0 110.356 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -74.8 -27.93 60.51 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.834 0.35 . . . . 0.0 110.668 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.22 -47.17 7.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.18 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 151' ' ' LYS . 43.7 mt-10 -89.7 1.8 55.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.745 -176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.76 45.45 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.798 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 7.5 Cg_exo -71.21 107.07 2.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.174 1.916 . . . . 0.0 111.15 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.34 -43.39 13.74 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.7 m -92.74 97.22 10.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.143 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 33.8 m -107.38 142.28 20.52 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -146.65 133.46 20.08 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.27 144.69 45.61 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.011 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -131.98 115.65 16.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.6 t -93.27 134.54 35.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 73.67 178.29 0.23 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.829 1.252 . . . . 0.0 111.501 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.4 tptm 72.41 101.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.063 1.345 . . . . 0.0 110.736 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.8 122.96 19.66 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.643 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t60 70.87 97.35 0.07 Allowed 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.389 1.056 . . . . 0.0 112.997 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 83.5 mtp -126.39 152.77 45.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 85.5 m -142.7 174.85 10.28 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.509 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 55.5 p90 -65.54 -17.6 64.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.1 m -73.19 -23.33 60.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.626 0.25 . . . . 0.0 111.454 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -128.51 3.34 5.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 111.514 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.509 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 8.3 p -65.09 -34.77 72.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.867 -173.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -97.71 5.1 49.73 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.75 -24.56 18.53 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.173 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -97.38 149.74 36.04 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.718 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.59 128.88 18.88 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 122.67 2.247 . . . . 0.0 112.028 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.68 160.27 41.29 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.436 2.09 . . . . 0.0 111.256 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -76.79 -41.95 42.55 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.489 0.661 . . . . 0.0 109.378 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.635 ' OD2' ' HG3' ' A' ' 126' ' ' LYS . 14.9 t70 -161.71 146.71 13.24 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -127.99 124.17 36.54 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 173.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -119.05 172.89 7.24 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.085 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.44 134.59 55.14 Favored 'General case' 0 N--CA 1.405 -2.676 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 118' ' ' LEU . 28.4 tp -69.57 121.54 17.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -98.03 169.59 9.52 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.861 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -31.77 72.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.42 ' HA ' ' HE2' ' A' ' 119' ' ' LYS . 15.0 pt-20 -70.87 -33.88 71.05 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.82 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.631 HD21 ' HA ' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -64.44 -42.57 95.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.052 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 113' ' ' LEU . 87.2 mt -62.19 -4.87 1.93 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.83 1.252 . . . . 0.0 113.642 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 116' ' ' GLU . 57.1 mtmt -113.14 -9.39 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 122.821 0.448 . . . . 0.0 109.976 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.83 0.58 34.19 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.914 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 31.9 mmmt -75.34 131.52 77.74 Favored Pre-proline 0 C--O 1.246 0.907 0 O-C-N 123.592 0.231 . . . . 0.0 111.375 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 29.7 Cg_exo -65.14 119.54 6.59 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.288 2.659 . . . . 0.0 111.639 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.0 t -97.54 136.0 29.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.04 117.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.405 0.621 . . . . 0.0 111.252 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.469 HD11 HD22 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.54 -175.59 4.74 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.401 176.224 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.635 ' HG3' ' OD2' ' A' ' 109' ' ' ASP . 29.9 mtpp -64.54 89.9 0.07 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.619 0.723 . . . . 0.0 112.06 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -69.68 -21.37 63.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.732 1.213 . . . . 0.0 110.959 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 m -80.33 -19.23 12.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.03 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 9.9 tmtt? -92.85 -41.84 9.86 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 125' ' ' LEU . 91.8 m-85 -75.77 78.97 2.71 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 112.021 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -107.99 -40.44 5.23 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.418 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.29 112.65 23.44 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.388 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 49.0 t -123.3 102.38 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -95.87 -31.07 13.32 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.4 p -156.94 162.99 39.62 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 137' ' ' THR . 4.4 tt -148.82 133.99 18.29 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.476 ' N ' HD23 ' A' ' 136' ' ' LEU . 64.6 m -104.32 124.7 49.65 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mp -103.03 125.96 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.63 118.25 27.72 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.501 HG13 ' HB2' ' A' ' 60' ' ' LEU . 10.5 pt -112.46 114.32 46.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.68 0.753 . . . . 0.0 109.76 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.66 -42.43 9.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.612 -172.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.24 150.58 38.16 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.899 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.08 167.99 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.834 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -48.47 -48.61 37.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.0 m -92.84 -19.45 21.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.81 42.38 61.26 Favored Glycine 0 C--N 1.311 -0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.6 t -87.86 9.86 20.57 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.938 -0.631 . . . . 0.0 110.752 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 68.15 8.39 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.379 1.072 . . . . 0.0 112.318 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 54' ' ' SER . 7.7 p -136.02 112.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-O 121.976 0.893 . . . . 0.0 109.378 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.6 m -106.74 121.28 44.05 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.449 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 4.9 ttmp? -113.4 133.62 55.07 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.232 0.539 . . . . 0.0 110.485 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.7 t -125.68 116.1 45.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.654 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.47 ' OE1' ' HB2' ' A' ' 47' ' ' ASP . 9.7 pt20 -85.87 -29.92 23.32 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.45 145.43 12.96 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.28 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.36 129.32 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.59 129.63 20.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.98 144.73 42.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 84.5 m-85 -124.16 113.21 18.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.307 0.575 . . . . 0.0 111.042 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.96 -167.24 11.0 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.4 p -162.44 162.95 27.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 118.315 1.057 . . . . 0.0 112.556 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.302 -1.469 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.315 173.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -168.99 97.21 0.36 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.275 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.11 21.81 13.07 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -77.3 110.98 12.48 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.542 0.687 . . . . 0.0 111.817 179.197 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.8 m -141.07 93.82 2.63 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.378 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.536 ' HB2' HE21 ' A' ' 42' ' ' GLN . . . -152.94 134.54 14.48 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.374 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 p -83.55 81.32 8.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.921 0.867 . . . . 0.0 110.77 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -129.41 11.37 5.83 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.486 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.6 mt -104.75 112.67 65.32 Favored Pre-proline 0 C--N 1.299 -1.619 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.66 -172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.26 143.22 4.62 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 122.3 2.0 . . . . 0.0 111.715 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -59.18 130.67 48.09 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.69 0.757 . . . . 0.0 112.021 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -42.26 1.96 Allowed Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -106.67 173.3 6.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.615 0.721 . . . . 0.0 110.064 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.431 HG11 HG23 ' A' ' 161' ' ' THR . 14.6 p -130.15 143.94 39.5 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 154.5 29.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.029 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 20' ' ' ILE . 4.3 mm? -101.64 8.83 41.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.927 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 42' ' ' GLN . 4.4 tt -78.48 -48.49 15.24 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.85 -27.22 68.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.788 -1.097 . . . . 0.0 110.918 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -84.07 9.84 11.56 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.494 HG22 ' H ' ' A' ' 22' ' ' TRP . 75.4 mt -93.71 127.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.28 -15.99 41.6 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.508 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' H ' HG22 ' A' ' 20' ' ' ILE . 86.0 m95 58.88 30.7 20.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.709 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -57.31 -36.19 70.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.933 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.2 -47.37 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 22' ' ' TRP . 2.7 t 62.7 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.348 1.059 . . . . 0.0 109.885 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -121.78 139.85 53.08 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.018 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.54 128.74 29.81 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.44 HD13 HD12 ' A' ' 61' ' ' LEU . 8.6 mp -62.58 -26.78 68.77 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -99.41 -105.02 0.22 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.325 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 54.73 15.61 1.15 Allowed 'General case' 0 CA--C 1.573 1.842 0 CA-C-O 122.322 1.058 . . . . 0.0 110.306 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 t -78.36 -30.1 47.81 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.613 1.165 . . . . 0.0 107.931 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 4.9 p -64.95 7.09 0.18 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m 76.66 -17.23 0.56 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.417 ' ND1' ' HB3' ' A' ' 53' ' ' GLU . 29.6 m80 -77.62 134.98 38.08 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.659 174.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -83.05 157.31 22.93 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 52' ' ' LEU . 2.8 tm? -81.74 -53.74 0.7 Allowed Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.83 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 31.9 Cg_exo -60.3 -15.19 33.57 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 121.845 1.697 . . . . 0.0 113.661 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.751 ' HB2' HD13 ' A' ' 50' ' ' LEU . 32.0 p30 -75.25 -22.64 57.69 Favored 'General case' 0 C--O 1.209 -1.045 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.905 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.79 1.18 36.92 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.362 0.601 . . . . 0.0 110.825 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.84 -43.7 2.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.091 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.11 130.43 35.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.925 0.393 . . . . 0.0 110.947 -174.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.536 HE21 ' HB2' ' A' ' 6' ' ' ALA . 21.5 tm0? -57.82 140.05 52.66 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 124.501 1.12 . . . . 0.0 110.641 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.8 -59.5 0.53 Allowed Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -73.77 -41.04 62.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.7 ' O ' ' HD2' ' A' ' 45' ' ' ARG . 2.7 tmm_? -53.49 -11.44 0.34 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.961 2.104 . . . . 0.0 111.569 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -65.44 100.53 0.5 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.22 98.83 0.84 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.0 -75.24 0.32 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.225 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.34 -54.38 0.79 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.957 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.751 HD13 ' HB2' ' A' ' 38' ' ' ASN . 1.8 pp -85.03 147.46 26.67 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.757 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 30.6 p30 -164.06 166.32 21.51 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.641 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 36' ' ' LEU . 61.2 tp -83.59 123.47 29.81 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' ND1' ' A' ' 34' ' ' HIS . 32.2 tt0 -140.71 130.53 24.41 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.729 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 64.7 p -101.91 151.05 22.56 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' HG12 ' A' ' 149' ' ' VAL . 17.3 t70 -123.8 -54.28 1.74 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.584 -170.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.95 -26.41 25.52 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.192 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -130.39 145.97 51.89 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 117.958 -1.497 . . . . 0.0 111.634 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.25 -31.75 24.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.929 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -68.49 114.96 7.36 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.334 0.587 . . . . 0.0 110.855 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 HD21 ' CD2' ' A' ' 52' ' ' LEU . 17.8 tp -126.05 107.53 10.51 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.408 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD12 HD13 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -107.61 130.71 54.87 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -179.589 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.407 HD11 ' HG ' ' A' ' 60' ' ' LEU . 3.3 mp -127.61 132.87 68.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -113.91 126.19 54.89 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 46.5 mm -107.71 121.23 44.78 Favored Pre-proline 0 N--CA 1.425 -1.694 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.36 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 64' ' ' ILE . 6.3 Cg_exo -77.94 112.59 3.3 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.593 2.196 . . . . 0.0 110.273 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -80.2 164.13 23.5 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 126.065 1.746 . . . . 0.0 113.922 -175.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -106.11 -37.53 6.57 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.069 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -150.62 160.6 43.71 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.64 128.2 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 124.028 0.83 . . . . 0.0 109.323 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -134.44 174.06 13.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 174.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 160' ' ' SER . 38.6 ttpt -97.13 146.8 24.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' HG ' HG21 ' A' ' 133' ' ' VAL . 87.3 mt -78.83 159.11 27.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HA ' ' CE2' ' A' ' 127' ' ' TYR . 13.2 t60 -146.82 -66.02 0.28 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.793 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.9 p -137.77 163.02 32.38 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.821 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 41.7 p90 -140.1 149.06 42.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.99 111.66 8.73 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.745 0.307 . . . . 0.0 110.25 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.7 mt -123.81 120.6 60.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 153' ' ' GLN . 85.2 mttt -96.46 136.38 37.04 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.273 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.574 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -164.39 156.56 28.53 Favored Glycine 1 C--N 1.25 -4.23 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 177.219 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.53 172.49 12.32 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 122.002 1.801 . . . . 0.0 112.887 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -75.98 -24.53 55.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.959 0.885 . . . . 0.0 109.416 177.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.19 -55.14 4.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.0 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -109.18 7.96 25.68 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.703 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.94 158.23 36.41 Favored Glycine 0 C--N 1.305 -1.188 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.272 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.0 Cg_exo -77.12 107.66 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.888 1.725 . . . . 0.0 110.902 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 1.0 OUTLIER -89.19 -51.78 5.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.981 -176.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.7 m -93.44 95.46 9.3 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.715 0.769 . . . . 0.0 109.699 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -98.02 135.04 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.779 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.58 141.82 49.77 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.813 0.816 . . . . 0.0 110.256 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 53.3 m-85 -115.17 145.39 42.44 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.551 ' CZ ' ' HB ' ' A' ' 102' ' ' VAL 0.257 76.2 m-85 -118.12 146.74 43.93 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 178.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -74.14 -158.5 0.07 Allowed 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.651 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -53.21 -20.06 3.67 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.492 1.917 . . . . 0.0 112.862 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -72.33 111.8 7.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.38 161.15 13.79 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 65.35 23.48 12.05 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 111.365 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.451 ' HE2' ' HB3' ' A' ' 97' ' ' MET . 79.7 mtp -68.29 135.41 51.88 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.897 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.472 ' O ' HG13 ' A' ' 102' ' ' VAL . 19.9 p -102.91 174.04 6.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -62.37 -29.14 70.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -87.27 -5.7 58.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -104.4 -19.64 13.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.551 ' HB ' ' CZ ' ' A' ' 91' ' ' PHE . 33.1 m -83.69 2.72 3.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.778 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -88.62 -26.33 21.96 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.993 0.425 . . . . 0.0 111.944 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -110.48 10.22 23.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.796 0.331 . . . . 0.0 111.166 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -124.22 131.68 24.22 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.65 126.93 11.88 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.76 162.03 42.96 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.356 2.037 . . . . 0.0 111.567 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 16.7 m -60.42 -45.36 93.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.038 0.923 . . . . 0.0 108.826 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -167.9 166.18 13.51 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -133.45 128.58 35.76 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.0 172.85 8.21 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.302 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 39.4 tt0 -125.38 138.05 54.04 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.94 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 27.6 tp -70.15 100.87 1.73 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.9 t -91.37 167.61 12.16 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.3 -35.68 67.79 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.69 0.396 . . . . 0.0 111.748 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 121' ' ' LYS . 8.4 tp10 -67.4 -38.84 85.27 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.408 ' HB3' HD12 ' A' ' 113' ' ' LEU . 1.4 t-20 -71.36 -44.41 65.08 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 79' ' ' GLY . 5.1 tt -57.91 -31.81 67.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.527 1.531 . . . . 0.0 109.671 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -85.2 -3.02 58.67 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.02 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HB2' ' HG3' ' A' ' 116' ' ' GLU . 73.2 mmtt -94.24 137.05 22.94 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 18.9 Cg_endo -62.08 115.19 2.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.673 2.915 . . . . 0.0 112.934 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.4 t -96.42 137.71 23.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.68 123.88 32.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.18 176.87 5.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.587 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -94.9 110.5 22.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.063 0.458 . . . . 0.0 110.394 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 73' ' ' HIS . 45.2 p90 -125.41 26.48 6.81 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.47 -33.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.01 0.434 . . . . 0.0 111.463 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -90.42 -32.6 16.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.421 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 56.3 m-85 -90.41 69.94 6.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.814 0.816 . . . . 0.0 112.169 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -88.41 -12.7 42.44 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.79 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -146.2 120.99 9.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.436 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.47 HG21 ' HG ' ' A' ' 72' ' ' LEU . 94.1 t -121.42 104.61 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.139 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -71.78 -50.44 29.83 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.801 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.6 p -134.66 150.72 50.68 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -129.98 135.44 48.3 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.869 0.366 . . . . 0.0 110.511 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 70.2 m -121.95 129.64 52.67 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.7 mp -107.56 121.21 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 74.3 t80 -124.35 125.72 44.8 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.014 0.435 . . . . 0.0 112.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.1 pt -119.51 126.13 75.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.9 pt-20 -108.78 -17.98 13.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.97 22.34 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.253 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -98.15 -174.22 2.79 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -62.08 -63.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.485 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -103.43 -42.22 5.77 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.927 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.79 69.21 0.64 Allowed Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 -174.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.8 m -84.78 16.72 3.14 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.409 0.684 . . . . 0.0 111.329 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 76.2 -43.67 0.48 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.405 1.482 . . . . 0.0 111.9 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 55' ' ' ASP . 11.4 m -102.35 157.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.623 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 59.2 m -121.94 128.68 51.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -129.25 133.58 47.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.001 0.429 . . . . 0.0 110.079 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 7.2 p -134.77 125.36 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 12.1 mm100 -73.68 -47.57 38.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.532 -174.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 147.06 10.31 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -122.74 122.99 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.73 121.42 12.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.05 147.09 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -124.93 118.95 27.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.97 -157.0 11.05 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 38.7 m -152.75 126.22 8.75 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.431 HG23 HG11 ' A' ' 14' ' ' VAL . 24.9 p . . . . . 0 C--N 1.276 -2.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.422 175.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.436 -1.146 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 t -171.6 152.43 3.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.61 134.59 54.64 Favored 'General case' 0 C--O 1.248 0.98 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.47 173.49 6.8 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 121.326 0.584 . . . . 0.0 110.995 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -162.95 141.88 8.61 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.84 80.37 8.5 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.269 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.5 p -101.04 95.04 6.31 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.529 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 67.59 17.56 9.94 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.87 113.09 12.68 Favored Pre-proline 0 C--O 1.243 0.737 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -87.0 170.56 7.14 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.257 1.971 . . . . 0.0 112.855 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -59.62 114.73 2.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.544 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.51 -61.98 0.55 Allowed Glycine 0 N--CA 1.423 -2.202 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.105 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -112.53 -171.86 1.94 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.395 0.617 . . . . 0.0 111.034 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.49 150.48 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 173.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 32.9 t0 -72.29 126.38 29.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 157' ' ' LEU . 59.2 mt -81.06 4.36 20.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' HA ' HD12 ' A' ' 20' ' ' ILE . 5.4 tt -51.42 -35.86 41.14 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.299 1.047 . . . . 0.0 108.411 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.37 -38.93 81.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.21 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.69 -2.46 58.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 17' ' ' LEU . 89.5 mt -74.11 136.98 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 25' ' ' VAL . 16.2 t70 -99.54 112.89 25.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -80.52 1.51 29.18 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -93.05 -35.89 12.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.36 -19.99 61.27 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.756 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 21' ' ' ASP . 28.4 m -54.2 130.89 16.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.756 0.789 . . . . 0.0 112.126 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.7 tp10 -112.06 127.5 55.92 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' HB2' ' OE1' ' A' ' 30' ' ' GLN . 26.4 p -130.26 113.59 14.6 Favored 'General case' 0 N--CA 1.398 -3.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.198 -175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 61' ' ' LEU . 3.2 mm? -72.62 -75.17 0.14 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.299 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.541 HD21 ' HB3' ' A' ' 56' ' ' ALA . 64.2 t30 -116.41 -81.43 0.61 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.561 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.47 ' OE1' ' HB2' ' A' ' 27' ' ' CYS . 3.1 mp0 62.82 23.29 13.9 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 14.4 m 89.52 139.86 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 127.609 2.363 . . . . 0.0 112.675 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.4 t -70.35 -46.36 64.29 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.675 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.3 m -77.45 -35.68 53.66 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.695 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 98.1 m-70 -124.61 149.27 47.25 Favored 'General case' 0 C--O 1.189 -2.102 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -140.98 -168.29 2.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 116.745 -1.982 . . . . 0.0 115.378 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 30' ' ' GLN . 29.8 tp -60.88 -52.47 72.1 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 50.2 Cg_exo -54.47 -32.23 72.4 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.1 1.867 . . . . 0.0 112.751 -172.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.693 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.9 p-10 -84.43 3.43 36.16 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.87 -23.8 3.04 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.936 0.398 . . . . 0.0 112.042 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -105.13 -18.12 14.25 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.116 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -80.28 147.68 31.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -66.09 143.67 57.17 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.32 -37.09 3.03 Favored Glycine 0 N--CA 1.413 -2.882 0 CA-C-N 114.87 -1.059 . . . . 0.0 114.386 170.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -74.6 -25.71 59.44 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.301 0.0 OUTLIER -60.14 67.51 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -160.91 141.76 11.56 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.754 1.622 . . . . 0.0 107.979 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.8 100.43 10.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.646 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.12 17.9 0.76 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.426 0.631 . . . . 0.0 109.931 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.14 -59.92 0.23 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.3 pp -105.19 149.38 25.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.695 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 47.1 t30 -161.72 163.41 29.69 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 60' ' ' LEU . 3.8 tt -105.32 111.98 24.91 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 171.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -141.45 122.34 14.48 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.624 ' HA ' ' OG ' ' A' ' 31' ' ' SER 0.27 36.2 p -51.76 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -171.328 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 18.8 t70 -113.52 88.13 2.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.14 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . 157.4 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.211 2.204 . . . . 0.0 107.987 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -139.03 157.16 46.48 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.986 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -89.02 75.14 8.02 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.422 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.1 pp0? -174.53 139.66 0.58 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.396 1.078 . . . . 0.0 109.139 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.662 ' HB2' HG13 ' A' ' 140' ' ' ILE . 10.3 mp -135.19 147.28 49.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.619 0.768 . . . . 0.0 109.645 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 4.6 tt -149.24 124.44 10.14 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -139.43 135.05 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.552 ' N ' HD13 ' A' ' 62' ' ' ILE . 45.1 t80 -105.78 125.64 51.23 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.93 0.892 . . . . 0.0 110.324 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -116.77 120.73 33.82 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.403 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -97.85 127.43 0.23 Allowed 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 123.054 2.503 . . . . 0.0 110.421 170.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -95.14 139.75 31.04 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.21 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -72.73 -20.57 61.18 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.164 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -147.48 144.47 28.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.77 120.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.684 0.754 . . . . 0.0 111.16 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 168.43 10.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HE2' ' OE1' ' A' ' 131' ' ' GLN . 7.5 mtpm? -96.16 113.62 25.24 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 55.3 tp -71.2 152.5 43.29 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 56.3 t-80 -139.22 -49.57 0.5 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.978 0.418 . . . . 0.0 111.526 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -147.19 167.54 23.92 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 122.036 -0.415 . . . . 0.0 111.91 -175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.588 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 12.3 p90 -129.43 158.21 39.81 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.606 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -151.66 131.94 13.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.868 0.366 . . . . 0.0 111.039 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.411 HG21 ' HG2' ' A' ' 85' ' ' PRO . 67.7 mt -140.19 128.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -104.04 155.63 18.52 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.347 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.26 -178.07 42.61 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 151' ' ' LYS . 15.3 Cg_exo -68.18 159.99 50.76 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 122.91 2.407 . . . . 0.0 110.86 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.09 -29.15 68.02 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 35.1 mt-10 -93.34 -41.53 9.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.42 0.629 . . . . 0.0 111.463 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 15.35 25.88 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.096 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -85.79 150.73 24.43 Favored Glycine 0 C--N 1.307 -1.054 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 47.8 Cg_exo -55.61 160.66 8.97 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.807 2.338 . . . . 0.0 112.646 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.82 -56.31 0.18 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.8 m -80.99 100.05 8.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.861 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 140' ' ' ILE . 48.8 t -123.39 119.72 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.361 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.22 131.12 56.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 109' ' ' ASP 0.253 32.5 p90 -138.26 134.11 33.98 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 177.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -110.25 159.39 17.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 p -148.47 167.54 25.05 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 117.965 0.348 . . . . 0.0 111.838 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.268 19.2 m120 86.48 -24.59 0.12 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 48.7 mtpt -97.92 148.09 23.8 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.889 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.84 134.85 37.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 68.25 94.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.275 1.03 . . . . 0.0 111.365 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.6 mmm -127.41 107.2 9.75 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.652 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.405 ' O ' HG23 ' A' ' 102' ' ' VAL . 22.0 p -98.45 177.99 5.17 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -67.35 -25.87 66.21 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.9 t -56.62 -49.85 73.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.35 -38.89 92.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.958 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 98' ' ' CYS . 82.5 t -64.97 -29.79 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -75.69 -19.87 58.81 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.299 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -104.61 -42.38 5.43 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.32 124.83 47.69 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.953 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.95 135.93 71.9 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.963 2.442 . . . . 0.0 110.882 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.17 167.36 14.58 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.552 2.168 . . . . 0.0 112.383 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -83.14 -44.77 14.72 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 20.0 t70 -143.14 151.02 40.23 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.915 174.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.1 p -115.35 118.21 32.59 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.34 150.73 26.95 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.103 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.98 107.04 10.43 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 8.5 tt -72.21 134.42 45.64 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.197 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.4 p -116.36 169.17 9.51 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.483 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.64 -33.05 72.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.867 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 121' ' ' LYS . 39.1 tt0 -60.17 -40.99 91.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.29 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.606 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.9 t-20 -63.38 -47.18 83.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.621 -177.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.46 -14.26 61.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -87.76 10.32 18.76 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.716 0.77 . . . . 0.0 109.065 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.06 12.7 56.12 Favored Glycine 0 CA--C 1.507 -0.438 0 CA-C-N 114.272 -1.331 . . . . 0.0 114.627 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 12.2 mptt -99.31 117.55 63.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.35 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 67.3 Cg_exo -56.29 119.73 7.11 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.954 3.103 . . . . 0.0 112.481 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 58.5 t -93.01 131.59 39.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 m -83.19 127.45 39.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 121.523 0.678 . . . . 0.0 111.455 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.458 HD12 ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.52 179.03 4.99 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.933 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.59 94.49 6.3 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 20.0 p90 -105.08 12.43 32.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.75 -26.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.539 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.611 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -99.33 14.54 29.28 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.176 175.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.04 74.87 1.18 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.475 ' OE1' ' HE2' ' A' ' 71' ' ' LYS . 28.7 mm-40 -109.1 -37.91 5.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -112.55 114.31 26.9 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 t -122.48 100.88 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.806 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.592 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -87.1 -36.39 18.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 109.766 169.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.9 p -141.84 141.67 33.11 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.598 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 137' ' ' THR . 5.8 tt -140.16 141.48 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.578 ' N ' HD23 ' A' ' 136' ' ' LEU . 35.7 m -127.01 120.64 29.55 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -104.97 122.16 57.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 122.799 0.44 . . . . 0.0 110.405 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -122.59 107.27 11.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.662 HG13 ' HB2' ' A' ' 60' ' ' LEU . 2.0 pp -104.45 141.14 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.512 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -111.13 -25.66 9.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -158.51 158.43 34.03 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.66 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.401 ' HB3' HG23 ' A' ' 150' ' ' THR . 7.1 p30 -99.9 179.4 4.52 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.621 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 85.8 mm-40 -50.12 -59.82 3.55 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.632 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.5 m -91.03 -8.44 49.07 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.203 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.14 42.28 96.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.2 m -88.96 15.64 8.23 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 74.38 -42.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.807 1.243 . . . . 0.0 113.54 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -102.14 105.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.368 1.08 . . . . 0.0 110.576 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 34.5 m -97.02 124.22 40.95 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.109 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.515 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -97.11 133.73 41.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.412 0.625 . . . . 0.0 109.64 177.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.11 107.78 10.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 124.946 1.298 . . . . 0.0 107.742 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -91.12 -32.33 15.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.28 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.565 ' HE3' ' HB2' ' A' ' 156' ' ' ALA . 7.4 tmtm? -152.93 133.49 13.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.2 mt -118.52 136.69 54.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.565 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . . . -144.36 148.59 34.92 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 121.411 0.624 . . . . 0.0 110.643 174.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 2.8 mm? -117.57 127.38 53.92 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.451 ' HB3' ' CB ' ' A' ' 13' ' ' GLN . 61.7 m-85 -108.38 128.81 55.1 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -149.72 -166.73 13.54 Favored Glycine 0 C--N 1.286 -2.218 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -152.92 142.66 22.0 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.309 0.555 . . . . 0.0 110.44 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 117.566 -1.207 . . . . 0.0 109.743 176.535 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 120.727 0.299 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 29.8 p -93.09 81.2 4.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.792 -0.567 . . . . 0.0 110.648 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.58 134.29 5.25 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.6 163.8 21.21 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.587 0.554 . . . . 0.0 110.67 176.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.7 m -159.76 -54.07 0.06 Allowed 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.26 100.78 3.87 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.123 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 p -118.64 162.21 18.78 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.361 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -86.82 79.34 8.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 11' ' ' LYS . 45.9 mm -98.02 119.49 62.02 Favored Pre-proline 0 C--N 1.289 -2.03 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.264 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -91.95 27.1 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.284 2.656 . . . . 0.0 111.214 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 9' ' ' ILE . 88.1 tttt 64.06 112.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.744 1.618 . . . . 0.0 112.028 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.89 -81.21 0.19 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.84 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HG2' ' CD2' ' A' ' 73' ' ' HIS . 2.2 mp0 -100.1 175.48 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 19' ' ' PHE . 17.4 m -107.2 162.54 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 CA-C-O 120.803 0.335 . . . . 0.0 111.406 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.81 118.63 21.77 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.521 HD22 HG13 ' A' ' 70' ' ' ILE . 35.3 mt -69.99 2.52 3.45 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.236 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.58 -42.86 97.55 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.127 0.965 . . . . 0.0 108.651 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.49 -26.1 67.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.016 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HE2' HG21 ' A' ' 14' ' ' VAL . 43.6 m-85 -102.55 22.33 13.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.092 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 2' ' ' SER . 78.6 mt -97.45 126.33 50.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 121.411 -0.116 . . . . 0.0 110.815 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.74 118.05 28.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -90.82 6.82 42.8 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.486 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 m -89.93 -18.72 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 7.31 7.21 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.586 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.18 141.08 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 117.645 0.723 . . . . 0.0 111.538 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -129.61 134.56 47.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.232 0.539 . . . . 0.0 110.144 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . 19.8 p -110.92 114.56 27.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.958 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.9 -68.82 0.32 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.75 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' A' ' 60' ' ' LEU 0.255 7.2 p-10 -104.17 -52.9 2.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.387 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 22.8 tt0 69.36 0.95 3.09 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 122.923 0.489 . . . . 0.0 111.551 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.59 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 79.1 p 73.94 130.29 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 127.472 2.309 . . . . 0.0 110.712 -168.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.7 m -62.35 15.65 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.0 m -138.2 -28.91 0.84 Allowed 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -124.48 165.57 17.55 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.715 -0.616 . . . . 0.0 112.18 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -91.07 -179.44 5.45 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -174.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.546 ' H ' ' HD2' ' A' ' 37' ' ' PRO . 15.8 tp -98.3 -56.8 0.18 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 36' ' ' LEU . 24.7 Cg_endo -58.11 -22.09 54.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.663 2.242 . . . . 0.0 112.584 -175.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.604 HD22 ' HB2' ' A' ' 50' ' ' LEU . 31.7 p-10 -64.83 -30.04 71.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.57 -6.17 12.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.616 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -105.27 -25.23 12.51 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.391 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -81.87 137.24 35.27 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.463 0.649 . . . . 0.0 111.603 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -63.29 134.89 56.58 Favored 'General case' 0 N--CA 1.39 -3.47 0 C-N-CA 125.182 1.393 . . . . 0.0 108.538 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.09 -56.81 1.78 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.666 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.84 -35.74 79.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.896 0.478 . . . . 0.0 111.488 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.486 ' HD2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -54.79 174.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.414 2.375 . . . . 0.0 117.414 -175.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 153' ' ' GLN 0.375 44.3 mt-10 74.34 145.43 0.08 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.751 1.62 . . . . 0.0 115.162 177.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.03 117.88 6.56 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.06 -172.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.57 -68.48 0.26 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.97 -51.39 0.1 OUTLIER Glycine 0 CA--C 1.484 -1.886 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' HD22 ' A' ' 38' ' ' ASN . 3.8 pp -78.87 156.34 28.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.007 -0.597 . . . . 0.0 109.808 174.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -161.38 165.88 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 36' ' ' LEU . 4.7 tt -118.05 116.8 27.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' A' ' 31' ' ' SER . 8.3 pt-20 -109.99 163.03 13.95 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.8 p -52.0 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 O-C-N 123.763 0.664 . . . . 0.0 112.211 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 54' ' ' SER . 13.8 t70 163.59 -156.89 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.67 -24.75 61.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.09 154.86 18.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.992 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.531 ' HB2' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.67 16.75 21.05 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -103.56 104.47 14.54 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' OD1' ' A' ' 29' ' ' ASN . 60.8 tp -114.53 132.62 56.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 62' ' ' ILE . 5.0 tt -137.87 133.83 34.36 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.913 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.485 ' N ' HD23 ' A' ' 61' ' ' LEU . 3.3 mp -133.76 132.18 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -100.94 129.18 46.75 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 20' ' ' ILE . 3.0 mp -120.98 124.02 27.62 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.582 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -95.64 157.64 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.977 2.451 . . . . 0.0 110.815 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.413 ' H ' ' HD1' ' A' ' 66' ' ' PHE . 8.7 p90 -84.52 162.24 19.93 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.497 1.141 . . . . 0.0 113.438 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -97.82 -47.91 5.39 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.881 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -133.46 149.25 51.76 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.661 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.45 116.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.521 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -129.95 173.06 14.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -91.9 143.63 26.3 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.44 158.02 21.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.485 ' CD2' ' HG2' ' A' ' 13' ' ' GLN . 57.5 t60 -148.76 -63.77 0.24 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.3 p -143.7 165.71 26.9 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.724 -171.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 4.9 p90 -133.51 159.25 40.98 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.609 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -151.98 100.13 2.62 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 120.914 0.388 . . . . 0.0 111.802 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 64.8 mt -102.62 136.13 36.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 55.2 mtpt -118.49 144.09 46.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.454 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.414 ' HA2' ' HG3' ' A' ' 153' ' ' GLN . . . -165.23 -178.74 38.64 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 22.4 Cg_exo -69.29 157.23 62.06 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.202 1.935 . . . . 0.0 110.29 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 mt-10 -62.0 -35.92 79.98 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.54 -48.22 6.2 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 43.7 mt-10 -80.1 20.44 0.65 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.631 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.62 167.5 24.55 Favored Glycine 0 C--N 1.301 -1.416 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.274 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 35.9 Cg_endo -76.79 178.97 6.95 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 121.835 1.69 . . . . 0.0 111.012 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 144' ' ' GLN . 3.1 tmmm? -144.26 -61.85 0.38 Allowed 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.608 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.41 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 51.3 m -80.43 103.45 10.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.55 116.51 51.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.436 -175.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -107.66 135.84 48.41 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.547 0.689 . . . . 0.0 111.111 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.41 134.76 53.76 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.53 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.0 m-85 -124.57 115.57 21.06 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 175.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' CE1' ' A' ' 130' ' ' PHE . 20.4 m -110.92 150.57 29.03 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m120 82.08 154.68 0.12 Allowed 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.801 1.313 . . . . 0.0 108.39 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.649 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER 67.68 100.87 0.05 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.649 0.737 . . . . 0.0 110.287 -175.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.63 140.16 38.45 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.527 0.68 . . . . 0.0 112.056 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 67.45 89.58 0.1 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 125.664 1.586 . . . . 0.0 111.839 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 81.8 mtp -119.86 142.37 48.72 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.467 ' O ' ' HB ' ' A' ' 102' ' ' VAL . 59.9 m -128.98 176.39 7.91 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -56.9 -20.42 23.16 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.0 m -81.5 -50.26 9.61 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.695 -0.628 . . . . 0.0 111.31 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -95.57 6.65 48.42 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.894 0.378 . . . . 0.0 111.529 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 11.4 p -59.31 -37.35 68.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 123.823 0.849 . . . . 0.0 112.222 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -108.78 16.82 22.48 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.782 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -86.51 -20.98 27.24 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.064 0.935 . . . . 0.0 109.06 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -113.41 138.7 22.59 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.106 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.46 138.05 68.47 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.698 2.265 . . . . 0.0 112.538 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.23 152.67 45.16 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.4 2.066 . . . . 0.0 111.875 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -61.71 -45.58 93.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -167.98 168.96 11.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -128.59 123.19 32.72 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.41 169.05 10.36 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.365 0.603 . . . . 0.0 111.777 -174.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.6 mp0 -120.31 127.46 52.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.42 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.403 HD21 HD21 ' A' ' 118' ' ' LEU . 29.9 tp -72.48 110.89 7.19 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.9 t -101.0 174.46 6.0 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.65 -34.8 74.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.758 0.823 . . . . 0.0 110.641 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.21 -32.55 68.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.997 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.609 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.3 t-20 -68.81 -34.27 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 96.9 mt -62.2 2.68 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.493 1.517 . . . . 0.0 113.26 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.1 -14.11 12.97 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.472 1.109 . . . . 0.0 108.944 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.5 1.89 43.77 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.999 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -75.55 126.32 87.6 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.75 121.53 8.77 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.408 2.739 . . . . 0.0 114.067 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 57.7 t -99.04 141.37 16.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.62 144.01 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -131.9 -174.75 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.046 0.938 . . . . 0.0 111.745 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -82.39 115.74 21.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -138.63 15.03 2.73 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.434 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.22 -38.51 81.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.181 0.515 . . . . 0.0 110.429 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -95.0 2.36 55.33 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 92' ' ' SER . 76.6 m-85 -117.78 66.32 0.75 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.653 0.74 . . . . 0.0 111.737 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.83 1.91 53.43 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 0.0 109.483 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -148.2 116.07 6.39 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.78 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.8 t -116.88 137.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.444 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -116.98 -55.84 2.31 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.288 1.035 . . . . 0.0 108.802 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.0 p -118.57 139.21 51.83 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.8 tp -135.35 111.95 9.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.874 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 29.3 m -102.64 121.62 42.77 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.81 116.73 49.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 61.1 t80 -122.83 119.62 31.11 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.466 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.3 pp -108.9 131.41 59.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 12.9 pt-20 -119.86 -14.92 8.92 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.803 -0.759 . . . . 0.0 113.01 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB3' ' CB ' ' A' ' 87' ' ' THR . . . -134.69 145.8 48.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.531 HD21 ' HB2' ' A' ' 58' ' ' GLU . 87.2 m-20 -101.79 169.14 8.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 7.7 tp60 -62.94 -56.08 20.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.876 0.735 . . . . 0.0 109.167 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.9 t -122.05 9.52 9.94 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.315 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.469 ' HA2' ' HB2' ' A' ' 143' ' ' ASN . . . 62.29 67.59 2.03 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.0 m -100.74 9.2 42.71 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 68.22 -55.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.49 1.116 . . . . 0.0 111.478 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 53' ' ' GLU . 49.1 t -102.46 108.05 23.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 62.9 m -102.04 111.43 23.7 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.245 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 64.1 pttt -96.49 134.09 40.11 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.913 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.83 136.47 39.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.117 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 79.3 mt-30 -87.42 -51.87 5.69 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.57 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -162.01 149.25 14.1 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.546 178.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.3 112.86 35.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.64 137.08 29.73 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 5.7 mp -112.05 159.55 18.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 56.1 m-85 -125.72 132.84 52.28 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -153.52 -149.96 5.32 Favored Glycine 0 C--N 1.299 -1.5 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.515 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 46.3 m -157.87 161.33 38.3 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 70' ' ' ILE . 66.9 p . . . . . 0 C--N 1.279 -2.488 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.384 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.2 p -159.21 163.68 35.72 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.05 -177.9 6.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.494 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -86.8 -72.69 0.5 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.016 0.436 . . . . 0.0 111.439 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p -87.12 90.25 8.29 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.151 0.501 . . . . 0.0 111.669 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.76 92.36 3.13 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.063 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.2 p -165.31 135.7 3.74 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.049 0.452 . . . . 0.0 111.635 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.587 ' H ' HD12 ' A' ' 9' ' ' ILE . 5.4 tp60 -152.36 35.97 0.52 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.587 HD12 ' H ' ' A' ' 8' ' ' GLN . 2.2 mp -72.87 124.75 91.09 Favored Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.388 -174.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 3.5 Cg_exo -72.92 -69.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.271 1.981 . . . . 0.0 111.808 175.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -162.08 -68.73 0.05 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.94 -10.99 82.19 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.241 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.72 134.21 50.72 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -174.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 p -105.9 153.69 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.818 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.97 120.62 12.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.45 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.5 mt -93.96 10.19 34.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.479 ' HG ' ' NH2' ' A' ' 45' ' ' ARG . 3.4 tm? -64.97 -36.66 85.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.493 0.663 . . . . 0.0 110.922 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -85.52 1.77 47.57 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.237 1.017 . . . . 0.0 110.498 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 m-85 -101.15 7.47 43.16 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.404 HD12 HD22 ' A' ' 17' ' ' LEU . 70.6 mt -89.97 133.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.332 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.58 113.8 23.61 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -85.04 -0.54 54.77 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.855 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.9 m -87.3 -36.79 17.67 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.7 -13.2 32.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.207 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 64' ' ' ILE . 14.5 p -54.93 132.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 117.166 0.483 . . . . 0.0 110.626 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 32.6 tt0 -145.05 159.57 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.066 0.46 . . . . 0.0 110.054 -177.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 53.2 t -135.78 135.61 40.05 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -60.27 -57.86 10.97 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.323 1.015 . . . . 0.0 108.543 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.7 -64.19 0.91 Allowed 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 70.27 -52.31 0.65 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.988 1.315 . . . . 0.0 114.274 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 48.0 m -155.86 87.63 1.08 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -175.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.0 p -67.17 -29.34 69.01 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.976 162.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.2 m -154.49 -57.49 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.154 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.514 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.5 m-70 -88.0 162.38 16.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.0 m -112.1 174.79 5.71 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.45 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -67.82 -58.14 8.61 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 26.8 Cg_exo -63.02 -17.92 62.63 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.973 1.782 . . . . 0.0 112.455 -174.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.0 m-20 -56.82 -46.58 81.55 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.736 1.214 . . . . 0.0 112.238 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 45' ' ' ARG . . . -104.32 2.66 31.66 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.42 0.628 . . . . 0.0 111.458 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -105.31 -44.46 4.73 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -79.94 123.69 28.01 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -173.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -55.36 117.71 3.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.935 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.54 -45.76 1.1 Allowed Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.47 ' HB3' HD11 ' A' ' 50' ' ' LEU . 63.2 m-85 -95.58 -51.49 4.51 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HD3' ' HG2' ' A' ' 154' ' ' LYS . 89.6 mtt-85 22.7 -83.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 176.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 153' ' ' GLN . 41.9 mt-10 -61.91 134.71 57.01 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -166.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.471 ' H ' ' HB2' ' A' ' 153' ' ' GLN . 10.2 t70 -59.86 110.26 1.13 Allowed 'General case' 0 C--O 1.249 1.067 0 CA-C-N 113.121 -1.854 . . . . 0.0 110.328 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.71 -73.15 0.15 Allowed 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.56 -30.27 4.13 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.477 ' HB2' HD22 ' A' ' 38' ' ' ASN . 2.3 pp -132.21 148.19 52.45 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.014 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 29.8 p-10 -162.56 167.81 22.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 36' ' ' LEU . 40.9 tp -91.41 116.57 28.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 168.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.479 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 33.8 tt0 -136.69 112.57 9.57 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.599 0.714 . . . . 0.0 109.881 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.62 ' HB2' HD13 ' A' ' 60' ' ' LEU . 31.8 t -94.79 101.88 13.72 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.816 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.3 -30.44 11.07 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.033 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.36 72.4 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.047 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.99 160.75 22.89 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.86 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.469 ' O ' HD11 ' A' ' 140' ' ' ILE . 43.7 tt0 -92.6 -31.7 15.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -77.32 118.35 19.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.071 -174.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 54' ' ' SER . 23.7 tp -116.31 116.28 27.46 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 6.8 tt -118.95 128.83 54.78 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 57.2 mt -127.59 144.94 35.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 122.951 0.501 . . . . 0.0 109.718 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HE1' ' O ' ' A' ' 94' ' ' LYS . 83.9 t80 -117.26 126.86 53.42 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.959 0.504 . . . . 0.0 110.362 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 25' ' ' VAL . 45.2 mm -120.97 121.58 28.75 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.911 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.79 127.13 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.735 2.29 . . . . 0.0 109.55 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -93.0 141.31 28.54 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -51.89 -50.17 61.56 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.754 2.022 . . . . 0.0 109.623 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -130.58 159.6 36.69 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.389 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 7.3 p -83.26 108.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.45 172.98 12.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.516 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -95.24 132.33 40.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.6 tp -78.04 143.99 37.0 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -129.93 -54.2 1.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.144 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' HD22 ' A' ' 125' ' ' LEU . 16.1 p -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -117.72 158.14 25.25 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -153.53 105.44 2.83 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.835 0.35 . . . . 0.0 111.851 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.531 HG23 HG12 ' A' ' 155' ' ' ILE . 55.5 mt -120.39 130.21 74.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 96.4 mttt -104.97 143.24 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.23 32.5 Favored Glycine 0 C--N 1.257 -3.834 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.7 139.42 48.2 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 121.492 1.461 . . . . 0.0 108.936 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.628 ' HA ' HD11 ' A' ' 118' ' ' LEU . 11.9 pt-20 -58.68 -25.63 63.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.969 0.414 . . . . 0.0 112.069 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.53 -57.08 4.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.898 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 4.4 mm-40 -81.46 -59.62 2.56 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.905 -170.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.19 119.41 0.0 OUTLIER Glycine 0 N--CA 1.506 3.303 0 C-N-CA 127.326 2.394 . . . . 0.0 118.158 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.654 ' HA ' ' OD1' ' A' ' 143' ' ' ASN . 56.8 Cg_endo -69.29 112.18 2.92 Favored 'Trans proline' 0 C--N 1.356 0.958 0 CA-C-N 119.932 1.866 . . . . 0.0 110.06 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 112' ' ' GLU . 30.5 ttmt -90.39 -75.37 0.46 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.071 -171.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.71 102.25 3.29 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.235 -174.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG12 HG22 ' A' ' 140' ' ' ILE . 34.2 m -104.68 117.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.845 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HG3' ' OG1' ' A' ' 110' ' ' THR . 25.7 ttmm -107.11 132.83 52.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -112.69 139.02 48.64 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.54 155.55 19.97 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -77.97 -171.04 2.14 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.125 0.891 . . . . 0.0 110.926 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' SER . 8.9 p30 -57.22 104.4 0.16 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 111.512 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.417 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 55.3 tptt -163.51 164.8 24.21 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 96' ' ' HIS . 41.3 tt0 -75.95 174.01 10.5 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.467 ' H ' ' HG2' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -48.76 137.09 12.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.509 ' HB2' HG21 ' A' ' 137' ' ' THR . 18.5 mmt -93.8 173.53 7.63 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.226 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.513 ' O ' HG13 ' A' ' 102' ' ' VAL . 75.6 m -149.36 155.55 40.66 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -55.99 -24.65 40.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.4 t -85.09 -6.41 59.31 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -116.72 -15.99 10.7 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 98' ' ' CYS . 29.0 m -67.64 -3.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -97.18 -19.4 18.66 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.398 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -89.33 -37.32 14.98 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.746 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 93.5 m-85 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.302 -1.47 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.138 -175.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 13.3 Cg_exo -70.13 128.72 16.07 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.741 2.294 . . . . 0.0 111.216 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.31 165.23 29.73 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.548 2.165 . . . . 0.0 111.521 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 22.4 m -76.48 -47.48 22.74 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -162.72 169.09 20.57 Favored 'General case' 0 CA--C 1.471 -2.09 0 C-N-CA 123.513 0.725 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 40.9 m -146.2 114.43 6.64 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.29 172.87 8.32 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HB2' ' HG2' ' A' ' 86' ' ' LYS . 11.7 pt-20 -125.35 139.67 53.48 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 86' ' ' LYS . 22.4 tp -59.79 113.2 2.15 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.703 0.801 . . . . 0.0 108.903 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.1 p -85.25 166.4 16.55 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 115' ' ' GLU . 4.1 mp0 -57.74 -39.21 76.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.46 -38.62 77.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.72 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.594 HD22 HG23 ' A' ' 123' ' ' VAL . 8.8 t-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 81' ' ' GLU . 7.5 tt -62.22 -23.33 66.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.115 1.366 . . . . 0.0 110.671 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.477 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 58.2 mtpt -102.52 1.9 35.61 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.47 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.54 68.04 0.87 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.812 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.402 ' HD2' ' HD2' ' A' ' 122' ' ' PRO . 52.3 tptt -137.39 117.58 10.48 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.501 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 15.0 Cg_endo -58.17 101.64 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.379 2.053 . . . . 0.0 111.886 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 117' ' ' ASN . 53.3 t -85.43 126.71 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 m -83.35 144.22 10.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.526 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 74' ' ' SER . 1.2 mm? -98.71 -173.44 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.409 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.99 141.4 34.46 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -96.19 27.45 3.69 Favored 'General case' 0 C--N 1.281 -2.374 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.655 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.32 -49.89 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 108' ' ' SER . 27.5 tptp -95.4 -6.13 41.64 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.79 15.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.22 121.9 14.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.325 20.9 p-10 42.97 112.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 127.221 2.208 . . . . 0.0 114.765 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 44.4 t -121.53 104.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.735 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -99.49 -28.45 13.24 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 59.9 m -143.2 151.17 40.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 137' ' ' THR . 5.6 tt -146.33 138.42 25.01 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 97' ' ' MET . 60.6 m -118.04 133.07 56.25 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 64.1 mt -108.18 122.86 63.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.33 116.85 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 58' ' ' GLU 0.267 2.0 pp -90.37 138.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 117.749 -1.58 . . . . 0.0 111.079 176.389 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -94.47 -48.46 6.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.936 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.85 159.78 43.85 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.071 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.654 ' OD1' ' HA ' ' A' ' 85' ' ' PRO . 94.3 m-20 -109.11 167.13 10.33 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -47.6 -53.14 15.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 111.558 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.3 t -112.93 4.15 16.65 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.541 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.95 62.51 6.28 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -83.88 8.1 16.03 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 65.68 7.09 4.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 112.949 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.68 155.73 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 93.2 m -121.58 111.39 17.17 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.478 0.656 . . . . 0.0 110.736 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.41 149.04 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 20.6 pt20 -118.1 -5.08 10.96 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.562 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -172.79 118.66 0.34 Allowed 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.398 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.531 HG12 HG23 ' A' ' 77' ' ' ILE . 68.4 mt -114.73 124.85 71.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.11 152.07 41.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.32 147.47 51.86 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 81.9 m-85 -124.38 133.71 53.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.59 -173.23 13.06 Favored Glycine 0 CA--C 1.489 -1.531 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.8 m -134.23 135.32 42.87 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.253 0.549 . . . . 0.0 110.862 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.421 -1.905 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.526 179.114 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.445 -0.715 0 CA-C-O 121.005 0.431 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 p -91.43 94.77 9.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.07 116.67 7.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.041 0.448 . . . . 0.0 112.045 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.44 144.37 49.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 39.8 t -105.46 137.05 43.91 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.09 119.42 14.26 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.9 m -40.17 103.65 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 124.966 1.306 . . . . 0.0 114.507 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -94.74 21.29 7.6 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 11' ' ' LYS . 39.5 mm -56.11 113.66 6.2 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.456 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -89.79 11.91 2.71 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.58 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' H ' HG22 ' A' ' 9' ' ' ILE . 39.7 ttmt 65.96 97.02 0.05 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.882 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.61 -63.27 0.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -112.87 176.07 5.17 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 16' ' ' LEU . 34.1 m -106.23 169.63 2.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -84.09 95.96 8.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.861 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 157' ' ' LEU . 5.7 mp -74.79 -2.41 26.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.1 tt -74.06 -36.91 64.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 16.1 t70 -66.25 -21.14 66.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.998 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -97.21 12.2 33.71 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.022 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 16' ' ' LEU . 74.3 mt -84.13 131.63 33.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.47 124.54 35.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.693 0.759 . . . . 0.0 110.887 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -103.74 19.23 20.28 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.854 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 m -93.12 -30.89 15.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.94 3.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.839 -1.172 . . . . 0.0 114.133 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.0 135.89 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.63 148.91 36.53 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.195 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HB3' ' HG2' ' A' ' 30' ' ' GLN . 47.7 t -135.87 140.66 44.29 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 97' ' ' MET . 91.1 mt -79.35 19.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.431 0.634 . . . . 0.0 111.808 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -154.9 -60.47 0.11 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.67 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 47.9 mt-30 67.39 14.5 9.67 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 124.116 0.966 . . . . 0.0 109.86 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.67 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 3.2 m 74.75 135.03 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.219 1.808 . . . . 0.0 109.447 -174.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.429 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 33.1 t -66.83 -46.93 73.56 Favored 'General case' 0 CA--C 1.559 1.313 0 O-C-N 121.415 -0.803 . . . . 0.0 111.577 175.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.5 t -89.82 -47.1 8.12 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.108 0.956 . . . . 0.0 111.151 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.67 ' O ' ' HB2' ' A' ' 31' ' ' SER . 54.0 m80 -83.05 166.91 18.36 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 125.054 1.342 . . . . 0.0 111.146 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 m -110.49 169.5 8.71 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.914 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 4.1 tt -65.12 -57.61 14.96 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.022 0.529 . . . . 0.0 111.68 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 5.7 Cg_exo -78.64 -1.83 11.94 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 121.848 1.699 . . . . 0.0 111.296 -176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.488 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.0 t-20 -49.12 -48.45 44.58 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 125.515 1.526 . . . . 0.0 109.648 -176.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . . . -142.24 78.68 1.63 Allowed 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.764 0.793 . . . . 0.0 110.036 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.0 tp -168.26 -38.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.776 -1.557 . . . . 0.0 106.846 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 10.7 tmtt? -90.66 133.45 35.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.418 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 14.9 mm100 -53.28 142.55 20.84 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.48 -37.57 3.44 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.218 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' HD11 ' A' ' 50' ' ' LEU . 68.6 m-85 -89.72 -43.2 10.87 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 38.0 ttp180 -43.49 117.32 1.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.948 1.699 . . . . 0.0 113.206 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -177.53 137.42 0.21 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.78 91.86 8.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.881 0.372 . . . . 0.0 111.924 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -151.6 -71.67 0.16 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.018 0.927 . . . . 0.0 109.577 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -56.8 0.5 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.451 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 38' ' ' ASN . 2.3 pp -89.11 142.21 27.84 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.106 0.479 . . . . 0.0 111.884 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.595 ' HA ' ' CB ' ' A' ' 39' ' ' ALA . 6.3 p30 -163.49 165.65 23.49 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.505 ' CD2' HD21 ' A' ' 60' ' ' LEU . 3.3 tt -88.07 126.83 35.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 171.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 44.8 tt0 -128.99 143.17 50.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 90.5 p -78.01 82.26 4.37 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 32' ' ' SER . 38.9 t70 -117.13 96.52 5.48 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.352 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 148.7 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 128.075 2.55 . . . . 0.0 104.878 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 54' ' ' SER . 10.7 t70 -157.75 155.35 29.71 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.676 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.18 -21.13 39.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.003 0.43 . . . . 0.0 110.652 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.81 109.7 17.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.527 HD23 HD11 ' A' ' 140' ' ' ILE . 27.8 tp -116.81 117.51 29.96 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.427 0.632 . . . . 0.0 110.487 -174.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.534 HD11 ' O ' ' A' ' 96' ' ' HIS . 1.8 tm? -107.21 124.38 49.65 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.506 HG13 ' SG ' ' A' ' 27' ' ' CYS . 2.0 mp -127.01 134.58 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -103.54 121.57 43.16 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.575 0.75 . . . . 0.0 109.095 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.42 120.17 29.05 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.151 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.02 154.54 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.749 2.299 . . . . 0.0 109.574 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -112.19 152.34 28.49 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -62.73 -50.63 70.33 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.586 1.554 . . . . 0.0 108.084 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -127.51 143.13 51.22 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.671 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.86 112.18 13.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -134.32 173.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.193 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.54 143.24 30.31 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.239 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.442 HD13 HD23 ' A' ' 157' ' ' LEU . 57.8 tp -92.32 105.56 17.74 Favored 'General case' 0 C--O 1.19 -2.057 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -96.37 -54.62 3.2 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.979 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 p -145.44 161.87 38.67 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.844 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' CE1' HD11 ' A' ' 125' ' ' LEU . 2.7 p90 -131.97 157.66 43.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.534 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -143.0 114.44 7.95 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.209 0.604 . . . . 0.0 109.773 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.5 mt -113.21 129.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.513 ' HE2' ' C ' ' A' ' 119' ' ' LYS . 68.2 mttt -117.2 157.98 25.07 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.481 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.03 -152.79 20.89 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 15.0 Cg_exo -72.11 152.38 56.51 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.201 1.934 . . . . 0.0 109.533 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.55 -38.93 81.22 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 144' ' ' GLN . 42.5 mt-10 -94.69 -34.7 12.46 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 5.0 mp0 -93.78 11.58 28.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.491 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.8 150.42 25.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.157 -0.802 . . . . 0.0 111.636 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 23.6 Cg_exo -63.05 113.92 2.23 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.436 2.757 . . . . 0.0 113.375 -175.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HD3' ' HG3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -104.31 -49.5 3.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -176.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.5 m -83.11 100.52 10.57 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.818 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.9 t -115.57 122.98 70.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.959 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -115.73 133.79 55.67 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 92.0 m-85 -111.96 152.1 28.47 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 25.4 t80 -140.68 117.06 10.72 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 172.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 m -91.61 138.2 31.75 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 47.95 81.91 0.04 OUTLIER 'General case' 0 C--O 1.244 0.775 0 C-N-CA 126.171 1.788 . . . . 0.0 113.965 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -171.51 170.72 5.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -81.43 175.7 10.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' HD11 ' A' ' 61' ' ' LEU . 33.1 p80 -44.67 -40.65 6.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.46 ' O ' HD11 ' A' ' 28' ' ' LEU . 87.1 mtp 61.6 -165.75 0.22 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.502 ' O ' HG23 ' A' ' 102' ' ' VAL . 30.8 p -150.06 163.81 37.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 42.0 p90 -68.98 -17.89 63.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -67.47 -20.2 65.44 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -103.76 -31.66 9.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.603 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 98' ' ' CYS . 95.9 t -59.57 -29.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.21 -7.22 58.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.28 -38.45 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.81 0.338 . . . . 0.0 111.557 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -95.75 137.57 21.87 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.138 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.3 131.08 27.13 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.452 2.101 . . . . 0.0 111.508 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.37 161.17 38.07 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.414 2.076 . . . . 0.0 111.487 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . 28.5 m -61.78 -46.02 91.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 110.03 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.11 143.43 15.42 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -104.85 115.03 29.6 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.52 152.59 24.53 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.465 ' HG3' ' HD3' ' A' ' 86' ' ' LYS . 35.0 tt0 -125.62 118.35 25.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.229 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 20.8 tp -61.86 105.17 0.53 Allowed 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -92.64 170.57 9.63 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.505 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 42.9 tt0 -54.98 -46.09 75.07 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.767 0.427 . . . . 0.0 111.276 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -64.85 -34.66 78.91 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.4 t-20 -61.65 -44.59 96.69 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 tm? -65.36 -32.77 74.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.314 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.513 ' C ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -84.77 9.96 12.69 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.35 31.3 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 115.149 0.819 . . . . 0.0 115.149 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -93.4 132.74 29.65 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 117.648 0.724 . . . . 0.0 111.338 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 26.5 Cg_endo -65.37 117.33 4.49 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 123.208 2.605 . . . . 0.0 112.471 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.87 130.74 44.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.78 133.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 122.956 0.502 . . . . 0.0 111.236 -174.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.464 HD11 ' CE1' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -100.0 175.1 5.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 126' ' ' LYS . 8.5 mmpt? -86.15 49.05 1.71 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -74.69 25.62 0.09 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -170.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.8 m -57.02 -27.49 27.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -95.24 -41.18 9.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.491 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 28.0 m-85 -72.13 84.42 1.02 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.054 -173.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.55 -11.36 14.07 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.245 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -124.37 113.85 18.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.494 0.664 . . . . 0.0 109.846 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 72' ' ' LEU . 47.1 t -123.31 105.74 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.17 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -104.9 -32.1 8.95 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.9 m -135.93 135.25 39.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.431 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.2 tp -135.65 126.36 27.26 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.877 0.37 . . . . 0.0 110.085 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.6 m -94.2 117.01 29.49 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.27 115.84 50.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 141' ' ' GLU . 48.5 t80 -114.39 114.88 26.47 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 60' ' ' LEU . 28.2 pt -104.12 114.85 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.881 0.848 . . . . 0.0 109.277 174.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.453 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 43.6 tt0 -90.78 -28.38 18.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.66 -172.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -162.25 154.83 19.62 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.271 -177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -89.63 175.95 7.06 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.006 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.45 ' HB3' ' O ' ' A' ' 82' ' ' GLU . 64.6 tp60 -51.12 -43.89 61.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.432 1.093 . . . . 0.0 112.909 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m -96.59 -37.68 10.27 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.515 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.92 42.62 3.03 Favored Glycine 0 C--N 1.302 -1.345 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.8 m -85.47 13.95 6.14 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.326 1.05 . . . . 0.0 112.655 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 74.93 -34.87 0.27 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.823 1.649 . . . . 0.0 111.625 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.1 p -100.69 98.69 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-O 122.315 1.055 . . . . 0.0 110.471 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.7 m -92.25 113.71 26.06 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.418 ' HE3' ' ND2' ' A' ' 51' ' ' ASN . 86.7 tttt -113.96 135.23 54.22 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.018 -174.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.69 137.2 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.309 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 11.7 pt20 -96.7 -28.64 14.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.19 177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -171.23 150.9 3.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.02 111.95 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.404 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -107.69 147.12 31.16 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 4.7 mp -123.34 143.91 49.79 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 67.9 m-85 -125.68 137.94 53.87 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -166.39 -140.62 2.93 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.6 t -162.83 149.9 13.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.423 -1.813 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.951 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.2 p . . . . . 0 C--O 1.243 0.717 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 m -105.77 114.1 28.05 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.99 110.14 22.21 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -96.88 173.79 7.11 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.194 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.8 t -155.07 123.97 6.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 120.863 0.363 . . . . 0.0 111.743 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.76 115.47 25.23 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 172.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.6 t -148.78 -179.85 7.3 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -81.31 97.26 7.6 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-O 121.675 0.75 . . . . 0.0 109.158 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.6 mm -93.64 127.64 45.14 Favored Pre-proline 0 N--CA 1.396 -3.169 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -85.5 136.43 5.48 Favored 'Trans proline' 0 N--CA 1.427 -2.42 0 C-N-CA 121.715 1.61 . . . . 0.0 111.191 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -50.64 113.49 0.91 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 112.155 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.13 8.36 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.51 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.19 147.36 34.76 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 117.25 0.525 . . . . 0.0 111.373 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.93 149.14 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.97 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.83 134.42 39.07 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.2 mm? -62.87 -14.04 41.29 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.373 1.069 . . . . 0.0 113.813 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 41' ' ' LYS . 2.1 tm? -51.32 -36.4 42.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.499 0.666 . . . . 0.0 109.93 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.27 -26.25 60.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.214 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -107.67 34.35 3.58 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.8 mm -116.4 145.1 22.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.056 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -96.23 131.59 42.55 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -104.38 8.85 35.89 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -97.3 -34.96 10.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' C ' ' HG3' ' A' ' 65' ' ' PRO . . . -89.22 -4.86 73.71 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.458 -0.792 . . . . 0.0 114.05 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -53.59 143.43 5.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -142.55 139.62 31.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.136 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 30' ' ' GLN . 5.5 p -135.61 128.85 31.93 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.891 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.657 HD23 HD12 ' A' ' 61' ' ' LEU . 2.7 mm? -91.92 123.71 35.5 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.502 HD21 ' HB3' ' A' ' 56' ' ' ALA . 47.3 t-20 76.26 -59.78 0.5 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.759 1.624 . . . . 0.0 108.263 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 34.2 tt0 73.14 -74.77 0.08 Allowed 'General case' 0 C--N 1.37 1.474 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p 174.16 115.95 0.02 OUTLIER 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.4 t -48.91 -37.23 19.18 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -100.63 -42.63 6.46 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.725 -0.609 . . . . 0.0 111.233 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -85.13 166.57 16.51 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -106.96 152.94 23.28 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.644 ' HA ' HD13 ' A' ' 52' ' ' LEU . 3.1 tm? -54.47 -57.89 16.59 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.82 -17.06 58.36 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.183 1.922 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.538 HD22 ' HB2' ' A' ' 50' ' ' LEU . 3.1 m-20 -58.75 -27.55 65.05 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 113.086 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . . . -133.04 15.71 4.21 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.206 0.526 . . . . 0.0 110.749 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -112.29 -43.16 3.57 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.21 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.448 ' HA ' HD21 ' A' ' 17' ' ' LEU . 16.0 ptpt -98.28 137.58 36.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.353 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.19 121.62 14.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.97 -64.64 0.44 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.501 ' O ' HD11 ' A' ' 50' ' ' LEU . 59.0 m-85 -77.04 -39.79 48.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 26.4 ttp180 -37.35 103.58 0.03 OUTLIER 'General case' 0 C--O 1.243 0.739 0 C-N-CA 126.106 1.762 . . . . 0.0 113.324 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -164.65 89.27 0.51 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -57.96 104.32 0.19 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.889 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 178.1 -67.55 0.01 OUTLIER 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.308 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.17 -59.06 0.73 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' O ' HD12 ' A' ' 50' ' ' LEU . 3.5 pp -104.25 120.9 42.18 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.788 0.804 . . . . 0.0 110.006 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.472 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 3.0 p-10 -161.48 165.63 28.37 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.644 HD13 ' HA ' ' A' ' 36' ' ' LEU . 26.6 tp -91.65 112.42 24.33 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -131.71 113.46 13.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.592 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 35.6 p -74.4 82.22 1.92 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.059 0.933 . . . . 0.0 110.237 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.49 -30.55 29.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.893 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.502 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . -69.23 -35.68 76.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 54' ' ' SER . 19.1 t70 -171.47 156.42 4.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.619 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.2 tt0 -80.49 -11.69 59.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.911 0.884 . . . . 0.0 112.545 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.89 112.94 17.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -127.14 136.16 51.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.403 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.657 HD12 HD23 ' A' ' 28' ' ' LEU . 1.6 tm? -131.39 126.22 34.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.3 mp -128.12 134.64 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.659 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 49.4 t80 -103.7 128.1 51.08 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 123.708 0.803 . . . . 0.0 110.187 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.417 ' CG2' HD12 ' A' ' 20' ' ' ILE . 49.5 mm -120.94 124.03 27.63 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 78.2 Cg_endo -92.37 159.96 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 123.29 2.66 . . . . 0.0 110.365 171.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.401 ' H ' ' HD1' ' A' ' 66' ' ' PHE . 4.3 p90 -95.23 154.88 16.97 Favored 'General case' 0 CA--C 1.459 -2.553 0 CA-C-O 122.568 1.175 . . . . 0.0 113.919 -174.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -88.05 -42.89 12.1 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 112.877 -1.965 . . . . 0.0 106.968 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -150.65 139.07 20.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -73.17 124.68 30.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-O 121.639 0.733 . . . . 0.0 111.643 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.15 174.59 11.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -92.51 138.68 31.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -79.35 144.16 34.46 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -136.07 -45.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.928 -0.483 . . . . 0.0 111.807 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.6 m -151.38 175.92 11.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.391 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -135.62 152.46 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -158.87 107.65 1.91 Allowed 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 77' ' ' ILE . 2.3 mp -107.38 132.58 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HE2' ' CA ' ' A' ' 120' ' ' GLY . 90.9 mttt -117.69 167.5 11.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.337 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.37 -168.25 34.14 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HG3' ' HG3' ' A' ' 151' ' ' LYS . 41.9 Cg_endo -68.76 149.43 73.06 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 122.262 1.974 . . . . 0.0 111.214 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.53 -26.37 66.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.01 -55.92 4.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.918 0.866 . . . . 0.0 111.04 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.74 13.04 36.22 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.416 -170.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.31 148.14 26.4 Favored Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 16.4 Cg_endo -58.1 176.21 0.39 Allowed 'Trans proline' 0 C--O 1.218 -0.52 0 C-N-CA 123.191 2.594 . . . . 0.0 113.971 -175.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 84.0 tttt -154.63 -68.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.8 m -78.26 108.39 11.55 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.47 146.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.072 0.463 . . . . 0.0 111.871 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -130.4 148.84 52.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -126.94 152.97 46.43 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -137.59 144.41 41.98 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 130' ' ' PHE . 48.2 t -137.27 155.19 49.77 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.362 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 m120 76.67 -43.32 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.662 1.585 . . . . 0.0 113.469 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.612 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -87.21 107.78 18.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 178.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 34.6 tt0 -65.03 134.44 53.85 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 59.94 87.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.428 1.091 . . . . 0.0 112.447 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.612 ' SD ' ' HD3' ' A' ' 94' ' ' LYS . 95.6 mmm -123.75 98.63 5.9 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.284 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.522 ' O ' HG23 ' A' ' 102' ' ' VAL . 64.3 m -88.78 167.87 12.94 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 89.6 t80 -49.11 -33.75 12.47 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.64 0.776 . . . . 0.0 112.585 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -56.64 -26.31 55.67 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.329 0.652 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -114.66 -18.14 11.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 98' ' ' CYS . 60.7 t -63.45 -18.89 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.126 0.971 . . . . 0.0 113.352 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -87.57 -22.91 24.52 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.729 -0.607 . . . . 0.0 112.062 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -94.38 -36.09 12.08 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -95.99 150.4 37.24 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.929 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.89 117.19 5.02 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.677 2.251 . . . . 0.0 113.06 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.37 172.09 17.01 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.088 1.859 . . . . 0.0 110.272 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.512 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 19.7 m -67.43 -46.99 71.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -172.54 -176.08 1.46 Allowed 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -139.91 130.99 26.34 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.02 173.07 11.59 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.382 0.611 . . . . 0.0 112.138 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 35.1 tt0 -123.97 128.97 50.17 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.84 105.52 2.81 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 t -86.85 163.12 17.38 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.24 -37.99 73.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.01 -31.88 68.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 123.238 0.337 . . . . 0.0 111.289 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.2 t-20 -63.66 -47.02 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 118' ' ' LEU . 5.7 tt -67.05 -20.3 65.82 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.002 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HA ' ' CE ' ' A' ' 119' ' ' LYS . 1.2 tpmt? -86.02 -14.29 44.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.065 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.527 ' CA ' ' HE2' ' A' ' 78' ' ' LYS . . . 111.71 11.71 16.32 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.934 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.58 125.53 57.36 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.498 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 55.6 Cg_endo -70.38 109.65 2.49 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.953 2.435 . . . . 0.0 111.15 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.5 t -85.81 122.37 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.91 110.1 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 122.106 0.955 . . . . 0.0 113.048 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -93.05 -165.68 1.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.605 178.489 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -93.24 115.03 27.65 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 120.639 0.257 . . . . 0.0 111.11 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -132.93 18.13 4.16 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.69 -29.52 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.452 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -83.92 -29.49 27.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.219 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 70.8 m-85 -93.12 75.67 4.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.115 0.96 . . . . 0.0 112.537 -172.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -94.58 -2.32 51.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.158 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -151.53 115.75 5.02 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.021 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.94 102.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -81.15 -64.95 1.08 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.06 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 p -132.99 149.4 52.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 137' ' ' THR . 3.5 tt -129.19 139.89 51.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.506 ' N ' HD23 ' A' ' 136' ' ' LEU . 79.3 m -119.78 124.44 46.15 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -104.55 123.92 58.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.502 ' CE2' ' HG2' ' A' ' 141' ' ' GLU . 33.8 t80 -116.43 110.84 19.17 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.404 0.621 . . . . 0.0 110.613 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.4 mt -99.92 125.74 53.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.502 ' HG2' ' CE2' ' A' ' 139' ' ' PHE . 36.2 mt-10 -100.5 -50.27 3.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.11 167.69 23.49 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' PRO . 83.1 m-20 -110.67 170.15 8.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 123.575 0.547 . . . . 0.0 111.454 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 86' ' ' LYS . 35.4 mm-40 -47.38 -57.9 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.255 0.972 . . . . 0.0 110.064 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -87.02 -26.89 23.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.55 75.68 0.59 Allowed Glycine 0 C--O 1.221 -0.679 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.1 t -107.72 -2.22 20.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.581 0.229 . . . . 0.0 110.95 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 38.7 mt-10 74.73 0.44 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.266 1.026 . . . . 0.0 112.13 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' SER . 5.7 p -139.95 124.58 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 32.5 m -109.7 111.78 23.45 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.972 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 18.9 pttm -109.85 134.75 51.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.183 171.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 155' ' ' ILE . 29.2 m -123.01 148.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.767 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.5 tp60 -85.81 -48.7 8.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.987 174.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -167.53 136.16 2.56 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 176.472 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 152' ' ' VAL . 2.5 mp -104.72 112.27 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 154' ' ' LYS . . . -139.92 157.28 45.94 Favored 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.11 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 1.9 mm? -119.43 157.21 28.69 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 72.4 m-85 -116.18 128.02 55.28 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.37 15.29 Favored Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.392 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 55.7 p -135.1 117.98 16.23 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.218 0.533 . . . . 0.0 111.438 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.0 p . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.653 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 p . . . . . 0 N--CA 1.445 -0.704 0 CA-C-O 121.193 0.52 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 22' ' ' TRP . 48.3 t -69.29 -67.62 0.46 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.288 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . . . -158.45 33.3 0.23 Allowed 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 3' ' ' ALA . 36.1 mt-10 -82.09 100.45 9.78 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 112.1 -2.318 . . . . 0.0 111.461 -169.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.601 ' HB2' ' HG3' ' A' ' 42' ' ' GLN . 66.2 m -159.06 149.5 19.54 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 9' ' ' ILE . . . -115.07 105.55 13.08 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.667 0.27 . . . . 0.0 110.907 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -112.77 146.61 38.49 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.754 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 66.52 73.98 0.35 Allowed 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.376 1.084 . . . . 0.0 110.4 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 11' ' ' LYS . 45.8 mm -110.25 115.95 53.8 Favored Pre-proline 0 C--N 1.285 -2.221 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.818 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.96 17.97 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.239 2.626 . . . . 0.0 111.507 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 9.9 mmpt? 64.69 12.49 7.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.119 1.367 . . . . 0.0 112.999 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.73 -83.43 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 29.7 mm-40 -103.77 -175.99 2.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 m -106.82 158.22 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 19.8 t0 -83.7 105.33 14.53 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.643 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 mp -60.23 -2.21 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 125.46 1.504 . . . . 0.0 114.233 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.533 HD21 ' H ' ' A' ' 42' ' ' GLN . 4.0 tt -56.01 -38.76 70.94 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.1 -17.59 64.59 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.065 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.79 23.35 12.02 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 16' ' ' LEU . 59.5 mt -102.79 142.62 16.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.38 -48.75 78.38 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' A' ' 40' ' ' LEU . 53.3 m95 70.95 -27.84 0.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 t -69.45 -35.61 75.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.18 -83.51 1.1 Allowed Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.912 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG11 ' CE3' ' A' ' 22' ' ' TRP 0.337 27.6 m 43.22 103.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -176.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.74 136.87 51.84 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.322 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -135.76 137.42 41.63 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.127 0.489 . . . . 0.0 110.176 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.3 -30.89 68.01 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.637 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.695 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 14.0 m120 -84.65 -93.57 0.08 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.777 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.503 HE22 ' HB3' ' A' ' 36' ' ' LEU . 4.0 tp-100 51.7 30.3 6.63 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -106.97 -75.39 0.63 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -163.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 p -48.83 -44.68 39.62 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -176.48 -61.92 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.48 0.657 . . . . 0.0 109.44 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.818 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.0 m-70 -72.42 144.0 48.31 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.941 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -107.7 164.36 12.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -169.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.503 ' HB3' HE22 ' A' ' 30' ' ' GLN . 2.8 tm? -60.07 -60.29 11.08 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.242 1.417 . . . . 0.0 113.812 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.15 -22.02 54.32 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.212 1.941 . . . . 0.0 112.965 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.3 m-20 -59.85 -29.12 68.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.669 1.188 . . . . 0.0 111.422 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -114.93 7.89 15.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.24 0.543 . . . . 0.0 111.415 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . 11.2 mp -119.49 -53.62 2.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -79.77 142.29 35.51 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.076 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.601 ' HG3' ' HB2' ' A' ' 5' ' ' SER . 14.0 tm0? -56.78 132.9 53.57 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 124.707 1.203 . . . . 0.0 110.651 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.13 -42.65 1.9 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -88.99 -49.94 6.47 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.367 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.0 ptm180 -47.92 90.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 4.9 tp10 171.03 143.69 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 153' ' ' GLN . 33.6 t70 -74.6 131.16 40.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.69 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.99 -52.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.23 -56.41 0.01 OUTLIER Glycine 0 CA--C 1.474 -2.484 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 50' ' ' LEU . 2.6 pp -80.94 135.61 35.91 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.588 174.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.818 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 34.8 p30 -161.83 169.55 21.11 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 tp -98.2 109.68 22.39 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 118.889 0.768 . . . . 0.0 108.989 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.04 131.01 44.01 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.069 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 60' ' ' LEU . 57.5 p -97.04 112.41 24.19 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.178 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.38 -35.68 8.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.502 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.37 -48.2 82.35 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.742 0.782 . . . . 0.0 109.291 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.83 151.14 43.72 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -100.32 7.47 44.34 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.937 0.875 . . . . 0.0 109.221 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -105.63 128.6 53.73 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.695 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 3.5 tt -133.56 131.74 40.06 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.224 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 7.0 tt -131.14 132.75 44.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.062 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.429 HD11 HD22 ' A' ' 60' ' ' LEU . 2.6 mp -130.73 145.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -114.19 121.5 43.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.65 121.51 37.13 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -91.38 141.93 2.85 Favored 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.265 2.643 . . . . 0.0 111.621 173.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.68 164.37 26.35 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 122.871 1.32 . . . . 0.0 113.874 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -104.82 -45.99 4.43 Favored 'General case' 0 N--CA 1.395 -3.197 0 CA-C-N 112.572 -2.104 . . . . 0.0 107.022 171.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -143.79 146.57 33.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.457 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -75.37 117.47 19.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 122.178 0.99 . . . . 0.0 111.654 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.98 173.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.542 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 3.7 mppt? -97.97 136.37 38.34 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.458 -1.297 . . . . 0.0 111.058 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' CD1' HD11 ' A' ' 125' ' ' LEU . 2.1 tm? -89.89 114.02 25.73 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -110.01 -37.95 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.8 m -143.62 171.23 14.46 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.207 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -142.75 157.57 44.51 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.604 ' HB3' ' HE1' ' A' ' 158' ' ' TYR . . . -149.39 143.74 25.94 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.837 0.351 . . . . 0.0 110.364 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.1 mt -145.71 137.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HE2' ' O ' ' A' ' 119' ' ' LYS . 87.2 mttt -112.86 157.38 21.48 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.372 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 178.5 36.86 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' CG ' ' HB2' ' A' ' 151' ' ' LYS . 7.5 Cg_exo -75.18 160.06 39.98 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.507 1.472 . . . . 0.0 110.032 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.51 -29.72 26.54 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.517 1.127 . . . . 0.0 112.065 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -93.15 -57.08 2.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 mp0 -68.44 -52.37 33.41 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.14 109.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.167 0 O-C-N 125.365 1.666 . . . . 0.0 116.56 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' CG ' HG22 ' A' ' 152' ' ' VAL . 26.6 Cg_exo -61.85 108.06 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.208 1.939 . . . . 0.0 110.217 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 38.0 ttpt -99.42 -63.86 1.09 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -167.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.9 m -78.62 94.8 5.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.458 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 111' ' ' ALA . 16.7 m -100.96 137.65 27.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -128.5 141.6 51.33 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.924 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 82.3 m-85 -117.45 148.12 42.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.679 -175.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.484 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 47.1 m-85 -114.53 126.72 55.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.724 174.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.5 t -91.79 96.51 10.46 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.186 0.517 . . . . 0.0 110.382 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 64.99 9.64 5.6 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.591 1.156 . . . . 0.0 112.824 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -88.72 139.88 30.02 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.4 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 95' ' ' GLU . 1.7 mp0 -55.45 169.12 0.32 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.538 1.535 . . . . 0.0 112.197 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -61.7 97.41 0.08 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.748 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.416 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . 83.8 mtp -98.78 106.75 19.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.475 ' O ' HG13 ' A' ' 102' ' ' VAL . 83.2 m -75.86 -168.98 0.98 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 102' ' ' VAL . 60.5 m-85 -46.65 -44.55 18.51 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -81.24 -31.73 33.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.39 0.615 . . . . 0.0 111.127 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -77.96 -19.67 54.12 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.977 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 98' ' ' CYS . 34.0 m -64.27 -5.72 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -91.41 -1.28 57.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.583 0.23 . . . . 0.0 110.9 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -101.55 -31.93 10.62 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 5.9 p90 -96.22 152.64 38.94 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.203 -171.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 6.6 Cg_endo -89.09 120.14 1.04 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.031 1.821 . . . . 0.0 108.724 170.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.12 142.27 99.1 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.153 1.902 . . . . 0.0 112.46 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 18.7 m -59.67 -42.41 92.8 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.465 0.65 . . . . 0.0 109.783 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -158.23 168.95 25.63 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.5 t -152.1 115.31 4.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -133.38 161.68 33.88 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.344 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.1 mp0 -114.96 128.61 56.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.2 tt -66.16 134.47 52.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.52 0.676 . . . . 0.0 111.612 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 t -121.15 179.32 4.43 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.32 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 40.8 mt-10 -54.74 -45.92 74.2 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.808 0.843 . . . . 0.0 112.983 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -70.88 -35.24 72.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.238 0.542 . . . . 0.0 109.682 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' HB3' ' HG ' ' A' ' 113' ' ' LEU . 62.7 t30 -65.18 -40.19 93.93 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.422 HD13 HD21 ' A' ' 113' ' ' LEU . 20.3 tp -61.02 -24.47 66.2 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 111.127 -178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 14.4 mmmm -79.29 -3.37 45.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.633 0.73 . . . . 0.0 109.27 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.05 17.02 52.94 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.156 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 98.8 mttt -87.9 141.15 31.33 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-N 116.714 0.257 . . . . 0.0 110.962 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 17.1 Cg_exo -67.31 119.37 6.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.02 2.48 . . . . 0.0 112.633 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.54 134.52 41.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.55 144.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.286 0.565 . . . . 0.0 112.293 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -131.86 -170.82 2.47 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.121 174.066 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -67.92 89.49 0.28 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.43 0.633 . . . . 0.0 112.692 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -69.18 -32.15 71.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.895 0.878 . . . . 0.0 110.107 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.13 -27.63 36.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.896 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 6.1 tmtt? -85.16 -45.26 12.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -78.27 90.26 4.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -106.49 -39.96 5.72 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -113.02 120.28 40.82 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.273 176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -118.8 102.05 12.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.786 176.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -102.82 -38.95 7.2 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.683 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.9 m -152.47 154.19 35.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.47 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 130.39 18.83 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.9 m -106.13 131.41 53.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 69.8 mt -111.14 122.28 65.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 57.3 t80 -122.94 121.82 37.08 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.718 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.447 HG22 HG12 ' A' ' 88' ' ' VAL . 2.0 pp -115.58 129.13 72.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.4 pt-20 -106.84 -20.76 13.24 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.421 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.67 31.66 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.064 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 6.8 p30 -102.8 175.4 5.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.019 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.502 HE21 ' HD3' ' A' ' 86' ' ' LYS . 7.9 tp60 -45.13 -50.13 11.42 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.625 1.57 . . . . 0.0 111.68 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -107.36 -37.77 6.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.48 46.83 2.27 Favored Glycine 0 C--N 1.312 -0.789 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.3 t -84.63 12.57 6.89 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.359 0.664 . . . . 0.0 112.771 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 69.26 1.95 3.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.862 0.865 . . . . 0.0 112.61 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.84 134.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 83.5 m -118.47 111.44 18.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.407 ' HB2' ' CG ' ' A' ' 80' ' ' PRO . 60.1 mttp -94.4 134.88 36.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.402 HG22 ' CG ' ' A' ' 85' ' ' PRO . 49.0 t -122.27 120.93 62.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.492 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 20.6 pt20 -98.0 -13.44 21.1 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.361 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 23.1 pttt -168.07 150.21 5.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.149 168.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.4 HG13 HG11 ' A' ' 152' ' ' VAL . 65.4 mt -131.05 112.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.05 137.97 52.38 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 6.1 mp -103.08 140.85 36.77 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.604 ' HE1' ' HB3' ' A' ' 76' ' ' ALA . 97.5 m-85 -125.32 139.84 53.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.482 0.658 . . . . 0.0 111.279 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 71' ' ' LYS . . . -173.53 -154.86 10.99 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.6 p -161.43 154.52 21.03 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.905 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.42 -1.96 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.789 173.167 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 m -76.33 88.01 3.14 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -175.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 43' ' ' GLY . . . -150.23 79.11 1.35 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 171.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.461 ' O ' ' HA2' ' A' ' 43' ' ' GLY . 11.6 pt-20 -158.73 171.26 20.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.765 -169.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 p -93.36 127.97 39.19 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 121.101 0.477 . . . . 0.0 109.879 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.14 82.41 1.89 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.531 0.681 . . . . 0.0 109.43 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.1 p -89.99 158.65 17.27 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.991 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.468 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 23.0 tp60 -128.93 86.74 2.47 Favored 'General case' 0 CA--C 1.471 -2.071 0 C-N-CA 119.513 -0.875 . . . . 0.0 108.706 -178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.525 HG13 ' H ' ' A' ' 15' ' ' ASP . 2.3 mp -82.93 114.97 56.15 Favored Pre-proline 0 C--N 1.287 -2.125 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.451 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 8' ' ' GLN . 72.9 Cg_endo -89.6 143.23 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.826 1.684 . . . . 0.0 108.864 172.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -69.8 99.29 1.34 Allowed 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.167 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.87 -48.34 0.32 Allowed Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -119.36 178.83 4.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.79 142.6 39.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' HG13 ' A' ' 9' ' ' ILE . 10.1 t0 -72.73 116.87 13.74 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 20' ' ' ILE . 52.6 mt -79.61 5.54 12.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 42' ' ' GLN . 4.7 tt -55.18 -38.11 67.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.919 0.866 . . . . 0.0 108.759 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.76 -17.07 54.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.671 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' HA ' ' ND2' ' A' ' 67' ' ' ASN . 7.7 m-85 -90.52 -4.85 56.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.597 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 64' ' ' ILE . 92.4 mt -86.64 138.16 19.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.17 101.64 14.38 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 172.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CH2' ' HA ' ' A' ' 41' ' ' LYS . 98.7 m95 -76.36 1.55 15.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -92.32 -28.31 17.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.81 4.67 56.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.903 -0.665 . . . . 0.0 114.274 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.6 m -61.22 136.31 24.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.182 0.515 . . . . 0.0 111.765 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 9.3 tp10 -134.57 144.25 47.84 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.596 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 62.7 m -137.28 138.3 39.91 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.857 -176.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 28' ' ' LEU . 3.1 tm? -72.19 -49.03 38.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.134 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -103.87 -64.32 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.596 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 28.6 pt20 54.79 22.9 4.46 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.463 1.505 . . . . 0.0 111.854 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 40.7 t 73.82 129.64 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.285 1.834 . . . . 0.0 112.47 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.92 -4.87 34.74 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.218 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -121.36 -68.9 0.87 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.437 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.616 ' O ' ' HB3' ' A' ' 31' ' ' SER . 78.0 m80 -99.95 112.37 24.65 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.421 -173.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 m -66.48 130.16 42.25 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.613 HD21 HD23 ' A' ' 40' ' ' LEU 0.258 5.5 tt -45.15 -39.59 9.28 Favored Pre-proline 0 CA--C 1.568 1.656 0 N-CA-C 118.618 2.821 . . . . 0.0 118.618 -177.212 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 76.5 Cg_exo -53.97 -1.35 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.823 2.348 . . . . 0.0 114.895 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.534 HD22 ' HB2' ' A' ' 50' ' ' LEU . 30.8 p30 -86.24 -48.1 8.84 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.13 -14.16 15.48 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 36' ' ' LEU . 45.4 tp -102.23 -40.33 6.83 Favored 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 118.839 -1.144 . . . . 0.0 107.957 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.02 97.87 6.98 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 170.248 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.628 ' HB3' HD11 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -70.22 102.6 2.14 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.308 -172.673 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 4' ' ' GLU . . . -165.1 -56.11 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.557 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -89.15 -9.9 49.23 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.234 0.614 . . . . 0.0 110.124 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.591 ' O ' ' HD2' ' A' ' 45' ' ' ARG . 2.4 ppt_? -52.54 130.1 30.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.122 -172.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER 174.06 139.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 173.539 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.83 88.38 6.78 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.55 -69.34 0.17 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.78 -47.18 0.63 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.43 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.534 ' HB2' HD22 ' A' ' 38' ' ' ASN . 1.0 OUTLIER -125.61 113.75 17.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.027 0.918 . . . . 0.0 112.566 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -149.04 160.39 43.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 151' ' ' LYS . 3.4 tm? -90.61 120.32 31.58 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.35 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.9 pt-20 -141.01 119.35 12.17 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.341 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 49.6 p -35.05 -65.79 0.21 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.08 1.752 . . . . 0.0 115.549 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 67.16 17.66 10.36 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.701 0.762 . . . . 0.0 112.15 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.01 -62.92 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.286 0.565 . . . . 0.0 109.523 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 54' ' ' SER . 22.7 m-20 -131.36 127.91 38.57 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -73.47 -30.1 62.95 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 124.078 0.861 . . . . 0.0 110.341 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -74.37 115.58 14.06 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.56 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 95.0 mt -119.04 126.78 52.49 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.028 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 62' ' ' ILE . 1.4 tm? -113.0 121.69 45.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 61' ' ' LEU . 2.7 mp -127.92 142.75 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' HB2' ' HB3' ' A' ' 96' ' ' HIS . 50.5 t80 -110.45 121.81 46.2 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 123.816 0.846 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 20' ' ' ILE . 48.4 mm -120.85 121.47 28.9 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.793 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.52 124.82 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.476 2.117 . . . . 0.0 111.23 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -95.71 157.38 15.92 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 121.226 0.536 . . . . 0.0 111.217 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 19' ' ' PHE . 34.2 p30 -78.5 -23.34 46.41 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.92 160.73 39.78 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.659 HG23 ' H ' ' A' ' 133' ' ' VAL . 7.7 p -84.4 108.67 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 172.56 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -90.7 113.58 25.7 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 133' ' ' VAL . 98.0 mt -69.41 128.46 36.64 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 44.2 t60 -118.39 -50.64 2.43 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.1 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 p -147.18 174.11 11.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.82 159.74 43.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.06 139.58 39.62 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.215 0.322 . . . . 0.0 110.252 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 71.6 mt -140.93 117.62 7.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -107.45 125.76 51.65 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.818 0.818 . . . . 0.0 110.318 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.98 -174.08 22.99 Favored Glycine 0 C--N 1.261 -3.621 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.48 135.47 3.07 Favored 'Trans proline' 0 N--CA 1.424 -2.604 0 CA-C-N 119.598 1.699 . . . . 0.0 108.632 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -58.57 -25.85 62.99 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.673 0.749 . . . . 0.0 110.798 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.89 -53.17 27.52 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.783 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.467 ' OE1' ' HD3' ' A' ' 151' ' ' LYS . 4.7 mp0 -103.78 -59.82 1.66 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 85' ' ' PRO . . . 27.03 128.75 0.0 OUTLIER Glycine 0 N--CA 1.511 3.647 0 C-N-CA 127.98 2.705 . . . . 0.0 118.443 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 84' ' ' GLY . 5.7 Cg_exo -75.45 114.55 4.0 Favored 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.168 1.912 . . . . 0.0 110.373 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 51.3 tttp -99.82 -69.84 0.75 Allowed 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -57.21 106.97 0.37 Allowed 'General case' 0 C--O 1.249 1.073 0 O-C-N 123.183 0.302 . . . . 0.0 111.314 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 86' ' ' LYS . 96.3 t -109.26 116.32 51.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.447 ' HZ2' ' HB2' ' A' ' 89' ' ' LYS . 4.3 ttmp? -118.83 136.46 54.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.443 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 97.3 m-85 -121.83 166.47 14.32 Favored 'General case' 0 C--O 1.201 -1.456 0 O-C-N 122.038 -0.413 . . . . 0.0 111.927 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.426 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 80.8 t80 -151.41 121.64 7.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 t -97.9 143.71 28.21 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.789 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 77.73 172.34 0.2 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 125.08 1.352 . . . . 0.0 112.722 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 71.21 177.92 0.26 Allowed 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.605 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 155.65 21.42 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 42.9 p-80 -51.08 124.42 11.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 80.6 mtp -98.83 116.93 32.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.362 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 67.6 m -72.02 158.04 36.7 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.568 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 64.6 t80 -48.9 -37.43 19.73 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 m -59.6 -22.56 61.98 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 120.846 0.355 . . . . 0.0 111.591 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.51 -13.06 11.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.099 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.568 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 2.7 p -67.48 -33.89 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.801 0.334 . . . . 0.0 111.214 -171.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.53 94.91 10.04 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.948 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -178.77 -45.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.19 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -98.01 149.89 36.19 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.481 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.39 126.74 19.16 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.463 2.109 . . . . 0.0 111.866 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.52 163.51 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.289 2.659 . . . . 0.0 112.398 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 9.6 t -61.43 -47.68 84.63 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.53 ' OD1' ' HB2' ' A' ' 126' ' ' LYS . 20.5 m-20 -174.26 -177.6 1.3 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.15 2.58 . . . . 0.0 104.038 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -157.33 145.61 19.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.751 0.705 . . . . 0.0 110.278 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 88' ' ' VAL . . . -154.63 172.14 18.35 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -125.5 138.13 53.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 22.7 tp -61.67 143.84 55.51 Favored 'General case' 0 C--O 1.25 1.092 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 117' ' ' ASN . 8.0 t -134.52 165.47 25.12 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.423 ' O ' ' HD3' ' A' ' 119' ' ' LYS . 46.3 mt-10 -62.9 -28.24 69.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 119.089 0.859 . . . . 0.0 111.387 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' HG2' ' CB ' ' A' ' 121' ' ' LYS . 41.1 tt0 -66.34 -40.63 89.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.77 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.54 ' H ' HG23 ' A' ' 114' ' ' THR . 2.4 t-20 -67.47 -34.24 76.77 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.4 tp -67.31 -28.34 67.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.732 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 14.1 mptt -87.76 1.02 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 110.508 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.64 23.93 Favored Glycine 0 C--N 1.303 -1.272 0 C-N-CA 120.294 -0.955 . . . . 0.0 115.146 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.434 ' CB ' ' HG2' ' A' ' 116' ' ' GLU . 17.5 tppt? -75.08 119.11 75.38 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 117.93 0.865 . . . . 0.0 108.918 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.89 100.92 0.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.878 1.718 . . . . 0.0 109.663 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.32 133.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 27.9 m -64.68 135.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.48 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.475 HD12 ' H ' ' A' ' 125' ' ' LEU . 2.7 mp -65.06 -67.04 0.47 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.53 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 34.8 mmtp -171.54 -174.58 1.42 Allowed 'General case' 0 C--N 1.287 -2.143 1 N-CA-C 100.081 -4.044 . . . . 0.0 100.081 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.403 ' HA ' ' CE1' ' A' ' 130' ' ' PHE . 37.4 t80 -146.36 24.39 1.27 Allowed 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 123.186 1.469 . . . . 0.0 108.078 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.16 -40.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.658 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.9 tmtt? -116.53 -20.47 9.62 Favored 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 118.732 -1.187 . . . . 0.0 114.045 -167.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 127' ' ' TYR . 32.6 p90 -58.44 18.08 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.445 0 C-N-CA 125.209 1.404 . . . . 0.0 114.415 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.37 2.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -163.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -166.56 115.52 0.9 Allowed 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.659 ' H ' HG23 ' A' ' 69' ' ' VAL . 60.4 t -120.01 125.23 74.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.757 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -121.13 -61.29 1.56 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 173.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 29.6 p -116.37 152.44 33.92 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.9 tp -136.32 122.83 20.82 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.077 0.465 . . . . 0.0 110.006 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 87.9 m -93.37 113.45 25.63 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.9 mt -104.78 116.52 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -115.4 108.73 16.89 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.291 0.567 . . . . 0.0 111.006 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 8.2 pt -89.46 114.07 26.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-O 121.848 0.832 . . . . 0.0 108.877 172.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.59 -40.53 16.16 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.13 -1.396 . . . . 0.0 113.028 -168.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.94 150.63 27.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.685 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -91.19 154.66 19.16 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.454 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.464 ' HG3' ' HD2' ' A' ' 86' ' ' LYS . 25.8 tt0 -58.44 -36.4 73.6 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 123.662 0.785 . . . . 0.0 112.295 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.1 t -103.35 -7.6 20.92 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.582 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.72 56.41 23.07 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.9 p -87.77 -1.47 57.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.616 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 42.6 mt-10 72.19 -37.07 0.38 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.092 0.957 . . . . 0.0 112.081 -177.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.3 t -106.09 118.24 53.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.178 0.513 . . . . 0.0 109.618 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 39.4 m -93.29 110.99 22.51 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.467 ' HD3' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -119.35 135.71 54.6 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.874 0.369 . . . . 0.0 110.392 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.1 p -142.09 148.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.04 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 74.1 mt-30 -108.99 -32.35 7.29 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -155.24 115.97 3.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.762 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.422 ' HB ' ' CD1' ' A' ' 40' ' ' LEU . 66.4 mt -122.71 127.17 74.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.43 152.67 40.99 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.29 155.56 21.9 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 15' ' ' ASP . 99.5 m-85 -124.56 130.59 52.73 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.573 0.701 . . . . 0.0 111.297 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.05 -171.12 12.24 Favored Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.3 m -142.57 133.88 26.21 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.395 0.617 . . . . 0.0 111.599 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.425 -1.719 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.12 174.047 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -98.27 119.33 36.75 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.328 0.585 . . . . 0.0 110.942 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.58 111.27 6.56 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.11 89.62 4.83 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.151 0.977 . . . . 0.0 112.55 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.3 m -156.43 100.76 1.99 Allowed 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 17' ' ' LEU . . . -166.12 107.9 0.73 Allowed 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 123.29 0.369 . . . . 0.0 111.944 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -157.02 111.85 2.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.859 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.449 ' H ' HD12 ' A' ' 9' ' ' ILE . 52.0 mt-30 -134.03 19.34 3.77 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.569 HG13 ' HB3' ' A' ' 15' ' ' ASP . 3.0 mp -76.28 123.67 87.98 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.72 -177.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.46 160.99 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.705 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -71.3 107.02 4.07 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.87 -76.04 0.24 Allowed Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -106.69 168.88 8.88 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.64 125.77 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.534 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.569 ' HB3' HG13 ' A' ' 9' ' ' ILE . 34.0 t0 -72.11 130.09 40.05 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 176.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.626 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.2 mm? -68.86 -1.2 6.66 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.494 ' CD1' ' HB1' ' A' ' 6' ' ' ALA . 1.6 tm? -51.24 -45.17 61.89 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.571 1.148 . . . . 0.0 109.1 174.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.42 -16.04 56.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.807 0.813 . . . . 0.0 110.863 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.526 ' CD1' HD12 ' A' ' 16' ' ' LEU . 11.1 t80 -92.58 -14.24 28.54 Favored 'General case' 0 N--CA 1.415 -2.195 0 C-N-CA 124.251 1.02 . . . . 0.0 112.058 -174.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 16' ' ' LEU . 96.3 mt -75.04 140.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 120.701 0.286 . . . . 0.0 111.035 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.76 -29.44 63.32 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.277 0.561 . . . . 0.0 110.527 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' H ' HG22 ' A' ' 20' ' ' ILE . 98.3 m95 71.18 -15.82 0.39 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 173.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -67.86 -25.37 65.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.481 0.658 . . . . 0.0 110.58 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.68 -81.24 1.58 Allowed Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.053 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.565 ' H ' ' CG ' ' A' ' 65' ' ' PRO 0.345 27.4 m 46.87 79.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.983 0 CA-C-O 122.476 1.131 . . . . 0.0 112.842 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -112.83 148.83 34.05 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.951 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.7 t -135.93 128.85 31.27 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.12 7.91 5.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.684 0.754 . . . . 0.0 110.568 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 6.0 m120 -126.01 -92.16 0.51 Allowed 'General case' 0 CA--C 1.479 -1.785 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.381 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 45.63 32.15 1.11 Allowed 'General case' 0 C--N 1.379 1.85 0 CA-C-O 122.677 1.227 . . . . 0.0 109.467 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.4 t -37.5 -63.64 0.44 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.729 2.811 . . . . 0.0 113.367 -171.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -50.04 -48.1 52.95 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.2 m 147.27 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.749 0 C-N-CA 128.127 2.571 . . . . 0.0 106.664 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.843 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 89.5 m-70 -62.14 132.66 53.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.149 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -106.77 -173.1 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.406 -0.918 . . . . 0.0 113.293 -164.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.8 tp -86.71 -46.74 0.53 Allowed Pre-proline 0 C--O 1.212 -0.895 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.09 -38.8 71.03 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.424 1.416 . . . . 0.0 111.415 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.502 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.8 p-10 -75.06 -2.0 25.44 Favored 'General case' 0 C--O 1.203 -1.365 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.618 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.19 0.14 6.43 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 tp -121.64 -30.48 4.18 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.516 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 6.0 tmtt? -82.24 143.13 31.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -68.88 149.14 49.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.575 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.31 -35.41 3.71 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.494 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 81.4 m-85 -89.4 -28.03 20.03 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.158 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -68.85 80.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -167.67 110.97 0.65 Allowed 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.005 0.922 . . . . 0.0 109.154 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.679 ' H ' ' HG3' ' A' ' 153' ' ' GLN . 20.0 t70 -71.22 116.47 11.57 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.121 0.486 . . . . 0.0 110.188 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -164.62 -63.12 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.08 -49.82 0.36 Allowed Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.1 pp -105.95 141.42 37.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 120.976 0.417 . . . . 0.0 110.623 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.843 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 36.5 p30 -162.28 169.63 20.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tt -102.16 124.81 48.41 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -138.73 165.07 27.93 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.274 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 66.4 p -101.47 148.65 24.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.961 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -125.17 -68.69 0.83 Allowed 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.4 -39.71 22.3 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.612 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 54' ' ' SER . 40.6 m-20 -123.21 121.21 35.36 Favored 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.784 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.9 tt0 -69.58 -26.22 64.36 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.323 1.015 . . . . 0.0 108.537 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.82 108.22 10.89 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.81 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.568 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 96.3 mt -115.54 132.29 56.67 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.49 -172.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.77 128.32 49.39 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.04 136.63 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 122.81 0.444 . . . . 0.0 110.716 -173.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -106.95 131.56 53.89 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.548 0.339 . . . . 0.0 110.887 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -108.38 117.08 55.42 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.022 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.565 ' CG ' ' H ' ' A' ' 25' ' ' VAL . 8.3 Cg_exo -73.34 144.58 36.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.608 2.205 . . . . 0.0 110.942 175.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' HE2' ' NH2' ' A' ' 134' ' ' ARG . 24.5 p90 -122.38 161.91 22.58 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -98.4 -43.34 6.95 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.328 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -153.93 178.85 9.48 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.617 -171.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.449 HG22 ' HD2' ' A' ' 134' ' ' ARG . 93.2 t -83.04 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.836 -0.166 . . . . 0.0 110.581 174.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.67 172.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.63 114.13 27.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.6 tp -72.75 133.8 44.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -111.76 -52.71 2.77 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.872 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -145.15 164.63 30.68 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.019 0.438 . . . . 0.0 111.946 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -135.2 153.8 51.82 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -148.64 110.09 4.43 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.219 0.533 . . . . 0.0 111.227 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.9 117.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 79' ' ' GLY . 7.8 tmtt? -116.43 141.53 48.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -173.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.575 ' N ' ' HD3' ' A' ' 78' ' ' LYS . . . -171.39 -156.35 11.72 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 174.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.473 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 78.2 Cg_endo -75.06 165.98 30.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.36 2.04 . . . . 0.0 110.902 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HA ' HD11 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -70.41 -33.64 71.59 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.76 -47.84 6.58 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 31.2 mt-10 -86.73 15.44 5.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.675 -175.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.28 148.78 19.86 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.424 ' O ' HD22 ' A' ' 113' ' ' LEU . 44.9 Cg_exo -59.01 162.86 12.63 Favored 'Trans proline' 0 C--O 1.217 -0.534 0 C-N-CA 122.614 2.21 . . . . 0.0 111.888 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 36.3 ttpt -132.94 -73.43 0.5 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.062 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.5 m -76.68 108.67 9.85 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.806 0.336 . . . . 0.0 110.122 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.633 HG12 HG22 ' A' ' 140' ' ' ILE . 7.6 m -118.97 142.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 -177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -125.6 149.45 48.37 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -127.09 152.73 46.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.614 ' CE2' ' HB ' ' A' ' 137' ' ' THR 0.252 23.4 p90 -148.83 116.22 6.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.74 0.781 . . . . 0.0 111.66 173.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' SER . 20.6 m -103.99 149.36 25.22 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.849 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.5 116.02 0.05 Allowed 'General case' 0 C--O 1.239 0.537 0 O-C-N 124.632 1.208 . . . . 0.0 109.676 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 94' ' ' LYS 0.279 0.5 OUTLIER 81.75 108.55 0.07 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.4 1.08 . . . . 0.0 112.256 -175.288 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.51 177.19 4.99 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.324 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 79.01 0.76 2.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.368 1.067 . . . . 0.0 111.022 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.594 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 44.6 ttm -70.22 115.14 9.07 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.851 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.3 m -100.33 177.11 5.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.256 36.9 p90 -55.8 -29.88 60.44 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.6 p -62.46 -35.95 80.91 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.973 0.892 . . . . 0.0 109.86 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 2.3 m-20 -87.75 -29.09 21.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.697 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 98' ' ' CYS . 97.8 t -62.4 -29.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.294 0.569 . . . . 0.0 110.52 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -88.71 -10.35 48.72 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.509 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.48 -50.13 6.28 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.063 0.459 . . . . 0.0 109.792 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -96.36 143.25 25.8 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.333 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 143.31 78.41 Favored 'Trans proline' 0 C--O 1.249 1.048 0 C-N-CA 122.144 1.896 . . . . 0.0 111.109 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.23 178.13 7.95 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.36 2.04 . . . . 0.0 111.406 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 32.1 m -78.45 -44.39 24.79 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -168.35 168.85 11.08 Favored 'General case' 0 C--O 1.256 1.395 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -144.16 138.24 28.0 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.95 159.69 39.23 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.511 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.2 tp10 -109.05 116.98 33.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 10.3 tt -61.35 113.27 2.54 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.253 1.025 . . . . 0.0 110.174 -176.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 117' ' ' ASN . 9.6 t -85.09 157.9 20.57 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.566 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.88 -22.11 65.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.279 0.561 . . . . 0.0 111.014 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.411 ' HG3' ' HD2' ' A' ' 121' ' ' LYS . 6.7 tp10 -65.81 -36.55 83.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.539 HD22 HG23 ' A' ' 123' ' ' VAL . 17.3 t-20 -71.77 -42.82 66.7 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' A' ' 113' ' ' LEU . 7.7 tt -62.02 -21.31 64.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.076 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -82.4 -13.64 56.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.131 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.43 10.9 21.0 Favored Glycine 0 C--O 1.24 0.521 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.083 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HD2' ' HG3' ' A' ' 116' ' ' GLU . 99.0 mttt -94.04 135.98 24.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 61.4 Cg_endo -71.48 104.58 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.15 2.567 . . . . 0.0 112.353 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.539 HG23 HD22 ' A' ' 117' ' ' ASN . 66.1 t -83.33 127.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.675 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.29 121.66 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 110.411 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.2 168.5 11.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.395 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.82 94.02 7.58 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.222 0.534 . . . . 0.0 109.911 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . 0.312 26.8 p90 -88.44 67.41 8.59 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.12 -47.49 13.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.2 tmtt? -80.27 -30.74 38.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -73.5 84.16 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.184 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -110.67 -68.18 0.95 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.405 ' HB2' HG11 ' A' ' 69' ' ' VAL . 3.1 p30 -104.5 115.79 30.97 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.1 t -100.2 103.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 C-N-CA 118.472 -1.291 . . . . 0.0 110.675 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HD2' HG22 ' A' ' 69' ' ' VAL . 28.8 mmm180 -78.37 -80.64 0.11 Allowed 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.554 170.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 92' ' ' SER . 42.6 p -105.55 149.73 26.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.48 129.75 41.53 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.614 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 20.8 m -130.84 144.18 51.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.4 mt -117.74 135.99 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 122.501 0.32 . . . . 0.0 110.191 -174.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 83.5 t80 -123.21 112.23 17.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.633 HG22 HG12 ' A' ' 88' ' ' VAL . 26.1 pt -109.27 114.96 48.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.6 pt-20 -105.31 -9.45 17.62 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.29 166.82 29.77 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.129 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -119.18 164.57 15.39 Favored 'General case' 0 CA--C 1.496 -1.117 0 O-C-N 124.164 0.915 . . . . 0.0 109.903 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.426 ' N ' ' HB2' ' A' ' 86' ' ' LYS . 34.2 mm-40 -46.32 -61.4 1.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 110.374 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.2 t -91.24 -11.07 39.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.697 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.64 65.28 2.96 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.6 t -100.21 -2.35 34.15 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 58' ' ' GLU 0.286 45.0 mt-10 68.7 -27.25 0.15 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.2 p -102.22 103.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 25.0 m -101.19 111.27 23.44 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.504 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -104.84 132.49 51.02 Favored 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.485 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.99 124.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.869 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.679 ' HG3' ' H ' ' A' ' 47' ' ' ASP . 36.0 tt0 -97.3 -27.62 14.42 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.102 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 20.4 ttmm -160.72 129.26 4.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.6 112.11 38.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 165.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.438 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -130.87 141.84 50.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 156' ' ' ALA . 5.8 mp -130.69 142.67 50.44 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 79.4 m-85 -124.53 114.27 19.2 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -109.94 -174.08 20.7 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.3 m -139.23 129.94 26.03 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--N 1.293 -1.866 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.253 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m -154.66 111.96 3.38 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.745 -0.597 . . . . 0.0 112.261 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 41' ' ' LYS . . . 42.31 72.91 0.15 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.127 1.371 . . . . 0.0 113.046 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 41' ' ' LYS . 11.3 pt-20 -149.73 18.68 0.91 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.572 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.1 m -108.36 17.35 22.24 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.969 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.69 35.35 4.3 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.093 -177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -80.84 151.02 28.9 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.152 0.501 . . . . 0.0 110.932 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -105.55 100.25 9.82 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.5 mp -94.12 114.41 63.15 Favored Pre-proline 0 C--N 1.284 -2.239 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.965 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 13' ' ' GLN . 19.3 Cg_endo -93.09 -173.87 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.513 2.142 . . . . 0.0 110.525 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -96.93 137.45 35.99 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.67 -40.22 2.6 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.452 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -143.05 137.52 29.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.83 155.22 7.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 123.816 0.698 . . . . 0.0 110.001 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -58.95 129.53 42.6 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.092 0.957 . . . . 0.0 110.886 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.599 ' O ' HG13 ' A' ' 20' ' ' ILE . 80.6 mt -98.19 5.89 48.03 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.001 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.527 HD22 ' HG2' ' A' ' 42' ' ' GLN . 64.9 tp -64.22 -42.22 96.67 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.797 0.808 . . . . 0.0 109.497 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.5 -20.03 65.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.896 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' C ' ' HB2' ' A' ' 67' ' ' ASN . 24.7 m-85 -95.17 19.87 9.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.914 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 16' ' ' LEU . 72.1 mt -108.19 127.76 64.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.985 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 -38.25 85.1 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CZ2' HD12 ' A' ' 40' ' ' LEU . 90.0 m95 76.46 -29.19 0.18 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.4 t -80.05 -36.37 35.78 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.485 0.66 . . . . 0.0 110.044 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.13 12.43 66.34 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.004 -0.617 . . . . 0.0 114.575 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 34.7 m -62.53 152.31 7.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-N 117.504 0.652 . . . . 0.0 111.989 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.97 127.45 13.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 p -134.02 108.22 8.23 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.677 0.751 . . . . 0.0 109.897 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -76.5 121.49 23.19 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.624 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 46.3 t30 72.53 -55.1 0.68 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.371 1.468 . . . . 0.0 110.978 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 23.9 pt20 63.2 -62.71 0.13 Allowed 'General case' 0 C--O 1.209 -1.069 0 C-N-CA 127.442 2.297 . . . . 0.0 110.0 -176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 23.9 m 176.87 119.77 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 129.608 3.163 . . . . 0.0 103.109 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.6 p -62.63 -18.39 62.16 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 117.073 -1.851 . . . . 0.0 113.124 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -111.3 -14.72 13.75 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.584 ' O ' ' HB2' ' A' ' 31' ' ' SER . 94.8 m-70 -125.43 163.62 22.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.914 -0.492 . . . . 0.0 110.289 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.539 ' OG ' ' HD2' ' A' ' 37' ' ' PRO . 29.5 t -114.03 171.19 7.75 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.799 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -77.38 -54.6 1.44 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.941 0.897 . . . . 0.0 112.722 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD2' ' OG ' ' A' ' 35' ' ' SER . 30.8 Cg_exo -40.34 -50.31 3.68 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 123.392 2.728 . . . . 0.0 114.823 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -55.85 -45.81 78.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.76 -11.06 57.63 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.465 HD12 ' CZ2' ' A' ' 22' ' ' TRP . 1.3 tm? -104.28 -27.28 12.1 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HD2' ' HB3' ' A' ' 4' ' ' GLU . 70.9 mmtt -78.0 120.36 22.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HG2' HD22 ' A' ' 17' ' ' LEU . 8.5 mm100 -75.56 92.07 2.88 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 121.923 0.868 . . . . 0.0 109.27 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.511 ' H ' ' HG3' ' A' ' 45' ' ' ARG . . . 170.14 -56.36 0.19 Allowed Glycine 1 N--CA 1.386 -4.66 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.46 -171.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -81.62 -29.3 33.3 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.511 0.672 . . . . 0.0 110.185 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 43' ' ' GLY . 5.1 ppt_? -60.95 17.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.93 137.15 36.13 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.344 -0.848 . . . . 0.0 112.209 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 8.3 t70 -58.96 85.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.927 1.691 . . . . 0.0 112.497 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER 160.61 -55.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.635 1.974 . . . . 0.0 108.097 174.469 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.22 -78.24 0.14 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.626 -0.716 . . . . 0.0 114.256 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 163.58 29.28 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.9 p-10 -161.19 166.35 27.96 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.474 HD21 HD13 ' A' ' 60' ' ' LEU . 5.4 tt -110.63 128.69 55.79 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 55' ' ' ASP . 10.9 pt-20 -141.96 158.82 43.33 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 120.579 0.228 . . . . 0.0 111.435 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.2 p -79.49 79.57 5.94 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 122.187 0.994 . . . . 0.0 108.418 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 25.8 t70 -97.27 79.97 2.86 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.206 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 155.21 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.514 2.326 . . . . 0.0 107.115 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.8 -170.3 1.63 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.493 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -18.88 12.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -102.27 154.79 18.71 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.023 0.929 . . . . 0.0 109.558 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.518 ' HB2' HG13 ' A' ' 140' ' ' ILE . 78.7 mt -146.51 147.32 31.05 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 1.2 tm? -123.21 116.92 24.18 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -124.33 120.89 60.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -109.79 134.52 51.94 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.88 0.472 . . . . 0.0 110.806 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 mm -120.78 131.83 24.35 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.492 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 53.6 Cg_endo -87.84 150.7 7.25 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.49 2.793 . . . . 0.0 111.577 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.472 ' HD1' ' H ' ' A' ' 66' ' ' PHE . 4.7 p90 -89.6 162.99 15.35 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -173.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.577 ' HB2' ' C ' ' A' ' 19' ' ' PHE . 4.6 t-20 -101.66 -43.14 5.96 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 112.509 -2.132 . . . . 0.0 107.322 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -153.07 150.73 29.44 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.29 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.51 122.92 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.67 175.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.424 ' HE2' ' HG2' ' A' ' 131' ' ' GLN . 38.4 ttmt -81.04 142.47 33.33 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 73' ' ' HIS . 3.1 tm? -81.05 150.91 28.62 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.562 ' N ' HD13 ' A' ' 72' ' ' LEU . 3.6 t-160 -141.96 -62.61 0.45 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.878 177.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.479 ' HA ' HD22 ' A' ' 125' ' ' LEU . 12.1 p -152.65 163.22 40.07 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 7.7 p90 -125.56 157.17 37.78 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -148.72 107.13 3.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.783 0.265 . . . . 0.0 110.513 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.87 136.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 91.3 mttt -114.01 158.12 21.6 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.663 176.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 153' ' ' GLN . . . -178.91 -177.49 47.54 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.99 150.14 89.03 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.833 1.689 . . . . 0.0 109.088 172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.59 -25.5 68.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 45.4 mt-10 -87.33 -54.52 4.26 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.486 0.66 . . . . 0.0 111.26 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.73 8.68 18.9 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.203 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.9 153.37 38.05 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.668 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.577 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 39.1 Cg_exo -60.98 147.41 95.76 Favored 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 122.14 1.893 . . . . 0.0 110.517 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.527 ' HB2' HE21 ' A' ' 144' ' ' GLN . 0.6 OUTLIER -130.33 -53.89 1.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 54.6 m -80.53 97.03 6.97 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.57 116.19 40.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.003 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -109.34 132.67 53.91 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -117.07 140.12 49.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.508 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 88.2 t80 -130.3 129.2 42.93 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -113.4 145.79 40.56 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 75.82 172.56 0.25 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.523 1.529 . . . . 0.0 111.272 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt 67.51 164.97 0.22 Allowed 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.373 1.069 . . . . 0.0 111.716 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.09 164.42 26.53 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -49.39 136.02 16.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.489 ' HE3' ' HB3' ' A' ' 101' ' ' ASN . 86.0 mtp -110.15 127.97 55.21 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.531 ' O ' HG23 ' A' ' 102' ' ' VAL . 25.9 p -86.9 176.6 7.6 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.9 -29.41 67.02 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -61.93 -19.34 62.63 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.086 0.554 . . . . 0.0 111.224 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.489 ' HB3' ' HE3' ' A' ' 97' ' ' MET . 13.3 m120 -109.32 -26.74 9.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.306 0.574 . . . . 0.0 110.207 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 98' ' ' CYS . 52.4 t -58.48 -38.04 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.574 1.15 . . . . 0.0 113.838 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -57.85 -14.34 5.89 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.95 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.61 71.19 1.23 Allowed 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.61 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 102' ' ' VAL . 3.0 p90 -128.14 153.77 78.65 Favored Pre-proline 0 C--O 1.249 1.046 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.184 167.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.92 118.55 5.07 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.242 1.961 . . . . 0.0 109.921 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.26 136.19 42.87 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.067 1.845 . . . . 0.0 111.875 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -69.05 -45.27 70.81 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -162.53 155.86 20.22 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.0 p -119.41 114.63 22.62 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.72 153.91 33.62 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.512 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mp0 -114.61 126.43 54.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.832 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 7.6 tt -73.59 113.1 10.33 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -103.26 175.23 5.55 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.449 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -38.22 60.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.023 0.529 . . . . 0.0 111.779 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.419 ' OE1' ' HD2' ' A' ' 121' ' ' LYS . 5.4 tp10 -61.33 -43.68 98.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.353 0.661 . . . . 0.0 109.894 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.55 HD22 HG23 ' A' ' 123' ' ' VAL . 13.8 t-20 -71.95 -38.37 69.79 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.442 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 118' ' ' LEU . 2.3 tm? -63.27 -22.93 67.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.832 1.253 . . . . 0.0 108.801 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -87.24 -0.37 56.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.428 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.24 52.73 Favored Glycine 0 CA--C 1.496 -1.103 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.419 ' HD2' ' OE1' ' A' ' 116' ' ' GLU . 98.4 mttt -86.36 142.29 35.36 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.515 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 48.6 Cg_endo -67.83 121.36 8.4 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.453 2.769 . . . . 0.0 112.401 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.55 HG23 HD22 ' A' ' 117' ' ' ASN . 76.7 t -97.35 119.96 46.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 130.5 34.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.314 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 74' ' ' SER . 0.7 OUTLIER -101.87 178.53 4.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 10.4 mptt -89.7 95.24 10.16 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -109.04 23.61 14.3 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.177 -173.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.6 t -53.05 -38.8 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.627 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -103.98 4.93 35.12 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.876 179.18 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' HE3' ' A' ' 129' ' ' LYS . 55.5 m-85 -108.23 71.89 0.82 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.932 0.873 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.424 ' HG2' ' HE2' ' A' ' 71' ' ' LYS . 46.4 mt-30 -102.49 0.24 33.37 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.444 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -142.37 114.72 8.38 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.456 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.12 107.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -74.35 -44.48 52.14 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.293 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.7 m -157.43 171.33 20.57 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 tp -142.56 131.64 23.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.931 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.9 m -111.46 118.34 35.5 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.0 mp -104.52 114.97 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -110.68 109.71 20.09 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.533 0.682 . . . . 0.0 109.973 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' A' ' 60' ' ' LEU . 7.2 pt -96.71 114.5 33.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.256 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.89 -48.65 5.92 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.664 -173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.92 146.2 48.93 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.664 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.12 -179.55 5.29 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.002 0.814 . . . . 0.0 109.121 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.527 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.3 mp0 -54.72 -62.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 p -93.44 -36.49 12.45 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.6 1.54 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.3 m -84.68 16.63 3.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.271 12.8 pt-20 63.11 -1.0 0.55 Allowed 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 126.147 1.779 . . . . 0.0 114.2 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.94 122.57 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.94 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -93.35 128.31 39.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -116.35 133.49 55.96 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 79.1 t -134.02 128.48 53.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.405 ' HG2' ' HA2' ' A' ' 79' ' ' GLY . 10.0 mm-40 -88.99 -46.35 8.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.386 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.506 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -146.02 142.94 29.11 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.396 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.76 127.19 73.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.34 141.24 41.83 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.37 137.31 52.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 88.3 m-85 -124.39 139.11 54.21 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.235 0.541 . . . . 0.0 111.265 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.29 -176.18 14.25 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 46.9 m -134.04 130.16 37.12 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 117.477 0.639 . . . . 0.0 110.729 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 C--N 1.288 -2.07 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.321 176.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.456 HG23 ' HA ' ' A' ' 14' ' ' VAL . 2.0 mp . . . . . 0 N--CA 1.399 -2.978 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.64 -166.55 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -104.55 109.17 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.414 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.14 -41.69 0.89 Allowed Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -137.8 142.58 40.84 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.449 -0.876 . . . . 0.0 111.214 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.456 ' HA ' HG23 ' A' ' 9' ' ' ILE . 11.6 p -106.52 156.4 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.8 143.97 43.74 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.651 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.6 mp -102.82 7.18 39.52 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.653 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.52 -43.24 85.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.66 -16.67 60.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.662 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.39 -2.85 57.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 16' ' ' LEU . 94.9 mt -74.66 145.38 11.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.6 -42.54 70.84 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 122.751 0.421 . . . . 0.0 111.097 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 72.44 -33.97 0.28 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -79.11 -37.14 39.43 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.832 0.348 . . . . 0.0 110.871 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 17.68 55.28 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.48 -0.867 . . . . 0.0 114.011 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.61 143.64 14.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 117.487 0.643 . . . . 0.0 109.793 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -141.2 134.93 30.22 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.858 0.361 . . . . 0.0 110.395 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 81.2 m -135.72 121.86 20.22 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.045 0.45 . . . . 0.0 111.104 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.452 HD23 HD12 ' A' ' 61' ' ' LEU . 3.5 mm? -83.44 5.94 21.96 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.832 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 57' ' ' ASP . 50.3 t-20 -151.64 -67.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.495 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 4.0 pt20 50.98 25.22 2.14 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 125.342 1.457 . . . . 0.0 112.653 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 m 78.89 112.91 0.07 Allowed 'General case' 0 C--O 1.208 -1.095 0 C-N-CA 125.08 1.352 . . . . 0.0 108.616 -174.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -52.58 -25.27 10.09 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -112.86 -1.89 14.49 Favored 'General case' 0 CA--C 1.562 1.43 0 O-C-N 121.847 -0.533 . . . . 0.0 112.349 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 94.7 m-70 -126.34 166.56 16.93 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.0 m -105.82 166.26 10.6 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.011 -0.431 . . . . 0.0 111.78 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 3.1 tm? -64.92 -50.09 64.66 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 3.0 Cg_endo -46.03 -29.35 6.13 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 123.85 3.033 . . . . 0.0 114.066 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 50' ' ' LEU . 3.2 m-20 -44.47 -48.96 10.07 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.872 1.669 . . . . 0.0 113.375 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -111.19 -7.9 14.42 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.116 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.4 tp -104.23 -42.81 5.4 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.903 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -84.28 103.88 13.84 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 19.9 mm-40 -59.19 127.03 30.11 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.683 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.26 -42.41 1.38 Allowed Glycine 1 N--CA 1.388 -4.559 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.197 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.6 -9.36 44.4 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.144 1.777 . . . . 0.0 115.747 -174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.51 104.33 16.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.734 -0.604 . . . . 0.0 111.503 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 18.1 t70 -70.93 85.58 0.69 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.352 0.596 . . . . 0.0 110.756 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 5.8 mm-40 -167.78 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 127.6 2.36 . . . . 0.0 106.307 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.02 -54.92 0.89 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.913 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 1.4 pt? -140.27 137.8 34.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.43 165.74 34.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 35.0 tp -99.1 128.87 45.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.4 171.05 14.59 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-O 121.723 0.773 . . . . 0.0 112.967 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 71.9 p -96.93 111.47 23.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.33 -50.44 59.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.168 0.508 . . . . 0.0 110.1 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.1 -41.87 0.65 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.128 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 54' ' ' SER . 3.8 m-20 -85.73 112.85 21.44 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.696 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -70.57 -26.82 63.71 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.815 0.697 . . . . 0.0 110.046 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 15.9 pt20 -84.15 113.75 21.29 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.854 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.3 mt -116.4 134.6 54.69 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.404 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.452 HD12 HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -120.44 114.91 22.5 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.12 124.19 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.42 ' HD1' ' OG1' ' A' ' 137' ' ' THR . 69.4 t80 -104.0 123.71 47.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.14 116.36 31.17 Favored Pre-proline 0 N--CA 1.437 -1.109 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.527 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -90.01 153.05 4.84 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.158 1.905 . . . . 0.0 109.794 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -112.2 162.42 15.48 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.141 0.496 . . . . 0.0 112.195 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -87.98 -22.69 24.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.64 156.68 47.78 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.72 114.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.839 0.828 . . . . 0.0 111.008 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 161' ' ' THR . 2.0 pp -129.74 172.96 14.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.164 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.6 ' HG3' ' OXT' ' A' ' 161' ' ' THR . 56.4 mttp -106.44 129.88 54.34 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.301 0.501 . . . . 0.0 109.915 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -77.13 126.14 30.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -116.03 -38.64 3.59 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.727 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 158' ' ' TYR . 26.6 p -147.88 154.11 39.97 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.501 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -130.4 154.98 47.14 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.62 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -143.57 110.25 5.55 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.563 0.345 . . . . 0.0 110.643 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -122.27 134.5 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 53.5 mtpt -129.19 153.58 47.6 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.311 0.577 . . . . 0.0 112.256 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.39 -166.16 29.75 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -71.42 158.04 55.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 122.215 1.943 . . . . 0.0 109.657 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.43 -37.27 86.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.35 -33.61 22.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.12 13.98 33.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.237 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.42 147.61 25.76 Favored Glycine 0 C--N 1.301 -1.406 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.583 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 6.0 Cg_exo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.49 2.127 . . . . 0.0 111.908 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 3.7 tmmm? -95.29 -48.06 6.06 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.729 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -85.8 95.02 9.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.443 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.42 119.03 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.399 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.98 148.21 41.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -132.58 155.21 49.09 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 52.3 p90 -152.29 118.96 5.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.587 0.708 . . . . 0.0 110.673 168.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.2 t -103.53 175.93 5.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.251 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 m120 66.12 23.27 11.02 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.423 0.689 . . . . 0.0 111.615 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -148.25 107.27 3.86 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.184 0.516 . . . . 0.0 109.971 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.96 122.07 30.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.4 m80 71.01 107.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.487 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 51.2 ttm -161.48 128.55 4.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.452 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -90.2 162.62 15.16 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.521 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 50.5 p90 -61.8 -18.5 60.15 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -173.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.8 t -60.87 -36.13 78.41 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.99 0.424 . . . . 0.0 110.315 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.487 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 41.8 m-80 -89.39 -25.07 21.75 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.835 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 40.3 t -62.89 -13.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.263 1.03 . . . . 0.0 110.323 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.23 -20.53 28.36 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.786 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.06 -23.77 13.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.516 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -96.6 133.19 24.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.585 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 24.1 Cg_exo -65.45 126.67 16.62 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.364 2.043 . . . . 0.0 110.657 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 25.1 Cg_exo -64.52 161.5 34.89 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 122.566 2.177 . . . . 0.0 111.253 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 39.6 m -63.34 -45.42 91.31 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 17.7 t70 -158.88 153.78 24.94 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -126.87 115.28 19.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.29 165.08 12.05 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.573 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 8.9 mp0 -123.77 138.25 54.54 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.4 tp -72.64 107.77 5.3 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.5 p -82.16 160.96 22.96 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.15 -30.73 71.25 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.846 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 121' ' ' LYS . 11.4 pt-20 -72.22 -32.52 66.82 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.693 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.62 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.6 t-20 -66.4 -36.89 83.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 2.6 tm? -64.05 -8.0 10.45 Favored 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 126.786 2.035 . . . . 0.0 110.387 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 90.8 mttt -110.94 -6.85 14.62 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.541 0.736 . . . . 0.0 109.498 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 78' ' ' LYS . . . 99.06 30.92 6.45 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.811 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 64.6 tttm -102.37 121.59 49.53 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.523 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.08 112.84 1.34 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.272 2.648 . . . . 0.0 111.458 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 132.52 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.08 136.61 22.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.524 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.525 HD11 HD12 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -115.4 -172.84 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.491 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 109' ' ' ASP . 72.5 mmtt -70.57 89.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -68.5 -21.95 64.57 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.787 1.235 . . . . 0.0 110.52 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.71 -24.89 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.443 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -94.57 -36.21 11.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.346 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -79.08 93.25 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.264 0.554 . . . . 0.0 110.778 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -114.6 -41.06 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -121.95 115.64 22.92 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.887 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.72 102.37 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.973 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -104.17 -24.08 13.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 168.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.3 p -138.74 144.24 39.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.852 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.8 tp -147.27 121.1 9.28 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.42 ' OG1' ' HD1' ' A' ' 63' ' ' TYR . 23.2 m -105.74 132.11 52.26 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.857 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -105.15 117.75 51.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -117.86 107.23 13.85 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.52 0.676 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.637 HG13 ' HB2' ' A' ' 60' ' ' LEU . 11.3 pt -107.1 114.06 45.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.463 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 12.1 pt-20 -105.43 -23.0 12.91 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.28 152.0 44.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.812 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.435 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 31.7 p30 -108.92 170.08 8.27 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.981 -178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 21.0 tp60 -48.32 -60.03 2.98 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.917 1.687 . . . . 0.0 113.799 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.8 m -104.0 7.82 36.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.439 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.36 46.12 94.53 Favored Glycine 0 C--O 1.224 -0.509 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 m -90.5 10.8 23.89 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.21 0.604 . . . . 0.0 112.342 -171.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 43.9 mt-10 69.85 -45.83 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.147 0.979 . . . . 0.0 112.802 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.52 137.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.119 0.485 . . . . 0.0 109.844 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.5 m -120.33 138.31 53.79 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -131.1 135.42 47.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 61.8 t -120.6 125.77 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -86.9 -48.81 7.85 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -153.8 143.17 21.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -177.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.3 mt -121.86 132.3 71.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.44 134.09 26.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -113.56 135.81 53.5 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.414 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 80.1 m-85 -120.01 133.13 55.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.381 0.61 . . . . 0.0 109.908 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -128.87 178.63 17.14 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.5 m -128.82 25.94 5.59 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 117.151 0.476 . . . . 0.0 112.266 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.6 ' OXT' ' HG3' ' A' ' 71' ' ' LYS . 63.8 p . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.643 HG22 ' H ' ' A' ' 11' ' ' LYS . 3.2 mp . . . . . 0 N--CA 1.435 -1.185 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -95.02 29.22 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.552 2.834 . . . . 0.0 110.95 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 9' ' ' ILE . 41.0 ttmt 68.44 106.25 0.05 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.281 1.433 . . . . 0.0 112.16 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.32 -79.84 0.2 Allowed Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.11 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 26.8 mm-40 -109.84 -173.82 2.35 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.57 152.5 8.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 3.1 p30 -74.62 138.95 43.29 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.197 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -78.78 -13.26 59.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.441 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 4.6 tt -59.79 -43.5 94.39 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.174 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -24.72 62.58 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -90.29 14.74 11.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.322 0.582 . . . . 0.0 111.34 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 16' ' ' LEU . 67.3 mt -100.48 134.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.32 -26.04 51.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.738 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 74.09 2.75 4.25 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -88.63 -28.13 20.85 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.946 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.21 23.15 7.74 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 119.33 -1.414 . . . . 0.0 114.515 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.63 133.44 31.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 117.564 0.682 . . . . 0.0 110.838 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.429 ' CG ' ' HB3' ' A' ' 63' ' ' TYR . 11.7 pt-20 -141.06 154.93 46.19 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.217 -0.302 . . . . 0.0 110.809 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HB3' HE21 ' A' ' 30' ' ' GLN . 47.2 t -136.21 141.11 43.97 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.911 0.485 . . . . 0.0 109.836 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 5.7 tt -52.71 -61.48 2.26 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.885 1.274 . . . . 0.0 110.928 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 28.2 t-20 -95.11 -88.8 0.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.613 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.559 HE21 ' HB3' ' A' ' 27' ' ' CYS . 7.8 tt0 55.47 17.88 2.41 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.503 1.144 . . . . 0.0 109.426 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -81.54 -23.5 37.18 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.233 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 34' ' ' HIS . 44.7 t -55.37 -4.75 0.1 Allowed 'General case' 0 CA--C 1.578 2.022 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.976 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 m 80.11 -17.16 0.6 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.35 1.46 . . . . 0.0 110.158 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.799 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 12.7 m170 -71.39 110.82 6.25 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -95.23 164.4 12.87 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -164.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 5.4 tt -63.73 -50.51 71.11 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.417 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 85.2 Cg_exo -53.67 -27.01 40.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.964 1.776 . . . . 0.0 112.835 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.471 ' ND2' HD22 ' A' ' 50' ' ' LEU . 13.4 m120 -59.61 -48.18 82.66 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-O 120.995 0.426 . . . . 0.0 110.338 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HA ' ' HE ' ' A' ' 45' ' ' ARG . . . -102.88 -0.35 31.31 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 44.2 tp -132.34 5.64 4.1 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 119.431 -0.907 . . . . 0.0 113.024 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -121.97 143.72 49.3 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 121.222 -0.924 . . . . 0.0 111.574 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.62 152.13 36.02 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.511 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.85 -52.27 4.69 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.58 -9.61 59.77 Favored 'General case' 0 C--O 1.194 -1.851 0 C-N-CA 123.017 0.527 . . . . 0.0 111.059 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -75.07 -91.83 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.329 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' ARG 0.311 9.3 pt-20 39.39 84.73 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.883 0.849 . . . . 0.0 113.061 -174.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.338 5.6 p-10 -67.24 85.68 0.15 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -169.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 169.91 103.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 107.31 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.32 -99.5 0.44 Allowed Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD22 ' ND2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -77.67 147.19 35.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.799 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.8 p30 -164.59 169.36 17.13 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 52' ' ' LEU . 7.2 tt -105.47 121.87 44.83 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.065 -1.454 . . . . 0.0 108.626 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.33 159.68 41.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.65 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 25.1 p -85.91 177.21 7.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.528 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.7 -64.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.05 68.4 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 54' ' ' SER . 8.5 t70 -131.64 174.44 10.11 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -109.61 -24.58 10.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 141' ' ' GLU . 87.8 mm-40 -84.28 139.46 32.31 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.588 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 29' ' ' ASN . 47.2 mt -135.64 122.39 21.02 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 122.12 0.962 . . . . 0.0 112.725 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.9 tt -130.42 120.96 25.02 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.13 123.02 66.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.429 ' HB3' ' CG ' ' A' ' 26' ' ' GLU . 35.9 t80 -101.38 123.43 45.44 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.18 113.91 32.32 Favored Pre-proline 0 N--CA 1.441 -0.887 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -89.18 139.23 3.55 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.862 2.374 . . . . 0.0 111.051 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.16 163.33 17.91 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.252 35.9 t-20 -104.44 -38.59 6.75 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 111.993 -2.367 . . . . 0.0 106.355 170.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -153.44 144.76 23.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 m -75.09 128.09 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.189 0.519 . . . . 0.0 111.114 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.503 HG22 HG22 ' A' ' 161' ' ' THR . 0.1 OUTLIER -139.34 173.21 11.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -97.37 117.93 32.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 125' ' ' LEU . 2.1 tm? -74.97 123.72 25.65 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -106.19 -48.54 3.56 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.4 p -145.26 160.18 41.89 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -130.37 151.52 50.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.518 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.422 ' C ' HD12 ' A' ' 77' ' ' ILE . . . -148.99 116.69 6.24 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 mp -132.25 122.45 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -99.13 163.25 12.64 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.162 0.506 . . . . 0.0 110.344 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.05 -177.51 48.26 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -74.82 172.36 16.44 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.53 1.665 . . . . 0.0 108.306 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 -56.28 5.29 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.331 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.5 mp0 -63.21 -55.25 26.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.115 0.959 . . . . 0.0 110.896 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -90.62 17.13 7.88 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.404 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.09 159.29 25.33 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.567 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 9.8 Cg_exo -72.54 107.26 2.26 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 119.417 1.608 . . . . 0.0 110.434 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 113' ' ' LEU . 12.6 tmtt? -83.34 -51.39 7.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.94 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.3 m -103.63 108.9 20.37 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.575 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.54 HG12 HG22 ' A' ' 140' ' ' ILE . 30.4 m -108.52 134.91 48.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.047 0.451 . . . . 0.0 111.321 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -121.69 134.26 54.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.31 138.85 47.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.3 m-85 -128.9 118.51 22.81 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.0 p -110.2 133.93 52.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.46 ' C ' ' HE3' ' A' ' 94' ' ' LYS . 86.4 m-20 76.37 -4.29 2.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.557 1.543 . . . . 0.0 114.991 173.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.541 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -88.35 104.43 16.76 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.56 150.11 31.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 72.1 99.63 0.07 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.275 1.03 . . . . 0.0 109.639 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 12.7 mmt -134.35 137.52 44.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.476 ' H ' ' HB2' ' A' ' 101' ' ' ASN . 32.0 p -159.17 -172.16 3.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.558 ' CZ ' HD11 ' A' ' 28' ' ' LEU . 92.7 m-85 -54.75 -44.57 73.71 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.301 0.501 . . . . 0.0 111.621 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 m -62.02 -20.61 64.11 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.495 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.3 m120 -93.67 -47.44 6.8 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.499 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.49 -20.13 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -93.2 -12.98 28.94 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.999 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -99.13 -37.57 9.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.892 0.377 . . . . 0.0 111.628 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -96.83 142.34 24.4 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.427 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.98 143.51 29.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 122.166 1.911 . . . . 0.0 111.293 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.14 163.8 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.413 2.075 . . . . 0.0 111.984 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -72.99 -44.8 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -169.35 171.95 7.5 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t -143.92 145.3 32.17 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.34 172.3 13.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.11 139.41 53.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.324 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 50.9 tp -60.5 112.68 2.07 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.923 0.764 . . . . 0.0 110.902 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.3 p -113.62 172.48 6.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.236 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.19 -24.69 67.35 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.728 0.775 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.31 -34.05 67.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.311 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.551 HD21 HG21 ' A' ' 123' ' ' VAL . 13.5 m120 -71.02 -45.42 63.95 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.269 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.35 -26.43 66.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.705 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.77 -13.75 55.71 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.228 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.88 41.41 23.23 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -95.5 134.96 23.52 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.12 109.94 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.782 1.655 . . . . 0.0 110.161 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.551 HG21 HD21 ' A' ' 117' ' ' ASN . 61.6 t -98.34 131.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.89 105.97 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.54 0.686 . . . . 0.0 111.458 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -83.61 -165.85 1.23 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.767 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -76.97 92.18 3.67 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.165 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.43 -27.55 66.14 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.615 1.566 . . . . 0.0 111.753 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.41 -16.04 16.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -80.82 -51.1 8.99 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.817 0.818 . . . . 0.0 110.149 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 90.33 6.63 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.178 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -98.91 -31.42 11.84 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.131 0.491 . . . . 0.0 110.272 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -149.39 119.55 7.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.395 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.09 112.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.742 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -92.65 -45.58 8.0 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -141.1 139.68 34.04 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.444 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.8 tp -131.69 125.31 31.77 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.233 0.54 . . . . 0.0 110.152 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 96.2 m -106.97 126.54 52.46 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.565 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 157' ' ' LEU . 62.6 mt -104.7 109.49 27.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 49.2 t80 -113.59 111.23 21.52 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.106 0.479 . . . . 0.0 110.646 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.54 HG22 HG12 ' A' ' 88' ' ' VAL . 30.9 pt -100.94 113.72 37.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 14.7 pt-20 -99.59 -12.94 19.65 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.643 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.76 142.32 10.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 118.99 -1.084 . . . . 0.0 113.385 -175.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.71 -173.76 2.47 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 170.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -60.49 -56.03 26.26 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.1 m -124.64 6.58 8.2 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.826 -169.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.82 60.9 3.48 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.2 m -83.07 17.34 2.0 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.898 0.879 . . . . 0.0 111.766 -174.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 78.51 -32.05 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 112.794 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.5 147.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 92.5 m -114.05 124.27 51.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HE3' HD21 ' A' ' 51' ' ' ASN . 88.1 tttt -111.37 134.35 53.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 123.174 0.589 . . . . 0.0 110.071 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 44.5 t -125.23 126.12 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -97.42 -11.44 23.9 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 39.8 ttmt -170.15 130.45 0.95 Allowed 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.82 -0.55 . . . . 0.0 111.449 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.95 116.65 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.29 121.09 21.91 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.444 HD11 HD11 ' A' ' 138' ' ' ILE . 84.1 mt -117.45 144.62 44.84 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 88.0 m-85 -126.24 145.47 50.38 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.818 0.342 . . . . 0.0 111.629 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -148.46 -168.64 14.62 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.384 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.5 p -151.07 140.65 21.63 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 122.5 0.32 . . . . 0.0 110.504 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 HG22 ' A' ' 70' ' ' ILE . 40.4 p . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.631 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.3 mm . . . . . 0 N--CA 1.421 -1.904 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HG2' HE21 ' A' ' 13' ' ' GLN . 59.1 Cg_endo -95.56 -178.9 0.51 Allowed 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 122.432 2.088 . . . . 0.0 110.468 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -76.37 131.25 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.49 -51.55 0.83 Allowed Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.155 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.541 HE21 ' HG2' ' A' ' 10' ' ' PRO . 1.6 pm0 -130.84 172.15 12.35 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 159' ' ' GLY . 14.5 p -118.04 154.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.79 147.47 37.21 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 20' ' ' ILE . 66.4 mt -108.27 17.75 21.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.8 -43.47 75.56 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -83.06 -11.7 57.8 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.507 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.99 0.93 42.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.904 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 16' ' ' LEU . 70.9 mt -86.72 140.39 15.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.22 -28.9 31.68 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.544 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CH2' HD12 ' A' ' 40' ' ' LEU . 98.9 m95 76.45 -4.37 2.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 t -102.89 -30.76 10.63 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.61 -0.39 66.98 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.706 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.4 m -64.83 139.2 21.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 117.146 0.473 . . . . 0.0 111.453 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.35 143.77 27.08 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HB3' ' NE2' ' A' ' 30' ' ' GLN . 51.6 t -137.39 140.32 41.29 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.9 mm? -123.69 90.92 3.36 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.177 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' LEU . 10.7 t30 152.47 -17.29 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.963 1.305 . . . . 0.0 111.83 170.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -54.74 -14.73 1.48 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 122.897 0.479 . . . . 0.0 111.681 176.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.4 t -58.81 -21.96 57.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.621 1.169 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.53 ' HB2' ' H ' ' A' ' 56' ' ' ALA . 33.7 p -77.14 -14.96 59.71 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 33.1 t -154.75 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.603 ' O ' ' HB2' ' A' ' 30' ' ' GLN . 68.7 m-70 -124.35 162.95 22.74 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -88.82 172.87 8.89 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -169.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -70.52 -55.3 7.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.16 -20.13 36.89 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.08 1.853 . . . . 0.0 111.85 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 2.4 m-20 -58.04 -41.54 83.45 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 124.839 1.255 . . . . 0.0 111.628 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -110.96 6.63 21.21 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.21 0.529 . . . . 0.0 110.659 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.612 HD12 ' CH2' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -105.22 -43.22 5.07 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -79.83 130.4 35.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.135 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -45.82 139.04 4.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.239 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.28 -52.89 4.38 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 114.935 -1.029 . . . . 0.0 114.179 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -67.47 -28.74 68.12 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.24 -13.12 16.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.139 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -48.49 119.55 3.12 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.652 0.595 . . . . 0.0 110.596 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 153' ' ' GLN 0.258 4.8 p-10 -72.49 96.62 1.96 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -169.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 175.91 -52.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.356 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.54 -69.62 1.37 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.691 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -128.78 145.37 51.2 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.967 0.413 . . . . 0.0 111.107 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 3.5 p-10 -159.08 166.38 31.77 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 53.5 tp -84.22 130.04 34.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 35.5 tt0 -143.0 135.54 27.54 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.146 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.62 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 46.1 p -110.45 112.83 25.01 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 12.1 t70 -94.32 -44.72 7.8 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 120.796 0.331 . . . . 0.0 111.591 -175.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.53 ' H ' ' HB2' ' A' ' 32' ' ' SER . . . -81.78 -57.93 3.22 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.211 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 54' ' ' SER . 11.5 m-20 -106.87 141.88 37.39 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.964 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.49 4.3 47.1 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.575 1.179 . . . . 0.0 109.319 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.92 120.9 43.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.395 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 HD12 HD22 ' A' ' 29' ' ' ASN . 9.1 tt -141.26 130.57 23.63 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.52 0.676 . . . . 0.0 111.028 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 62' ' ' ILE . 1.1 tm? -101.79 134.13 45.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.914 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 61' ' ' LEU . 29.9 mt -129.19 129.98 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -112.71 115.73 29.0 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.11 116.76 31.02 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.45 144.35 4.72 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.515 2.143 . . . . 0.0 110.925 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.11 143.87 36.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.788 0.804 . . . . 0.0 112.854 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -56.51 -42.63 78.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 126.413 1.885 . . . . 0.0 110.515 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -142.71 154.36 44.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.95 123.42 38.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 121.525 0.679 . . . . 0.0 111.513 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -130.52 173.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.74 127.47 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.15 109.27 15.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.405 ' H ' ' HA2' ' A' ' 159' ' ' GLY . 14.4 t60 -91.53 -52.04 4.97 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.41 . . . . 0.0 111.237 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 p -140.36 157.12 46.03 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.194 0.521 . . . . 0.0 111.89 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.58 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 35.4 p90 -127.1 152.55 47.16 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -144.17 106.43 4.37 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.784 0.326 . . . . 0.0 111.722 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 62.4 mt -111.18 118.16 56.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 154' ' ' LYS . 10.0 tmtt? -101.79 134.83 44.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.11 -176.21 41.48 Favored Glycine 0 N--CA 1.414 -2.812 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.007 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.85 151.87 57.44 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.755 2.304 . . . . 0.0 110.521 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -61.66 -34.02 74.97 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.21 -38.12 11.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.79 18.26 16.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.351 -173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.49 148.1 19.13 Favored Glycine 0 C--N 1.299 -1.516 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.891 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.3 107.48 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 CA-C-N 119.328 1.564 . . . . 0.0 110.058 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 31.5 ttpt -85.75 -55.12 4.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.131 0.491 . . . . 0.0 110.477 -173.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -82.29 103.84 12.17 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.245 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.21 136.93 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.812 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.52 151.14 50.47 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 136' ' ' LEU . 47.4 m-85 -126.17 155.93 40.96 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -105.97 161.5 14.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.9 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.9 p -95.95 79.27 3.24 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 38.04 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -151.94 166.97 29.86 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -101.77 146.51 27.68 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.579 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 51.99 84.41 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.48 1.112 . . . . 0.0 112.125 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 17.3 tpt -119.09 110.51 17.16 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 23.7 p -124.49 -170.7 2.2 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 83.3 t80 -63.62 -26.03 68.49 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 118.838 0.744 . . . . 0.0 111.639 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.8 m -71.16 -8.64 54.91 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.661 0.743 . . . . 0.0 110.4 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.585 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 12.1 m120 -105.64 -20.17 13.54 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.473 1.109 . . . . 0.0 110.35 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 55.5 t -58.39 -39.69 75.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.32 10.51 37.78 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.43 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -120.37 -35.77 3.36 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 90.6 m-85 -96.46 127.64 39.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 O-C-N 121.953 -0.467 . . . . 0.0 111.801 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 59.1 Cg_exo -54.11 129.56 35.01 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.893 3.062 . . . . 0.0 114.036 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 71.7 Cg_endo -80.79 156.55 20.95 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.648 2.232 . . . . 0.0 110.885 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.1 m -84.32 -45.9 12.32 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.896 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.476 ' HB2' ' HE2' ' A' ' 129' ' ' LYS . 28.9 t70 -163.07 171.71 16.02 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.1 p -127.96 119.9 26.48 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB1' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.98 152.42 24.98 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.429 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 39.9 tt0 -126.49 125.6 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.555 HD23 HE22 ' A' ' 144' ' ' GLN . 19.6 tp -66.96 145.57 55.29 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.571 HG23 ' H ' ' A' ' 117' ' ' ASN . 2.8 t -135.23 163.67 29.43 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -58.63 -27.29 64.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.672 0.749 . . . . 0.0 110.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -65.52 -51.4 60.24 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.026 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.667 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.3 t-20 -65.31 -49.4 69.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.915 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 3.0 pp -71.31 -9.45 58.16 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -89.59 3.72 51.67 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.24 33.66 6.17 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.682 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.2 tmtp? -115.96 120.75 35.02 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 117.271 0.536 . . . . 0.0 109.675 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 32.5 Cg_exo -58.69 117.72 4.49 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 C-N-CA 123.574 2.849 . . . . 0.0 112.29 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.468 HG23 ' ND2' ' A' ' 117' ' ' ASN . 80.9 t -93.51 131.06 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -73.68 123.29 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.439 HD23 ' CD1' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -98.7 174.52 6.37 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.827 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -86.51 89.96 8.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 130' ' ' PHE . 45.2 p90 -101.52 21.17 14.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.423 ' C ' HE22 ' A' ' 131' ' ' GLN . 35.0 m -64.78 -3.76 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -123.02 1.01 9.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.404 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.0 m-85 -101.03 78.62 1.94 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.423 HE22 ' C ' ' A' ' 128' ' ' VAL . 2.0 mp0 -92.2 -32.36 15.11 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.303 0.573 . . . . 0.0 110.023 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -141.78 121.62 13.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.772 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.56 108.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -96.4 -40.33 9.15 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 m -138.13 136.39 36.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 90' ' ' PHE . 44.1 tp -126.74 119.84 27.91 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.282 0.563 . . . . 0.0 110.236 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 93.6 m -102.27 121.32 42.03 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.591 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.4 mt -104.71 113.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 82.3 t80 -111.5 116.91 31.68 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.5 pp -106.91 136.03 43.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.633 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.0 pt-20 -123.47 -13.73 7.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.61 146.03 20.61 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.148 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -97.85 174.83 6.39 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.555 HE22 HD23 ' A' ' 113' ' ' LEU . 18.3 mp0 -60.47 -52.54 64.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.001 0.429 . . . . 0.0 110.855 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.3 t -92.04 -22.19 20.08 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.369 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.33 81.54 0.45 Allowed Glycine 0 CA--C 1.499 -0.928 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 149' ' ' VAL . 34.4 m -111.78 6.21 19.58 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.427 -0.386 . . . . 0.0 111.868 -172.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 67.76 -36.16 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.496 1.118 . . . . 0.0 112.72 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' SER . 4.6 p -102.87 132.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 123.498 0.719 . . . . 0.0 109.674 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.62 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 61.3 m -121.39 128.83 52.61 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.422 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 40.1 ttmt -109.9 132.66 53.95 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 19.4 t -123.71 116.3 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 97.5 mt-30 -94.77 -19.48 20.32 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.363 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -172.34 134.33 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.588 0.355 . . . . 0.0 110.563 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.496 ' HB ' HD22 ' A' ' 40' ' ' LEU . 1.8 mp -129.88 117.85 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.93 147.78 35.81 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.897 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.54 141.18 48.07 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 122' ' ' PRO . 82.2 m-85 -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 14' ' ' VAL . . . -139.58 -168.34 11.27 Favored Glycine 0 CA--C 1.488 -1.651 0 C-N-CA 119.909 -1.138 . . . . 0.0 112.487 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.3 p -163.08 147.89 11.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 120.487 0.184 . . . . 0.0 110.883 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.411 HG23 HG22 ' A' ' 70' ' ' ILE . 18.0 p . . . . . 0 C--N 1.297 -1.716 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.382 170.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 11' ' ' LYS . 4.2 mp . . . . . 0 C--O 1.237 0.443 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.7 25.25 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.06 2.507 . . . . 0.0 110.887 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.639 ' H ' HG22 ' A' ' 9' ' ' ILE . 40.6 ttmt 61.85 99.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.767 1.227 . . . . 0.0 111.272 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.55 -78.83 0.19 Allowed Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.488 ' O ' HG23 ' A' ' 9' ' ' ILE . 28.0 mm-40 -109.7 168.42 9.42 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 15.5 m -105.34 156.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.886 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 17' ' ' LEU . 3.3 p30 -78.28 112.63 15.47 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 122.694 1.235 . . . . 0.0 109.531 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.603 ' O ' HG13 ' A' ' 20' ' ' ILE . 36.9 mt -68.65 6.04 0.93 Allowed 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.639 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.51 HD11 ' H ' ' A' ' 42' ' ' GLN . 5.2 tt -60.42 -41.65 94.38 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.67 -22.01 60.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.173 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 32.8 m-85 -93.71 15.11 17.17 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.982 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 16' ' ' LEU . 86.8 mt -95.97 134.95 31.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.52 -44.38 96.11 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 94.4 m95 66.46 7.19 4.84 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.96 -84.96 1.66 Allowed Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.497 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 t 39.16 84.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.951 1.3 . . . . 0.0 111.87 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -117.5 131.53 56.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.127 -168.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . 49.1 t -129.18 130.99 47.05 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.25 -72.01 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -70.69 -59.55 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 35.0 tt0 59.78 27.53 16.84 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.172 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 30.0 t 71.06 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.135 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -57.83 -34.12 69.34 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.238 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -109.67 -48.14 3.26 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 31' ' ' SER . 97.9 m-70 -99.58 164.92 11.87 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -169.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.432 ' C ' HD23 ' A' ' 52' ' ' LEU . 16.2 m -100.82 141.5 33.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.734 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 3.0 tm? -62.37 -46.38 90.09 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.094 0.558 . . . . 0.0 112.281 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 9.9 Cg_endo -52.04 -24.45 19.69 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.275 1.984 . . . . 0.0 112.492 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.545 ' HB3' HD13 ' A' ' 50' ' ' LEU . 96.6 m-20 -69.03 -19.3 64.11 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -110.2 1.22 18.57 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.232 0.539 . . . . 0.0 110.573 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -124.36 -40.36 2.25 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.36 103.52 16.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.151 0.5 . . . . 0.0 111.066 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' H ' HD11 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -75.51 113.35 12.83 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.98 -50.43 0.43 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 105.772 -2.931 . . . . 0.0 105.772 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -89.7 -41.27 12.01 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 153' ' ' GLN . 54.2 ttp180 -73.53 122.17 21.78 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.275 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.54 106.77 8.73 Favored 'General case' 0 C--N 1.262 -3.206 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 165.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 153' ' ' GLN 0.335 7.7 p-10 -64.03 84.54 0.03 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -166.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 160.42 99.71 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 128.758 2.823 . . . . 0.0 104.401 175.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.46 -103.47 0.46 Allowed Glycine 0 C--N 1.303 -1.271 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 38' ' ' ASN 0.251 1.9 pp -77.09 125.73 29.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.941 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -154.44 165.72 35.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 36' ' ' LEU . 2.9 tm? -94.84 112.13 23.87 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.5 pt-20 -131.15 121.33 24.7 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.771 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -69.59 149.23 48.39 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -103.99 -28.52 11.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.64 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.83 -53.87 2.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.042 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.74 158.36 44.08 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 117.489 -1.685 . . . . 0.0 115.333 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 41.9 mt-10 -70.15 -33.22 71.51 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.32 1.048 . . . . 0.0 112.119 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.25 109.54 12.46 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.657 0.741 . . . . 0.0 111.131 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' H ' HG13 ' A' ' 140' ' ' ILE . 14.7 tp -116.42 134.22 55.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.93 127.69 49.26 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -144.34 127.52 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 CA-C-O 121.473 0.654 . . . . 0.0 111.547 177.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 5.1 t80 -91.89 123.88 35.6 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.614 1.566 . . . . 0.0 111.414 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.426 HG23 HG23 ' A' ' 20' ' ' ILE . 35.3 mt -120.79 120.29 29.59 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -89.66 152.38 5.17 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.944 2.429 . . . . 0.0 111.178 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -88.15 162.79 16.53 Favored 'General case' 0 CA--C 1.474 -1.955 0 CA-C-O 121.919 0.866 . . . . 0.0 112.752 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -99.45 -32.94 10.89 Favored 'General case' 0 N--CA 1.404 -2.775 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.662 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.67 145.99 25.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.1 t -73.74 108.75 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.457 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -133.02 173.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -90.75 133.24 35.32 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.18 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.646 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.2 121.46 27.11 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.27 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -115.23 -46.16 2.91 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -153.62 169.23 23.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -139.88 154.49 47.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -141.1 117.33 10.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.415 HG23 HG12 ' A' ' 155' ' ' ILE . 60.0 mt -126.72 119.84 54.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.34 144.35 25.96 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.68 176.31 34.81 Favored Glycine 1 C--N 1.253 -4.08 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.69 178.09 6.14 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 CA-C-N 119.612 1.706 . . . . 0.0 111.03 175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -68.56 -44.35 74.66 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.402 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.59 -53.31 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.82 12.33 2.73 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 147.69 28.89 Favored Glycine 0 C--O 1.251 1.191 0 C-N-CA 120.134 -1.032 . . . . 0.0 110.768 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_endo -77.12 115.99 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.847 1.698 . . . . 0.0 110.209 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.631 ' HE3' ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -87.06 -71.04 0.58 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.025 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.8 m -75.34 102.05 4.96 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.488 0.661 . . . . 0.0 111.28 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 140' ' ' ILE . 34.9 m -101.76 144.44 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.397 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -133.75 133.79 42.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.91 146.06 43.21 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.672 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' ' 102' ' ' VAL . 95.1 m-85 -129.82 115.06 16.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 m -103.3 154.76 19.03 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 120.87 0.367 . . . . 0.0 110.748 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 73.96 -42.12 0.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.25 1.42 . . . . 0.0 112.853 173.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -69.08 122.44 18.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 0.0 110.081 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.565 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 35.9 tt0 -93.68 122.34 36.04 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.279 -174.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t60 58.4 96.08 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 124.174 0.989 . . . . 0.0 112.923 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 53.0 mtm -131.34 155.59 46.97 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.152 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' VAL . 24.5 p -109.19 -179.16 3.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -58.68 -30.6 67.51 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.838 0.455 . . . . 0.0 111.706 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 t -62.29 -41.61 98.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.057 0.455 . . . . 0.0 109.859 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 104' ' ' ASP . 94.7 m-20 -85.88 -15.8 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 98' ' ' CYS . 51.3 t -62.0 -29.23 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.588 0.709 . . . . 0.0 110.121 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.84 9.29 39.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.597 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 20.6 t70 -109.13 -48.27 3.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.414 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -97.5 127.01 39.33 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 53.0 Cg_exo -57.97 136.35 74.55 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.801 2.334 . . . . 0.0 111.782 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 19.2 Cg_exo -66.28 158.03 57.07 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.723 2.282 . . . . 0.0 112.878 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -70.19 -45.77 65.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -164.84 157.44 16.35 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -141.16 117.06 10.45 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.58 172.5 11.51 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.944 -170.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.2 mp0 -117.04 137.81 52.01 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.9 tp -61.55 113.09 2.5 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.704 0.801 . . . . 0.0 109.049 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.6 t -107.11 165.45 11.35 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.57 -37.44 62.93 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.202 0.525 . . . . 0.0 111.57 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.14 -35.05 70.93 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.634 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.67 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -71.31 -36.87 71.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.756 -175.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.85 -21.84 65.16 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -83.61 6.68 19.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.979 0.895 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.32 26.3 64.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.438 -1.256 . . . . 0.0 113.591 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -92.57 135.02 26.97 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.944 0.372 . . . . 0.0 111.492 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.519 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 35.5 Cg_endo -65.51 109.46 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.323 2.682 . . . . 0.0 112.465 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.9 t -86.97 132.25 32.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.1 m -80.59 132.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.582 0.706 . . . . 0.0 112.67 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.37 -178.92 3.8 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.696 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.58 105.36 0.2 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.826 0.822 . . . . 0.0 111.102 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -111.1 -22.69 11.32 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.416 -170.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.1 t -71.2 -27.52 29.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.362 0.601 . . . . 0.0 111.028 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -96.63 -10.28 27.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.563 0.697 . . . . 0.0 110.538 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.539 ' HB3' HD11 ' A' ' 72' ' ' LEU . 83.2 m-85 -120.43 112.7 19.31 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -123.77 -0.64 8.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.302 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -149.21 127.55 12.19 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.974 -175.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.9 t -97.58 115.07 36.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.523 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' SER . 12.7 mmm180 -115.19 -0.38 13.28 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.261 174.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' ARG . 12.0 t 171.98 163.67 0.1 Allowed 'General case' 0 C--O 1.252 1.214 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -155.56 119.88 4.63 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.128 0.489 . . . . 0.0 110.012 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.1 m -108.76 126.92 53.54 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.5 mp -104.38 124.09 58.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -124.36 131.0 53.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.425 HG22 HG12 ' A' ' 88' ' ' VAL . 26.3 pt -116.02 132.01 66.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.582 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -107.41 -31.08 8.31 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.16 143.7 27.26 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.433 0.635 . . . . 0.0 111.899 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.465 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 5.8 m-20 -96.56 163.07 13.19 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.043 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.631 ' OE1' ' HE3' ' A' ' 86' ' ' LYS . 6.4 tp-100 -47.94 -45.73 31.34 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 112.778 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.2 t -122.55 16.2 10.38 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.497 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.44 4.3 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.6 m -96.09 11.87 32.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.319 13.0 pt-20 63.3 -23.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.368 1.867 . . . . 0.0 115.163 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.78 158.93 37.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 27.6 m -121.45 136.93 54.91 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 121.338 -0.145 . . . . 0.0 111.231 -175.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -114.99 134.23 55.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 27.5 m -129.71 122.09 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 110.013 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 18.3 mm-40 -87.96 -44.73 10.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.054 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.64 111.49 5.07 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.877 -174.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.415 HG12 HG23 ' A' ' 77' ' ' ILE . 65.9 mt -109.54 125.52 66.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.84 144.46 32.53 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.107 0.48 . . . . 0.0 110.488 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 5.3 mp -106.88 138.16 43.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 98.7 m-85 -125.22 135.34 52.46 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.033 0.444 . . . . 0.0 112.046 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -158.0 -156.97 8.19 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.9 t -153.23 149.44 27.97 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.749 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 C--O 1.255 1.355 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.137 174.188 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.408 ' CG1' ' HB2' ' A' ' 15' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.28 130.98 26.87 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.484 1.456 . . . . 0.0 110.677 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -69.21 99.17 1.11 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.68 -36.38 0.63 Allowed Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.449 ' HA ' ' OG ' ' A' ' 160' ' ' SER . 28.9 mm-40 -120.35 -173.98 2.69 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -134.41 153.42 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 11.1 t0 -71.42 127.98 34.34 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 20' ' ' ILE . 57.3 mt -76.51 -1.45 27.34 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.37 -36.03 41.39 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.809 0.814 . . . . 0.0 109.306 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.31 -24.22 66.5 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.001 -175.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -106.52 7.06 30.67 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 16' ' ' LEU . 77.3 mt -85.34 136.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.96 115.17 27.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -88.52 10.09 21.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.9 m -97.79 -33.8 11.13 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.318 0.58 . . . . 0.0 109.438 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.82 -18.89 53.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.945 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG21 HD12 ' A' ' 36' ' ' LEU . 7.1 p -48.61 126.06 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.02 143.84 49.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.805 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 80.2 m -136.47 133.42 36.57 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.037 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -61.13 -40.57 94.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.746 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.567 ' HB3' HD12 ' A' ' 60' ' ' LEU . 62.2 t30 -126.65 149.28 49.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.55 ' NE2' ' HB2' ' A' ' 27' ' ' CYS . 4.1 pt20 164.1 -5.63 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 126.791 2.036 . . . . 0.0 107.007 -168.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 30' ' ' GLN . 38.9 t -65.66 -19.61 65.97 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.682 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 m -55.44 16.83 0.0 OUTLIER 'General case' 0 CA--C 1.594 2.642 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.6 t 75.33 -1.05 3.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.17 0.988 . . . . 0.0 113.218 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -125.05 153.0 43.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -107.27 167.62 9.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.903 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.525 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.1 tm? -57.52 -49.72 92.25 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.632 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 4.6 Cg_endo -48.98 -25.99 9.56 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.866 2.378 . . . . 0.0 112.879 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.532 ' HA ' HD12 ' A' ' 50' ' ' LEU . 2.1 m-20 -60.93 -31.68 71.21 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.24 0.616 . . . . 0.0 111.607 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.521 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -121.96 23.53 9.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.09 0.472 . . . . 0.0 110.329 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 155' ' ' ILE . 0.7 OUTLIER -139.91 -36.7 0.49 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.72 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -78.32 105.98 9.93 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-O 121.237 0.542 . . . . 0.0 111.051 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HG2' ' NH2' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -49.91 118.2 2.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.3 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.17 -62.26 0.59 Allowed Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.588 ' HB3' ' HG ' ' A' ' 50' ' ' LEU . 21.7 m-85 -99.03 -11.08 21.82 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.722 -0.281 . . . . 0.0 110.349 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.524 ' NH2' ' HG2' ' A' ' 42' ' ' GLN 0.371 3.4 ppt_? -70.26 -4.69 23.09 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 -170.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -83.33 156.6 22.95 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.367 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.03 145.63 41.28 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 81.86 2.14 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.992 1.717 . . . . 0.0 111.735 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.443 ' O ' HD23 ' A' ' 50' ' ' LEU . . . -95.98 -86.01 1.74 Allowed Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' A' ' 44' ' ' TYR . 7.1 mt -135.24 170.31 16.12 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.5 p-10 -157.86 152.83 25.42 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 119.115 0.87 . . . . 0.0 109.272 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.521 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 55.2 tp -87.11 142.58 27.81 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.68 148.97 44.67 Favored 'General case' 0 C--N 1.255 -3.505 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.583 ' HB3' ' H ' ' A' ' 150' ' ' THR . 23.3 t -112.75 21.37 15.6 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.648 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.39 84.93 0.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.109 0.48 . . . . 0.0 111.116 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 174.29 -44.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.778 1.631 . . . . 0.0 107.952 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -140.26 157.62 45.3 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.416 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 148' ' ' GLU . 0.8 OUTLIER -79.17 -25.33 42.8 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -177.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -101.97 151.04 22.59 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.497 0.665 . . . . 0.0 110.705 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 29' ' ' ASN . 24.2 tp -134.89 131.33 37.2 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 5.6 tt -140.66 127.63 20.68 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.63 132.07 71.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -106.82 122.86 47.23 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.222 0.609 . . . . 0.0 109.537 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -116.83 119.91 34.79 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.981 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -95.92 123.0 0.28 Allowed 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.757 2.304 . . . . 0.0 111.319 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.62 155.27 17.38 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.763 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -73.36 -14.76 61.34 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -157.95 177.72 11.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 29.5 m -89.03 132.4 33.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.728 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.91 171.92 11.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.488 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -85.35 113.75 21.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.79 154.48 41.9 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 40.5 t60 -153.49 -67.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 p -142.18 152.44 43.16 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.426 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 42.0 p90 -125.55 155.19 41.04 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.78 116.7 6.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.775 0.321 . . . . 0.0 110.528 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG23 HG12 ' A' ' 155' ' ' ILE . 63.9 mt -119.75 134.41 63.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -123.97 168.51 12.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.028 0.442 . . . . 0.0 110.162 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 153' ' ' GLN . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.33 134.72 23.27 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 CA-C-N 119.61 1.705 . . . . 0.0 108.547 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.48 -37.37 62.63 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.43 -36.43 19.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.72 0.16 56.73 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.15 33.03 Favored Glycine 0 C--O 1.26 1.726 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.033 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.8 Cg_endo -84.24 125.54 3.52 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.853 2.369 . . . . 0.0 111.323 -176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 32.8 ttpt -91.26 -72.09 0.6 Allowed 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.946 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.4 m -77.93 97.58 5.36 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.105 0.479 . . . . 0.0 110.072 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 140' ' ' ILE . 24.3 m -108.59 139.52 30.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.484 ' CG ' ' HB3' ' A' ' 139' ' ' PHE . 18.2 ptpt -125.39 155.3 40.59 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 24.6 m-85 -132.07 151.19 51.9 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.553 ' CE2' ' HB ' ' A' ' 137' ' ' THR . 22.5 p90 -154.72 149.94 27.07 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 123.528 0.517 . . . . 0.0 109.838 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.8 m -127.22 155.77 42.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 69.67 -37.93 0.39 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.087 2.155 . . . . 0.0 116.015 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.589 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 1.1 tpmt? -75.19 109.41 8.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.135 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.03 149.18 24.15 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 65.52 62.48 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 109.13 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.3 tpp -134.77 110.13 9.02 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.251 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.476 ' O ' HG13 ' A' ' 102' ' ' VAL . 75.2 m -129.41 -172.22 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -52.13 -29.9 23.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -88.8 -1.39 58.06 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.967 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -118.29 -32.45 4.66 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.83 0.348 . . . . 0.0 110.104 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 98' ' ' CYS . 31.0 m -58.62 -15.58 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -171.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -93.1 73.57 4.68 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.664 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 172.69 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.74 1.216 . . . . 0.0 110.53 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.76 128.31 40.08 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.22 122.58 11.36 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.937 2.425 . . . . 0.0 112.61 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 91' ' ' PHE . 83.2 Cg_endo -82.08 -178.56 4.17 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 122.26 1.974 . . . . 0.0 110.711 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.618 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 18.3 m -76.78 -47.17 22.43 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 110' ' ' THR . 18.7 t70 172.58 -167.1 0.02 OUTLIER 'General case' 0 C--O 1.248 0.999 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.409 ' H ' ' CG ' ' A' ' 109' ' ' ASP . 7.4 t -148.99 143.18 25.95 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.84 12.13 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.695 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 33.5 mt-10 -120.92 140.26 52.09 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 124.227 1.011 . . . . 0.0 110.252 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 57.8 tp -59.58 101.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.078 0.861 . . . . 0.0 110.322 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 117' ' ' ASN . 4.4 t -95.26 164.43 12.85 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.978 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.5 -23.89 59.12 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.616 0.766 . . . . 0.0 110.385 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.515 ' OE2' HG22 ' A' ' 123' ' ' VAL . 31.0 tt0 -71.88 -45.41 61.38 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.515 ' H ' HG23 ' A' ' 114' ' ' THR . 2.3 m120 -65.42 -47.78 75.08 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.951 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.18 -30.84 66.73 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.599 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -92.41 -1.82 56.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.328 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.8 20.49 26.27 Favored Glycine 0 CA--C 1.494 -1.266 0 C-N-CA 120.318 -0.944 . . . . 0.0 114.727 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 1.0 OUTLIER -95.81 134.46 23.98 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.821 177.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 12.7 Cg_exo -70.86 109.83 2.63 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.426 2.084 . . . . 0.0 111.271 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.515 HG22 ' OE2' ' A' ' 116' ' ' GLU . 94.3 t -87.5 128.24 40.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.7 m -77.56 125.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.164 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.49 175.91 6.5 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.46 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . 0.313 50.0 mtmt -91.48 84.94 5.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.898 1.332 . . . . 0.0 113.782 -175.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.54 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 36.2 p90 -87.94 19.16 3.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.848 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -60.01 -29.1 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -107.22 10.72 29.85 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.434 174.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.618 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 91.4 m-85 -123.47 86.28 2.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 112.074 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -105.63 -9.19 17.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 3.6 p-10 -144.08 113.69 7.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.813 0.816 . . . . 0.0 111.304 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 65.9 t -122.53 120.65 61.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.032 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.453 ' HB2' HG12 ' A' ' 69' ' ' VAL . 43.1 ttp180 -103.0 -38.92 7.13 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.1 m -120.72 134.0 55.31 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.3 tp -126.02 140.24 52.77 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.553 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 22.8 m -134.21 131.36 38.46 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 3.0 mp -111.7 128.04 68.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HB3' ' CG ' ' A' ' 89' ' ' LYS . 51.6 t80 -122.76 126.31 47.21 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.556 HG12 ' H ' ' A' ' 60' ' ' LEU . 24.2 pt -95.42 129.2 45.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 117.98 -1.488 . . . . 0.0 107.505 172.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -93.92 -24.03 17.85 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.214 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -166.2 142.76 5.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.084 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -90.82 161.79 15.12 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.488 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 6.8 tp-100 -46.23 -44.86 16.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.058 0.943 . . . . 0.0 112.227 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.5 p -124.42 9.87 8.51 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.298 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 59.62 70.62 0.95 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 149' ' ' VAL . 22.8 t -86.7 -10.11 54.45 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.921 -165.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 40.0 mt-10 66.9 -44.6 0.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.291 0.637 . . . . 0.0 110.869 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 147' ' ' SER . 3.3 p -119.34 96.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-O 122.386 1.089 . . . . 0.0 109.197 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.583 ' H ' ' HB3' ' A' ' 54' ' ' SER . 31.1 m -82.15 119.65 24.32 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.587 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.16 132.36 35.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.3 t -119.71 115.49 47.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.035 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.477 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 53.3 tt0 -71.69 -63.7 1.07 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -160.48 145.19 14.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.375 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.501 ' O ' HD22 ' A' ' 40' ' ' LEU . 78.3 mt -120.5 114.64 44.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.32 160.81 36.23 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.94 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 6.7 tt -147.23 140.43 25.28 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.466 ' N ' HD23 ' A' ' 157' ' ' LEU . 76.9 m-85 -114.67 141.91 47.17 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.333 0.587 . . . . 0.0 110.19 -175.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -156.89 -165.3 14.65 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 13' ' ' GLN . 75.4 m -164.72 167.42 19.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.993 0.897 . . . . 0.0 109.046 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.264 -3.138 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.756 175.204 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.26 178.73 7.12 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.762 2.308 . . . . 0.0 111.827 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -97.75 101.5 13.02 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.48 -39.68 0.7 Allowed Glycine 0 C--N 1.303 -1.292 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.543 ' HG3' ' OG ' ' A' ' 74' ' ' SER . 1.4 pm0 -135.48 149.37 49.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.818 0.847 . . . . 0.0 109.766 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 4.4 m -111.37 170.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 123.431 0.457 . . . . 0.0 110.501 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.0 98.64 0.78 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.457 1.122 . . . . 0.0 110.285 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 16' ' ' LEU . 2.4 tm? -55.72 -23.81 31.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.267 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.9 tt -53.0 -35.95 59.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.311 1.044 . . . . 0.0 110.986 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.0 -20.45 61.01 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -94.65 22.33 6.39 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.096 0.474 . . . . 0.0 110.964 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.4 131.46 47.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' PHE . 20.9 t70 -80.13 -23.54 41.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.219 0.533 . . . . 0.0 111.185 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' A' ' 40' ' ' LEU . 97.3 m95 67.43 10.22 7.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.1 p -87.1 10.82 15.48 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.278 0.561 . . . . 0.0 110.768 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.04 -88.35 0.13 Allowed Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' H ' ' HD3' ' A' ' 65' ' ' PRO 0.276 11.0 p 43.9 75.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.196 1.399 . . . . 0.0 113.002 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -119.72 151.16 39.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.596 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 49.2 t -136.6 130.96 33.09 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -45.58 -63.34 0.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.724 1.209 . . . . 0.0 112.38 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -90.2 -57.76 2.74 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 34.2 tt0 69.51 -78.56 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.782 1.233 . . . . 0.0 107.889 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 35.7 t 176.35 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -53.29 -20.09 3.9 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -130.63 -34.07 1.58 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' SER . 94.5 m-70 -93.39 163.92 13.41 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.983 -0.448 . . . . 0.0 111.853 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -122.96 150.27 43.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.477 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 53.1 tp -70.49 -48.87 17.01 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 7.7 Cg_endo -48.23 -28.04 10.5 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.584 2.19 . . . . 0.0 113.003 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.2 m-20 -66.29 -29.38 69.59 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.912 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -116.06 6.07 13.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.712 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.504 HD12 ' CH2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -104.41 -43.76 5.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 18.6 ptpt -90.53 148.1 22.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.656 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 20.5 mm-40 -81.64 144.62 31.08 Favored 'General case' 0 CA--C 1.473 -2.002 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.607 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 121.72 -50.38 0.84 Allowed Glycine 0 N--CA 1.397 -3.927 0 C-N-CA 119.115 -1.517 . . . . 0.0 111.013 -171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.58 ' O ' HD11 ' A' ' 50' ' ' LEU . 96.8 m-85 -92.97 -10.47 36.25 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -55.86 25.98 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.075 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -95.08 102.09 13.88 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.35 97.86 1.01 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.249 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -156.75 -80.45 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.31 1.444 . . . . 0.0 110.226 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.23 -26.21 24.26 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 44' ' ' TYR . 2.3 pp -126.31 137.17 53.46 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.798 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.1 p-10 -163.77 166.77 21.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.503 ' HB3' ' CG2' ' A' ' 152' ' ' VAL . 40.4 tp -103.84 106.87 17.51 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.754 -1.578 . . . . 0.0 108.515 171.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -127.66 134.7 49.62 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.847 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 62.4 p -64.96 160.69 20.14 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.383 0.427 . . . . 0.0 110.243 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -123.84 -78.82 0.6 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.544 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.76 -14.76 36.36 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.742 0.306 . . . . 0.0 111.258 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' SER . 32.0 t70 -156.05 148.98 24.17 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.229 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HB2' HD21 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -99.96 14.17 31.44 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -83.71 119.22 24.52 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.437 0.637 . . . . 0.0 110.152 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.529 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 3.8 mm? -115.46 107.34 15.05 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.558 0.694 . . . . 0.0 111.32 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 6.3 tt -116.76 115.46 25.64 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.2 mt -113.42 136.59 49.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 123.328 0.651 . . . . 0.0 111.113 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 95' ' ' GLU . 93.4 t80 -107.94 123.97 49.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -108.08 115.52 58.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.298 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HD3' ' H ' ' A' ' 25' ' ' VAL . 63.6 Cg_endo -77.83 142.8 20.36 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.706 2.27 . . . . 0.0 109.53 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HD1' ' H ' ' A' ' 66' ' ' PHE . 2.2 p90 -101.68 162.04 13.2 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -167.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -91.99 -50.9 5.46 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.869 -2.423 . . . . 0.0 108.482 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -156.57 177.93 10.91 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.222 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.73 124.03 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.414 HD11 HD21 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.92 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -92.93 115.72 28.38 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 125' ' ' LEU . 1.1 tm? -73.81 124.23 25.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -120.38 -49.94 2.24 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.911 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.543 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 50.3 p -143.95 161.76 37.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -134.99 152.9 52.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -146.82 115.95 6.95 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.08 0.467 . . . . 0.0 111.305 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.466 ' HB ' HD11 ' A' ' 113' ' ' LEU . 69.1 mt -123.63 128.46 74.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 4.7 tmtt? -112.26 120.5 41.94 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.409 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -149.25 -172.99 19.46 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -66.36 -175.7 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.83 2.353 . . . . 0.0 111.48 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -71.67 -56.88 4.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -173.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.28 -18.13 20.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.297 0.57 . . . . 0.0 112.135 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.52 15.68 6.38 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.486 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.53 156.98 16.0 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.451 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 32.2 Cg_exo -62.68 153.26 73.3 Favored 'Trans proline' 0 C--O 1.204 -1.192 0 C-N-CA 122.095 1.863 . . . . 0.0 110.16 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 37.2 ttpt -126.27 -65.41 0.98 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.868 -0.52 . . . . 0.0 110.377 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.9 m -75.75 101.74 5.16 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.24 0.543 . . . . 0.0 110.464 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 86' ' ' LYS . 52.5 t -106.02 130.52 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.103 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -130.61 151.84 50.64 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.769 0.828 . . . . 0.0 110.139 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' A' ' 125' ' ' LEU . 14.0 m-85 -136.0 160.71 37.8 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.178 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.35 116.69 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.45 ' HB2' HG22 ' A' ' 133' ' ' VAL . 21.8 p -84.24 14.6 4.18 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.89 1.276 . . . . 0.0 114.342 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -147.05 172.22 14.07 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.061 -0.4 . . . . 0.0 110.133 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 3.4 ttmp? 69.94 145.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 10.4 pt-20 -102.81 138.25 39.95 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.467 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m80 55.82 72.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.507 0.723 . . . . 0.0 112.489 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.48 ' HB3' HG21 ' A' ' 137' ' ' THR . 12.6 tpt -90.85 94.15 9.53 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.03 154.06 29.76 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.772 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.567 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 72.9 t80 -57.36 -23.23 47.74 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.7 t -79.71 -11.97 59.82 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.943 -0.473 . . . . 0.0 110.637 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -124.36 -13.31 7.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.583 . . . . 0.0 110.61 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.567 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 6.4 p -62.9 -30.06 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 C-N-CA 124.451 1.1 . . . . 0.0 112.129 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -109.03 -1.66 18.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.331 0.586 . . . . 0.0 111.098 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -82.65 -40.24 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -100.63 139.38 20.55 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.3 140.95 94.45 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.86 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.66 179.1 5.97 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.771 2.314 . . . . 0.0 110.747 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.725 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 44.8 m -79.56 -49.13 12.67 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.442 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -162.0 -179.6 7.26 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -153.27 150.49 29.0 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.73 169.21 18.2 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.495 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 5.6 tp10 -126.18 106.64 9.7 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.1 tt -73.05 122.57 21.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.7 p -122.04 -176.58 3.37 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.643 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 1.6 mp0 -51.77 -36.34 47.11 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 125.118 1.367 . . . . 0.0 109.813 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.505 ' CG ' ' HD2' ' A' ' 121' ' ' LYS . 40.4 tt0 -64.56 -38.78 92.21 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.443 HD22 ' CG2' ' A' ' 123' ' ' VAL . 23.8 t-20 -71.0 -38.28 72.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.81 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.44 -14.42 60.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.55 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.52 -1.69 56.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.555 0.693 . . . . 0.0 109.687 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.39 27.47 20.24 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.602 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.505 ' HD2' ' CG ' ' A' ' 116' ' ' GLU . 96.6 mttt -99.81 142.49 24.72 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 117.271 0.536 . . . . 0.0 111.146 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 39.6 Cg_endo -73.83 103.78 1.71 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.897 1.731 . . . . 0.0 109.313 170.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.443 ' CG2' HD22 ' A' ' 117' ' ' ASN . 78.9 t -84.58 127.34 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.748 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.68 101.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.652 ' HG ' ' H ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -54.57 -71.53 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.293 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.652 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 80.1 tttt -171.47 165.39 6.96 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -144.31 24.8 1.58 Allowed 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.689 -171.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.91 -47.24 13.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.725 ' HB3' ' O ' ' A' ' 108' ' ' SER . 8.8 tmtt? -111.29 -9.12 14.3 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.694 -166.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.406 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 39.7 p90 -60.51 10.2 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.927 0 O-C-N 121.497 -0.752 . . . . 0.0 112.94 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 129' ' ' LYS . 79.9 mm-40 -59.7 119.42 7.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.217 0.532 . . . . 0.0 111.279 -166.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.355 0.2 OUTLIER 59.54 113.74 0.01 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 128.078 2.551 . . . . 0.0 112.997 -170.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 92' ' ' SER . 63.3 t -102.3 110.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.892 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 134' ' ' ARG . 31.8 mmt180 -88.75 -31.5 18.38 Favored 'General case' 0 C--O 1.19 -2.077 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.575 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -160.86 164.09 31.56 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 tp -126.86 118.82 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 117.684 -1.607 . . . . 0.0 112.889 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 97' ' ' MET . 91.7 m -103.03 123.87 47.44 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.12 109.85 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 141' ' ' GLU . 53.1 t80 -114.5 111.72 21.83 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.407 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 1.8 pp -104.53 131.44 53.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.1 pt-20 -112.37 -2.27 14.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.06 142.16 5.92 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.311 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.475 HD21 ' HB2' ' A' ' 58' ' ' GLU . 38.4 m-80 -83.67 177.76 8.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.809 0.693 . . . . 0.0 109.864 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 2.4 mp0 -50.11 -58.53 5.34 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.4 m -119.64 -22.31 6.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.954 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.43 1.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 m -84.37 16.33 3.14 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.445 0.698 . . . . 0.0 112.305 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 73.48 -52.15 0.7 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.652 1.181 . . . . 0.0 111.078 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.18 106.09 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.014 0.912 . . . . 0.0 111.397 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.0 m -82.68 116.26 21.98 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.465 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -104.29 133.97 48.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.503 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 30.5 m -132.96 128.15 56.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.201 0.524 . . . . 0.0 109.609 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -84.41 -33.79 23.67 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -166.38 141.46 4.47 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.164 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.419 HG23 HG12 ' A' ' 77' ' ' ILE . 71.9 mt -121.6 111.98 33.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.49 124.58 21.56 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 159.4 15.47 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 83.8 m-85 -125.37 113.44 17.56 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.15 0.5 . . . . 0.0 109.939 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.62 167.2 12.25 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.0 m -120.34 132.98 55.52 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 117.39 0.595 . . . . 0.0 110.55 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--N 1.281 -2.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.832 173.256 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 15' ' ' ASP . 2.6 mp . . . . . 0 N--CA 1.44 -0.933 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.56 159.4 19.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.602 2.201 . . . . 0.0 110.421 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -83.81 101.9 11.95 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.834 0.826 . . . . 0.0 111.961 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.96 -30.77 2.34 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.205 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -121.96 170.15 10.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 122.281 -0.54 . . . . 0.0 110.783 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.94 143.01 18.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.572 ' HB2' HG13 ' A' ' 9' ' ' ILE . 11.8 t70 -71.95 127.43 32.53 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.86 0.362 . . . . 0.0 110.108 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 19' ' ' PHE . 33.2 mt -101.33 3.47 40.68 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 42' ' ' GLN . 3.1 tm? -73.06 -35.33 66.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.165 0.983 . . . . 0.0 108.541 -177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.94 -9.83 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.044 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 92.0 t80 -97.77 14.26 27.57 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 124.766 1.226 . . . . 0.0 110.977 -172.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.7 mt -88.84 142.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.489 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -93.9 120.24 33.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -92.93 7.9 42.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 m -103.64 -12.11 17.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.258 0.552 . . . . 0.0 110.836 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.95 -18.53 5.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.396 -0.906 . . . . 0.0 113.578 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.75 129.5 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.9 142.93 50.7 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.776 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' ' NE2' ' A' ' 30' ' ' GLN . 9.3 p -131.87 119.7 21.55 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.536 -175.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 3.8 mm? -94.41 132.34 39.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.222 0.534 . . . . 0.0 110.214 176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' A' ' 56' ' ' ALA . 64.0 t30 68.65 -70.97 0.12 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 126.945 2.098 . . . . 0.0 110.186 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 8.1 tt0 63.31 -168.93 0.2 Allowed 'General case' 0 C--N 1.372 1.573 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.661 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 41.5 t -93.39 123.42 36.68 Favored 'General case' 0 C--N 1.251 -3.714 0 O-C-N 120.449 -1.407 . . . . 0.0 108.477 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -57.93 -17.46 16.95 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.891 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -100.16 -43.6 6.26 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.661 ' O ' ' HB3' ' A' ' 31' ' ' SER . 83.4 m-70 -122.06 151.97 40.31 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 122.05 -0.406 . . . . 0.0 110.745 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.542 ' HA ' ' OE1' ' A' ' 30' ' ' GLN . 49.0 m -87.98 160.89 17.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.72 -49.47 2.1 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.68 -23.99 28.22 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.072 1.848 . . . . 0.0 111.284 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.566 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.2 m-20 -58.91 -27.68 65.48 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 125.636 1.574 . . . . 0.0 111.453 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -123.7 8.41 8.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 tp -118.36 -47.71 2.54 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.649 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -83.0 130.81 35.18 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.81 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.419 ' HG2' HH21 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -67.94 123.26 20.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.43 -47.49 0.98 Allowed Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.084 -2.007 . . . . 0.0 108.084 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -93.93 -44.37 8.11 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.419 HH21 ' HG2' ' A' ' 42' ' ' GLN . 58.9 ttp85 -54.97 101.96 0.06 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.389 -176.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 178.45 125.07 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.696 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 18.5 t70 -68.07 85.36 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.696 ' HG3' ' O ' ' A' ' 47' ' ' ASP . 35.3 mt-10 -173.1 108.08 0.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 127.227 2.211 . . . . 0.0 110.137 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.27 -52.87 4.11 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.996 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.566 ' HB2' HD22 ' A' ' 38' ' ' ASN . 1.3 pt? -133.44 127.77 34.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 122.737 -0.273 . . . . 0.0 110.405 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' A' ' 153' ' ' GLN . 6.7 t30 -161.35 153.32 19.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.46 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 2.8 tm? -85.32 110.25 18.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.941 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' THR . 12.6 pt-20 -132.31 112.65 12.4 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.5 p -59.95 137.37 58.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -141.74 85.42 1.94 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.519 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . 164.94 -50.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.155 1.782 . . . . 0.0 107.129 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -147.7 155.71 42.02 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.085 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -85.08 -25.2 27.72 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -77.0 130.83 38.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.738 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.8 mt -133.88 143.07 48.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.622 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.5 tm? -135.08 119.47 17.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.8 mp -123.85 129.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -105.63 122.84 46.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.24 113.02 39.3 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.685 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -90.27 125.33 1.21 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 122.58 2.186 . . . . 0.0 108.835 168.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.465 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 90.3 m-85 -87.92 158.17 18.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -59.69 -51.75 68.44 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.251 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -125.41 173.23 9.02 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.087 -0.383 . . . . 0.0 109.981 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 120.908 0.385 . . . . 0.0 110.501 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -132.87 172.61 16.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -96.83 136.23 37.68 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 130' ' ' PHE . 82.6 mt -76.01 146.63 39.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 27.6 t60 -124.83 -50.54 1.71 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -139.46 163.37 32.7 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 49.7 p90 -136.23 154.47 50.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -149.81 106.39 3.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.502 0.668 . . . . 0.0 111.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.13 131.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.543 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 53.6 mtpt -121.16 161.82 21.17 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.05 0.452 . . . . 0.0 111.716 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.07 -169.18 39.28 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' CG ' ' HD2' ' A' ' 151' ' ' LYS . 14.2 Cg_exo -73.37 166.47 29.8 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.937 2.424 . . . . 0.0 111.157 175.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 118' ' ' LEU . 13.3 pt-20 -58.66 -41.48 86.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.12 -26.26 15.55 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -92.53 11.29 26.88 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.891 -169.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.21 146.13 18.15 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.778 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 22.7 Cg_exo -67.05 110.05 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.332 2.021 . . . . 0.0 111.356 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HB2' HE21 ' A' ' 144' ' ' GLN . 0.8 OUTLIER -82.84 -39.67 21.36 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.925 -176.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.1 m -103.44 112.01 24.7 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.84 130.2 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.015 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -117.29 146.28 43.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.74 149.22 52.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 65.6 t80 -143.42 115.77 8.52 Favored 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.494 169.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 135' ' ' SER . 48.9 m -102.36 153.73 19.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.677 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 81.44 145.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.052 1.341 . . . . 0.0 108.573 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 72.9 116.0 0.05 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.57 149.74 29.81 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.689 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.267 13.9 p-80 50.31 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 88.1 mtp -139.6 142.08 37.11 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 22.8 p -120.06 174.08 6.69 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -69.84 -18.86 63.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 p -77.72 -21.72 51.48 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -130.35 18.75 5.34 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.72 -32.28 51.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.177 0.513 . . . . 0.0 110.717 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -97.27 73.53 2.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.637 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -124.41 -4.17 7.83 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -139.24 156.51 71.95 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.648 -1.615 . . . . 0.0 106.862 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.83 140.93 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.117 1.212 . . . . 0.0 109.589 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.72 153.52 36.1 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 122.42 2.08 . . . . 0.0 111.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 31.8 m -62.09 -44.8 95.88 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.717 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -169.56 166.78 9.98 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -139.24 139.71 37.52 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.4 172.71 11.57 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.673 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 37.2 tt0 -122.61 134.54 54.51 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 34.0 tp -62.99 108.58 1.24 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.701 0.626 . . . . 0.0 109.713 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.5 m -82.23 156.85 24.17 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -54.27 -39.58 67.0 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.191 0.596 . . . . 0.0 111.046 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' HB3' ' HD3' ' A' ' 121' ' ' LYS . 44.9 mt-10 -70.94 -31.47 68.07 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.244 0.618 . . . . 0.0 112.231 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.627 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.7 t-20 -62.56 -39.68 94.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 118' ' ' LEU . 7.5 tt -71.99 -7.62 49.79 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 45.2 mmtm -104.3 -14.15 15.89 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 121.761 -0.587 . . . . 0.0 110.136 176.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.543 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 127.59 -14.43 6.43 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 119.926 -1.131 . . . . 0.0 114.005 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 53.8 mtpt -74.88 133.36 76.13 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 35.8 Cg_exo -64.15 116.99 4.04 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.541 2.828 . . . . 0.0 111.707 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 135.7 26.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.92 131.29 34.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.16 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.38 177.47 5.03 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.809 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.6 96.49 10.49 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -80.08 21.83 0.55 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.89 -13.58 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.09 21.06 9.82 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.365 0.602 . . . . 0.0 110.668 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.636 ' CD2' HD12 ' A' ' 72' ' ' LEU . 96.3 m-85 -122.62 27.01 8.02 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.444 -173.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -63.22 -35.59 80.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -129.16 115.51 17.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.28 0.562 . . . . 0.0 109.805 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.476 HG21 ' HG ' ' A' ' 72' ' ' LEU . 47.4 t -121.15 104.47 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -108.27 -44.04 4.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 170.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' SER . 32.9 t -104.91 130.78 53.0 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.943 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.3 tp -137.87 104.23 5.21 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.137 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.5 m -92.3 115.42 28.07 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.74 122.73 58.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -121.53 127.71 51.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.897 0.38 . . . . 0.0 110.439 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 60' ' ' LEU . 12.0 pt -133.29 116.44 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -31.47 4.11 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.378 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.77 126.45 52.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.83 -174.84 2.65 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.709 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.517 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.2 mp0 -56.4 -66.51 0.42 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.6 t -120.14 9.27 11.09 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.545 -173.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.27 93.21 0.2 Allowed Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 23.4 t -111.99 -1.86 15.27 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 147' ' ' SER . 10.2 pt-20 68.0 -40.85 0.43 Allowed 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 126.764 2.026 . . . . 0.0 111.344 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.53 113.28 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.4 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 43.7 m -92.92 125.64 37.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 80' ' ' PRO . 39.2 ttmt -123.52 133.67 53.98 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.5 120.02 31.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.008 0.432 . . . . 0.0 111.117 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.472 ' HA ' ' OD1' ' A' ' 51' ' ' ASN . 4.7 pt20 -93.21 -6.24 48.17 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.675 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.401 ' CB ' ' HD2' ' A' ' 45' ' ' ARG . 38.5 pttt -172.11 144.81 1.7 Allowed 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.84 109.97 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 165.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.64 134.08 29.91 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 5.5 mp -117.85 156.29 28.64 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -123.14 127.97 49.42 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.22 -163.92 10.25 Favored Glycine 0 C--N 1.302 -1.329 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.381 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.6 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.1 t -142.18 143.29 32.87 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 117.428 0.614 . . . . 0.0 109.715 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 70' ' ' ILE . 41.0 p . . . . . 0 N--CA 1.433 -1.286 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.045 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.44 -0.932 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.24 144.0 14.36 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.971 1.781 . . . . 0.0 110.451 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.12 105.68 1.44 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.543 0.687 . . . . 0.0 110.214 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.79 -23.28 3.98 Favored Glycine 0 N--CA 1.42 -2.378 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.38 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -129.83 174.89 9.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.21 145.05 34.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -77.84 130.33 36.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' A' ' 70' ' ' ILE . 4.1 mm? -68.15 -8.85 42.07 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.822 0.849 . . . . 0.0 113.277 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 42' ' ' GLN . 2.0 tm? -55.51 -34.06 64.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.26 -25.94 64.52 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.057 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.78 22.84 15.17 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -172.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.45 133.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.9 105.84 18.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -75.09 -13.44 60.48 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 m -73.87 -22.23 59.81 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 6.4 13.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.574 -1.298 . . . . 0.0 114.387 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.14 136.91 25.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 CA-C-N 117.838 0.819 . . . . 0.0 110.176 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.8 tp10 -152.17 148.14 27.26 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.093 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.89 123.82 22.73 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.63 -44.71 96.47 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.693 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.69 -94.23 0.1 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.587 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 59.6 11.69 2.49 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.722 0.772 . . . . 0.0 109.996 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -83.56 -12.93 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 3.0 m -50.25 -47.83 54.99 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.5 m 153.14 -55.21 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 127.967 2.507 . . . . 0.0 108.372 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 80.1 m-70 -67.96 149.26 49.98 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.1 m -108.13 -175.84 2.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -171.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.519 HD23 HD22 ' A' ' 52' ' ' LEU . 2.4 tm? -90.84 -49.18 0.35 Allowed Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.693 0.797 . . . . 0.0 112.431 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 31.2 Cg_exo -62.38 -2.0 2.89 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.931 2.421 . . . . 0.0 114.46 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.432 ' HB2' HD13 ' A' ' 50' ' ' LEU . 34.8 p30 -84.02 -48.61 9.75 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.219 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.38 -2.5 57.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.3 tp -109.23 -9.12 15.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 5.8 tmtt? -89.7 133.29 34.74 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.443 ' HB2' HD11 ' A' ' 17' ' ' LEU . 6.4 tp-100 -54.58 133.21 46.32 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.78 -34.56 2.1 Favored Glycine 0 N--CA 1.413 -2.886 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.8 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.66 -20.77 45.86 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 117.657 0.728 . . . . 0.0 109.944 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 18.03 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.67 109.33 3.26 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.19 117.58 15.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 175.3 -81.39 0.0 OUTLIER 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.547 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.26 -33.1 77.16 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 50' ' ' LEU . 3.9 pp -119.66 126.69 51.76 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 8.1 p30 -163.54 167.26 21.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.519 HD22 HD23 ' A' ' 36' ' ' LEU . 48.1 tp -94.56 103.78 15.73 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 150' ' ' THR . 11.7 pt-20 -124.67 159.77 30.06 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.729 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.485 ' HA ' ' OG ' ' A' ' 32' ' ' SER . 86.9 p -95.74 -174.29 3.1 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.816 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 t70 175.03 -48.41 0.01 OUTLIER 'General case' 0 CA--C 1.467 -2.245 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.34 35.73 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.148 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.552 ' OD1' ' HG2' ' A' ' 59' ' ' GLN . 10.6 t70 -157.44 146.97 20.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.18 -31.53 69.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.955 0.902 . . . . 0.0 112.49 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG2' ' OD1' ' A' ' 57' ' ' ASP . 3.9 pt20 -86.91 126.74 34.88 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.121 0.962 . . . . 0.0 111.949 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' HD11 ' A' ' 140' ' ' ILE . 54.5 mt -131.07 120.73 23.83 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.343 -173.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -96.96 119.77 36.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.81 128.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . 8.6 t80 -109.84 117.91 35.08 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.1 mt -122.55 114.0 30.33 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-O 120.515 0.198 . . . . 0.0 111.37 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -89.33 141.18 4.0 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 121.998 1.798 . . . . 0.0 109.881 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -103.93 150.87 23.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.597 0.713 . . . . 0.0 112.638 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -55.35 -45.61 76.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -153.98 163.16 40.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.81 127.61 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.901 0.858 . . . . 0.0 111.748 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.501 ' CD1' HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -128.3 172.1 15.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -96.28 114.18 25.84 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 157' ' ' LEU . 53.2 tp -73.27 154.47 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.541 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 31.3 t60 -139.16 -38.17 0.5 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.785 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.1 p -153.97 169.73 22.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.477 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -141.29 155.17 46.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -149.65 100.2 2.95 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.868 0.366 . . . . 0.0 111.934 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.446 HG23 HG12 ' A' ' 155' ' ' ILE . 56.8 mt -106.24 136.58 40.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HB3' ' OE1' ' A' ' 153' ' ' GLN . 90.1 mttt -112.06 150.96 29.94 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.991 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 118' ' ' LEU . . . -166.56 168.01 39.85 Favored Glycine 0 N--CA 1.41 -3.041 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 83' ' ' GLU . 32.5 Cg_exo -62.22 151.94 79.2 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.892 1.728 . . . . 0.0 111.117 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HG2' ' HG3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -54.64 -39.78 68.32 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.346 0.659 . . . . 0.0 111.62 -178.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.428 ' HG3' ' HG2' ' A' ' 81' ' ' GLU . 45.6 mt-10 -94.48 -44.0 8.09 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 80' ' ' PRO . 37.5 tt0 -101.56 18.95 18.94 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.692 -166.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.93 178.87 36.45 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.163 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.412 ' HG2' HD22 ' A' ' 113' ' ' LEU . 35.5 Cg_endo -73.5 -179.88 4.9 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 119.765 1.782 . . . . 0.0 110.439 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.56 ' HG2' ' OE2' ' A' ' 112' ' ' GLU . 23.0 ttpp -154.98 -71.23 0.12 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.863 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.4 m -85.74 118.19 25.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.261 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.595 HG12 HG22 ' A' ' 140' ' ' ILE . 23.0 m -118.28 137.19 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.762 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -110.95 133.87 53.03 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -113.97 145.3 41.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -135.37 114.96 12.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 171.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -94.42 133.81 37.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.7 OUTLIER 74.35 175.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.411 1.084 . . . . 0.0 111.357 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.578 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER 72.82 127.8 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.819 0.819 . . . . 0.0 110.902 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 3.6 mp0 -93.89 146.68 23.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.948 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.1 m80 69.91 98.14 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.955 1.302 . . . . 0.0 111.948 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 92.5 mmm -139.26 142.54 37.78 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.004 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.542 ' O ' HG23 ' A' ' 102' ' ' VAL . 26.4 p -144.78 169.73 17.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.61 -30.5 68.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.276 0.489 . . . . 0.0 112.072 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 t -63.54 -24.26 67.74 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 120.689 0.28 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.432 ' O ' ' HD1' ' A' ' 105' ' ' PHE . 92.8 m-20 -98.6 -23.11 15.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.945 0.402 . . . . 0.0 111.315 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 98' ' ' CYS . 56.0 t -58.53 -32.09 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.718 0.807 . . . . 0.0 112.271 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.85 -15.59 60.2 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -113.44 -15.89 12.53 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.699 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 101' ' ' ASN . 79.3 m-85 -96.75 148.05 33.85 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -82.56 139.81 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.164 1.909 . . . . 0.0 112.032 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.07 149.05 64.34 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.133 1.889 . . . . 0.0 110.939 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.8 m -73.76 -45.16 53.58 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.553 0.692 . . . . 0.0 109.332 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -161.25 160.6 30.12 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -131.7 125.72 32.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.23 170.19 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.32 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.56 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.8 tp10 -125.25 134.96 52.12 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 19.8 tp -70.11 101.94 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 117' ' ' ASN . 5.1 t -80.07 158.4 26.45 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.62 -22.83 66.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.588 0.709 . . . . 0.0 109.749 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.09 -35.31 74.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.257 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.636 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.5 t-20 -71.73 -32.72 68.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 79' ' ' GLY . 96.8 mt -57.48 -23.27 49.01 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.737 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.14 -12.65 52.35 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.712 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 2.82 55.56 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 122.71 88.13 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.096 0.448 . . . . 0.0 110.389 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -59.42 111.12 0.84 Allowed 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 123.157 2.571 . . . . 0.0 112.107 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.508 HG23 ' ND2' ' A' ' 117' ' ' ASN . 86.4 t -82.98 124.88 39.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.7 101.54 2.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.198 0.523 . . . . 0.0 109.952 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.89 172.8 13.27 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.637 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -89.64 84.06 6.31 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.19 0.995 . . . . 0.0 110.031 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 39.9 p90 -76.42 24.69 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.919 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.531 HG13 ' HD2' ' A' ' 129' ' ' LYS . 7.4 p -63.47 -25.57 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.679 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.531 ' HD2' HG13 ' A' ' 128' ' ' VAL . 13.1 mptt -93.43 -20.29 20.46 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.436 0.636 . . . . 0.0 110.501 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 127' ' ' TYR . 82.2 m-85 -91.1 32.63 1.0 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.633 -171.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -67.32 -31.76 72.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.807 0.337 . . . . 0.0 111.309 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -142.2 116.15 9.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.54 106.51 20.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.795 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -89.52 -62.9 1.37 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.2 t -109.03 151.57 26.17 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.195 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.4 tp -147.95 129.67 15.12 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.261 0.553 . . . . 0.0 109.952 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 m -114.71 124.64 52.32 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.5 112.23 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 69.3 t80 -109.0 114.62 28.53 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.851 0.357 . . . . 0.0 110.697 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.595 HG22 HG12 ' A' ' 88' ' ' VAL . 2.3 pp -97.47 124.45 50.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 11.5 pt-20 -110.79 -22.56 11.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.339 -0.945 . . . . 0.0 111.968 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.64 156.39 44.96 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.847 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 147' ' ' SER . 34.2 t-20 -110.61 148.09 32.9 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 126.221 1.809 . . . . 0.0 107.862 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 29.1 mm-40 -36.37 -56.81 0.77 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.652 1.181 . . . . 0.0 111.973 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -124.25 -12.02 7.41 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.688 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 87.59 0.94 Allowed Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 149' ' ' VAL . 32.6 t -111.05 9.55 22.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.98 -0.13 . . . . 0.0 110.7 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 77.14 -23.59 0.24 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 124.441 1.096 . . . . 0.0 110.157 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 147' ' ' SER . 25.9 m -128.5 124.31 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.9 m -101.41 111.1 23.23 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 51' ' ' ASN . 87.2 tttt -95.95 133.6 39.96 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 92.9 t -122.66 115.8 47.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.428 ' OE1' ' HB3' ' A' ' 78' ' ' LYS . 97.0 mt-30 -74.1 -44.33 54.35 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.839 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.05 153.66 3.85 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.495 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.446 HG12 HG23 ' A' ' 77' ' ' ILE . 71.9 mt -124.49 118.03 52.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.4 141.02 35.59 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 72' ' ' LEU . 6.2 mp -120.43 151.59 39.1 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -124.44 127.11 47.02 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.723 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.3 -163.59 10.23 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.2 m -143.94 138.36 28.44 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.383 0.611 . . . . 0.0 111.863 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.464 HG22 HG22 ' A' ' 70' ' ' ILE . 17.8 p . . . . . 0 C--N 1.293 -1.88 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.087 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.241 0.646 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.11 -173.55 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.633 2.222 . . . . 0.0 112.349 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -92.74 11.76 25.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.812 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -143.7 -50.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.741 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -87.42 173.38 9.17 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.924 0.392 . . . . 0.0 111.107 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 18.0 m -115.36 167.79 7.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.51 108.56 16.0 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.363 1.078 . . . . 0.0 108.979 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.488 HD22 HG13 ' A' ' 70' ' ' ILE . 44.7 mt -68.82 3.98 1.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.778 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.62 -41.45 99.01 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.16 -7.42 57.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.867 0.841 . . . . 0.0 110.86 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 13.4 m-85 -92.1 1.71 57.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.01 133.35 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.07 -28.05 22.79 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.837 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.48 ' HA ' HG13 ' A' ' 25' ' ' VAL . 97.5 m95 66.15 -6.85 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 m -82.18 -19.95 38.82 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.614 -0.679 . . . . 0.0 112.659 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.35 26.69 4.9 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.75 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 22' ' ' TRP . 35.7 m -71.89 139.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 110.911 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.68 128.2 32.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.108 0.48 . . . . 0.0 109.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.599 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 6.1 p -103.23 118.15 36.12 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.495 HD23 HD22 ' A' ' 61' ' ' LEU . 3.3 mm? -76.82 -14.92 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.483 0.659 . . . . 0.0 110.746 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -160.45 -83.98 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.776 168.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.615 ' HA ' HD23 ' A' ' 60' ' ' LEU 0.394 3.1 pp0? 51.65 14.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.51 1.124 . . . . 0.0 112.634 -168.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.433 ' CB ' ' H ' ' A' ' 55' ' ' ASP 0.293 58.6 m 72.68 115.02 0.06 Allowed 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 126.995 2.118 . . . . 0.0 114.007 -173.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -55.34 16.9 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 C-N-CA 126.965 2.106 . . . . 0.0 115.218 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 31' ' ' SER . 34.1 t -103.91 -58.67 1.84 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.711 -0.618 . . . . 0.0 109.962 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CE1' ' HA ' ' A' ' 52' ' ' LEU . 23.7 p80 -93.81 163.37 13.55 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 17.7 m -90.49 166.97 12.94 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.818 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 62.1 tp -67.45 -45.58 47.96 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 11.6 Cg_endo -55.47 -25.91 51.29 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.957 1.771 . . . . 0.0 111.503 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 1.9 m-20 -63.04 -24.55 67.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.281 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -95.11 -49.53 5.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.154 0.502 . . . . 0.0 111.886 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.2 tp -105.16 -20.71 13.43 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -170.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -80.08 118.66 21.99 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.292 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -70.87 140.72 51.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.558 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.58 -33.25 6.58 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.438 ' HB3' HD11 ' A' ' 50' ' ' LEU . 95.6 m-85 -98.92 -50.13 4.3 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.44 0.296 . . . . 0.0 110.859 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -52.75 119.29 4.41 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.998 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -153.7 124.4 7.2 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.53 92.61 0.85 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.649 0.738 . . . . 0.0 112.522 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 170.86 -66.26 0.01 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.693 1.597 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.42 -57.03 1.81 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.29 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.4 pt? -134.68 113.71 11.97 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.626 0.727 . . . . 0.0 110.808 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -161.41 169.48 21.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.635 ' HB3' HG22 ' A' ' 152' ' ' VAL . 6.6 tt -75.92 122.69 24.52 Favored 'General case' 0 CA--C 1.487 -1.461 0 C-N-CA 117.191 -1.803 . . . . 0.0 106.17 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -138.22 110.12 7.2 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 113.094 -1.866 . . . . 0.0 107.267 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.516 ' HB3' ' H ' ' A' ' 150' ' ' THR . 8.0 t -93.48 123.65 36.94 Favored 'General case' 0 N--CA 1.411 -2.397 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.325 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.433 ' H ' ' CB ' ' A' ' 31' ' ' SER . 13.1 t70 -119.11 -24.1 6.6 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.722 -175.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.95 -69.61 0.68 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.314 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.91 171.5 8.59 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.534 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 148' ' ' GLU . 5.2 tm-20 -89.9 -24.77 21.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.028 0.931 . . . . 0.0 109.945 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.4 ' C ' HD12 ' A' ' 60' ' ' LEU . 55.5 mt-30 -114.27 134.65 54.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.122 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 30' ' ' GLN . 8.4 mp -128.76 165.28 21.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.373 0.606 . . . . 0.0 112.39 -172.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.495 HD22 HD23 ' A' ' 28' ' ' LEU . 5.9 tt -152.42 128.1 10.14 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 61' ' ' LEU . 2.9 mp -126.02 135.5 63.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.72 118.74 35.85 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -121.64 122.71 27.79 Favored Pre-proline 0 C--O 1.214 -0.772 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.357 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -92.56 137.43 1.6 Allowed 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.657 2.238 . . . . 0.0 111.415 171.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -92.43 162.89 14.06 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.293 0.568 . . . . 0.0 111.421 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 68' ' ' GLN . 34.4 p30 -69.84 -36.11 75.29 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HG2' ' OD1' ' A' ' 67' ' ' ASN . 19.5 pt20 -147.63 176.88 9.73 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.029 -0.419 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 27.3 m -82.18 124.48 39.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.23 0.538 . . . . 0.0 110.384 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.488 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -137.0 172.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 174.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -93.24 114.31 26.75 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 65.4 tp -76.66 127.97 33.8 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 6.2 t-160 -126.08 -45.94 1.69 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.866 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 p -142.74 155.18 44.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -128.27 158.24 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.24 113.77 5.64 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 122.602 0.361 . . . . 0.0 110.284 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.45 HG23 HG12 ' A' ' 155' ' ' ILE . 67.2 mt -125.17 126.35 70.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 54.2 mtpt -117.79 152.42 35.35 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.421 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.85 -167.96 30.23 Favored Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 108.186 -1.965 . . . . 0.0 108.186 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.11 155.53 69.17 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.85 1.7 . . . . 0.0 109.078 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.97 -42.83 60.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.91 -37.25 10.78 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -76.6 2.27 14.49 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.77 150.2 30.78 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.594 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.9 161.74 35.21 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 121.938 1.759 . . . . 0.0 111.088 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 69.8 tttt -127.89 -73.98 0.59 Allowed 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.561 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.606 ' HA ' ' HG2' ' A' ' 112' ' ' GLU . 29.5 m -76.15 103.91 6.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.477 0.656 . . . . 0.0 110.193 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 86' ' ' LYS . 99.8 t -114.93 116.66 53.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.627 -173.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 139' ' ' PHE . 98.8 mttt -101.91 147.23 26.78 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.231 -0.293 . . . . 0.0 110.26 172.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.54 138.91 54.47 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 86.6 m-85 -130.95 116.78 18.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 135' ' ' SER . 50.8 p -100.63 -14.09 18.29 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 26.1 t-20 -140.3 84.7 1.97 Allowed 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.146 -1.421 . . . . 0.0 113.87 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 85.5 tttt 171.69 148.81 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.109 1.364 . . . . 0.0 108.06 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -85.97 122.94 30.71 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.289 0.566 . . . . 0.0 111.427 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.366 0.3 OUTLIER 39.39 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.002 2.521 . . . . 0.0 117.299 176.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.553 ' HB2' HG21 ' A' ' 137' ' ' THR . 91.7 mmm -83.91 148.51 26.9 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 174.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.7 m -129.33 162.93 26.84 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -52.68 -38.63 60.84 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 t -81.29 3.26 24.69 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.43 ' HA ' ' OD1' ' A' ' 104' ' ' ASP . 4.0 p-10 -147.23 13.64 1.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.229 0.538 . . . . 0.0 110.616 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 p -75.5 -25.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -96.63 4.78 51.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.478 0.656 . . . . 0.0 110.618 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 101' ' ' ASN . 8.3 m-20 -91.71 4.61 52.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.923 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 82.1 t80 -144.19 134.65 12.09 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 26.2 Cg_exo -65.08 127.0 17.48 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.628 2.219 . . . . 0.0 111.7 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.14 168.55 23.02 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.597 2.198 . . . . 0.0 112.505 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.8 m -69.72 -40.66 76.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.43 174.11 3.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 76.0 m -143.7 113.45 7.11 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.27 163.7 20.18 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.563 -174.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 50.5 mt-10 -128.04 138.75 52.7 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.768 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.1 116.71 7.49 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 112.651 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 t -96.42 174.07 7.05 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.44 -36.34 68.91 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 118.257 0.48 . . . . 0.0 110.715 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 121' ' ' LYS . 38.8 tt0 -59.93 -42.36 93.79 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.498 HD22 HG23 ' A' ' 123' ' ' VAL . 14.1 t-20 -71.54 -41.66 68.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 118' ' ' LEU . 8.4 tt -73.85 -0.76 16.9 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.735 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -113.61 -5.07 13.41 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.174 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.517 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 118.63 -3.33 15.29 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.645 -1.264 . . . . 0.0 116.136 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 116' ' ' GLU . 12.4 mptt -88.33 126.57 60.02 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 46.9 Cg_exo -59.91 108.54 0.49 Allowed 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.707 2.938 . . . . 0.0 111.844 175.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 HD22 ' A' ' 117' ' ' ASN . 68.9 t -88.65 127.1 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.23 141.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.412 0.445 . . . . 0.0 111.75 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.63 -172.85 2.2 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -72.7 103.79 3.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 110.355 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.45 ' HA ' ' CD2' ' A' ' 130' ' ' PHE . 60.4 t80 -75.16 1.77 12.51 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.361 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.64 -22.52 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.79 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -109.69 -9.97 14.83 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -170.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 127' ' ' TYR . 41.4 p90 -77.62 11.11 2.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.128 -0.982 . . . . 0.0 112.447 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -58.51 133.42 55.8 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -163.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.294 2.8 p-10 53.7 113.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.911 2.084 . . . . 0.0 112.697 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 55.0 t -121.01 122.51 67.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.674 -173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -117.3 -28.28 6.19 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.551 0.691 . . . . 0.0 109.545 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 92' ' ' SER . 52.3 p -144.67 171.86 13.8 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.897 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.92 106.49 4.85 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 97' ' ' MET . 19.9 m -96.73 120.24 36.7 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.5 mt -105.1 111.28 33.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 65.1 t80 -107.55 107.89 18.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.99 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 88' ' ' VAL . 11.9 pt -106.64 113.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.633 0.73 . . . . 0.0 109.986 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 41.8 tt0 -112.66 13.38 19.9 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.999 0.904 . . . . 0.0 111.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.3 153.44 11.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.764 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.413 ' C ' ' HB2' ' A' ' 86' ' ' LYS . 39.8 m-80 -117.76 168.34 10.54 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 124.044 0.84 . . . . 0.0 108.91 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -44.21 -43.5 7.22 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.814 0.846 . . . . 0.0 112.186 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.2 m -124.1 8.77 8.61 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.732 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.39 55.56 28.99 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -83.35 2.72 34.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -168.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 58' ' ' GLU . 47.2 mt-10 69.22 -4.28 1.34 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.802 0.841 . . . . 0.0 112.536 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 54' ' ' SER . 2.7 p -137.95 103.3 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 123.829 0.852 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.516 ' H ' ' HB3' ' A' ' 54' ' ' SER . 41.0 m -82.57 122.78 28.53 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 87.8 tttt -131.12 134.17 46.32 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 52' ' ' LEU . 11.3 m -130.46 148.38 33.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.129 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -86.54 -44.83 11.62 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.328 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.13 145.11 6.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.702 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.45 HG12 HG23 ' A' ' 77' ' ' ILE . 73.9 mt -117.98 122.87 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.1 137.28 42.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.27 137.56 51.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 74.3 m-85 -122.33 139.33 53.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.753 0.787 . . . . 0.0 111.703 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.94 -168.46 22.84 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.9 m -145.73 149.82 35.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 117.431 0.616 . . . . 0.0 109.676 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--N 1.29 -2.016 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.295 178.171 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 11' ' ' LYS . 2.0 mp . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.1 1.63 9.07 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.805 2.336 . . . . 0.0 112.964 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' H ' HG22 ' A' ' 9' ' ' ILE . 24.2 ttmm 70.83 118.95 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.796 1.238 . . . . 0.0 111.423 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.81 -44.31 1.28 Allowed Glycine 0 C--N 1.307 -1.05 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -134.87 152.37 51.69 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 13.0 m -106.2 167.51 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.069 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.475 ' H ' HG13 ' A' ' 9' ' ' ILE . 21.9 t70 -76.82 95.33 4.03 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.75 -0.38 0.11 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 126.917 2.087 . . . . 0.0 114.054 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.5 tt -64.02 -31.73 73.02 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.49 -24.12 67.69 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.864 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.75 8.66 41.8 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.047 -0.408 . . . . 0.0 110.398 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.9 mt -85.57 119.08 33.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.25 -34.82 42.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.517 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 96.2 m95 70.23 6.57 5.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.8 t -84.96 -28.79 25.59 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.8 -89.23 1.78 Allowed Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 108.089 -2.005 . . . . 0.0 108.089 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.517 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 92.3 t 41.89 94.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.246 1.418 . . . . 0.0 114.283 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.48 128.1 56.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.906 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.2 p -102.01 119.87 39.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.645 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.424 HD13 ' C ' ' A' ' 28' ' ' LEU . 2.6 tm? -64.3 -44.29 92.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.066 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -117.64 -99.63 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.127 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 8.5 tt0 56.08 22.14 5.7 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.301 1.048 . . . . 0.0 110.204 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -102.77 -12.67 17.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.88 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -54.76 -48.31 72.8 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.5 m 179.97 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 124.483 1.113 . . . . 0.0 110.399 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -73.31 163.36 28.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.628 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.459 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 45.8 m -98.51 140.22 33.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.542 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.463 ' CB ' ' HG ' ' A' ' 52' ' ' LEU . 7.0 tt -77.85 -44.82 2.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.453 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.07 -24.66 20.41 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.141 1.894 . . . . 0.0 112.79 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.569 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.0 m-20 -57.37 -48.43 79.07 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 121.227 0.537 . . . . 0.0 110.264 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.02 4.94 20.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.109 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' O ' ' HZ2' ' A' ' 22' ' ' TRP . 49.2 tp -140.25 10.5 2.33 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 5.3 tmtm? -127.68 141.75 51.52 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.54 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 15.6 mm-40 -58.88 132.81 55.06 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -39.77 2.77 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.478 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -76.0 -48.25 21.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.611 -0.294 . . . . 0.0 111.287 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' A' ' 17' ' ' LEU . 32.1 ptt180 -68.12 107.8 2.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.056 0.931 . . . . 0.0 111.596 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.82 100.63 5.77 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' HB2' ' OE1' ' A' ' 153' ' ' GLN . 4.8 p-10 -71.68 84.65 0.89 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -173.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 16.9 tp10 168.96 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 113.241 -1.799 . . . . 0.0 108.29 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.11 -68.88 1.51 Allowed Glycine 0 C--O 1.238 0.396 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.785 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 38' ' ' ASN . 1.9 pp -104.79 158.07 16.77 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 120.966 0.412 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.449 ' ND2' ' HG3' ' A' ' 151' ' ' LYS . 3.5 p-10 -161.76 166.41 26.56 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.463 ' HG ' ' CB ' ' A' ' 36' ' ' LEU . 3.2 tm? -111.51 128.82 56.13 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.04 162.44 35.46 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.763 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 51.2 p -92.12 176.09 6.63 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.944 0.153 . . . . 0.0 110.774 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 175.79 -46.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.925 0.89 . . . . 0.0 109.067 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.19 -28.84 63.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.59 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.3 t70 -160.29 145.71 15.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -74.06 -27.81 61.09 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 123.519 0.512 . . . . 0.0 112.236 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.2 132.19 34.06 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.304 0.574 . . . . 0.0 110.542 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 54' ' ' SER . 93.2 mt -131.12 144.43 51.39 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.327 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 62' ' ' ILE . 6.0 tt -153.06 144.35 23.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.515 ' N ' HD23 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -150.29 138.94 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.474 ' N ' HD13 ' A' ' 62' ' ' ILE . 68.2 t80 -105.32 122.76 46.62 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.914 0.486 . . . . 0.0 111.825 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 62' ' ' ILE . 2.3 mp -116.26 119.47 36.45 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.652 177.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -86.84 127.74 2.7 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.538 2.159 . . . . 0.0 109.219 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -90.81 162.65 14.75 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -48.8 -57.6 6.12 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 126.376 1.87 . . . . 0.0 110.165 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -149.48 177.94 9.26 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 57.7 t -78.49 111.72 15.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.57 173.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -100.61 133.8 44.52 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 125' ' ' LEU . 2.4 tt -98.19 123.22 42.15 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -102.2 -41.44 6.39 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.822 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.0 p -154.63 160.93 41.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.027 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -135.23 150.23 50.03 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -143.6 98.11 3.19 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.7 mt -108.26 132.21 56.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 54.0 mtpt -116.55 159.3 22.31 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.264 0.554 . . . . 0.0 112.42 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.4 39.64 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -73.85 172.62 15.49 Favored 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 122.25 1.966 . . . . 0.0 110.356 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -74.8 -27.93 60.51 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.834 0.35 . . . . 0.0 110.668 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.22 -47.17 7.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.18 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 151' ' ' LYS . 43.7 mt-10 -89.7 1.8 55.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.745 -176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.76 45.45 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.798 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 7.5 Cg_exo -71.21 107.07 2.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.174 1.916 . . . . 0.0 111.15 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.34 -43.39 13.74 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.7 m -92.74 97.22 10.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.143 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 33.8 m -107.38 142.28 20.52 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -146.65 133.46 20.08 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.27 144.69 45.61 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.011 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -131.98 115.65 16.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.6 t -93.27 134.54 35.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 73.67 178.29 0.23 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.829 1.252 . . . . 0.0 111.501 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.4 tptm 72.41 101.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.063 1.345 . . . . 0.0 110.736 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.8 122.96 19.66 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.643 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t60 70.87 97.35 0.07 Allowed 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.389 1.056 . . . . 0.0 112.997 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 83.5 mtp -126.39 152.77 45.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 85.5 m -142.7 174.85 10.28 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.509 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 55.5 p90 -65.54 -17.6 64.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.1 m -73.19 -23.33 60.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.626 0.25 . . . . 0.0 111.454 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -128.51 3.34 5.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 111.514 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.509 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 8.3 p -65.09 -34.77 72.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.867 -173.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -97.71 5.1 49.73 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.75 -24.56 18.53 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.173 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -97.38 149.74 36.04 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.718 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.59 128.88 18.88 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 122.67 2.247 . . . . 0.0 112.028 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.68 160.27 41.29 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.436 2.09 . . . . 0.0 111.256 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -76.79 -41.95 42.55 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.489 0.661 . . . . 0.0 109.378 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.635 ' OD2' ' HG3' ' A' ' 126' ' ' LYS . 14.9 t70 -161.71 146.71 13.24 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -127.99 124.17 36.54 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 173.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -119.05 172.89 7.24 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.085 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.44 134.59 55.14 Favored 'General case' 0 N--CA 1.405 -2.676 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 118' ' ' LEU . 28.4 tp -69.57 121.54 17.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -98.03 169.59 9.52 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.861 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -31.77 72.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.42 ' HA ' ' HE2' ' A' ' 119' ' ' LYS . 15.0 pt-20 -70.87 -33.88 71.05 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.82 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.631 HD21 ' HA ' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -64.44 -42.57 95.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 113' ' ' LEU . 87.2 mt -62.19 -4.87 1.93 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.83 1.252 . . . . 0.0 113.642 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 116' ' ' GLU . 57.1 mtmt -113.14 -9.39 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 122.821 0.448 . . . . 0.0 109.976 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.83 0.58 34.19 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.914 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 31.9 mmmt -75.34 131.52 77.74 Favored Pre-proline 0 C--O 1.246 0.907 0 O-C-N 123.592 0.231 . . . . 0.0 111.375 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 29.7 Cg_exo -65.14 119.54 6.59 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.288 2.659 . . . . 0.0 111.639 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.0 t -97.54 136.0 29.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.04 117.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.405 0.621 . . . . 0.0 111.252 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.469 HD11 HD22 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.54 -175.59 4.74 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.401 176.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.635 ' HG3' ' OD2' ' A' ' 109' ' ' ASP . 29.9 mtpp -64.54 89.9 0.07 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.619 0.723 . . . . 0.0 112.06 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -69.68 -21.37 63.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.732 1.213 . . . . 0.0 110.959 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 m -80.33 -19.23 12.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.03 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 9.9 tmtt? -92.85 -41.84 9.86 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 125' ' ' LEU . 91.8 m-85 -75.77 78.97 2.71 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 112.021 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -107.99 -40.44 5.23 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.418 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.29 112.65 23.44 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.388 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 49.0 t -123.3 102.38 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -95.87 -31.07 13.32 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.4 p -156.94 162.99 39.62 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 137' ' ' THR . 4.4 tt -148.82 133.99 18.29 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.476 ' N ' HD23 ' A' ' 136' ' ' LEU . 64.6 m -104.32 124.7 49.65 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mp -103.03 125.96 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.63 118.25 27.72 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.501 HG13 ' HB2' ' A' ' 60' ' ' LEU . 10.5 pt -112.46 114.32 46.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.68 0.753 . . . . 0.0 109.76 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.66 -42.43 9.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.612 -172.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.24 150.58 38.16 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.899 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.08 167.99 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.834 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.571 HE21 HD23 ' A' ' 113' ' ' LEU . 82.6 mm-40 -48.47 -48.61 37.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.0 m -92.84 -19.45 21.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.81 42.38 61.26 Favored Glycine 0 C--N 1.311 -0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.6 t -87.86 9.86 20.57 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.938 -0.631 . . . . 0.0 110.752 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 68.15 8.39 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.379 1.072 . . . . 0.0 112.318 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 54' ' ' SER . 7.7 p -136.02 112.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-O 121.976 0.893 . . . . 0.0 109.378 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.6 m -106.74 121.28 44.05 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.449 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 4.9 ttmp? -113.4 133.62 55.07 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.232 0.539 . . . . 0.0 110.485 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.7 t -125.68 116.1 45.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.654 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.47 ' OE1' ' HB2' ' A' ' 47' ' ' ASP . 9.7 pt20 -85.87 -29.92 23.32 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.45 145.43 12.96 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.28 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.36 129.32 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.59 129.63 20.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.98 144.73 42.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 84.5 m-85 -124.16 113.21 18.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.307 0.575 . . . . 0.0 111.042 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.96 -167.24 11.0 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.4 p -162.44 162.95 27.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 118.315 1.057 . . . . 0.0 112.556 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.302 -1.469 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.315 173.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.6 mt . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.26 143.22 4.62 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 122.3 2.0 . . . . 0.0 111.715 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -59.18 130.67 48.09 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.69 0.757 . . . . 0.0 112.021 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -42.26 1.96 Allowed Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -106.67 173.3 6.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.615 0.721 . . . . 0.0 110.064 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.431 HG11 HG23 ' A' ' 161' ' ' THR . 14.6 p -130.15 143.94 39.5 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 154.5 29.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.029 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 20' ' ' ILE . 4.3 mm? -101.64 8.83 41.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.927 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 42' ' ' GLN . 4.4 tt -78.48 -48.49 15.24 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.85 -27.22 68.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.788 -1.097 . . . . 0.0 110.918 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -84.07 9.84 11.56 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.494 HG22 ' H ' ' A' ' 22' ' ' TRP . 75.4 mt -93.71 127.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.28 -15.99 41.6 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.508 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' H ' HG22 ' A' ' 20' ' ' ILE . 86.0 m95 58.88 30.7 20.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.709 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -57.31 -36.19 70.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.933 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.2 -47.37 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 22' ' ' TRP . 2.7 t 62.7 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.348 1.059 . . . . 0.0 109.885 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -121.78 139.85 53.08 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.018 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.54 128.74 29.81 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD13 HD12 ' A' ' 61' ' ' LEU . 8.6 mp -62.58 -26.78 68.77 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -99.41 -105.02 0.22 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.325 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 54.73 15.61 1.15 Allowed 'General case' 0 CA--C 1.573 1.842 0 CA-C-O 122.322 1.058 . . . . 0.0 110.306 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 t -78.36 -30.1 47.81 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.613 1.165 . . . . 0.0 107.931 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 4.9 p -64.95 7.09 0.18 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m 76.66 -17.23 0.56 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.417 ' ND1' ' HB3' ' A' ' 53' ' ' GLU . 29.6 m80 -77.62 134.98 38.08 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.659 174.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -83.05 157.31 22.93 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 52' ' ' LEU . 2.8 tm? -81.74 -53.74 0.7 Allowed Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.83 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 31.9 Cg_exo -60.3 -15.19 33.57 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 121.845 1.697 . . . . 0.0 113.661 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.751 ' HB2' HD13 ' A' ' 50' ' ' LEU . 32.0 p30 -75.25 -22.64 57.69 Favored 'General case' 0 C--O 1.209 -1.045 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.905 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.79 1.18 36.92 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.362 0.601 . . . . 0.0 110.825 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.84 -43.7 2.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.091 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.11 130.43 35.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.925 0.393 . . . . 0.0 110.947 -174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' HB2' HD11 ' A' ' 17' ' ' LEU . 21.5 tm0? -57.82 140.05 52.66 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 124.501 1.12 . . . . 0.0 110.641 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.8 -59.5 0.53 Allowed Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -73.77 -41.04 62.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.7 ' HD2' ' O ' ' A' ' 45' ' ' ARG . 2.7 tmm_? -53.49 -11.44 0.34 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.961 2.104 . . . . 0.0 111.569 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -65.44 100.53 0.5 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.22 98.83 0.84 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.0 -75.24 0.32 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.225 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.34 -54.38 0.79 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.957 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.751 HD13 ' HB2' ' A' ' 38' ' ' ASN . 1.8 pp -85.03 147.46 26.67 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.757 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -164.06 166.32 21.51 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.641 -177.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 36' ' ' LEU . 61.2 tp -83.59 123.47 29.81 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' ND1' ' A' ' 34' ' ' HIS . 32.2 tt0 -140.71 130.53 24.41 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.729 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 64.7 p -101.91 151.05 22.56 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' HG12 ' A' ' 149' ' ' VAL . 17.3 t70 -123.8 -54.28 1.74 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.584 -170.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.95 -26.41 25.52 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.192 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -130.39 145.97 51.89 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 117.958 -1.497 . . . . 0.0 111.634 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.25 -31.75 24.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.929 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -68.49 114.96 7.36 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.334 0.587 . . . . 0.0 110.855 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 HD21 ' CD2' ' A' ' 52' ' ' LEU . 17.8 tp -126.05 107.53 10.51 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.408 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD12 HD13 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -107.61 130.71 54.87 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -179.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.407 HD11 ' HG ' ' A' ' 60' ' ' LEU . 3.3 mp -127.61 132.87 68.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -113.91 126.19 54.89 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 46.5 mm -107.71 121.23 44.78 Favored Pre-proline 0 N--CA 1.425 -1.694 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.36 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 64' ' ' ILE . 6.3 Cg_exo -77.94 112.59 3.3 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.593 2.196 . . . . 0.0 110.273 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -80.2 164.13 23.5 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 126.065 1.746 . . . . 0.0 113.922 -175.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -106.11 -37.53 6.57 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.069 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -150.62 160.6 43.71 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.64 128.2 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 124.028 0.83 . . . . 0.0 109.323 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -134.44 174.06 13.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 174.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 160' ' ' SER . 38.6 ttpt -97.13 146.8 24.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.47 ' HG ' HG21 ' A' ' 133' ' ' VAL . 87.3 mt -78.83 159.11 27.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HA ' ' CE2' ' A' ' 127' ' ' TYR . 13.2 t60 -146.82 -66.02 0.28 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.793 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.9 p -137.77 163.02 32.38 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.821 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 41.7 p90 -140.1 149.06 42.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.99 111.66 8.73 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.745 0.307 . . . . 0.0 110.25 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.7 mt -123.81 120.6 60.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 153' ' ' GLN . 85.2 mttt -96.46 136.38 37.04 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.273 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.574 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -164.39 156.56 28.53 Favored Glycine 1 C--N 1.25 -4.23 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 177.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.53 172.49 12.32 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 122.002 1.801 . . . . 0.0 112.887 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -75.98 -24.53 55.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.959 0.885 . . . . 0.0 109.416 177.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.19 -55.14 4.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.0 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -109.18 7.96 25.68 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.703 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.94 158.23 36.41 Favored Glycine 0 C--N 1.305 -1.188 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.272 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.0 Cg_exo -77.12 107.66 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.888 1.725 . . . . 0.0 110.902 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 1.0 OUTLIER -89.19 -51.78 5.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.981 -176.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.7 m -93.44 95.46 9.3 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.715 0.769 . . . . 0.0 109.699 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -98.02 135.04 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.779 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.58 141.82 49.77 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.813 0.816 . . . . 0.0 110.256 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 53.3 m-85 -115.17 145.39 42.44 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.551 ' CZ ' ' HB ' ' A' ' 102' ' ' VAL 0.257 76.2 m-85 -118.12 146.74 43.93 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 178.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -74.14 -158.5 0.07 Allowed 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.651 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 134' ' ' ARG . 27.7 t-20 -53.21 -20.06 3.67 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.492 1.917 . . . . 0.0 112.862 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -72.33 111.8 7.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.38 161.15 13.79 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 65.35 23.48 12.05 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 111.365 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.451 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 79.7 mtp -68.29 135.41 51.88 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.897 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.472 ' O ' HG13 ' A' ' 102' ' ' VAL . 19.9 p -102.91 174.04 6.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -62.37 -29.14 70.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -87.27 -5.7 58.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -104.4 -19.64 13.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.551 ' HB ' ' CZ ' ' A' ' 91' ' ' PHE . 33.1 m -83.69 2.72 3.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.778 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.62 -26.33 21.96 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.993 0.425 . . . . 0.0 111.944 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -110.48 10.22 23.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.796 0.331 . . . . 0.0 111.166 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -124.22 131.68 24.22 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.65 126.93 11.88 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.76 162.03 42.96 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.356 2.037 . . . . 0.0 111.567 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 16.7 m -60.42 -45.36 93.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.038 0.923 . . . . 0.0 108.826 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -167.9 166.18 13.51 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -133.45 128.58 35.76 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.0 172.85 8.21 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.302 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 39.4 tt0 -125.38 138.05 54.04 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.94 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 27.6 tp -70.15 100.87 1.73 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.9 t -91.37 167.61 12.16 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.3 -35.68 67.79 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.69 0.396 . . . . 0.0 111.748 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 121' ' ' LYS . 8.4 tp10 -67.4 -38.84 85.27 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.408 ' HB3' HD12 ' A' ' 113' ' ' LEU . 1.4 t-20 -71.36 -44.41 65.08 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 79' ' ' GLY . 5.1 tt -57.91 -31.81 67.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.527 1.531 . . . . 0.0 109.671 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -85.2 -3.02 58.67 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.02 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HB2' ' HG3' ' A' ' 116' ' ' GLU . 73.2 mmtt -94.24 137.05 22.94 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 18.9 Cg_endo -62.08 115.19 2.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.673 2.915 . . . . 0.0 112.934 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.4 t -96.42 137.71 23.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.68 123.88 32.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.18 176.87 5.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.587 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -94.9 110.5 22.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.063 0.458 . . . . 0.0 110.394 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 73' ' ' HIS . 45.2 p90 -125.41 26.48 6.81 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.47 -33.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.01 0.434 . . . . 0.0 111.463 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -90.42 -32.6 16.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.421 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 56.3 m-85 -90.41 69.94 6.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.814 0.816 . . . . 0.0 112.169 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -88.41 -12.7 42.44 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.79 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -146.2 120.99 9.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.436 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.47 HG21 ' HG ' ' A' ' 72' ' ' LEU . 94.1 t -121.42 104.61 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.139 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 93' ' ' ASN . 29.3 tpt180 -71.78 -50.44 29.83 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.801 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.6 p -134.66 150.72 50.68 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -129.98 135.44 48.3 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.869 0.366 . . . . 0.0 110.511 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 70.2 m -121.95 129.64 52.67 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.7 mp -107.56 121.21 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 74.3 t80 -124.35 125.72 44.8 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.014 0.435 . . . . 0.0 112.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.1 pt -119.51 126.13 75.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.9 pt-20 -108.78 -17.98 13.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.97 22.34 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.253 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -98.15 -174.22 2.79 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -62.08 -63.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.485 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -103.43 -42.22 5.77 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.927 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.79 69.21 0.64 Allowed Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 -174.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.8 m -84.78 16.72 3.14 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.409 0.684 . . . . 0.0 111.329 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 76.2 -43.67 0.48 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.405 1.482 . . . . 0.0 111.9 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 55' ' ' ASP . 11.4 m -102.35 157.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.623 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 59.2 m -121.94 128.68 51.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -129.25 133.58 47.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.001 0.429 . . . . 0.0 110.079 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 7.2 p -134.77 125.36 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 24.5 mm-40 -73.68 -47.57 38.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.532 -174.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 147.06 10.31 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -122.74 122.99 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.73 121.42 12.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.05 147.09 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -124.93 118.95 27.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.97 -157.0 11.05 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 38.7 m -152.75 126.22 8.75 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.431 HG23 HG11 ' A' ' 14' ' ' VAL . 24.9 p . . . . . 0 C--N 1.276 -2.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.422 175.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--O 1.243 0.737 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -87.0 170.56 7.14 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.257 1.971 . . . . 0.0 112.855 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -59.62 114.73 2.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.544 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.51 -61.98 0.55 Allowed Glycine 0 N--CA 1.423 -2.202 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.105 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -112.53 -171.86 1.94 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.395 0.617 . . . . 0.0 111.034 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.49 150.48 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 173.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 32.9 t0 -72.29 126.38 29.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 157' ' ' LEU . 59.2 mt -81.06 4.36 20.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' HA ' HD12 ' A' ' 20' ' ' ILE . 5.4 tt -51.42 -35.86 41.14 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.299 1.047 . . . . 0.0 108.411 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.37 -38.93 81.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.21 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.69 -2.46 58.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 17' ' ' LEU . 89.5 mt -74.11 136.98 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 25' ' ' VAL . 16.2 t70 -99.54 112.89 25.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -80.52 1.51 29.18 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -93.05 -35.89 12.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.36 -19.99 61.27 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.756 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 21' ' ' ASP . 28.4 m -54.2 130.89 16.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.756 0.789 . . . . 0.0 112.126 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.7 tp10 -112.06 127.5 55.92 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.616 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 26.4 p -130.26 113.59 14.6 Favored 'General case' 0 N--CA 1.398 -3.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.198 -175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 61' ' ' LEU . 3.2 mm? -72.62 -75.17 0.14 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.299 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.541 HD21 ' HB3' ' A' ' 56' ' ' ALA . 64.2 t30 -116.41 -81.43 0.61 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.561 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.616 ' NE2' ' HB2' ' A' ' 27' ' ' CYS . 1.9 mp0 62.82 23.29 13.9 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 14.4 m 89.52 139.86 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 127.609 2.363 . . . . 0.0 112.675 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.4 t -70.35 -46.36 64.29 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.675 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.3 m -77.45 -35.68 53.66 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.695 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 98.1 m-70 -124.61 149.27 47.25 Favored 'General case' 0 C--O 1.189 -2.102 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -140.98 -168.29 2.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 116.745 -1.982 . . . . 0.0 115.378 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 30' ' ' GLN . 29.8 tp -60.88 -52.47 72.1 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 50.2 Cg_exo -54.47 -32.23 72.4 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.1 1.867 . . . . 0.0 112.751 -172.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.693 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.9 p-10 -84.43 3.43 36.16 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.87 -23.8 3.04 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.936 0.398 . . . . 0.0 112.042 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -105.13 -18.12 14.25 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.116 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -80.28 147.68 31.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -66.09 143.67 57.17 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.32 -37.09 3.03 Favored Glycine 0 N--CA 1.413 -2.882 0 CA-C-N 114.87 -1.059 . . . . 0.0 114.386 170.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -74.6 -25.71 59.44 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.301 0.0 OUTLIER -60.14 67.51 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -160.91 141.76 11.56 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.754 1.622 . . . . 0.0 107.979 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.8 100.43 10.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.646 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.12 17.9 0.76 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.426 0.631 . . . . 0.0 109.931 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.14 -59.92 0.23 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.3 pp -105.19 149.38 25.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.695 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 47.1 t30 -161.72 163.41 29.69 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 60' ' ' LEU . 3.8 tt -105.32 111.98 24.91 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 171.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -141.45 122.34 14.48 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.624 ' HA ' ' OG ' ' A' ' 31' ' ' SER 0.27 36.2 p -51.76 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -171.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 18.8 t70 -113.52 88.13 2.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.14 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . 157.4 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.211 2.204 . . . . 0.0 107.987 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -139.03 157.16 46.48 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.986 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -89.02 75.14 8.02 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.545 HE21 ' C ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -174.53 139.66 0.58 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.396 1.078 . . . . 0.0 109.139 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.662 ' HB2' HG13 ' A' ' 140' ' ' ILE . 10.3 mp -135.19 147.28 49.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.619 0.768 . . . . 0.0 109.645 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 4.6 tt -149.24 124.44 10.14 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -139.43 135.05 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.552 ' N ' HD13 ' A' ' 62' ' ' ILE . 45.1 t80 -105.78 125.64 51.23 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.93 0.892 . . . . 0.0 110.324 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -116.77 120.73 33.82 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.403 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -97.85 127.43 0.23 Allowed 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 123.054 2.503 . . . . 0.0 110.421 170.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -95.14 139.75 31.04 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.21 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -72.73 -20.57 61.18 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.164 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -147.48 144.47 28.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.77 120.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.684 0.754 . . . . 0.0 111.16 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 168.43 10.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HE2' ' OE1' ' A' ' 131' ' ' GLN . 7.5 mtpm? -96.16 113.62 25.24 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 55.3 tp -71.2 152.5 43.29 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 17.9 t60 -139.22 -49.57 0.5 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.978 0.418 . . . . 0.0 111.526 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -147.19 167.54 23.92 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 122.036 -0.415 . . . . 0.0 111.91 -175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.588 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 12.3 p90 -129.43 158.21 39.81 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.606 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -151.66 131.94 13.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.868 0.366 . . . . 0.0 111.039 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.411 HG21 ' HG2' ' A' ' 85' ' ' PRO . 67.7 mt -140.19 128.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -104.04 155.63 18.52 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.347 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.26 -178.07 42.61 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 151' ' ' LYS . 15.3 Cg_exo -68.18 159.99 50.76 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 122.91 2.407 . . . . 0.0 110.86 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.09 -29.15 68.02 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 35.1 mt-10 -93.34 -41.53 9.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.42 0.629 . . . . 0.0 111.463 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 15.35 25.88 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.096 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -85.79 150.73 24.43 Favored Glycine 0 C--N 1.307 -1.054 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 47.8 Cg_exo -55.61 160.66 8.97 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.807 2.338 . . . . 0.0 112.646 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.82 -56.31 0.18 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.8 m -80.99 100.05 8.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.861 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 140' ' ' ILE . 48.8 t -123.39 119.72 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.361 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.22 131.12 56.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 109' ' ' ASP 0.253 32.5 p90 -138.26 134.11 33.98 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 177.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -110.25 159.39 17.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 p -148.47 167.54 25.05 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 117.965 0.348 . . . . 0.0 111.838 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.268 19.2 m120 86.48 -24.59 0.12 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 48.7 mtpt -97.92 148.09 23.8 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.889 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.84 134.85 37.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 68.25 94.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.275 1.03 . . . . 0.0 111.365 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.6 mmm -127.41 107.2 9.75 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.652 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.405 ' O ' HG23 ' A' ' 102' ' ' VAL . 22.0 p -98.45 177.99 5.17 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -67.35 -25.87 66.21 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.9 t -56.62 -49.85 73.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.35 -38.89 92.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.958 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 98' ' ' CYS . 82.5 t -64.97 -29.79 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.69 -19.87 58.81 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.299 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -104.61 -42.38 5.43 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.32 124.83 47.69 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.953 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.95 135.93 71.9 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.963 2.442 . . . . 0.0 110.882 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.17 167.36 14.58 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.552 2.168 . . . . 0.0 112.383 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -83.14 -44.77 14.72 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 20.0 t70 -143.14 151.02 40.23 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.915 174.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.1 p -115.35 118.21 32.59 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.34 150.73 26.95 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.103 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.98 107.04 10.43 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 8.5 tt -72.21 134.42 45.64 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.197 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.4 p -116.36 169.17 9.51 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.483 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.64 -33.05 72.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.867 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 121' ' ' LYS . 39.1 tt0 -60.17 -40.99 91.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.29 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.606 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.9 t-20 -63.38 -47.18 83.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.621 -177.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.46 -14.26 61.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -87.76 10.32 18.76 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.716 0.77 . . . . 0.0 109.065 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.06 12.7 56.12 Favored Glycine 0 CA--C 1.507 -0.438 0 CA-C-N 114.272 -1.331 . . . . 0.0 114.627 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 12.2 mptt -99.31 117.55 63.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.35 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 67.3 Cg_exo -56.29 119.73 7.11 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.954 3.103 . . . . 0.0 112.481 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 58.5 t -93.01 131.59 39.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 m -83.19 127.45 39.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 121.523 0.678 . . . . 0.0 111.455 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.458 HD12 ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.52 179.03 4.99 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.933 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.59 94.49 6.3 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 20.0 p90 -105.08 12.43 32.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.75 -26.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.539 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -99.33 14.54 29.28 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.176 175.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.04 74.87 1.18 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.475 ' OE1' ' HE2' ' A' ' 71' ' ' LYS . 28.7 mm-40 -109.1 -37.91 5.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -112.55 114.31 26.9 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 t -122.48 100.88 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.806 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.592 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -87.1 -36.39 18.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 109.766 169.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.9 p -141.84 141.67 33.11 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.598 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 137' ' ' THR . 5.8 tt -140.16 141.48 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.578 ' N ' HD23 ' A' ' 136' ' ' LEU . 35.7 m -127.01 120.64 29.55 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -104.97 122.16 57.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 122.799 0.44 . . . . 0.0 110.405 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -122.59 107.27 11.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.662 HG13 ' HB2' ' A' ' 60' ' ' LEU . 2.0 pp -104.45 141.14 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.512 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -111.13 -25.66 9.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -158.51 158.43 34.03 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.66 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.401 ' HB3' HG23 ' A' ' 150' ' ' THR . 7.1 p30 -99.9 179.4 4.52 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.621 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 85.8 mm-40 -50.12 -59.82 3.55 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.632 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.5 m -91.03 -8.44 49.07 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.203 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.14 42.28 96.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.2 m -88.96 15.64 8.23 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 74.38 -42.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.807 1.243 . . . . 0.0 113.54 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -102.14 105.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.368 1.08 . . . . 0.0 110.576 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 34.5 m -97.02 124.22 40.95 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.109 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.515 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -97.11 133.73 41.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.412 0.625 . . . . 0.0 109.64 177.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.11 107.78 10.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 124.946 1.298 . . . . 0.0 107.742 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -91.12 -32.33 15.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.28 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.565 ' HE3' ' HB2' ' A' ' 156' ' ' ALA . 7.4 tmtm? -152.93 133.49 13.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.2 mt -118.52 136.69 54.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.565 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . . . -144.36 148.59 34.92 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 121.411 0.624 . . . . 0.0 110.643 174.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 2.8 mm? -117.57 127.38 53.92 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.451 ' HB3' ' CB ' ' A' ' 13' ' ' GLN . 61.7 m-85 -108.38 128.81 55.1 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -149.72 -166.73 13.54 Favored Glycine 0 C--N 1.286 -2.218 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -152.92 142.66 22.0 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.309 0.555 . . . . 0.0 110.44 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 117.566 -1.207 . . . . 0.0 109.743 176.535 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 11' ' ' LYS . 45.9 mm . . . . . 0 N--CA 1.427 -1.581 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -91.95 27.1 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.284 2.656 . . . . 0.0 111.214 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 9' ' ' ILE . 88.1 tttt 64.06 112.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.744 1.618 . . . . 0.0 112.028 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.89 -81.21 0.19 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.84 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 2.2 mp0 -100.1 175.48 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 19' ' ' PHE . 17.4 m -107.2 162.54 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 CA-C-O 120.803 0.335 . . . . 0.0 111.406 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.81 118.63 21.77 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.521 HD22 HG13 ' A' ' 70' ' ' ILE . 35.3 mt -69.99 2.52 3.45 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.236 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.58 -42.86 97.55 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.127 0.965 . . . . 0.0 108.651 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.49 -26.1 67.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.016 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HE2' HG21 ' A' ' 14' ' ' VAL . 43.6 m-85 -102.55 22.33 13.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.092 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 64' ' ' ILE . 78.6 mt -97.45 126.33 50.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 121.411 -0.116 . . . . 0.0 110.815 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.74 118.05 28.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -90.82 6.82 42.8 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.486 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 m -89.93 -18.72 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 7.31 7.21 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.586 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.18 141.08 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 117.645 0.723 . . . . 0.0 111.538 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -129.61 134.56 47.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.232 0.539 . . . . 0.0 110.144 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . 19.8 p -110.92 114.56 27.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.958 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.9 -68.82 0.32 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.75 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' A' ' 60' ' ' LEU 0.255 7.2 p-10 -104.17 -52.9 2.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 33.1 tt0 69.36 0.95 3.09 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 122.923 0.489 . . . . 0.0 111.551 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.59 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 79.1 p 73.94 130.29 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 127.472 2.309 . . . . 0.0 110.712 -168.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.7 m -62.35 15.65 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.0 m -138.2 -28.91 0.84 Allowed 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -124.48 165.57 17.55 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.715 -0.616 . . . . 0.0 112.18 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -91.07 -179.44 5.45 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -174.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.546 ' H ' ' HD2' ' A' ' 37' ' ' PRO . 15.8 tp -98.3 -56.8 0.18 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 36' ' ' LEU . 24.7 Cg_endo -58.11 -22.09 54.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.663 2.242 . . . . 0.0 112.584 -175.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.604 HD22 ' HB2' ' A' ' 50' ' ' LEU . 31.7 p-10 -64.83 -30.04 71.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.57 -6.17 12.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.616 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -105.27 -25.23 12.51 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.391 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -81.87 137.24 35.27 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.463 0.649 . . . . 0.0 111.603 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -63.29 134.89 56.58 Favored 'General case' 0 N--CA 1.39 -3.47 0 C-N-CA 125.182 1.393 . . . . 0.0 108.538 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.09 -56.81 1.78 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.666 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.84 -35.74 79.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.896 0.478 . . . . 0.0 111.488 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.486 ' HD2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -54.79 174.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.414 2.375 . . . . 0.0 117.414 -175.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 153' ' ' GLN 0.375 44.3 mt-10 74.34 145.43 0.08 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.751 1.62 . . . . 0.0 115.162 177.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.03 117.88 6.56 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.06 -172.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.57 -68.48 0.26 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.97 -51.39 0.1 OUTLIER Glycine 0 CA--C 1.484 -1.886 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' HD22 ' A' ' 38' ' ' ASN . 3.8 pp -78.87 156.34 28.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.007 -0.597 . . . . 0.0 109.808 174.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -161.38 165.88 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 36' ' ' LEU . 4.7 tt -118.05 116.8 27.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' A' ' 31' ' ' SER . 8.3 pt-20 -109.99 163.03 13.95 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.8 p -52.0 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 O-C-N 123.763 0.664 . . . . 0.0 112.211 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 54' ' ' SER . 13.8 t70 163.59 -156.89 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.67 -24.75 61.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.09 154.86 18.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.992 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.531 ' HB2' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.67 16.75 21.05 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -103.56 104.47 14.54 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' OD1' ' A' ' 29' ' ' ASN . 60.8 tp -114.53 132.62 56.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 62' ' ' ILE . 5.0 tt -137.87 133.83 34.36 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.913 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.485 ' N ' HD23 ' A' ' 61' ' ' LEU . 3.3 mp -133.76 132.18 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -100.94 129.18 46.75 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 20' ' ' ILE . 3.0 mp -120.98 124.02 27.62 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.582 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -95.64 157.64 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.977 2.451 . . . . 0.0 110.815 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.413 ' H ' ' HD1' ' A' ' 66' ' ' PHE . 8.7 p90 -84.52 162.24 19.93 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.497 1.141 . . . . 0.0 113.438 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -97.82 -47.91 5.39 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.881 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -133.46 149.25 51.76 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.661 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.45 116.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.521 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -129.95 173.06 14.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -91.9 143.63 26.3 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.44 158.02 21.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -148.76 -63.77 0.24 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.3 p -143.7 165.71 26.9 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.724 -171.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 4.9 p90 -133.51 159.25 40.98 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.609 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -151.98 100.13 2.62 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 120.914 0.388 . . . . 0.0 111.802 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 64.8 mt -102.62 136.13 36.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 55.2 mtpt -118.49 144.09 46.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.454 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.414 ' HA2' ' HG3' ' A' ' 153' ' ' GLN . . . -165.23 -178.74 38.64 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 22.4 Cg_exo -69.29 157.23 62.06 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.202 1.935 . . . . 0.0 110.29 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 mt-10 -62.0 -35.92 79.98 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.54 -48.22 6.2 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 43.7 mt-10 -80.1 20.44 0.65 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.631 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.62 167.5 24.55 Favored Glycine 0 C--N 1.301 -1.416 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.274 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 35.9 Cg_endo -76.79 178.97 6.95 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 121.835 1.69 . . . . 0.0 111.012 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 144' ' ' GLN . 3.1 tmmm? -144.26 -61.85 0.38 Allowed 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.608 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.41 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 51.3 m -80.43 103.45 10.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.55 116.51 51.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.436 -175.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -107.66 135.84 48.41 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.547 0.689 . . . . 0.0 111.111 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.41 134.76 53.76 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.53 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.0 m-85 -124.57 115.57 21.06 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 175.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' CE1' ' A' ' 130' ' ' PHE . 20.4 m -110.92 150.57 29.03 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m120 82.08 154.68 0.12 Allowed 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.801 1.313 . . . . 0.0 108.39 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.649 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER 67.68 100.87 0.05 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.649 0.737 . . . . 0.0 110.287 -175.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.63 140.16 38.45 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.527 0.68 . . . . 0.0 112.056 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 67.45 89.58 0.1 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 125.664 1.586 . . . . 0.0 111.839 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 81.8 mtp -119.86 142.37 48.72 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.467 ' O ' ' HB ' ' A' ' 102' ' ' VAL . 59.9 m -128.98 176.39 7.91 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -56.9 -20.42 23.16 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.0 m -81.5 -50.26 9.61 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.695 -0.628 . . . . 0.0 111.31 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -95.57 6.65 48.42 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.894 0.378 . . . . 0.0 111.529 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 11.4 p -59.31 -37.35 68.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 123.823 0.849 . . . . 0.0 112.222 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -108.78 16.82 22.48 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.782 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -86.51 -20.98 27.24 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.064 0.935 . . . . 0.0 109.06 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -113.41 138.7 22.59 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.106 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.46 138.05 68.47 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.698 2.265 . . . . 0.0 112.538 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.23 152.67 45.16 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.4 2.066 . . . . 0.0 111.875 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -61.71 -45.58 93.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -167.98 168.96 11.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -128.59 123.19 32.72 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.41 169.05 10.36 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.365 0.603 . . . . 0.0 111.777 -174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.6 mp0 -120.31 127.46 52.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.42 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.403 HD21 HD21 ' A' ' 118' ' ' LEU . 29.9 tp -72.48 110.89 7.19 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.9 t -101.0 174.46 6.0 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.65 -34.8 74.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.758 0.823 . . . . 0.0 110.641 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.21 -32.55 68.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.997 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.609 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.3 t-20 -68.81 -34.27 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 96.9 mt -62.2 2.68 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.493 1.517 . . . . 0.0 113.26 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.1 -14.11 12.97 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.472 1.109 . . . . 0.0 108.944 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.5 1.89 43.77 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.999 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -75.55 126.32 87.6 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.75 121.53 8.77 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.408 2.739 . . . . 0.0 114.067 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 57.7 t -99.04 141.37 16.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.62 144.01 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -131.9 -174.75 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.046 0.938 . . . . 0.0 111.745 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -82.39 115.74 21.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -138.63 15.03 2.73 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.434 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.22 -38.51 81.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.181 0.515 . . . . 0.0 110.429 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.533 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -95.0 2.36 55.33 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 92' ' ' SER . 76.6 m-85 -117.78 66.32 0.75 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.653 0.74 . . . . 0.0 111.737 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.83 1.91 53.43 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 0.0 109.483 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -148.2 116.07 6.39 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.78 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.8 t -116.88 137.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.444 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -116.98 -55.84 2.31 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.288 1.035 . . . . 0.0 108.802 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.0 p -118.57 139.21 51.83 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.8 tp -135.35 111.95 9.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.874 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 29.3 m -102.64 121.62 42.77 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.81 116.73 49.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 61.1 t80 -122.83 119.62 31.11 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.466 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.3 pp -108.9 131.41 59.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 12.9 pt-20 -119.86 -14.92 8.92 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.803 -0.759 . . . . 0.0 113.01 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB3' ' CB ' ' A' ' 87' ' ' THR . . . -134.69 145.8 48.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.531 HD21 ' HB2' ' A' ' 58' ' ' GLU . 87.2 m-20 -101.79 169.14 8.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -62.94 -56.08 20.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.876 0.735 . . . . 0.0 109.167 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.9 t -122.05 9.52 9.94 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.315 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.469 ' HA2' ' HB2' ' A' ' 143' ' ' ASN . . . 62.29 67.59 2.03 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.0 m -100.74 9.2 42.71 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 68.22 -55.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.49 1.116 . . . . 0.0 111.478 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 53' ' ' GLU . 49.1 t -102.46 108.05 23.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 62.9 m -102.04 111.43 23.7 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.245 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 64.1 pttt -96.49 134.09 40.11 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.913 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.83 136.47 39.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.117 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 79.3 mt-30 -87.42 -51.87 5.69 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.57 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -162.01 149.25 14.1 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.546 178.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.3 112.86 35.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.64 137.08 29.73 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 5.7 mp -112.05 159.55 18.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 56.1 m-85 -125.72 132.84 52.28 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -153.52 -149.96 5.32 Favored Glycine 0 C--N 1.299 -1.5 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.515 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 46.3 m -157.87 161.33 38.3 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 70' ' ' ILE . 66.9 p . . . . . 0 C--N 1.279 -2.488 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.384 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 13' ' ' GLN . 2.2 mp . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 3.5 Cg_exo -72.92 -69.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.271 1.981 . . . . 0.0 111.808 175.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -162.08 -68.73 0.05 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.94 -10.99 82.19 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.241 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.72 134.21 50.72 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -174.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 p -105.9 153.69 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.818 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.97 120.62 12.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.45 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.5 mt -93.96 10.19 34.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.479 ' HG ' ' NH2' ' A' ' 45' ' ' ARG . 3.4 tm? -64.97 -36.66 85.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.493 0.663 . . . . 0.0 110.922 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -85.52 1.77 47.57 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.237 1.017 . . . . 0.0 110.498 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 m-85 -101.15 7.47 43.16 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.404 HD12 HD22 ' A' ' 17' ' ' LEU . 70.6 mt -89.97 133.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.332 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.58 113.8 23.61 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -85.04 -0.54 54.77 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.855 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.9 m -87.3 -36.79 17.67 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.7 -13.2 32.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.207 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 64' ' ' ILE . 14.5 p -54.93 132.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 117.166 0.483 . . . . 0.0 110.626 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 32.6 tt0 -145.05 159.57 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.066 0.46 . . . . 0.0 110.054 -177.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 53.2 t -135.78 135.61 40.05 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -60.27 -57.86 10.97 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.323 1.015 . . . . 0.0 108.543 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.7 -64.19 0.91 Allowed 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 70.27 -52.31 0.65 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.988 1.315 . . . . 0.0 114.274 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 48.0 m -155.86 87.63 1.08 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -175.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.0 p -67.17 -29.34 69.01 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.976 162.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.2 m -154.49 -57.49 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.154 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.514 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.5 m-70 -88.0 162.38 16.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.0 m -112.1 174.79 5.71 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.45 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -67.82 -58.14 8.61 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 26.8 Cg_exo -63.02 -17.92 62.63 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.973 1.782 . . . . 0.0 112.455 -174.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.0 m-20 -56.82 -46.58 81.55 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.736 1.214 . . . . 0.0 112.238 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 45' ' ' ARG . . . -104.32 2.66 31.66 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.42 0.628 . . . . 0.0 111.458 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -105.31 -44.46 4.73 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -79.94 123.69 28.01 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -173.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -55.36 117.71 3.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.935 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.54 -45.76 1.1 Allowed Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.47 ' HB3' HD11 ' A' ' 50' ' ' LEU . 63.2 m-85 -95.58 -51.49 4.51 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HD3' ' HG2' ' A' ' 154' ' ' LYS . 89.6 mtt-85 22.7 -83.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 176.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 153' ' ' GLN . 41.9 mt-10 -61.91 134.71 57.01 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -166.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.471 ' H ' ' HB2' ' A' ' 153' ' ' GLN . 10.2 t70 -59.86 110.26 1.13 Allowed 'General case' 0 C--O 1.249 1.067 0 CA-C-N 113.121 -1.854 . . . . 0.0 110.328 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.71 -73.15 0.15 Allowed 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.56 -30.27 4.13 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.477 ' HB2' HD22 ' A' ' 38' ' ' ASN . 2.3 pp -132.21 148.19 52.45 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.014 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 29.8 p-10 -162.56 167.81 22.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 36' ' ' LEU . 40.9 tp -91.41 116.57 28.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 168.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.479 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 33.8 tt0 -136.69 112.57 9.57 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.599 0.714 . . . . 0.0 109.881 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.62 ' HB2' HD13 ' A' ' 60' ' ' LEU . 31.8 t -94.79 101.88 13.72 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.816 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.3 -30.44 11.07 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.033 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.36 72.4 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.047 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.99 160.75 22.89 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.86 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.469 ' O ' HD11 ' A' ' 140' ' ' ILE . 43.7 tt0 -92.6 -31.7 15.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -77.32 118.35 19.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.071 -174.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 54' ' ' SER . 23.7 tp -116.31 116.28 27.46 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 6.8 tt -118.95 128.83 54.78 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 57.2 mt -127.59 144.94 35.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 122.951 0.501 . . . . 0.0 109.718 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HE1' ' O ' ' A' ' 94' ' ' LYS . 83.9 t80 -117.26 126.86 53.42 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.959 0.504 . . . . 0.0 110.362 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 25' ' ' VAL . 45.2 mm -120.97 121.58 28.75 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.911 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.79 127.13 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.735 2.29 . . . . 0.0 109.55 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -93.0 141.31 28.54 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -51.89 -50.17 61.56 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.754 2.022 . . . . 0.0 109.623 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -130.58 159.6 36.69 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.389 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 7.3 p -83.26 108.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.45 172.98 12.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.516 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -95.24 132.33 40.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.6 tp -78.04 143.99 37.0 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -129.93 -54.2 1.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.144 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' HD22 ' A' ' 125' ' ' LEU . 16.1 p -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -117.72 158.14 25.25 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -153.53 105.44 2.83 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.835 0.35 . . . . 0.0 111.851 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.531 HG23 HG12 ' A' ' 155' ' ' ILE . 55.5 mt -120.39 130.21 74.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 96.4 mttt -104.97 143.24 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.23 32.5 Favored Glycine 0 C--N 1.257 -3.834 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.7 139.42 48.2 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 121.492 1.461 . . . . 0.0 108.936 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.628 ' HA ' HD11 ' A' ' 118' ' ' LEU . 11.9 pt-20 -58.68 -25.63 63.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.969 0.414 . . . . 0.0 112.069 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.53 -57.08 4.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.898 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 4.4 mm-40 -81.46 -59.62 2.56 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.905 -170.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.19 119.41 0.0 OUTLIER Glycine 0 N--CA 1.506 3.303 0 C-N-CA 127.326 2.394 . . . . 0.0 118.158 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.654 ' HA ' ' OD1' ' A' ' 143' ' ' ASN . 56.8 Cg_endo -69.29 112.18 2.92 Favored 'Trans proline' 0 C--N 1.356 0.958 0 CA-C-N 119.932 1.866 . . . . 0.0 110.06 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 112' ' ' GLU . 30.5 ttmt -90.39 -75.37 0.46 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.071 -171.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.71 102.25 3.29 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.235 -174.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG12 HG22 ' A' ' 140' ' ' ILE . 34.2 m -104.68 117.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.845 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HG3' ' OG1' ' A' ' 110' ' ' THR . 25.7 ttmm -107.11 132.83 52.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -112.69 139.02 48.64 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.54 155.55 19.97 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -77.97 -171.04 2.14 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.125 0.891 . . . . 0.0 110.926 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' SER . 8.9 p30 -57.22 104.4 0.16 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 111.512 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.417 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 55.3 tptt -163.51 164.8 24.21 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 96' ' ' HIS . 41.3 tt0 -75.95 174.01 10.5 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.467 ' H ' ' HG2' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -48.76 137.09 12.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.509 ' HB2' HG21 ' A' ' 137' ' ' THR . 18.5 mmt -93.8 173.53 7.63 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.226 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.513 ' O ' HG13 ' A' ' 102' ' ' VAL . 75.6 m -149.36 155.55 40.66 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -55.99 -24.65 40.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.4 t -85.09 -6.41 59.31 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -116.72 -15.99 10.7 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 98' ' ' CYS . 29.0 m -67.64 -3.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -97.18 -19.4 18.66 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.398 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -89.33 -37.32 14.98 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.746 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 93.5 m-85 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.302 -1.47 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.138 -175.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 13.3 Cg_exo -70.13 128.72 16.07 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.741 2.294 . . . . 0.0 111.216 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.31 165.23 29.73 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.548 2.165 . . . . 0.0 111.521 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 22.4 m -76.48 -47.48 22.74 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -162.72 169.09 20.57 Favored 'General case' 0 CA--C 1.471 -2.09 0 C-N-CA 123.513 0.725 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 40.9 m -146.2 114.43 6.64 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.29 172.87 8.32 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HB2' ' HG2' ' A' ' 86' ' ' LYS . 11.7 pt-20 -125.35 139.67 53.48 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 86' ' ' LYS . 22.4 tp -59.79 113.2 2.15 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.703 0.801 . . . . 0.0 108.903 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.1 p -85.25 166.4 16.55 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 4.1 mp0 -57.74 -39.21 76.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.46 -38.62 77.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.72 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.594 HD22 HG23 ' A' ' 123' ' ' VAL . 8.8 t-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 81' ' ' GLU . 7.5 tt -62.22 -23.33 66.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.115 1.366 . . . . 0.0 110.671 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.477 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 58.2 mtpt -102.52 1.9 35.61 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.47 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.54 68.04 0.87 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.812 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.402 ' HD2' ' HD2' ' A' ' 122' ' ' PRO . 52.3 tptt -137.39 117.58 10.48 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.501 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 15.0 Cg_endo -58.17 101.64 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.379 2.053 . . . . 0.0 111.886 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 117' ' ' ASN . 53.3 t -85.43 126.71 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 m -83.35 144.22 10.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.526 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 74' ' ' SER . 1.2 mm? -98.71 -173.44 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.409 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.99 141.4 34.46 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -96.19 27.45 3.69 Favored 'General case' 0 C--N 1.281 -2.374 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.655 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.32 -49.89 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 108' ' ' SER . 27.5 tptp -95.4 -6.13 41.64 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.79 15.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.22 121.9 14.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.325 20.9 p-10 42.97 112.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 127.221 2.208 . . . . 0.0 114.765 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 44.4 t -121.53 104.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.735 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -99.49 -28.45 13.24 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 59.9 m -143.2 151.17 40.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 137' ' ' THR . 5.6 tt -146.33 138.42 25.01 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 97' ' ' MET . 60.6 m -118.04 133.07 56.25 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 64.1 mt -108.18 122.86 63.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.33 116.85 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 58' ' ' GLU 0.267 2.0 pp -90.37 138.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 117.749 -1.58 . . . . 0.0 111.079 176.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -94.47 -48.46 6.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.936 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.85 159.78 43.85 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.071 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.654 ' OD1' ' HA ' ' A' ' 85' ' ' PRO . 94.3 m-20 -109.11 167.13 10.33 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.648 HE21 ' HA ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -47.6 -53.14 15.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 111.558 -177.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.3 t -112.93 4.15 16.65 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.541 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.95 62.51 6.28 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -83.88 8.1 16.03 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 65.68 7.09 4.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 112.949 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.68 155.73 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 93.2 m -121.58 111.39 17.17 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.478 0.656 . . . . 0.0 110.736 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.41 149.04 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 20.6 pt20 -118.1 -5.08 10.96 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.562 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -172.79 118.66 0.34 Allowed 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.398 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.531 HG12 HG23 ' A' ' 77' ' ' ILE . 68.4 mt -114.73 124.85 71.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.11 152.07 41.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.32 147.47 51.86 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 81.9 m-85 -124.38 133.71 53.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.59 -173.23 13.06 Favored Glycine 0 CA--C 1.489 -1.531 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.8 m -134.23 135.32 42.87 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.253 0.549 . . . . 0.0 110.862 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.421 -1.905 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.526 179.114 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 11' ' ' LYS . 39.5 mm . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 120.68 0.276 . . . . 0.0 111.456 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -89.79 11.91 2.71 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.58 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' H ' HG22 ' A' ' 9' ' ' ILE . 39.7 ttmt 65.96 97.02 0.05 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.882 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.61 -63.27 0.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -112.87 176.07 5.17 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 16' ' ' LEU . 34.1 m -106.23 169.63 2.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -84.09 95.96 8.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.861 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 157' ' ' LEU . 5.7 mp -74.79 -2.41 26.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.1 tt -74.06 -36.91 64.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.25 -21.14 66.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.998 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -97.21 12.2 33.71 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.022 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 16' ' ' LEU . 74.3 mt -84.13 131.63 33.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.47 124.54 35.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.693 0.759 . . . . 0.0 110.887 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -103.74 19.23 20.28 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.854 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 m -93.12 -30.89 15.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.94 3.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.839 -1.172 . . . . 0.0 114.133 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.0 135.89 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.63 148.91 36.53 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.195 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HB3' ' HG2' ' A' ' 30' ' ' GLN . 47.7 t -135.87 140.66 44.29 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 97' ' ' MET . 91.1 mt -79.35 19.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.431 0.634 . . . . 0.0 111.808 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -154.9 -60.47 0.11 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.67 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 47.9 mt-30 67.39 14.5 9.67 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 124.116 0.966 . . . . 0.0 109.86 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.67 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 3.2 m 74.75 135.03 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.219 1.808 . . . . 0.0 109.447 -174.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.429 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 33.1 t -66.83 -46.93 73.56 Favored 'General case' 0 CA--C 1.559 1.313 0 O-C-N 121.415 -0.803 . . . . 0.0 111.577 175.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.5 t -89.82 -47.1 8.12 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.108 0.956 . . . . 0.0 111.151 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.67 ' O ' ' HB2' ' A' ' 31' ' ' SER . 54.0 m80 -83.05 166.91 18.36 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 125.054 1.342 . . . . 0.0 111.146 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 m -110.49 169.5 8.71 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.914 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 4.1 tt -65.12 -57.61 14.96 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.022 0.529 . . . . 0.0 111.68 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 5.7 Cg_exo -78.64 -1.83 11.94 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 121.848 1.699 . . . . 0.0 111.296 -176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.488 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.0 t-20 -49.12 -48.45 44.58 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 125.515 1.526 . . . . 0.0 109.648 -176.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . . . -142.24 78.68 1.63 Allowed 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.764 0.793 . . . . 0.0 110.036 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.0 tp -168.26 -38.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.776 -1.557 . . . . 0.0 106.846 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 10.7 tmtt? -90.66 133.45 35.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.418 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 14.9 mm100 -53.28 142.55 20.84 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.48 -37.57 3.44 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.218 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' HD11 ' A' ' 50' ' ' LEU . 68.6 m-85 -89.72 -43.2 10.87 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 38.0 ttp180 -43.49 117.32 1.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.948 1.699 . . . . 0.0 113.206 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -177.53 137.42 0.21 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.78 91.86 8.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.881 0.372 . . . . 0.0 111.924 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -151.6 -71.67 0.16 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.018 0.927 . . . . 0.0 109.577 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -56.8 0.5 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.451 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 38' ' ' ASN . 2.3 pp -89.11 142.21 27.84 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.106 0.479 . . . . 0.0 111.884 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.597 ' ND2' ' HB2' ' A' ' 53' ' ' GLU . 3.6 p-10 -163.49 165.65 23.49 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.505 ' CD2' HD21 ' A' ' 60' ' ' LEU . 3.3 tt -88.07 126.83 35.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 171.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.597 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 44.8 tt0 -128.99 143.17 50.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 90.5 p -78.01 82.26 4.37 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 32' ' ' SER . 38.9 t70 -117.13 96.52 5.48 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.352 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 148.7 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 128.075 2.55 . . . . 0.0 104.878 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 54' ' ' SER . 10.7 t70 -157.75 155.35 29.71 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.676 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.18 -21.13 39.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.003 0.43 . . . . 0.0 110.652 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.81 109.7 17.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.527 HD23 HD11 ' A' ' 140' ' ' ILE . 27.8 tp -116.81 117.51 29.96 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.427 0.632 . . . . 0.0 110.487 -174.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.534 HD11 ' O ' ' A' ' 96' ' ' HIS . 1.8 tm? -107.21 124.38 49.65 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.506 HG13 ' SG ' ' A' ' 27' ' ' CYS . 2.0 mp -127.01 134.58 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -103.54 121.57 43.16 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.575 0.75 . . . . 0.0 109.095 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.42 120.17 29.05 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.151 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.02 154.54 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.749 2.299 . . . . 0.0 109.574 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -112.19 152.34 28.49 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -62.73 -50.63 70.33 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.586 1.554 . . . . 0.0 108.084 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -127.51 143.13 51.22 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.671 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.86 112.18 13.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -134.32 173.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.54 143.24 30.31 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.239 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.442 HD13 HD23 ' A' ' 157' ' ' LEU . 57.8 tp -92.32 105.56 17.74 Favored 'General case' 0 C--O 1.19 -2.057 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -96.37 -54.62 3.2 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.979 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 p -145.44 161.87 38.67 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.844 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' CE1' HD11 ' A' ' 125' ' ' LEU . 2.7 p90 -131.97 157.66 43.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.534 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -143.0 114.44 7.95 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.209 0.604 . . . . 0.0 109.773 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.5 mt -113.21 129.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.513 ' HE2' ' C ' ' A' ' 119' ' ' LYS . 68.2 mttt -117.2 157.98 25.07 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.481 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.03 -152.79 20.89 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 15.0 Cg_exo -72.11 152.38 56.51 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.201 1.934 . . . . 0.0 109.533 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.55 -38.93 81.22 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 144' ' ' GLN . 42.5 mt-10 -94.69 -34.7 12.46 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 5.0 mp0 -93.78 11.58 28.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.491 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.8 150.42 25.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.157 -0.802 . . . . 0.0 111.636 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 23.6 Cg_exo -63.05 113.92 2.23 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.436 2.757 . . . . 0.0 113.375 -175.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HD3' ' HG3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -104.31 -49.5 3.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -176.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.5 m -83.11 100.52 10.57 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.818 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.9 t -115.57 122.98 70.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.959 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -115.73 133.79 55.67 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 92.0 m-85 -111.96 152.1 28.47 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 25.4 t80 -140.68 117.06 10.72 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 172.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 m -91.61 138.2 31.75 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 47.95 81.91 0.04 OUTLIER 'General case' 0 C--O 1.244 0.775 0 C-N-CA 126.171 1.788 . . . . 0.0 113.965 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -171.51 170.72 5.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -81.43 175.7 10.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' HD11 ' A' ' 61' ' ' LEU . 33.1 p80 -44.67 -40.65 6.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.46 ' O ' HD11 ' A' ' 28' ' ' LEU . 87.1 mtp 61.6 -165.75 0.22 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.502 ' O ' HG23 ' A' ' 102' ' ' VAL . 30.8 p -150.06 163.81 37.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 42.0 p90 -68.98 -17.89 63.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -67.47 -20.2 65.44 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -103.76 -31.66 9.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.603 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 98' ' ' CYS . 95.9 t -59.57 -29.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.21 -7.22 58.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.28 -38.45 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.81 0.338 . . . . 0.0 111.557 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -95.75 137.57 21.87 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.138 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.3 131.08 27.13 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.452 2.101 . . . . 0.0 111.508 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.37 161.17 38.07 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.414 2.076 . . . . 0.0 111.487 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . 28.5 m -61.78 -46.02 91.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 110.03 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.11 143.43 15.42 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -104.85 115.03 29.6 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.52 152.59 24.53 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.465 ' HG3' ' HD3' ' A' ' 86' ' ' LYS . 35.0 tt0 -125.62 118.35 25.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.229 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 20.8 tp -61.86 105.17 0.53 Allowed 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -92.64 170.57 9.63 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.505 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 42.9 tt0 -54.98 -46.09 75.07 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.767 0.427 . . . . 0.0 111.276 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -64.85 -34.66 78.91 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.4 t-20 -61.65 -44.59 96.69 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 tm? -65.36 -32.77 74.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.314 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.513 ' C ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -84.77 9.96 12.69 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.35 31.3 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 115.149 0.819 . . . . 0.0 115.149 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -93.4 132.74 29.65 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 117.648 0.724 . . . . 0.0 111.338 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 26.5 Cg_endo -65.37 117.33 4.49 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 123.208 2.605 . . . . 0.0 112.471 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.87 130.74 44.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.78 133.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 122.956 0.502 . . . . 0.0 111.236 -174.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.464 HD11 ' CE1' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -100.0 175.1 5.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 8.5 mmpt? -86.15 49.05 1.71 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -74.69 25.62 0.09 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -170.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.8 m -57.02 -27.49 27.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -95.24 -41.18 9.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.491 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 28.0 m-85 -72.13 84.42 1.02 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.054 -173.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.55 -11.36 14.07 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.245 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -124.37 113.85 18.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.494 0.664 . . . . 0.0 109.846 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 72' ' ' LEU . 47.1 t -123.31 105.74 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.17 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -104.9 -32.1 8.95 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.9 m -135.93 135.25 39.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.431 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.2 tp -135.65 126.36 27.26 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.877 0.37 . . . . 0.0 110.085 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.6 m -94.2 117.01 29.49 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.27 115.84 50.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 141' ' ' GLU . 48.5 t80 -114.39 114.88 26.47 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 60' ' ' LEU . 28.2 pt -104.12 114.85 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.881 0.848 . . . . 0.0 109.277 174.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.453 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 43.6 tt0 -90.78 -28.38 18.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.66 -172.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -162.25 154.83 19.62 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.271 -177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -89.63 175.95 7.06 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.006 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.45 ' HB3' ' O ' ' A' ' 82' ' ' GLU . 8.5 tp-100 -51.12 -43.89 61.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.432 1.093 . . . . 0.0 112.909 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m -96.59 -37.68 10.27 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.515 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.92 42.62 3.03 Favored Glycine 0 C--N 1.302 -1.345 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.8 m -85.47 13.95 6.14 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.326 1.05 . . . . 0.0 112.655 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 74.93 -34.87 0.27 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.823 1.649 . . . . 0.0 111.625 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.1 p -100.69 98.69 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-O 122.315 1.055 . . . . 0.0 110.471 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.7 m -92.25 113.71 26.06 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.531 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 86.7 tttt -113.96 135.23 54.22 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.018 -174.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.69 137.2 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.309 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 11.7 pt20 -96.7 -28.64 14.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.19 177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -171.23 150.9 3.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.02 111.95 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.404 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -107.69 147.12 31.16 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 4.7 mp -123.34 143.91 49.79 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 67.9 m-85 -125.68 137.94 53.87 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -166.39 -140.62 2.93 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.6 t -162.83 149.9 13.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.423 -1.813 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.6 mm . . . . . 0 N--CA 1.396 -3.169 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -85.5 136.43 5.48 Favored 'Trans proline' 0 N--CA 1.427 -2.42 0 C-N-CA 121.715 1.61 . . . . 0.0 111.191 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -50.64 113.49 0.91 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 112.155 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.13 8.36 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.51 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.19 147.36 34.76 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 117.25 0.525 . . . . 0.0 111.373 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.93 149.14 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.97 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.83 134.42 39.07 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.2 mm? -62.87 -14.04 41.29 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.373 1.069 . . . . 0.0 113.813 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 41' ' ' LYS . 2.1 tm? -51.32 -36.4 42.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.499 0.666 . . . . 0.0 109.93 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.27 -26.25 60.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.214 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -107.67 34.35 3.58 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.8 mm -116.4 145.1 22.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.056 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -96.23 131.59 42.55 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -104.38 8.85 35.89 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -97.3 -34.96 10.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' C ' ' HG3' ' A' ' 65' ' ' PRO . . . -89.22 -4.86 73.71 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.458 -0.792 . . . . 0.0 114.05 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -53.59 143.43 5.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -142.55 139.62 31.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.136 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 30' ' ' GLN . 5.5 p -135.61 128.85 31.93 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.891 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.657 HD23 HD12 ' A' ' 61' ' ' LEU . 2.7 mm? -91.92 123.71 35.5 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.502 HD21 ' HB3' ' A' ' 56' ' ' ALA . 47.3 t-20 76.26 -59.78 0.5 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.759 1.624 . . . . 0.0 108.263 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 34.2 tt0 73.14 -74.77 0.08 Allowed 'General case' 0 C--N 1.37 1.474 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p 174.16 115.95 0.02 OUTLIER 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.4 t -48.91 -37.23 19.18 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -100.63 -42.63 6.46 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.725 -0.609 . . . . 0.0 111.233 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -85.13 166.57 16.51 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -106.96 152.94 23.28 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.644 ' HA ' HD13 ' A' ' 52' ' ' LEU . 3.1 tm? -54.47 -57.89 16.59 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.82 -17.06 58.36 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.183 1.922 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.538 HD22 ' HB2' ' A' ' 50' ' ' LEU . 3.1 m-20 -58.75 -27.55 65.05 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 113.086 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . . . -133.04 15.71 4.21 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.206 0.526 . . . . 0.0 110.749 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -112.29 -43.16 3.57 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.21 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.448 ' HA ' HD21 ' A' ' 17' ' ' LEU . 16.0 ptpt -98.28 137.58 36.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.353 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.19 121.62 14.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.97 -64.64 0.44 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.501 ' O ' HD11 ' A' ' 50' ' ' LEU . 59.0 m-85 -77.04 -39.79 48.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 26.4 ttp180 -37.35 103.58 0.03 OUTLIER 'General case' 0 C--O 1.243 0.739 0 C-N-CA 126.106 1.762 . . . . 0.0 113.324 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -164.65 89.27 0.51 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -57.96 104.32 0.19 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.889 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 178.1 -67.55 0.01 OUTLIER 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.308 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.17 -59.06 0.73 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 50' ' ' LEU . 3.5 pp -104.25 120.9 42.18 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.788 0.804 . . . . 0.0 110.006 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.472 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 3.0 p-10 -161.48 165.63 28.37 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.644 HD13 ' HA ' ' A' ' 36' ' ' LEU . 26.6 tp -91.65 112.42 24.33 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -131.71 113.46 13.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.592 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 35.6 p -74.4 82.22 1.92 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.059 0.933 . . . . 0.0 110.237 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.49 -30.55 29.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.893 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.502 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . -69.23 -35.68 76.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 54' ' ' SER . 19.1 t70 -171.47 156.42 4.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.619 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.2 tt0 -80.49 -11.69 59.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.911 0.884 . . . . 0.0 112.545 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.89 112.94 17.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -127.14 136.16 51.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.403 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.657 HD12 HD23 ' A' ' 28' ' ' LEU . 1.6 tm? -131.39 126.22 34.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.3 mp -128.12 134.64 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.659 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 49.4 t80 -103.7 128.1 51.08 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 123.708 0.803 . . . . 0.0 110.187 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.417 ' CG2' HD12 ' A' ' 20' ' ' ILE . 49.5 mm -120.94 124.03 27.63 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 78.2 Cg_endo -92.37 159.96 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 123.29 2.66 . . . . 0.0 110.365 171.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.401 ' H ' ' HD1' ' A' ' 66' ' ' PHE . 4.3 p90 -95.23 154.88 16.97 Favored 'General case' 0 CA--C 1.459 -2.553 0 CA-C-O 122.568 1.175 . . . . 0.0 113.919 -174.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -88.05 -42.89 12.1 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 112.877 -1.965 . . . . 0.0 106.968 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -150.65 139.07 20.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -73.17 124.68 30.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-O 121.639 0.733 . . . . 0.0 111.643 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.15 174.59 11.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -92.51 138.68 31.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -79.35 144.16 34.46 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -136.07 -45.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.928 -0.483 . . . . 0.0 111.807 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.6 m -151.38 175.92 11.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.391 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -135.62 152.46 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -158.87 107.65 1.91 Allowed 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 77' ' ' ILE . 2.3 mp -107.38 132.58 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HE2' ' CA ' ' A' ' 120' ' ' GLY . 90.9 mttt -117.69 167.5 11.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.337 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.37 -168.25 34.14 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HG3' ' HG3' ' A' ' 151' ' ' LYS . 41.9 Cg_endo -68.76 149.43 73.06 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 122.262 1.974 . . . . 0.0 111.214 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.53 -26.37 66.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.01 -55.92 4.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.918 0.866 . . . . 0.0 111.04 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.74 13.04 36.22 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.416 -170.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.31 148.14 26.4 Favored Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 16.4 Cg_endo -58.1 176.21 0.39 Allowed 'Trans proline' 0 C--O 1.218 -0.52 0 C-N-CA 123.191 2.594 . . . . 0.0 113.971 -175.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 84.0 tttt -154.63 -68.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.8 m -78.26 108.39 11.55 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.47 146.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.072 0.463 . . . . 0.0 111.871 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -130.4 148.84 52.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -126.94 152.97 46.43 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -137.59 144.41 41.98 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 130' ' ' PHE . 48.2 t -137.27 155.19 49.77 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.362 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 m120 76.67 -43.32 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.662 1.585 . . . . 0.0 113.469 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.612 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -87.21 107.78 18.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 178.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 34.6 tt0 -65.03 134.44 53.85 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 59.94 87.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.428 1.091 . . . . 0.0 112.447 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.612 ' SD ' ' HD3' ' A' ' 94' ' ' LYS . 95.6 mmm -123.75 98.63 5.9 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.284 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.522 ' O ' HG23 ' A' ' 102' ' ' VAL . 64.3 m -88.78 167.87 12.94 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 89.6 t80 -49.11 -33.75 12.47 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.64 0.776 . . . . 0.0 112.585 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -56.64 -26.31 55.67 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.329 0.652 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -114.66 -18.14 11.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 98' ' ' CYS . 60.7 t -63.45 -18.89 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.126 0.971 . . . . 0.0 113.352 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -87.57 -22.91 24.52 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.729 -0.607 . . . . 0.0 112.062 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -94.38 -36.09 12.08 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -95.99 150.4 37.24 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.929 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.89 117.19 5.02 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.677 2.251 . . . . 0.0 113.06 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.37 172.09 17.01 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.088 1.859 . . . . 0.0 110.272 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.512 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 19.7 m -67.43 -46.99 71.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -172.54 -176.08 1.46 Allowed 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -139.91 130.99 26.34 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.02 173.07 11.59 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.382 0.611 . . . . 0.0 112.138 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 35.1 tt0 -123.97 128.97 50.17 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.84 105.52 2.81 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 t -86.85 163.12 17.38 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.24 -37.99 73.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.01 -31.88 68.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 123.238 0.337 . . . . 0.0 111.289 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.2 t-20 -63.66 -47.02 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 118' ' ' LEU . 5.7 tt -67.05 -20.3 65.82 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.002 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tpmt? -86.02 -14.29 44.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.065 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.527 ' CA ' ' HE2' ' A' ' 78' ' ' LYS . . . 111.71 11.71 16.32 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.934 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.58 125.53 57.36 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.498 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 55.6 Cg_endo -70.38 109.65 2.49 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.953 2.435 . . . . 0.0 111.15 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.5 t -85.81 122.37 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.91 110.1 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 122.106 0.955 . . . . 0.0 113.048 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -93.05 -165.68 1.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.605 178.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -93.24 115.03 27.65 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 120.639 0.257 . . . . 0.0 111.11 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -132.93 18.13 4.16 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.69 -29.52 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.452 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -83.92 -29.49 27.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 70.8 m-85 -93.12 75.67 4.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.115 0.96 . . . . 0.0 112.537 -172.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -94.58 -2.32 51.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.158 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -151.53 115.75 5.02 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.021 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.94 102.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -81.15 -64.95 1.08 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.06 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 p -132.99 149.4 52.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 137' ' ' THR . 3.5 tt -129.19 139.89 51.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.506 ' N ' HD23 ' A' ' 136' ' ' LEU . 79.3 m -119.78 124.44 46.15 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 138' ' ' ILE . 2.9 mp -104.55 123.92 58.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.502 ' CE2' ' HG2' ' A' ' 141' ' ' GLU . 33.8 t80 -116.43 110.84 19.17 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.404 0.621 . . . . 0.0 110.613 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.4 mt -99.92 125.74 53.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.502 ' HG2' ' CE2' ' A' ' 139' ' ' PHE . 36.2 mt-10 -100.5 -50.27 3.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.11 167.69 23.49 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' PRO . 83.1 m-20 -110.67 170.15 8.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 123.575 0.547 . . . . 0.0 111.454 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 86' ' ' LYS . 35.4 mm-40 -47.38 -57.9 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.255 0.972 . . . . 0.0 110.064 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -87.02 -26.89 23.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.55 75.68 0.59 Allowed Glycine 0 C--O 1.221 -0.679 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.1 t -107.72 -2.22 20.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.581 0.229 . . . . 0.0 110.95 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 38.7 mt-10 74.73 0.44 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.266 1.026 . . . . 0.0 112.13 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' SER . 5.7 p -139.95 124.58 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 32.5 m -109.7 111.78 23.45 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.972 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 18.9 pttm -109.85 134.75 51.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.183 171.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 155' ' ' ILE . 29.2 m -123.01 148.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.767 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.5 tp60 -85.81 -48.7 8.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.987 174.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -167.53 136.16 2.56 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 176.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 152' ' ' VAL . 2.5 mp -104.72 112.27 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 154' ' ' LYS . . . -139.92 157.28 45.94 Favored 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.11 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 1.9 mm? -119.43 157.21 28.69 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 72.4 m-85 -116.18 128.02 55.28 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.37 15.29 Favored Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.392 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 55.7 p -135.1 117.98 16.23 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.218 0.533 . . . . 0.0 111.438 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.0 p . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.653 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 11' ' ' LYS . 45.8 mm . . . . . 0 N--CA 1.415 -2.201 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.96 17.97 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.239 2.626 . . . . 0.0 111.507 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.9 mmpt? 64.69 12.49 7.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.119 1.367 . . . . 0.0 112.999 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.73 -83.43 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 29.7 mm-40 -103.77 -175.99 2.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 m -106.82 158.22 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 19.8 t0 -83.7 105.33 14.53 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.643 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 mp -60.23 -2.21 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 125.46 1.504 . . . . 0.0 114.233 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.533 HD21 ' H ' ' A' ' 42' ' ' GLN . 4.0 tt -56.01 -38.76 70.94 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.1 -17.59 64.59 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.065 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.79 23.35 12.02 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 16' ' ' LEU . 59.5 mt -102.79 142.62 16.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.38 -48.75 78.38 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' A' ' 40' ' ' LEU . 53.3 m95 70.95 -27.84 0.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 t -69.45 -35.61 75.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.18 -83.51 1.1 Allowed Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.912 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.416 HG11 ' CE3' ' A' ' 22' ' ' TRP 0.337 27.6 m 43.22 103.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -176.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.74 136.87 51.84 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.322 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -135.76 137.42 41.63 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.127 0.489 . . . . 0.0 110.176 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.3 -30.89 68.01 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.637 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.695 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 14.0 m120 -84.65 -93.57 0.08 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.777 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.503 HE22 ' HB3' ' A' ' 36' ' ' LEU . 4.0 tp-100 51.7 30.3 6.63 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -106.97 -75.39 0.63 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -163.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 p -48.83 -44.68 39.62 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -176.48 -61.92 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.48 0.657 . . . . 0.0 109.44 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.818 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.0 m-70 -72.42 144.0 48.31 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.941 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -107.7 164.36 12.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -169.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.503 ' HB3' HE22 ' A' ' 30' ' ' GLN . 2.8 tm? -60.07 -60.29 11.08 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.242 1.417 . . . . 0.0 113.812 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.15 -22.02 54.32 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.212 1.941 . . . . 0.0 112.965 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.3 m-20 -59.85 -29.12 68.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.669 1.188 . . . . 0.0 111.422 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -114.93 7.89 15.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.24 0.543 . . . . 0.0 111.415 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . 11.2 mp -119.49 -53.62 2.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -79.77 142.29 35.51 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.076 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' H ' HD21 ' A' ' 17' ' ' LEU . 14.0 tm0? -56.78 132.9 53.57 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 124.707 1.203 . . . . 0.0 110.651 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.13 -42.65 1.9 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -88.99 -49.94 6.47 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.367 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.0 ptm180 -47.92 90.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 4.9 tp10 171.03 143.69 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 153' ' ' GLN . 33.6 t70 -74.6 131.16 40.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.69 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.99 -52.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.23 -56.41 0.01 OUTLIER Glycine 0 CA--C 1.474 -2.484 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 50' ' ' LEU . 2.6 pp -80.94 135.61 35.91 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.588 174.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.818 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 34.8 p30 -161.83 169.55 21.11 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 tp -98.2 109.68 22.39 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 118.889 0.768 . . . . 0.0 108.989 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.04 131.01 44.01 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.069 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 60' ' ' LEU . 57.5 p -97.04 112.41 24.19 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.178 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.38 -35.68 8.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.502 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.37 -48.2 82.35 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.742 0.782 . . . . 0.0 109.291 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.83 151.14 43.72 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -100.32 7.47 44.34 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.937 0.875 . . . . 0.0 109.221 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -105.63 128.6 53.73 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.695 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 3.5 tt -133.56 131.74 40.06 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.224 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 7.0 tt -131.14 132.75 44.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.062 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.429 HD11 HD22 ' A' ' 60' ' ' LEU . 2.6 mp -130.73 145.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -114.19 121.5 43.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.65 121.51 37.13 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -91.38 141.93 2.85 Favored 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.265 2.643 . . . . 0.0 111.621 173.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.68 164.37 26.35 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 122.871 1.32 . . . . 0.0 113.874 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -104.82 -45.99 4.43 Favored 'General case' 0 N--CA 1.395 -3.197 0 CA-C-N 112.572 -2.104 . . . . 0.0 107.022 171.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -143.79 146.57 33.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.457 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -75.37 117.47 19.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 122.178 0.99 . . . . 0.0 111.654 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.98 173.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.542 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 3.7 mppt? -97.97 136.37 38.34 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.458 -1.297 . . . . 0.0 111.058 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.532 ' CD1' HD11 ' A' ' 125' ' ' LEU . 2.1 tm? -89.89 114.02 25.73 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -110.01 -37.95 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.8 m -143.62 171.23 14.46 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.207 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -142.75 157.57 44.51 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.604 ' HB3' ' HE1' ' A' ' 158' ' ' TYR . . . -149.39 143.74 25.94 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.837 0.351 . . . . 0.0 110.364 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.1 mt -145.71 137.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HE2' ' O ' ' A' ' 119' ' ' LYS . 87.2 mttt -112.86 157.38 21.48 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.372 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 178.5 36.86 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' CG ' ' HB2' ' A' ' 151' ' ' LYS . 7.5 Cg_exo -75.18 160.06 39.98 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.507 1.472 . . . . 0.0 110.032 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.51 -29.72 26.54 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.517 1.127 . . . . 0.0 112.065 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -93.15 -57.08 2.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 mp0 -68.44 -52.37 33.41 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.14 109.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.167 0 O-C-N 125.365 1.666 . . . . 0.0 116.56 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.402 ' CG ' HG22 ' A' ' 152' ' ' VAL . 26.6 Cg_exo -61.85 108.06 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.208 1.939 . . . . 0.0 110.217 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 38.0 ttpt -99.42 -63.86 1.09 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -167.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.9 m -78.62 94.8 5.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.458 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 111' ' ' ALA . 16.7 m -100.96 137.65 27.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -128.5 141.6 51.33 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.924 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 82.3 m-85 -117.45 148.12 42.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.679 -175.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.484 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 47.1 m-85 -114.53 126.72 55.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.724 174.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.5 t -91.79 96.51 10.46 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.186 0.517 . . . . 0.0 110.382 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 64.99 9.64 5.6 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.591 1.156 . . . . 0.0 112.824 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -88.72 139.88 30.02 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.4 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 1.7 mp0 -55.45 169.12 0.32 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.538 1.535 . . . . 0.0 112.197 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -61.7 97.41 0.08 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.748 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.416 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . 83.8 mtp -98.78 106.75 19.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.475 ' O ' HG13 ' A' ' 102' ' ' VAL . 83.2 m -75.86 -168.98 0.98 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 102' ' ' VAL . 60.5 m-85 -46.65 -44.55 18.51 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -81.24 -31.73 33.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.39 0.615 . . . . 0.0 111.127 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -77.96 -19.67 54.12 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.977 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 98' ' ' CYS . 34.0 m -64.27 -5.72 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -91.41 -1.28 57.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.583 0.23 . . . . 0.0 110.9 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -101.55 -31.93 10.62 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 5.9 p90 -96.22 152.64 38.94 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.203 -171.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 6.6 Cg_endo -89.09 120.14 1.04 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.031 1.821 . . . . 0.0 108.724 170.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.12 142.27 99.1 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.153 1.902 . . . . 0.0 112.46 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 18.7 m -59.67 -42.41 92.8 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.465 0.65 . . . . 0.0 109.783 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -158.23 168.95 25.63 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.5 t -152.1 115.31 4.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -133.38 161.68 33.88 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.344 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.1 mp0 -114.96 128.61 56.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.2 tt -66.16 134.47 52.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.52 0.676 . . . . 0.0 111.612 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 t -121.15 179.32 4.43 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.32 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 40.8 mt-10 -54.74 -45.92 74.2 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.808 0.843 . . . . 0.0 112.983 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -70.88 -35.24 72.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.238 0.542 . . . . 0.0 109.682 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.7 t-20 -65.18 -40.19 93.93 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.422 HD13 HD21 ' A' ' 113' ' ' LEU . 20.3 tp -61.02 -24.47 66.2 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 111.127 -178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 14.4 mmmm -79.29 -3.37 45.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.633 0.73 . . . . 0.0 109.27 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.05 17.02 52.94 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.156 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 98.8 mttt -87.9 141.15 31.33 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-N 116.714 0.257 . . . . 0.0 110.962 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 17.1 Cg_exo -67.31 119.37 6.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.02 2.48 . . . . 0.0 112.633 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.54 134.52 41.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.55 144.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.286 0.565 . . . . 0.0 112.293 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -131.86 -170.82 2.47 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.121 174.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -67.92 89.49 0.28 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.43 0.633 . . . . 0.0 112.692 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -69.18 -32.15 71.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.895 0.878 . . . . 0.0 110.107 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.13 -27.63 36.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.896 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 6.1 tmtt? -85.16 -45.26 12.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -78.27 90.26 4.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -106.49 -39.96 5.72 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -113.02 120.28 40.82 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.273 176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -118.8 102.05 12.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.786 176.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -102.82 -38.95 7.2 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.683 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.9 m -152.47 154.19 35.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.47 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 130.39 18.83 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.9 m -106.13 131.41 53.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 69.8 mt -111.14 122.28 65.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 57.3 t80 -122.94 121.82 37.08 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.718 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.447 HG22 HG12 ' A' ' 88' ' ' VAL . 2.0 pp -115.58 129.13 72.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.4 pt-20 -106.84 -20.76 13.24 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.421 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.67 31.66 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.064 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 6.8 p30 -102.8 175.4 5.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.019 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.502 HE21 ' HD3' ' A' ' 86' ' ' LYS . 7.9 tp60 -45.13 -50.13 11.42 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.625 1.57 . . . . 0.0 111.68 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -107.36 -37.77 6.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.48 46.83 2.27 Favored Glycine 0 C--N 1.312 -0.789 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.3 t -84.63 12.57 6.89 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.359 0.664 . . . . 0.0 112.771 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 69.26 1.95 3.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.862 0.865 . . . . 0.0 112.61 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.84 134.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 83.5 m -118.47 111.44 18.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.407 ' HB2' ' CG ' ' A' ' 80' ' ' PRO . 60.1 mttp -94.4 134.88 36.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.402 HG22 ' CG ' ' A' ' 85' ' ' PRO . 49.0 t -122.27 120.93 62.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.492 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 20.6 pt20 -98.0 -13.44 21.1 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.361 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 23.1 pttt -168.07 150.21 5.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.149 168.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.4 HG13 HG11 ' A' ' 152' ' ' VAL . 65.4 mt -131.05 112.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.05 137.97 52.38 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 6.1 mp -103.08 140.85 36.77 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.604 ' HE1' ' HB3' ' A' ' 76' ' ' ALA . 97.5 m-85 -125.32 139.84 53.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.482 0.658 . . . . 0.0 111.279 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 71' ' ' LYS . . . -173.53 -154.86 10.99 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.6 p -161.43 154.52 21.03 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.905 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.42 -1.96 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.789 173.167 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.525 HG13 ' H ' ' A' ' 15' ' ' ASP . 2.3 mp . . . . . 0 N--CA 1.425 -1.7 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.6 143.23 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.826 1.684 . . . . 0.0 108.864 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -69.8 99.29 1.34 Allowed 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.167 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.87 -48.34 0.32 Allowed Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -119.36 178.83 4.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.79 142.6 39.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' HG13 ' A' ' 9' ' ' ILE . 10.1 t0 -72.73 116.87 13.74 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 20' ' ' ILE . 52.6 mt -79.61 5.54 12.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 42' ' ' GLN . 4.7 tt -55.18 -38.11 67.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.919 0.866 . . . . 0.0 108.759 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.76 -17.07 54.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.671 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' HA ' ' ND2' ' A' ' 67' ' ' ASN . 7.7 m-85 -90.52 -4.85 56.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.597 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 64' ' ' ILE . 92.4 mt -86.64 138.16 19.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.17 101.64 14.38 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 172.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CH2' ' HA ' ' A' ' 41' ' ' LYS . 98.7 m95 -76.36 1.55 15.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -92.32 -28.31 17.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.81 4.67 56.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.903 -0.665 . . . . 0.0 114.274 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.6 m -61.22 136.31 24.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.182 0.515 . . . . 0.0 111.765 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 9.3 tp10 -134.57 144.25 47.84 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.596 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 62.7 m -137.28 138.3 39.91 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.857 -176.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 28' ' ' LEU . 3.1 tm? -72.19 -49.03 38.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.134 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -103.87 -64.32 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.596 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 4.3 pt20 54.79 22.9 4.46 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.463 1.505 . . . . 0.0 111.854 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 40.7 t 73.82 129.64 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.285 1.834 . . . . 0.0 112.47 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.92 -4.87 34.74 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.218 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -121.36 -68.9 0.87 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.437 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.616 ' O ' ' HB3' ' A' ' 31' ' ' SER . 77.4 m-70 -99.95 112.37 24.65 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.421 -173.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 m -66.48 130.16 42.25 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.613 HD21 HD23 ' A' ' 40' ' ' LEU 0.258 5.5 tt -45.15 -39.59 9.28 Favored Pre-proline 0 CA--C 1.568 1.656 0 N-CA-C 118.618 2.821 . . . . 0.0 118.618 -177.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 76.5 Cg_exo -53.97 -1.35 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.823 2.348 . . . . 0.0 114.895 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.534 HD22 ' HB2' ' A' ' 50' ' ' LEU . 30.8 p30 -86.24 -48.1 8.84 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.13 -14.16 15.48 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 36' ' ' LEU . 45.4 tp -102.23 -40.33 6.83 Favored 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 118.839 -1.144 . . . . 0.0 107.957 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.02 97.87 6.98 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 170.248 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.628 ' HB3' HD11 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -70.22 102.6 2.14 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.308 -172.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.1 -56.11 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.557 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -89.15 -9.9 49.23 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.234 0.614 . . . . 0.0 110.124 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 45' ' ' ARG . 2.4 ppt_? -52.54 130.1 30.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.122 -172.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER 174.06 139.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 173.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.83 88.38 6.78 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.55 -69.34 0.17 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.78 -47.18 0.63 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.43 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.534 ' HB2' HD22 ' A' ' 38' ' ' ASN . 1.0 OUTLIER -125.61 113.75 17.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.027 0.918 . . . . 0.0 112.566 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -149.04 160.39 43.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 151' ' ' LYS . 3.4 tm? -90.61 120.32 31.58 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.35 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.9 pt-20 -141.01 119.35 12.17 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.341 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 49.6 p -35.05 -65.79 0.21 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.08 1.752 . . . . 0.0 115.549 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 67.16 17.66 10.36 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.701 0.762 . . . . 0.0 112.15 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.01 -62.92 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.286 0.565 . . . . 0.0 109.523 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 54' ' ' SER . 22.7 m-20 -131.36 127.91 38.57 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -73.47 -30.1 62.95 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 124.078 0.861 . . . . 0.0 110.341 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -74.37 115.58 14.06 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.56 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 95.0 mt -119.04 126.78 52.49 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.028 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 62' ' ' ILE . 1.4 tm? -113.0 121.69 45.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 61' ' ' LEU . 2.7 mp -127.92 142.75 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.495 ' HB2' ' HB3' ' A' ' 96' ' ' HIS . 50.5 t80 -110.45 121.81 46.2 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 123.816 0.846 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 20' ' ' ILE . 48.4 mm -120.85 121.47 28.9 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.793 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.52 124.82 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.476 2.117 . . . . 0.0 111.23 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -95.71 157.38 15.92 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 121.226 0.536 . . . . 0.0 111.217 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 19' ' ' PHE . 34.2 p30 -78.5 -23.34 46.41 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.92 160.73 39.78 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.659 HG23 ' H ' ' A' ' 133' ' ' VAL . 7.7 p -84.4 108.67 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 172.56 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -90.7 113.58 25.7 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 133' ' ' VAL . 98.0 mt -69.41 128.46 36.64 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 44.2 t60 -118.39 -50.64 2.43 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.1 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 p -147.18 174.11 11.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.82 159.74 43.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.06 139.58 39.62 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.215 0.322 . . . . 0.0 110.252 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 71.6 mt -140.93 117.62 7.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -107.45 125.76 51.65 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.818 0.818 . . . . 0.0 110.318 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.98 -174.08 22.99 Favored Glycine 0 C--N 1.261 -3.621 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.48 135.47 3.07 Favored 'Trans proline' 0 N--CA 1.424 -2.604 0 CA-C-N 119.598 1.699 . . . . 0.0 108.632 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -58.57 -25.85 62.99 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.673 0.749 . . . . 0.0 110.798 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.89 -53.17 27.52 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.783 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' OE1' ' HD3' ' A' ' 151' ' ' LYS . 4.7 mp0 -103.78 -59.82 1.66 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 85' ' ' PRO . . . 27.03 128.75 0.0 OUTLIER Glycine 0 N--CA 1.511 3.647 0 C-N-CA 127.98 2.705 . . . . 0.0 118.443 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 84' ' ' GLY . 5.7 Cg_exo -75.45 114.55 4.0 Favored 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.168 1.912 . . . . 0.0 110.373 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 51.3 tttp -99.82 -69.84 0.75 Allowed 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -57.21 106.97 0.37 Allowed 'General case' 0 C--O 1.249 1.073 0 O-C-N 123.183 0.302 . . . . 0.0 111.314 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 86' ' ' LYS . 96.3 t -109.26 116.32 51.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 89' ' ' LYS . 4.3 ttmp? -118.83 136.46 54.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.443 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 97.3 m-85 -121.83 166.47 14.32 Favored 'General case' 0 C--O 1.201 -1.456 0 O-C-N 122.038 -0.413 . . . . 0.0 111.927 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.426 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 80.8 t80 -151.41 121.64 7.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 t -97.9 143.71 28.21 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.789 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER 77.73 172.34 0.2 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 125.08 1.352 . . . . 0.0 112.722 179.022 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 71.21 177.92 0.26 Allowed 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.605 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 155.65 21.42 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 42.9 p-80 -51.08 124.42 11.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 80.6 mtp -98.83 116.93 32.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.362 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 67.6 m -72.02 158.04 36.7 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.568 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 64.6 t80 -48.9 -37.43 19.73 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 m -59.6 -22.56 61.98 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 120.846 0.355 . . . . 0.0 111.591 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.51 -13.06 11.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.099 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.568 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 2.7 p -67.48 -33.89 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.801 0.334 . . . . 0.0 111.214 -171.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.53 94.91 10.04 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.948 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -178.77 -45.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.19 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -98.01 149.89 36.19 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.481 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.39 126.74 19.16 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.463 2.109 . . . . 0.0 111.866 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.52 163.51 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.289 2.659 . . . . 0.0 112.398 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 9.6 t -61.43 -47.68 84.63 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.53 ' OD1' ' HB2' ' A' ' 126' ' ' LYS . 20.5 m-20 -174.26 -177.6 1.3 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.15 2.58 . . . . 0.0 104.038 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -157.33 145.61 19.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.751 0.705 . . . . 0.0 110.278 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 88' ' ' VAL . . . -154.63 172.14 18.35 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -125.5 138.13 53.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 22.7 tp -61.67 143.84 55.51 Favored 'General case' 0 C--O 1.25 1.092 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 117' ' ' ASN . 8.0 t -134.52 165.47 25.12 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.423 ' O ' ' HD3' ' A' ' 119' ' ' LYS . 46.3 mt-10 -62.9 -28.24 69.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 119.089 0.859 . . . . 0.0 111.387 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.434 ' HG2' ' CB ' ' A' ' 121' ' ' LYS . 41.1 tt0 -66.34 -40.63 89.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.77 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.54 ' H ' HG23 ' A' ' 114' ' ' THR . 2.4 t-20 -67.47 -34.24 76.77 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.4 tp -67.31 -28.34 67.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.732 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 14.1 mptt -87.76 1.02 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 110.508 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.64 23.93 Favored Glycine 0 C--N 1.303 -1.272 0 C-N-CA 120.294 -0.955 . . . . 0.0 115.146 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.434 ' CB ' ' HG2' ' A' ' 116' ' ' GLU . 17.5 tppt? -75.08 119.11 75.38 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 117.93 0.865 . . . . 0.0 108.918 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.89 100.92 0.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.878 1.718 . . . . 0.0 109.663 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.32 133.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 27.9 m -64.68 135.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.48 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 125' ' ' LEU . 2.7 mp -65.06 -67.04 0.47 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.53 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 34.8 mmtp -171.54 -174.58 1.42 Allowed 'General case' 0 C--N 1.287 -2.143 1 N-CA-C 100.081 -4.044 . . . . 0.0 100.081 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.403 ' HA ' ' CE1' ' A' ' 130' ' ' PHE . 37.4 t80 -146.36 24.39 1.27 Allowed 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 123.186 1.469 . . . . 0.0 108.078 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.16 -40.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.658 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.9 tmtt? -116.53 -20.47 9.62 Favored 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 118.732 -1.187 . . . . 0.0 114.045 -167.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 127' ' ' TYR . 32.6 p90 -58.44 18.08 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.445 0 C-N-CA 125.209 1.404 . . . . 0.0 114.415 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.37 2.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -163.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -166.56 115.52 0.9 Allowed 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.659 ' H ' HG23 ' A' ' 69' ' ' VAL . 60.4 t -120.01 125.23 74.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.757 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -121.13 -61.29 1.56 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 173.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 29.6 p -116.37 152.44 33.92 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.9 tp -136.32 122.83 20.82 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.077 0.465 . . . . 0.0 110.006 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 87.9 m -93.37 113.45 25.63 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.9 mt -104.78 116.52 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -115.4 108.73 16.89 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.291 0.567 . . . . 0.0 111.006 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 8.2 pt -89.46 114.07 26.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-O 121.848 0.832 . . . . 0.0 108.877 172.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.59 -40.53 16.16 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.13 -1.396 . . . . 0.0 113.028 -168.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.94 150.63 27.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.685 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -91.19 154.66 19.16 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.454 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.464 ' HG3' ' HD2' ' A' ' 86' ' ' LYS . 25.8 tt0 -58.44 -36.4 73.6 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 123.662 0.785 . . . . 0.0 112.295 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.1 t -103.35 -7.6 20.92 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.582 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.72 56.41 23.07 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.9 p -87.77 -1.47 57.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.616 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 42.6 mt-10 72.19 -37.07 0.38 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.092 0.957 . . . . 0.0 112.081 -177.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.3 t -106.09 118.24 53.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.178 0.513 . . . . 0.0 109.618 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 39.4 m -93.29 110.99 22.51 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.467 ' HD3' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -119.35 135.71 54.6 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.874 0.369 . . . . 0.0 110.392 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.1 p -142.09 148.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.04 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 74.1 mt-30 -108.99 -32.35 7.29 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -155.24 115.97 3.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.762 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.422 ' HB ' ' CD1' ' A' ' 40' ' ' LEU . 66.4 mt -122.71 127.17 74.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.43 152.67 40.99 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.29 155.56 21.9 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 15' ' ' ASP . 99.5 m-85 -124.56 130.59 52.73 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.573 0.701 . . . . 0.0 111.297 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.05 -171.12 12.24 Favored Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.3 m -142.57 133.88 26.21 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.395 0.617 . . . . 0.0 111.599 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.425 -1.719 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.12 174.047 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.569 HG13 ' HB3' ' A' ' 15' ' ' ASP . 3.0 mp . . . . . 0 N--CA 1.441 -0.916 0 CA-C-O 120.462 0.172 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.46 160.99 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.705 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -71.3 107.02 4.07 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.87 -76.04 0.24 Allowed Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -106.69 168.88 8.88 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.64 125.77 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.534 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.569 ' HB3' HG13 ' A' ' 9' ' ' ILE . 34.0 t0 -72.11 130.09 40.05 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 176.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.626 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.2 mm? -68.86 -1.2 6.66 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -51.24 -45.17 61.89 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.571 1.148 . . . . 0.0 109.1 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.42 -16.04 56.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.807 0.813 . . . . 0.0 110.863 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.526 ' CD1' HD12 ' A' ' 16' ' ' LEU . 11.1 t80 -92.58 -14.24 28.54 Favored 'General case' 0 N--CA 1.415 -2.195 0 C-N-CA 124.251 1.02 . . . . 0.0 112.058 -174.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 16' ' ' LEU . 96.3 mt -75.04 140.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 120.701 0.286 . . . . 0.0 111.035 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.76 -29.44 63.32 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.277 0.561 . . . . 0.0 110.527 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' H ' HG22 ' A' ' 20' ' ' ILE . 98.3 m95 71.18 -15.82 0.39 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 173.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -67.86 -25.37 65.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.481 0.658 . . . . 0.0 110.58 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.68 -81.24 1.58 Allowed Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.053 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.565 ' H ' ' CG ' ' A' ' 65' ' ' PRO 0.345 27.4 m 46.87 79.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.983 0 CA-C-O 122.476 1.131 . . . . 0.0 112.842 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -112.83 148.83 34.05 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.951 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.7 t -135.93 128.85 31.27 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.12 7.91 5.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.684 0.754 . . . . 0.0 110.568 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 6.0 m120 -126.01 -92.16 0.51 Allowed 'General case' 0 CA--C 1.479 -1.785 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.381 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 45.63 32.15 1.11 Allowed 'General case' 0 C--N 1.379 1.85 0 CA-C-O 122.677 1.227 . . . . 0.0 109.467 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.4 t -37.5 -63.64 0.44 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.729 2.811 . . . . 0.0 113.367 -171.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -50.04 -48.1 52.95 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.2 m 147.27 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.749 0 C-N-CA 128.127 2.571 . . . . 0.0 106.664 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.843 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 89.5 m-70 -62.14 132.66 53.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.149 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -106.77 -173.1 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.406 -0.918 . . . . 0.0 113.293 -164.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.8 tp -86.71 -46.74 0.53 Allowed Pre-proline 0 C--O 1.212 -0.895 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.09 -38.8 71.03 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.424 1.416 . . . . 0.0 111.415 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.502 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.8 p-10 -75.06 -2.0 25.44 Favored 'General case' 0 C--O 1.203 -1.365 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.618 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.19 0.14 6.43 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 tp -121.64 -30.48 4.18 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.516 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 6.0 tmtt? -82.24 143.13 31.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -68.88 149.14 49.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.575 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.31 -35.41 3.71 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.494 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 81.4 m-85 -89.4 -28.03 20.03 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.158 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -68.85 80.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -167.67 110.97 0.65 Allowed 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.005 0.922 . . . . 0.0 109.154 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.679 ' H ' ' HG3' ' A' ' 153' ' ' GLN . 20.0 t70 -71.22 116.47 11.57 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.121 0.486 . . . . 0.0 110.188 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -164.62 -63.12 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.08 -49.82 0.36 Allowed Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.1 pp -105.95 141.42 37.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 120.976 0.417 . . . . 0.0 110.623 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.843 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 36.5 p30 -162.28 169.63 20.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tt -102.16 124.81 48.41 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -138.73 165.07 27.93 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.274 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 66.4 p -101.47 148.65 24.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.961 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -125.17 -68.69 0.83 Allowed 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.4 -39.71 22.3 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.612 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 54' ' ' SER . 40.6 m-20 -123.21 121.21 35.36 Favored 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.784 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.9 tt0 -69.58 -26.22 64.36 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.323 1.015 . . . . 0.0 108.537 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.82 108.22 10.89 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.81 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.568 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 96.3 mt -115.54 132.29 56.67 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.49 -172.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.77 128.32 49.39 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.04 136.63 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 122.81 0.444 . . . . 0.0 110.716 -173.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -106.95 131.56 53.89 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.548 0.339 . . . . 0.0 110.887 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -108.38 117.08 55.42 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.022 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.565 ' CG ' ' H ' ' A' ' 25' ' ' VAL . 8.3 Cg_exo -73.34 144.58 36.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.608 2.205 . . . . 0.0 110.942 175.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' HE2' ' NH2' ' A' ' 134' ' ' ARG . 24.5 p90 -122.38 161.91 22.58 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -98.4 -43.34 6.95 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.328 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -153.93 178.85 9.48 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.617 -171.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.449 HG22 ' HD2' ' A' ' 134' ' ' ARG . 93.2 t -83.04 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.836 -0.166 . . . . 0.0 110.581 174.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.67 172.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.63 114.13 27.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.6 tp -72.75 133.8 44.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -111.76 -52.71 2.77 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.872 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -145.15 164.63 30.68 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.019 0.438 . . . . 0.0 111.946 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -135.2 153.8 51.82 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -148.64 110.09 4.43 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.219 0.533 . . . . 0.0 111.227 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.9 117.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 79' ' ' GLY . 7.8 tmtt? -116.43 141.53 48.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -173.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.575 ' N ' ' HD3' ' A' ' 78' ' ' LYS . . . -171.39 -156.35 11.72 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 174.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.473 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 78.2 Cg_endo -75.06 165.98 30.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.36 2.04 . . . . 0.0 110.902 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HA ' HD11 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -70.41 -33.64 71.59 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.76 -47.84 6.58 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 31.2 mt-10 -86.73 15.44 5.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.675 -175.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.28 148.78 19.86 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.424 ' O ' HD22 ' A' ' 113' ' ' LEU . 44.9 Cg_exo -59.01 162.86 12.63 Favored 'Trans proline' 0 C--O 1.217 -0.534 0 C-N-CA 122.614 2.21 . . . . 0.0 111.888 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 36.3 ttpt -132.94 -73.43 0.5 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.062 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.5 m -76.68 108.67 9.85 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.806 0.336 . . . . 0.0 110.122 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.633 HG12 HG22 ' A' ' 140' ' ' ILE . 7.6 m -118.97 142.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 -177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -125.6 149.45 48.37 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -127.09 152.73 46.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.614 ' CE2' ' HB ' ' A' ' 137' ' ' THR 0.252 23.4 p90 -148.83 116.22 6.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.74 0.781 . . . . 0.0 111.66 173.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' SER . 20.6 m -103.99 149.36 25.22 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.849 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.5 116.02 0.05 Allowed 'General case' 0 C--O 1.239 0.537 0 O-C-N 124.632 1.208 . . . . 0.0 109.676 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 94' ' ' LYS 0.279 0.5 OUTLIER 81.75 108.55 0.07 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.4 1.08 . . . . 0.0 112.256 -175.288 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.51 177.19 4.99 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.324 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 79.01 0.76 2.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.368 1.067 . . . . 0.0 111.022 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.594 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 44.6 ttm -70.22 115.14 9.07 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.851 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.3 m -100.33 177.11 5.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.256 36.9 p90 -55.8 -29.88 60.44 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.6 p -62.46 -35.95 80.91 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.973 0.892 . . . . 0.0 109.86 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 2.3 m-20 -87.75 -29.09 21.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.697 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 98' ' ' CYS . 97.8 t -62.4 -29.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.294 0.569 . . . . 0.0 110.52 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -88.71 -10.35 48.72 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.509 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.48 -50.13 6.28 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.063 0.459 . . . . 0.0 109.792 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -96.36 143.25 25.8 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.333 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 143.31 78.41 Favored 'Trans proline' 0 C--O 1.249 1.048 0 C-N-CA 122.144 1.896 . . . . 0.0 111.109 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.23 178.13 7.95 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.36 2.04 . . . . 0.0 111.406 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 32.1 m -78.45 -44.39 24.79 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -168.35 168.85 11.08 Favored 'General case' 0 C--O 1.256 1.395 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -144.16 138.24 28.0 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.95 159.69 39.23 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.511 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.2 tp10 -109.05 116.98 33.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 10.3 tt -61.35 113.27 2.54 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.253 1.025 . . . . 0.0 110.174 -176.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 117' ' ' ASN . 9.6 t -85.09 157.9 20.57 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.566 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.88 -22.11 65.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.279 0.561 . . . . 0.0 111.014 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.411 ' HG3' ' HD2' ' A' ' 121' ' ' LYS . 6.7 tp10 -65.81 -36.55 83.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.539 HD22 HG23 ' A' ' 123' ' ' VAL . 17.3 t-20 -71.77 -42.82 66.7 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' A' ' 113' ' ' LEU . 7.7 tt -62.02 -21.31 64.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.076 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -82.4 -13.64 56.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.131 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.43 10.9 21.0 Favored Glycine 0 C--O 1.24 0.521 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.083 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HD2' ' HG3' ' A' ' 116' ' ' GLU . 99.0 mttt -94.04 135.98 24.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 61.4 Cg_endo -71.48 104.58 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.15 2.567 . . . . 0.0 112.353 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.539 HG23 HD22 ' A' ' 117' ' ' ASN . 66.1 t -83.33 127.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.675 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.29 121.66 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 110.411 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.2 168.5 11.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.395 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.82 94.02 7.58 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.222 0.534 . . . . 0.0 109.911 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . 0.312 26.8 p90 -88.44 67.41 8.59 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.12 -47.49 13.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.2 tmtt? -80.27 -30.74 38.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -73.5 84.16 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.184 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -110.67 -68.18 0.95 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.405 ' HB2' HG11 ' A' ' 69' ' ' VAL . 3.1 p30 -104.5 115.79 30.97 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.1 t -100.2 103.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 C-N-CA 118.472 -1.291 . . . . 0.0 110.675 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HD2' HG22 ' A' ' 69' ' ' VAL . 28.8 mmm180 -78.37 -80.64 0.11 Allowed 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.554 170.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 92' ' ' SER . 42.6 p -105.55 149.73 26.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.48 129.75 41.53 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.614 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 20.8 m -130.84 144.18 51.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.4 mt -117.74 135.99 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 122.501 0.32 . . . . 0.0 110.191 -174.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 83.5 t80 -123.21 112.23 17.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.633 HG22 HG12 ' A' ' 88' ' ' VAL . 26.1 pt -109.27 114.96 48.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.6 pt-20 -105.31 -9.45 17.62 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.29 166.82 29.77 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.129 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -119.18 164.57 15.39 Favored 'General case' 0 CA--C 1.496 -1.117 0 O-C-N 124.164 0.915 . . . . 0.0 109.903 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.426 ' N ' ' HB2' ' A' ' 86' ' ' LYS . 34.2 mm-40 -46.32 -61.4 1.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 110.374 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.2 t -91.24 -11.07 39.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.697 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.64 65.28 2.96 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.6 t -100.21 -2.35 34.15 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 58' ' ' GLU 0.286 45.0 mt-10 68.7 -27.25 0.15 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.2 p -102.22 103.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 25.0 m -101.19 111.27 23.44 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.504 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -104.84 132.49 51.02 Favored 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.485 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.99 124.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.869 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.679 ' HG3' ' H ' ' A' ' 47' ' ' ASP . 36.0 tt0 -97.3 -27.62 14.42 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.102 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 20.4 ttmm -160.72 129.26 4.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.6 112.11 38.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 165.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.438 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -130.87 141.84 50.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 156' ' ' ALA . 5.8 mp -130.69 142.67 50.44 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 79.4 m-85 -124.53 114.27 19.2 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -109.94 -174.08 20.7 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.3 m -139.23 129.94 26.03 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--N 1.293 -1.866 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.253 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.5 mp . . . . . 0 N--CA 1.418 -2.038 0 CA-C-O 120.453 0.168 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 13' ' ' GLN . 19.3 Cg_endo -93.09 -173.87 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.513 2.142 . . . . 0.0 110.525 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -96.93 137.45 35.99 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.67 -40.22 2.6 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.452 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -143.05 137.52 29.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.83 155.22 7.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 123.816 0.698 . . . . 0.0 110.001 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -58.95 129.53 42.6 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.092 0.957 . . . . 0.0 110.886 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.599 ' O ' HG13 ' A' ' 20' ' ' ILE . 80.6 mt -98.19 5.89 48.03 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.001 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.527 HD22 ' HG2' ' A' ' 42' ' ' GLN . 64.9 tp -64.22 -42.22 96.67 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.797 0.808 . . . . 0.0 109.497 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.5 -20.03 65.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.896 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.577 ' C ' ' HB2' ' A' ' 67' ' ' ASN . 24.7 m-85 -95.17 19.87 9.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.914 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 16' ' ' LEU . 72.1 mt -108.19 127.76 64.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.985 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 -38.25 85.1 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CZ2' HD12 ' A' ' 40' ' ' LEU . 90.0 m95 76.46 -29.19 0.18 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.4 t -80.05 -36.37 35.78 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.485 0.66 . . . . 0.0 110.044 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.13 12.43 66.34 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.004 -0.617 . . . . 0.0 114.575 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 34.7 m -62.53 152.31 7.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-N 117.504 0.652 . . . . 0.0 111.989 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.97 127.45 13.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 p -134.02 108.22 8.23 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.677 0.751 . . . . 0.0 109.897 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -76.5 121.49 23.19 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.624 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 46.3 t30 72.53 -55.1 0.68 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.371 1.468 . . . . 0.0 110.978 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.2 pt20 63.2 -62.71 0.13 Allowed 'General case' 0 C--O 1.209 -1.069 0 C-N-CA 127.442 2.297 . . . . 0.0 110.0 -176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 23.9 m 176.87 119.77 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 129.608 3.163 . . . . 0.0 103.109 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.6 p -62.63 -18.39 62.16 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 117.073 -1.851 . . . . 0.0 113.124 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -111.3 -14.72 13.75 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.584 ' O ' ' HB2' ' A' ' 31' ' ' SER . 94.8 m-70 -125.43 163.62 22.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.914 -0.492 . . . . 0.0 110.289 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.539 ' OG ' ' HD2' ' A' ' 37' ' ' PRO . 29.5 t -114.03 171.19 7.75 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.799 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -77.38 -54.6 1.44 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.941 0.897 . . . . 0.0 112.722 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD2' ' OG ' ' A' ' 35' ' ' SER . 30.8 Cg_exo -40.34 -50.31 3.68 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 123.392 2.728 . . . . 0.0 114.823 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -55.85 -45.81 78.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.76 -11.06 57.63 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.465 HD12 ' CZ2' ' A' ' 22' ' ' TRP . 1.3 tm? -104.28 -27.28 12.1 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.0 120.36 22.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.638 ' NE2' ' HG2' ' A' ' 45' ' ' ARG . 17.9 mm-40 -75.56 92.07 2.88 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 121.923 0.868 . . . . 0.0 109.27 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.511 ' H ' ' HG3' ' A' ' 45' ' ' ARG . . . 170.14 -56.36 0.19 Allowed Glycine 1 N--CA 1.386 -4.66 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.46 -171.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -81.62 -29.3 33.3 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.511 0.672 . . . . 0.0 110.185 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.638 ' HG2' ' NE2' ' A' ' 42' ' ' GLN . 5.1 ppt_? -60.95 17.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.93 137.15 36.13 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.344 -0.848 . . . . 0.0 112.209 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 8.3 t70 -58.96 85.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.927 1.691 . . . . 0.0 112.497 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER 160.61 -55.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.635 1.974 . . . . 0.0 108.097 174.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.22 -78.24 0.14 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.626 -0.716 . . . . 0.0 114.256 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 163.58 29.28 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.9 p-10 -161.19 166.35 27.96 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.474 HD21 HD13 ' A' ' 60' ' ' LEU . 5.4 tt -110.63 128.69 55.79 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 55' ' ' ASP . 10.9 pt-20 -141.96 158.82 43.33 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 120.579 0.228 . . . . 0.0 111.435 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.2 p -79.49 79.57 5.94 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 122.187 0.994 . . . . 0.0 108.418 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 25.8 t70 -97.27 79.97 2.86 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.206 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 155.21 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.514 2.326 . . . . 0.0 107.115 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.8 -170.3 1.63 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.493 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -18.88 12.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -102.27 154.79 18.71 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.023 0.929 . . . . 0.0 109.558 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.518 ' HB2' HG13 ' A' ' 140' ' ' ILE . 78.7 mt -146.51 147.32 31.05 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 1.2 tm? -123.21 116.92 24.18 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -124.33 120.89 60.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -109.79 134.52 51.94 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.88 0.472 . . . . 0.0 110.806 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 mm -120.78 131.83 24.35 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.492 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 53.6 Cg_endo -87.84 150.7 7.25 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.49 2.793 . . . . 0.0 111.577 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.472 ' HD1' ' H ' ' A' ' 66' ' ' PHE . 4.7 p90 -89.6 162.99 15.35 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -173.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.577 ' HB2' ' C ' ' A' ' 19' ' ' PHE . 4.6 t-20 -101.66 -43.14 5.96 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 112.509 -2.132 . . . . 0.0 107.322 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -153.07 150.73 29.44 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.29 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.51 122.92 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.67 175.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.424 ' HE2' ' HG2' ' A' ' 131' ' ' GLN . 38.4 ttmt -81.04 142.47 33.33 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 73' ' ' HIS . 3.1 tm? -81.05 150.91 28.62 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.562 ' N ' HD13 ' A' ' 72' ' ' LEU . 3.6 t-160 -141.96 -62.61 0.45 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.878 177.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.479 ' HA ' HD22 ' A' ' 125' ' ' LEU . 12.1 p -152.65 163.22 40.07 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 7.7 p90 -125.56 157.17 37.78 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -148.72 107.13 3.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.783 0.265 . . . . 0.0 110.513 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.87 136.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 91.3 mttt -114.01 158.12 21.6 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.663 176.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 153' ' ' GLN . . . -178.91 -177.49 47.54 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.99 150.14 89.03 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.833 1.689 . . . . 0.0 109.088 172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.59 -25.5 68.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 45.4 mt-10 -87.33 -54.52 4.26 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.486 0.66 . . . . 0.0 111.26 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.73 8.68 18.9 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.203 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.9 153.37 38.05 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.668 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.577 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 39.1 Cg_exo -60.98 147.41 95.76 Favored 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 122.14 1.893 . . . . 0.0 110.517 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.527 ' HB2' HE21 ' A' ' 144' ' ' GLN . 0.6 OUTLIER -130.33 -53.89 1.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 54.6 m -80.53 97.03 6.97 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.57 116.19 40.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.003 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -109.34 132.67 53.91 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -117.07 140.12 49.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.508 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 88.2 t80 -130.3 129.2 42.93 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -113.4 145.79 40.56 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 75.82 172.56 0.25 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.523 1.529 . . . . 0.0 111.272 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt 67.51 164.97 0.22 Allowed 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.373 1.069 . . . . 0.0 111.716 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.09 164.42 26.53 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -49.39 136.02 16.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.489 ' HE3' ' HB3' ' A' ' 101' ' ' ASN . 86.0 mtp -110.15 127.97 55.21 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.531 ' O ' HG23 ' A' ' 102' ' ' VAL . 25.9 p -86.9 176.6 7.6 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.9 -29.41 67.02 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -61.93 -19.34 62.63 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.086 0.554 . . . . 0.0 111.224 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.489 ' HB3' ' HE3' ' A' ' 97' ' ' MET . 13.3 m120 -109.32 -26.74 9.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.306 0.574 . . . . 0.0 110.207 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 98' ' ' CYS . 52.4 t -58.48 -38.04 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.574 1.15 . . . . 0.0 113.838 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -57.85 -14.34 5.89 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.95 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.61 71.19 1.23 Allowed 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.61 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 102' ' ' VAL . 3.0 p90 -128.14 153.77 78.65 Favored Pre-proline 0 C--O 1.249 1.046 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.184 167.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.92 118.55 5.07 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.242 1.961 . . . . 0.0 109.921 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.26 136.19 42.87 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.067 1.845 . . . . 0.0 111.875 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -69.05 -45.27 70.81 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -162.53 155.86 20.22 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.0 p -119.41 114.63 22.62 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.72 153.91 33.62 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.512 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mp0 -114.61 126.43 54.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.832 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 7.6 tt -73.59 113.1 10.33 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -103.26 175.23 5.55 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.449 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -38.22 60.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.023 0.529 . . . . 0.0 111.779 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.419 ' OE1' ' HD2' ' A' ' 121' ' ' LYS . 5.4 tp10 -61.33 -43.68 98.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.353 0.661 . . . . 0.0 109.894 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.55 HD22 HG23 ' A' ' 123' ' ' VAL . 13.8 t-20 -71.95 -38.37 69.79 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.442 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 118' ' ' LEU . 2.3 tm? -63.27 -22.93 67.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.832 1.253 . . . . 0.0 108.801 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -87.24 -0.37 56.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.428 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.24 52.73 Favored Glycine 0 CA--C 1.496 -1.103 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.419 ' HD2' ' OE1' ' A' ' 116' ' ' GLU . 98.4 mttt -86.36 142.29 35.36 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.515 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 48.6 Cg_endo -67.83 121.36 8.4 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.453 2.769 . . . . 0.0 112.401 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.55 HG23 HD22 ' A' ' 117' ' ' ASN . 76.7 t -97.35 119.96 46.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 130.5 34.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.314 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 74' ' ' SER . 0.7 OUTLIER -101.87 178.53 4.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 10.4 mptt -89.7 95.24 10.16 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -109.04 23.61 14.3 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.177 -173.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.6 t -53.05 -38.8 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.627 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -103.98 4.93 35.12 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.876 179.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' HE3' ' A' ' 129' ' ' LYS . 55.5 m-85 -108.23 71.89 0.82 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.932 0.873 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.424 ' HG2' ' HE2' ' A' ' 71' ' ' LYS . 46.4 mt-30 -102.49 0.24 33.37 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.444 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -142.37 114.72 8.38 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.456 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.12 107.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -74.35 -44.48 52.14 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.293 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.7 m -157.43 171.33 20.57 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 tp -142.56 131.64 23.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.931 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.9 m -111.46 118.34 35.5 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 138' ' ' ILE . 3.0 mp -104.52 114.97 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -110.68 109.71 20.09 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.533 0.682 . . . . 0.0 109.973 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' A' ' 60' ' ' LEU . 7.2 pt -96.71 114.5 33.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.256 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.89 -48.65 5.92 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.664 -173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.92 146.2 48.93 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.664 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.12 -179.55 5.29 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.002 0.814 . . . . 0.0 109.121 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.527 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.3 mp0 -54.72 -62.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 p -93.44 -36.49 12.45 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.6 1.54 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.3 m -84.68 16.63 3.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.271 12.8 pt-20 63.11 -1.0 0.55 Allowed 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 126.147 1.779 . . . . 0.0 114.2 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.94 122.57 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.94 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -93.35 128.31 39.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -116.35 133.49 55.96 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 79.1 t -134.02 128.48 53.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.405 ' HG2' ' HA2' ' A' ' 79' ' ' GLY . 10.0 mm-40 -88.99 -46.35 8.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.386 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.506 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -146.02 142.94 29.11 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.396 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.76 127.19 73.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.34 141.24 41.83 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.37 137.31 52.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 88.3 m-85 -124.39 139.11 54.21 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.235 0.541 . . . . 0.0 111.265 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.29 -176.18 14.25 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 46.9 m -134.04 130.16 37.12 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 117.477 0.639 . . . . 0.0 110.729 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 C--N 1.288 -2.07 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.321 176.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.9 m . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m -85.46 105.58 16.18 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.17 112.74 16.15 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.72 -177.24 5.41 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.7 t -176.49 -73.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.67 73.54 1.41 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 m -113.49 135.21 54.13 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.746 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.18 105.53 13.9 Favored 'General case' 0 CA--C 1.471 -2.069 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.022 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.456 HG23 ' HA ' ' A' ' 14' ' ' VAL . 2.0 mp -92.75 116.2 66.1 Favored Pre-proline 0 N--CA 1.399 -2.978 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.546 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.64 -166.55 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -104.55 109.17 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.414 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.14 -41.69 0.89 Allowed Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -137.8 142.58 40.84 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.449 -0.876 . . . . 0.0 111.214 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.456 ' HA ' HG23 ' A' ' 9' ' ' ILE . 11.6 p -106.52 156.4 7.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -74.8 143.97 43.74 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.651 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.6 mp -102.82 7.18 39.52 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.653 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.52 -43.24 85.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.66 -16.67 60.16 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.662 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -91.39 -2.85 57.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 16' ' ' LEU . 94.9 mt -74.66 145.38 11.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.6 -42.54 70.84 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 122.751 0.421 . . . . 0.0 111.097 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 72.44 -33.97 0.28 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.4 t -79.11 -37.14 39.43 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.832 0.348 . . . . 0.0 110.871 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 17.68 55.28 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.48 -0.867 . . . . 0.0 114.011 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.61 143.64 14.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-N 117.487 0.643 . . . . 0.0 109.793 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -141.2 134.93 30.22 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.858 0.361 . . . . 0.0 110.395 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 81.2 m -135.72 121.86 20.22 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 121.045 0.45 . . . . 0.0 111.104 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD23 HD12 ' A' ' 61' ' ' LEU . 3.5 mm? -83.44 5.94 21.96 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.832 177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 57' ' ' ASP . 50.3 t-20 -151.64 -67.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.495 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 4.0 pt20 50.98 25.22 2.14 Favored 'General case' 0 N--CA 1.507 2.425 0 C-N-CA 125.342 1.457 . . . . 0.0 112.653 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.414 ' CB ' ' HB2' ' A' ' 34' ' ' HIS . 14.2 m 78.89 112.91 0.07 Allowed 'General case' 0 C--O 1.208 -1.095 0 C-N-CA 125.08 1.352 . . . . 0.0 108.616 -174.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -52.58 -25.27 10.09 Favored 'General case' 0 CA--C 1.572 1.818 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -112.86 -1.89 14.49 Favored 'General case' 0 CA--C 1.562 1.43 0 O-C-N 121.847 -0.533 . . . . 0.0 112.349 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.414 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 94.7 m-70 -126.34 166.56 16.93 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.0 m -105.82 166.26 10.6 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.011 -0.431 . . . . 0.0 111.78 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 3.1 tm? -64.92 -50.09 64.66 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 3.0 Cg_endo -46.03 -29.35 6.13 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 123.85 3.033 . . . . 0.0 114.066 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.539 ' ND2' ' HB2' ' A' ' 50' ' ' LEU . 3.2 m-20 -44.47 -48.96 10.07 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 125.872 1.669 . . . . 0.0 113.375 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -111.19 -7.9 14.42 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.116 -174.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.4 tp -104.23 -42.81 5.4 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.903 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -84.28 103.88 13.84 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 19.9 mm-40 -59.19 127.03 30.11 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.683 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.26 -42.41 1.38 Allowed Glycine 1 N--CA 1.388 -4.559 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.197 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.6 -9.36 44.4 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.833 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 20.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.144 1.777 . . . . 0.0 115.747 -174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -89.51 104.33 16.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.734 -0.604 . . . . 0.0 111.503 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 18.1 t70 -70.93 85.58 0.69 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.352 0.596 . . . . 0.0 110.756 176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 47' ' ' ASP . 5.8 mm-40 -167.78 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 127.6 2.36 . . . . 0.0 106.307 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.02 -54.92 0.89 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.913 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 1.4 pt? -140.27 137.8 34.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.289 0.566 . . . . 0.0 111.843 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.43 165.74 34.11 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 35.0 tp -99.1 128.87 45.31 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.4 171.05 14.59 Favored 'General case' 0 C--N 1.277 -2.583 0 CA-C-O 121.723 0.773 . . . . 0.0 112.967 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 71.9 p -96.93 111.47 23.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.33 -50.44 59.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.168 0.508 . . . . 0.0 110.1 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.1 -41.87 0.65 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.128 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 54' ' ' SER . 3.8 m-20 -85.73 112.85 21.44 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.696 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -70.57 -26.82 63.71 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.815 0.697 . . . . 0.0 110.046 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 15.9 pt20 -84.15 113.75 21.29 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.854 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.3 mt -116.4 134.6 54.69 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.404 -172.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.452 HD12 HD23 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -120.44 114.91 22.5 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.12 124.19 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.42 ' HD1' ' OG1' ' A' ' 137' ' ' THR . 69.4 t80 -104.0 123.71 47.7 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.14 116.36 31.17 Favored Pre-proline 0 N--CA 1.437 -1.109 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.527 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -90.01 153.05 4.84 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 122.158 1.905 . . . . 0.0 109.794 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -112.2 162.42 15.48 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.141 0.496 . . . . 0.0 112.195 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -87.98 -22.69 24.14 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.64 156.68 47.78 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.72 114.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.839 0.828 . . . . 0.0 111.008 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 161' ' ' THR . 2.0 pp -129.74 172.96 14.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.164 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.6 ' HG3' ' OXT' ' A' ' 161' ' ' THR . 56.4 mttp -106.44 129.88 54.34 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 118.301 0.501 . . . . 0.0 109.915 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -77.13 126.14 30.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -116.03 -38.64 3.59 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.727 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 158' ' ' TYR . 26.6 p -147.88 154.11 39.97 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.501 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -130.4 154.98 47.14 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.62 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -143.57 110.25 5.55 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.563 0.345 . . . . 0.0 110.643 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 57.3 mt -122.27 134.5 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 53.5 mtpt -129.19 153.58 47.6 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.311 0.577 . . . . 0.0 112.256 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.39 -166.16 29.75 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -71.42 158.04 55.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 122.215 1.943 . . . . 0.0 109.657 172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.43 -37.27 86.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.732 0.301 . . . . 0.0 111.595 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.35 -33.61 22.0 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.12 13.98 33.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.237 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.42 147.61 25.76 Favored Glycine 0 C--N 1.301 -1.406 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.583 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 6.0 Cg_exo -78.03 115.79 3.83 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.49 2.127 . . . . 0.0 111.908 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 3.7 tmmm? -95.29 -48.06 6.06 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.729 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.2 m -85.8 95.02 9.28 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.443 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.42 119.03 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.399 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -116.98 148.21 41.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.194 0.521 . . . . 0.0 109.908 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -132.58 155.21 49.09 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.601 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 52.3 p90 -152.29 118.96 5.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.587 0.708 . . . . 0.0 110.673 168.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.2 t -103.53 175.93 5.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.251 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 m120 66.12 23.27 11.02 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.423 0.689 . . . . 0.0 111.615 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' HA ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -148.25 107.27 3.86 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.184 0.516 . . . . 0.0 109.971 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.96 122.07 30.31 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.4 m80 71.01 107.6 0.06 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.487 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 51.2 ttm -161.48 128.55 4.0 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.452 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 25.4 p -90.2 162.62 15.16 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.521 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 50.5 p90 -61.8 -18.5 60.15 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -173.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.8 t -60.87 -36.13 78.41 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.99 0.424 . . . . 0.0 110.315 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.487 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 41.8 m-80 -89.39 -25.07 21.75 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.835 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 40.3 t -62.89 -13.23 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.263 1.03 . . . . 0.0 110.323 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.23 -20.53 28.36 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.786 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.06 -23.77 13.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.516 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -96.6 133.19 24.95 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.585 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 24.1 Cg_exo -65.45 126.67 16.62 Favored 'Trans proline' 0 C--O 1.249 1.03 0 C-N-CA 122.364 2.043 . . . . 0.0 110.657 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 25.1 Cg_exo -64.52 161.5 34.89 Favored 'Trans proline' 0 C--O 1.243 0.752 0 C-N-CA 122.566 2.177 . . . . 0.0 111.253 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 39.6 m -63.34 -45.42 91.31 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 126' ' ' LYS . 17.7 t70 -158.88 153.78 24.94 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.1 m -126.87 115.28 19.07 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -110.29 165.08 12.05 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.573 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.549 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 8.9 mp0 -123.77 138.25 54.54 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.4 tp -72.64 107.77 5.3 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.5 p -82.16 160.96 22.96 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.15 -30.73 71.25 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.846 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 121' ' ' LYS . 11.4 pt-20 -72.22 -32.52 66.82 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.693 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.62 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.6 t-20 -66.4 -36.89 83.97 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 2.6 tm? -64.05 -8.0 10.45 Favored 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 126.786 2.035 . . . . 0.0 110.387 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 115' ' ' GLU . 90.8 mttt -110.94 -6.85 14.62 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.541 0.736 . . . . 0.0 109.498 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 78' ' ' LYS . . . 99.06 30.92 6.45 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.811 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 64.6 tttm -102.37 121.59 49.53 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.523 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.08 112.84 1.34 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.272 2.648 . . . . 0.0 111.458 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 132.52 37.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.0 m -82.08 136.61 22.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.524 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.525 HD11 HD12 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -115.4 -172.84 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.491 179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.472 ' HG2' ' OD1' ' A' ' 109' ' ' ASP . 72.5 mmtt -70.57 89.99 0.73 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -68.5 -21.95 64.57 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.787 1.235 . . . . 0.0 110.52 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -64.71 -24.89 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.443 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -94.57 -36.21 11.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.346 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -79.08 93.25 5.12 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.264 0.554 . . . . 0.0 110.778 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -114.6 -41.06 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -121.95 115.64 22.92 Favored 'General case' 0 CA--C 1.478 -1.8 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.887 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.72 102.37 11.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.973 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -104.17 -24.08 13.2 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 168.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 55.3 p -138.74 144.24 39.38 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.852 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.8 tp -147.27 121.1 9.28 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.42 ' OG1' ' HD1' ' A' ' 63' ' ' TYR . 23.2 m -105.74 132.11 52.26 Favored 'General case' 0 C--N 1.287 -2.141 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.857 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -105.15 117.75 51.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -117.86 107.23 13.85 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.52 0.676 . . . . 0.0 110.208 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.637 HG13 ' HB2' ' A' ' 60' ' ' LEU . 11.3 pt -107.1 114.06 45.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.463 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' GLN . 12.1 pt-20 -105.43 -23.0 12.91 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.28 152.0 44.13 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.812 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.435 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 31.7 p30 -108.92 170.08 8.27 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.981 -178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 21.0 tp60 -48.32 -60.03 2.98 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.917 1.687 . . . . 0.0 113.799 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.8 m -104.0 7.82 36.62 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.439 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.36 46.12 94.53 Favored Glycine 0 C--O 1.224 -0.509 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 m -90.5 10.8 23.89 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 123.21 0.604 . . . . 0.0 112.342 -171.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 43.9 mt-10 69.85 -45.83 0.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.147 0.979 . . . . 0.0 112.802 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.3 p -102.52 137.34 30.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.119 0.485 . . . . 0.0 109.844 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.5 m -120.33 138.31 53.79 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -131.1 135.42 47.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 61.8 t -120.6 125.77 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.107 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -86.9 -48.81 7.85 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -153.8 143.17 21.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.329 -177.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.3 mt -121.86 132.3 71.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.44 134.09 26.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -113.56 135.81 53.5 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.414 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 80.1 m-85 -120.01 133.13 55.63 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.381 0.61 . . . . 0.0 109.908 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -128.87 178.63 17.14 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.5 m -128.82 25.94 5.59 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 117.151 0.476 . . . . 0.0 112.266 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.6 ' OXT' ' HG3' ' A' ' 71' ' ' LYS . 63.8 p . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.3 p . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -95.44 107.49 19.64 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.17 15.12 9.36 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -155.01 158.85 39.78 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.8 p -88.28 94.8 9.95 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.06 108.32 3.42 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.559 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.4 p -94.44 154.93 17.2 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.824 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 26.1 tt0 -119.09 20.37 12.69 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.009 0.909 . . . . 0.0 109.871 -177.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.643 HG22 ' H ' ' A' ' 11' ' ' LYS . 3.2 mp -79.79 120.44 80.02 Favored Pre-proline 0 C--N 1.298 -1.633 0 O-C-N 121.769 -0.582 . . . . 0.0 111.98 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -95.02 29.22 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.552 2.834 . . . . 0.0 110.95 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 9' ' ' ILE . 41.0 ttmt 68.44 106.25 0.05 Allowed 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.281 1.433 . . . . 0.0 112.16 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.32 -79.84 0.2 Allowed Glycine 0 N--CA 1.432 -1.609 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.11 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 26.8 mm-40 -109.84 -173.82 2.35 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.57 152.5 8.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 17' ' ' LEU . 3.1 p30 -74.62 138.95 43.29 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.197 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -78.78 -13.26 59.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.441 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 40' ' ' LEU . 4.6 tt -59.79 -43.5 94.39 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.174 -176.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -24.72 62.58 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -90.29 14.74 11.95 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.322 0.582 . . . . 0.0 111.34 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 16' ' ' LEU . 67.3 mt -100.48 134.27 40.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.32 -26.04 51.8 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.738 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 74.09 2.75 4.25 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 m -88.63 -28.13 20.85 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.946 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.21 23.15 7.74 Favored Glycine 0 C--N 1.318 -0.428 0 C-N-CA 119.33 -1.414 . . . . 0.0 114.515 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.63 133.44 31.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 117.564 0.682 . . . . 0.0 110.838 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.429 ' CG ' ' HB3' ' A' ' 63' ' ' TYR . 11.7 pt-20 -141.06 154.93 46.19 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 122.217 -0.302 . . . . 0.0 110.809 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HB3' HE21 ' A' ' 30' ' ' GLN . 47.2 t -136.21 141.11 43.97 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 122.911 0.485 . . . . 0.0 109.836 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 5.7 tt -52.71 -61.48 2.26 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 124.885 1.274 . . . . 0.0 110.928 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 28.2 t-20 -95.11 -88.8 0.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.613 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.559 HE21 ' HB3' ' A' ' 27' ' ' CYS . 7.8 tt0 55.47 17.88 2.41 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.503 1.144 . . . . 0.0 109.426 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -81.54 -23.5 37.18 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.233 -171.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 34' ' ' HIS . 44.7 t -55.37 -4.75 0.1 Allowed 'General case' 0 CA--C 1.578 2.022 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.976 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 m 80.11 -17.16 0.6 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.35 1.46 . . . . 0.0 110.158 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.799 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 12.7 m170 -71.39 110.82 6.25 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 171.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -95.23 164.4 12.87 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -164.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.462 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 5.4 tt -63.73 -50.51 71.11 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.417 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 85.2 Cg_exo -53.67 -27.01 40.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.964 1.776 . . . . 0.0 112.835 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' ND2' HD22 ' A' ' 50' ' ' LEU . 13.4 m120 -59.61 -48.18 82.66 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-O 120.995 0.426 . . . . 0.0 110.338 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' HA ' ' HE ' ' A' ' 45' ' ' ARG . . . -102.88 -0.35 31.31 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -170.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 44.2 tp -132.34 5.64 4.1 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 119.431 -0.907 . . . . 0.0 113.024 -177.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -121.97 143.72 49.3 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 121.222 -0.924 . . . . 0.0 111.574 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.62 152.13 36.02 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.511 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.85 -52.27 4.69 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -80.58 -9.61 59.77 Favored 'General case' 0 C--O 1.194 -1.851 0 C-N-CA 123.017 0.527 . . . . 0.0 111.059 176.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -75.07 -91.83 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.329 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' ARG 0.311 9.3 pt-20 39.39 84.73 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.883 0.849 . . . . 0.0 113.061 -174.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.338 5.6 p-10 -67.24 85.68 0.15 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 -169.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 169.91 103.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.385 2.274 . . . . 0.0 107.31 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.32 -99.5 0.44 Allowed Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD22 ' ND2' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -77.67 147.19 35.63 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.799 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.8 p30 -164.59 169.36 17.13 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 52' ' ' LEU . 7.2 tt -105.47 121.87 44.83 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 118.065 -1.454 . . . . 0.0 108.626 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.33 159.68 41.23 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.65 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 25.1 p -85.91 177.21 7.69 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.528 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -170.7 -64.28 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 120.711 0.291 . . . . 0.0 110.711 -174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.05 68.4 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 54' ' ' SER . 8.5 t70 -131.64 174.44 10.11 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -109.61 -24.58 10.88 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 141' ' ' GLU . 87.8 mm-40 -84.28 139.46 32.31 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.588 -174.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 29' ' ' ASN . 47.2 mt -135.64 122.39 21.02 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 122.12 0.962 . . . . 0.0 112.725 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 5.9 tt -130.42 120.96 25.02 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -111.13 123.02 66.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.429 ' HB3' ' CG ' ' A' ' 26' ' ' GLU . 35.9 t80 -101.38 123.43 45.44 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -121.18 113.91 32.32 Favored Pre-proline 0 N--CA 1.441 -0.887 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -89.18 139.23 3.55 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 122.862 2.374 . . . . 0.0 111.051 171.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.16 163.33 17.91 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . 0.252 35.9 t-20 -104.44 -38.59 6.75 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-N 111.993 -2.367 . . . . 0.0 106.355 170.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -153.44 144.76 23.1 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.9 m -75.09 128.09 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 CA-C-O 121.189 0.519 . . . . 0.0 111.114 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.503 HG22 HG22 ' A' ' 161' ' ' THR . 0.1 OUTLIER -139.34 173.21 11.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -97.37 117.93 32.71 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 125' ' ' LEU . 2.1 tm? -74.97 123.72 25.65 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -106.19 -48.54 3.56 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.4 p -145.26 160.18 41.89 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -130.37 151.52 50.77 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.518 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.422 ' C ' HD12 ' A' ' 77' ' ' ILE . . . -148.99 116.69 6.24 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 154' ' ' LYS . 3.3 mp -132.25 122.45 48.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -99.13 163.25 12.64 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.162 0.506 . . . . 0.0 110.344 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.05 -177.51 48.26 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -74.82 172.36 16.44 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.53 1.665 . . . . 0.0 108.306 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 -56.28 5.29 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.331 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.5 mp0 -63.21 -55.25 26.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.115 0.959 . . . . 0.0 110.896 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -90.62 17.13 7.88 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.404 -172.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.09 159.29 25.33 Favored Glycine 0 C--N 1.301 -1.372 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.567 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 9.8 Cg_exo -72.54 107.26 2.26 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 119.417 1.608 . . . . 0.0 110.434 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 113' ' ' LEU . 12.6 tmtt? -83.34 -51.39 7.46 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.94 -175.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.3 m -103.63 108.9 20.37 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.575 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.54 HG12 HG22 ' A' ' 140' ' ' ILE . 30.4 m -108.52 134.91 48.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-O 121.047 0.451 . . . . 0.0 111.321 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -121.69 134.26 54.96 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.31 138.85 47.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.3 m-85 -128.9 118.51 22.81 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.0 p -110.2 133.93 52.73 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.46 ' C ' ' HE3' ' A' ' 94' ' ' LYS . 86.4 m-20 76.37 -4.29 2.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.557 1.543 . . . . 0.0 114.991 173.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.541 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -88.35 104.43 16.76 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -79.56 150.11 31.2 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 72.1 99.63 0.07 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.275 1.03 . . . . 0.0 109.639 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 12.7 mmt -134.35 137.52 44.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.476 ' H ' ' HB2' ' A' ' 101' ' ' ASN . 32.0 p -159.17 -172.16 3.65 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.558 ' CZ ' HD11 ' A' ' 28' ' ' LEU . 92.7 m-85 -54.75 -44.57 73.71 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.301 0.501 . . . . 0.0 111.621 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 m -62.02 -20.61 64.11 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.495 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.3 m120 -93.67 -47.44 6.8 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.499 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.49 -20.13 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -93.2 -12.98 28.94 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.999 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -99.13 -37.57 9.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.892 0.377 . . . . 0.0 111.628 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -96.83 142.34 24.4 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.427 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.98 143.51 29.2 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 122.166 1.911 . . . . 0.0 111.293 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.14 163.8 35.78 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.413 2.075 . . . . 0.0 111.984 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -72.99 -44.8 60.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -169.35 171.95 7.5 Favored 'General case' 0 C--O 1.251 1.169 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t -143.92 145.3 32.17 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.34 172.3 13.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -124.11 139.41 53.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.324 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 50.9 tp -60.5 112.68 2.07 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.923 0.764 . . . . 0.0 110.902 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 36.3 p -113.62 172.48 6.95 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.236 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.19 -24.69 67.35 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.728 0.775 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.31 -34.05 67.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.311 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.551 HD21 HG21 ' A' ' 123' ' ' VAL . 13.5 m120 -71.02 -45.42 63.95 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.269 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.35 -26.43 66.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.705 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.77 -13.75 55.71 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.228 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.88 41.41 23.23 Favored Glycine 0 CA--C 1.502 -0.755 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -95.5 134.96 23.52 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.12 109.94 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.782 1.655 . . . . 0.0 110.161 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.551 HG21 HD21 ' A' ' 117' ' ' ASN . 61.6 t -98.34 131.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.89 105.97 10.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.54 0.686 . . . . 0.0 111.458 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -83.61 -165.85 1.23 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.767 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -76.97 92.18 3.67 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.165 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.43 -27.55 66.14 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.615 1.566 . . . . 0.0 111.753 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.41 -16.04 16.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -80.82 -51.1 8.99 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.817 0.818 . . . . 0.0 110.149 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 90.33 6.63 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.178 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -98.91 -31.42 11.84 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.131 0.491 . . . . 0.0 110.272 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -149.39 119.55 7.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.395 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.09 112.72 41.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.742 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -92.65 -45.58 8.0 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.8 t -141.1 139.68 34.04 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.444 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.8 tp -131.69 125.31 31.77 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.233 0.54 . . . . 0.0 110.152 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 96.2 m -106.97 126.54 52.46 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.565 177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.444 HD11 HD11 ' A' ' 157' ' ' LEU . 62.6 mt -104.7 109.49 27.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 49.2 t80 -113.59 111.23 21.52 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 121.106 0.479 . . . . 0.0 110.646 -177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.54 HG22 HG12 ' A' ' 88' ' ' VAL . 30.9 pt -100.94 113.72 37.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.523 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 14.7 pt-20 -99.59 -12.94 19.65 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.643 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -161.76 142.32 10.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 118.99 -1.084 . . . . 0.0 113.385 -175.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.71 -173.76 2.47 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 170.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -60.49 -56.03 26.26 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.1 m -124.64 6.58 8.2 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.826 -169.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.82 60.9 3.48 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.2 m -83.07 17.34 2.0 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 123.898 0.879 . . . . 0.0 111.766 -174.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 78.51 -32.05 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 112.794 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.5 147.42 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 92.5 m -114.05 124.27 51.71 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HE3' HD21 ' A' ' 51' ' ' ASN . 88.1 tttt -111.37 134.35 53.01 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 123.174 0.589 . . . . 0.0 110.071 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 44.5 t -125.23 126.12 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -97.42 -11.44 23.9 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 39.8 ttmt -170.15 130.45 0.95 Allowed 'General case' 0 CA--C 1.492 -1.279 0 O-C-N 121.82 -0.55 . . . . 0.0 111.449 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.95 116.65 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 166.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.29 121.09 21.91 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.444 HD11 HD11 ' A' ' 138' ' ' ILE . 84.1 mt -117.45 144.62 44.84 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 13' ' ' GLN . 88.0 m-85 -126.24 145.47 50.38 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.818 0.342 . . . . 0.0 111.629 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -148.46 -168.64 14.62 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.384 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.5 p -151.07 140.65 21.63 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 122.5 0.32 . . . . 0.0 110.504 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 HG22 ' A' ' 70' ' ' ILE . 40.4 p . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.631 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.629 0.252 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.0 m -133.18 -177.7 4.64 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.81 91.8 3.83 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.185 0.517 . . . . 0.0 110.891 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.1 140.17 47.51 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.3 t -93.02 85.72 5.2 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.406 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.73 110.46 16.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 p -154.65 145.89 22.88 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.39 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 6.2 tp60 -95.05 87.05 4.79 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 175.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.3 mm -100.43 107.66 49.2 Favored Pre-proline 0 N--CA 1.421 -1.904 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.657 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HG2' HE21 ' A' ' 13' ' ' GLN . 59.1 Cg_endo -95.56 -178.9 0.51 Allowed 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 122.432 2.088 . . . . 0.0 110.468 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -76.37 131.25 39.03 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.49 -51.55 0.83 Allowed Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.155 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.541 HE21 ' HG2' ' A' ' 10' ' ' PRO . 1.6 pm0 -130.84 172.15 12.35 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 159' ' ' GLY . 14.5 p -118.04 154.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -76.79 147.47 37.21 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 20' ' ' ILE . 66.4 mt -108.27 17.75 21.85 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.8 -43.47 75.56 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -83.06 -11.7 57.8 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.507 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.99 0.93 42.4 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.904 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 16' ' ' LEU . 70.9 mt -86.72 140.39 15.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.22 -28.9 31.68 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.544 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.612 ' CH2' HD12 ' A' ' 40' ' ' LEU . 98.9 m95 76.45 -4.37 2.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 t -102.89 -30.76 10.63 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.61 -0.39 66.98 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.706 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.4 m -64.83 139.2 21.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 117.146 0.473 . . . . 0.0 111.453 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -148.35 143.77 27.08 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HB3' ' NE2' ' A' ' 30' ' ' GLN . 51.6 t -137.39 140.32 41.29 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.9 mm? -123.69 90.92 3.36 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.177 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' LEU . 10.7 t30 152.47 -17.29 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.519 0 C-N-CA 124.963 1.305 . . . . 0.0 111.83 170.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 0.4 OUTLIER -54.74 -14.73 1.48 Allowed 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 122.897 0.479 . . . . 0.0 111.681 176.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.4 t -58.81 -21.96 57.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.621 1.169 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.53 ' HB2' ' H ' ' A' ' 56' ' ' ALA . 33.7 p -77.14 -14.96 59.71 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 55' ' ' ASP . 33.1 t -154.75 -90.03 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.603 ' O ' ' HB2' ' A' ' 30' ' ' GLN . 68.7 m-70 -124.35 162.95 22.74 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -88.82 172.87 8.89 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -169.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -70.52 -55.3 7.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.16 -20.13 36.89 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 122.08 1.853 . . . . 0.0 111.85 -177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 2.4 m-20 -58.04 -41.54 83.45 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 124.839 1.255 . . . . 0.0 111.628 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -110.96 6.63 21.21 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.21 0.529 . . . . 0.0 110.659 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.612 HD12 ' CH2' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -105.22 -43.22 5.07 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -175.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -79.83 130.4 35.28 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.135 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -45.82 139.04 4.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.654 -1.157 . . . . 0.0 113.239 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.28 -52.89 4.38 Favored Glycine 0 N--CA 1.411 -3.023 0 CA-C-N 114.935 -1.029 . . . . 0.0 114.179 172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -67.47 -28.74 68.12 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -61.24 -13.12 16.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.139 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -48.49 119.55 3.12 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.652 0.595 . . . . 0.0 110.596 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' A' ' 153' ' ' GLN 0.258 4.8 p-10 -72.49 96.62 1.96 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -169.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 175.91 -52.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.356 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.54 -69.62 1.37 Allowed Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.691 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -128.78 145.37 51.2 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.967 0.413 . . . . 0.0 111.107 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 3.5 p-10 -159.08 166.38 31.77 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' HB3' ' HB ' ' A' ' 152' ' ' VAL . 53.5 tp -84.22 130.04 34.85 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 35.5 tt0 -143.0 135.54 27.54 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.146 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.62 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 46.1 p -110.45 112.83 25.01 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 12.1 t70 -94.32 -44.72 7.8 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 120.796 0.331 . . . . 0.0 111.591 -175.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.53 ' H ' ' HB2' ' A' ' 32' ' ' SER . . . -81.78 -57.93 3.22 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.211 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 54' ' ' SER . 11.5 m-20 -106.87 141.88 37.39 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.964 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -88.49 4.3 47.1 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.575 1.179 . . . . 0.0 109.319 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.92 120.9 43.91 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.395 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 HD12 HD22 ' A' ' 29' ' ' ASN . 9.1 tt -141.26 130.57 23.63 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 121.52 0.676 . . . . 0.0 111.028 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 62' ' ' ILE . 1.1 tm? -101.79 134.13 45.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.914 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 61' ' ' LEU . 29.9 mt -129.19 129.98 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -112.71 115.73 29.0 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 68.7 mt -121.11 116.76 31.02 Favored Pre-proline 0 C--N 1.313 -1.019 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.45 144.35 4.72 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.515 2.143 . . . . 0.0 110.925 174.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.11 143.87 36.28 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.788 0.804 . . . . 0.0 112.854 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -56.51 -42.63 78.71 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 126.413 1.885 . . . . 0.0 110.515 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -142.71 154.36 44.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.95 123.42 38.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 121.525 0.679 . . . . 0.0 111.513 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -130.52 173.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -91.74 127.47 37.21 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.15 109.27 15.54 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.405 ' H ' ' HA2' ' A' ' 159' ' ' GLY . 14.4 t60 -91.53 -52.04 4.97 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.41 . . . . 0.0 111.237 -175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.8 p -140.36 157.12 46.03 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.194 0.521 . . . . 0.0 111.89 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.58 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 35.4 p90 -127.1 152.55 47.16 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -144.17 106.43 4.37 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.784 0.326 . . . . 0.0 111.722 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 62.4 mt -111.18 118.16 56.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 154' ' ' LYS . 10.0 tmtt? -101.79 134.83 44.36 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.11 -176.21 41.48 Favored Glycine 0 N--CA 1.414 -2.812 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.007 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.85 151.87 57.44 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.755 2.304 . . . . 0.0 110.521 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -61.66 -34.02 74.97 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.21 -38.12 11.21 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.79 18.26 16.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.351 -173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.49 148.1 19.13 Favored Glycine 0 C--N 1.299 -1.516 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.891 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.3 107.48 2.28 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 CA-C-N 119.328 1.564 . . . . 0.0 110.058 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 31.5 ttpt -85.75 -55.12 4.12 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.131 0.491 . . . . 0.0 110.477 -173.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.9 m -82.29 103.84 12.17 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.245 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.21 136.93 44.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.812 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.52 151.14 50.47 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 136' ' ' LEU . 47.4 m-85 -126.17 155.93 40.96 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -105.97 161.5 14.41 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.9 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.9 p -95.95 79.27 3.24 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 38.04 96.9 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -151.94 166.97 29.86 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -101.77 146.51 27.68 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.579 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 51.99 84.41 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.48 1.112 . . . . 0.0 112.125 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' A' ' 101' ' ' ASN . 17.3 tpt -119.09 110.51 17.16 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 101' ' ' ASN . 23.7 p -124.49 -170.7 2.2 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.495 ' HA ' ' CG2' ' A' ' 102' ' ' VAL . 83.3 t80 -63.62 -26.03 68.49 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 118.838 0.744 . . . . 0.0 111.639 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.8 m -71.16 -8.64 54.91 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.661 0.743 . . . . 0.0 110.4 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.585 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 12.1 m120 -105.64 -20.17 13.54 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 124.473 1.109 . . . . 0.0 110.35 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 99' ' ' PHE . 55.5 t -58.39 -39.69 75.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.32 10.51 37.78 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.43 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -120.37 -35.77 3.36 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 90.6 m-85 -96.46 127.64 39.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 O-C-N 121.953 -0.467 . . . . 0.0 111.801 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 59.1 Cg_exo -54.11 129.56 35.01 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.893 3.062 . . . . 0.0 114.036 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 71.7 Cg_endo -80.79 156.55 20.95 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.648 2.232 . . . . 0.0 110.885 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.1 m -84.32 -45.9 12.32 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.896 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.476 ' HB2' ' HE2' ' A' ' 129' ' ' LYS . 28.9 t70 -163.07 171.71 16.02 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.1 p -127.96 119.9 26.48 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB1' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.98 152.42 24.98 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.429 ' HG3' ' HG2' ' A' ' 86' ' ' LYS . 39.9 tt0 -126.49 125.6 42.35 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.555 HD23 HE22 ' A' ' 144' ' ' GLN . 19.6 tp -66.96 145.57 55.29 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.571 HG23 ' H ' ' A' ' 117' ' ' ASN . 2.8 t -135.23 163.67 29.43 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -58.63 -27.29 64.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.672 0.749 . . . . 0.0 110.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -65.52 -51.4 60.24 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.026 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.667 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.3 t-20 -65.31 -49.4 69.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.915 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 3.0 pp -71.31 -9.45 58.16 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -89.59 3.72 51.67 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.24 33.66 6.17 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.682 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.2 tmtp? -115.96 120.75 35.02 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 117.271 0.536 . . . . 0.0 109.675 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 32.5 Cg_exo -58.69 117.72 4.49 Favored 'Trans proline' 0 N--CA 1.487 1.12 0 C-N-CA 123.574 2.849 . . . . 0.0 112.29 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.468 HG23 ' ND2' ' A' ' 117' ' ' ASN . 80.9 t -93.51 131.06 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 m -73.68 123.29 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.439 HD23 ' CD1' ' A' ' 75' ' ' PHE . 0.8 OUTLIER -98.7 174.52 6.37 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.827 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -86.51 89.96 8.07 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 130' ' ' PHE . 45.2 p90 -101.52 21.17 14.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -169.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.423 ' C ' HE22 ' A' ' 131' ' ' GLN . 35.0 m -64.78 -3.76 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 109' ' ' ASP . 0.0 OUTLIER -123.02 1.01 9.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 175.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.404 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.0 m-85 -101.03 78.62 1.94 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.423 HE22 ' C ' ' A' ' 128' ' ' VAL . 2.0 mp0 -92.2 -32.36 15.11 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.303 0.573 . . . . 0.0 110.023 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -141.78 121.62 13.56 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.772 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 56.4 t -114.56 108.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -96.4 -40.33 9.15 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.5 m -138.13 136.39 36.65 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' A' ' 90' ' ' PHE . 44.1 tp -126.74 119.84 27.91 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.282 0.563 . . . . 0.0 110.236 177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 93.6 m -102.27 121.32 42.03 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.591 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.4 mt -104.71 113.18 41.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 82.3 t80 -111.5 116.91 31.68 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.5 pp -106.91 136.03 43.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.633 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.0 pt-20 -123.47 -13.73 7.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.61 146.03 20.61 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.148 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -97.85 174.83 6.39 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.555 HE22 HD23 ' A' ' 113' ' ' LEU . 18.3 mp0 -60.47 -52.54 64.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.001 0.429 . . . . 0.0 110.855 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.3 t -92.04 -22.19 20.08 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.369 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.33 81.54 0.45 Allowed Glycine 0 CA--C 1.499 -0.928 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 149' ' ' VAL . 34.4 m -111.78 6.21 19.58 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.427 -0.386 . . . . 0.0 111.868 -172.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 67.76 -36.16 0.29 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.496 1.118 . . . . 0.0 112.72 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 147' ' ' SER . 4.6 p -102.87 132.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 123.498 0.719 . . . . 0.0 109.674 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.62 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 61.3 m -121.39 128.83 52.61 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.422 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 40.1 ttmt -109.9 132.66 53.95 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 52' ' ' LEU . 19.4 t -123.71 116.3 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.194 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 97.5 mt-30 -94.77 -19.48 20.32 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.363 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -172.34 134.33 0.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.588 0.355 . . . . 0.0 110.563 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.496 ' HB ' HD22 ' A' ' 40' ' ' LEU . 1.8 mp -129.88 117.85 42.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.93 147.78 35.81 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.897 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -114.54 141.18 48.07 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 122' ' ' PRO . 82.2 m-85 -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 14' ' ' VAL . . . -139.58 -168.34 11.27 Favored Glycine 0 CA--C 1.488 -1.651 0 C-N-CA 119.909 -1.138 . . . . 0.0 112.487 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.3 p -163.08 147.89 11.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 120.487 0.184 . . . . 0.0 110.883 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.411 HG23 HG22 ' A' ' 70' ' ' ILE . 18.0 p . . . . . 0 C--N 1.297 -1.716 0 CA-C-O 119.243 -0.408 . . . . 0.0 110.382 170.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 m -139.48 114.5 9.54 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.033 0.444 . . . . 0.0 111.239 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.28 -21.79 24.26 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -89.52 155.63 19.16 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.612 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -78.61 -40.53 34.19 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 55.08 71.38 0.54 Allowed 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.732 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.0 t -147.79 114.83 6.16 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.236 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -121.9 4.31 9.95 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.962 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.639 HG22 ' H ' ' A' ' 11' ' ' LYS . 4.2 mp -62.08 117.15 26.72 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.393 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -92.7 25.25 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.06 2.507 . . . . 0.0 110.887 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.639 ' H ' HG22 ' A' ' 9' ' ' ILE . 40.6 ttmt 61.85 99.51 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.767 1.227 . . . . 0.0 111.272 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.55 -78.83 0.19 Allowed Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.488 ' O ' HG23 ' A' ' 9' ' ' ILE . 28.0 mm-40 -109.7 168.42 9.42 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 173.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 15.5 m -105.34 156.39 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.886 0 C-N-CA 120.369 -0.533 . . . . 0.0 109.921 -175.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 17' ' ' LEU . 3.3 p30 -78.28 112.63 15.47 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 122.694 1.235 . . . . 0.0 109.531 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.603 ' O ' HG13 ' A' ' 20' ' ' ILE . 36.9 mt -68.65 6.04 0.93 Allowed 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 113.677 -1.602 . . . . 0.0 110.639 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.51 HD11 ' H ' ' A' ' 42' ' ' GLN . 5.2 tt -60.42 -41.65 94.38 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.67 -22.01 60.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.173 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 32.8 m-85 -93.71 15.11 17.17 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.982 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 16' ' ' LEU . 86.8 mt -95.97 134.95 31.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.52 -44.38 96.11 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 94.4 m95 66.46 7.19 4.84 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 m -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.96 -84.96 1.66 Allowed Glycine 0 N--CA 1.416 -2.639 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.497 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 65.8 t 39.16 84.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 C-N-CA 124.951 1.3 . . . . 0.0 111.87 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -117.5 131.53 56.7 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.515 -1.22 . . . . 0.0 112.127 -168.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . 49.1 t -129.18 130.99 47.05 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -59.25 -72.01 0.11 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -70.69 -59.55 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.54 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 35.0 tt0 59.78 27.53 16.84 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.172 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 30.0 t 71.06 130.53 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.135 -177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.4 t -57.83 -34.12 69.34 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.238 173.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -109.67 -48.14 3.26 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 31' ' ' SER . 97.9 m-70 -99.58 164.92 11.87 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -169.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.432 ' C ' HD23 ' A' ' 52' ' ' LEU . 16.2 m -100.82 141.5 33.61 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.734 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 3.0 tm? -62.37 -46.38 90.09 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.094 0.558 . . . . 0.0 112.281 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 9.9 Cg_endo -52.04 -24.45 19.69 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.275 1.984 . . . . 0.0 112.492 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.545 ' HB3' HD13 ' A' ' 50' ' ' LEU . 96.6 m-20 -69.03 -19.3 64.11 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -110.2 1.22 18.57 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.232 0.539 . . . . 0.0 110.573 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 tp -124.36 -40.36 2.25 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -90.36 103.52 16.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.151 0.5 . . . . 0.0 111.066 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' H ' HD11 ' A' ' 17' ' ' LEU . 0.7 OUTLIER -75.51 113.35 12.83 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.98 -50.43 0.43 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 105.772 -2.931 . . . . 0.0 105.772 -175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -89.7 -41.27 12.01 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 168.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HD2' ' O ' ' A' ' 153' ' ' GLN . 54.2 ttp180 -73.53 122.17 21.78 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.275 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -130.54 106.77 8.73 Favored 'General case' 0 C--N 1.262 -3.206 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 165.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 153' ' ' GLN 0.335 7.7 p-10 -64.03 84.54 0.03 OUTLIER 'General case' 0 C--O 1.241 0.655 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -166.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER 160.42 99.71 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 128.758 2.823 . . . . 0.0 104.401 175.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.46 -103.47 0.46 Allowed Glycine 0 C--N 1.303 -1.271 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 38' ' ' ASN 0.251 1.9 pp -77.09 125.73 29.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 119.344 -0.943 . . . . 0.0 109.941 174.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -154.44 165.72 35.52 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -176.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 36' ' ' LEU . 2.9 tm? -94.84 112.13 23.87 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.5 pt-20 -131.15 121.33 24.7 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.771 176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.9 t -69.59 149.23 48.39 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.34 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -103.99 -28.52 11.49 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.64 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.83 -53.87 2.57 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.042 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -140.74 158.36 44.08 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 117.489 -1.685 . . . . 0.0 115.333 -172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 143' ' ' ASN . 41.9 mt-10 -70.15 -33.22 71.51 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.32 1.048 . . . . 0.0 112.119 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -78.25 109.54 12.46 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.657 0.741 . . . . 0.0 111.131 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' H ' HG13 ' A' ' 140' ' ' ILE . 14.7 tp -116.42 134.22 55.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.93 127.69 49.26 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -144.34 127.52 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 CA-C-O 121.473 0.654 . . . . 0.0 111.547 177.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 5.1 t80 -91.89 123.88 35.6 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.614 1.566 . . . . 0.0 111.414 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.426 HG23 HG23 ' A' ' 20' ' ' ILE . 35.3 mt -120.79 120.29 29.59 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -89.66 152.38 5.17 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.944 2.429 . . . . 0.0 111.178 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -88.15 162.79 16.53 Favored 'General case' 0 CA--C 1.474 -1.955 0 CA-C-O 121.919 0.866 . . . . 0.0 112.752 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -99.45 -32.94 10.89 Favored 'General case' 0 N--CA 1.404 -2.775 0 CA-C-N 113.6 -1.636 . . . . 0.0 108.662 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -151.67 145.99 25.46 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.1 t -73.74 108.75 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.457 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -133.02 173.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -90.75 133.24 35.32 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.18 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.646 HD13 ' H ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.2 121.46 27.11 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.27 177.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -115.23 -46.16 2.91 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 p -153.62 169.23 23.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.166 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -139.88 154.49 47.29 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -141.1 117.33 10.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.415 HG23 HG12 ' A' ' 155' ' ' ILE . 60.0 mt -126.72 119.84 54.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.34 144.35 25.96 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.68 176.31 34.81 Favored Glycine 1 C--N 1.253 -4.08 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.69 178.09 6.14 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 CA-C-N 119.612 1.706 . . . . 0.0 111.03 175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -68.56 -44.35 74.66 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.402 -178.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.59 -53.31 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -79.82 12.33 2.73 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.28 147.69 28.89 Favored Glycine 0 C--O 1.251 1.191 0 C-N-CA 120.134 -1.032 . . . . 0.0 110.768 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_endo -77.12 115.99 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.847 1.698 . . . . 0.0 110.209 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.631 ' HE3' ' OE1' ' A' ' 144' ' ' GLN . 0.8 OUTLIER -87.06 -71.04 0.58 Allowed 'General case' 0 N--CA 1.428 -1.555 0 C-N-CA 118.652 -1.219 . . . . 0.0 110.025 -175.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.8 m -75.34 102.05 4.96 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.488 0.661 . . . . 0.0 111.28 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 140' ' ' ILE . 34.9 m -101.76 144.44 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.397 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -133.75 133.79 42.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -116.91 146.06 43.21 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.672 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' ' 102' ' ' VAL . 95.1 m-85 -129.82 115.06 16.71 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.9 m -103.3 154.76 19.03 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 120.87 0.367 . . . . 0.0 110.748 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.7 m120 73.96 -42.12 0.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 125.25 1.42 . . . . 0.0 112.853 173.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -69.08 122.44 18.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.964 0.412 . . . . 0.0 110.081 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.565 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 35.9 tt0 -93.68 122.34 36.04 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.279 -174.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t60 58.4 96.08 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 124.174 0.989 . . . . 0.0 112.923 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 53.0 mtm -131.34 155.59 46.97 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.152 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' VAL . 24.5 p -109.19 -179.16 3.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -58.68 -30.6 67.51 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 122.838 0.455 . . . . 0.0 111.706 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 t -62.29 -41.61 98.65 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.057 0.455 . . . . 0.0 109.859 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 104' ' ' ASP . 94.7 m-20 -85.88 -15.8 40.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 98' ' ' CYS . 51.3 t -62.0 -29.23 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.588 0.709 . . . . 0.0 110.121 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.84 9.29 39.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.597 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 101' ' ' ASN . 20.6 t70 -109.13 -48.27 3.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.414 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -97.5 127.01 39.33 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 53.0 Cg_exo -57.97 136.35 74.55 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.801 2.334 . . . . 0.0 111.782 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 19.2 Cg_exo -66.28 158.03 57.07 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.723 2.282 . . . . 0.0 112.878 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -70.19 -45.77 65.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -164.84 157.44 16.35 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -141.16 117.06 10.45 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.58 172.5 11.51 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.944 -170.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.2 mp0 -117.04 137.81 52.01 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.246 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 29.9 tp -61.55 113.09 2.5 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.704 0.801 . . . . 0.0 109.049 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.6 t -107.11 165.45 11.35 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.57 -37.44 62.93 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.202 0.525 . . . . 0.0 111.57 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.14 -35.05 70.93 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.634 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.67 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -71.31 -36.87 71.78 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.756 -175.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.85 -21.84 65.16 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -83.61 6.68 19.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.979 0.895 . . . . 0.0 108.883 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.32 26.3 64.04 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.438 -1.256 . . . . 0.0 113.591 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -92.57 135.02 26.97 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.944 0.372 . . . . 0.0 111.492 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.519 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 35.5 Cg_endo -65.51 109.46 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.323 2.682 . . . . 0.0 112.465 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.9 t -86.97 132.25 32.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.1 m -80.59 132.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.582 0.706 . . . . 0.0 112.67 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.37 -178.92 3.8 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.696 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.58 105.36 0.2 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.826 0.822 . . . . 0.0 111.102 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -111.1 -22.69 11.32 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.416 -170.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 67.1 t -71.2 -27.52 29.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-O 121.362 0.601 . . . . 0.0 111.028 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -96.63 -10.28 27.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.563 0.697 . . . . 0.0 110.538 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.539 ' HB3' HD11 ' A' ' 72' ' ' LEU . 83.2 m-85 -120.43 112.7 19.31 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -123.77 -0.64 8.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.302 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -149.21 127.55 12.19 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.974 -175.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 92.9 t -97.58 115.07 36.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.523 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' SER . 12.7 mmm180 -115.19 -0.38 13.28 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.261 174.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 134' ' ' ARG . 12.0 t 171.98 163.67 0.1 Allowed 'General case' 0 C--O 1.252 1.214 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -155.56 119.88 4.63 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.128 0.489 . . . . 0.0 110.012 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.1 m -108.76 126.92 53.54 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.5 mp -104.38 124.09 58.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -124.36 131.0 53.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.998 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.425 HG22 HG12 ' A' ' 88' ' ' VAL . 26.3 pt -116.02 132.01 66.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.582 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -107.41 -31.08 8.31 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.16 143.7 27.26 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.433 0.635 . . . . 0.0 111.899 -174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.465 ' HA ' ' H ' ' A' ' 86' ' ' LYS . 5.8 m-20 -96.56 163.07 13.19 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.043 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.631 ' OE1' ' HE3' ' A' ' 86' ' ' LYS . 6.4 tp-100 -47.94 -45.73 31.34 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.831 1.252 . . . . 0.0 112.778 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.2 t -122.55 16.2 10.38 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.497 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.44 4.3 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.6 m -96.09 11.87 32.66 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -167.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.319 13.0 pt-20 63.3 -23.5 0.06 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.368 1.867 . . . . 0.0 115.163 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.78 158.93 37.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 27.6 m -121.45 136.93 54.91 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 121.338 -0.145 . . . . 0.0 111.231 -175.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -114.99 134.23 55.36 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 27.5 m -129.71 122.09 54.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.411 0.624 . . . . 0.0 110.013 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 18.3 mm-40 -87.96 -44.73 10.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.054 -176.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.64 111.49 5.07 Favored 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.877 -174.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.415 HG12 HG23 ' A' ' 77' ' ' ILE . 65.9 mt -109.54 125.52 66.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.84 144.46 32.53 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.107 0.48 . . . . 0.0 110.488 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 5.3 mp -106.88 138.16 43.58 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.519 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 98.7 m-85 -125.22 135.34 52.46 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.033 0.444 . . . . 0.0 112.046 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -158.0 -156.97 8.19 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.9 t -153.23 149.44 27.97 Favored 'General case' 0 C--O 1.249 1.054 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.749 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 C--O 1.255 1.355 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.137 174.188 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.244 0.808 0 N-CA-C 111.44 0.163 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -151.74 -63.05 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 0.0 110.229 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.02 -55.82 0.49 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.912 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HA ' HE22 ' A' ' 42' ' ' GLN 0.438 1.5 pm0 40.19 77.44 0.05 Allowed 'General case' 0 C--O 1.236 0.342 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.0 p -150.89 107.53 3.51 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.645 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.05 91.87 0.07 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.252 1.021 . . . . 0.0 111.721 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 p -135.78 133.97 38.49 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.473 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -78.88 77.29 5.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -175.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.408 ' CG1' ' HB2' ' A' ' 15' ' ' ASP . 1.7 mp -93.24 137.6 23.51 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 170.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.28 130.98 26.87 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.484 1.456 . . . . 0.0 110.677 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -69.21 99.17 1.11 Allowed 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.68 -36.38 0.63 Allowed Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.449 ' HA ' ' OG ' ' A' ' 160' ' ' SER . 28.9 mm-40 -120.35 -173.98 2.69 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.4 p -134.41 153.42 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HB2' ' CG1' ' A' ' 9' ' ' ILE . 11.1 t0 -71.42 127.98 34.34 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 20' ' ' ILE . 57.3 mt -76.51 -1.45 27.34 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -174.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.37 -36.03 41.39 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.809 0.814 . . . . 0.0 109.306 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.31 -24.22 66.5 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.001 -175.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -106.52 7.06 30.67 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 16' ' ' LEU . 77.3 mt -85.34 136.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -92.96 115.17 27.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -88.52 10.09 21.53 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.9 m -97.79 -33.8 11.13 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.318 0.58 . . . . 0.0 109.438 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.82 -18.89 53.52 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.945 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG21 HD12 ' A' ' 36' ' ' LEU . 7.1 p -48.61 126.06 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.02 143.84 49.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.805 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 80.2 m -136.47 133.42 36.57 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.037 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -61.13 -40.57 94.32 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.746 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.567 ' HB3' HD12 ' A' ' 60' ' ' LEU . 62.2 t30 -126.65 149.28 49.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.55 ' NE2' ' HB2' ' A' ' 27' ' ' CYS . 4.1 pt20 164.1 -5.63 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 126.791 2.036 . . . . 0.0 107.007 -168.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 30' ' ' GLN . 38.9 t -65.66 -19.61 65.97 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.682 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 m -55.44 16.83 0.0 OUTLIER 'General case' 0 CA--C 1.594 2.642 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.6 t 75.33 -1.05 3.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.17 0.988 . . . . 0.0 113.218 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -125.05 153.0 43.56 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -107.27 167.62 9.79 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.903 -172.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.525 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.1 tm? -57.52 -49.72 92.25 Favored Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.632 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 4.6 Cg_endo -48.98 -25.99 9.56 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.866 2.378 . . . . 0.0 112.879 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.532 ' HA ' HD12 ' A' ' 50' ' ' LEU . 2.1 m-20 -60.93 -31.68 71.21 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.24 0.616 . . . . 0.0 111.607 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.521 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -121.96 23.53 9.96 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.09 0.472 . . . . 0.0 110.329 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 155' ' ' ILE . 0.7 OUTLIER -139.91 -36.7 0.49 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.72 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -78.32 105.98 9.93 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-O 121.237 0.542 . . . . 0.0 111.051 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HG2' ' NH2' ' A' ' 45' ' ' ARG . 0.4 OUTLIER -49.91 118.2 2.74 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.3 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.17 -62.26 0.59 Allowed Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.588 ' HB3' ' HG ' ' A' ' 50' ' ' LEU . 21.7 m-85 -99.03 -11.08 21.82 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.722 -0.281 . . . . 0.0 110.349 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.524 ' NH2' ' HG2' ' A' ' 42' ' ' GLN 0.371 3.4 ppt_? -70.26 -4.69 23.09 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 -170.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -83.33 156.6 22.95 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.367 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.03 145.63 41.28 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 81.86 2.14 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.992 1.717 . . . . 0.0 111.735 -174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.443 ' O ' HD23 ' A' ' 50' ' ' LEU . . . -95.98 -86.01 1.74 Allowed Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 174.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' A' ' 44' ' ' TYR . 7.1 mt -135.24 170.31 16.12 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 171.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.5 p-10 -157.86 152.83 25.42 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-N 119.115 0.87 . . . . 0.0 109.272 174.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.521 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 55.2 tp -87.11 142.58 27.81 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -122.68 148.97 44.67 Favored 'General case' 0 C--N 1.255 -3.505 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.583 ' HB3' ' H ' ' A' ' 150' ' ' THR . 23.3 t -112.75 21.37 15.6 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.648 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.39 84.93 0.27 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.109 0.48 . . . . 0.0 111.116 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 174.29 -44.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 125.778 1.631 . . . . 0.0 107.952 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -140.26 157.62 45.3 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.416 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 148' ' ' GLU . 0.8 OUTLIER -79.17 -25.33 42.8 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -177.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -101.97 151.04 22.59 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.497 0.665 . . . . 0.0 110.705 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.567 HD12 ' HB3' ' A' ' 29' ' ' ASN . 24.2 tp -134.89 131.33 37.2 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 5.6 tt -140.66 127.63 20.68 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.63 132.07 71.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -106.82 122.86 47.23 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.222 0.609 . . . . 0.0 109.537 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -116.83 119.91 34.79 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.981 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -95.92 123.0 0.28 Allowed 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.757 2.304 . . . . 0.0 111.319 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -93.62 155.27 17.38 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.763 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -73.36 -14.76 61.34 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.7 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -157.95 177.72 11.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 29.5 m -89.03 132.4 33.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.728 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.91 171.92 11.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.488 174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -85.35 113.75 21.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.3 tp -68.79 154.48 41.9 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 40.5 t60 -153.49 -67.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 p -142.18 152.44 43.16 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.426 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 42.0 p90 -125.55 155.19 41.04 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.78 116.7 6.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.775 0.321 . . . . 0.0 110.528 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG23 HG12 ' A' ' 155' ' ' ILE . 63.9 mt -119.75 134.41 63.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -123.97 168.51 12.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.028 0.442 . . . . 0.0 110.162 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 153' ' ' GLN . . . 155.83 -167.42 33.18 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.33 134.72 23.27 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 CA-C-N 119.61 1.705 . . . . 0.0 108.547 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.48 -37.37 62.63 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -86.43 -36.43 19.12 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.72 0.16 56.73 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 166.15 33.03 Favored Glycine 0 C--O 1.26 1.726 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.033 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 2.8 Cg_endo -84.24 125.54 3.52 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.853 2.369 . . . . 0.0 111.323 -176.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 32.8 ttpt -91.26 -72.09 0.6 Allowed 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.946 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.4 m -77.93 97.58 5.36 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.105 0.479 . . . . 0.0 110.072 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 140' ' ' ILE . 24.3 m -108.59 139.52 30.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.857 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.484 ' CG ' ' HB3' ' A' ' 139' ' ' PHE . 18.2 ptpt -125.39 155.3 40.59 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 24.6 m-85 -132.07 151.19 51.9 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.553 ' CE2' ' HB ' ' A' ' 137' ' ' THR . 22.5 p90 -154.72 149.94 27.07 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 123.528 0.517 . . . . 0.0 109.838 174.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 27.8 m -127.22 155.77 42.91 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 69.67 -37.93 0.39 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.087 2.155 . . . . 0.0 116.015 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.589 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 1.1 tpmt? -75.19 109.41 8.67 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.135 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -88.03 149.18 24.15 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.819 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 65.52 62.48 0.66 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.271 1.028 . . . . 0.0 109.13 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.3 tpp -134.77 110.13 9.02 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.251 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.476 ' O ' HG13 ' A' ' 102' ' ' VAL . 75.2 m -129.41 -172.22 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -52.13 -29.9 23.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.5 p -88.8 -1.39 58.06 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.967 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -118.29 -32.45 4.66 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.83 0.348 . . . . 0.0 110.104 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 98' ' ' CYS . 31.0 m -58.62 -15.58 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -171.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -93.1 73.57 4.68 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.084 -1.046 . . . . 0.0 110.664 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 172.69 -34.88 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.74 1.216 . . . . 0.0 110.53 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.76 128.31 40.08 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.22 122.58 11.36 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.937 2.425 . . . . 0.0 112.61 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 91' ' ' PHE . 83.2 Cg_endo -82.08 -178.56 4.17 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 122.26 1.974 . . . . 0.0 110.711 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.618 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 18.3 m -76.78 -47.17 22.43 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 110' ' ' THR . 18.7 t70 172.58 -167.1 0.02 OUTLIER 'General case' 0 C--O 1.248 0.999 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.409 ' H ' ' CG ' ' A' ' 109' ' ' ASP . 7.4 t -148.99 143.18 25.95 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.84 12.13 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.77 0.319 . . . . 0.0 110.599 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.695 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 33.5 mt-10 -120.92 140.26 52.09 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 124.227 1.011 . . . . 0.0 110.252 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 57.8 tp -59.58 101.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.078 0.861 . . . . 0.0 110.322 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.515 HG23 ' H ' ' A' ' 117' ' ' ASN . 4.4 t -95.26 164.43 12.85 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.978 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.5 -23.89 59.12 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.616 0.766 . . . . 0.0 110.385 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.515 ' OE2' HG22 ' A' ' 123' ' ' VAL . 31.0 tt0 -71.88 -45.41 61.38 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.515 ' H ' HG23 ' A' ' 114' ' ' THR . 2.3 m120 -65.42 -47.78 75.08 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.951 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.18 -30.84 66.73 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.599 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -92.41 -1.82 56.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.328 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.8 20.49 26.27 Favored Glycine 0 CA--C 1.494 -1.266 0 C-N-CA 120.318 -0.944 . . . . 0.0 114.727 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 1.0 OUTLIER -95.81 134.46 23.98 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.821 177.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 12.7 Cg_exo -70.86 109.83 2.63 Favored 'Trans proline' 0 N--CA 1.441 -1.609 0 C-N-CA 122.426 2.084 . . . . 0.0 111.271 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.515 HG22 ' OE2' ' A' ' 116' ' ' GLU . 94.3 t -87.5 128.24 40.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.7 m -77.56 125.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.164 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.49 175.91 6.5 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.46 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . 0.313 50.0 mtmt -91.48 84.94 5.61 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 122.898 1.332 . . . . 0.0 113.782 -175.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.54 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 36.2 p90 -87.94 19.16 3.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.848 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 m -60.01 -29.1 42.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -107.22 10.72 29.85 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.434 174.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.618 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 91.4 m-85 -123.47 86.28 2.55 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.377 0.608 . . . . 0.0 112.074 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -105.63 -9.19 17.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' HB2' ' HB ' ' A' ' 69' ' ' VAL . 3.6 p-10 -144.08 113.69 7.1 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.813 0.816 . . . . 0.0 111.304 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 65.9 t -122.53 120.65 61.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.032 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.453 ' HB2' HG12 ' A' ' 69' ' ' VAL . 43.1 ttp180 -103.0 -38.92 7.13 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.1 m -120.72 134.0 55.31 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.3 tp -126.02 140.24 52.77 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.553 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 22.8 m -134.21 131.36 38.46 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 3.0 mp -111.7 128.04 68.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HB3' ' CG ' ' A' ' 89' ' ' LYS . 51.6 t80 -122.76 126.31 47.21 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.556 HG12 ' H ' ' A' ' 60' ' ' LEU . 24.2 pt -95.42 129.2 45.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 117.98 -1.488 . . . . 0.0 107.505 172.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -93.92 -24.03 17.85 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.214 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -166.2 142.76 5.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.084 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -90.82 161.79 15.12 Favored 'General case' 0 CA--C 1.486 -1.513 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.488 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 6.8 tp-100 -46.23 -44.86 16.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.058 0.943 . . . . 0.0 112.227 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.5 p -124.42 9.87 8.51 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.298 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 59.62 70.62 0.95 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -171.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 149' ' ' VAL . 22.8 t -86.7 -10.11 54.45 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.921 -165.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 40.0 mt-10 66.9 -44.6 0.45 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.291 0.637 . . . . 0.0 110.869 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 147' ' ' SER . 3.3 p -119.34 96.97 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-O 122.386 1.089 . . . . 0.0 109.197 175.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.583 ' H ' ' HB3' ' A' ' 54' ' ' SER . 31.1 m -82.15 119.65 24.32 Favored 'General case' 0 C--N 1.273 -2.75 0 CA-C-N 114.002 -1.454 . . . . 0.0 108.587 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.16 132.36 35.51 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.511 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.3 t -119.71 115.49 47.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.035 -175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.477 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 53.3 tt0 -71.69 -63.7 1.07 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -160.48 145.19 14.38 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.375 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.501 ' O ' HD22 ' A' ' 40' ' ' LEU . 78.3 mt -120.5 114.64 44.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.32 160.81 36.23 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.94 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 6.7 tt -147.23 140.43 25.28 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.466 ' N ' HD23 ' A' ' 157' ' ' LEU . 76.9 m-85 -114.67 141.91 47.17 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.333 0.587 . . . . 0.0 110.19 -175.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -156.89 -165.3 14.65 Favored Glycine 0 N--CA 1.418 -2.503 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 13' ' ' GLN . 75.4 m -164.72 167.42 19.03 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.993 0.897 . . . . 0.0 109.046 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.264 -3.138 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.756 175.204 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 C--O 1.237 0.413 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -79.14 122.74 26.64 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.9 95.18 10.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.637 -177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 63.0 -166.28 0.23 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.013 0.821 . . . . 0.0 109.955 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.4 p -134.98 83.57 2.03 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-O 121.521 0.677 . . . . 0.0 109.472 174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.49 117.02 25.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.286 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 m -81.17 76.75 8.11 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.649 0.737 . . . . 0.0 111.066 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -116.06 -25.03 7.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.406 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 mp -70.38 119.96 75.54 Favored Pre-proline 0 N--CA 1.441 -0.896 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.241 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.26 178.73 7.12 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.762 2.308 . . . . 0.0 111.827 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -97.75 101.5 13.02 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.48 -39.68 0.7 Allowed Glycine 0 C--N 1.303 -1.292 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.543 ' HG3' ' OG ' ' A' ' 74' ' ' SER . 1.4 pm0 -135.48 149.37 49.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.818 0.847 . . . . 0.0 109.766 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 4.4 m -111.37 170.41 3.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 123.431 0.457 . . . . 0.0 110.501 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.0 98.64 0.78 Allowed 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.457 1.122 . . . . 0.0 110.285 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 16' ' ' LEU . 2.4 tm? -55.72 -23.81 31.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.267 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.9 tt -53.0 -35.95 59.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.311 1.044 . . . . 0.0 110.986 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.0 -20.45 61.01 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.465 -177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -94.65 22.33 6.39 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.096 0.474 . . . . 0.0 110.964 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.4 131.46 47.89 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' PHE . 20.9 t70 -80.13 -23.54 41.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.219 0.533 . . . . 0.0 111.185 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' A' ' 40' ' ' LEU . 97.3 m95 67.43 10.22 7.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.1 p -87.1 10.82 15.48 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.278 0.561 . . . . 0.0 110.768 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.04 -88.35 0.13 Allowed Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' H ' ' HD3' ' A' ' 65' ' ' PRO 0.276 11.0 p 43.9 75.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.196 1.399 . . . . 0.0 113.002 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -119.72 151.16 39.19 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.596 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 49.2 t -136.6 130.96 33.09 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' HD13 ' A' ' 28' ' ' LEU . 2.7 tm? -45.58 -63.34 0.98 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.724 1.209 . . . . 0.0 112.38 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -90.2 -57.76 2.74 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 34.2 tt0 69.51 -78.56 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 124.782 1.233 . . . . 0.0 107.889 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 35.7 t 176.35 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -53.29 -20.09 3.9 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -130.63 -34.07 1.58 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.559 ' O ' ' HB3' ' A' ' 31' ' ' SER . 94.5 m-70 -93.39 163.92 13.41 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.983 -0.448 . . . . 0.0 111.853 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.9 m -122.96 150.27 43.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.477 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 53.1 tp -70.49 -48.87 17.01 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 7.7 Cg_endo -48.23 -28.04 10.5 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.584 2.19 . . . . 0.0 113.003 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.2 m-20 -66.29 -29.38 69.59 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.912 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -116.06 6.07 13.98 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.712 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.504 HD12 ' CH2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -104.41 -43.76 5.1 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 18.6 ptpt -90.53 148.1 22.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.656 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 20.5 mm-40 -81.64 144.62 31.08 Favored 'General case' 0 CA--C 1.473 -2.002 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.607 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 121.72 -50.38 0.84 Allowed Glycine 0 N--CA 1.397 -3.927 0 C-N-CA 119.115 -1.517 . . . . 0.0 111.013 -171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.58 ' O ' HD11 ' A' ' 50' ' ' LEU . 96.8 m-85 -92.97 -10.47 36.25 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -55.86 25.98 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.075 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -95.08 102.09 13.88 Favored 'General case' 0 C--N 1.282 -2.347 0 O-C-N 121.453 -0.779 . . . . 0.0 110.347 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -69.35 97.86 1.01 Allowed 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.249 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -156.75 -80.45 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.31 1.444 . . . . 0.0 110.226 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -90.23 -26.21 24.26 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 44' ' ' TYR . 2.3 pp -126.31 137.17 53.46 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.221 -0.49 . . . . 0.0 109.798 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 30.1 p-10 -163.77 166.77 21.7 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.503 ' HB3' ' CG2' ' A' ' 152' ' ' VAL . 40.4 tp -103.84 106.87 17.51 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 117.754 -1.578 . . . . 0.0 108.515 171.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -127.66 134.7 49.62 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.847 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 62.4 p -64.96 160.69 20.14 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.383 0.427 . . . . 0.0 110.243 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -123.84 -78.82 0.6 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.544 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.76 -14.76 36.36 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.742 0.306 . . . . 0.0 111.258 -177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' SER . 32.0 t70 -156.05 148.98 24.17 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.229 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.475 ' HB2' HD21 ' A' ' 143' ' ' ASN . 0.0 OUTLIER -99.96 14.17 31.44 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -174.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -83.71 119.22 24.52 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.437 0.637 . . . . 0.0 110.152 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.529 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 3.8 mm? -115.46 107.34 15.05 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 121.558 0.694 . . . . 0.0 111.32 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 6.3 tt -116.76 115.46 25.64 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.2 mt -113.42 136.59 49.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 123.328 0.651 . . . . 0.0 111.113 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 95' ' ' GLU . 93.4 t80 -107.94 123.97 49.43 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -108.08 115.52 58.37 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.298 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HD3' ' H ' ' A' ' 25' ' ' VAL . 63.6 Cg_endo -77.83 142.8 20.36 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.706 2.27 . . . . 0.0 109.53 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.437 ' HD1' ' H ' ' A' ' 66' ' ' PHE . 2.2 p90 -101.68 162.04 13.2 Favored 'General case' 0 CA--C 1.472 -2.05 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -167.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -91.99 -50.9 5.46 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.869 -2.423 . . . . 0.0 108.482 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -156.57 177.93 10.91 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.222 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -84.73 124.03 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.414 HD11 HD21 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.92 174.11 13.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -92.93 115.72 28.38 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 125' ' ' LEU . 1.1 tm? -73.81 124.23 25.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -120.38 -49.94 2.24 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.911 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.543 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 50.3 p -143.95 161.76 37.89 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -175.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -134.99 152.9 52.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -146.82 115.95 6.95 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.08 0.467 . . . . 0.0 111.305 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.466 ' HB ' HD11 ' A' ' 113' ' ' LEU . 69.1 mt -123.63 128.46 74.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . 4.7 tmtt? -112.26 120.5 41.94 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.409 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -149.25 -172.99 19.46 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -66.36 -175.7 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.83 2.353 . . . . 0.0 111.48 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -71.67 -56.88 4.99 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 114.263 1.209 . . . . 0.0 114.263 -173.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.28 -18.13 20.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.297 0.57 . . . . 0.0 112.135 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -87.52 15.68 6.38 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.486 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.53 156.98 16.0 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.451 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 32.2 Cg_exo -62.68 153.26 73.3 Favored 'Trans proline' 0 C--O 1.204 -1.192 0 C-N-CA 122.095 1.863 . . . . 0.0 110.16 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 37.2 ttpt -126.27 -65.41 0.98 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.868 -0.52 . . . . 0.0 110.377 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.9 m -75.75 101.74 5.16 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.24 0.543 . . . . 0.0 110.464 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 86' ' ' LYS . 52.5 t -106.02 130.52 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.103 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -130.61 151.84 50.64 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 123.769 0.828 . . . . 0.0 110.139 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' A' ' 125' ' ' LEU . 14.0 m-85 -136.0 160.71 37.8 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.178 -173.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -144.35 116.69 8.51 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.45 ' HB2' HG22 ' A' ' 133' ' ' VAL . 21.8 p -84.24 14.6 4.18 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.89 1.276 . . . . 0.0 114.342 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -147.05 172.22 14.07 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 122.061 -0.4 . . . . 0.0 110.133 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HB2' ' NZ ' ' A' ' 94' ' ' LYS . 3.4 ttmp? 69.94 145.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 63' ' ' TYR . 10.4 pt-20 -102.81 138.25 39.95 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.467 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m80 55.82 72.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.507 0.723 . . . . 0.0 112.489 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.48 ' HB3' HG21 ' A' ' 137' ' ' THR . 12.6 tpt -90.85 94.15 9.53 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 28.5 p -79.03 154.06 29.76 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.772 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.567 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 72.9 t80 -57.36 -23.23 47.74 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.7 t -79.71 -11.97 59.82 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.943 -0.473 . . . . 0.0 110.637 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -124.36 -13.31 7.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.323 0.583 . . . . 0.0 110.61 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.567 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 6.4 p -62.9 -30.06 48.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.483 0 C-N-CA 124.451 1.1 . . . . 0.0 112.129 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -109.03 -1.66 18.75 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.331 0.586 . . . . 0.0 111.098 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -82.65 -40.24 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -100.63 139.38 20.55 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.3 140.95 94.45 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.86 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.66 179.1 5.97 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 122.771 2.314 . . . . 0.0 110.747 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.725 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 44.8 m -79.56 -49.13 12.67 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.442 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -162.0 -179.6 7.26 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -153.27 150.49 29.0 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.73 169.21 18.2 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.495 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 5.6 tp10 -126.18 106.64 9.7 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.1 tt -73.05 122.57 21.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.7 p -122.04 -176.58 3.37 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.643 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 1.6 mp0 -51.77 -36.34 47.11 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 125.118 1.367 . . . . 0.0 109.813 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.505 ' CG ' ' HD2' ' A' ' 121' ' ' LYS . 40.4 tt0 -64.56 -38.78 92.21 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.271 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.443 HD22 ' CG2' ' A' ' 123' ' ' VAL . 23.8 t-20 -71.0 -38.28 72.67 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.81 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.44 -14.42 60.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.55 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -84.52 -1.69 56.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.555 0.693 . . . . 0.0 109.687 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.39 27.47 20.24 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.602 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.505 ' HD2' ' CG ' ' A' ' 116' ' ' GLU . 96.6 mttt -99.81 142.49 24.72 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 117.271 0.536 . . . . 0.0 111.146 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 39.6 Cg_endo -73.83 103.78 1.71 Allowed 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 121.897 1.731 . . . . 0.0 109.313 170.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.443 ' CG2' HD22 ' A' ' 117' ' ' ASN . 78.9 t -84.58 127.34 39.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.748 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.68 101.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 173.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.652 ' HG ' ' H ' ' A' ' 126' ' ' LYS . 0.2 OUTLIER -54.57 -71.53 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.293 178.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.652 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 80.1 tttt -171.47 165.39 6.96 Favored 'General case' 0 N--CA 1.401 -2.901 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -144.31 24.8 1.58 Allowed 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.689 -171.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.91 -47.24 13.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.725 ' HB3' ' O ' ' A' ' 108' ' ' SER . 8.8 tmtt? -111.29 -9.12 14.3 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.694 -166.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.406 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 39.7 p90 -60.51 10.2 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.927 0 O-C-N 121.497 -0.752 . . . . 0.0 112.94 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 129' ' ' LYS . 79.9 mm-40 -59.7 119.42 7.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.217 0.532 . . . . 0.0 111.279 -166.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.355 0.2 OUTLIER 59.54 113.74 0.01 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 128.078 2.551 . . . . 0.0 112.997 -170.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 92' ' ' SER . 63.3 t -102.3 110.15 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.892 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 134' ' ' ARG . 31.8 mmt180 -88.75 -31.5 18.38 Favored 'General case' 0 C--O 1.19 -2.077 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.575 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.4 m -160.86 164.09 31.56 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 tp -126.86 118.82 25.37 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 117.684 -1.607 . . . . 0.0 112.889 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 97' ' ' MET . 91.7 m -103.03 123.87 47.44 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 173.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.12 109.85 30.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 141' ' ' GLU . 53.1 t80 -114.5 111.72 21.83 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.407 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.529 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 1.8 pp -104.53 131.44 53.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.1 pt-20 -112.37 -2.27 14.82 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.06 142.16 5.92 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.311 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.475 HD21 ' HB2' ' A' ' 58' ' ' GLU . 38.4 m-80 -83.67 177.76 8.25 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.809 0.693 . . . . 0.0 109.864 173.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 2.4 mp0 -50.11 -58.53 5.34 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.4 m -119.64 -22.31 6.96 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.954 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.01 67.43 1.38 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 41.9 m -84.37 16.33 3.14 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 123.445 0.698 . . . . 0.0 112.305 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 73.48 -52.15 0.7 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.652 1.181 . . . . 0.0 111.078 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.18 106.09 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.014 0.912 . . . . 0.0 111.397 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.0 m -82.68 116.26 21.98 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.465 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -104.29 133.97 48.31 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.503 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 30.5 m -132.96 128.15 56.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.201 0.524 . . . . 0.0 109.609 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -84.41 -33.79 23.67 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -166.38 141.46 4.47 Favored 'General case' 0 C--O 1.252 1.232 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.164 176.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.419 HG23 HG12 ' A' ' 77' ' ' ILE . 71.9 mt -121.6 111.98 33.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.49 124.58 21.56 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.5 mp -102.47 159.4 15.47 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 83.8 m-85 -125.37 113.44 17.56 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.15 0.5 . . . . 0.0 109.939 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.62 167.2 12.25 Favored Glycine 0 CA--C 1.492 -1.405 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.0 m -120.34 132.98 55.52 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 117.39 0.595 . . . . 0.0 110.55 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 C--N 1.281 -2.374 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.832 173.256 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 C--O 1.237 0.44 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.516 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 20.1 m -96.82 9.44 41.8 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.805 0.812 . . . . 0.0 110.134 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.03 1.75 46.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.934 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -108.14 105.72 15.59 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.1 p -101.75 91.63 4.48 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.481 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.22 92.24 4.43 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.563 0.697 . . . . 0.0 110.844 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m -122.42 148.91 44.54 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.567 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -91.16 98.84 11.99 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.572 HG13 ' HB2' ' A' ' 15' ' ' ASP . 2.6 mp -86.7 123.11 71.26 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.016 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.56 159.4 19.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.602 2.201 . . . . 0.0 110.421 176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -83.81 101.9 11.95 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.834 0.826 . . . . 0.0 111.961 -177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.96 -30.77 2.34 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.205 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -121.96 170.15 10.1 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 122.281 -0.54 . . . . 0.0 110.783 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.94 143.01 18.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.228 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.572 ' HB2' HG13 ' A' ' 9' ' ' ILE . 11.8 t70 -71.95 127.43 32.53 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 120.86 0.362 . . . . 0.0 110.108 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 19' ' ' PHE . 33.2 mt -101.33 3.47 40.68 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 42' ' ' GLN . 3.1 tm? -73.06 -35.33 66.67 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.165 0.983 . . . . 0.0 108.541 -177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.94 -9.83 54.7 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.044 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 92.0 t80 -97.77 14.26 27.57 Favored 'General case' 0 N--CA 1.416 -2.144 0 C-N-CA 124.766 1.226 . . . . 0.0 110.977 -172.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 80.7 mt -88.84 142.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.489 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -93.9 120.24 33.89 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -92.93 7.9 42.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.7 m -103.64 -12.11 17.25 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.258 0.552 . . . . 0.0 110.836 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.95 -18.53 5.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.396 -0.906 . . . . 0.0 113.578 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.75 129.5 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -123.9 142.93 50.7 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.776 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' ' NE2' ' A' ' 30' ' ' GLN . 9.3 p -131.87 119.7 21.55 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.536 -175.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 3.8 mm? -94.41 132.34 39.15 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.222 0.534 . . . . 0.0 110.214 176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' A' ' 56' ' ' ALA . 64.0 t30 68.65 -70.97 0.12 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 126.945 2.098 . . . . 0.0 110.186 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' OE1' ' HA ' ' A' ' 35' ' ' SER . 8.1 tt0 63.31 -168.93 0.2 Allowed 'General case' 0 C--N 1.372 1.573 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -172.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.661 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 41.5 t -93.39 123.42 36.68 Favored 'General case' 0 C--N 1.251 -3.714 0 O-C-N 120.449 -1.407 . . . . 0.0 108.477 173.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -57.93 -17.46 16.95 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.891 170.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -100.16 -43.6 6.26 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.661 ' O ' ' HB3' ' A' ' 31' ' ' SER . 83.4 m-70 -122.06 151.97 40.31 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 122.05 -0.406 . . . . 0.0 110.745 -176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.542 ' HA ' ' OE1' ' A' ' 30' ' ' GLN . 49.0 m -87.98 160.89 17.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.72 -49.47 2.1 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.68 -23.99 28.22 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.072 1.848 . . . . 0.0 111.284 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.566 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.2 m-20 -58.91 -27.68 65.48 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 125.636 1.574 . . . . 0.0 111.453 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB2' ' H ' ' A' ' 52' ' ' LEU . . . -123.7 8.41 8.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.983 0.421 . . . . 0.0 110.954 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.1 tp -118.36 -47.71 2.54 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.649 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -83.0 130.81 35.18 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.81 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.419 ' HG2' HH21 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -67.94 123.26 20.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 2' ' ' SER . . . 135.43 -47.49 0.98 Allowed Glycine 0 N--CA 1.419 -2.445 0 N-CA-C 108.084 -2.007 . . . . 0.0 108.084 -174.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -93.93 -44.37 8.11 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.419 HH21 ' HG2' ' A' ' 42' ' ' GLN . 58.9 ttp85 -54.97 101.96 0.06 Allowed 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.389 -176.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 178.45 125.07 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.696 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 18.5 t70 -68.07 85.36 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.696 ' HG3' ' O ' ' A' ' 47' ' ' ASP . 35.3 mt-10 -173.1 108.08 0.16 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 127.227 2.211 . . . . 0.0 110.137 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.27 -52.87 4.11 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.996 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.566 ' HB2' HD22 ' A' ' 38' ' ' ASN . 1.3 pt? -133.44 127.77 34.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 122.737 -0.273 . . . . 0.0 110.405 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' A' ' 153' ' ' GLN . 6.7 t30 -161.35 153.32 19.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.46 ' H ' ' HB2' ' A' ' 39' ' ' ALA . 2.8 tm? -85.32 110.25 18.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 119.443 -0.903 . . . . 0.0 108.941 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' THR . 12.6 pt-20 -132.31 112.65 12.4 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.5 p -59.95 137.37 58.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -141.74 85.42 1.94 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.519 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . 164.94 -50.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.155 1.782 . . . . 0.0 107.129 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -147.7 155.71 42.02 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.085 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -85.08 -25.2 27.72 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -77.0 130.83 38.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.738 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' HG13 ' A' ' 140' ' ' ILE . 96.8 mt -133.88 143.07 48.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.622 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 28' ' ' LEU . 1.5 tm? -135.08 119.47 17.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.8 mp -123.85 129.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -105.63 122.84 46.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.24 113.02 39.3 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.685 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -90.27 125.33 1.21 Allowed 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 122.58 2.186 . . . . 0.0 108.835 168.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.465 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 90.3 m-85 -87.92 158.17 18.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -59.69 -51.75 68.44 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.251 178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -125.41 173.23 9.02 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.087 -0.383 . . . . 0.0 109.981 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.47 117.32 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 120.908 0.385 . . . . 0.0 110.501 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -132.87 172.61 16.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -96.83 136.23 37.68 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 130' ' ' PHE . 82.6 mt -76.01 146.63 39.36 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 27.6 t60 -124.83 -50.54 1.71 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.201 0.524 . . . . 0.0 109.707 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 p -139.46 163.37 32.7 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.959 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 49.7 p90 -136.23 154.47 50.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -149.81 106.39 3.52 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.502 0.668 . . . . 0.0 111.529 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -119.13 131.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.543 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 53.6 mtpt -121.16 161.82 21.17 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.05 0.452 . . . . 0.0 111.716 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -179.07 -169.18 39.28 Favored Glycine 0 N--CA 1.41 -3.072 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' CG ' ' HD2' ' A' ' 151' ' ' LYS . 14.2 Cg_exo -73.37 166.47 29.8 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.937 2.424 . . . . 0.0 111.157 175.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 118' ' ' LEU . 13.3 pt-20 -58.66 -41.48 86.21 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -173.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -96.12 -26.26 15.55 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -92.53 11.29 26.88 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.891 -169.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.21 146.13 18.15 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.778 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 22.7 Cg_exo -67.05 110.05 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.332 2.021 . . . . 0.0 111.356 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.517 ' HB2' HE21 ' A' ' 144' ' ' GLN . 0.8 OUTLIER -82.84 -39.67 21.36 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.925 -176.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.1 m -103.44 112.01 24.7 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.131 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m -113.84 130.2 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.015 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -117.29 146.28 43.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -130.74 149.22 52.48 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 65.6 t80 -143.42 115.77 8.52 Favored 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.494 169.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 135' ' ' SER . 48.9 m -102.36 153.73 19.73 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.677 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.2 m120 81.44 145.2 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.052 1.341 . . . . 0.0 108.573 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 72.9 116.0 0.05 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.414 0.626 . . . . 0.0 111.114 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.57 149.74 29.81 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.689 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.267 13.9 p-80 50.31 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 88.1 mtp -139.6 142.08 37.11 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 22.8 p -120.06 174.08 6.69 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -69.84 -18.86 63.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.3 p -77.72 -21.72 51.48 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -130.35 18.75 5.34 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.3 p -69.72 -32.28 51.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.177 0.513 . . . . 0.0 110.717 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -97.27 73.53 2.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.637 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -124.41 -4.17 7.83 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -139.24 156.51 71.95 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 113.648 -1.615 . . . . 0.0 106.862 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.83 140.93 21.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.117 1.212 . . . . 0.0 109.589 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.72 153.52 36.1 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 122.42 2.08 . . . . 0.0 111.861 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.419 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 31.8 m -62.09 -44.8 95.88 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.717 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -169.56 166.78 9.98 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -139.24 139.71 37.52 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.4 172.71 11.57 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.673 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 37.2 tt0 -122.61 134.54 54.51 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 34.0 tp -62.99 108.58 1.24 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.701 0.626 . . . . 0.0 109.713 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 28.5 m -82.23 156.85 24.17 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -54.27 -39.58 67.0 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.191 0.596 . . . . 0.0 111.046 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' HB3' ' HD3' ' A' ' 121' ' ' LYS . 44.9 mt-10 -70.94 -31.47 68.07 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.244 0.618 . . . . 0.0 112.231 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.627 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.7 t-20 -62.56 -39.68 94.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 118' ' ' LEU . 7.5 tt -71.99 -7.62 49.79 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.498 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 45.2 mmtm -104.3 -14.15 15.89 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 121.761 -0.587 . . . . 0.0 110.136 176.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.543 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 127.59 -14.43 6.43 Favored Glycine 0 CA--C 1.485 -1.829 0 C-N-CA 119.926 -1.131 . . . . 0.0 114.005 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 53.8 mtpt -74.88 133.36 76.13 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 35.8 Cg_exo -64.15 116.99 4.04 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.541 2.828 . . . . 0.0 111.707 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.56 135.7 26.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 32.7 m -82.92 131.29 34.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 C-N-CA 119.529 -0.869 . . . . 0.0 111.16 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.38 177.47 5.03 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.809 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -91.6 96.49 10.49 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 130' ' ' PHE . 1.0 OUTLIER -80.08 21.83 0.55 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.89 -13.58 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -123.09 21.06 9.82 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.365 0.602 . . . . 0.0 110.668 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.636 ' CD2' HD12 ' A' ' 72' ' ' LEU . 96.3 m-85 -122.62 27.01 8.02 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.444 -173.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -63.22 -35.59 80.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -129.16 115.51 17.79 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.28 0.562 . . . . 0.0 109.805 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.476 HG21 ' HG ' ' A' ' 72' ' ' LEU . 47.4 t -121.15 104.47 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.515 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -108.27 -44.04 4.22 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 170.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 92' ' ' SER . 32.9 t -104.91 130.78 53.0 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 113.651 -1.613 . . . . 0.0 108.943 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.3 tp -137.87 104.23 5.21 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.137 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 42.5 m -92.3 115.42 28.07 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.74 122.73 58.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -121.53 127.71 51.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.897 0.38 . . . . 0.0 110.439 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 60' ' ' LEU . 12.0 pt -133.29 116.44 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.18 -31.47 4.11 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.378 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.77 126.45 52.64 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -102.83 -174.84 2.65 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.709 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.517 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.2 mp0 -56.4 -66.51 0.42 Allowed 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.6 t -120.14 9.27 11.09 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.969 -0.692 . . . . 0.0 112.545 -173.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.27 93.21 0.2 Allowed Glycine 0 C--O 1.219 -0.803 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 23.4 t -111.99 -1.86 15.27 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 147' ' ' SER . 10.2 pt-20 68.0 -40.85 0.43 Allowed 'General case' 0 N--CA 1.517 2.884 0 C-N-CA 126.764 2.026 . . . . 0.0 111.344 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.1 p -102.53 113.28 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.4 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 43.7 m -92.92 125.64 37.62 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.423 ' HD2' ' CG ' ' A' ' 80' ' ' PRO . 39.2 ttmt -123.52 133.67 53.98 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.5 120.02 31.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.008 0.432 . . . . 0.0 111.117 -176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.472 ' HA ' ' OD1' ' A' ' 51' ' ' ASN . 4.7 pt20 -93.21 -6.24 48.17 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.675 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' CB ' ' HD2' ' A' ' 45' ' ' ARG . 38.5 pttt -172.11 144.81 1.7 Allowed 'General case' 0 CA--C 1.494 -1.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.28 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.84 109.97 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 165.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.64 134.08 29.91 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 5.5 mp -117.85 156.29 28.64 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -123.14 127.97 49.42 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -135.22 -163.92 10.25 Favored Glycine 0 C--N 1.302 -1.329 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.381 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.6 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.1 t -142.18 143.29 32.87 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 117.428 0.614 . . . . 0.0 109.715 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 70' ' ' ILE . 41.0 p . . . . . 0 N--CA 1.433 -1.286 0 CA-C-O 118.738 -0.649 . . . . 0.0 110.045 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 CA--C 1.508 -0.639 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -142.78 79.38 1.65 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.383 0.611 . . . . 0.0 109.715 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.84 87.45 2.29 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.225 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -134.43 140.44 46.26 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.9 t -73.37 107.11 5.48 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.515 0.674 . . . . 0.0 110.644 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.62 15.07 30.33 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -96.78 144.6 26.61 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -110.0 95.28 5.49 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.855 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 mp -77.27 116.48 57.99 Favored Pre-proline 0 C--N 1.303 -1.441 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.704 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.24 144.0 14.36 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 C-N-CA 121.971 1.781 . . . . 0.0 110.451 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.12 105.68 1.44 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.543 0.687 . . . . 0.0 110.214 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.79 -23.28 3.98 Favored Glycine 0 N--CA 1.42 -2.378 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.38 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -129.83 174.89 9.3 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.21 145.05 34.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -77.84 130.33 36.52 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.501 HD11 ' CD1' ' A' ' 70' ' ' ILE . 4.1 mm? -68.15 -8.85 42.07 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.822 0.849 . . . . 0.0 113.277 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 42' ' ' GLN . 2.0 tm? -55.51 -34.06 64.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.26 -25.94 64.52 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.057 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.78 22.84 15.17 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -172.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.45 133.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -97.9 105.84 18.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -75.09 -13.44 60.48 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 m -73.87 -22.23 59.81 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.838 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 6.4 13.76 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.574 -1.298 . . . . 0.0 114.387 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -65.14 136.91 25.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 CA-C-N 117.838 0.819 . . . . 0.0 110.176 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.8 tp10 -152.17 148.14 27.26 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.093 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.8 t -135.89 123.82 22.73 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 172.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.63 -44.71 96.47 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.693 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -88.69 -94.23 0.1 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.587 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 59.6 11.69 2.49 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.722 0.772 . . . . 0.0 109.996 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.6 m -83.56 -12.93 55.53 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -170.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 3.0 m -50.25 -47.83 54.99 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.5 m 153.14 -55.21 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 C-N-CA 127.967 2.507 . . . . 0.0 108.372 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 80.1 m-70 -67.96 149.26 49.98 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.1 m -108.13 -175.84 2.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -171.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.519 HD23 HD22 ' A' ' 52' ' ' LEU . 2.4 tm? -90.84 -49.18 0.35 Allowed Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.693 0.797 . . . . 0.0 112.431 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 31.2 Cg_exo -62.38 -2.0 2.89 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.931 2.421 . . . . 0.0 114.46 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.432 ' HB2' HD13 ' A' ' 50' ' ' LEU . 34.8 p30 -84.02 -48.61 9.75 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.458 -0.497 . . . . 0.0 112.219 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.38 -2.5 57.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.204 0.526 . . . . 0.0 111.45 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 35.3 tp -109.23 -9.12 15.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.263 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 5.8 tmtt? -89.7 133.29 34.74 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.443 ' HB2' HD11 ' A' ' 17' ' ' LEU . 6.4 tp-100 -54.58 133.21 46.32 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.78 -34.56 2.1 Favored Glycine 0 N--CA 1.413 -2.886 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.8 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.66 -20.77 45.86 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 117.657 0.728 . . . . 0.0 109.944 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 18.03 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.67 109.33 3.26 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -73.19 117.58 15.1 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -171.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 175.3 -81.39 0.0 OUTLIER 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.547 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -68.26 -33.1 77.16 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 50' ' ' LEU . 3.9 pp -119.66 126.69 51.76 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 8.1 p30 -163.54 167.26 21.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.519 HD22 HD23 ' A' ' 36' ' ' LEU . 48.1 tp -94.56 103.78 15.73 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 150' ' ' THR . 11.7 pt-20 -124.67 159.77 30.06 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.729 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.485 ' HA ' ' OG ' ' A' ' 32' ' ' SER . 86.9 p -95.74 -174.29 3.1 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.816 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 t70 175.03 -48.41 0.01 OUTLIER 'General case' 0 CA--C 1.467 -2.245 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.34 35.73 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.148 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.552 ' OD1' ' HG2' ' A' ' 59' ' ' GLN . 10.6 t70 -157.44 146.97 20.19 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 176.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -59.18 -31.53 69.09 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.955 0.902 . . . . 0.0 112.49 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.552 ' HG2' ' OD1' ' A' ' 57' ' ' ASP . 3.9 pt20 -86.91 126.74 34.88 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.121 0.962 . . . . 0.0 111.949 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' HD11 ' A' ' 140' ' ' ILE . 54.5 mt -131.07 120.73 23.83 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.343 -173.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -96.96 119.77 36.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.81 128.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 26' ' ' GLU . 8.6 t80 -109.84 117.91 35.08 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.1 mt -122.55 114.0 30.33 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-O 120.515 0.198 . . . . 0.0 111.37 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -89.33 141.18 4.0 Favored 'Trans proline' 0 N--CA 1.439 -1.696 0 C-N-CA 121.998 1.798 . . . . 0.0 109.881 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -103.93 150.87 23.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.597 0.713 . . . . 0.0 112.638 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -55.35 -45.61 76.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.179 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -153.98 163.16 40.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.7 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.81 127.61 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-O 121.901 0.858 . . . . 0.0 111.748 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.501 ' CD1' HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -128.3 172.1 15.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 177.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -96.28 114.18 25.84 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 157' ' ' LEU . 53.2 tp -73.27 154.47 40.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.541 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 31.3 t60 -139.16 -38.17 0.5 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.785 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.1 p -153.97 169.73 22.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.477 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -141.29 155.17 46.01 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -149.65 100.2 2.95 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.868 0.366 . . . . 0.0 111.934 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.446 HG23 HG12 ' A' ' 155' ' ' ILE . 56.8 mt -106.24 136.58 40.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HB3' ' OE1' ' A' ' 153' ' ' GLN . 90.1 mttt -112.06 150.96 29.94 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.991 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 118' ' ' LEU . . . -166.56 168.01 39.85 Favored Glycine 0 N--CA 1.41 -3.041 0 N-CA-C 107.634 -2.187 . . . . 0.0 107.634 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 83' ' ' GLU . 32.5 Cg_exo -62.22 151.94 79.2 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.892 1.728 . . . . 0.0 111.117 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' HG2' ' HG3' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -54.64 -39.78 68.32 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 123.346 0.659 . . . . 0.0 111.62 -178.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.428 ' HG3' ' HG2' ' A' ' 81' ' ' GLU . 45.6 mt-10 -94.48 -44.0 8.09 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 80' ' ' PRO . 37.5 tt0 -101.56 18.95 18.94 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.692 -166.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.93 178.87 36.45 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.163 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.412 ' HG2' HD22 ' A' ' 113' ' ' LEU . 35.5 Cg_endo -73.5 -179.88 4.9 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 119.765 1.782 . . . . 0.0 110.439 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.56 ' HG2' ' OE2' ' A' ' 112' ' ' GLU . 23.0 ttpp -154.98 -71.23 0.12 Allowed 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.863 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.4 m -85.74 118.19 25.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.261 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.595 HG12 HG22 ' A' ' 140' ' ' ILE . 23.0 m -118.28 137.19 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.762 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -110.95 133.87 53.03 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -113.97 145.3 41.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -135.37 114.96 12.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 171.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.0 p -94.42 133.81 37.61 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.26 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.7 OUTLIER 74.35 175.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.411 1.084 . . . . 0.0 111.357 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.578 ' N ' ' HE3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER 72.82 127.8 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.819 0.819 . . . . 0.0 110.902 -176.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HA ' ' OH ' ' A' ' 63' ' ' TYR . 3.6 mp0 -93.89 146.68 23.73 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.948 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 46.1 m80 69.91 98.14 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.955 1.302 . . . . 0.0 111.948 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 92.5 mmm -139.26 142.54 37.78 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.004 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.542 ' O ' HG23 ' A' ' 102' ' ' VAL . 26.4 p -144.78 169.73 17.47 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.61 -30.5 68.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.276 0.489 . . . . 0.0 112.072 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 t -63.54 -24.26 67.74 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 120.689 0.28 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.432 ' O ' ' HD1' ' A' ' 105' ' ' PHE . 92.8 m-20 -98.6 -23.11 15.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.945 0.402 . . . . 0.0 111.315 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 98' ' ' CYS . 56.0 t -58.53 -32.09 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.718 0.807 . . . . 0.0 112.271 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -75.85 -15.59 60.2 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -113.44 -15.89 12.53 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.699 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.432 ' HD1' ' O ' ' A' ' 101' ' ' ASN . 79.3 m-85 -96.75 148.05 33.85 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -82.56 139.81 10.31 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.164 1.909 . . . . 0.0 112.032 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.07 149.05 64.34 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.133 1.889 . . . . 0.0 110.939 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.8 m -73.76 -45.16 53.58 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.553 0.692 . . . . 0.0 109.332 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -161.25 160.6 30.12 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.4 p -131.7 125.72 32.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.23 170.19 12.69 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.32 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.56 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.8 tp10 -125.25 134.96 52.12 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 105.923 -1.881 . . . . 0.0 105.923 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 19.8 tp -70.11 101.94 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 117' ' ' ASN . 5.1 t -80.07 158.4 26.45 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.62 -22.83 66.71 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.588 0.709 . . . . 0.0 109.749 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.09 -35.31 74.08 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.257 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.636 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.5 t-20 -71.73 -32.72 68.05 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 79' ' ' GLY . 96.8 mt -57.48 -23.27 49.01 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.737 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -85.14 -12.65 52.35 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.712 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.43 2.82 55.56 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.79 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.5 122.71 88.13 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.096 0.448 . . . . 0.0 110.389 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -59.42 111.12 0.84 Allowed 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 123.157 2.571 . . . . 0.0 112.107 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.508 HG23 ' ND2' ' A' ' 117' ' ' ASN . 86.4 t -82.98 124.88 39.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.7 101.54 2.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.198 0.523 . . . . 0.0 109.952 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.89 172.8 13.27 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.637 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -89.64 84.06 6.31 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.19 0.995 . . . . 0.0 110.031 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 39.9 p90 -76.42 24.69 0.14 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.138 -1.392 . . . . 0.0 113.919 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.531 HG13 ' HD2' ' A' ' 129' ' ' LYS . 7.4 p -63.47 -25.57 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.679 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.531 ' HD2' HG13 ' A' ' 128' ' ' VAL . 13.1 mptt -93.43 -20.29 20.46 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.436 0.636 . . . . 0.0 110.501 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 127' ' ' TYR . 82.2 m-85 -91.1 32.63 1.0 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.633 -171.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -67.32 -31.76 72.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.807 0.337 . . . . 0.0 111.309 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -142.2 116.15 9.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -113.54 106.51 20.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.795 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -89.52 -62.9 1.37 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 47.2 t -109.03 151.57 26.17 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.195 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.4 tp -147.95 129.67 15.12 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.261 0.553 . . . . 0.0 109.952 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.4 m -114.71 124.64 52.32 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.9 mt -113.5 112.23 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 69.3 t80 -109.0 114.62 28.53 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 120.851 0.357 . . . . 0.0 110.697 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.595 HG22 HG12 ' A' ' 88' ' ' VAL . 2.3 pp -97.47 124.45 50.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 11.5 pt-20 -110.79 -22.56 11.5 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.339 -0.945 . . . . 0.0 111.968 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.64 156.39 44.96 Favored 'General case' 0 CA--C 1.484 -1.586 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.847 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 147' ' ' SER . 34.2 t-20 -110.61 148.09 32.9 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 126.221 1.809 . . . . 0.0 107.862 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' LYS . 29.1 mm-40 -36.37 -56.81 0.77 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.652 1.181 . . . . 0.0 111.973 177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -124.25 -12.02 7.41 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.688 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 87.59 0.94 Allowed Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 149' ' ' VAL . 32.6 t -111.05 9.55 22.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.98 -0.13 . . . . 0.0 110.7 -173.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 77.14 -23.59 0.24 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 124.441 1.096 . . . . 0.0 110.157 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 147' ' ' SER . 25.9 m -128.5 124.31 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 85.9 m -101.41 111.1 23.23 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 51' ' ' ASN . 87.2 tttt -95.95 133.6 39.96 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 92.9 t -122.66 115.8 47.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.428 ' OE1' ' HB3' ' A' ' 78' ' ' LYS . 97.0 mt-30 -74.1 -44.33 54.35 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.839 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.05 153.66 3.85 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.495 176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.446 HG12 HG23 ' A' ' 77' ' ' ILE . 71.9 mt -124.49 118.03 52.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.4 141.02 35.59 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 72' ' ' LEU . 6.2 mp -120.43 151.59 39.1 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -124.44 127.11 47.02 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.723 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.3 -163.59 10.23 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 69.2 m -143.94 138.36 28.44 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.383 0.611 . . . . 0.0 111.863 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.464 HG22 HG22 ' A' ' 70' ' ' ILE . 17.8 p . . . . . 0 C--N 1.293 -1.88 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.087 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 120.799 0.333 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -90.09 -54.59 3.96 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.8 104.36 0.69 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.43 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -111.93 84.86 2.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.0 m -76.04 108.46 8.96 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.01 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 69.92 -57.99 0.54 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.025 1.33 . . . . 0.0 111.914 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.7 p 50.82 83.55 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.394 1.478 . . . . 0.0 113.7 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -100.06 66.68 1.35 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.213 0.53 . . . . 0.0 111.064 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.25 133.09 64.85 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.034 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.11 -173.55 0.64 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.633 2.222 . . . . 0.0 112.349 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -92.74 11.76 25.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.812 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -143.7 -50.92 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.741 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -87.42 173.38 9.17 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.924 0.392 . . . . 0.0 111.107 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 18.0 m -115.36 167.79 7.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.51 108.56 16.0 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.363 1.078 . . . . 0.0 108.979 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.488 HD22 HG13 ' A' ' 70' ' ' ILE . 44.7 mt -68.82 3.98 1.7 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.778 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.62 -41.45 99.01 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.16 -7.42 57.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.867 0.841 . . . . 0.0 110.86 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 13.4 m-85 -92.1 1.71 57.03 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 77.8 mt -85.01 133.35 29.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -87.07 -28.05 22.79 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.837 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.48 ' HA ' HG13 ' A' ' 25' ' ' VAL . 97.5 m95 66.15 -6.85 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 175.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.7 m -82.18 -19.95 38.82 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.614 -0.679 . . . . 0.0 112.659 -175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.35 26.69 4.9 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.75 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 22' ' ' TRP . 35.7 m -71.89 139.68 19.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 110.911 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -134.68 128.2 32.57 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.108 0.48 . . . . 0.0 109.888 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.599 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . 6.1 p -103.23 118.15 36.12 Favored 'General case' 0 N--CA 1.401 -2.894 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.495 HD23 HD22 ' A' ' 61' ' ' LEU . 3.3 mm? -76.82 -14.92 59.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.483 0.659 . . . . 0.0 110.746 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -160.45 -83.98 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.776 168.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.615 ' HA ' HD23 ' A' ' 60' ' ' LEU 0.394 3.1 pp0? 51.65 14.08 0.26 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 124.51 1.124 . . . . 0.0 112.634 -168.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.433 ' CB ' ' H ' ' A' ' 55' ' ' ASP 0.293 58.6 m 72.68 115.02 0.06 Allowed 'General case' 0 N--CA 1.416 -2.169 0 C-N-CA 126.995 2.118 . . . . 0.0 114.007 -173.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -55.34 16.9 0.0 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 C-N-CA 126.965 2.106 . . . . 0.0 115.218 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 31' ' ' SER . 34.1 t -103.91 -58.67 1.84 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.711 -0.618 . . . . 0.0 109.962 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CE1' ' HA ' ' A' ' 52' ' ' LEU . 23.7 p80 -93.81 163.37 13.55 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 17.7 m -90.49 166.97 12.94 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.818 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 62.1 tp -67.45 -45.58 47.96 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 11.6 Cg_endo -55.47 -25.91 51.29 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.957 1.771 . . . . 0.0 111.503 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 1.9 m-20 -63.04 -24.55 67.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.281 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 52' ' ' LEU . . . -95.11 -49.53 5.48 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.154 0.502 . . . . 0.0 111.886 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.2 tp -105.16 -20.71 13.43 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -170.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -80.08 118.66 21.99 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.292 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -70.87 140.72 51.17 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.558 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.58 -33.25 6.58 Favored Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.438 ' HB3' HD11 ' A' ' 50' ' ' LEU . 95.6 m-85 -98.92 -50.13 4.3 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.44 0.296 . . . . 0.0 110.859 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -52.75 119.29 4.41 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.998 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -153.7 124.4 7.2 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.53 92.61 0.85 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.649 0.738 . . . . 0.0 112.522 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 170.86 -66.26 0.01 OUTLIER 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.693 1.597 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.42 -57.03 1.81 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.29 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.4 pt? -134.68 113.71 11.97 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.626 0.727 . . . . 0.0 110.808 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -161.41 169.48 21.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.635 ' HB3' HG22 ' A' ' 152' ' ' VAL . 6.6 tt -75.92 122.69 24.52 Favored 'General case' 0 CA--C 1.487 -1.461 0 C-N-CA 117.191 -1.803 . . . . 0.0 106.17 174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -138.22 110.12 7.2 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 113.094 -1.866 . . . . 0.0 107.267 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.516 ' HB3' ' H ' ' A' ' 150' ' ' THR . 8.0 t -93.48 123.65 36.94 Favored 'General case' 0 N--CA 1.411 -2.397 0 C-N-CA 118.866 -1.134 . . . . 0.0 110.325 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.433 ' H ' ' CB ' ' A' ' 31' ' ' SER . 13.1 t70 -119.11 -24.1 6.6 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.722 -175.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.95 -69.61 0.68 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.314 -175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.91 171.5 8.59 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.534 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 148' ' ' GLU . 5.2 tm-20 -89.9 -24.77 21.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.028 0.931 . . . . 0.0 109.945 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.4 ' C ' HD12 ' A' ' 60' ' ' LEU . 55.5 mt-30 -114.27 134.65 54.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.122 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.615 HD23 ' HA ' ' A' ' 30' ' ' GLN . 8.4 mp -128.76 165.28 21.23 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.373 0.606 . . . . 0.0 112.39 -172.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.495 HD22 HD23 ' A' ' 28' ' ' LEU . 5.9 tt -152.42 128.1 10.14 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 61' ' ' LEU . 2.9 mp -126.02 135.5 63.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.72 118.74 35.85 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -121.64 122.71 27.79 Favored Pre-proline 0 C--O 1.214 -0.772 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.357 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -92.56 137.43 1.6 Allowed 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 122.657 2.238 . . . . 0.0 111.415 171.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -92.43 162.89 14.06 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 121.293 0.568 . . . . 0.0 111.421 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 68' ' ' GLN . 34.4 p30 -69.84 -36.11 75.29 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HG2' ' OD1' ' A' ' 67' ' ' ASN . 19.5 pt20 -147.63 176.88 9.73 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.029 -0.419 . . . . 0.0 110.461 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 27.3 m -82.18 124.48 39.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 CA-C-O 121.23 0.538 . . . . 0.0 110.384 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.488 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -137.0 172.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 174.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -93.24 114.31 26.75 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 65.4 tp -76.66 127.97 33.8 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 13' ' ' GLN . 6.2 t-160 -126.08 -45.94 1.69 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.866 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.0 p -142.74 155.18 44.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -128.27 158.24 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.24 113.77 5.64 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 122.602 0.361 . . . . 0.0 110.284 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.45 HG23 HG12 ' A' ' 155' ' ' ILE . 67.2 mt -125.17 126.35 70.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HD2' ' CA ' ' A' ' 120' ' ' GLY . 54.2 mtpt -117.79 152.42 35.35 Favored 'General case' 0 CA--C 1.481 -1.708 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.421 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -168.85 -167.96 30.23 Favored Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 108.186 -1.965 . . . . 0.0 108.186 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.11 155.53 69.17 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.85 1.7 . . . . 0.0 109.078 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.97 -42.83 60.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.91 -37.25 10.78 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -76.6 2.27 14.49 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.77 150.2 30.78 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.594 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.9 161.74 35.21 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 121.938 1.759 . . . . 0.0 111.088 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.712 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 69.8 tttt -127.89 -73.98 0.59 Allowed 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.561 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.606 ' HA ' ' HG2' ' A' ' 112' ' ' GLU . 29.5 m -76.15 103.91 6.42 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.477 0.656 . . . . 0.0 110.193 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 86' ' ' LYS . 99.8 t -114.93 116.66 53.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.627 -173.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 139' ' ' PHE . 98.8 mttt -101.91 147.23 26.78 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.231 -0.293 . . . . 0.0 110.26 172.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.54 138.91 54.47 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.474 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 86.6 m-85 -130.95 116.78 18.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 135' ' ' SER . 50.8 p -100.63 -14.09 18.29 Favored 'General case' 0 C--O 1.252 1.193 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 26.1 t-20 -140.3 84.7 1.97 Allowed 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 118.146 -1.421 . . . . 0.0 113.87 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 85.5 tttt 171.69 148.81 0.04 OUTLIER 'General case' 0 C--O 1.244 0.786 0 C-N-CA 125.109 1.364 . . . . 0.0 108.06 171.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -85.97 122.94 30.71 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.289 0.566 . . . . 0.0 111.427 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . 0.366 0.3 OUTLIER 39.39 96.45 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.002 2.521 . . . . 0.0 117.299 176.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.553 ' HB2' HG21 ' A' ' 137' ' ' THR . 91.7 mmm -83.91 148.51 26.9 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 174.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.7 m -129.33 162.93 26.84 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -52.68 -38.63 60.84 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.0 t -81.29 3.26 24.69 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.43 ' HA ' ' OD1' ' A' ' 104' ' ' ASP . 4.0 p-10 -147.23 13.64 1.1 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.229 0.538 . . . . 0.0 110.616 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 p -75.5 -25.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.894 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -96.63 4.78 51.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.478 0.656 . . . . 0.0 110.618 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 101' ' ' ASN . 8.3 m-20 -91.71 4.61 52.36 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.923 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 82.1 t80 -144.19 134.65 12.09 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 26.2 Cg_exo -65.08 127.0 17.48 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.628 2.219 . . . . 0.0 111.7 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.14 168.55 23.02 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.597 2.198 . . . . 0.0 112.505 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.8 m -69.72 -40.66 76.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.43 174.11 3.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 76.0 m -143.7 113.45 7.11 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.27 163.7 20.18 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.563 -174.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 50.5 mt-10 -128.04 138.75 52.7 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.768 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.1 116.71 7.49 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 112.651 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.4 t -96.42 174.07 7.05 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -56.44 -36.34 68.91 Favored 'General case' 0 C--O 1.206 -1.195 0 CA-C-N 118.257 0.48 . . . . 0.0 110.715 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 121' ' ' LYS . 38.8 tt0 -59.93 -42.36 93.79 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.498 HD22 HG23 ' A' ' 123' ' ' VAL . 14.1 t-20 -71.54 -41.66 68.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 118' ' ' LEU . 8.4 tt -73.85 -0.76 16.9 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.735 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -113.61 -5.07 13.41 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.174 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.517 ' CA ' ' HD2' ' A' ' 78' ' ' LYS . . . 118.63 -3.33 15.29 Favored Glycine 0 CA--C 1.498 -1.016 0 C-N-CA 119.645 -1.264 . . . . 0.0 116.136 172.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 116' ' ' GLU . 12.4 mptt -88.33 126.57 60.02 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 46.9 Cg_exo -59.91 108.54 0.49 Allowed 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 123.707 2.938 . . . . 0.0 111.844 175.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.498 HG23 HD22 ' A' ' 117' ' ' ASN . 68.9 t -88.65 127.1 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.8 m -82.23 141.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 O-C-N 123.412 0.445 . . . . 0.0 111.75 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.63 -172.85 2.2 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -72.7 103.79 3.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.719 0.771 . . . . 0.0 110.355 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.45 ' HA ' ' CD2' ' A' ' 130' ' ' PHE . 60.4 t80 -75.16 1.77 12.51 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.361 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.6 p -94.64 -22.52 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.79 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -109.69 -9.97 14.83 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -170.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 127' ' ' TYR . 41.4 p90 -77.62 11.11 2.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.128 -0.982 . . . . 0.0 112.447 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -58.51 133.42 55.8 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -163.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.294 2.8 p-10 53.7 113.01 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.911 2.084 . . . . 0.0 112.697 -172.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 55.0 t -121.01 122.51 67.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.674 -173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -117.3 -28.28 6.19 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.551 0.691 . . . . 0.0 109.545 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 92' ' ' SER . 52.3 p -144.67 171.86 13.8 Favored 'General case' 0 N--CA 1.398 -3.032 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.897 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.92 106.49 4.85 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 97' ' ' MET . 19.9 m -96.73 120.24 36.7 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.5 mt -105.1 111.28 33.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' LYS . 65.1 t80 -107.55 107.89 18.93 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.99 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.479 HG22 HG22 ' A' ' 88' ' ' VAL . 11.9 pt -106.64 113.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.633 0.73 . . . . 0.0 109.986 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 41.8 tt0 -112.66 13.38 19.9 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.999 0.904 . . . . 0.0 111.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -165.3 153.44 11.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.764 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.413 ' C ' ' HB2' ' A' ' 86' ' ' LYS . 39.8 m-80 -117.76 168.34 10.54 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 124.044 0.84 . . . . 0.0 108.91 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -44.21 -43.5 7.22 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.814 0.846 . . . . 0.0 112.186 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.2 m -124.1 8.77 8.61 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.732 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.39 55.56 28.99 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -172.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -83.35 2.72 34.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -168.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 58' ' ' GLU . 47.2 mt-10 69.22 -4.28 1.34 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.802 0.841 . . . . 0.0 112.536 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 54' ' ' SER . 2.7 p -137.95 103.3 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 C-N-CA 123.829 0.852 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.516 ' H ' ' HB3' ' A' ' 54' ' ' SER . 41.0 m -82.57 122.78 28.53 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 87.8 tttt -131.12 134.17 46.32 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.635 HG22 ' HB3' ' A' ' 52' ' ' LEU . 11.3 m -130.46 148.38 33.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.129 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -86.54 -44.83 11.62 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.328 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.13 145.11 6.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.702 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.45 HG12 HG23 ' A' ' 77' ' ' ILE . 73.9 mt -117.98 122.87 70.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -135.1 137.28 42.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.27 137.56 51.9 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 74.3 m-85 -122.33 139.33 53.94 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.753 0.787 . . . . 0.0 111.703 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.94 -168.46 22.84 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.9 m -145.73 149.82 35.12 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 117.431 0.616 . . . . 0.0 109.676 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--N 1.29 -2.016 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.295 178.171 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.8 p 53.32 27.92 6.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.672 1.189 . . . . 0.0 112.891 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.99 138.39 40.48 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -83.57 -40.35 19.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.723 0.773 . . . . 0.0 109.221 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -150.09 94.24 2.12 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.022 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.88 87.95 7.38 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.592 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.0 m -95.27 79.61 3.51 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 121.58 0.705 . . . . 0.0 110.268 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.514 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 4.8 tp60 -145.26 5.65 1.1 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.788 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 11' ' ' LYS . 2.0 mp -83.61 123.55 76.31 Favored Pre-proline 0 N--CA 1.425 -1.68 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.1 1.63 9.07 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.805 2.336 . . . . 0.0 112.964 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' H ' HG22 ' A' ' 9' ' ' ILE . 24.2 ttmm 70.83 118.95 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.796 1.238 . . . . 0.0 111.423 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.81 -44.31 1.28 Allowed Glycine 0 C--N 1.307 -1.05 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -134.87 152.37 51.69 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 158' ' ' TYR . 13.0 m -106.2 167.51 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.899 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.069 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.475 ' H ' HG13 ' A' ' 9' ' ' ILE . 21.9 t70 -76.82 95.33 4.03 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.0 tp -58.75 -0.38 0.11 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 126.917 2.087 . . . . 0.0 114.054 -174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.5 tt -64.02 -31.73 73.02 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.49 -24.12 67.69 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.864 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.75 8.66 41.8 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 122.047 -0.408 . . . . 0.0 110.398 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.9 mt -85.57 119.08 33.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.25 -34.82 42.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.517 ' CZ3' HG11 ' A' ' 25' ' ' VAL . 96.2 m95 70.23 6.57 5.84 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.8 t -84.96 -28.79 25.59 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.8 -89.23 1.78 Allowed Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 108.089 -2.005 . . . . 0.0 108.089 175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.517 HG11 ' CZ3' ' A' ' 22' ' ' TRP . 92.3 t 41.89 94.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.246 1.418 . . . . 0.0 114.283 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.48 128.1 56.23 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.906 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.2 p -102.01 119.87 39.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.645 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD13 ' C ' ' A' ' 28' ' ' LEU . 2.6 tm? -64.3 -44.29 92.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.066 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -117.64 -99.63 0.44 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.127 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 30' ' ' GLN . 8.5 tt0 56.08 22.14 5.7 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.301 1.048 . . . . 0.0 110.204 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -102.77 -12.67 17.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.88 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.9 p -54.76 -48.31 72.8 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.5 m 179.97 -67.01 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 124.483 1.113 . . . . 0.0 110.399 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -73.31 163.36 28.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.628 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.459 ' HB2' ' ND2' ' A' ' 38' ' ' ASN . 45.8 m -98.51 140.22 33.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.542 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.463 ' CB ' ' HG ' ' A' ' 52' ' ' LEU . 7.0 tt -77.85 -44.82 2.4 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.453 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.07 -24.66 20.41 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.141 1.894 . . . . 0.0 112.79 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.569 ' HB3' HD13 ' A' ' 50' ' ' LEU . 86.0 m-20 -57.37 -48.43 79.07 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 121.227 0.537 . . . . 0.0 110.264 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.02 4.94 20.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.109 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' O ' ' HZ2' ' A' ' 22' ' ' TRP . 49.2 tp -140.25 10.5 2.33 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 5.3 tmtm? -127.68 141.75 51.52 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.54 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 15.6 mm-40 -58.88 132.81 55.06 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.79 -39.77 2.77 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.478 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -76.0 -48.25 21.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.611 -0.294 . . . . 0.0 111.287 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' A' ' 17' ' ' LEU . 32.1 ptt180 -68.12 107.8 2.88 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.056 0.931 . . . . 0.0 111.596 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.82 100.63 5.77 Favored 'General case' 0 C--N 1.273 -2.719 0 N-CA-C 103.134 -2.913 . . . . 0.0 103.134 174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' HB2' ' OE1' ' A' ' 153' ' ' GLN . 4.8 p-10 -71.68 84.65 0.89 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -173.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 16.9 tp10 168.96 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 113.241 -1.799 . . . . 0.0 108.29 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.11 -68.88 1.51 Allowed Glycine 0 C--O 1.238 0.396 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.785 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 38' ' ' ASN . 1.9 pp -104.79 158.07 16.77 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 120.966 0.412 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.449 ' ND2' ' HG3' ' A' ' 151' ' ' LYS . 3.5 p-10 -161.76 166.41 26.56 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.463 ' HG ' ' CB ' ' A' ' 36' ' ' LEU . 3.2 tm? -111.51 128.82 56.13 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 174.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.04 162.44 35.46 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.763 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 51.2 p -92.12 176.09 6.63 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 122.944 0.153 . . . . 0.0 110.774 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 175.79 -46.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.925 0.89 . . . . 0.0 109.067 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.19 -28.84 63.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.59 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.689 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.3 t70 -160.29 145.71 15.01 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -74.06 -27.81 61.09 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 123.519 0.512 . . . . 0.0 112.236 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.2 132.19 34.06 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.304 0.574 . . . . 0.0 110.542 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 54' ' ' SER . 93.2 mt -131.12 144.43 51.39 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.327 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 62' ' ' ILE . 6.0 tt -153.06 144.35 23.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.515 ' N ' HD23 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -150.29 138.94 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.474 ' N ' HD13 ' A' ' 62' ' ' ILE . 68.2 t80 -105.32 122.76 46.62 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 122.914 0.486 . . . . 0.0 111.825 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 62' ' ' ILE . 2.3 mp -116.26 119.47 36.45 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.652 177.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -86.84 127.74 2.7 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.538 2.159 . . . . 0.0 109.219 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -90.81 162.65 14.75 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -48.8 -57.6 6.12 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 126.376 1.87 . . . . 0.0 110.165 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -149.48 177.94 9.26 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 57.7 t -78.49 111.72 15.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.57 173.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -100.61 133.8 44.52 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 125' ' ' LEU . 2.4 tt -98.19 123.22 42.15 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -102.2 -41.44 6.39 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.822 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 26.0 p -154.63 160.93 41.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.027 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -135.23 150.23 50.03 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -143.6 98.11 3.19 Favored 'General case' 0 C--O 1.25 1.08 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.7 mt -108.26 132.21 56.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 54.0 mtpt -116.55 159.3 22.31 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.264 0.554 . . . . 0.0 112.42 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.81 -171.4 39.64 Favored Glycine 0 N--CA 1.422 -2.25 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -73.85 172.62 15.49 Favored 'Trans proline' 0 C--N 1.326 -0.623 0 C-N-CA 122.25 1.966 . . . . 0.0 110.356 174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -74.8 -27.93 60.51 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 120.834 0.35 . . . . 0.0 110.668 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.22 -47.17 7.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.18 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 151' ' ' LYS . 43.7 mt-10 -89.7 1.8 55.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.745 -176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.76 45.45 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.041 -0.866 . . . . 0.0 111.798 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 7.5 Cg_exo -71.21 107.07 2.04 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.174 1.916 . . . . 0.0 111.15 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.34 -43.39 13.74 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.7 m -92.74 97.22 10.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.143 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 111' ' ' ALA . 33.8 m -107.38 142.28 20.52 Favored 'Isoleucine or valine' 0 C--O 1.254 1.338 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -146.65 133.46 20.08 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -118.27 144.69 45.61 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.011 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -131.98 115.65 16.11 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.6 t -93.27 134.54 35.37 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 73.67 178.29 0.23 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.829 1.252 . . . . 0.0 111.501 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.4 tptm 72.41 101.85 0.07 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.063 1.345 . . . . 0.0 110.736 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.8 122.96 19.66 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.643 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t60 70.87 97.35 0.07 Allowed 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.389 1.056 . . . . 0.0 112.997 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 83.5 mtp -126.39 152.77 45.88 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 85.5 m -142.7 174.85 10.28 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.509 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 55.5 p90 -65.54 -17.6 64.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.1 m -73.19 -23.33 60.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.626 0.25 . . . . 0.0 111.454 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -128.51 3.34 5.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 111.514 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.509 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 8.3 p -65.09 -34.77 72.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.867 -173.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -97.71 5.1 49.73 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.75 -24.56 18.53 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.173 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -97.38 149.74 36.04 Favored Pre-proline 0 C--N 1.311 -1.104 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.718 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.59 128.88 18.88 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 122.67 2.247 . . . . 0.0 112.028 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.68 160.27 41.29 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.436 2.09 . . . . 0.0 111.256 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.7 m -76.79 -41.95 42.55 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.489 0.661 . . . . 0.0 109.378 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.635 ' OD2' ' HG3' ' A' ' 126' ' ' LYS . 14.9 t70 -161.71 146.71 13.24 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.7 t -127.99 124.17 36.54 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 173.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . . . -119.05 172.89 7.24 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.085 -173.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.44 134.59 55.14 Favored 'General case' 0 N--CA 1.405 -2.676 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 118' ' ' LEU . 28.4 tp -69.57 121.54 17.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.1 p -98.03 169.59 9.52 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.861 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -31.77 72.73 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.144 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.42 ' HA ' ' HE2' ' A' ' 119' ' ' LYS . 15.0 pt-20 -70.87 -33.88 71.05 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.82 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.631 HD21 ' HA ' ' A' ' 76' ' ' ALA . 0.7 OUTLIER -64.44 -42.57 95.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 113' ' ' LEU . 87.2 mt -62.19 -4.87 1.93 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.83 1.252 . . . . 0.0 113.642 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 116' ' ' GLU . 57.1 mtmt -113.14 -9.39 13.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 122.821 0.448 . . . . 0.0 109.976 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.83 0.58 34.19 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.914 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 31.9 mmmt -75.34 131.52 77.74 Favored Pre-proline 0 C--O 1.246 0.907 0 O-C-N 123.592 0.231 . . . . 0.0 111.375 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 29.7 Cg_exo -65.14 119.54 6.59 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 123.288 2.659 . . . . 0.0 111.639 176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 91.0 t -97.54 136.0 29.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.04 117.11 30.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.405 0.621 . . . . 0.0 111.252 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.469 HD11 HD22 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.54 -175.59 4.74 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.401 176.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.635 ' HG3' ' OD2' ' A' ' 109' ' ' ASP . 29.9 mtpp -64.54 89.9 0.07 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.619 0.723 . . . . 0.0 112.06 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -69.68 -21.37 63.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.732 1.213 . . . . 0.0 110.959 -175.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 m -80.33 -19.23 12.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.03 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 9.9 tmtt? -92.85 -41.84 9.86 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 125' ' ' LEU . 91.8 m-85 -75.77 78.97 2.71 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.442 0.639 . . . . 0.0 112.021 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -107.99 -40.44 5.23 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.418 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.29 112.65 23.44 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.388 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 49.0 t -123.3 102.38 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -95.87 -31.07 13.32 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 56.4 p -156.94 162.99 39.62 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 137' ' ' THR . 4.4 tt -148.82 133.99 18.29 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.476 ' N ' HD23 ' A' ' 136' ' ' LEU . 64.6 m -104.32 124.7 49.65 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 2.8 mp -103.03 125.96 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.63 118.25 27.72 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.164 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.501 HG13 ' HB2' ' A' ' 60' ' ' LEU . 10.5 pt -112.46 114.32 46.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.68 0.753 . . . . 0.0 109.76 175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.66 -42.43 9.18 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.612 -172.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.24 150.58 38.16 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.899 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.08 167.99 10.36 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.834 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.571 HE21 HD23 ' A' ' 113' ' ' LEU . 82.6 mm-40 -48.47 -48.61 37.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.0 m -92.84 -19.45 21.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.81 42.38 61.26 Favored Glycine 0 C--N 1.311 -0.851 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.6 t -87.86 9.86 20.57 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.938 -0.631 . . . . 0.0 110.752 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 68.15 8.39 6.51 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.379 1.072 . . . . 0.0 112.318 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 54' ' ' SER . 7.7 p -136.02 112.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-O 121.976 0.893 . . . . 0.0 109.378 176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.6 m -106.74 121.28 44.05 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.449 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 4.9 ttmp? -113.4 133.62 55.07 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.232 0.539 . . . . 0.0 110.485 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 57.7 t -125.68 116.1 45.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.654 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.47 ' OE1' ' HB2' ' A' ' 47' ' ' ASP . 9.7 pt20 -85.87 -29.92 23.32 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.45 145.43 12.96 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.28 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.36 129.32 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.59 129.63 20.76 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.98 144.73 42.05 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 84.5 m-85 -124.16 113.21 18.02 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.307 0.575 . . . . 0.0 111.042 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.96 -167.24 11.0 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 75.4 p -162.44 162.95 27.84 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 118.315 1.057 . . . . 0.0 112.556 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.302 -1.469 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.315 173.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 p . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -168.99 97.21 0.36 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.275 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.11 21.81 13.07 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -77.3 110.98 12.48 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.542 0.687 . . . . 0.0 111.817 179.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.8 m -141.07 93.82 2.63 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.378 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.536 ' HB2' HE21 ' A' ' 42' ' ' GLN . . . -152.94 134.54 14.48 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.374 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 p -83.55 81.32 8.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.921 0.867 . . . . 0.0 110.77 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -129.41 11.37 5.83 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.486 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.6 mt -104.75 112.67 65.32 Favored Pre-proline 0 C--N 1.299 -1.619 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.66 -172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.26 143.22 4.62 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 122.3 2.0 . . . . 0.0 111.715 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -59.18 130.67 48.09 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.69 0.757 . . . . 0.0 112.021 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.21 -42.26 1.96 Allowed Glycine 0 N--CA 1.412 -2.923 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -106.67 173.3 6.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.615 0.721 . . . . 0.0 110.064 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.431 HG11 HG23 ' A' ' 161' ' ' THR . 14.6 p -130.15 143.94 39.5 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 154.5 29.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.029 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 20' ' ' ILE . 4.3 mm? -101.64 8.83 41.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.927 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.403 HD11 ' HB2' ' A' ' 42' ' ' GLN . 4.4 tt -78.48 -48.49 15.24 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.85 -27.22 68.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.788 -1.097 . . . . 0.0 110.918 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -84.07 9.84 11.56 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.494 HG22 ' H ' ' A' ' 22' ' ' TRP . 75.4 mt -93.71 127.91 45.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -85.28 -15.99 41.6 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.508 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' H ' HG22 ' A' ' 20' ' ' ILE . 86.0 m95 58.88 30.7 20.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.709 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 m -57.31 -36.19 70.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.933 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.2 -47.37 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 22' ' ' TRP . 2.7 t 62.7 97.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 124.348 1.059 . . . . 0.0 109.885 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -121.78 139.85 53.08 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.018 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.54 128.74 29.81 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.44 HD13 HD12 ' A' ' 61' ' ' LEU . 8.6 mp -62.58 -26.78 68.77 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -99.41 -105.02 0.22 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.325 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 54.73 15.61 1.15 Allowed 'General case' 0 CA--C 1.573 1.842 0 CA-C-O 122.322 1.058 . . . . 0.0 110.306 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.1 t -78.36 -30.1 47.81 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 124.613 1.165 . . . . 0.0 107.931 -176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 4.9 p -64.95 7.09 0.18 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m 76.66 -17.23 0.56 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.417 ' ND1' ' HB3' ' A' ' 53' ' ' GLU . 29.6 m80 -77.62 134.98 38.08 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.659 174.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -83.05 157.31 22.93 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -168.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.44 ' CD2' HD22 ' A' ' 52' ' ' LEU . 2.8 tm? -81.74 -53.74 0.7 Allowed Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.83 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 31.9 Cg_exo -60.3 -15.19 33.57 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 121.845 1.697 . . . . 0.0 113.661 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.751 ' HB2' HD13 ' A' ' 50' ' ' LEU . 32.0 p30 -75.25 -22.64 57.69 Favored 'General case' 0 C--O 1.209 -1.045 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.905 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.79 1.18 36.92 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.362 0.601 . . . . 0.0 110.825 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.84 -43.7 2.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.091 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.11 130.43 35.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.925 0.393 . . . . 0.0 110.947 -174.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.536 HE21 ' HB2' ' A' ' 6' ' ' ALA . 21.5 tm0? -57.82 140.05 52.66 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 124.501 1.12 . . . . 0.0 110.641 -176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.8 -59.5 0.53 Allowed Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -73.77 -41.04 62.99 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.7 ' HD2' ' O ' ' A' ' 45' ' ' ARG . 2.7 tmm_? -53.49 -11.44 0.34 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.961 2.104 . . . . 0.0 111.569 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -65.44 100.53 0.5 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -68.22 98.83 0.84 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -141.0 -75.24 0.32 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.225 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -104.34 -54.38 0.79 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.957 -175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.751 HD13 ' HB2' ' A' ' 38' ' ' ASN . 1.8 pp -85.03 147.46 26.67 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.757 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -164.06 166.32 21.51 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.641 -177.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 36' ' ' LEU . 61.2 tp -83.59 123.47 29.81 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' ND1' ' A' ' 34' ' ' HIS . 32.2 tt0 -140.71 130.53 24.41 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.729 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 150' ' ' THR . 64.7 p -101.91 151.05 22.56 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' HG12 ' A' ' 149' ' ' VAL . 17.3 t70 -123.8 -54.28 1.74 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.584 -170.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.95 -26.41 25.52 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.192 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -130.39 145.97 51.89 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 117.958 -1.497 . . . . 0.0 111.634 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -84.25 -31.75 24.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.929 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -68.49 114.96 7.36 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.334 0.587 . . . . 0.0 110.855 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 HD21 ' CD2' ' A' ' 52' ' ' LEU . 17.8 tp -126.05 107.53 10.51 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.408 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD12 HD13 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -107.61 130.71 54.87 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -179.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.407 HD11 ' HG ' ' A' ' 60' ' ' LEU . 3.3 mp -127.61 132.87 68.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -113.91 126.19 54.89 Favored 'General case' 0 C--O 1.252 1.223 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 46.5 mm -107.71 121.23 44.78 Favored Pre-proline 0 N--CA 1.425 -1.694 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.36 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 64' ' ' ILE . 6.3 Cg_exo -77.94 112.59 3.3 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.593 2.196 . . . . 0.0 110.273 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -80.2 164.13 23.5 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 126.065 1.746 . . . . 0.0 113.922 -175.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -106.11 -37.53 6.57 Favored 'General case' 0 N--CA 1.392 -3.355 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.069 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -150.62 160.6 43.71 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -172.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -80.64 128.2 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 124.028 0.83 . . . . 0.0 109.323 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -134.44 174.06 13.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 174.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 160' ' ' SER . 38.6 ttpt -97.13 146.8 24.7 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' HG ' HG21 ' A' ' 133' ' ' VAL . 87.3 mt -78.83 159.11 27.99 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.44 ' HA ' ' CE2' ' A' ' 127' ' ' TYR . 13.2 t60 -146.82 -66.02 0.28 Allowed 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.793 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.9 p -137.77 163.02 32.38 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.821 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 41.7 p90 -140.1 149.06 42.62 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.99 111.66 8.73 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.745 0.307 . . . . 0.0 110.25 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.7 mt -123.81 120.6 60.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 153' ' ' GLN . 85.2 mttt -96.46 136.38 37.04 Favored 'General case' 0 CA--C 1.469 -2.153 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.273 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.574 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -164.39 156.56 28.53 Favored Glycine 1 C--N 1.25 -4.23 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 177.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.53 172.49 12.32 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 122.002 1.801 . . . . 0.0 112.887 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -75.98 -24.53 55.38 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.959 0.885 . . . . 0.0 109.416 177.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.19 -55.14 4.06 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.0 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -109.18 7.96 25.68 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.703 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.94 158.23 36.41 Favored Glycine 0 C--N 1.305 -1.188 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.272 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 3.0 Cg_exo -77.12 107.66 2.47 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.888 1.725 . . . . 0.0 110.902 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 1.0 OUTLIER -89.19 -51.78 5.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.981 -176.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 89.7 m -93.44 95.46 9.3 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.715 0.769 . . . . 0.0 109.699 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -98.02 135.04 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.779 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -131.58 141.82 49.77 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.813 0.816 . . . . 0.0 110.256 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 53.3 m-85 -115.17 145.39 42.44 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.551 ' CZ ' ' HB ' ' A' ' 102' ' ' VAL 0.257 76.2 m-85 -118.12 146.74 43.93 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 178.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -74.14 -158.5 0.07 Allowed 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.597 -1.638 . . . . 0.0 112.651 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 134' ' ' ARG . 27.7 t-20 -53.21 -20.06 3.67 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.492 1.917 . . . . 0.0 112.862 -178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -72.33 111.8 7.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.38 161.15 13.79 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 65.35 23.48 12.05 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.314 1.046 . . . . 0.0 111.365 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.451 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 79.7 mtp -68.29 135.41 51.88 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.897 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.472 ' O ' HG13 ' A' ' 102' ' ' VAL . 19.9 p -102.91 174.04 6.05 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -62.37 -29.14 70.25 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.0 t -87.27 -5.7 58.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -104.4 -19.64 13.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.496 0.665 . . . . 0.0 111.238 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.551 ' HB ' ' CZ ' ' A' ' 91' ' ' PHE . 33.1 m -83.69 2.72 3.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.778 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -88.62 -26.33 21.96 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.993 0.425 . . . . 0.0 111.944 -174.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -110.48 10.22 23.23 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.796 0.331 . . . . 0.0 111.166 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -124.22 131.68 24.22 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.65 126.93 11.88 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.76 162.03 42.96 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.356 2.037 . . . . 0.0 111.567 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.461 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 16.7 m -60.42 -45.36 93.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 122.038 0.923 . . . . 0.0 108.826 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -167.9 166.18 13.51 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -133.45 128.58 35.76 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.0 172.85 8.21 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.302 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 39.4 tt0 -125.38 138.05 54.04 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.94 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 27.6 tp -70.15 100.87 1.73 Allowed 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 175.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.9 t -91.37 167.61 12.16 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.3 -35.68 67.79 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.69 0.396 . . . . 0.0 111.748 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 121' ' ' LYS . 8.4 tp10 -67.4 -38.84 85.27 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.408 ' HB3' HD12 ' A' ' 113' ' ' LEU . 1.4 t-20 -71.36 -44.41 65.08 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 79' ' ' GLY . 5.1 tt -57.91 -31.81 67.13 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.527 1.531 . . . . 0.0 109.671 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -85.2 -3.02 58.67 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.02 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 174.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HB2' ' HG3' ' A' ' 116' ' ' GLU . 73.2 mmtt -94.24 137.05 22.94 Favored Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 75' ' ' PHE . 18.9 Cg_endo -62.08 115.19 2.68 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.673 2.915 . . . . 0.0 112.934 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.4 t -96.42 137.71 23.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -75.68 123.88 32.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.18 176.87 5.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.587 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -94.9 110.5 22.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.063 0.458 . . . . 0.0 110.394 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 73' ' ' HIS . 45.2 p90 -125.41 26.48 6.81 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.47 -33.56 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 121.01 0.434 . . . . 0.0 111.463 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -90.42 -32.6 16.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.421 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 56.3 m-85 -90.41 69.94 6.96 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.814 0.816 . . . . 0.0 112.169 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -88.41 -12.7 42.44 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.79 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -146.2 120.99 9.89 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.436 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.47 HG21 ' HG ' ' A' ' 72' ' ' LEU . 94.1 t -121.42 104.61 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.139 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.43 ' HB3' ' ND2' ' A' ' 93' ' ' ASN . 29.3 tpt180 -71.78 -50.44 29.83 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.801 176.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.6 p -134.66 150.72 50.68 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -129.98 135.44 48.3 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.869 0.366 . . . . 0.0 110.511 -177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 70.2 m -121.95 129.64 52.67 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.7 mp -107.56 121.21 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 74.3 t80 -124.35 125.72 44.8 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.014 0.435 . . . . 0.0 112.165 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.1 pt -119.51 126.13 75.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.9 pt-20 -108.78 -17.98 13.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -153.61 143.97 22.34 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.253 -175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -98.15 -174.22 2.79 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -62.08 -63.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.485 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.0 p -103.43 -42.22 5.77 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.927 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 108.79 69.21 0.64 Allowed Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 -174.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.8 m -84.78 16.72 3.14 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 123.409 0.684 . . . . 0.0 111.329 -175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 76.2 -43.67 0.48 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.405 1.482 . . . . 0.0 111.9 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 55' ' ' ASP . 11.4 m -102.35 157.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.623 ' HB ' ' OG ' ' A' ' 54' ' ' SER . 59.2 m -121.94 128.68 51.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -129.25 133.58 47.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.001 0.429 . . . . 0.0 110.079 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 7.2 p -134.77 125.36 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 78' ' ' LYS . 24.5 mm-40 -73.68 -47.57 38.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.532 -174.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 147.06 10.31 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.777 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.6 mt -122.74 122.99 67.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.73 121.42 12.6 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.05 147.09 27.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -124.93 118.95 27.42 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -115.97 -157.0 11.05 Favored Glycine 0 C--N 1.283 -2.366 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 38.7 m -152.75 126.22 8.75 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.431 HG23 HG11 ' A' ' 14' ' ' VAL . 24.9 p . . . . . 0 C--N 1.276 -2.605 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.422 175.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.436 -1.146 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 t -171.6 152.43 3.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.61 134.59 54.64 Favored 'General case' 0 C--O 1.248 0.98 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.47 173.49 6.8 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 121.326 0.584 . . . . 0.0 110.995 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -162.95 141.88 8.61 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.84 80.37 8.5 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.869 -0.733 . . . . 0.0 110.269 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.5 p -101.04 95.04 6.31 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.529 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 67.59 17.56 9.94 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.87 113.09 12.68 Favored Pre-proline 0 C--O 1.243 0.737 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 171.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -87.0 170.56 7.14 Favored 'Trans proline' 0 N--CA 1.441 -1.615 0 C-N-CA 122.257 1.971 . . . . 0.0 112.855 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -59.62 114.73 2.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.544 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.51 -61.98 0.55 Allowed Glycine 0 N--CA 1.423 -2.202 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.105 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . 1.5 mp0 -112.53 -171.86 1.94 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.395 0.617 . . . . 0.0 111.034 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.49 150.48 30.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 173.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 32.9 t0 -72.29 126.38 29.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 157' ' ' LEU . 59.2 mt -81.06 4.36 20.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -175.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' HA ' HD12 ' A' ' 20' ' ' ILE . 5.4 tt -51.42 -35.86 41.14 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.299 1.047 . . . . 0.0 108.411 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.37 -38.93 81.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.21 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -89.69 -2.46 58.28 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 17' ' ' LEU . 89.5 mt -74.11 136.98 24.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.52 ' O ' HG13 ' A' ' 25' ' ' VAL . 16.2 t70 -99.54 112.89 25.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 173.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -80.52 1.51 29.18 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.5 m -93.05 -35.89 12.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.36 -19.99 61.27 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.058 -0.974 . . . . 0.0 113.756 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 21' ' ' ASP . 28.4 m -54.2 130.89 16.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.756 0.789 . . . . 0.0 112.126 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 7.7 tp10 -112.06 127.5 55.92 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.616 ' HB2' ' NE2' ' A' ' 30' ' ' GLN . 26.4 p -130.26 113.59 14.6 Favored 'General case' 0 N--CA 1.398 -3.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.198 -175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.429 HD23 HD22 ' A' ' 61' ' ' LEU . 3.2 mm? -72.62 -75.17 0.14 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.299 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.541 HD21 ' HB3' ' A' ' 56' ' ' ALA . 64.2 t30 -116.41 -81.43 0.61 Allowed 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.561 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.616 ' NE2' ' HB2' ' A' ' 27' ' ' CYS . 1.9 mp0 62.82 23.29 13.9 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -173.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 54' ' ' SER . 14.4 m 89.52 139.86 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 127.609 2.363 . . . . 0.0 112.675 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.4 t -70.35 -46.36 64.29 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.675 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.3 m -77.45 -35.68 53.66 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.695 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 98.1 m-70 -124.61 149.27 47.25 Favored 'General case' 0 C--O 1.189 -2.102 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.4 m -140.98 -168.29 2.57 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 116.745 -1.982 . . . . 0.0 115.378 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 30' ' ' GLN . 29.8 tp -60.88 -52.47 72.1 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 50.2 Cg_exo -54.47 -32.23 72.4 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.1 1.867 . . . . 0.0 112.751 -172.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.693 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.9 p-10 -84.43 3.43 36.16 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -128.87 -23.8 3.04 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.936 0.398 . . . . 0.0 112.042 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -105.13 -18.12 14.25 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.116 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -80.28 147.68 31.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -66.09 143.67 57.17 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.32 -37.09 3.03 Favored Glycine 0 N--CA 1.413 -2.882 0 CA-C-N 114.87 -1.059 . . . . 0.0 114.386 170.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -74.6 -25.71 59.44 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.301 0.0 OUTLIER -60.14 67.51 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -174.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -160.91 141.76 11.56 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.754 1.622 . . . . 0.0 107.979 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.8 100.43 10.93 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.646 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.12 17.9 0.76 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.426 0.631 . . . . 0.0 109.931 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.14 -59.92 0.23 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.3 pp -105.19 149.38 25.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 172.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.695 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 47.1 t30 -161.72 163.41 29.69 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 60' ' ' LEU . 3.8 tt -105.32 111.98 24.91 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 171.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.3 pt-20 -141.45 122.34 14.48 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.624 ' HA ' ' OG ' ' A' ' 31' ' ' SER 0.27 36.2 p -51.76 93.73 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -171.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 31' ' ' SER . 18.8 t70 -113.52 88.13 2.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-N 113.604 -1.635 . . . . 0.0 109.14 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . 157.4 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.211 2.204 . . . . 0.0 107.987 176.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -139.03 157.16 46.48 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.986 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -89.02 75.14 8.02 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 173.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.545 HE21 ' C ' ' A' ' 59' ' ' GLN . 0.0 OUTLIER -174.53 139.66 0.58 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.396 1.078 . . . . 0.0 109.139 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.662 ' HB2' HG13 ' A' ' 140' ' ' ILE . 10.3 mp -135.19 147.28 49.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.619 0.768 . . . . 0.0 109.645 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 4.6 tt -149.24 124.44 10.14 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -139.43 135.05 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.552 ' N ' HD13 ' A' ' 62' ' ' ILE . 45.1 t80 -105.78 125.64 51.23 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.93 0.892 . . . . 0.0 110.324 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -116.77 120.73 33.82 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.403 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -97.85 127.43 0.23 Allowed 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 123.054 2.503 . . . . 0.0 110.421 170.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -95.14 139.75 31.04 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.21 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -72.73 -20.57 61.18 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.164 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -147.48 144.47 28.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.77 120.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.684 0.754 . . . . 0.0 111.16 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 168.43 10.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HE2' ' OE1' ' A' ' 131' ' ' GLN . 7.5 mtpm? -96.16 113.62 25.24 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 55.3 tp -71.2 152.5 43.29 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.447 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . 17.9 t60 -139.22 -49.57 0.5 Allowed 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.978 0.418 . . . . 0.0 111.526 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.0 p -147.19 167.54 23.92 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 122.036 -0.415 . . . . 0.0 111.91 -175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.588 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 12.3 p90 -129.43 158.21 39.81 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.606 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -151.66 131.94 13.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.868 0.366 . . . . 0.0 111.039 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.411 HG21 ' HG2' ' A' ' 85' ' ' PRO . 67.7 mt -140.19 128.43 25.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -104.04 155.63 18.52 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.976 -0.69 . . . . 0.0 112.347 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.26 -178.07 42.61 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.515 ' CD ' ' HB2' ' A' ' 151' ' ' LYS . 15.3 Cg_exo -68.18 159.99 50.76 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 122.91 2.407 . . . . 0.0 110.86 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.09 -29.15 68.02 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 35.1 mt-10 -93.34 -41.53 9.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.42 0.629 . . . . 0.0 111.463 -178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 15.35 25.88 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.096 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -85.79 150.73 24.43 Favored Glycine 0 C--N 1.307 -1.054 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.49 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 47.8 Cg_exo -55.61 160.66 8.97 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.807 2.338 . . . . 0.0 112.646 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.82 -56.31 0.18 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.8 m -80.99 100.05 8.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.861 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' HG22 ' A' ' 140' ' ' ILE . 48.8 t -123.39 119.72 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.361 -174.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.22 131.12 56.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 173.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 109' ' ' ASP 0.253 32.5 p90 -138.26 134.11 33.98 Favored 'General case' 0 CA--C 1.475 -1.938 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 177.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -110.25 159.39 17.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.3 p -148.47 167.54 25.05 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 117.965 0.348 . . . . 0.0 111.838 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.268 19.2 m120 86.48 -24.59 0.12 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 48.7 mtpt -97.92 148.09 23.8 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.889 175.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -94.84 134.85 37.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 68.25 94.35 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.275 1.03 . . . . 0.0 111.365 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 87.6 mmm -127.41 107.2 9.75 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.652 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.405 ' O ' HG23 ' A' ' 102' ' ' VAL . 22.0 p -98.45 177.99 5.17 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -67.35 -25.87 66.21 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.9 t -56.62 -49.85 73.76 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -63.35 -38.89 92.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.958 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 98' ' ' CYS . 82.5 t -64.97 -29.79 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.69 -19.87 58.81 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.129 -0.357 . . . . 0.0 111.299 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -104.61 -42.38 5.43 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.32 124.83 47.69 Favored Pre-proline 0 C--N 1.303 -1.439 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.953 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.95 135.93 71.9 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.963 2.442 . . . . 0.0 110.882 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.17 167.36 14.58 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.552 2.168 . . . . 0.0 112.383 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -83.14 -44.77 14.72 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 90' ' ' PHE . 20.0 t70 -143.14 151.02 40.23 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.915 174.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.1 p -115.35 118.21 32.59 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 75' ' ' PHE . . . -108.34 150.73 26.95 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.103 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.98 107.04 10.43 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 8.5 tt -72.21 134.42 45.64 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.197 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.4 p -116.36 169.17 9.51 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.483 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.64 -33.05 72.22 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.867 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 121' ' ' LYS . 39.1 tt0 -60.17 -40.99 91.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.29 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.606 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.9 t-20 -63.38 -47.18 83.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.621 -177.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.46 -14.26 61.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -87.76 10.32 18.76 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.716 0.77 . . . . 0.0 109.065 175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.06 12.7 56.12 Favored Glycine 0 CA--C 1.507 -0.438 0 CA-C-N 114.272 -1.331 . . . . 0.0 114.627 174.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 12.2 mptt -99.31 117.55 63.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 C-N-CA 120.312 -0.555 . . . . 0.0 112.35 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 67.3 Cg_exo -56.29 119.73 7.11 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 123.954 3.103 . . . . 0.0 112.481 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.588 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 58.5 t -93.01 131.59 39.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 m -83.19 127.45 39.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 121.523 0.678 . . . . 0.0 111.455 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.458 HD12 ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -97.52 179.03 4.99 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.933 176.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.59 94.49 6.3 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 73' ' ' HIS . 20.0 p90 -105.08 12.43 32.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -173.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 89.8 t -65.75 -26.4 38.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.539 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -99.33 14.54 29.28 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.176 175.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.04 74.87 1.18 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.787 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.475 ' OE1' ' HE2' ' A' ' 71' ' ' LYS . 28.7 mm-40 -109.1 -37.91 5.68 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -112.55 114.31 26.9 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.2 t -122.48 100.88 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.806 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.592 172.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -87.1 -36.39 18.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.177 0.513 . . . . 0.0 109.766 169.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.9 p -141.84 141.67 33.11 Favored 'General case' 0 N--CA 1.411 -2.399 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.598 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 137' ' ' THR . 5.8 tt -140.16 141.48 36.03 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.578 ' N ' HD23 ' A' ' 136' ' ' LEU . 35.7 m -127.01 120.64 29.55 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -178.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -104.97 122.16 57.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 122.799 0.44 . . . . 0.0 110.405 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -122.59 107.27 11.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.662 HG13 ' HB2' ' A' ' 60' ' ' LEU . 2.0 pp -104.45 141.14 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.512 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -111.13 -25.66 9.63 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -158.51 158.43 34.03 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.66 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.401 ' HB3' HG23 ' A' ' 150' ' ' THR . 7.1 p30 -99.9 179.4 4.52 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.621 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 85.8 mm-40 -50.12 -59.82 3.55 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.632 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.5 m -91.03 -8.44 49.07 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.203 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.14 42.28 96.57 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.2 m -88.96 15.64 8.23 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 74.38 -42.08 0.49 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.807 1.243 . . . . 0.0 113.54 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -102.14 105.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.368 1.08 . . . . 0.0 110.576 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 34.5 m -97.02 124.22 40.95 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.109 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.515 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -97.11 133.73 41.39 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.412 0.625 . . . . 0.0 109.64 177.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.11 107.78 10.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 C-N-CA 124.946 1.298 . . . . 0.0 107.742 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -91.12 -32.33 15.89 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.28 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.565 ' HE3' ' HB2' ' A' ' 156' ' ' ALA . 7.4 tmtm? -152.93 133.49 13.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -174.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 68.2 mt -118.52 136.69 54.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.565 ' HB2' ' HE3' ' A' ' 154' ' ' LYS . . . -144.36 148.59 34.92 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-O 121.411 0.624 . . . . 0.0 110.643 174.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 2.8 mm? -117.57 127.38 53.92 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 169.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.451 ' HB3' ' CB ' ' A' ' 13' ' ' GLN . 61.7 m-85 -108.38 128.81 55.1 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.31 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -149.72 -166.73 13.54 Favored Glycine 0 C--N 1.286 -2.218 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.0 m -152.92 142.66 22.0 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 117.309 0.555 . . . . 0.0 110.44 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 117.566 -1.207 . . . . 0.0 109.743 176.535 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 120.727 0.299 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 29.8 p -93.09 81.2 4.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.792 -0.567 . . . . 0.0 110.648 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.58 134.29 5.25 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.6 163.8 21.21 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 123.587 0.554 . . . . 0.0 110.67 176.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.7 m -159.76 -54.07 0.06 Allowed 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.26 100.78 3.87 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.123 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 p -118.64 162.21 18.78 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.361 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.3 tp60 -86.82 79.34 8.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 11' ' ' LYS . 45.9 mm -98.02 119.49 62.02 Favored Pre-proline 0 C--N 1.289 -2.03 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.264 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -91.95 27.1 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.284 2.656 . . . . 0.0 111.214 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 9' ' ' ILE . 88.1 tttt 64.06 112.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.744 1.618 . . . . 0.0 112.028 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.89 -81.21 0.19 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.84 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 159' ' ' GLY . 2.2 mp0 -100.1 175.48 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.443 HG21 ' HE2' ' A' ' 19' ' ' PHE . 17.4 m -107.2 162.54 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.8 0 CA-C-O 120.803 0.335 . . . . 0.0 111.406 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.81 118.63 21.77 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.521 HD22 HG13 ' A' ' 70' ' ' ILE . 35.3 mt -69.99 2.52 3.45 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.236 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.58 -42.86 97.55 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.127 0.965 . . . . 0.0 108.651 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -61.49 -26.1 67.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.016 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.443 ' HE2' HG21 ' A' ' 14' ' ' VAL . 43.6 m-85 -102.55 22.33 13.74 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.092 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 2' ' ' SER . 78.6 mt -97.45 126.33 50.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 C-N-CA 121.411 -0.116 . . . . 0.0 110.815 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -88.74 118.05 28.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -90.82 6.82 42.8 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.486 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 m -89.93 -18.72 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 7.31 7.21 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.196 -1.002 . . . . 0.0 114.586 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.18 141.08 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 117.645 0.723 . . . . 0.0 111.538 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -129.61 134.56 47.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.232 0.539 . . . . 0.0 110.144 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . 19.8 p -110.92 114.56 27.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.958 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.9 -68.82 0.32 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.75 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' A' ' 60' ' ' LEU 0.255 7.2 p-10 -104.17 -52.9 2.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 33.1 tt0 69.36 0.95 3.09 Favored 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 122.923 0.489 . . . . 0.0 111.551 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.59 ' HB3' ' O ' ' A' ' 53' ' ' GLU . 79.1 p 73.94 130.29 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 127.472 2.309 . . . . 0.0 110.712 -168.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.7 m -62.35 15.65 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.0 m -138.2 -28.91 0.84 Allowed 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -124.48 165.57 17.55 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.715 -0.616 . . . . 0.0 112.18 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.3 m -91.07 -179.44 5.45 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -174.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.546 ' H ' ' HD2' ' A' ' 37' ' ' PRO . 15.8 tp -98.3 -56.8 0.18 Allowed Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 174.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 36' ' ' LEU . 24.7 Cg_endo -58.11 -22.09 54.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.663 2.242 . . . . 0.0 112.584 -175.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.604 HD22 ' HB2' ' A' ' 50' ' ' LEU . 31.7 p-10 -64.83 -30.04 71.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.57 -6.17 12.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.616 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.9 tp -105.27 -25.23 12.51 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.391 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -81.87 137.24 35.27 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.463 0.649 . . . . 0.0 111.603 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -63.29 134.89 56.58 Favored 'General case' 0 N--CA 1.39 -3.47 0 C-N-CA 125.182 1.393 . . . . 0.0 108.538 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.09 -56.81 1.78 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.666 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -67.84 -35.74 79.12 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 122.896 0.478 . . . . 0.0 111.488 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.486 ' HD2' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -54.79 174.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.414 2.375 . . . . 0.0 117.414 -175.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 153' ' ' GLN 0.375 44.3 mt-10 74.34 145.43 0.08 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.751 1.62 . . . . 0.0 115.162 177.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -62.03 117.88 6.56 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.06 -172.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.57 -68.48 0.26 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -130.97 -51.39 0.1 OUTLIER Glycine 0 CA--C 1.484 -1.886 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' HD22 ' A' ' 38' ' ' ASN . 3.8 pp -78.87 156.34 28.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.007 -0.597 . . . . 0.0 109.808 174.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -161.38 165.88 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 36' ' ' LEU . 4.7 tt -118.05 116.8 27.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.59 ' O ' ' HB3' ' A' ' 31' ' ' SER . 8.3 pt-20 -109.99 163.03 13.95 Favored 'General case' 0 C--N 1.264 -3.135 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 9.8 p -52.0 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.193 0 O-C-N 123.763 0.664 . . . . 0.0 112.211 -178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 54' ' ' SER . 13.8 t70 163.59 -156.89 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.67 -24.75 61.89 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.09 154.86 18.85 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.992 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.531 ' HB2' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -98.67 16.75 21.05 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -103.56 104.47 14.54 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.431 HD12 ' OD1' ' A' ' 29' ' ' ASN . 60.8 tp -114.53 132.62 56.25 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -172.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 62' ' ' ILE . 5.0 tt -137.87 133.83 34.36 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.913 -176.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.485 ' N ' HD23 ' A' ' 61' ' ' LEU . 3.3 mp -133.76 132.18 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -100.94 129.18 46.75 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 20' ' ' ILE . 3.0 mp -120.98 124.02 27.62 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.582 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -95.64 157.64 1.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.977 2.451 . . . . 0.0 110.815 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.413 ' H ' ' HD1' ' A' ' 66' ' ' PHE . 8.7 p90 -84.52 162.24 19.93 Favored 'General case' 0 CA--C 1.477 -1.862 0 CA-C-O 122.497 1.141 . . . . 0.0 113.438 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -97.82 -47.91 5.39 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.87 -1.968 . . . . 0.0 106.881 169.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -133.46 149.25 51.76 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.661 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.45 116.38 22.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.521 HG13 HD22 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -129.95 173.06 14.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -91.9 143.63 26.3 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.44 158.02 21.18 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -148.76 -63.77 0.24 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.3 p -143.7 165.71 26.9 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.724 -171.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CE1' ' HB ' ' A' ' 123' ' ' VAL . 4.9 p90 -133.51 159.25 40.98 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.609 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -151.98 100.13 2.62 Favored 'General case' 0 C--O 1.258 1.539 0 CA-C-O 120.914 0.388 . . . . 0.0 111.802 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 64.8 mt -102.62 136.13 36.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 118' ' ' LEU . 55.2 mtpt -118.49 144.09 46.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.454 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.414 ' HA2' ' HG3' ' A' ' 153' ' ' GLN . . . -165.23 -178.74 38.64 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 22.4 Cg_exo -69.29 157.23 62.06 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.202 1.935 . . . . 0.0 110.29 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 41.0 mt-10 -62.0 -35.92 79.98 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.54 -48.22 6.2 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 43.7 mt-10 -80.1 20.44 0.65 Allowed 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.631 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.62 167.5 24.55 Favored Glycine 0 C--N 1.301 -1.416 0 C-N-CA 120.232 -0.985 . . . . 0.0 111.274 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 35.9 Cg_endo -76.79 178.97 6.95 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 121.835 1.69 . . . . 0.0 111.012 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 144' ' ' GLN . 3.1 tmmm? -144.26 -61.85 0.38 Allowed 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.608 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.41 ' CB ' ' HB3' ' A' ' 142' ' ' ALA . 51.3 m -80.43 103.45 10.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.55 116.51 51.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.436 -175.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -107.66 135.84 48.41 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.547 0.689 . . . . 0.0 111.111 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -112.41 134.76 53.76 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.53 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 88.0 m-85 -124.57 115.57 21.06 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 175.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' CE1' ' A' ' 130' ' ' PHE . 20.4 m -110.92 150.57 29.03 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m120 82.08 154.68 0.12 Allowed 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.801 1.313 . . . . 0.0 108.39 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.649 ' HA ' ' HE3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER 67.68 100.87 0.05 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.649 0.737 . . . . 0.0 110.287 -175.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.63 140.16 38.45 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.527 0.68 . . . . 0.0 112.056 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 67.45 89.58 0.1 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 125.664 1.586 . . . . 0.0 111.839 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 81.8 mtp -119.86 142.37 48.72 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.467 ' O ' ' HB ' ' A' ' 102' ' ' VAL . 59.9 m -128.98 176.39 7.91 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -56.9 -20.42 23.16 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.0 m -81.5 -50.26 9.61 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.695 -0.628 . . . . 0.0 111.31 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -95.57 6.65 48.42 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.894 0.378 . . . . 0.0 111.529 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 98' ' ' CYS . 11.4 p -59.31 -37.35 68.68 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 C-N-CA 123.823 0.849 . . . . 0.0 112.222 -174.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -108.78 16.82 22.48 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.782 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -86.51 -20.98 27.24 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.064 0.935 . . . . 0.0 109.06 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -113.41 138.7 22.59 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.106 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.46 138.05 68.47 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.698 2.265 . . . . 0.0 112.538 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.23 152.67 45.16 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.4 2.066 . . . . 0.0 111.875 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -61.71 -45.58 93.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -167.98 168.96 11.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -128.59 123.19 32.72 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -119.41 169.05 10.36 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.365 0.603 . . . . 0.0 111.777 -174.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 5.6 mp0 -120.31 127.46 52.38 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.42 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.403 HD21 HD21 ' A' ' 118' ' ' LEU . 29.9 tp -72.48 110.89 7.19 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.9 t -101.0 174.46 6.0 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -60.65 -34.8 74.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.758 0.823 . . . . 0.0 110.641 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.21 -32.55 68.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.997 -179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.609 HD21 ' HA ' ' A' ' 76' ' ' ALA . 1.3 t-20 -68.81 -34.27 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -176.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' HE3' ' A' ' 78' ' ' LYS . 96.9 mt -62.2 2.68 0.22 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.493 1.517 . . . . 0.0 113.26 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -113.1 -14.11 12.97 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 124.472 1.109 . . . . 0.0 108.944 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.5 1.89 43.77 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.999 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -75.55 126.32 87.6 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.75 121.53 8.77 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.408 2.739 . . . . 0.0 114.067 -177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 75' ' ' PHE . 57.7 t -99.04 141.37 16.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 174.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.62 144.01 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -131.9 -174.75 3.51 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.046 0.938 . . . . 0.0 111.745 177.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -82.39 115.74 21.56 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -138.63 15.03 2.73 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.434 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.22 -38.51 81.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.181 0.515 . . . . 0.0 110.429 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.533 ' HD2' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -95.0 2.36 55.33 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 92' ' ' SER . 76.6 m-85 -117.78 66.32 0.75 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.653 0.74 . . . . 0.0 111.737 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -95.83 1.91 53.43 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.731 0.777 . . . . 0.0 109.483 176.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -148.2 116.07 6.39 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.78 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 66.8 t -116.88 137.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.444 -178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -116.98 -55.84 2.31 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.288 1.035 . . . . 0.0 108.802 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.0 p -118.57 139.21 51.83 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.222 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.8 tp -135.35 111.95 9.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.874 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 29.3 m -102.64 121.62 42.77 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -104.81 116.73 49.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 61.1 t80 -122.83 119.62 31.11 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.963 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.466 ' O ' HD12 ' A' ' 140' ' ' ILE . 2.3 pp -108.9 131.41 59.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.48 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 12.9 pt-20 -119.86 -14.92 8.92 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.803 -0.759 . . . . 0.0 113.01 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB3' ' CB ' ' A' ' 87' ' ' THR . . . -134.69 145.8 48.87 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.531 HD21 ' HB2' ' A' ' 58' ' ' GLU . 87.2 m-20 -101.79 169.14 8.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.021 -174.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -62.94 -56.08 20.32 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 123.876 0.735 . . . . 0.0 109.167 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.9 t -122.05 9.52 9.94 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.315 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.469 ' HA2' ' HB2' ' A' ' 143' ' ' ASN . . . 62.29 67.59 2.03 Favored Glycine 0 N--CA 1.469 0.862 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.105 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.0 m -100.74 9.2 42.71 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 68.22 -55.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.49 1.116 . . . . 0.0 111.478 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 53' ' ' GLU . 49.1 t -102.46 108.05 23.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 62.9 m -102.04 111.43 23.7 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.967 -1.469 . . . . 0.0 108.245 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 64.1 pttt -96.49 134.09 40.11 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 118.206 -1.398 . . . . 0.0 110.913 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.83 136.47 39.97 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.117 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 79.3 mt-30 -87.42 -51.87 5.69 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.57 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -162.01 149.25 14.1 Favored 'General case' 0 C--O 1.246 0.91 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.546 178.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.3 112.86 35.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -142.64 137.08 29.73 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 5.7 mp -112.05 159.55 18.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 56.1 m-85 -125.72 132.84 52.28 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' GLN . . . -153.52 -149.96 5.32 Favored Glycine 0 C--N 1.299 -1.5 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.515 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 46.3 m -157.87 161.33 38.3 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 70' ' ' ILE . 66.9 p . . . . . 0 C--N 1.279 -2.488 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.384 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.2 p -159.21 163.68 35.72 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.05 -177.9 6.14 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.494 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -86.8 -72.69 0.5 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.016 0.436 . . . . 0.0 111.439 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p -87.12 90.25 8.29 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.151 0.501 . . . . 0.0 111.669 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.636 ' HB2' HE21 ' A' ' 42' ' ' GLN . . . -131.76 92.36 3.13 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.063 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.2 p -165.31 135.7 3.74 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.049 0.452 . . . . 0.0 111.635 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.587 ' H ' HD12 ' A' ' 9' ' ' ILE . 5.4 tp60 -152.36 35.97 0.52 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.587 HD12 ' H ' ' A' ' 8' ' ' GLN . 2.2 mp -72.87 124.75 91.09 Favored Pre-proline 0 N--CA 1.437 -1.107 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.388 -174.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 9' ' ' ILE . 3.5 Cg_exo -72.92 -69.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.271 1.981 . . . . 0.0 111.808 175.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -162.08 -68.73 0.05 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.94 -10.99 82.19 Favored Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 121.31 -0.471 . . . . 0.0 114.241 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.539 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -126.72 134.21 50.72 Favored 'General case' 0 C--N 1.275 -2.67 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -174.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 p -105.9 153.69 7.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.818 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.97 120.62 12.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.45 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 83.5 mt -93.96 10.19 34.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -177.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.479 ' HG ' ' NH2' ' A' ' 45' ' ' ARG . 3.4 tm? -64.97 -36.66 85.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.493 0.663 . . . . 0.0 110.922 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -85.52 1.77 47.57 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.237 1.017 . . . . 0.0 110.498 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 16' ' ' LEU . 3.0 m-85 -101.15 7.47 43.16 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.679 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.404 HD12 HD22 ' A' ' 17' ' ' LEU . 70.6 mt -89.97 133.04 33.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.332 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -87.58 113.8 23.61 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -85.04 -0.54 54.77 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.855 -173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.9 m -87.3 -36.79 17.67 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.7 -13.2 32.91 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.207 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 64' ' ' ILE . 14.5 p -54.93 132.23 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 117.166 0.483 . . . . 0.0 110.626 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' N ' ' A' ' 27' ' ' CYS . 32.6 tt0 -145.05 159.57 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.066 0.46 . . . . 0.0 110.054 -177.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' N ' ' HG2' ' A' ' 26' ' ' GLU . 53.2 t -135.78 135.61 40.05 Favored 'General case' 0 N--CA 1.412 -2.372 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -60.27 -57.86 10.97 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 124.323 1.015 . . . . 0.0 108.543 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -68.7 -64.19 0.91 Allowed 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 70.27 -52.31 0.65 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.988 1.315 . . . . 0.0 114.274 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' HIS . 48.0 m -155.86 87.63 1.08 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -175.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.0 p -67.17 -29.34 69.01 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 118.287 -1.365 . . . . 0.0 107.976 162.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.2 m -154.49 -57.49 0.11 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.917 0.887 . . . . 0.0 110.154 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.514 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.5 m-70 -88.0 162.38 16.87 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.0 m -112.1 174.79 5.71 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.45 ' HA ' HD13 ' A' ' 52' ' ' LEU . 2.8 tm? -67.82 -58.14 8.61 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 26.8 Cg_exo -63.02 -17.92 62.63 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 121.973 1.782 . . . . 0.0 112.455 -174.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.0 m-20 -56.82 -46.58 81.55 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.736 1.214 . . . . 0.0 112.238 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 45' ' ' ARG . . . -104.32 2.66 31.66 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.42 0.628 . . . . 0.0 111.458 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -105.31 -44.46 4.73 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.489 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -79.94 123.69 28.01 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -173.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.636 HE21 ' HB2' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -55.36 117.71 3.78 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.935 179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.54 -45.76 1.1 Allowed Glycine 0 N--CA 1.418 -2.517 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.47 ' HB3' HD11 ' A' ' 50' ' ' LEU . 63.2 m-85 -95.58 -51.49 4.51 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HD3' ' HG2' ' A' ' 154' ' ' LYS . 89.6 mtt-85 22.7 -83.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 176.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 153' ' ' GLN . 41.9 mt-10 -61.91 134.71 57.01 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -166.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.471 ' H ' ' HB2' ' A' ' 153' ' ' GLN . 10.2 t70 -59.86 110.26 1.13 Allowed 'General case' 0 C--O 1.249 1.067 0 CA-C-N 113.121 -1.854 . . . . 0.0 110.328 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -151.71 -73.15 0.15 Allowed 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -107.56 -30.27 4.13 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.477 ' HB2' HD22 ' A' ' 38' ' ' ASN . 2.3 pp -132.21 148.19 52.45 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.064 -0.568 . . . . 0.0 110.014 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 29.8 p-10 -162.56 167.81 22.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 36' ' ' LEU . 40.9 tp -91.41 116.57 28.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 168.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.479 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 33.8 tt0 -136.69 112.57 9.57 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.599 0.714 . . . . 0.0 109.881 -175.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.62 ' HB2' HD13 ' A' ' 60' ' ' LEU . 31.8 t -94.79 101.88 13.72 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 114.536 -1.211 . . . . 0.0 107.816 176.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -102.3 -30.44 11.07 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.033 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -43.36 72.4 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.047 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -120.99 160.75 22.89 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.86 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.469 ' O ' HD11 ' A' ' 140' ' ' ILE . 43.7 tt0 -92.6 -31.7 15.07 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -77.32 118.35 19.71 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.071 -174.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.62 HD13 ' HB2' ' A' ' 54' ' ' SER . 23.7 tp -116.31 116.28 27.46 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -175.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 6.8 tt -118.95 128.83 54.78 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 57.2 mt -127.59 144.94 35.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 122.951 0.501 . . . . 0.0 109.718 -175.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' HE1' ' O ' ' A' ' 94' ' ' LYS . 83.9 t80 -117.26 126.86 53.42 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.959 0.504 . . . . 0.0 110.362 178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 25' ' ' VAL . 45.2 mm -120.97 121.58 28.75 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.911 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.79 127.13 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.735 2.29 . . . . 0.0 109.55 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -93.0 141.31 28.54 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -51.89 -50.17 61.56 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 126.754 2.022 . . . . 0.0 109.623 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -130.58 159.6 36.69 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.389 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 133' ' ' VAL . 7.3 p -83.26 108.18 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.45 172.98 12.27 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.516 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -95.24 132.33 40.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.6 tp -78.04 143.99 37.0 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -129.93 -54.2 1.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.144 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.438 ' HA ' HD22 ' A' ' 125' ' ' LEU . 16.1 p -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -117.72 158.14 25.25 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.44 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -153.53 105.44 2.83 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.835 0.35 . . . . 0.0 111.851 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.531 HG23 HG12 ' A' ' 155' ' ' ILE . 55.5 mt -120.39 130.21 74.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 96.4 mttt -104.97 143.24 33.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -154.66 176.23 32.5 Favored Glycine 0 C--N 1.257 -3.834 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.7 139.42 48.2 Favored 'Trans proline' 0 N--CA 1.439 -1.701 0 C-N-CA 121.492 1.461 . . . . 0.0 108.936 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.628 ' HA ' HD11 ' A' ' 118' ' ' LEU . 11.9 pt-20 -58.68 -25.63 63.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.969 0.414 . . . . 0.0 112.069 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.53 -57.08 4.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.898 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 4.4 mm-40 -81.46 -59.62 2.56 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.424 -0.51 . . . . 0.0 109.905 -170.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.19 119.41 0.0 OUTLIER Glycine 0 N--CA 1.506 3.303 0 C-N-CA 127.326 2.394 . . . . 0.0 118.158 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.654 ' HA ' ' OD1' ' A' ' 143' ' ' ASN . 56.8 Cg_endo -69.29 112.18 2.92 Favored 'Trans proline' 0 C--N 1.356 0.958 0 CA-C-N 119.932 1.866 . . . . 0.0 110.06 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.618 ' HG2' ' HB2' ' A' ' 112' ' ' GLU . 30.5 ttmt -90.39 -75.37 0.46 Allowed 'General case' 0 C--O 1.213 -0.818 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.071 -171.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -72.71 102.25 3.29 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.235 -174.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG12 HG22 ' A' ' 140' ' ' ILE . 34.2 m -104.68 117.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.845 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HG3' ' OG1' ' A' ' 110' ' ' THR . 25.7 ttmm -107.11 132.83 52.56 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -112.69 139.02 48.64 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -107.54 155.55 19.97 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.8 m -77.97 -171.04 2.14 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 124.125 0.891 . . . . 0.0 110.926 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 135' ' ' SER . 8.9 p30 -57.22 104.4 0.16 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.589 0.709 . . . . 0.0 111.512 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.417 ' O ' ' HE1' ' A' ' 63' ' ' TYR . 55.3 tptt -163.51 164.8 24.21 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 96' ' ' HIS . 41.3 tt0 -75.95 174.01 10.5 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.467 ' H ' ' HG2' ' A' ' 95' ' ' GLU . 0.4 OUTLIER -48.76 137.09 12.78 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -175.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.509 ' HB2' HG21 ' A' ' 137' ' ' THR . 18.5 mmt -93.8 173.53 7.63 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.226 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.513 ' O ' HG13 ' A' ' 102' ' ' VAL . 75.6 m -149.36 155.55 40.66 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 174.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -55.99 -24.65 40.06 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.4 t -85.09 -6.41 59.31 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -116.72 -15.99 10.7 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.419 -0.801 . . . . 0.0 110.836 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 98' ' ' CYS . 29.0 m -67.64 -3.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -97.18 -19.4 18.66 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.398 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -89.33 -37.32 14.98 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.746 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 93.5 m-85 -96.44 137.32 21.56 Favored Pre-proline 0 C--N 1.302 -1.47 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.138 -175.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 13.3 Cg_exo -70.13 128.72 16.07 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.741 2.294 . . . . 0.0 111.216 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.31 165.23 29.73 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.548 2.165 . . . . 0.0 111.521 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 129' ' ' LYS . 22.4 m -76.48 -47.48 22.74 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -162.72 169.09 20.57 Favored 'General case' 0 CA--C 1.471 -2.09 0 C-N-CA 123.513 0.725 . . . . 0.0 109.337 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 40.9 m -146.2 114.43 6.64 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -123.29 172.87 8.32 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.618 ' HB2' ' HG2' ' A' ' 86' ' ' LYS . 11.7 pt-20 -125.35 139.67 53.48 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 86' ' ' LYS . 22.4 tp -59.79 113.2 2.15 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.703 0.801 . . . . 0.0 108.903 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 41.1 p -85.25 166.4 16.55 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 4.1 mp0 -57.74 -39.21 76.82 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.46 -38.62 77.83 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.72 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.594 HD22 HG23 ' A' ' 123' ' ' VAL . 8.8 t-20 -66.28 -41.14 90.24 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 81' ' ' GLU . 7.5 tt -62.22 -23.33 66.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.115 1.366 . . . . 0.0 110.671 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.477 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 58.2 mtpt -102.52 1.9 35.61 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.47 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.54 68.04 0.87 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.812 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.402 ' HD2' ' HD2' ' A' ' 122' ' ' PRO . 52.3 tptt -137.39 117.58 10.48 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.501 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 15.0 Cg_endo -58.17 101.64 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.379 2.053 . . . . 0.0 111.886 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 117' ' ' ASN . 53.3 t -85.43 126.71 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 m -83.35 144.22 10.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.526 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 74' ' ' SER . 1.2 mm? -98.71 -173.44 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.409 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -80.99 141.4 34.46 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -96.19 27.45 3.69 Favored 'General case' 0 C--N 1.281 -2.374 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.655 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 63.8 t -94.32 -49.89 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 108' ' ' SER . 27.5 tptp -95.4 -6.13 41.64 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.79 15.37 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -62.22 121.9 14.26 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . 0.325 20.9 p-10 42.97 112.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 127.221 2.208 . . . . 0.0 114.765 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 44.4 t -121.53 104.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.735 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -99.49 -28.45 13.24 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 93' ' ' ASN . 59.9 m -143.2 151.17 40.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 137' ' ' THR . 5.6 tt -146.33 138.42 25.01 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.509 HG21 ' HB2' ' A' ' 97' ' ' MET . 60.6 m -118.04 133.07 56.25 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 64.1 mt -108.18 122.86 63.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -123.33 116.85 23.99 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 58' ' ' GLU 0.267 2.0 pp -90.37 138.86 18.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 117.749 -1.58 . . . . 0.0 111.079 176.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -94.47 -48.46 6.11 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.936 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -148.85 159.78 43.85 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.071 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.654 ' OD1' ' HA ' ' A' ' 85' ' ' PRO . 94.3 m-20 -109.11 167.13 10.33 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.648 HE21 ' HA ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -47.6 -53.14 15.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.602 1.561 . . . . 0.0 111.558 -177.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.3 t -112.93 4.15 16.65 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.541 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 56.95 62.51 6.28 Favored Glycine 0 C--O 1.217 -0.907 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -83.88 8.1 16.03 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 65.68 7.09 4.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 112.949 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -146.68 155.73 11.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 93.2 m -121.58 111.39 17.17 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.478 0.656 . . . . 0.0 110.736 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -112.8 133.69 54.68 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.41 149.04 29.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 46' ' ' GLU . 20.6 pt20 -118.1 -5.08 10.96 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.562 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -172.79 118.66 0.34 Allowed 'General case' 0 C--O 1.208 -1.091 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.398 176.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.531 HG12 HG23 ' A' ' 77' ' ' ILE . 68.4 mt -114.73 124.85 71.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -143.11 152.07 41.43 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.32 147.47 51.86 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 81.9 m-85 -124.38 133.71 53.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.225 0.536 . . . . 0.0 110.404 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.59 -173.23 13.06 Favored Glycine 0 CA--C 1.489 -1.531 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.8 m -134.23 135.32 42.87 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.253 0.549 . . . . 0.0 110.862 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.421 -1.905 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.526 179.114 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.445 -0.715 0 CA-C-O 121.005 0.431 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 p -91.43 94.77 9.63 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.07 116.67 7.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.041 0.448 . . . . 0.0 112.045 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.44 144.37 49.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 39.8 t -105.46 137.05 43.91 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.09 119.42 14.26 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 174.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.9 m -40.17 103.65 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 124.966 1.306 . . . . 0.0 114.507 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -94.74 21.29 7.6 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 11' ' ' LYS . 39.5 mm -56.11 113.66 6.2 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.456 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -89.79 11.91 2.71 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.747 2.298 . . . . 0.0 111.58 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' H ' HG22 ' A' ' 9' ' ' ILE . 39.7 ttmt 65.96 97.02 0.05 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 110.882 -176.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.61 -63.27 0.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -112.87 176.07 5.17 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 16' ' ' LEU . 34.1 m -106.23 169.63 2.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -84.09 95.96 8.76 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.861 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 157' ' ' LEU . 5.7 mp -74.79 -2.41 26.47 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.1 tt -74.06 -36.91 64.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 5' ' ' SER . 16.1 t70 -66.25 -21.14 66.28 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.998 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -97.21 12.2 33.71 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.022 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 16' ' ' LEU . 74.3 mt -84.13 131.63 33.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -91.47 124.54 35.72 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 121.693 0.759 . . . . 0.0 110.887 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -103.74 19.23 20.28 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.854 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.0 m -93.12 -30.89 15.03 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.5 23.94 3.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.839 -1.172 . . . . 0.0 114.133 -178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.0 135.89 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -143.63 148.91 36.53 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.195 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.67 ' HB3' ' HG2' ' A' ' 30' ' ' GLN . 47.7 t -135.87 140.66 44.29 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 97' ' ' MET . 91.1 mt -79.35 19.92 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.431 0.634 . . . . 0.0 111.808 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -154.9 -60.47 0.11 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.67 ' HG2' ' HB3' ' A' ' 27' ' ' CYS . 47.9 mt-30 67.39 14.5 9.67 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 124.116 0.966 . . . . 0.0 109.86 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.67 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 3.2 m 74.75 135.03 0.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.219 1.808 . . . . 0.0 109.447 -174.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.429 ' HB3' ' OD2' ' A' ' 55' ' ' ASP . 33.1 t -66.83 -46.93 73.56 Favored 'General case' 0 CA--C 1.559 1.313 0 O-C-N 121.415 -0.803 . . . . 0.0 111.577 175.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.5 t -89.82 -47.1 8.12 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.108 0.956 . . . . 0.0 111.151 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.67 ' O ' ' HB2' ' A' ' 31' ' ' SER . 54.0 m80 -83.05 166.91 18.36 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 125.054 1.342 . . . . 0.0 111.146 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 m -110.49 169.5 8.71 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.914 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.528 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . 4.1 tt -65.12 -57.61 14.96 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 123.022 0.529 . . . . 0.0 111.68 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 5.7 Cg_exo -78.64 -1.83 11.94 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 121.848 1.699 . . . . 0.0 111.296 -176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.488 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.0 t-20 -49.12 -48.45 44.58 Favored 'General case' 0 C--O 1.211 -0.944 0 C-N-CA 125.515 1.526 . . . . 0.0 109.648 -176.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . . . -142.24 78.68 1.63 Allowed 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.764 0.793 . . . . 0.0 110.036 173.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.0 tp -168.26 -38.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 113.776 -1.557 . . . . 0.0 106.846 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 10.7 tmtt? -90.66 133.45 35.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.418 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 14.9 mm100 -53.28 142.55 20.84 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.48 -37.57 3.44 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.218 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' HD11 ' A' ' 50' ' ' LEU . 68.6 m-85 -89.72 -43.2 10.87 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 175.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 38.0 ttp180 -43.49 117.32 1.11 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.948 1.699 . . . . 0.0 113.206 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -177.53 137.42 0.21 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -89.78 91.86 8.8 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 120.881 0.372 . . . . 0.0 111.924 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -151.6 -71.67 0.16 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.018 0.927 . . . . 0.0 109.577 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.79 -56.8 0.5 Allowed Glycine 0 N--CA 1.426 -1.993 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.451 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 38' ' ' ASN . 2.3 pp -89.11 142.21 27.84 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.106 0.479 . . . . 0.0 111.884 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.597 ' ND2' ' HB2' ' A' ' 53' ' ' GLU . 3.6 p-10 -163.49 165.65 23.49 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.505 ' CD2' HD21 ' A' ' 60' ' ' LEU . 3.3 tt -88.07 126.83 35.31 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 171.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.597 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 44.8 tt0 -128.99 143.17 50.79 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 90.5 p -78.01 82.26 4.37 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 32' ' ' SER . 38.9 t70 -117.13 96.52 5.48 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.352 -175.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 148.7 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 128.075 2.55 . . . . 0.0 104.878 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 54' ' ' SER . 10.7 t70 -157.75 155.35 29.71 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.289 -1.778 . . . . 0.0 106.676 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.18 -21.13 39.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.003 0.43 . . . . 0.0 110.652 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.81 109.7 17.75 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.527 HD23 HD11 ' A' ' 140' ' ' ILE . 27.8 tp -116.81 117.51 29.96 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.427 0.632 . . . . 0.0 110.487 -174.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.534 HD11 ' O ' ' A' ' 96' ' ' HIS . 1.8 tm? -107.21 124.38 49.65 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.506 HG13 ' SG ' ' A' ' 27' ' ' CYS . 2.0 mp -127.01 134.58 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -103.54 121.57 43.16 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.575 0.75 . . . . 0.0 109.095 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.42 120.17 29.05 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.151 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.02 154.54 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.749 2.299 . . . . 0.0 109.574 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -112.19 152.34 28.49 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -62.73 -50.63 70.33 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.586 1.554 . . . . 0.0 108.084 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -127.51 143.13 51.22 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.671 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.86 112.18 13.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -134.32 173.16 15.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -83.54 143.24 30.31 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.239 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.442 HD13 HD23 ' A' ' 157' ' ' LEU . 57.8 tp -92.32 105.56 17.74 Favored 'General case' 0 C--O 1.19 -2.057 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -96.37 -54.62 3.2 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.979 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 p -145.44 161.87 38.67 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.844 -173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' CE1' HD11 ' A' ' 125' ' ' LEU . 2.7 p90 -131.97 157.66 43.47 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.534 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -143.0 114.44 7.95 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.209 0.604 . . . . 0.0 109.773 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 60.5 mt -113.21 129.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.513 ' HE2' ' C ' ' A' ' 119' ' ' LYS . 68.2 mttt -117.2 157.98 25.07 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.481 175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.03 -152.79 20.89 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 15.0 Cg_exo -72.11 152.38 56.51 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.201 1.934 . . . . 0.0 109.533 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.55 -38.93 81.22 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 144' ' ' GLN . 42.5 mt-10 -94.69 -34.7 12.46 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 5.0 mp0 -93.78 11.58 28.72 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.491 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -84.8 150.42 25.27 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-O 119.157 -0.802 . . . . 0.0 111.636 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 113' ' ' LEU . 23.6 Cg_exo -63.05 113.92 2.23 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.436 2.757 . . . . 0.0 113.375 -175.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.465 ' HD3' ' HG3' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -104.31 -49.5 3.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -176.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.5 m -83.11 100.52 10.57 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.818 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.9 t -115.57 122.98 70.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.959 -173.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -115.73 133.79 55.67 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 170.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 92.0 m-85 -111.96 152.1 28.47 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 25.4 t80 -140.68 117.06 10.72 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 172.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.6 m -91.61 138.2 31.75 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 47.95 81.91 0.04 OUTLIER 'General case' 0 C--O 1.244 0.775 0 C-N-CA 126.171 1.788 . . . . 0.0 113.965 177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -171.51 170.72 5.69 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -81.43 175.7 10.33 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' HD11 ' A' ' 61' ' ' LEU . 33.1 p80 -44.67 -40.65 6.07 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.46 ' O ' HD11 ' A' ' 28' ' ' LEU . 87.1 mtp 61.6 -165.75 0.22 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.502 ' O ' HG23 ' A' ' 102' ' ' VAL . 30.8 p -150.06 163.81 37.19 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 139' ' ' PHE . 42.0 p90 -68.98 -17.89 63.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -67.47 -20.2 65.44 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -103.76 -31.66 9.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.603 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 98' ' ' CYS . 95.9 t -59.57 -29.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.21 -7.22 58.07 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.28 -38.45 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.81 0.338 . . . . 0.0 111.557 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -95.75 137.57 21.87 Favored Pre-proline 0 C--N 1.305 -1.355 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.138 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.3 131.08 27.13 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.452 2.101 . . . . 0.0 111.508 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.37 161.17 38.07 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.414 2.076 . . . . 0.0 111.487 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . 28.5 m -61.78 -46.02 91.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.329 0.585 . . . . 0.0 110.03 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -159.11 143.43 15.42 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.5 p -104.85 115.03 29.6 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -108.52 152.59 24.53 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 -175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.465 ' HG3' ' HD3' ' A' ' 86' ' ' LYS . 35.0 tt0 -125.62 118.35 25.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.229 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 20.8 tp -61.86 105.17 0.53 Allowed 'General case' 0 C--O 1.247 0.952 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -92.64 170.57 9.63 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.505 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 42.9 tt0 -54.98 -46.09 75.07 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.767 0.427 . . . . 0.0 111.276 -177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -64.85 -34.66 78.91 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.4 t-20 -61.65 -44.59 96.69 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 tm? -65.36 -32.77 74.58 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.314 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.513 ' C ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -84.77 9.96 12.69 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 175.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.35 31.3 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 115.149 0.819 . . . . 0.0 115.149 171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -93.4 132.74 29.65 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 117.648 0.724 . . . . 0.0 111.338 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 26.5 Cg_endo -65.37 117.33 4.49 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 123.208 2.605 . . . . 0.0 112.471 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.87 130.74 44.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.8 t -80.78 133.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 122.956 0.502 . . . . 0.0 111.236 -174.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.464 HD11 ' CE1' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -100.0 175.1 5.88 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 8.5 mmpt? -86.15 49.05 1.71 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -74.69 25.62 0.09 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 -170.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.8 m -57.02 -27.49 27.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -95.24 -41.18 9.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.655 0.741 . . . . 0.0 110.491 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' HB3' ' A' ' 108' ' ' SER . 28.0 m-85 -72.13 84.42 1.02 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.159 -1.382 . . . . 0.0 113.054 -173.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -111.55 -11.36 14.07 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.245 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -124.37 113.85 18.74 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.494 0.664 . . . . 0.0 109.846 174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 72' ' ' LEU . 47.1 t -123.31 105.74 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.17 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -104.9 -32.1 8.95 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 44.9 m -135.93 135.25 39.48 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.431 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 57.2 tp -135.65 126.36 27.26 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.877 0.37 . . . . 0.0 110.085 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.6 m -94.2 117.01 29.49 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.27 115.84 50.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 141' ' ' GLU . 48.5 t80 -114.39 114.88 26.47 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.089 0.471 . . . . 0.0 111.323 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 60' ' ' LEU . 28.2 pt -104.12 114.85 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.881 0.848 . . . . 0.0 109.277 174.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.453 ' HB2' ' CE2' ' A' ' 139' ' ' PHE . 43.6 tt0 -90.78 -28.38 18.28 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.66 -172.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -162.25 154.83 19.62 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 120.469 -0.493 . . . . 0.0 111.271 -177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -89.63 175.95 7.06 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.006 176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.45 ' HB3' ' O ' ' A' ' 82' ' ' GLU . 8.5 tp-100 -51.12 -43.89 61.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.432 1.093 . . . . 0.0 112.909 -175.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.7 m -96.59 -37.68 10.27 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.515 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.92 42.62 3.03 Favored Glycine 0 C--N 1.302 -1.345 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.8 m -85.47 13.95 6.14 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.326 1.05 . . . . 0.0 112.655 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 74.93 -34.87 0.27 Allowed 'General case' 0 C--N 1.35 0.624 0 C-N-CA 125.823 1.649 . . . . 0.0 111.625 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.1 p -100.69 98.69 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-O 122.315 1.055 . . . . 0.0 110.471 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.7 m -92.25 113.71 26.06 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.531 ' HG3' ' ND2' ' A' ' 51' ' ' ASN . 86.7 tttt -113.96 135.23 54.22 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.018 -174.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.5 p -134.69 137.2 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.309 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 11.7 pt20 -96.7 -28.64 14.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.19 177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -171.23 150.9 3.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 173.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.02 111.95 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.404 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -107.69 147.12 31.16 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 4.7 mp -123.34 143.91 49.79 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 67.9 m-85 -125.68 137.94 53.87 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -166.39 -140.62 2.93 Favored Glycine 0 C--N 1.296 -1.648 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 32.6 t -162.83 149.9 13.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.423 -1.813 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.2 p . . . . . 0 C--O 1.243 0.717 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 m -105.77 114.1 28.05 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.99 110.14 22.21 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -96.88 173.79 7.11 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.194 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.8 t -155.07 123.97 6.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 120.863 0.363 . . . . 0.0 111.743 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.76 115.47 25.23 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 172.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.6 t -148.78 -179.85 7.3 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -81.31 97.26 7.6 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-O 121.675 0.75 . . . . 0.0 109.158 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.6 mm -93.64 127.64 45.14 Favored Pre-proline 0 N--CA 1.396 -3.169 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -85.5 136.43 5.48 Favored 'Trans proline' 0 N--CA 1.427 -2.42 0 C-N-CA 121.715 1.61 . . . . 0.0 111.191 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -50.64 113.49 0.91 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.873 0.869 . . . . 0.0 112.155 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.13 8.36 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.51 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.19 147.36 34.76 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 117.25 0.525 . . . . 0.0 111.373 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.93 149.14 10.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.97 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.83 134.42 39.07 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 20' ' ' ILE . 2.2 mm? -62.87 -14.04 41.29 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.373 1.069 . . . . 0.0 113.813 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.448 HD21 ' HA ' ' A' ' 41' ' ' LYS . 2.1 tm? -51.32 -36.4 42.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.499 0.666 . . . . 0.0 109.93 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.27 -26.25 60.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.214 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -107.67 34.35 3.58 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 16' ' ' LEU . 33.8 mm -116.4 145.1 22.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.056 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -96.23 131.59 42.55 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -104.38 8.85 35.89 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.1 m -97.3 -34.96 10.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' C ' ' HG3' ' A' ' 65' ' ' PRO . . . -89.22 -4.86 73.71 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.458 -0.792 . . . . 0.0 114.05 -176.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -53.59 143.43 5.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -142.55 139.62 31.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.136 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 30' ' ' GLN . 5.5 p -135.61 128.85 31.93 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.891 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.657 HD23 HD12 ' A' ' 61' ' ' LEU . 2.7 mm? -91.92 123.71 35.5 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.502 HD21 ' HB3' ' A' ' 56' ' ' ALA . 47.3 t-20 76.26 -59.78 0.5 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 125.759 1.624 . . . . 0.0 108.263 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 34.2 tt0 73.14 -74.77 0.08 Allowed 'General case' 0 C--N 1.37 1.474 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -176.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p 174.16 115.95 0.02 OUTLIER 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.4 t -48.91 -37.23 19.18 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.1 t -100.63 -42.63 6.46 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 121.725 -0.609 . . . . 0.0 111.233 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -85.13 166.57 16.51 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -106.96 152.94 23.28 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.644 ' HA ' HD13 ' A' ' 52' ' ' LEU . 3.1 tm? -54.47 -57.89 16.59 Favored Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 115.529 1.678 . . . . 0.0 115.529 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.82 -17.06 58.36 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.183 1.922 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.538 HD22 ' HB2' ' A' ' 50' ' ' LEU . 3.1 m-20 -58.75 -27.55 65.05 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 113.086 -176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . . . -133.04 15.71 4.21 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.206 0.526 . . . . 0.0 110.749 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.8 tp -112.29 -43.16 3.57 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.21 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.448 ' HA ' HD21 ' A' ' 17' ' ' LEU . 16.0 ptpt -98.28 137.58 36.8 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.353 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.19 121.62 14.67 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.97 -64.64 0.44 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.501 ' O ' HD11 ' A' ' 50' ' ' LEU . 59.0 m-85 -77.04 -39.79 48.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 153' ' ' GLN . 26.4 ttp180 -37.35 103.58 0.03 OUTLIER 'General case' 0 C--O 1.243 0.739 0 C-N-CA 126.106 1.762 . . . . 0.0 113.324 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -164.65 89.27 0.51 Allowed 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -57.96 104.32 0.19 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.889 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 178.1 -67.55 0.01 OUTLIER 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.308 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -103.17 -59.06 0.73 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 50' ' ' LEU . 3.5 pp -104.25 120.9 42.18 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.788 0.804 . . . . 0.0 110.006 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.472 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 3.0 p-10 -161.48 165.63 28.37 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.644 HD13 ' HA ' ' A' ' 36' ' ' LEU . 26.6 tp -91.65 112.42 24.33 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -131.71 113.46 13.58 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.592 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 35.6 p -74.4 82.22 1.92 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.059 0.933 . . . . 0.0 110.237 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.49 -30.55 29.82 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.893 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.502 ' HB3' HD21 ' A' ' 29' ' ' ASN . . . -69.23 -35.68 76.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 54' ' ' SER . 19.1 t70 -171.47 156.42 4.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.619 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.2 tt0 -80.49 -11.69 59.64 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.911 0.884 . . . . 0.0 112.545 -173.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -79.89 112.94 17.66 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -127.14 136.16 51.71 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.403 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.657 HD12 HD23 ' A' ' 28' ' ' LEU . 1.6 tm? -131.39 126.22 34.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.3 mp -128.12 134.64 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.659 ' CE1' ' HG3' ' A' ' 95' ' ' GLU . 49.4 t80 -103.7 128.1 51.08 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 123.708 0.803 . . . . 0.0 110.187 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.417 ' CG2' HD12 ' A' ' 20' ' ' ILE . 49.5 mm -120.94 124.03 27.63 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.426 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 78.2 Cg_endo -92.37 159.96 3.06 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 123.29 2.66 . . . . 0.0 110.365 171.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.401 ' H ' ' HD1' ' A' ' 66' ' ' PHE . 4.3 p90 -95.23 154.88 16.97 Favored 'General case' 0 CA--C 1.459 -2.553 0 CA-C-O 122.568 1.175 . . . . 0.0 113.919 -174.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -88.05 -42.89 12.1 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 112.877 -1.965 . . . . 0.0 106.968 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -150.65 139.07 20.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.8 m -73.17 124.68 30.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 CA-C-O 121.639 0.733 . . . . 0.0 111.643 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.43 ' CD1' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -128.15 174.59 11.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -92.51 138.68 31.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 125' ' ' LEU . 0.5 OUTLIER -79.35 144.16 34.46 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.109 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -136.07 -45.51 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.928 -0.483 . . . . 0.0 111.807 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.6 m -151.38 175.92 11.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.842 -0.536 . . . . 0.0 110.391 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 157' ' ' LEU . 27.7 p90 -135.62 152.46 51.26 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.475 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . . . -158.87 107.65 1.91 Allowed 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.218 0.533 . . . . 0.0 111.616 177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 77' ' ' ILE . 2.3 mp -107.38 132.58 54.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HE2' ' CA ' ' A' ' 120' ' ' GLY . 90.9 mttt -117.69 167.5 11.3 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.337 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.37 -168.25 34.14 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' HG3' ' HG3' ' A' ' 151' ' ' LYS . 41.9 Cg_endo -68.76 149.43 73.06 Favored 'Trans proline' 0 C--N 1.332 -0.297 0 C-N-CA 122.262 1.974 . . . . 0.0 111.214 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.53 -26.37 66.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.01 -55.92 4.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.918 0.866 . . . . 0.0 111.04 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.74 13.04 36.22 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.416 -170.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.31 148.14 26.4 Favored Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 143' ' ' ASN . 16.4 Cg_endo -58.1 176.21 0.39 Allowed 'Trans proline' 0 C--O 1.218 -0.52 0 C-N-CA 123.191 2.594 . . . . 0.0 113.971 -175.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 112' ' ' GLU . 84.0 tttt -154.63 -68.38 0.13 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.8 m -78.26 108.39 11.55 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.47 146.19 33.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.072 0.463 . . . . 0.0 111.871 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -130.4 148.84 52.26 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -126.94 152.97 46.43 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -137.59 144.41 41.98 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 130' ' ' PHE . 48.2 t -137.27 155.19 49.77 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.362 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 m120 76.67 -43.32 0.45 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.662 1.585 . . . . 0.0 113.469 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.612 ' HD3' ' SD ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -87.21 107.78 18.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 178.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HG3' ' CE1' ' A' ' 63' ' ' TYR . 34.6 tt0 -65.03 134.44 53.85 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 59.94 87.88 0.08 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.428 1.091 . . . . 0.0 112.447 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.612 ' SD ' ' HD3' ' A' ' 94' ' ' LYS . 95.6 mmm -123.75 98.63 5.9 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.284 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.522 ' O ' HG23 ' A' ' 102' ' ' VAL . 64.3 m -88.78 167.87 12.94 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 89.6 t80 -49.11 -33.75 12.47 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.64 0.776 . . . . 0.0 112.585 -176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.7 t -56.64 -26.31 55.67 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.329 0.652 . . . . 0.0 112.007 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -114.66 -18.14 11.48 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.123 0.487 . . . . 0.0 111.108 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 98' ' ' CYS . 60.7 t -63.45 -18.89 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.126 0.971 . . . . 0.0 113.352 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -87.57 -22.91 24.52 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.729 -0.607 . . . . 0.0 112.062 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -94.38 -36.09 12.08 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -95.99 150.4 37.24 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.929 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.89 117.19 5.02 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.677 2.251 . . . . 0.0 113.06 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.37 172.09 17.01 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.088 1.859 . . . . 0.0 110.272 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.512 ' HA ' ' CE2' ' A' ' 130' ' ' PHE . 19.7 m -67.43 -46.99 71.51 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -172.54 -176.08 1.46 Allowed 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 172.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.9 t -139.91 130.99 26.34 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.02 173.07 11.59 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-O 121.382 0.611 . . . . 0.0 112.138 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 35.1 tt0 -123.97 128.97 50.17 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 24.7 tp -69.84 105.52 2.81 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 t -86.85 163.12 17.38 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.24 -37.99 73.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.01 -31.88 68.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 123.238 0.337 . . . . 0.0 111.289 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 76' ' ' ALA . 2.2 t-20 -63.66 -47.02 82.95 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 118' ' ' LEU . 5.7 tt -67.05 -20.3 65.82 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.002 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tpmt? -86.02 -14.29 44.92 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.065 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.527 ' CA ' ' HE2' ' A' ' 78' ' ' LYS . . . 111.71 11.71 16.32 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.934 179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.58 125.53 57.36 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.184 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.498 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 55.6 Cg_endo -70.38 109.65 2.49 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.953 2.435 . . . . 0.0 111.15 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.5 t -85.81 122.37 38.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.91 110.1 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 122.106 0.955 . . . . 0.0 113.048 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -93.05 -165.68 1.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.605 178.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -93.24 115.03 27.65 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 120.639 0.257 . . . . 0.0 111.11 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -132.93 18.13 4.16 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.69 -29.52 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.452 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 0.7 OUTLIER -83.92 -29.49 27.08 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.219 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 70.8 m-85 -93.12 75.67 4.67 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.115 0.96 . . . . 0.0 112.537 -172.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -94.58 -2.32 51.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.108 -1.405 . . . . 0.0 109.158 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -151.53 115.75 5.02 Favored 'General case' 0 CA--C 1.479 -1.783 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.021 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.94 102.65 13.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 173.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -81.15 -64.95 1.08 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.06 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.5 p -132.99 149.4 52.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 137' ' ' THR . 3.5 tt -129.19 139.89 51.71 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -176.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.506 ' N ' HD23 ' A' ' 136' ' ' LEU . 79.3 m -119.78 124.44 46.15 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 138' ' ' ILE . 2.9 mp -104.55 123.92 58.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.502 ' CE2' ' HG2' ' A' ' 141' ' ' GLU . 33.8 t80 -116.43 110.84 19.17 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.404 0.621 . . . . 0.0 110.613 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 41.4 mt -99.92 125.74 53.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.502 ' HG2' ' CE2' ' A' ' 139' ' ' PHE . 36.2 mt-10 -100.5 -50.27 3.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.11 167.69 23.49 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 85' ' ' PRO . 83.1 m-20 -110.67 170.15 8.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 O-C-N 123.575 0.547 . . . . 0.0 111.454 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 86' ' ' LYS . 35.4 mm-40 -47.38 -57.9 4.76 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.255 0.972 . . . . 0.0 110.064 175.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.2 t -87.02 -26.89 23.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.215 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.55 75.68 0.59 Allowed Glycine 0 C--O 1.221 -0.679 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.1 t -107.72 -2.22 20.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.581 0.229 . . . . 0.0 110.95 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 38.7 mt-10 74.73 0.44 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.266 1.026 . . . . 0.0 112.13 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 54' ' ' SER . 5.7 p -139.95 124.58 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 32.5 m -109.7 111.78 23.45 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.972 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 18.9 pttm -109.85 134.75 51.71 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.183 171.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 155' ' ' ILE . 29.2 m -123.01 148.49 26.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.767 -172.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.482 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 5.5 tp60 -85.81 -48.7 8.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.987 174.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -167.53 136.16 2.56 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 176.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 152' ' ' VAL . 2.5 mp -104.72 112.27 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.226 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 154' ' ' LYS . . . -139.92 157.28 45.94 Favored 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.11 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 75' ' ' PHE . 1.9 mm? -119.43 157.21 28.69 Favored 'General case' 0 C--N 1.272 -2.765 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 72.4 m-85 -116.18 128.02 55.28 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.37 15.29 Favored Glycine 0 N--CA 1.423 -2.223 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.392 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 55.7 p -135.1 117.98 16.23 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.218 0.533 . . . . 0.0 111.438 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.0 p . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.653 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 p . . . . . 0 N--CA 1.445 -0.704 0 CA-C-O 121.193 0.52 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 22' ' ' TRP . 48.3 t -69.29 -67.62 0.46 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.288 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . . . -158.45 33.3 0.23 Allowed 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 3' ' ' ALA . 36.1 mt-10 -82.09 100.45 9.78 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 112.1 -2.318 . . . . 0.0 111.461 -169.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.601 ' HB2' ' HG3' ' A' ' 42' ' ' GLN . 66.2 m -159.06 149.5 19.54 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 9' ' ' ILE . . . -115.07 105.55 13.08 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.667 0.27 . . . . 0.0 110.907 -176.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m -112.77 146.61 38.49 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.754 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 66.52 73.98 0.35 Allowed 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.376 1.084 . . . . 0.0 110.4 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 11' ' ' LYS . 45.8 mm -110.25 115.95 53.8 Favored Pre-proline 0 C--N 1.285 -2.221 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.818 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.96 17.97 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.239 2.626 . . . . 0.0 111.507 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.9 mmpt? 64.69 12.49 7.63 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.119 1.367 . . . . 0.0 112.999 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.73 -83.43 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 158' ' ' TYR . 29.7 mm-40 -103.77 -175.99 2.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 m -106.82 158.22 6.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 17' ' ' LEU . 19.8 t0 -83.7 105.33 14.53 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.643 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.5 mp -60.23 -2.21 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 125.46 1.504 . . . . 0.0 114.233 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.533 HD21 ' H ' ' A' ' 42' ' ' GLN . 4.0 tt -56.01 -38.76 70.94 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.1 -17.59 64.59 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.065 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.79 23.35 12.02 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.643 HG13 ' O ' ' A' ' 16' ' ' LEU . 59.5 mt -102.79 142.62 16.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.38 -48.75 78.38 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' A' ' 40' ' ' LEU . 53.3 m95 70.95 -27.84 0.18 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 t -69.45 -35.61 75.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.18 -83.51 1.1 Allowed Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.912 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG11 ' CE3' ' A' ' 22' ' ' TRP 0.337 27.6 m 43.22 103.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -176.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -112.74 136.87 51.84 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.322 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.4 t -135.76 137.42 41.63 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.127 0.489 . . . . 0.0 110.176 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.1 tp -70.3 -30.89 68.01 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.637 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.695 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 14.0 m120 -84.65 -93.57 0.08 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.777 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.503 HE22 ' HB3' ' A' ' 36' ' ' LEU . 4.0 tp-100 51.7 30.3 6.63 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 p -106.97 -75.39 0.63 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -163.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.3 p -48.83 -44.68 39.62 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -176.48 -61.92 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.48 0.657 . . . . 0.0 109.44 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.818 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 93.0 m-70 -72.42 144.0 48.31 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.941 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -107.7 164.36 12.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -169.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.503 ' HB3' HE22 ' A' ' 30' ' ' GLN . 2.8 tm? -60.07 -60.29 11.08 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.242 1.417 . . . . 0.0 113.812 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.15 -22.02 54.32 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.212 1.941 . . . . 0.0 112.965 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 50' ' ' LEU . 2.3 m-20 -59.85 -29.12 68.07 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.669 1.188 . . . . 0.0 111.422 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 154' ' ' LYS . . . -114.93 7.89 15.75 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.24 0.543 . . . . 0.0 111.415 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HB3' ' CH2' ' A' ' 22' ' ' TRP . 11.2 mp -119.49 -53.62 2.21 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -176.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -79.77 142.29 35.51 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.076 -173.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.601 ' HG3' ' HB2' ' A' ' 5' ' ' SER . 14.0 tm0? -56.78 132.9 53.57 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 124.707 1.203 . . . . 0.0 110.651 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.13 -42.65 1.9 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -88.99 -49.94 6.47 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.367 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.0 ptm180 -47.92 90.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 4.9 tp10 171.03 143.69 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 153' ' ' GLN . 33.6 t70 -74.6 131.16 40.71 Favored 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.69 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.99 -52.9 0.05 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.23 -56.41 0.01 OUTLIER Glycine 0 CA--C 1.474 -2.484 0 N-CA-C 107.091 -2.404 . . . . 0.0 107.091 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 50' ' ' LEU . 2.6 pp -80.94 135.61 35.91 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 115.163 -0.518 . . . . 0.0 110.588 174.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.818 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 34.8 p30 -161.83 169.55 21.11 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.7 tp -98.2 109.68 22.39 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 118.889 0.768 . . . . 0.0 108.989 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.04 131.01 44.01 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.069 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB3' HD12 ' A' ' 60' ' ' LEU . 57.5 p -97.04 112.41 24.19 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.178 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -102.38 -35.68 8.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.502 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.37 -48.2 82.35 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.742 0.782 . . . . 0.0 109.291 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -123.83 151.14 43.72 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -100.32 7.47 44.34 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.937 0.875 . . . . 0.0 109.221 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -105.63 128.6 53.73 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.695 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 3.5 tt -133.56 131.74 40.06 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.224 -172.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 7.0 tt -131.14 132.75 44.99 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.062 -174.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.429 HD11 HD22 ' A' ' 60' ' ' LEU . 2.6 mp -130.73 145.6 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -177.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -114.19 121.5 43.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.8 mt -113.65 121.51 37.13 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -91.38 141.93 2.85 Favored 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.265 2.643 . . . . 0.0 111.621 173.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.68 164.37 26.35 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 122.871 1.32 . . . . 0.0 113.874 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -104.82 -45.99 4.43 Favored 'General case' 0 N--CA 1.395 -3.197 0 CA-C-N 112.572 -2.104 . . . . 0.0 107.022 171.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -143.79 146.57 33.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.457 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.8 m -75.37 117.47 19.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 122.178 0.99 . . . . 0.0 111.654 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.421 HG13 ' HG ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -134.98 173.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.542 ' O ' ' HA3' ' A' ' 159' ' ' GLY . 3.7 mppt? -97.97 136.37 38.34 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.458 -1.297 . . . . 0.0 111.058 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' CD1' HD11 ' A' ' 125' ' ' LEU . 2.1 tm? -89.89 114.02 25.73 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -110.01 -37.95 5.46 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.8 m -143.62 171.23 14.46 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.207 -175.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -142.75 157.57 44.51 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.604 ' HB3' ' HE1' ' A' ' 158' ' ' TYR . . . -149.39 143.74 25.94 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.837 0.351 . . . . 0.0 110.364 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 56.1 mt -145.71 137.35 19.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HE2' ' O ' ' A' ' 119' ' ' LYS . 87.2 mttt -112.86 157.38 21.48 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.372 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.9 178.5 36.86 Favored Glycine 0 N--CA 1.41 -3.078 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' CG ' ' HB2' ' A' ' 151' ' ' LYS . 7.5 Cg_exo -75.18 160.06 39.98 Favored 'Trans proline' 0 N--CA 1.432 -2.091 0 C-N-CA 121.507 1.472 . . . . 0.0 110.032 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.51 -29.72 26.54 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 124.517 1.127 . . . . 0.0 112.065 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -93.15 -57.08 2.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 1.4 mp0 -68.44 -52.37 33.41 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 27.14 109.44 0.0 OUTLIER Glycine 0 N--CA 1.504 3.167 0 O-C-N 125.365 1.666 . . . . 0.0 116.56 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.402 ' CG ' HG22 ' A' ' 152' ' ' VAL . 26.6 Cg_exo -61.85 108.06 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.208 1.939 . . . . 0.0 110.217 -178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 38.0 ttpt -99.42 -63.86 1.09 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -167.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.9 m -78.62 94.8 5.1 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.826 0.346 . . . . 0.0 110.458 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 111' ' ' ALA . 16.7 m -100.96 137.65 27.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.927 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -128.5 141.6 51.33 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.924 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 108' ' ' SER . 82.3 m-85 -117.45 148.12 42.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.679 -175.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.484 ' HB2' ' HB ' ' A' ' 137' ' ' THR . 47.1 m-85 -114.53 126.72 55.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.724 174.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.5 t -91.79 96.51 10.46 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.186 0.517 . . . . 0.0 110.382 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 64.99 9.64 5.6 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.591 1.156 . . . . 0.0 112.824 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -88.72 139.88 30.02 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.4 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 1.7 mp0 -55.45 169.12 0.32 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.538 1.535 . . . . 0.0 112.197 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -61.7 97.41 0.08 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.748 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.416 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . 83.8 mtp -98.78 106.75 19.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.475 ' O ' HG13 ' A' ' 102' ' ' VAL . 83.2 m -75.86 -168.98 0.98 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 102' ' ' VAL . 60.5 m-85 -46.65 -44.55 18.51 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -81.24 -31.73 33.69 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.39 0.615 . . . . 0.0 111.127 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -77.96 -19.67 54.12 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.977 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 98' ' ' CYS . 34.0 m -64.27 -5.72 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -91.41 -1.28 57.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.583 0.23 . . . . 0.0 110.9 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -101.55 -31.93 10.62 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 5.9 p90 -96.22 152.64 38.94 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.203 -171.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 6.6 Cg_endo -89.09 120.14 1.04 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.031 1.821 . . . . 0.0 108.724 170.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.12 142.27 99.1 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.153 1.902 . . . . 0.0 112.46 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 90' ' ' PHE . 18.7 m -59.67 -42.41 92.8 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.465 0.65 . . . . 0.0 109.783 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -158.23 168.95 25.63 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.5 t -152.1 115.31 4.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 88' ' ' VAL . . . -133.38 161.68 33.88 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.344 -177.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.1 mp0 -114.96 128.61 56.38 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 6.2 tt -66.16 134.47 52.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.52 0.676 . . . . 0.0 111.612 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.7 t -121.15 179.32 4.43 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.32 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 40.8 mt-10 -54.74 -45.92 74.2 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.808 0.843 . . . . 0.0 112.983 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -70.88 -35.24 72.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.238 0.542 . . . . 0.0 109.682 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 76' ' ' ALA . 2.7 t-20 -65.18 -40.19 93.93 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.422 HD13 HD21 ' A' ' 113' ' ' LEU . 20.3 tp -61.02 -24.47 66.2 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.739 1.216 . . . . 0.0 111.127 -178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 115' ' ' GLU . 14.4 mmmm -79.29 -3.37 45.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.633 0.73 . . . . 0.0 109.27 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.05 17.02 52.94 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 114.971 -1.013 . . . . 0.0 114.156 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 98.8 mttt -87.9 141.15 31.33 Favored Pre-proline 0 C--N 1.295 -1.768 0 CA-C-N 116.714 0.257 . . . . 0.0 110.962 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 121' ' ' LYS . 17.1 Cg_exo -67.31 119.37 6.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.02 2.48 . . . . 0.0 112.633 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.54 134.52 41.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.55 144.1 14.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.286 0.565 . . . . 0.0 112.293 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.532 HD11 ' CD1' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -131.86 -170.82 2.47 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.121 174.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -67.92 89.49 0.28 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.43 0.633 . . . . 0.0 112.692 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -69.18 -32.15 71.27 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.895 0.878 . . . . 0.0 110.107 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.13 -27.63 36.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.896 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 6.1 tmtt? -85.16 -45.26 12.21 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -78.27 90.26 4.34 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -106.49 -39.96 5.72 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -113.02 120.28 40.82 Favored 'General case' 0 CA--C 1.481 -1.702 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.273 176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.419 HG21 ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -118.8 102.05 12.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.786 176.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -102.82 -38.95 7.2 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.683 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.9 m -152.47 154.19 35.01 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.47 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 130.39 18.83 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.9 m -106.13 131.41 53.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 69.8 mt -111.14 122.28 65.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 57.3 t80 -122.94 121.82 37.08 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.718 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.447 HG22 HG12 ' A' ' 88' ' ' VAL . 2.0 pp -115.58 129.13 72.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.4 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.4 pt-20 -106.84 -20.76 13.24 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.265 -0.574 . . . . 0.0 112.421 -177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.67 31.66 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.064 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 6.8 p30 -102.8 175.4 5.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.019 177.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.502 HE21 ' HD3' ' A' ' 86' ' ' LYS . 7.9 tp60 -45.13 -50.13 11.42 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 125.625 1.57 . . . . 0.0 111.68 -175.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -107.36 -37.77 6.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 97.48 46.83 2.27 Favored Glycine 0 C--N 1.312 -0.789 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -173.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.3 t -84.63 12.57 6.89 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.359 0.664 . . . . 0.0 112.771 -172.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 69.26 1.95 3.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.862 0.865 . . . . 0.0 112.61 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.84 134.46 13.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 83.5 m -118.47 111.44 18.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.407 ' HB2' ' CG ' ' A' ' 80' ' ' PRO . 60.1 mttp -94.4 134.88 36.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.402 HG22 ' CG ' ' A' ' 85' ' ' PRO . 49.0 t -122.27 120.93 62.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.492 ' HG3' ' HB2' ' A' ' 78' ' ' LYS . 20.6 pt20 -98.0 -13.44 21.1 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.361 178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.76 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 23.1 pttt -168.07 150.21 5.43 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.149 168.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.4 HG13 HG11 ' A' ' 152' ' ' VAL . 65.4 mt -131.05 112.84 22.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.05 137.97 52.38 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 6.1 mp -103.08 140.85 36.77 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.604 ' HE1' ' HB3' ' A' ' 76' ' ' ALA . 97.5 m-85 -125.32 139.84 53.34 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.482 0.658 . . . . 0.0 111.279 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 71' ' ' LYS . . . -173.53 -154.86 10.99 Favored Glycine 0 C--N 1.282 -2.451 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.6 p -161.43 154.52 21.03 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 119.393 -0.923 . . . . 0.0 112.905 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.42 -1.96 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.789 173.167 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.1 m -76.33 88.01 3.14 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -175.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 43' ' ' GLY . . . -150.23 79.11 1.35 Allowed 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 171.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.461 ' O ' ' HA2' ' A' ' 43' ' ' GLY . 11.6 pt-20 -158.73 171.26 20.41 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.372 -1.285 . . . . 0.0 109.765 -169.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 p -93.36 127.97 39.19 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-O 121.101 0.477 . . . . 0.0 109.879 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.14 82.41 1.89 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.531 0.681 . . . . 0.0 109.43 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.1 p -89.99 158.65 17.27 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.991 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.468 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 23.0 tp60 -128.93 86.74 2.47 Favored 'General case' 0 CA--C 1.471 -2.071 0 C-N-CA 119.513 -0.875 . . . . 0.0 108.706 -178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.525 HG13 ' H ' ' A' ' 15' ' ' ASP . 2.3 mp -82.93 114.97 56.15 Favored Pre-proline 0 C--N 1.287 -2.125 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.451 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 8' ' ' GLN . 72.9 Cg_endo -89.6 143.23 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.826 1.684 . . . . 0.0 108.864 172.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -69.8 99.29 1.34 Allowed 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.167 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.87 -48.34 0.32 Allowed Glycine 0 N--CA 1.423 -2.226 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -119.36 178.83 4.39 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.79 142.6 39.94 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' HG13 ' A' ' 9' ' ' ILE . 10.1 t0 -72.73 116.87 13.74 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 20' ' ' ILE . 52.6 mt -79.61 5.54 12.87 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 42' ' ' GLN . 4.7 tt -55.18 -38.11 67.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.919 0.866 . . . . 0.0 108.759 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.76 -17.07 54.34 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.671 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' HA ' ' ND2' ' A' ' 67' ' ' ASN . 7.7 m-85 -90.52 -4.85 56.63 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.597 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 64' ' ' ILE . 92.4 mt -86.64 138.16 19.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -91.17 101.64 14.38 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 172.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CH2' ' HA ' ' A' ' 41' ' ' LYS . 98.7 m95 -76.36 1.55 15.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -92.32 -28.31 17.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.81 4.67 56.33 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.903 -0.665 . . . . 0.0 114.274 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.6 m -61.22 136.31 24.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.182 0.515 . . . . 0.0 111.765 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 63' ' ' TYR . 9.3 tp10 -134.57 144.25 47.84 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.596 ' CB ' ' HB3' ' A' ' 30' ' ' GLN . 62.7 m -137.28 138.3 39.91 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.213 0.53 . . . . 0.0 110.857 -176.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 28' ' ' LEU . 3.1 tm? -72.19 -49.03 38.74 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.134 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -103.87 -64.32 1.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.596 ' HB3' ' CB ' ' A' ' 27' ' ' CYS . 4.3 pt20 54.79 22.9 4.46 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.463 1.505 . . . . 0.0 111.854 -175.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.616 ' HB3' ' O ' ' A' ' 34' ' ' HIS . 40.7 t 73.82 129.64 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.285 1.834 . . . . 0.0 112.47 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.2 t -72.92 -4.87 34.74 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.218 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -121.36 -68.9 0.87 Allowed 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.437 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.616 ' O ' ' HB3' ' A' ' 31' ' ' SER . 77.4 m-70 -99.95 112.37 24.65 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.421 -173.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 m -66.48 130.16 42.25 Favored 'General case' 0 C--O 1.203 -1.382 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.613 HD21 HD23 ' A' ' 40' ' ' LEU 0.258 5.5 tt -45.15 -39.59 9.28 Favored Pre-proline 0 CA--C 1.568 1.656 0 N-CA-C 118.618 2.821 . . . . 0.0 118.618 -177.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.583 ' O ' ' HB3' ' A' ' 41' ' ' LYS . 76.5 Cg_exo -53.97 -1.35 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.823 2.348 . . . . 0.0 114.895 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.534 HD22 ' HB2' ' A' ' 50' ' ' LEU . 30.8 p30 -86.24 -48.1 8.84 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.13 -14.16 15.48 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.613 HD23 HD21 ' A' ' 36' ' ' LEU . 45.4 tp -102.23 -40.33 6.83 Favored 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 118.839 -1.144 . . . . 0.0 107.957 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.583 ' HB3' ' O ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.02 97.87 6.98 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 170.248 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.628 ' HB3' HD11 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -70.22 102.6 2.14 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.308 -172.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 4' ' ' GLU . . . -165.1 -56.11 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.557 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -89.15 -9.9 49.23 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.234 0.614 . . . . 0.0 110.124 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 45' ' ' ARG . 2.4 ppt_? -52.54 130.1 30.92 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.575 -1.193 . . . . 0.0 114.122 -172.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER 174.06 139.01 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 173.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -82.83 88.38 6.78 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.55 -69.34 0.17 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -113.78 -47.18 0.63 Allowed Glycine 0 N--CA 1.434 -1.489 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.43 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.534 ' HB2' HD22 ' A' ' 38' ' ' ASN . 1.0 OUTLIER -125.61 113.75 17.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.027 0.918 . . . . 0.0 112.566 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -149.04 160.39 43.37 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 151' ' ' LYS . 3.4 tm? -90.61 120.32 31.58 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.35 -177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 150' ' ' THR . 9.9 pt-20 -141.01 119.35 12.17 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.341 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 49.6 p -35.05 -65.79 0.21 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.08 1.752 . . . . 0.0 115.549 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t70 67.16 17.66 10.36 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.701 0.762 . . . . 0.0 112.15 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.01 -62.92 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.286 0.565 . . . . 0.0 109.523 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 54' ' ' SER . 22.7 m-20 -131.36 127.91 38.57 Favored 'General case' 0 CA--C 1.48 -1.742 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.616 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER -73.47 -30.1 62.95 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 124.078 0.861 . . . . 0.0 110.341 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -74.37 115.58 14.06 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.56 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 95.0 mt -119.04 126.78 52.49 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.028 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 62' ' ' ILE . 1.4 tm? -113.0 121.69 45.38 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.448 HD12 ' C ' ' A' ' 61' ' ' LEU . 2.7 mp -127.92 142.75 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' HB2' ' HB3' ' A' ' 96' ' ' HIS . 50.5 t80 -110.45 121.81 46.2 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 123.816 0.846 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 20' ' ' ILE . 48.4 mm -120.85 121.47 28.9 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.793 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -93.52 124.82 0.53 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.476 2.117 . . . . 0.0 111.23 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -95.71 157.38 15.92 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-O 121.226 0.536 . . . . 0.0 111.217 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 19' ' ' PHE . 34.2 p30 -78.5 -23.34 46.41 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -142.92 160.73 39.78 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.659 HG23 ' H ' ' A' ' 133' ' ' VAL . 7.7 p -84.4 108.67 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 172.56 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -90.7 113.58 25.7 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.744 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 133' ' ' VAL . 98.0 mt -69.41 128.46 36.64 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 124' ' ' VAL . 44.2 t60 -118.39 -50.64 2.43 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.1 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.5 p -147.18 174.11 11.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.82 159.74 43.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.06 139.58 39.62 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.215 0.322 . . . . 0.0 110.252 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 71.6 mt -140.93 117.62 7.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -107.45 125.76 51.65 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.818 0.818 . . . . 0.0 110.318 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.98 -174.08 22.99 Favored Glycine 0 C--N 1.261 -3.621 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.48 135.47 3.07 Favored 'Trans proline' 0 N--CA 1.424 -2.604 0 CA-C-N 119.598 1.699 . . . . 0.0 108.632 172.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -58.57 -25.85 62.99 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.673 0.749 . . . . 0.0 110.798 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -49.89 -53.17 27.52 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 113.821 -1.536 . . . . 0.0 112.783 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.467 ' OE1' ' HD3' ' A' ' 151' ' ' LYS . 4.7 mp0 -103.78 -59.82 1.66 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 85' ' ' PRO . . . 27.03 128.75 0.0 OUTLIER Glycine 0 N--CA 1.511 3.647 0 C-N-CA 127.98 2.705 . . . . 0.0 118.443 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 84' ' ' GLY . 5.7 Cg_exo -75.45 114.55 4.0 Favored 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.168 1.912 . . . . 0.0 110.373 -177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 51.3 tttp -99.82 -69.84 0.75 Allowed 'General case' 0 C--O 1.214 -0.793 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -57.21 106.97 0.37 Allowed 'General case' 0 C--O 1.249 1.073 0 O-C-N 123.183 0.302 . . . . 0.0 111.314 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 86' ' ' LYS . 96.3 t -109.26 116.32 51.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 89' ' ' LYS . 4.3 ttmp? -118.83 136.46 54.0 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 123.305 0.642 . . . . 0.0 109.443 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 97.3 m-85 -121.83 166.47 14.32 Favored 'General case' 0 C--O 1.201 -1.456 0 O-C-N 122.038 -0.413 . . . . 0.0 111.927 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.426 ' HB3' ' HB ' ' A' ' 137' ' ' THR . 80.8 t80 -151.41 121.64 7.25 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.5 t -97.9 143.71 28.21 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.789 -176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER 77.73 172.34 0.2 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 125.08 1.352 . . . . 0.0 112.722 179.022 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 71.21 177.92 0.26 Allowed 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.605 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.07 155.65 21.42 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 176.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' TYR . 42.9 p-80 -51.08 124.42 11.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 80.6 mtp -98.83 116.93 32.18 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.362 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 67.6 m -72.02 158.04 36.7 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.568 ' HA ' ' CG1' ' A' ' 102' ' ' VAL . 64.6 t80 -48.9 -37.43 19.73 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.6 m -59.6 -22.56 61.98 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 120.846 0.355 . . . . 0.0 111.591 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.51 -13.06 11.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.099 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.568 ' CG1' ' HA ' ' A' ' 99' ' ' PHE . 2.7 p -67.48 -33.89 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.801 0.334 . . . . 0.0 111.214 -171.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -89.53 94.91 10.04 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.948 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -178.77 -45.39 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.19 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -98.01 149.89 36.19 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.481 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.39 126.74 19.16 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.463 2.109 . . . . 0.0 111.866 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.52 163.51 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.289 2.659 . . . . 0.0 112.398 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 129' ' ' LYS . 9.6 t -61.43 -47.68 84.63 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.53 ' OD1' ' HB2' ' A' ' 126' ' ' LYS . 20.5 m-20 -174.26 -177.6 1.3 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 128.15 2.58 . . . . 0.0 104.038 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -157.33 145.61 19.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 118.751 0.705 . . . . 0.0 110.278 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 88' ' ' VAL . . . -154.63 172.14 18.35 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -125.5 138.13 53.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 22.7 tp -61.67 143.84 55.51 Favored 'General case' 0 C--O 1.25 1.092 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.54 HG23 ' H ' ' A' ' 117' ' ' ASN . 8.0 t -134.52 165.47 25.12 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.423 ' O ' ' HD3' ' A' ' 119' ' ' LYS . 46.3 mt-10 -62.9 -28.24 69.91 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 119.089 0.859 . . . . 0.0 111.387 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' HG2' ' CB ' ' A' ' 121' ' ' LYS . 41.1 tt0 -66.34 -40.63 89.96 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.77 177.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.54 ' H ' HG23 ' A' ' 114' ' ' THR . 2.4 t-20 -67.47 -34.24 76.77 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 14.4 tp -67.31 -28.34 67.92 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.419 -1.719 . . . . 0.0 111.732 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 14.1 mptt -87.76 1.02 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.611 0.719 . . . . 0.0 110.508 176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.78 15.64 23.93 Favored Glycine 0 C--N 1.303 -1.272 0 C-N-CA 120.294 -0.955 . . . . 0.0 115.146 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.434 ' CB ' ' HG2' ' A' ' 116' ' ' GLU . 17.5 tppt? -75.08 119.11 75.38 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 117.93 0.865 . . . . 0.0 108.918 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.89 100.92 0.37 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.878 1.718 . . . . 0.0 109.663 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.32 133.35 31.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 73' ' ' HIS . 27.9 m -64.68 135.33 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.48 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 125' ' ' LEU . 2.7 mp -65.06 -67.04 0.47 Allowed 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.53 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 34.8 mmtp -171.54 -174.58 1.42 Allowed 'General case' 0 C--N 1.287 -2.143 1 N-CA-C 100.081 -4.044 . . . . 0.0 100.081 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.403 ' HA ' ' CE1' ' A' ' 130' ' ' PHE . 37.4 t80 -146.36 24.39 1.27 Allowed 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 123.186 1.469 . . . . 0.0 108.078 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.16 -40.24 9.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.658 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.9 tmtt? -116.53 -20.47 9.62 Favored 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 118.732 -1.187 . . . . 0.0 114.045 -167.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 127' ' ' TYR . 32.6 p90 -58.44 18.08 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.445 0 C-N-CA 125.209 1.404 . . . . 0.0 114.415 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.37 2.55 0.15 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -163.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -166.56 115.52 0.9 Allowed 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.659 ' H ' HG23 ' A' ' 69' ' ' VAL . 60.4 t -120.01 125.23 74.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.757 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -121.13 -61.29 1.56 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 173.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . 29.6 p -116.37 152.44 33.92 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.9 tp -136.32 122.83 20.82 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-O 121.077 0.465 . . . . 0.0 110.006 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 87.9 m -93.37 113.45 25.63 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.9 mt -104.78 116.52 48.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -115.4 108.73 16.89 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.291 0.567 . . . . 0.0 111.006 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.56 ' CG1' ' HB2' ' A' ' 60' ' ' LEU . 8.2 pt -89.46 114.07 26.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-O 121.848 0.832 . . . . 0.0 108.877 172.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.59 -40.53 16.16 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.13 -1.396 . . . . 0.0 113.028 -168.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.94 150.63 27.6 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.685 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -91.19 154.66 19.16 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.454 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.464 ' HG3' ' HD2' ' A' ' 86' ' ' LYS . 25.8 tt0 -58.44 -36.4 73.6 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 123.662 0.785 . . . . 0.0 112.295 -175.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.1 t -103.35 -7.6 20.92 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.582 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 61.72 56.41 23.07 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.9 p -87.77 -1.47 57.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.616 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 42.6 mt-10 72.19 -37.07 0.38 Allowed 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.092 0.957 . . . . 0.0 112.081 -177.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.3 t -106.09 118.24 53.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.178 0.513 . . . . 0.0 109.618 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 39.4 m -93.29 110.99 22.51 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.467 ' HD3' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -119.35 135.71 54.6 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.874 0.369 . . . . 0.0 110.392 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.1 p -142.09 148.43 20.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.04 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 74.1 mt-30 -108.99 -32.35 7.29 Favored 'General case' 0 C--O 1.21 -0.98 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -155.24 115.97 3.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.762 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.422 ' HB ' ' CD1' ' A' ' 40' ' ' LEU . 66.4 mt -122.71 127.17 74.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.43 152.67 40.99 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.29 155.56 21.9 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 15' ' ' ASP . 99.5 m-85 -124.56 130.59 52.73 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.573 0.701 . . . . 0.0 111.297 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -140.05 -171.12 12.24 Favored Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.3 m -142.57 133.88 26.21 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.395 0.617 . . . . 0.0 111.599 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.425 -1.719 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.12 174.047 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -98.27 119.33 36.75 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.328 0.585 . . . . 0.0 110.942 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.58 111.27 6.56 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.11 89.62 4.83 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.151 0.977 . . . . 0.0 112.55 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.3 m -156.43 100.76 1.99 Allowed 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 17' ' ' LEU . . . -166.12 107.9 0.73 Allowed 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 123.29 0.369 . . . . 0.0 111.944 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.1 t -157.02 111.85 2.78 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.859 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.449 ' H ' HD12 ' A' ' 9' ' ' ILE . 52.0 mt-30 -134.03 19.34 3.77 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.569 HG13 ' HB3' ' A' ' 15' ' ' ASP . 3.0 mp -76.28 123.67 87.98 Favored Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.72 -177.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.46 160.99 12.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.018 1.812 . . . . 0.0 110.705 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -71.3 107.02 4.07 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.87 -76.04 0.24 Allowed Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.996 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -106.69 168.88 8.88 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 p -105.64 125.77 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 118.453 -1.299 . . . . 0.0 109.534 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.569 ' HB3' HG13 ' A' ' 9' ' ' ILE . 34.0 t0 -72.11 130.09 40.05 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 176.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.626 ' O ' HG13 ' A' ' 20' ' ' ILE . 3.2 mm? -68.86 -1.2 6.66 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.494 ' CD1' ' HB1' ' A' ' 6' ' ' ALA . 1.6 tm? -51.24 -45.17 61.89 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.571 1.148 . . . . 0.0 109.1 174.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.42 -16.04 56.83 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.807 0.813 . . . . 0.0 110.863 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.526 ' CD1' HD12 ' A' ' 16' ' ' LEU . 11.1 t80 -92.58 -14.24 28.54 Favored 'General case' 0 N--CA 1.415 -2.195 0 C-N-CA 124.251 1.02 . . . . 0.0 112.058 -174.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 16' ' ' LEU . 96.3 mt -75.04 140.88 16.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 120.701 0.286 . . . . 0.0 111.035 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.76 -29.44 63.32 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.277 0.561 . . . . 0.0 110.527 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' H ' HG22 ' A' ' 20' ' ' ILE . 98.3 m95 71.18 -15.82 0.39 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 173.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -67.86 -25.37 65.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.481 0.658 . . . . 0.0 110.58 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.68 -81.24 1.58 Allowed Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 115.671 -0.695 . . . . 0.0 113.053 -178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.565 ' H ' ' CG ' ' A' ' 65' ' ' PRO 0.345 27.4 m 46.87 79.05 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.983 0 CA-C-O 122.476 1.131 . . . . 0.0 112.842 -174.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -112.83 148.83 34.05 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.951 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.7 t -135.93 128.85 31.27 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.12 7.91 5.58 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.684 0.754 . . . . 0.0 110.568 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 6.0 m120 -126.01 -92.16 0.51 Allowed 'General case' 0 CA--C 1.479 -1.785 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.381 176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 45.63 32.15 1.11 Allowed 'General case' 0 C--N 1.379 1.85 0 CA-C-O 122.677 1.227 . . . . 0.0 109.467 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.4 t -37.5 -63.64 0.44 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.729 2.811 . . . . 0.0 113.367 -171.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -50.04 -48.1 52.95 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.2 m 147.27 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.749 0 C-N-CA 128.127 2.571 . . . . 0.0 106.664 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.843 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 89.5 m-70 -62.14 132.66 53.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.149 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -106.77 -173.1 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.406 -0.918 . . . . 0.0 113.293 -164.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.8 tp -86.71 -46.74 0.53 Allowed Pre-proline 0 C--O 1.212 -0.895 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.09 -38.8 71.03 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.424 1.416 . . . . 0.0 111.415 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.502 ' HB2' HD13 ' A' ' 50' ' ' LEU . 2.8 p-10 -75.06 -2.0 25.44 Favored 'General case' 0 C--O 1.203 -1.365 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.618 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.19 0.14 6.43 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.249 -0.907 . . . . 0.0 111.058 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.4 tp -121.64 -30.48 4.18 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.516 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 6.0 tmtt? -82.24 143.13 31.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -68.88 149.14 49.25 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.575 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.31 -35.41 3.71 Favored Glycine 0 C--N 1.309 -0.923 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.494 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 81.4 m-85 -89.4 -28.03 20.03 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.158 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -68.85 80.86 0.29 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.868 0.366 . . . . 0.0 110.706 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -167.67 110.97 0.65 Allowed 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.005 0.922 . . . . 0.0 109.154 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.679 ' H ' ' HG3' ' A' ' 153' ' ' GLN . 20.0 t70 -71.22 116.47 11.57 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.121 0.486 . . . . 0.0 110.188 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -164.62 -63.12 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.08 -49.82 0.36 Allowed Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 38' ' ' ASN . 2.1 pp -105.95 141.42 37.38 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 120.976 0.417 . . . . 0.0 110.623 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.843 ' O ' ' HB3' ' A' ' 34' ' ' HIS . 36.5 p30 -162.28 169.63 20.33 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 tt -102.16 124.81 48.41 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 150' ' ' THR . 10.9 pt-20 -138.73 165.07 27.93 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.274 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 66.4 p -101.47 148.65 24.94 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.961 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -125.17 -68.69 0.83 Allowed 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.4 -39.71 22.3 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.612 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 54' ' ' SER . 40.6 m-20 -123.21 121.21 35.36 Favored 'General case' 0 CA--C 1.49 -1.327 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.784 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 148' ' ' GLU . 41.9 tt0 -69.58 -26.22 64.36 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.323 1.015 . . . . 0.0 108.537 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -77.82 108.22 10.89 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.81 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.568 ' HB2' ' CG1' ' A' ' 140' ' ' ILE . 96.3 mt -115.54 132.29 56.67 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.49 -172.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.5 tt -123.77 128.32 49.39 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.04 136.63 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 122.81 0.444 . . . . 0.0 110.716 -173.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -106.95 131.56 53.89 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.548 0.339 . . . . 0.0 110.887 179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.8 mm -108.38 117.08 55.42 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.022 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.565 ' CG ' ' H ' ' A' ' 25' ' ' VAL . 8.3 Cg_exo -73.34 144.58 36.97 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.608 2.205 . . . . 0.0 110.942 175.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' HE2' ' NH2' ' A' ' 134' ' ' ARG . 24.5 p90 -122.38 161.91 22.58 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -174.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -98.4 -43.34 6.95 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.328 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -153.93 178.85 9.48 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 121.825 -0.547 . . . . 0.0 111.617 -171.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.449 HG22 ' HD2' ' A' ' 134' ' ' ARG . 93.2 t -83.04 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.836 -0.166 . . . . 0.0 110.581 174.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.67 172.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 172.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.63 114.13 27.0 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.6 tp -72.75 133.8 44.69 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -111.76 -52.71 2.77 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.872 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 p -145.15 164.63 30.68 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.019 0.438 . . . . 0.0 111.946 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -135.2 153.8 51.82 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -148.64 110.09 4.43 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.219 0.533 . . . . 0.0 111.227 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.9 117.92 56.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 79' ' ' GLY . 7.8 tmtt? -116.43 141.53 48.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -173.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.575 ' N ' ' HD3' ' A' ' 78' ' ' LYS . . . -171.39 -156.35 11.72 Favored Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 174.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.473 ' HG2' ' HB2' ' A' ' 83' ' ' GLU . 78.2 Cg_endo -75.06 165.98 30.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.36 2.04 . . . . 0.0 110.902 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HA ' HD11 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -70.41 -33.64 71.59 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -93.76 -47.84 6.58 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 31.2 mt-10 -86.73 15.44 5.72 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.675 -175.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.28 148.78 19.86 Favored Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.424 ' O ' HD22 ' A' ' 113' ' ' LEU . 44.9 Cg_exo -59.01 162.86 12.63 Favored 'Trans proline' 0 C--O 1.217 -0.534 0 C-N-CA 122.614 2.21 . . . . 0.0 111.888 -178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HA ' ' HB3' ' A' ' 113' ' ' LEU . 36.3 ttpt -132.94 -73.43 0.5 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.062 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.5 m -76.68 108.67 9.85 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.806 0.336 . . . . 0.0 110.122 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.633 HG12 HG22 ' A' ' 140' ' ' ILE . 7.6 m -118.97 142.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 -177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -125.6 149.45 48.37 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -127.09 152.73 46.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.614 ' CE2' ' HB ' ' A' ' 137' ' ' THR 0.252 23.4 p90 -148.83 116.22 6.17 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.74 0.781 . . . . 0.0 111.66 173.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 135' ' ' SER . 20.6 m -103.99 149.36 25.22 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.849 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.5 m120 72.5 116.02 0.05 Allowed 'General case' 0 C--O 1.239 0.537 0 O-C-N 124.632 1.208 . . . . 0.0 109.676 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 94' ' ' LYS 0.279 0.5 OUTLIER 81.75 108.55 0.07 Allowed 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 124.4 1.08 . . . . 0.0 112.256 -175.288 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -101.51 177.19 4.99 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.931 -1.486 . . . . 0.0 111.324 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 79.01 0.76 2.41 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.368 1.067 . . . . 0.0 111.022 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.594 ' HG3' ' HB2' ' A' ' 101' ' ' ASN . 44.6 ttm -70.22 115.14 9.07 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.851 176.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 102' ' ' VAL . 68.3 m -100.33 177.11 5.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . 0.256 36.9 p90 -55.8 -29.88 60.44 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.6 p -62.46 -35.95 80.91 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.973 0.892 . . . . 0.0 109.86 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 97' ' ' MET . 2.3 m-20 -87.75 -29.09 21.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.697 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 98' ' ' CYS . 97.8 t -62.4 -29.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.294 0.569 . . . . 0.0 110.52 178.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -88.71 -10.35 48.72 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.509 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.48 -50.13 6.28 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.063 0.459 . . . . 0.0 109.792 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -96.36 143.25 25.8 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.333 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.01 143.31 78.41 Favored 'Trans proline' 0 C--O 1.249 1.048 0 C-N-CA 122.144 1.896 . . . . 0.0 111.109 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.23 178.13 7.95 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.36 2.04 . . . . 0.0 111.406 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 91' ' ' PHE . 32.1 m -78.45 -44.39 24.79 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -168.35 168.85 11.08 Favored 'General case' 0 C--O 1.256 1.395 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.6 t -144.16 138.24 28.0 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.95 159.69 39.23 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.511 ' OE2' ' HG2' ' A' ' 86' ' ' LYS . 6.2 tp10 -109.05 116.98 33.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 86' ' ' LYS . 10.3 tt -61.35 113.27 2.54 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.253 1.025 . . . . 0.0 110.174 -176.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 117' ' ' ASN . 9.6 t -85.09 157.9 20.57 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.592 -1.64 . . . . 0.0 107.566 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.88 -22.11 65.12 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.279 0.561 . . . . 0.0 111.014 -176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.411 ' HG3' ' HD2' ' A' ' 121' ' ' LYS . 6.7 tp10 -65.81 -36.55 83.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.539 HD22 HG23 ' A' ' 123' ' ' VAL . 17.3 t-20 -71.77 -42.82 66.7 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' A' ' 113' ' ' LEU . 7.7 tt -62.02 -21.31 64.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.076 -178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -82.4 -13.64 56.49 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.131 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.43 10.9 21.0 Favored Glycine 0 C--O 1.24 0.521 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.083 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HD2' ' HG3' ' A' ' 116' ' ' GLU . 99.0 mttt -94.04 135.98 24.13 Favored Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.514 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 61.4 Cg_endo -71.48 104.58 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.15 2.567 . . . . 0.0 112.353 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.539 HG23 HD22 ' A' ' 117' ' ' ASN . 66.1 t -83.33 127.26 39.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.675 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.3 m -71.29 121.66 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.568 0.699 . . . . 0.0 110.411 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.2 168.5 11.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.395 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.82 94.02 7.58 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.222 0.534 . . . . 0.0 109.911 -176.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . 0.312 26.8 p90 -88.44 67.41 8.59 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.12 -47.49 13.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.555 ' HD3' ' O ' ' A' ' 129' ' ' LYS . 10.2 tmtt? -80.27 -30.74 38.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -73.5 84.16 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.184 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -110.67 -68.18 0.95 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.405 ' HB2' HG11 ' A' ' 69' ' ' VAL . 3.1 p30 -104.5 115.79 30.97 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 172.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.1 t -100.2 103.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.763 0 C-N-CA 118.472 -1.291 . . . . 0.0 110.675 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HD2' HG22 ' A' ' 69' ' ' VAL . 28.8 mmm180 -78.37 -80.64 0.11 Allowed 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.554 170.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 92' ' ' SER . 42.6 p -105.55 149.73 26.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -131.48 129.75 41.53 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.614 ' HB ' ' CE2' ' A' ' 91' ' ' PHE . 20.8 m -130.84 144.18 51.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.4 mt -117.74 135.99 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 122.501 0.32 . . . . 0.0 110.191 -174.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 141' ' ' GLU . 83.5 t80 -123.21 112.23 17.42 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.633 HG22 HG12 ' A' ' 88' ' ' VAL . 26.1 pt -109.27 114.96 48.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 10.6 pt-20 -105.31 -9.45 17.62 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.29 166.82 29.77 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.129 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -119.18 164.57 15.39 Favored 'General case' 0 CA--C 1.496 -1.117 0 O-C-N 124.164 0.915 . . . . 0.0 109.903 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.426 ' N ' ' HB2' ' A' ' 86' ' ' LYS . 34.2 mm-40 -46.32 -61.4 1.81 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 110.374 176.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.2 t -91.24 -11.07 39.29 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.697 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.64 65.28 2.96 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.6 t -100.21 -2.35 34.15 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -172.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 58' ' ' GLU 0.286 45.0 mt-10 68.7 -27.25 0.15 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -177.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.2 p -102.22 103.44 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 25.0 m -101.19 111.27 23.44 Favored 'General case' 0 C--N 1.277 -2.576 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.504 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -104.84 132.49 51.02 Favored 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.733 -1.587 . . . . 0.0 110.485 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.99 124.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.869 -175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.679 ' HG3' ' H ' ' A' ' 47' ' ' ASP . 36.0 tt0 -97.3 -27.62 14.42 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.102 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 20.4 ttmm -160.72 129.26 4.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.6 112.11 38.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 165.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.438 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -130.87 141.84 50.34 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 156' ' ' ALA . 5.8 mp -130.69 142.67 50.44 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 79.4 m-85 -124.53 114.27 19.2 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.583 0.706 . . . . 0.0 110.959 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -109.94 -174.08 20.7 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.3 m -139.23 129.94 26.03 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--N 1.293 -1.866 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.253 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 N--CA 1.443 -0.818 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m -154.66 111.96 3.38 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.745 -0.597 . . . . 0.0 112.261 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 41' ' ' LYS . . . 42.31 72.91 0.15 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.127 1.371 . . . . 0.0 113.046 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 41' ' ' LYS . 11.3 pt-20 -149.73 18.68 0.91 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.572 -175.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.1 m -108.36 17.35 22.24 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.969 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.69 35.35 4.3 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.093 -177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -80.84 151.02 28.9 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.152 0.501 . . . . 0.0 110.932 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -105.55 100.25 9.82 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.5 mp -94.12 114.41 63.15 Favored Pre-proline 0 C--N 1.284 -2.239 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.965 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 13' ' ' GLN . 19.3 Cg_endo -93.09 -173.87 0.42 Allowed 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.513 2.142 . . . . 0.0 110.525 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -96.93 137.45 35.99 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.67 -40.22 2.6 Favored Glycine 0 C--N 1.312 -0.765 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.452 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -143.05 137.52 29.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.83 155.22 7.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 O-C-N 123.816 0.698 . . . . 0.0 110.001 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -58.95 129.53 42.6 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.092 0.957 . . . . 0.0 110.886 176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.599 ' O ' HG13 ' A' ' 20' ' ' ILE . 80.6 mt -98.19 5.89 48.03 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.001 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.527 HD22 ' HG2' ' A' ' 42' ' ' GLN . 64.9 tp -64.22 -42.22 96.67 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.797 0.808 . . . . 0.0 109.497 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -67.5 -20.03 65.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.896 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' C ' ' HB2' ' A' ' 67' ' ' ASN . 24.7 m-85 -95.17 19.87 9.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.914 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 16' ' ' LEU . 72.1 mt -108.19 127.76 64.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.985 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 -38.25 85.1 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CZ2' HD12 ' A' ' 40' ' ' LEU . 90.0 m95 76.46 -29.19 0.18 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.4 t -80.05 -36.37 35.78 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.485 0.66 . . . . 0.0 110.044 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.13 12.43 66.34 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.004 -0.617 . . . . 0.0 114.575 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 34.7 m -62.53 152.31 7.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 CA-C-N 117.504 0.652 . . . . 0.0 111.989 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.97 127.45 13.19 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 p -134.02 108.22 8.23 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.677 0.751 . . . . 0.0 109.897 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 2.9 tm? -76.5 121.49 23.19 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.624 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 46.3 t30 72.53 -55.1 0.68 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.371 1.468 . . . . 0.0 110.978 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 29' ' ' ASN . 3.2 pt20 63.2 -62.71 0.13 Allowed 'General case' 0 C--O 1.209 -1.069 0 C-N-CA 127.442 2.297 . . . . 0.0 110.0 -176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 34' ' ' HIS . 23.9 m 176.87 119.77 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 129.608 3.163 . . . . 0.0 103.109 177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.6 p -62.63 -18.39 62.16 Favored 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 117.073 -1.851 . . . . 0.0 113.124 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -111.3 -14.72 13.75 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.584 ' O ' ' HB2' ' A' ' 31' ' ' SER . 94.8 m-70 -125.43 163.62 22.23 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.914 -0.492 . . . . 0.0 110.289 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.539 ' OG ' ' HD2' ' A' ' 37' ' ' PRO . 29.5 t -114.03 171.19 7.75 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.799 -177.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -77.38 -54.6 1.44 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.941 0.897 . . . . 0.0 112.722 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD2' ' OG ' ' A' ' 35' ' ' SER . 30.8 Cg_exo -40.34 -50.31 3.68 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 123.392 2.728 . . . . 0.0 114.823 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -55.85 -45.81 78.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.76 -11.06 57.63 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.465 HD12 ' CZ2' ' A' ' 22' ' ' TRP . 1.3 tm? -104.28 -27.28 12.1 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' HD2' ' HB3' ' A' ' 4' ' ' GLU . 70.9 mmtt -78.0 120.36 22.74 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.638 ' NE2' ' HG2' ' A' ' 45' ' ' ARG . 17.9 mm-40 -75.56 92.07 2.88 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-O 121.923 0.868 . . . . 0.0 109.27 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.511 ' H ' ' HG3' ' A' ' 45' ' ' ARG . . . 170.14 -56.36 0.19 Allowed Glycine 1 N--CA 1.386 -4.66 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.46 -171.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -81.62 -29.3 33.3 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.511 0.672 . . . . 0.0 110.185 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.638 ' HG2' ' NE2' ' A' ' 42' ' ' GLN . 5.1 ppt_? -60.95 17.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -80.93 137.15 36.13 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.344 -0.848 . . . . 0.0 112.209 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 8.3 t70 -58.96 85.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.927 1.691 . . . . 0.0 112.497 -175.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER 160.61 -55.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.635 1.974 . . . . 0.0 108.097 174.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.22 -78.24 0.14 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.626 -0.716 . . . . 0.0 114.256 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 163.58 29.28 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -176.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 3.9 p-10 -161.19 166.35 27.96 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.474 HD21 HD13 ' A' ' 60' ' ' LEU . 5.4 tt -110.63 128.69 55.79 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.44 ' HG3' ' HB2' ' A' ' 55' ' ' ASP . 10.9 pt-20 -141.96 158.82 43.33 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-O 120.579 0.228 . . . . 0.0 111.435 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.2 p -79.49 79.57 5.94 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 122.187 0.994 . . . . 0.0 108.418 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 25.8 t70 -97.27 79.97 2.86 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.206 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 155.21 -57.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 127.514 2.326 . . . . 0.0 107.115 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.8 -170.3 1.63 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.493 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.13 -18.88 12.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 173.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -102.27 154.79 18.71 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.023 0.929 . . . . 0.0 109.558 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.518 ' HB2' HG13 ' A' ' 140' ' ' ILE . 78.7 mt -146.51 147.32 31.05 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . 1.2 tm? -123.21 116.92 24.18 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.0 mm -124.33 120.89 60.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -109.79 134.52 51.94 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 122.88 0.472 . . . . 0.0 110.806 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 mm -120.78 131.83 24.35 Favored Pre-proline 0 N--CA 1.437 -1.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.492 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 53.6 Cg_endo -87.84 150.7 7.25 Favored 'Trans proline' 0 CA--C 1.551 1.339 0 C-N-CA 123.49 2.793 . . . . 0.0 111.577 174.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.472 ' HD1' ' H ' ' A' ' 66' ' ' PHE . 4.7 p90 -89.6 162.99 15.35 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -173.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.577 ' HB2' ' C ' ' A' ' 19' ' ' PHE . 4.6 t-20 -101.66 -43.14 5.96 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 112.509 -2.132 . . . . 0.0 107.322 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -153.07 150.73 29.44 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.29 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.5 m -77.51 122.92 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.67 175.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.424 ' HE2' ' HG2' ' A' ' 131' ' ' GLN . 38.4 ttmt -81.04 142.47 33.33 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.562 HD13 ' N ' ' A' ' 73' ' ' HIS . 3.1 tm? -81.05 150.91 28.62 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.562 ' N ' HD13 ' A' ' 72' ' ' LEU . 3.6 t-160 -141.96 -62.61 0.45 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.878 177.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.479 ' HA ' HD22 ' A' ' 125' ' ' LEU . 12.1 p -152.65 163.22 40.07 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -172.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' PRO . 7.7 p90 -125.56 157.17 37.78 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 117' ' ' ASN . . . -148.72 107.13 3.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 117.783 0.265 . . . . 0.0 110.513 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -122.87 136.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.531 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG3' ' HE3' ' A' ' 154' ' ' LYS . 91.3 mttt -114.01 158.12 21.6 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.663 176.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 153' ' ' GLN . . . -178.91 -177.49 47.54 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.99 150.14 89.03 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.833 1.689 . . . . 0.0 109.088 172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.59 -25.5 68.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 45.4 mt-10 -87.33 -54.52 4.26 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.486 0.66 . . . . 0.0 111.26 177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.73 8.68 18.9 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.203 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.9 153.37 38.05 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.668 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.577 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 39.1 Cg_exo -60.98 147.41 95.76 Favored 'Trans proline' 0 C--O 1.207 -1.064 0 C-N-CA 122.14 1.893 . . . . 0.0 110.517 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.527 ' HB2' HE21 ' A' ' 144' ' ' GLN . 0.6 OUTLIER -130.33 -53.89 1.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 54.6 m -80.53 97.03 6.97 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.57 116.19 40.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.003 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -109.34 132.67 53.91 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -117.07 140.12 49.89 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.508 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . 88.2 t80 -130.3 129.2 42.93 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 p -113.4 145.79 40.56 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 75.82 172.56 0.25 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.523 1.529 . . . . 0.0 111.272 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt 67.51 164.97 0.22 Allowed 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.373 1.069 . . . . 0.0 111.716 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.09 164.42 26.53 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -49.39 136.02 16.71 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -173.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.489 ' HE3' ' HB3' ' A' ' 101' ' ' ASN . 86.0 mtp -110.15 127.97 55.21 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.531 ' O ' HG23 ' A' ' 102' ' ' VAL . 25.9 p -86.9 176.6 7.6 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -58.9 -29.41 67.02 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.0 m -61.93 -19.34 62.63 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.086 0.554 . . . . 0.0 111.224 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.489 ' HB3' ' HE3' ' A' ' 97' ' ' MET . 13.3 m120 -109.32 -26.74 9.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.306 0.574 . . . . 0.0 110.207 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 98' ' ' CYS . 52.4 t -58.48 -38.04 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.574 1.15 . . . . 0.0 113.838 -176.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -57.85 -14.34 5.89 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.95 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -146.61 71.19 1.23 Allowed 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.61 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 102' ' ' VAL . 3.0 p90 -128.14 153.77 78.65 Favored Pre-proline 0 C--O 1.249 1.046 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.184 167.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -75.92 118.55 5.07 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.242 1.961 . . . . 0.0 109.921 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.26 136.19 42.87 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.067 1.845 . . . . 0.0 111.875 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -69.05 -45.27 70.81 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -162.53 155.86 20.22 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.0 p -119.41 114.63 22.62 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.72 153.91 33.62 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.512 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 3.5 mp0 -114.61 126.43 54.89 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.832 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 85' ' ' PRO . 7.6 tt -73.59 113.1 10.33 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 15.2 t -103.26 175.23 5.55 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.449 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -38.22 60.98 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.023 0.529 . . . . 0.0 111.779 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.419 ' OE1' ' HD2' ' A' ' 121' ' ' LYS . 5.4 tp10 -61.33 -43.68 98.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.353 0.661 . . . . 0.0 109.894 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.55 HD22 HG23 ' A' ' 123' ' ' VAL . 13.8 t-20 -71.95 -38.37 69.79 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.442 -177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 118' ' ' LEU . 2.3 tm? -63.27 -22.93 67.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.832 1.253 . . . . 0.0 108.801 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -87.24 -0.37 56.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.428 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.67 0.24 52.73 Favored Glycine 0 CA--C 1.496 -1.103 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.419 ' HD2' ' OE1' ' A' ' 116' ' ' GLU . 98.4 mttt -86.36 142.29 35.36 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.515 ' HB3' ' CD2' ' A' ' 158' ' ' TYR . 48.6 Cg_endo -67.83 121.36 8.4 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.453 2.769 . . . . 0.0 112.401 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.55 HG23 HD22 ' A' ' 117' ' ' ASN . 76.7 t -97.35 119.96 46.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.6 p -69.57 130.5 34.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.314 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 74' ' ' SER . 0.7 OUTLIER -101.87 178.53 4.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 10.4 mptt -89.7 95.24 10.16 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -109.04 23.61 14.3 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.145 -0.934 . . . . 0.0 113.177 -173.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.6 t -53.05 -38.8 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.627 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -103.98 4.93 35.12 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.876 179.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' HE3' ' A' ' 129' ' ' LYS . 55.5 m-85 -108.23 71.89 0.82 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.932 0.873 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.424 ' HG2' ' HE2' ' A' ' 71' ' ' LYS . 46.4 mt-30 -102.49 0.24 33.37 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.444 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -142.37 114.72 8.38 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.456 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.12 107.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -74.35 -44.48 52.14 Favored 'General case' 0 C--O 1.19 -2.056 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.293 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.7 m -157.43 171.33 20.57 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.0 tp -142.56 131.64 23.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.931 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 91' ' ' PHE . 88.9 m -111.46 118.34 35.5 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 138' ' ' ILE . 3.0 mp -104.52 114.97 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -110.68 109.71 20.09 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.533 0.682 . . . . 0.0 109.973 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.518 HG13 ' HB2' ' A' ' 60' ' ' LEU . 7.2 pt -96.71 114.5 33.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.256 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.89 -48.65 5.92 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.664 -173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.92 146.2 48.93 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.664 -172.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -92.12 -179.55 5.29 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.002 0.814 . . . . 0.0 109.121 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.527 HE21 ' HB2' ' A' ' 86' ' ' LYS . 2.3 mp0 -54.72 -62.39 1.69 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 p -93.44 -36.49 12.45 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -168.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.3 46.6 1.54 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.3 m -84.68 16.63 3.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . 0.271 12.8 pt-20 63.11 -1.0 0.55 Allowed 'General case' 0 N--CA 1.51 2.541 0 C-N-CA 126.147 1.779 . . . . 0.0 114.2 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.94 122.57 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.94 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 48.7 m -93.35 128.31 39.34 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -116.35 133.49 55.96 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 79.1 t -134.02 128.48 53.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.405 ' HG2' ' HA2' ' A' ' 79' ' ' GLY . 10.0 mm-40 -88.99 -46.35 8.94 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.386 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.506 ' HE3' ' HG3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -146.02 142.94 29.11 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.396 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 64.9 mt -123.76 127.19 73.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -137.34 141.24 41.83 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.37 137.31 52.55 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 88.3 m-85 -124.39 139.11 54.21 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.235 0.541 . . . . 0.0 111.265 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -137.29 -176.18 14.25 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 46.9 m -134.04 130.16 37.12 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 117.477 0.639 . . . . 0.0 110.729 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 C--N 1.288 -2.07 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.321 176.98 . . . . . . . . 0 0 . 1 stop_ save_